Citrus Sinensis ID: 021891
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.954 | 0.592 | 0.822 | 1e-144 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.967 | 0.604 | 0.796 | 1e-138 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.849 | 0.634 | 0.706 | 1e-103 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.758 | 0.568 | 0.700 | 6e-96 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.767 | 0.573 | 0.686 | 5e-94 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.774 | 0.575 | 0.680 | 3e-93 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.852 | 0.670 | 0.615 | 5e-91 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.928 | 0.666 | 0.554 | 1e-88 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.767 | 0.551 | 0.641 | 4e-86 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.764 | 0.601 | 0.623 | 1e-84 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 510 bits (1313), Expect = e-144, Method: Compositional matrix adjust.
Identities = 251/305 (82%), Positives = 268/305 (87%), Gaps = 13/305 (4%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 193 WLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 252
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGL+FLHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLAKD P+ KTHVSTRV
Sbjct: 253 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRV 312
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL
Sbjct: 313 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 372
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
++RRFYRL+DPRLEGHFSIKGAQK QLAA CLSRDPK RP MS+VVEALKPLP+LKDMA
Sbjct: 373 DKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMA 432
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ-----RSLSIPNGSYASPYHHQFP 296
SSSYYFQTMQAER+ +NG G SRNGQ R+LS P+GS SPY HQ P
Sbjct: 433 SSSYYFQTMQAERL------KNGSGRSQGFGSRNGQHQPVFRTLSSPHGS--SPYRHQIP 484
Query: 297 HPSPK 301
P PK
Sbjct: 485 SPKPK 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-138, Method: Compositional matrix adjust.
Identities = 242/304 (79%), Positives = 265/304 (87%), Gaps = 8/304 (2%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 187 WLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 246
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRV
Sbjct: 247 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRV 306
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL
Sbjct: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 366
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
++RRFYRL+DPRLEGHFS+KGAQK QLAA CLSRD K RP MSEVVE LKPLP+LKDMA
Sbjct: 367 DKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMA 426
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSY-ASPYHHQFPH 297
S+SYYFQTMQAER+ + + +G SRNGQ R+LS P+G +SPY HQ P
Sbjct: 427 SASYYFQTMQAERLKAGSGSGSGRGFG----SRNGQPVFRTLSSPHGQAGSSPYRHQIPS 482
Query: 298 PSPK 301
P PK
Sbjct: 483 PKPK 486
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-103, Method: Compositional matrix adjust.
Identities = 185/262 (70%), Positives = 210/262 (80%), Gaps = 2/262 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMK 60
W EVNFLG L H NLVKLIGYC EDD RLLVYEFM RGSLENHLFR++ PL WS RM
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMM 176
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IALGAAKGLAFLH AERPVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD+THVSTR
Sbjct: 177 IALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 235
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WARP L
Sbjct: 236 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKL 295
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
++R+ ++IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL D
Sbjct: 296 NDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDA 355
Query: 241 ASSSYYFQTMQAERIGSSPNTR 262
A +G P+ R
Sbjct: 356 LIPCATTTAGAAFAMGGVPDYR 377
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 164/234 (70%), Positives = 198/234 (84%), Gaps = 2/234 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMK 60
W AEV FLG L H NLVKLIGYC ED+ R+L+YE+M RGS+EN+LF R L PL W+IRMK
Sbjct: 127 WLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMK 186
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IA GAAKGLAFLHE A++PVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDK+HVSTR
Sbjct: 187 IAFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTR 245
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+MGTYGYAAPEY+MTGHLT SDVYSFGVVLLE+LTGR+S+DK+RP E NL++WA P L
Sbjct: 246 IMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLL 305
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
E+++ ++DP++ + +K QKAA LA HCL+R+PKARPLM ++V++L+PL
Sbjct: 306 KEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPL 359
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 344 bits (882), Expect = 5e-94, Method: Compositional matrix adjust.
Identities = 164/239 (68%), Positives = 199/239 (83%), Gaps = 4/239 (1%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIR 58
W AEVN+LG H +LVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR L PL W +R
Sbjct: 119 WLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLR 178
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+K+ALGAAKGLAFLH R VIYRDFKTSNILLD++YNAKLSDFGLAKDGP GDK+HVS
Sbjct: 179 LKVALGAAKGLAFLHSSETR-VIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVS 237
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
TRVMGT+GYAAPEY+ TGHLT++SDVYSFGVVLLE+L+GRR++DKNRP+GE NLVEWA+P
Sbjct: 238 TRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKP 297
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 237
+L +R+ +R+ID RL+ +S++ A K A L+ CL+ + K RP MSEVV L+ + +L
Sbjct: 298 YLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSL 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 164/241 (68%), Positives = 197/241 (81%), Gaps = 4/241 (1%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIR 58
W AEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR PL W++R
Sbjct: 120 WLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLR 179
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLSDFGLAKDGP GDK+HVS
Sbjct: 180 LKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVS 238
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
TR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++DKNRP GE LVEWARP
Sbjct: 239 TRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARP 298
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238
L +R+ +R+ID RL+ +S++ A K A LA CL+ + K RP M+EVV L+ + L
Sbjct: 299 LLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLN 358
Query: 239 D 239
+
Sbjct: 359 E 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 334 bits (856), Expect = 5e-91, Method: Compositional matrix adjust.
Identities = 163/265 (61%), Positives = 203/265 (76%), Gaps = 4/265 (1%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIR 58
W AE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLENHLFRR PL W+ R
Sbjct: 119 WLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTR 178
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLSDFGLA+DGP GD +HVS
Sbjct: 179 VRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVS 237
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
TRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GRR++DKN+P GEHNLV+WARP
Sbjct: 238 TRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARP 297
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238
+L +RR R++DPRL+G +S+ A K A LA C+S D K+RP M+E+V+ ++ L K
Sbjct: 298 YLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQK 357
Query: 239 DMASSSYYFQTMQAERIGSSPNTRN 263
+ + Q I SP N
Sbjct: 358 EASKEQQNPQISIDNIINKSPQAVN 382
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 168/303 (55%), Positives = 211/303 (69%), Gaps = 19/303 (6%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMK 60
W EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLENHLFRR + PL W+IRMK
Sbjct: 134 WLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMK 193
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDFGLAK GP GDKTHVST+
Sbjct: 194 VAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQ 252
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++DK++ E +LV+WA P+L
Sbjct: 253 VMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYL 312
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
G++R+ +R++D RL G + KGA AA LA CL+ D K RP MSEV+ L L + K
Sbjct: 313 GDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK-- 370
Query: 241 ASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSP 300
+G+ + R GS+ + R SY P H P SP
Sbjct: 371 ----------PGTGVGNRQAQIDSPRGSNGSIVQKSPRRY-----SYDRPLLHITPGASP 415
Query: 301 KPN 303
P
Sbjct: 416 LPT 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 152/237 (64%), Positives = 190/237 (80%), Gaps = 2/237 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMK 60
W EVN+LG L H NLV L+GYC E + RLLVYEFMP+GSLENHLFRR + PL W+IRMK
Sbjct: 137 WLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMK 196
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
+A+GAAKGL FLHE A+ VIYRDFK +NILLDAD+NAKLSDFGLAK GP GD THVST+
Sbjct: 197 VAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTK 255
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
V+GT+GYAAPEYV TG LT++SDVYSFGVVLLE+++GRR+MD + E++LV+WA P+L
Sbjct: 256 VIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYL 315
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 237
G++R+ +R++D +L G + KGA AA LA CL+ D K RP MSEV+ L+ L ++
Sbjct: 316 GDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESV 372
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 149/239 (62%), Positives = 186/239 (77%), Gaps = 5/239 (2%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF----RRSLPLPWSI 57
W E+N+LG L H NLVKLIGYC+ED+QRLLVYEFM +GSLENHLF + PL W +
Sbjct: 112 WLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPLSWIL 171
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
R+K+AL AAKGLAFLH + + VIYRD K SNILLD+D+NAKLSDFGLA+DGP G++++V
Sbjct: 172 RIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYV 230
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
STRVMGT+GYAAPEYV TGHL +RSDVYSFGVVLLE+L GR+++D NRP E NLV+WAR
Sbjct: 231 STRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVDWAR 290
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236
P+L RR+ ++D RL + +GA + A +A CLS +PK+RP M +VV AL L +
Sbjct: 291 PYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQD 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | ||||||
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 0.996 | 0.634 | 0.932 | 1e-168 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 0.996 | 0.616 | 0.932 | 1e-167 | |
| 224100451 | 445 | predicted protein [Populus trichocarpa] | 0.986 | 0.678 | 0.937 | 1e-167 | |
| 53689728 | 603 | serine/threonine protein kinase-like [So | 0.993 | 0.504 | 0.922 | 1e-167 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.990 | 0.617 | 0.928 | 1e-167 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.990 | 0.624 | 0.928 | 1e-167 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.990 | 0.622 | 0.931 | 1e-166 | |
| 224100247 | 478 | predicted protein [Populus trichocarpa] | 0.996 | 0.638 | 0.908 | 1e-165 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.990 | 0.622 | 0.924 | 1e-165 | |
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.990 | 0.612 | 0.921 | 1e-164 |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-168, Method: Compositional matrix adjust.
Identities = 288/309 (93%), Positives = 297/309 (96%), Gaps = 4/309 (1%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRMKI
Sbjct: 173 WLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRMKI 232
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 233 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRV 292
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG
Sbjct: 293 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 352
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKDMA
Sbjct: 353 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMA 412
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYH-HQFPH 297
SSSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSIPNGS+ASPYH +Q+P+
Sbjct: 413 SSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPY 472
Query: 298 PSPKPNGKP 306
SPKPNGKP
Sbjct: 473 QSPKPNGKP 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 288/309 (93%), Positives = 297/309 (96%), Gaps = 4/309 (1%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRMKI
Sbjct: 187 WLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRMKI 246
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 247 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRV 306
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG
Sbjct: 307 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKDMA
Sbjct: 367 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMA 426
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYH-HQFPH 297
SSSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSIPNGS+ASPYH +Q+P+
Sbjct: 427 SSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPY 486
Query: 298 PSPKPNGKP 306
SPKPNGKP
Sbjct: 487 QSPKPNGKP 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100451|ref|XP_002311881.1| predicted protein [Populus trichocarpa] gi|222851701|gb|EEE89248.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1530), Expect = e-167, Method: Compositional matrix adjust.
Identities = 285/304 (93%), Positives = 294/304 (96%), Gaps = 2/304 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 142 WLAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 201
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEE ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 202 ALGAAKGLAFLHEETERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 261
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHLG
Sbjct: 262 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHLG 321
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV ALKPLPNLKDMA
Sbjct: 322 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVNALKPLPNLKDMA 381
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPS 299
S+SYYFQTMQAER+GSSPN RNG+R+Q G LSRNG QRSLSIP+GS+ASPYH+Q+PH S
Sbjct: 382 STSYYFQTMQAERVGSSPNARNGVRSQAGLLSRNGHQQRSLSIPHGSHASPYHYQYPHKS 441
Query: 300 PKPN 303
PKPN
Sbjct: 442 PKPN 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|53689728|gb|AAU89742.1| serine/threonine protein kinase-like [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1529), Expect = e-167, Method: Compositional matrix adjust.
Identities = 284/308 (92%), Positives = 297/308 (96%), Gaps = 4/308 (1%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
+WQAEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMK
Sbjct: 296 IWQAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPWSIRMK 355
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR
Sbjct: 356 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 415
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHL
Sbjct: 416 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHL 475
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
GERRRFYRL+DPRLEGHFSIKGAQKAAQLAA CLSRDPKARP+MS+VVEALKPLPNLKDM
Sbjct: 476 GERRRFYRLVDPRLEGHFSIKGAQKAAQLAARCLSRDPKARPMMSDVVEALKPLPNLKDM 535
Query: 241 ASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSYASPYHHQFPH 297
ASSSYYFQTMQA+R+GSSP+T+NG+R Q GS SRNGQ RSLSIPNGS+ASPYH QFP
Sbjct: 536 ASSSYYFQTMQADRVGSSPSTKNGVRTQ-GSFSRNGQQHPRSLSIPNGSHASPYHQQFPQ 594
Query: 298 PSPKPNGK 305
SPKPNGK
Sbjct: 595 NSPKPNGK 602
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1528), Expect = e-167, Method: Compositional matrix adjust.
Identities = 284/306 (92%), Positives = 295/306 (96%), Gaps = 3/306 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVNFLGDLVH NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKI
Sbjct: 186 WLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPWSIRMKI 245
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 246 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 305
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWARPHLG
Sbjct: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWARPHLG 365
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRLEGHFS+KGAQKAAQLAAHCLSRDPK+RPLMSEVVEALKPLP+LKDMA
Sbjct: 366 ERRRFYRLIDPRLEGHFSVKGAQKAAQLAAHCLSRDPKSRPLMSEVVEALKPLPSLKDMA 425
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPS 299
SSSYYFQ MQA+R G+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQFP PS
Sbjct: 426 SSSYYFQAMQADRFGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQFPQPS 484
Query: 300 PKPNGK 305
PKPNGK
Sbjct: 485 PKPNGK 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1527), Expect = e-167, Method: Compositional matrix adjust.
Identities = 284/306 (92%), Positives = 295/306 (96%), Gaps = 3/306 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVNFLGDLVH NLVKL+GYCIE+DQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKI
Sbjct: 180 WLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLVYEFMPRGSLENHLFRRSIPLPWSIRMKI 239
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 240 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRV 299
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWARPHLG
Sbjct: 300 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWARPHLG 359
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRLEGHFS+KGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA
Sbjct: 360 ERRRFYRLIDPRLEGHFSVKGAQKAALLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 419
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPS 299
SSSYYFQ MQA+RIG+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQFP PS
Sbjct: 420 SSSYYFQAMQADRIGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQFPQPS 478
Query: 300 PKPNGK 305
PKPNGK
Sbjct: 479 PKPNGK 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 285/306 (93%), Positives = 294/306 (96%), Gaps = 3/306 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 182 WLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRV 301
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG
Sbjct: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA
Sbjct: 362 ERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 421
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPS 299
SSSYYFQTMQA+R +SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP PS
Sbjct: 422 SSSYYFQTMQADRFSASPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFPQPS 480
Query: 300 PKPNGK 305
PKPNGK
Sbjct: 481 PKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100247|ref|XP_002311801.1| predicted protein [Populus trichocarpa] gi|222851621|gb|EEE89168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-165, Method: Compositional matrix adjust.
Identities = 279/307 (90%), Positives = 294/307 (95%), Gaps = 2/307 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 172 WLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 231
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD PEGDKTHVSTRV
Sbjct: 232 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEGDKTHVSTRV 291
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARP+LG
Sbjct: 292 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPYLG 351
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRL+GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV+ LKPLPNLKDMA
Sbjct: 352 ERRRFYRLIDPRLQGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVDTLKPLPNLKDMA 411
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPS 299
SSSYYFQTMQ +R+GSSPN +NG+R+Q G LSRNG QRS SIP+G +ASP+HHQ+PH S
Sbjct: 412 SSSYYFQTMQGDRVGSSPNAKNGVRSQAGLLSRNGHQQRSFSIPHGPHASPFHHQYPHQS 471
Query: 300 PKPNGKP 306
PKP+GKP
Sbjct: 472 PKPSGKP 478
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 283/306 (92%), Positives = 293/306 (95%), Gaps = 3/306 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 182 WLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 241
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YN+KLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 242 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSKLSDFGLAKDGPEGDKTHVSTRV 301
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG
Sbjct: 302 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 361
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFY+LIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA
Sbjct: 362 ERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 421
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPS 299
SSSYYFQTMQA+R SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP PS
Sbjct: 422 SSSYYFQTMQADRFSVSPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFPQPS 480
Query: 300 PKPNGK 305
PKPNGK
Sbjct: 481 PKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-164, Method: Compositional matrix adjust.
Identities = 282/306 (92%), Positives = 291/306 (95%), Gaps = 3/306 (0%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 190 WLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 249
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV
Sbjct: 250 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 309
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRP GEHNLVEWARPHLG
Sbjct: 310 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPIGEHNLVEWARPHLG 369
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE LKPLPNLKDMA
Sbjct: 370 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEVLKPLPNLKDMA 429
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPS 299
SSSYYFQ+MQA++I SSPN ++ R QGG L RNG QRSLSIPNGS+ASPYHHQ+P S
Sbjct: 430 SSSYYFQSMQADKIASSPNAKSSNRTQGG-LLRNGQQQRSLSIPNGSHASPYHHQYPFQS 488
Query: 300 PKPNGK 305
PKPNGK
Sbjct: 489 PKPNGK 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.950 | 0.590 | 0.826 | 1e-130 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.967 | 0.604 | 0.802 | 2.2e-128 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.964 | 0.651 | 0.768 | 7.2e-123 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.758 | 0.565 | 0.769 | 6.1e-94 | |
| TAIR|locus:2161093 | 408 | AT5G56460 [Arabidopsis thalian | 0.781 | 0.585 | 0.684 | 5.3e-88 | |
| TAIR|locus:2064712 | 462 | RIPK "RPM1-induced protein kin | 0.970 | 0.642 | 0.614 | 8.6e-88 | |
| TAIR|locus:2200863 | 424 | AT1G61590 [Arabidopsis thalian | 0.882 | 0.636 | 0.613 | 5.4e-86 | |
| TAIR|locus:2060167 | 442 | AT2G07180 [Arabidopsis thalian | 0.888 | 0.615 | 0.636 | 8.9e-86 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.774 | 0.560 | 0.680 | 2.4e-85 | |
| TAIR|locus:2057770 | 424 | ARSK1 "root-specific kinase 1" | 0.758 | 0.547 | 0.696 | 1.2e-83 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 253/306 (82%), Positives = 271/306 (88%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 193 WLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 252
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGL+FLHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLAKD P+ KTHVSTRV
Sbjct: 253 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRV 312
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL
Sbjct: 313 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 372
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
++RRFYRL+DPRLEGHFSIKGAQK QLAA CLSRDPK RP MS+VVEALKPLP+LKDMA
Sbjct: 373 DKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMA 432
Query: 242 SSSYYFQTMQAERIGSSPNTRNGI-RAQGGSLSRNGQ-----RSLSIPNGSYASPYHHQF 295
SSSYYFQTMQAER+ +NG R+QG SRNGQ R+LS P+GS SPY HQ
Sbjct: 433 SSSYYFQTMQAERL------KNGSGRSQGFG-SRNGQHQPVFRTLSSPHGS--SPYRHQI 483
Query: 296 PHPSPK 301
P P PK
Sbjct: 484 PSPKPK 489
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 2.2e-128, P = 2.2e-128
Identities = 244/304 (80%), Positives = 267/304 (87%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI
Sbjct: 187 WLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 246
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRV
Sbjct: 247 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRV 306
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL
Sbjct: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 366
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
++RRFYRL+DPRLEGHFS+KGAQK QLAA CLSRD K RP MSEVVE LKPLP+LKDMA
Sbjct: 367 DKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMA 426
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSY-ASPYHHQFPH 297
S+SYYFQTMQAER+ + + +G R G SRNGQ R+LS P+G +SPY HQ P
Sbjct: 427 SASYYFQTMQAERLKAGSGSGSG-RGFG---SRNGQPVFRTLSSPHGQAGSSPYRHQIPS 482
Query: 298 PSPK 301
P PK
Sbjct: 483 PKPK 486
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
Identities = 236/307 (76%), Positives = 265/307 (86%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
W AE+NFLG+LVH +LVKL+GYC+E+DQRLLVYEFMPRGSLENHLFRR+LPLPWS+RMKI
Sbjct: 154 WLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRRTLPLPWSVRMKI 213
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
ALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ K+HVSTRV
Sbjct: 214 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRV 273
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
MGTYGYAAPEYVMTGHLT++SDVYSFGVVLLE+LTGRRS+DK+RPNGE NLVEW RPHL
Sbjct: 274 MGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRPHLL 333
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 241
+++RFYRL+DPRLEGH+SIKGAQKA Q+AA CL+RD KARP MSEVVEALKPLPNLKD A
Sbjct: 334 DKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKDFA 393
Query: 242 SSSYYFQTMQAERIGSSPNTRNGIRAQGGS-LSRNG--QRSLSIPNGSYASPYHHQFPHP 298
SSS FQTMQ P +NG+R QGG +SRNG RSLS N ASPY ++
Sbjct: 394 SSSSSFQTMQ-------PVAKNGVRTQGGGFVSRNGPPMRSLSSLNLPQASPY--RYARQ 444
Query: 299 SPKPNGK 305
SPKP GK
Sbjct: 445 SPKPKGK 451
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 180/234 (76%), Positives = 203/234 (86%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMK 60
W EVNFLG L H NLVKLIGYC EDD RLLVYEFM RGSLENHLFR++ PL WS RM
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMM 176
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IALGAAKGLAFLH AERPVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD+THVSTR
Sbjct: 177 IALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 235
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WARP L
Sbjct: 236 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKL 295
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
++R+ ++IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL
Sbjct: 296 NDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 879 (314.5 bits), Expect = 5.3e-88, P = 5.3e-88
Identities = 165/241 (68%), Positives = 201/241 (83%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMK 60
W AEV FLG L H NLVKLIGYC ED+ R+L+YE+M RGS+EN+LF R L PL W+IRMK
Sbjct: 127 WLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMK 186
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IA GAAKGLAFLHE A++PVIYRDFKTSNILLD DYNAKLSDFGLAKDGP GDK+HVSTR
Sbjct: 187 IAFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTR 245
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+MGTYGYAAPEY+MTGHLT SDVYSFGVVLLE+LTGR+S+DK+RP E NL++WA P L
Sbjct: 246 IMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLL 305
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
E+++ ++DP++ + +K QKAA LA HCL+R+PKARPLM ++V++L+PL ++
Sbjct: 306 KEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEE 365
Query: 241 A 241
A
Sbjct: 366 A 366
|
|
| TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 8.6e-88, P = 8.6e-88
Identities = 185/301 (61%), Positives = 212/301 (70%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMK 60
W EV FLG L H NLVKLIGYC E++ R LVYEFMPRGSLEN LFRR S LPWS RMK
Sbjct: 135 WLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSASLPWSTRMK 194
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IA GAA GL FLHE AE PVIYRDFK SNILLD+DY AKLSDFGLAKDGPEGD THVSTR
Sbjct: 195 IAHGAATGLQFLHE-AENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTR 253
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGT GYAAPEY+MTGHLT+RSDVYSFGVVLLE+LTGRRS+DK R + E NLV+WARP L
Sbjct: 254 VMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSREQNLVDWARPML 313
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
+ R+ R++DPRLEG +S GA+KAA LA CLS PK RP MS VV L L + D+
Sbjct: 314 NDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILNDLKDYNDI 373
Query: 241 ASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSP 300
++ + T+ + R G + + S + Q+ S S SP P P+
Sbjct: 374 PMGTFTY-TVPNTPDNKEDDGRVGNKPRKSSHHHHHQQQQSNHPRSSPSPTTKS-PSPTA 431
Query: 301 K 301
K
Sbjct: 432 K 432
|
|
| TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
Identities = 170/277 (61%), Positives = 214/277 (77%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMK 60
W +EV FLG L H NLVKLIGYC E+++R+L+YEFMPRGSLENHLFRR SL LPW+ R+K
Sbjct: 147 WLSEVIFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLENHLFRRISLSLPWATRLK 206
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IA+ AAKGLAFLH+ E P+IYRDFKTSNILLD+D+ AKLSDFGLAK GPEG K+HV+TR
Sbjct: 207 IAVAAAKGLAFLHD-LESPIIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSKSHVTTR 265
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGTYGYAAPEYV TGHLT++SDVYS+GVVLLE+LTGRR+ +K+RP + N+++W++P+L
Sbjct: 266 VMGTYGYAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEKSRPKNQQNIIDWSKPYL 325
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
RR ++DPRL G +S+K A+ A LA C+S +PK RP M VVEAL+ L + KDM
Sbjct: 326 TSSRRLRCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPKMLAVVEALESLIHYKDM 385
Query: 241 ASSSYYFQTMQAERIGS-SPNTR----NGIRAQGGSL 272
A SS ++ + G SP R +G ++ GSL
Sbjct: 386 AVSSGHWPLSPKSQGGKVSPKVRGDHRSGRKSAPGSL 422
|
|
| TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 177/278 (63%), Positives = 199/278 (71%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMK 60
W AEVN+LG L H NLVKLIGYC EDD RLLVYE+M GSLE HLFRR L W+ RMK
Sbjct: 138 WLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAMGSLEKHLFRRVGCTLTWTKRMK 197
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IAL AAKGLAFLH AER +IYRD KT+NILLD YNAKLSDFGLAKDGP GD+THVSTR
Sbjct: 198 IALDAAKGLAFLHG-AERSIIYRDLKTANILLDEGYNAKLSDFGLAKDGPRGDQTHVSTR 256
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGTYGYAAPEYVMTGHLTSRSDVY FGV+LLEML G+R+MDK+R EHNLVEWARP L
Sbjct: 257 VMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKRAMDKSRACREHNLVEWARPLL 316
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
++ R+IDPR++G + K K A LA CLS++PK RPLM+ VVE L+ LKD
Sbjct: 317 NHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPKGRPLMNHVVEVLE---TLKDD 373
Query: 241 ASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQR 278
+ T R G S G+ NGQR
Sbjct: 374 GDAQEEVMTNLHSR-GKSVTLYEASSDSQGTRDGNGQR 410
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 164/241 (68%), Positives = 197/241 (81%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIR 58
W AEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFRR PL W++R
Sbjct: 131 WLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLR 190
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLSDFGLAKDGP GDK+HVS
Sbjct: 191 LKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVS 249
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
TR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++DKNRP GE LVEWARP
Sbjct: 250 TRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARP 309
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238
L +R+ +R+ID RL+ +S++ A K A LA CL+ + K RP M+EVV L+ + L
Sbjct: 310 LLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLN 369
Query: 239 D 239
+
Sbjct: 370 E 370
|
|
| TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
Identities = 163/234 (69%), Positives = 192/234 (82%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMK 60
W AE+ FLG L + +LVKLIG+C E++QR+LVYE+MPRGSLEN LFRR SL + W IRMK
Sbjct: 136 WLAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMPRGSLENQLFRRNSLAMAWGIRMK 195
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IALGAAKGLAFLHE AE+PVIYRDFKTSNILLD+DYNAKLSDFGLAKDGPEG+ THV+TR
Sbjct: 196 IALGAAKGLAFLHE-AEKPVIYRDFKTSNILLDSDYNAKLSDFGLAKDGPEGEHTHVTTR 254
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
VMGT GYAAPEY+MTGHLT+ +DVYSFGVVLLE++TG+RSMD R E +LVEWARP L
Sbjct: 255 VMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGKRSMDNTRTRREQSLVEWARPML 314
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
++R+ R+IDPRL + AQ AA LA CLS+ PK RP M EVV+ L+ +
Sbjct: 315 RDQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHPKYRPTMCEVVKVLESI 368
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8229 | 0.9542 | 0.5922 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00028989001 | SubName- Full=Chromosome chr1 scaffold_46, whole genome shotgun sequence; (481 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 306 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-45
Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 56/229 (24%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L L H N+VKL G +++ LV E+ GSL++ L L ++I L
Sbjct: 41 EIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQ 100
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+GL +LH +I+RD K NILLD+D KL+DFGL+K ++G
Sbjct: 101 ILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVG 155
Query: 124 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
T Y APE ++ G+ + +SD++S GV+L E+
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------- 187
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
+ L L +DP+ RP E++E L
Sbjct: 188 ---------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 70/233 (30%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
+ E + L H N+VKL+G C E++ +V E+M G L ++L + L S +
Sbjct: 47 EFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLS 106
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
AL A+G+ +L + I+RD N L+ + K+SDFGL++D + D
Sbjct: 107 FALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG 163
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ APE + G TS+SDV+SFGV+L E+ T P + E +L
Sbjct: 164 -KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYL 216
Query: 181 --GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
G R P L L C + DP+ RP SE+VE L
Sbjct: 217 KNGYRLPQPPNCPPEL------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-41
Identities = 75/229 (32%), Positives = 109/229 (47%), Gaps = 22/229 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E+ L L H N+V+LI + D LV E+ G L R PL KIAL
Sbjct: 47 REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIAL 105
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+GL +LH +I+RD K NILLD + K++DFGLAK + ++T V G
Sbjct: 106 QILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-G 160
Query: 124 TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
T Y APE ++ G + DV+S GV+L E+LTG+ L +
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQ 207
Query: 183 RRRFYRLIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ R++ P LE G+++A L CL++DP RP E+++
Sbjct: 208 LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-40
Identities = 73/234 (31%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM 59
+ E + L H N+VKL+G C E++ ++V E+MP G L ++L R L S +
Sbjct: 47 EFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLL 106
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
AL A+G+ +L + I+RD N L+ + K+SDFGL++D + D V
Sbjct: 107 SFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG 163
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
+ APE + G TS+SDV+SFGV+L E+ T P + E +
Sbjct: 164 G-KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEY 216
Query: 180 L--GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
L G R P L +L C + DP+ RP SE+VE L
Sbjct: 217 LKKGYRLPKPPNCPPEL------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-39
Identities = 72/233 (30%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + + L H N+V+L+G C + + +V E+MP G L + L + L +++AL
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST----- 119
AKG+ +L + ++RD N L+ + K+SDFGL++D E D
Sbjct: 111 IAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 120 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ M APE + G TS+SDV+SFGV+L E+ T P + E
Sbjct: 168 IKWM------APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLE 215
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
L + YRL PR E + +L C + DP+ RP SE+VE L
Sbjct: 216 LLEDG---YRL--PRPEN-----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 74/247 (29%), Positives = 109/247 (44%), Gaps = 47/247 (19%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPW 55
E + L H N+V+L+G C E++ LV E+M G L ++L + L
Sbjct: 45 KEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSL 104
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
+ A+ AKG+ +L + ++RD N L+ D K+SDFGL++D + D
Sbjct: 105 KDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY 161
Query: 116 HVST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 169
T R M APE + G TS+SDV+SFGV+L E+ T G
Sbjct: 162 RKKTGGKLPIRWM------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGA 205
Query: 170 ---HNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
L E +L R+ YRL P + + +L C DP+ RP S
Sbjct: 206 TPYPGLSNEEVLEYL---RKGYRLPKPE---YCP----DELYELMLSCWQLDPEDRPTFS 255
Query: 226 EVVEALK 232
E+VE L+
Sbjct: 256 ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIAL 63
E+ L L H N+V+L ++D+ LV E+ G L + L R L R
Sbjct: 47 EIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLR 104
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
L +LH + +++RD K NILLD D + KL+DFGLA+ G+K T V G
Sbjct: 105 QILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-G 158
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGE 182
T Y APE ++ D++S GV+L E+LTG+ P G+ L+E +
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKP 212
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ F P E S +A L L +DP+ R E ++
Sbjct: 213 KPPF-----PPPEWDIS----PEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRM 59
+ E+ L L H N+V+ G ++++ L ++ E++ GSL + L ++ LP IR
Sbjct: 47 EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR- 104
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
K +GLA+LH +++RD K +NIL+D+D KL+DFG AK + + +
Sbjct: 105 KYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
V GT + APE + +D++S G ++EM TG+ P E A
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYK 215
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
+G P + H S ++A CL RDPK RP
Sbjct: 216 IG-----SSGEPPEIPEHLS----EEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 6/156 (3%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L H N+VK G ++ D+ +V EF GSL++ L + L S +
Sbjct: 45 INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVC 104
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
KGL +LH +I+RD K +NILL +D KL DFGL+ + + ++
Sbjct: 105 KELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMV 158
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
GT + APE + ++D++S G+ +E+ G+
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 59/159 (37%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM-- 59
E N L + H +VKL Y + +++L LV E+ P G L +HL + +
Sbjct: 42 TERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA 100
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+I L L +LH +IYRD K NILLDAD + KL+DFGLAK+ + +T
Sbjct: 101 EIVLA----LEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
GT Y APE ++ D +S GV+L EMLTG+
Sbjct: 153 FC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 77/236 (32%), Positives = 114/236 (48%), Gaps = 27/236 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ +G L H N+VKLIG C + L++E++ +L L L W R KIA+G
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIG 788
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
AK L FLH V+ + I++D L L+ G T+ +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----LCTDTKCFIS 841
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWAR-----P 178
Y APE T +T +SD+Y FG++L+E+LTG+ D G H ++VEWAR
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVEWARYCYSDC 899
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALK 232
HL IDP + G S+ + + LA HC + DP ARP ++V++ L+
Sbjct: 900 HLD------MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
++ E+ L L H N+VK G C + R L+ E++P GSL ++L R + +
Sbjct: 53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL 112
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+ KG+ +L + I+RD NIL++++ K+SDFGLAK PE +
Sbjct: 113 LFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169
Query: 120 --RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ Y APE + T +S SDV+SFGV L E+ T
Sbjct: 170 EPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (256), Expect = 4e-25
Identities = 77/278 (27%), Positives = 115/278 (41%), Gaps = 20/278 (7%)
Query: 3 QAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRM 59
E+ L L H N+VKL + ++ LV E++ GSLE+ L R PL S +
Sbjct: 45 LREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL 104
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAK----DGPEGDK 114
I L +LH + +I+RD K NILLD D KL DFGLAK G
Sbjct: 105 FILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161
Query: 115 THVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 171
+ + +GT GY APE ++ + +S SD++S G+ L E+LTG + + + +
Sbjct: 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221
Query: 172 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-A 230
+ P S + A+ L L++DPK R S +
Sbjct: 222 QT-LKIILELPTPSLASPLSPSNPELIS----KAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 231 LKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQ 268
L LK+ S A S P + + +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISS 314
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 58/158 (36%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
E++ L +L H N+VK IG IE L ++ E+ GSL + ++ P P S+
Sbjct: 47 MQEIDLLKNLKHPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVY 104
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+GLA+LHE+ VI+RD K +NIL D KL+DFG+A + K V
Sbjct: 105 VYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASV 159
Query: 122 MGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGR 158
+GT + APE + M+G T+ SD++S G ++E+LTG
Sbjct: 160 VGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-23
Identities = 52/160 (32%), Positives = 89/160 (55%), Gaps = 16/160 (10%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIA 62
AE + + L H NLV+L+G ++ + +V E+M +GSL ++L R + + ++ A
Sbjct: 49 AEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFA 108
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHVST 119
L +G+ +L E+ ++RD N+L+ D AK+SDFGLAK+ G + K V
Sbjct: 109 LDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK- 164
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158
+ APE + +++SDV+SFG++L E+ + GR
Sbjct: 165 -------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73
H N+VKLIG C++ +V E +P GSL L ++ L ++++L AA G+ +L
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 133
+ I+RD N L+ + K+SDFG++++ G T + APE +
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 134 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 193
G TS SDV+S+G++L E + + N + R + YR+ P+
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPAPQ 218
Query: 194 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
L + +L C + DP+ RP SE+ L+
Sbjct: 219 LCPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-23
Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q EV+ L L H+N+V+ +G C++D+ + EF+P GS+ + L R PLP + K
Sbjct: 50 QEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYT 108
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVS 118
G+A+LH V++RD K +N++L + KL DFG A+ G G +++
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEW 175
+ GT + APE + +SD++S G + EM TG+ SMD+
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---------- 215
Query: 176 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
A ++G R PRL FS A CL+RD RP
Sbjct: 216 AMFYIGAHRGLM----PRLPDSFS----AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-22
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRM 59
E L L +++ ++ + +V E+ G L L +R PLP W +
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+I LG LA LH + +++RD K+ N+ LDA N K+ D G+AK D T+ +
Sbjct: 109 QILLG----LAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFAN 159
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
++GT Y +PE +SDV++ GVVL E TG+ D N + L+
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI------ 210
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
+ R + P + +S Q+ AQL CL++D + RP
Sbjct: 211 ----LKIIRGVFPPVSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL---- 51
++ E L + H N+VK G C E D ++V+E+M G L L
Sbjct: 55 FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 52 ---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108
L S ++IA+ A G+ +L A + ++RD T N L+ D K+ DFG+++D
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171
Query: 109 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
D V M + PE +M T+ SDV+SFGVVL E+ T
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 22/151 (14%)
Query: 16 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------GTYGY 127
+I+RD K SNIL+++ KL DFG VS +++ GT Y
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE + + +SD++S G+ L+E+ TGR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 8e-22
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 26/230 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + L H NLV+L G C + +V E+M G L N+L R L + +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRV 121
+ + +L I+RD N L+ D K+SDFGLA+ D D+ S
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGT 161
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+A PE +S+SDV+SFGV++ E+ + + + N E +VE G
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG 217
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
YRL P+L + + C P+ RP +++ L
Sbjct: 218 -----YRLYRPKL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-22
Identities = 72/244 (29%), Positives = 112/244 (45%), Gaps = 22/244 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
W+ E+N L L H N+VK G C E + L+ E++P GSL ++L + L L + +
Sbjct: 53 WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLL 110
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VS 118
A +G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + + V
Sbjct: 111 LFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 167
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ A E + + SDV+SFGV L E+LT ++ P ++ +
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQG 226
Query: 179 HLGERR------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
+ R R RL P+ Q+ L +C + K RP ++ LK
Sbjct: 227 QMTVVRLIELLERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
Query: 233 PLPN 236
+ +
Sbjct: 280 EMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-21
Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + L H LV+L G C E LV+EFM G L ++L + + + L
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+G+A+L VI+RD N L+ + K+SDFG+ + + D+ ST
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFP 164
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 184
+++PE +S+SDV+SFGV++ E+ + ++ +NR N E +VE
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TIN 215
Query: 185 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
+RL PRL +Q +L HC P+ RP S ++ L
Sbjct: 216 AGFRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 42/235 (17%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---K 60
E+ L L H N+V+ +G E+D + E +P GSL L ++ P IR+ +
Sbjct: 52 EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQ 110
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
I LG L +LH+ R ++RD K +NIL+D + KL+DFG+AK V
Sbjct: 111 ILLG----LEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEF 155
Query: 121 VM-----GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
G+ + APE + G +D++S G +LEM TG+ P + V
Sbjct: 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA 209
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
A +G + P + H S +A CL RDP RP +E++E
Sbjct: 210 -AVFKIGRSKEL-----PPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 16 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH-- 116
Query: 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEY 132
+R +I+RD K SN+L+++ K++DFG++K + + T V GT Y +PE
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPER 171
Query: 133 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID- 191
+ + +D++S G+ LLE G+ F+ L+
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELMQA 214
Query: 192 ------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 222
P L FS + + CL +DPK RP
Sbjct: 215 ICDGPPPSLPAEEFS----PEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 63
E + L H NL++L G + ++V E P GSL + L + +L S A+
Sbjct: 46 EAAIMHSLDHENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV 104
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST---R 120
A G+ +L + I+RD NILL +D K+ DFGL + P+ + +V +
Sbjct: 105 QIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
V + + APE + T + SDV+ FGV L EM T
Sbjct: 162 V--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-20
Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+E+ L DL HLN+V+ +G+ ++ + E++P GS+ + R +
Sbjct: 57 SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTE 115
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+GLA+LH + +++RD K N+L+DAD K+SDFG++K + + + G
Sbjct: 116 QVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 124 TYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+ + APE + + +++ D++S G V+LEM GR RP + + A LG
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFKLG 225
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+R P + S+ + A C + +P RP E+++
Sbjct: 226 NKRS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-20
Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 50
++ E + DL H N+V L+G C ++ +++E++ G L L R S
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 51 ----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 106
L S + IA+ A G+ +L + ++RD N L+ K+SDFGL+
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 107 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154
+D D V ++ + + PE ++ G T+ SD++SFGVVL E+
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-20
Identities = 67/234 (28%), Positives = 94/234 (40%), Gaps = 37/234 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L L H NLVK G + ++ + E+ G+LE L L + L
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQ 107
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV--- 121
+GLA+LH +++RD K +NI LD + KL DFG A T + V
Sbjct: 108 LLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSL 163
Query: 122 MGTYGYAAPEYVMTGHLTSR---SDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEW 175
GT Y APE + G +D++S G V+LEM TG+R +D E+
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EF 213
Query: 176 A---RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226
G + + EG + CL DPK RP SE
Sbjct: 214 QIMFHVGAGHKPPIPDSLQLSPEGKDFLD----------RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-20
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSI 57
+Q EV L L H +L+ L C + ++ E M +GSL L + LP+ I
Sbjct: 48 DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI 107
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
M A A+G+A+L E + I+RD NIL+ D K++DFGLA+ E
Sbjct: 108 DM--ACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
++ Y + APE G +++SDV+SFG++L EM T
Sbjct: 163 DKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 9e-20
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 53/242 (21%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP---- 54
EV L L H N++K E+ +L V E+ G L + ++ P P
Sbjct: 47 LNEVKILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105
Query: 55 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 114
+++ L L +LH R +++RD K NI L ++ KL DFG++K
Sbjct: 106 LDWFVQLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTV 157
Query: 115 THVSTRVMGTYGYAAPE------YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 168
T V GT Y +PE Y +SD++S G VL E+ T + +
Sbjct: 158 DLAKTVV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
Query: 169 EHNLVEWARPHLGERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
L +++ P + +S + L + L +DP+ RP ++
Sbjct: 211 ---L-------------ALKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIA 250
Query: 226 EV 227
++
Sbjct: 251 QI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 40/233 (17%)
Query: 16 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 66
++V+L+G L+V E M +G L+++L L P + ++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
G+A+L A + ++RD N ++ D K+ DFG+ +D E D + +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 127 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----E 182
+ APE + G T++SDV+SFGVVL EM T L E +P+ G E
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQGLSNEE 229
Query: 183 RRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233
+F +ID GH K +L C +PK RP E+V +LK
Sbjct: 230 VLKF--VID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-19
Identities = 48/149 (32%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 12 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGL 69
V + + Y E L LV M G L+ H++ P P + + A GL
Sbjct: 49 KVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL 108
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 129
LH+ R ++YRD K N+LLD N ++SD GLA + G K GT GY A
Sbjct: 109 EHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMA 162
Query: 130 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
PE + D ++ G L EM+ GR
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRM 59
E+ +VK G +++ + E+ GSL++ + +R + +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVS 118
KIA KGL++LH R +I+RD K SNILL KL DFG++ + T
Sbjct: 109 KIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
GT Y APE + + SDV+S G+ LLE+ R P GE L
Sbjct: 165 ----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELL 217
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
L D E IK +++ CL +DP RP
Sbjct: 218 SYIVNMPNPELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKI 61
EV + H N+VK + D+ LV ++ GSL + + S P L +I +
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATV 107
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHV 117
KGL +LH + I+RD K NILL D + K++DFG LA G V
Sbjct: 108 LKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGG--DRTRKV 162
Query: 118 STRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 175
+GT + APE VM ++D++SFG+ +E+ TG K P L
Sbjct: 163 RKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221
Query: 176 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKARPLMSEVVE 229
P P LE K K+ ++ + CL +DP RP E+++
Sbjct: 222 NDP-------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLP 54
EV L L N+ +L+G C D ++ E+M G L L + S L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 55 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 114
+S + +A A G+ +L ++RD T N L+ +Y K++DFG++++ D
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
V R + A E V+ G T++SDV++FGV L E+LT
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-18
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 26/165 (15%)
Query: 14 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 71
H ++KL Y +D++ L V E+ P G L ++ SL R A L +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE-ILLALEY 117
Query: 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------- 122
LH + +I+RD K NILLD D + K++DFG AK +
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 123 ---------GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
GT Y +PE + SD+++ G ++ +MLTG+
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-18
Identities = 71/230 (30%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 60
E + L H LV+L C E++ +V E+M +GSL + L + L LP + M
Sbjct: 50 QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM- 108
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGD 113
A A+G+A+L R I+RD NIL+ + K++DFGLA+ EG
Sbjct: 109 -AAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 172
K + + APE G T +SDV+SFG++L E++T R P G N
Sbjct: 165 KFPIK--------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN- 210
Query: 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
R L + R YR+ PR ++ L C +DP+ RP
Sbjct: 211 ----REVLEQVERGYRM--PRPPNC-----PEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-18
Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--- 61
E+ + L + N+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 62 --------ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
A+ A G+ +L A ++RD T N L+ Y K++DFG++++ GD
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ R + + A E ++ G T+ SDV++FGV L EM T
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 6e-18
Identities = 50/155 (32%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E++ L +L H N+VKL+ + + LV+E+ L+ +L +R PL ++ I
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+GLA+ H +++RD K NIL++ D KL+DFGLA+ +T+ + V+ T
Sbjct: 107 LLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-T 161
Query: 125 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
Y APE ++ S + D++S G + EM+TG+
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-18
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 24/176 (13%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 50
+Q E + + H N+VKL+G C L++E+M G L L RS
Sbjct: 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 51 ----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 100
LPL + ++ IA A G+A+L +ER ++RD T N L+ + K+
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKI 171
Query: 101 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+DFGL+++ D S + PE + T+ SDV+++GVVL E+ +
Sbjct: 172 ADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-18
Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 9/162 (5%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E L +L H LV L Y +D++ + LV + + G L HL ++ ++ I
Sbjct: 50 ERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC- 107
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
L +LH + +I+RD K NILLD + ++DF +A T T G
Sbjct: 108 EIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSG 161
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 165
T GY APE + + D +S GV E L G+R +
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL------------- 51
EV L L N+++L+G C+++D ++ E+M G L L L
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 52 --PLP---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 106
LP +S + +AL A G+ +L + ++RD T N L+ + K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 107 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 166
++ GD + R + + A E ++ G T+ SDV++FGV L E+L + K +P
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQP 241
Query: 167 NGE---HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223
GE ++E A ++ R L P Q +L C SRD + RP
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPS 294
Query: 224 MSEV 227
S++
Sbjct: 295 FSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-18
Identities = 55/163 (33%), Positives = 88/163 (53%), Gaps = 13/163 (7%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIA 62
E + L H NLV+L+G I + +V E M +G+L N L R L I++ + +
Sbjct: 48 EETAVMTKLHHKNLVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS 106
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRV 121
L A+G+ +L + +++RD NIL+ D AK+SDFGLA+ G G D + + +
Sbjct: 107 LDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK- 162
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 163
+ APE + +S+SDV+S+GV+L E+ + GR K
Sbjct: 163 -----WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 50/141 (35%), Positives = 74/141 (52%), Gaps = 17/141 (12%)
Query: 24 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIALGAAKGLAFLHEEAERP 79
C + RL V E++ G L H+ R P + +I LG L FLHE R
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHE---RG 116
Query: 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHL 138
+IYRD K N+LLD++ + K++DFG+ K+G G T + GT Y APE +++
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPE-ILSYQP 172
Query: 139 TSRS-DVYSFGVVLLEMLTGR 158
+ D ++ GV+L EML G+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-18
Identities = 54/171 (31%), Positives = 81/171 (47%), Gaps = 20/171 (11%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------- 52
+Q E L +L H ++VK G C + D ++V+E+M G L N R P
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQ 112
Query: 53 -------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 105
L S + IA A G+ +L A + ++RD T N L+ A+ K+ DFG+
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM 169
Query: 106 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
++D D V M + PE +M T+ SDV+SFGV+L E+ T
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 9e-18
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ + D H N+V + D+ +V E+M GSL + + + + + +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+GL +LH + VI+RD K+ NILL D + KL+DFG A + S V+GT
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179
Query: 125 YGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 157
+ APE V+ + D++S G++ +EM G
Sbjct: 180 PYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + +G H N+++L G + +++ E+M GSL+ L + +
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR 113
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 121
G A G+ +L +E ++RD NIL++++ K+SDFGL++ + E T ++
Sbjct: 114 GIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ APE + TS SDV+SFG+V+ E+++
Sbjct: 171 --PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 60/183 (32%), Positives = 83/183 (45%), Gaps = 20/183 (10%)
Query: 3 QAEVNFL------GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--- 53
Q E +FL H N+V+LIG E R ++ E M G L++ L R + P
Sbjct: 51 QDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPER 109
Query: 54 PWSIRMK----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLA 106
P S+ MK A AKG +L E I+RD N LL AK++DFG+A
Sbjct: 110 PSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMA 166
Query: 107 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 166
+D R M + PE + G TS++DV+SFGV+L E+ + R
Sbjct: 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
Query: 167 NGE 169
N E
Sbjct: 227 NQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 44/168 (26%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAK 67
H ++V+L+G C+ Q L+ + MP G L +++ L W +++ AK
Sbjct: 68 HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
G+++L E + +++RD N+L+ + K++DFGLAK +K + + +
Sbjct: 121 GMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 174
A E ++ T +SDV+S+GV + E++T G + + +L+E
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 19/170 (11%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------- 52
+Q E L L H ++V+ G C E L+V+E+M G L N R P
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGE 112
Query: 53 ------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 106
L + IA A G+ +L A ++RD T N L+ K+ DFG++
Sbjct: 113 DVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
Query: 107 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+D D V R M + PE ++ T+ SD++SFGVVL E+ T
Sbjct: 170 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 53/156 (33%), Positives = 84/156 (53%), Gaps = 8/156 (5%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L +L H N+VK G C ED L+ EF+P GSL+ +L R + ++K A
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 120
+ KG+ +L R ++RD N+L+++++ K+ DFGL K E DK + + +
Sbjct: 116 VQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDD 171
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + APE ++ SDV+SFGV L E+LT
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E+ L +L H +V+ G C+ DD+ L ++ E+MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 121
+G+ +LH +++RD K +NIL D+ N KL DFG +K T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167
Query: 122 MGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLT 156
GT + +PE V++G R +DV+S G ++EMLT
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 34/235 (14%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKI 61
AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+L + + +L ++RD N+L+ D AK+SDFGL K E T + ++
Sbjct: 108 SLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL 161
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+ APE + +++SDV+SFG++L E+ + R V + R L
Sbjct: 162 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLK 206
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAA----QLAAHCLSRDPKARPLMSEVVEALK 232
+ + PR+E + + + C D RP ++ E L+
Sbjct: 207 D-------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------------ 52
E L +L H ++VK G C+E D ++V+E+M G L N R P
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPA 115
Query: 53 -LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111
L S + IA A G+ +L A + ++RD T N L+ + K+ DFG+++D
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 172
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
D V M + PE +M T+ SDV+S GVVL E+ T
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-17
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 4/148 (2%)
Query: 9 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 68
+G L H +V+L+G C LV + P GSL +H+ + L + + AKG
Sbjct: 63 MGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128
+ +L E +++R+ NILL +D +++DFG+A DK + + +
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 129 APEYVMTGHLTSRSDVYSFGVVLLEMLT 156
A E ++ G T +SDV+S+GV + EM++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-17
Identities = 48/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ + L H ++++++G ED L E+M GS+ +HL + ++ +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQ 111
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG----LAKDGPEGDKTHVST 119
+GL++LH E +I+RD K +N+L+D+ +++DFG LA G +
Sbjct: 112 LLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQG 166
Query: 120 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
+++GT + APE V+ G RS DV+S G V++EM T +
Sbjct: 167 QLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 56/157 (35%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 24 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 77
C + + RL V EF+ G L H+ R R LP +S + +AL FLHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHE--- 114
Query: 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTG 136
R +IYRD K N+LLDA+ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 137 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 171
D ++ GV++ EM+ GR D N + N
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 24 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82
C + RL LV E++ G L H+ +R LP A L FLHE R +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119
Query: 83 RDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 141
RD K N+LLDAD + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFS 176
Query: 142 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 201
D ++ GV++ EM+ GR D N + N ++ + E+ R+ S+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPRFLSV- 228
Query: 202 GAQKAAQLAAHCLSRDPKAR 221
KA+ + L++DPK R
Sbjct: 229 ---KASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP--- 54
+EVN L +L H N+V+ I+ + L V E+ G L L ++ +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEF 106
Query: 55 -WSIRMKIALGAAKGLAFLH--EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111
W I ++ L L H + V++RD K +NI LDA+ N KL DFGLAK
Sbjct: 107 IWRILTQLLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
Query: 112 GD---KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
KT+V GT Y +PE + +SD++S G ++ E+
Sbjct: 163 DSSFAKTYV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 44/143 (30%), Positives = 81/143 (56%), Gaps = 9/143 (6%)
Query: 17 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76
+V G + ++ + EFM GSL+ ++++ P+P I KIA+ +GL +L+
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT 135
+++RD K SNIL+++ KL DFG++ G+ + ++ +GT Y +PE +
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQG 176
Query: 136 GHLTSRSDVYSFGVVLLEMLTGR 158
G T +SDV+S G+ ++E+ G+
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 11 DLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAK 67
D H N++ L+G C+ + L+V +M G L N F RS +++ I G AK
Sbjct: 52 DFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAK 109
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTY 125
G+ +L A + ++RD N +LD + K++DFGLA+D E H T
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 126 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ A E + T T++SDV+SFGV+L E++T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L +L H N++KL+ LV+EFM L + R LP S+
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRV 121
+GLAF H +++RD K N+L++ + KL+DFGLA+ P TH V TR
Sbjct: 107 LLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR- 162
Query: 122 MGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ ++ D++S G + E+L+ R
Sbjct: 163 ----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 55/163 (33%), Positives = 79/163 (48%), Gaps = 27/163 (16%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM-- 59
E L + H LV L G +DD L LV E++P G L +HL + P P + R
Sbjct: 50 NEKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYA 107
Query: 60 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
++ L L +LH ++YRD K N+LLD+D K++DFG AK V
Sbjct: 108 AQVVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVK 152
Query: 119 TRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 157
R GT Y APE ++ G+ D ++ G+++ EML G
Sbjct: 153 GRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-16
Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWS 56
E + + + H N+VKL+G C+ ++ + ++ E M G L ++L F L L
Sbjct: 48 KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLK 106
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGPE 111
+ I L AKG +L + I+RD N L+ DAD K+ DFGLA+D +
Sbjct: 107 ELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK 163
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
D + + APE ++ G T++SDV+SFGV++ E+LT
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-16
Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPW 55
Q E L L H N+++ +ED ++V E+ P G+L N L L +
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDK 114
+++ +A LH + +++RD KT NILLD K+ DFG++K K
Sbjct: 107 FVQILLA---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSK 155
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162
+ T V+GT Y +PE +SD+++ G VL E+ + +R+ +
Sbjct: 156 SKAYT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-16
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 36/238 (15%)
Query: 11 DLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRM 59
D H N++KLIG C E +++ FM G L + L L LP +
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTH 116
K + A G+ +L + R I+RD N +L D ++DFGL+K GD +
Sbjct: 117 KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 176
++ + + A E + TS+SDV++FGV + E+ T R H + ++
Sbjct: 174 IAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL 228
Query: 177 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
R RL P + L C DPK RP +++ E L+ +
Sbjct: 229 -------RHGNRLKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 44/124 (35%), Positives = 73/124 (58%), Gaps = 7/124 (5%)
Query: 35 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 94
E M GSL+ L +++ +P +I KI++ +GL +L E+ +++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS 135
Query: 95 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154
KL DFG++ G D ++ +GT Y +PE + H T +SD++S G+ L+EM
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 155 LTGR 158
GR
Sbjct: 192 AIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 57/155 (36%), Positives = 84/155 (54%), Gaps = 10/155 (6%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + L ++ H +VKL Y + + +L L+ +F+ G L L + + ++ +A
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA- 105
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
A L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S G
Sbjct: 106 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 160
Query: 124 TYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTG 157
T Y APE V GH S +D +SFGV++ EMLTG
Sbjct: 161 TVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 73/229 (31%), Positives = 106/229 (46%), Gaps = 44/229 (19%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WS 56
+AE N L + H +V LI Y + +L L+ E++ G L HL R + + +
Sbjct: 48 KAERNILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL 106
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKT 115
+ +AL LH++ +IYRD K NILLDA + KL+DFGL K+ EG T
Sbjct: 107 SEISLALE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157
Query: 116 HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
H GT Y APE +M +GH D +S G ++ +MLTG
Sbjct: 158 HT---FCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG----------------- 196
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKAR 221
A P E R+ + ID L+G ++ +A L L R+P +R
Sbjct: 197 -APPFTAENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 48/180 (26%), Positives = 74/180 (41%), Gaps = 23/180 (12%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
M Q E ++ KL D LV E++ G + L + LP +
Sbjct: 51 MIQGESPYV--------AKLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQ 101
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
G+ LH+ R +I+RD K N+L+D + KL+DFGL+++G + +
Sbjct: 102 YIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKK 152
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 175
+GT Y APE ++ SD +S G V+ E L G P N + W
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
++ E+ L L H N+VK G C +R LV E++P GSL ++L + L +
Sbjct: 52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL 111
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
A KG+ +L + ++RD T NIL++++ K+ DFGL K P+ DK +
Sbjct: 112 LYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKV 167
Query: 120 RVMG---TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
R G + Y APE + + SDV+SFGVVL E+ T
Sbjct: 168 REPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 39/238 (16%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKI 61
E+ L L H N++ + ++D+ L+ E+ G+L + + R+ +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ +A ++++H+ +++RD KT NI L KL DFG++K G + ++ V
Sbjct: 109 QIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETV 161
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------EW 175
+GT Y +PE +SD+++ G VL E+LT +R+ D P NLV +
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQGNY 218
Query: 176 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233
P + + + + L L +DP+ RP EV++
Sbjct: 219 T---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR- 58
E+ L L H N+V+L + +V+E+M G L++ + + I+
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKC 104
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
MK L +GL +LH +++RD K SNIL++ D KL+DFGLA+ +
Sbjct: 105 YMKQLL---EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSAD 157
Query: 118 STRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
T + T Y PE ++ D++S G +L E+ G+
Sbjct: 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 54/147 (36%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 16 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75
+VK GY I D + E M L+ L R P+P I K+ + K L +L E+
Sbjct: 75 YIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 135
VI+RD K SNILLDA N KL DFG++ + K TR G Y APE +
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAK--TRSAGCAAYMAPERIDP 188
Query: 136 GHLTS----RSDVYSFGVVLLEMLTGR 158
R+DV+S G+ L+E+ TG+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 22/229 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+E L H N+VKLIG C + +V E +P G + L ++ L +K AL
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL 100
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
AA G+A+L + I+RD N L+ + K+SDFG+++ E D + S+ +
Sbjct: 101 DAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQ 155
Query: 124 T-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
+ APE + G +S SDV+S+G++L E S+ G N + AR +
Sbjct: 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV-- 207
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
+ YR+ P+ K ++ C P+ RP SE+ + L
Sbjct: 208 -EKGYRMSCPQ-------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 41/98 (41%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 124
A GL FLH + +IYRD K N++LDA+ + K++DFG+ K+ G KT TR GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGT 164
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162
Y APE + D ++FGV+L EML G+ D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRMKI 61
E+ L + H N++ ++ ++ +V E+ P G L + +R +P +I
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ +GL LHE + +++RD K++NILL A+ K+ D G++K K +++
Sbjct: 109 FIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQ 161
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+GT Y APE + +SD++S G +L EM T + AR
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQD 208
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227
R + R P + +S Q L PK RP ++
Sbjct: 209 LRYKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 53/158 (33%), Positives = 84/158 (53%), Gaps = 14/158 (8%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + + L H +V+LIG C + +LV E P G L +L +R +P S ++A
Sbjct: 45 REASVMAQLDHPCIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAH 102
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
A G+A+L E++ V +RD N+LL + AK+SDFG+++ G + +T
Sbjct: 103 QVAMGMAYL--ESKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT---- 155
Query: 124 TYG-----YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
T G + APE + G +S+SDV+S+GV L E +
Sbjct: 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 20/227 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + L H LV+L G C + +V EFM G L N+L +R L + + +
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+G+ +L + I+RD N L+ + K+SDFG+ + + D+ S+
Sbjct: 109 VCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFP 164
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 184
++ PE +S+SDV+SFGV++ E+ T + + + N E +VE
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVE-------MIS 215
Query: 185 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
R +RL P+L + + C P+ RP +E++ A+
Sbjct: 216 RGFRLYRPKLASMTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E++ L + H N+V L +++ ++ EF G+L++ + L +
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMG 123
+ L FLH VI+RD K NILL D + KL+DFG+ AK+ K +G
Sbjct: 112 MLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIG 165
Query: 124 TYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEMLTGR 158
T + APE V ++D++S G+ L+E+
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 58/175 (33%), Positives = 77/175 (44%), Gaps = 45/175 (25%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGLA 70
+VKL Y +D++ L LV E+MP G L N L R+ + + R + +AL + L
Sbjct: 63 IVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--------------- 115
F+H RD K NIL+DAD + KL+DFGL K +
Sbjct: 122 FIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 116 -------HVSTRVM-----GTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTG 157
H RV GT Y APE V+ G D +S GV+L EML G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 61/247 (24%), Positives = 90/247 (36%), Gaps = 40/247 (16%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIAL 63
EV L L H N+V L + LV+E++ R LE LP P ++R
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIW 107
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+ +A+ H +I+RD K NIL+ KL DFG A+ + ++ V
Sbjct: 108 QLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-A 163
Query: 124 TYGYAAPE----YVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSMDK 163
T Y APE G DV++ G ++ E+L G + +
Sbjct: 164 TRWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220
Query: 164 NRPNGEHNLVEWARPHLGERRRFYRLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPK 219
P H + + P +P LE + K + A CL DPK
Sbjct: 221 LPP--SHQELFSSNPRF----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPK 274
Query: 220 ARPLMSE 226
R E
Sbjct: 275 ERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-15
Identities = 65/231 (28%), Positives = 99/231 (42%), Gaps = 44/231 (19%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMK 60
AE N + L H LV+L + + ++ E+M GSL + L L + I M
Sbjct: 50 AEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM- 107
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGD 113
A A+G+AF+ + I+RD + +NIL+ K++DFGLA+ EG
Sbjct: 108 -AAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HN 171
K + + APE + G T +SDV+SFG++L E++T R N E N
Sbjct: 164 KFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215
Query: 172 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
L R YR+ P ++ +L C P+ RP
Sbjct: 216 L-----------ERGYRMPRPD-------NCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 53/148 (35%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 14 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-ALGAAKGLAF 71
H LV L C + + + V E+ G L H+ P R A GL +
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAACVVLGLQY 116
Query: 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVSTRVMGTYGYAAP 130
LHE ++YRD K N+LLD + K++DFGL K+G GD+T ST GT + AP
Sbjct: 117 LHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAP 170
Query: 131 EYVMTGHLTSRS-DVYSFGVVLLEMLTG 157
E V+T +R+ D + GV++ EML G
Sbjct: 171 E-VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-15
Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L +L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFV 112
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 120
KGL +LH R +I+RD K +NIL+D K+SDFG++K E + T
Sbjct: 113 RQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGA 168
Query: 121 ---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
+ G+ + APE V T ++D++S G +++EMLTG+
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
GL FLH+ + +IYRD K N+LLD D + K++DFG+ K+ G+ ++ GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE + D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 24/166 (14%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 60
AE + L H L++L C ++ +V E M GSL +L R+L LP I M
Sbjct: 50 AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM- 108
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGD 113
A A G+A+L + I+RD N+L+ + K++DFGLA+ + EG
Sbjct: 109 -AAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158
K + + APE + + +SDV+SFG++L E++T GR
Sbjct: 165 KFPIK--------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 26/176 (14%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---------------FR 48
+E N L + H +++KL G C +D LL+ E+ GSL + L R
Sbjct: 52 SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111
Query: 49 RSLPL------PWSIRMKI--ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 100
S L ++ I A ++G+ +L AE +++RD N+L+ K+
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKI 168
Query: 101 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
SDFGL++D E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------- 54
E+ + L N+++L+ CI D ++ E+M G L L R
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 55 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 114
+S + +A A G+ +L + ++RD T N L+ +Y K++DFG++++ GD
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ R + + + E ++ G T+ SDV++FGV L E+LT
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 32/207 (15%)
Query: 24 CIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 77
C + + RL V E++ G L H+ R R LP +S + +AL +LHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE--- 114
Query: 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG 136
R +IYRD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 137 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 194
D ++ GV++ EM+ GR D + N + N ++ + E++ R+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRI 224
Query: 195 EGHFSIKGAQKAAQLAAHCLSRDPKAR 221
S+ KAA + L++DPK R
Sbjct: 225 PRSLSV----KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 8/160 (5%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
E+ L H +VKL+ +LV E+MP L L PLP +
Sbjct: 45 QALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS 103
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
KG+A++H +++RD K +N+L+ AD K++DFGLA+ E + S +
Sbjct: 104 YMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160
Query: 121 VMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
V T Y APE ++ G D+++ G + E+L G
Sbjct: 161 V-ATRWYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 16 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 64
++V+L+G + L++ E M RG L+++L RSL P +++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 128 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 33/232 (14%)
Query: 4 AEVNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----W 55
+EV + + L H N+V+ +E+D+ +V + + P G N L + W
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
+I +++ L L +LH+E + +++RD +NI+L D ++DFGLAK K
Sbjct: 117 NIFVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL 170
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 175
T V+GT Y+ PE V ++DV++FG +L +M T P N++
Sbjct: 171 ---TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSL 221
Query: 176 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227
A + + +P EG +S + + CL+ D +ARP + +V
Sbjct: 222 A------TKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-- 62
EV + D H N+V++ + D+ +V EF+ G+L + + + +IA
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIATV 120
Query: 63 -LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHV 117
L K L+FLH + VI+RD K+ +ILL +D KLSDFG ++K+ P
Sbjct: 121 CLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR------ 171
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
++GT + APE + + D++S G++++EM+ G P
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----------- 220
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
L +R + P+L+ K + + L RDP R +E++
Sbjct: 221 --LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81
Y + D +L L+ +++ G L HL++R +R+ IA L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGII 127
Query: 82 YRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMT---G 136
YRD K NILLD++ + L+DFGL+K+ E ++ + GT Y APE + G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGG 184
Query: 137 HLTSRSDVYSFGVVLLEMLTG 157
H D +S GV+ E+LTG
Sbjct: 185 H-DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSIRMKI----- 61
H N++ L+G C ++ +V E+ G+L + L R S P +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 62 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
A A+G+ FL A + I+RD N+L+ D+ K++DFGLA+D D +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
T + APE + T +SDV+SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 46/160 (28%), Positives = 85/160 (53%), Gaps = 9/160 (5%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+E + +G H N+++L G + +++ E+M G+L+ +L + +
Sbjct: 55 SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR 114
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 120
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PEG T +
Sbjct: 115 GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK 171
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ + APE + TS SDV+SFG+V+ E+++ G R
Sbjct: 172 I--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 42/198 (21%)
Query: 45 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 104
++ + L +P I KIA+ K L +LH + VI+RD K SN+L++ + KL DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 105 --------LAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLL 152
+AK G K Y APE + +SDV+S G+ ++
Sbjct: 150 ISGYLVDSVAKTIDAGCKP-----------YMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLAA 211
E+ TGR D W P + ++ P+L FS +
Sbjct: 199 ELATGRFPYDS-----------WKTP-FQQLKQVVEEPSPQLPAEKFSP----EFQDFVN 242
Query: 212 HCLSRDPKARPLMSEVVE 229
CL ++ K RP E+++
Sbjct: 243 KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 52/154 (33%), Positives = 73/154 (47%), Gaps = 20/154 (12%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
GL LH+E ++YRD K NILLD + ++SD GLA PEG + RV GT GY
Sbjct: 114 GLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGY 167
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 187
APE V T D ++ G +L EM+ G+ + + + VE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------- 214
Query: 188 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221
RL+ ++ +S K + A L L +DPK R
Sbjct: 215 RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 13 VHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---G 68
V+ V + Y E D LV M G L+ H++ ++ P + AA+ G
Sbjct: 57 VNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAAEILCG 114
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128
L LH E +YRD K NILLD + ++SD GLA PEG+ + RV GT GY
Sbjct: 115 LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYM 168
Query: 129 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 188
APE + T D + G ++ EM+ G+ P G + + R
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRKEKVKR 210
Query: 189 -LIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 221
+D R+ E +S K +++A + L++DPK R
Sbjct: 211 EEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128
L FLH VIYRD K NILLDA+ + KL+DFG+ K+G T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 129 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE + D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFL 72
H N+V L+G C L++ E+ G L N L R R L + + AKG+AFL
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYGYAA 129
A + I+RD N+LL K+ DFGLA+D D +V + R+ + A
Sbjct: 158 ---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKWMA 211
Query: 130 PEYVMTGHLTSRSDVYSFGVVLLEMLT 156
PE + T SDV+S+G++L E+ +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
E + L +VKL Y + + L LV E++P G L L L +
Sbjct: 41 LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIY 98
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS--- 118
L +LH +I+RD K NIL+D++ + KL+DFGL+K G + +++
Sbjct: 99 IAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 119 ---TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 157
R++GT Y APE V+ G S++ D +S G +L E L G
Sbjct: 156 KEDKRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-14
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKI 61
E + L H LV+L + ++ +V E+M +GSL + L R+L LP + M
Sbjct: 51 EAQIMKKLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM-- 107
Query: 62 ALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
A A G+A++ ER I+RD +++NIL+ K++DFGLA+ + + T R
Sbjct: 108 AAQVAAGMAYI----ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---AR 160
Query: 121 VMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ + APE + G T +SDV+SFG++L E++T R N R
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------RE 211
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
L + R YR+ P+ +L C +DP+ RP
Sbjct: 212 VLEQVERGYRMPCPQ-------DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-14
Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+E + +G H N++ L G + +++ EFM G+L++ L + + +
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR 113
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
G A G+ +L +E ++RD NIL++++ K+SDFGL++ + T +G
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 124 ---TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH 179
+ APE + TS SDV+S+G+V+ E+++ G R N +E
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----- 225
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
+ YRL P + QL C +D ARP ++V L +
Sbjct: 226 -----QDYRLPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-14
Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE ++ + D +SFGV+L EML G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-14
Identities = 37/90 (41%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128
+LH R +IYRD K N+LLD++ KL DFG AK G KT GT Y
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYV 159
Query: 129 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE ++ D +S G++L E+LTGR
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 31/236 (13%)
Query: 3 QAEVNFLGDLVHLNLVKLI--GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
+ E L H N+V L+ G V+E++P +L L LP +
Sbjct: 26 RRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADG-ALPAGETGR 83
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGP---EGDK 114
+ L LA H + +++RD K NI++ +AK+ DFG+ P + D
Sbjct: 84 LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 115 THVS--TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 172
++ T V+GT Y APE + +T SD+Y++G++ LE LTG+R + G ++
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ-----GA-SV 194
Query: 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228
E L + P + GH Q+ L++DP+ R + +
Sbjct: 195 AEILYQQLSPVD---VSLPPWIAGH-------PLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 50
+Q E + + +L H N+V L+G ++ +++E++ +G L L RS
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 51 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 105
L + IA+ A G+ +L + +++D NIL+ + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 106 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+++ D V + + + PE +M G +S SD++SFGVVL E+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKI 61
E + ++ H NLV+L+G C + ++ EFM G+L ++L R + + + +
Sbjct: 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYM 109
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDK 114
A + + +L ++ I+RD N L+ ++ K++DFGL++ G K
Sbjct: 110 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + APE + + +SDV++FGV+L E+ T
Sbjct: 167 FPIK--------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 28/228 (12%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + L H LV+L G C + +V E+M G L N+L S +++
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+G+A+L + I+RD N L+D K+SDFGL++ D + S+ +G+
Sbjct: 109 VCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGS 161
Query: 125 ---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 180
++ PE ++ +S+SDV++FGV++ E+ + G+ ++ N E VE +
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KV 214
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228
+ R YR P L ++K + C + RP +++
Sbjct: 215 SQGLRLYR---PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-13
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 24/236 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q E+ L + K G ++D + ++ E++ GS + L PL + I
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATIL 107
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
KGL +LH E + I+RD K +N+LL KL+DFG+A G D +
Sbjct: 108 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV 162
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
GT + APE + S++D++S G+ +E+ G + P L+ P
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---- 218
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238
P LEG++S + + CL+++P RP E+++ + K
Sbjct: 219 ---------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
GL FLH + +IYRD K N++LD D + K++DFG+ K+ GD ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE + T D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 45/231 (19%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q E+ FL + K G ++ + ++ E+ GS + L + L + I
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFIL 104
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 120
GL +LHEE I+RD K +NILL + + KL+DFG++ G T ++
Sbjct: 105 REVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRN 156
Query: 121 -VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARP 178
+GT + APE + ++D++S G+ +E+ G P + H +
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG------EPPLSDLHPM------ 204
Query: 179 HLGERRRFYRLID----PRLEGH-FS--IKGAQKAAQLAAHCLSRDPKARP 222
R LI P LEG+ FS K + CL++DPK RP
Sbjct: 205 ------RVLFLIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIR 58
H N++ L+G C +D ++ E+ +G+L +L R P L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+ A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
T + APE + T +SDV+SFGV+L E+ T
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 44/156 (28%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+E + +G H N++ L G + ++V E+M GSL+ L + + +
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTR 120
G A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T +
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + APE + TS SDV+S+G+V+ E+++
Sbjct: 171 I--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-13
Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 7/158 (4%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
AE LG H N+V+L G + ++V E+M G+L++ L + L M +
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHVSTRVM 122
G A G+ +L +E +++ +L+++D K+S F L +D E T +S +
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ AAPE + H +S SDV+SFG+V+ E+++ G R
Sbjct: 172 VLW--AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 46/243 (18%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 57
E++ L L H N++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
+++ L +H + +++RD K +N+ + A KL D GL + KT
Sbjct: 112 FVQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ ++GT Y +PE + +SD++S G +L EM
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204
Query: 178 PHLGERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
P G++ Y L P H+S ++ L + C++ DP+ RP +S V++
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYS----EELRDLVSRCINPDPEKRPDISYVLQ 260
Query: 230 ALK 232
K
Sbjct: 261 VAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 45/142 (31%), Positives = 65/142 (45%), Gaps = 12/142 (8%)
Query: 21 IGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEA 76
+ Y E L LV M G L+ H++ R L + I + G+ LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGILHLHSMD 115
Query: 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 136
++YRD K N+LLD N +LSD GLA + +G T+ GT GY APE +
Sbjct: 116 ---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEE 169
Query: 137 HLTSRSDVYSFGVVLLEMLTGR 158
+ D ++ G + EM+ GR
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--MKI 61
E+ L +L H N++ L+ LV+EFM LE + +S+ L P I+ M +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VS 118
L +GL +LH +++RD K +N+L+ +D KL+DFGLA+ P TH V
Sbjct: 111 TL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 119 TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
TR Y APE + H D++S G + E+L
Sbjct: 165 TRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 23/162 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKI 61
E N + L H LV+L +++ ++ E+M +GSL + L + LP I
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDK 114
+ A+G+A++ + I+RD + +N+L+ K++DFGLA+ EG K
Sbjct: 111 QI--AEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + APE + G T +SDV+SFG++L E++T
Sbjct: 166 FPIK--------WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 60/158 (37%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 4 AEVN-FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 60
AE N L ++ H LV L Y + +L V +++ G L HL R RS P P R +
Sbjct: 44 AERNVLLKNVKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RAR 99
Query: 61 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
A A L +LH +IYRD K NILLD+ + L+DFGL K+G E KT ++
Sbjct: 100 FYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TS 154
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
GT Y APE + D + G VL EML G
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 64/229 (27%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 3 QAEVNFLGDLVHL---NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR 58
Q EV L L N+ K G RL ++ E+ GS+ R+L I
Sbjct: 47 QREVALLSQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIA 99
Query: 59 MK----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 114
K I L ++H+ VI+RD K +NIL+ N KL DFG+A +
Sbjct: 100 EKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156
Query: 115 THVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 173
ST V GT + APE + G +++D++S G+ + EM TG L+
Sbjct: 157 KR-STFV-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214
Query: 174 EWARPHLGERRRFYRLIDPRLEG-HFSIKGAQKAAQLAAHCLSRDPKAR 221
++P PRLE +S + + A CL +PK R
Sbjct: 215 PKSKP-------------PRLEDNGYS----KLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 13 VHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---G 68
V+ V + Y E D LV M G L+ H++ ++ P + AA+ G
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAAELCCG 114
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128
L L E ++YRD K NILLD + ++SD GLA PEG+ V RV GT GY
Sbjct: 115 LEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYM 168
Query: 129 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 188
APE + T D + G ++ EM+ G+ K + V+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE----------- 212
Query: 189 LIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 221
+D R+ + +S K ++ A + L+++PK R
Sbjct: 213 -VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-13
Identities = 50/145 (34%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 14 HLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 72
H L +L C + RL V EF+ G L H+ ++S + A L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 132
H+ + +IYRD K N+LLD + + KL+DFG+ K+G KT ++ GT Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEI 167
Query: 133 VMTGHLTSRSDVYSFGVVLLEMLTG 157
+ D ++ GV+L EML G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-13
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 66
L H N+++ +G CIE LLV EF P G L+N+L + + ++A A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVA 110
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
GL +LH+ I+ D N L AD + K+ D+GLA + D
Sbjct: 111 SGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 127 YAAPEYV-------MTGHLTSRSDVYSFGVVLLEMLT 156
+ APE V + T +S+++S GV + E+ T
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-13
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E++ L +VK G ++ +V E+ GS+ + + + L I
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
KGL +LH I+RD K NILL+ + AKL+DFG++ G D V+GT
Sbjct: 108 TLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGT 162
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
+ APE + +++D++S G+ +EM G+
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIR 58
H N++ L+G C +D ++ E+ +G+L +L R P L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+ A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
T + APE + T +SDV+SFGV+L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 16 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 65
++V+L+G + L+V E M G L+++L RSL P P +++ I + A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126
Query: 66 --AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 183
+ APE + G T+ SD++SFGVVL E+ + L E L
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228
Query: 184 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
+ ++D ++ L C +PK RP E+V LK
Sbjct: 229 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-13
Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 5/142 (3%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73
H ++VKLIG ++ +V E P G L ++L L + + + + LA+L
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 133
+ ++RD N+L+ + KL DFGL++ E + + +++ + APE +
Sbjct: 125 S---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESI 180
Query: 134 MTGHLTSRSDVYSFGVVLLEML 155
TS SDV+ FGV + E+L
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 45/142 (31%), Positives = 79/142 (55%), Gaps = 7/142 (4%)
Query: 17 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76
+V G D + + E M GSL+ + +++ +P I K+++ KGL +L E+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 136
+ +++RD K SNIL+++ KL DFG++ G D ++ +GT Y +PE +
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGT 177
Query: 137 HLTSRSDVYSFGVVLLEMLTGR 158
H + +SD++S G+ L+EM GR
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 55/165 (33%), Positives = 84/165 (50%), Gaps = 24/165 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKI 61
E N + L H LVKL + + ++ EFM +GSL + L PLP I
Sbjct: 51 EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDK 114
+ A+G+AF+ + R I+RD + +NIL+ A K++DFGLA+ EG K
Sbjct: 110 QI--AEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 164
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159
+ + APE + G T +SDV+SFG++L+E++T R
Sbjct: 165 FPIK--------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKI 61
E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 51 EAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM-- 107
Query: 62 ALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
A A G+A++ ER I+RD + +NIL+ + K++DFGLA+ + + T R
Sbjct: 108 AAQIADGMAYI----ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---AR 160
Query: 121 VMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ + APE + G T +SDV+SFG++L E++T R N R
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------RE 211
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
L + R YR+ P+ + +L C +DP RP
Sbjct: 212 VLEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 42/142 (29%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 17 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76
+V G D + + E M GSL+ + + + +P I K+++ +GLA+L E+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 136
+ +++RD K SNIL+++ KL DFG++ + ++ +GT Y +PE +
Sbjct: 124 Q--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 177
Query: 137 HLTSRSDVYSFGVVLLEMLTGR 158
H + +SD++S G+ L+E+ GR
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E+ L L H NLV LI ++L LV+E+ ++ N L + +P + KI
Sbjct: 50 EIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIW 107
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTR 120
+ + F H+ I+RD K NIL+ KL DFG A+ GP D T +V+TR
Sbjct: 108 QTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 121 VMGTYGYAAPEYVMTGHLT--SRSDVYSFGVVLLEMLTG 157
Y APE ++ G DV++ G V E+LTG
Sbjct: 165 -----WYRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 57/164 (34%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 5 EVNFLGDLV-HLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIR 58
E+ FL +L H N+VKL+ E+D+ + LV+E+M E L R ++ R
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKR 110
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKT 115
I K L ++H VI+RD K SNILL++D KL+DFGLA+ + E +
Sbjct: 111 Y-IMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
V T + T Y APE ++ ++ D++S G +L EML G+
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + L + +V++IG C E + +LV E G L L + + S +++
Sbjct: 45 EAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ 103
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+ G+ +L + ++RD N+LL + AK+SDFGL+K D ++ R G
Sbjct: 104 VSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGK 159
Query: 125 Y--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + APE + +SRSDV+S+G+ + E +
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 27/235 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIR 58
E++ L H N+V+L+G C E + ++ E+ G L+ L + P P S +
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 59 MKIALGA--AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
K+AL A G+ L + ++RD N L+ + K+S L+KD + +
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYY 173
Query: 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 176
+ + APE V +++SDV+SFGV++ E+ T E
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELP 218
Query: 177 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231
L + RL +LE + +L C + +PK RP SE+V AL
Sbjct: 219 FYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 53/164 (32%), Positives = 82/164 (50%), Gaps = 27/164 (16%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPW 55
E L ++ H +++L + E DQR L + E++P G L ++L F S L +
Sbjct: 49 HNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
+ + AL +LH + ++YRD K NILLD + + KL+DFG AK K
Sbjct: 107 ASEIVCAL------EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KL 151
Query: 116 HVSTRVM-GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 157
T + GT Y APE + GH + D ++ G+++ EML G
Sbjct: 152 RDRTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 54/287 (18%)
Query: 28 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGLAFLHEEAERPVIYRDF 85
D+ V E+ G L HL R + +S GA L +LH +E+ V+YRD
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLH--SEKNVVYRDL 122
Query: 86 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145
K N++LD D + K++DFGL K+G + T + GT Y APE + D +
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 146 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 205
GVV+ EM+ GR L+ L E RF R + P +
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPRTLSP------------E 222
Query: 206 AAQLAAHCLSRDPK---------ARPLMS---------EVVEALKPLPNLKDMASSS--- 244
A L + L +DPK A+ +M + V K +P K +S
Sbjct: 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDT 282
Query: 245 -YYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 290
Y+ + A+ I +P ++ + +R P SY++
Sbjct: 283 RYFDEEFTAQMITITPPDQDDSMETVDN-----ERRPHFPQFSYSAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIR 58
H N++ L+G C ++ ++ E+ +G+L L R P P +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+ A A+G+ +L R I+RD N+L+ D K++DFGLA+ + D +
Sbjct: 137 VSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + APE + T +SDV+SFG+++ E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 60/239 (25%), Positives = 98/239 (41%), Gaps = 38/239 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKI 61
E++ L L H N++K IED++ +V E G L H ++ +P K
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ L +H R V++RD K +N+ + A KL D GL + KT + +
Sbjct: 112 FVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSL 166
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+GT Y +PE + +SD++S G +L EM P G
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYG 208
Query: 182 ERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
++ Y L P H+S ++ QL C++ DP+ RP ++ V + K
Sbjct: 209 DKMNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 53/172 (30%), Positives = 72/172 (41%), Gaps = 24/172 (13%)
Query: 3 QAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGS---LENHLFRRSLP 52
+ E N L H N+ G DDQ LV E GS L L ++
Sbjct: 50 KEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR 109
Query: 53 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGP 110
L I +GLA+LHE VI+RD K NILL + KL DFG++ D
Sbjct: 110 LKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166
Query: 111 EGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG 157
G + + GT + APE + +RSDV+S G+ +E+ G
Sbjct: 167 LG-RRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 28 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 87
D+ + + M G L HL + + +R A GL +H R V+YRD K
Sbjct: 70 DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHN---RFVVYRDLKP 125
Query: 88 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYS 146
+NILLD + ++SD GLA D + K H S +GT+GY APE + G S +D +S
Sbjct: 126 ANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGYMAPEVLQKGTAYDSSADWFS 181
Query: 147 FGVVLLEMLTGRRSMDKNRPNGEHNL 172
G +L ++L G +++ +H +
Sbjct: 182 LGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 45/109 (41%), Positives = 59/109 (54%), Gaps = 8/109 (7%)
Query: 53 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112
+P I KIA+ K L +L EE + +I+RD K SNILLD + N KL DFG++ G
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLV 159
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGR 158
D TR G Y APE + RSDV+S G+ L E+ TG+
Sbjct: 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + L +L H +V ++ ++++ + EF+ G L HL R++ P +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHA 125
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+LH + +IYRD K N+LLD + K++DFG AK P+ T + G
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCG 177
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
T Y APE + + D ++ GV+L E + G
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 61
E++ + +L H N+V+L +++ +LV+E+M + ++ H R +L
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
L KG+AF HE V++RD K N+L++ KL+DFGLA+ T + V
Sbjct: 108 QL--LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
Query: 122 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
T Y AP+ ++ S S D++S G ++ EM+TGR
Sbjct: 163 --TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 9/160 (5%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRM 59
+ E+ L +L H +V+ G C+ D ++ L ++ E+MP GS+++ L + L S+
Sbjct: 52 ECEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTR 109
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
K +G+++LH +++RD K +NIL D+ N KL DFG +K +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 120 R-VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
R V GT + +PE + ++DV+S G ++EMLT +
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E L H N+V+LIG C + +V E + G L L +++
Sbjct: 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVEN 102
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
AA G+ +L + I+RD N L+ K+SDFG++++ E D + ST M
Sbjct: 103 AAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQ 157
Query: 125 --YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ APE + G +S SDV+SFG++L E +
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 125
+GL ++H V++RD K SN+LL+ + + K+ DFGLA+ PE D T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 126 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
Y APE ++ +++ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 71
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 72 LHEEAERPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDGPEGDKTHVSTR--VM 122
L ++ +++ + T NILL D + KLSD G+ V +R +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169
Query: 123 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+ APE V + +L+ +D +SFG L E+ NGE L + L
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216
Query: 182 ERRRFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVV 228
E+ RFY EG + ++ A L HC++ DP RP ++
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 24/163 (14%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMK 60
Q E++ L + H N+V G + D+ +V E+ GSL++ + R L +
Sbjct: 48 QQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----Q 102
Query: 61 IAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
IA KGLA+LHE I+RD K +NILL D + KL+DFG++ T
Sbjct: 103 IAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTAT 154
Query: 118 STR---VMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEM 154
+ +GT + APE G + D+++ G+ +E+
Sbjct: 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 70/244 (28%), Positives = 102/244 (41%), Gaps = 30/244 (12%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L L H NLV LI + LV+EF+ L + L + L S K
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQ 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRV 121
+G+ F H +I+RD K NIL+ KL DFG A+ P T +V+TR
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR- 164
Query: 122 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR------RSMDK---------NR 165
Y APE ++ R+ D+++ G ++ EMLTG +D+ N
Sbjct: 165 ----WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220
Query: 166 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
+ + G R + I+P LE F K + LA CL DP RP S
Sbjct: 221 IPRHQEIFQKNPLFAGMRLPEVKEIEP-LEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 226 EVVE 229
+++
Sbjct: 279 QLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 24/227 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q E+ L + + G ++ + ++ E++ GS + L + PL + I
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATIL 107
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
KGL +LH E + I+RD K +N+LL + KL+DFG+A G D +
Sbjct: 108 REILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV 162
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
GT + APE + ++D++S G+ +E+ G P L+ P
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---- 218
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
P LEG +S + + CL++DP+ RP E+++
Sbjct: 219 ---------PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 29/199 (14%)
Query: 35 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 94
EFM GSL+ ++R+ +P + +IA+ KGL +L +++RD K SN+L++
Sbjct: 79 EFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNT 130
Query: 95 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154
KL DFG++ ++ +GT Y APE + SDV+S G+ +E+
Sbjct: 131 RGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
Query: 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---PRL-EGHFSIKGAQKAAQLA 210
GR + + N + L + ++D P L G FS +K
Sbjct: 187 ALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPPVLPVGQFS----EKFVHFI 233
Query: 211 AHCLSRDPKARPLMSEVVE 229
C+ + PK RP +++
Sbjct: 234 TQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALGAAKGLAFLHEEAE 77
Y +DD+ L +V E+MP G L N + +P W+ + +AL A + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 135
RD K N+LLD + KL+DFG T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 136 --GHLTSRSDVYSFGVVLLEMLTG 157
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 52/159 (32%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 2 WQ---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 58
WQ EV FL L H N ++ G +++ LV E+ GS + L PL
Sbjct: 65 WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEI 123
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
I GA +GLA+LH +I+RD K NILL KL+DFG A K+ +
Sbjct: 124 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPA 174
Query: 119 TRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 154
+GT + APE ++ G + DV+S G+ +E+
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKI 61
E++ L +L H N+VKL+ +++ LV+EF+ + F + P +P +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSY 105
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+GLAF H + R V++RD K N+L++ + KL+DFGLA+ G T
Sbjct: 106 LFQLLQGLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHE 160
Query: 122 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
+ T Y APE ++ + ++ D++S G + EM+T R
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM------------- 59
H N++ L+G C +D ++ E+ +G+L +L RR + +S +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 60 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
T + APE + T +SDV+SFGV++ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 19/146 (13%)
Query: 24 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77
C + RL V E++ G L H+ F+ + ++ + + GL FLH
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHR--- 119
Query: 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTG 136
R +IYRD K N++LD++ + K++DFG+ K E V+TR GT Y APE +
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 137 HLTSRSDVYSFGVVLLEMLTGRRSMD 162
D +++GV+L EML G+ D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 14 HLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 62
H N+++LIG C++ + +++ FM G L + L L LP + +K
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
A G+ +L + + I+RD N +L+ + N ++DFGL+K GD
Sbjct: 119 TDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ A E + T++SDV+SFGV + E+ T
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 61
E + L H LV+L + ++ +V E+M +GSL + L + L LP + M
Sbjct: 51 EAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-- 107
Query: 62 ALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
A A G+A++ ER ++RD + +NIL+ + K++DFGLA+ + + T R
Sbjct: 108 AAQIASGMAYV----ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---AR 160
Query: 121 VMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ + APE + G T +SDV+SFG++L E+ T R N R
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------RE 211
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
L + R YR+ P + + L C ++P+ RP
Sbjct: 212 VLDQVERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ + + H N+V + + D+ +V E++ GSL + + M
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--------MDEGQI 117
Query: 65 AA------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHV 117
AA + L FLH VI+RD K+ NILL D + KL+DFG A+ PE K
Sbjct: 118 AAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 171
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ ++GT + APE V + D++S G++ +EM+ G
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 54/156 (34%), Positives = 73/156 (46%), Gaps = 29/156 (18%)
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGY 127
L +LH V+YRD K N++LD D + K++DFGL K+G +G GT Y
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEY 161
Query: 128 AAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRR 185
APE V+ + R+ D + GVV+ EM+ GR N +H L E L E R
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIR 213
Query: 186 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221
F R + P +A L A L +DPK R
Sbjct: 214 FPRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 28 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GLAFLHEEAERPVIYRD 84
D LV M G L+ H++ ++ P + AA+ GL LH E ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRD 127
Query: 85 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 144
K NILLD + ++SD GLA + PEG+ + RV GT GY APE V T D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 145 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQ 204
+ G ++ EM+ G+ + + + VE R + E +S K ++
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVE-------------RRVKEDQE-EYSEKFSE 230
Query: 205 KAAQLAAHCLSRDPKAR 221
A + L++DP R
Sbjct: 231 AARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 50/153 (32%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 13 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---G 68
VH + + Y + L LV M G L H++ P + A+ G
Sbjct: 50 VHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTY 125
L LH+ R +IYRD K N+LLD D N ++SD GLA KDG K + GT
Sbjct: 110 LEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTP 161
Query: 126 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
G+ APE + D ++ GV L EM+ R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 122
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL- 238
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
+ APE + T++SDV+SFGV+L E+ + S P + N R G
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGT 294
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
R R P + + C DPK RP S +VE L L
Sbjct: 295 RMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 15/99 (15%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKT-----HVSTR 120
+GL +LH VI+RD K SNIL++++ + K+ DFGLA+ P+ D+ +V TR
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 121 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
Y APE +++ +++ D++S G + E+LT +
Sbjct: 171 W-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 14/173 (8%)
Query: 5 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMK 60
E++ L + H ++ LI Y + V MP+ + LF RS PLP +
Sbjct: 136 EIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAIT 189
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
I + LA+LH R +I+RD KT NI LD NA L DFG A T
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNL 172
GT +PE + +++D++S G+VL EM ++ K + L
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 66/205 (32%), Positives = 86/205 (41%), Gaps = 35/205 (17%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGLAFLHEEAERP 79
Y + RL V E+ G L HL R + R GA L +LH R
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSALEYLHS---RD 115
Query: 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 139
V+YRD K N++LD D + K++DFGL K+G T + GT Y APE +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYG 173
Query: 140 SRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 196
D + GVV+ EM+ GR + D R L E L E RF R + P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIRFPRTLSP---- 220
Query: 197 HFSIKGAQKAAQLAAHCLSRDPKAR 221
+A L A L +DPK R
Sbjct: 221 --------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 26/165 (15%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
KGL +LH E + I+RD K +N+LL + KL+DFG+A G D +GT
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166
Query: 127 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 186
+ APE + S++D++S G+ +E+ G PN + + + R F
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE------PPNSDMHPM---------RVLF 211
Query: 187 Y--RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ P L G FS + + CL++DP RP E+++
Sbjct: 212 LIPKNNPPTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 8/106 (7%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+GY
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHGY 161
Query: 128 AAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 172
APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 65/191 (34%), Positives = 81/191 (42%), Gaps = 26/191 (13%)
Query: 32 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 91
LV F+ G L +HL R R A + L L + VIYRD K NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENIL 125
Query: 92 LDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150
LD + L DFGL K + + DKT+ GT Y APE ++ T D ++ GV+
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 210
L EMLTG P + N+ E R L E RF D + A L
Sbjct: 183 LYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGFD------------RDAKDLL 224
Query: 211 AHCLSRDPKAR 221
LSRDP R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ E++ L H N+VKL+ ++ ++ EF G+++ + PL +
Sbjct: 49 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV 108
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ L +LHE +I+RD K NIL D + KL+DFG++ + S
Sbjct: 109 CKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--F 163
Query: 122 MGTYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEM 154
+GT + APE VM R +DV+S G+ L+EM
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 59/157 (37%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 4 AEVN-FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 60
AE N L ++ H LV L Y + ++L V +F+ G L HL R RS P P + R
Sbjct: 44 AERNVLLKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFY 101
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
A A L +LH ++YRD K NILLD+ + L+DFGL K+G T +T
Sbjct: 102 AA-EIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTT 155
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
GT Y APE + + D + G VL EML G
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 41/152 (26%), Positives = 79/152 (51%), Gaps = 4/152 (2%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + + H +LV+L+G C+ +L V + MP G L +++ + + + +
Sbjct: 59 EALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
AKG+ +L E R +++RD N+L+ + + K++DFGLA+ +K + +
Sbjct: 118 IAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ A E + T +SDV+S+GV + E++T
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 38/241 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKI 61
E++ L L H N++K + IED++ +V E G L + ++ +P K
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + +H R V++RD K +N+ + A KL D GL + KT + +
Sbjct: 112 FVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSL 166
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+GT Y +PE + +SD++S G +L EM P G
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYG 208
Query: 182 ERRRFYRLID-------PRLEG-HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233
++ + L P L H+S +K +L + C+ DP RP + V + K
Sbjct: 209 DKMNLFSLCQKIEQCDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264
Query: 234 L 234
+
Sbjct: 265 M 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 34/169 (20%)
Query: 5 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIR 58
EV L L H N+VKL E+D+ V+E+M E +L+ R+ P S+
Sbjct: 47 EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVI 101
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDK 114
I +GLA +H+ +RD K N+L+ K++DFGLA++ P D
Sbjct: 102 RSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD- 157
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 158
+VSTR Y APE + L S S D+++ G ++ E+ T R
Sbjct: 158 -YVSTR-----WYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKI 61
E++ L +L H N+V L +++ + L++EF+ L+ +L SLP + +K
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKS 105
Query: 62 AL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
L +G+ F H R V++RD K N+L+D KL+DFGLA+ G V T
Sbjct: 106 YLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTH 160
Query: 121 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
+ T Y APE ++ S D++S G + EM T +
Sbjct: 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 23 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 76
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 135
RD K N+LLD + KL+DFG E T V GT Y +PE + +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 136 ---GHLTSRSDVYSFGVVLLEMLTG 157
G+ D +S GV L EML G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)
Query: 24 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77
C + RL V E++ G L + F+ + ++ + I GL FLH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG- 121
Query: 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTG 136
+IYRD K N++LD++ + K++DFG+ K E V+T+ GT Y APE +
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 137 HLTSRSDVYSFGVVLLEMLTGRRSMD 162
D ++FGV+L EML G+ +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRM 59
+ E+ L H +VKL+G D + ++ EF P G+++ + R L P I++
Sbjct: 56 YMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV 114
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
I + L +LH +I+RD K N+LL D + KL+DFG++ + + S
Sbjct: 115 -ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS- 169
Query: 120 RVMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEM 154
+GT + APE VM + ++D++S G+ L+EM
Sbjct: 170 -FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 56/156 (35%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 4 AEVN-FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
AE N L +L H LV L Y + ++L V +++ G L HL R L R
Sbjct: 44 AERNVLLKNLKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-Y 101
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
A A + +LH +IYRD K NILLD+ + L+DFGL K+G E ++T ++
Sbjct: 102 AAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTF 156
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
GT Y APE + D + G VL EML G
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 21/160 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL- 63
EV + D H N+V++ + ++ ++ EF+ G+L + + + L +IA
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLN-----EEQIATV 122
Query: 64 --GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHV 117
+ L +LH + VI+RD K+ +ILL D KLSDFG ++KD P+
Sbjct: 123 CESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------ 173
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
++GT + APE + + D++S G++++EM+ G
Sbjct: 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMK 60
+ E+ L +L+H +V+ G + +R L E MP GS+++ L + L ++ K
Sbjct: 52 ECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRK 110
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDK 114
+G+++LH +++RD K +NIL D+ N KL DFG +K G K
Sbjct: 111 YTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
+ V GT + +PE + ++D++S G ++EMLT +
Sbjct: 168 S-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPW 55
+ EV L + H N+V E+ + +V E+ G L LF L W
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDK 114
+ +I+LG L +H+ R +++RD K+ NI L + AKL DFG+A+ D
Sbjct: 107 FV--QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDS 155
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 164
++ +GT Y +PE +++D++S G VL E+ T + + N
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81
Y + D +L L+ +++ G L HL +R +++ L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG---II 127
Query: 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHL 138
YRD K NILLD++ + L+DFGL+K+ E D+ + GT Y AP+ V GH
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGGH- 185
Query: 139 TSRSDVYSFGVVLLEMLTG 157
D +S GV++ E+LTG
Sbjct: 186 DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 56/189 (29%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALGA 65
LVKL+ Y +DD+ L L E++P G L R + M A+ A
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AEMFEAVDA 116
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 125
L ++H RD K N L+DA + KL+DFGL+K + V+G+
Sbjct: 117 LHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSP 162
Query: 126 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA----RPH 179
Y APE V+ G + D +S G +L E L G + PN NL W RP
Sbjct: 163 DYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV 221
Query: 180 LGERRRFYR 188
+ R
Sbjct: 222 YDDPRFNLS 230
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 20/157 (12%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--KGL 69
L H N+V+ +G E+ + E +P GSL L + PL + + I +GL
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFG----LAKDGPEGDKTHVSTRVMG 123
+LH+ +++RD K N+L++ Y+ K+SDFG LA P + G
Sbjct: 122 KYLHDNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTG 171
Query: 124 TYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 158
T Y APE + G + +D++S G ++EM TG+
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 77
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 135
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 136 --GHLTSRSDVYSFGVVLLEMLTG 157
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 45/184 (24%)
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128
L LH+ ++YRD K NILLDA + L DFGL+K +KT + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 129 APEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 186
APE ++ G+ T D +S GV++ EM G W+ + + ++
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQM 205
Query: 187 YRLID------PR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236
YR I P+ EG +KG L+R+P+ R LK P
Sbjct: 206 YRNIAFGKVRFPKNVLSDEGRQFVKG----------LLNRNPQHRLGAHRDAVELKEHPF 255
Query: 237 LKDM 240
D+
Sbjct: 256 FADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 37/171 (21%)
Query: 5 EVNFLGDLVHLNLVKL---------------IGYCIEDDQRLLVYEFMPRGSLENHLFRR 49
E+ L +L H N+V+L + YC +D LL + MP
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT---------- 103
Query: 50 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 109
P S + L +GL +LHE +I+RD K SN+LL K++DFGLA+
Sbjct: 104 --PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR-- 156
Query: 110 PEGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGR 158
G T + T Y APE + T + T+ D+++ G +L E+L +
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 75/286 (26%), Positives = 119/286 (41%), Gaps = 45/286 (15%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 61
++E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEV 171
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
L + + L E R +++RD K++NI L KL DFG +K + V++
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT Y APE + ++D++S GV+L E+LT RP G
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKG 273
Query: 182 ERRR------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV--EALKP 233
+R Y DP F + L LS++P RP +++ E LK
Sbjct: 274 PSQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328
Query: 234 LPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRS 279
+ NL FQ + SP+ R I Q L +G+R+
Sbjct: 329 VANL---------FQDIVRHSETISPHDREEILRQ---LQESGERA 362
|
Length = 478 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 2 WQ---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 58
WQ EV FL L H N ++ G + + LV E+ GS + L PL
Sbjct: 59 WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEI 117
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
I GA +GLA+LH I+RD K NILL KL+DFG A +
Sbjct: 118 AAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPA 168
Query: 119 TRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 154
+GT + APE ++ G + DV+S G+ +E+
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 19/163 (11%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRM 59
+ E+ L +L H +V+ G C+ D +++L ++ E+MP GS+++ L + L ++
Sbjct: 52 ECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTR 109
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGD 113
+ +G+++LH +++RD K +NIL D+ N KL DFG +K G
Sbjct: 110 RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
K+ V GT + +PE + ++DV+S ++EMLT
Sbjct: 167 KS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 47/161 (29%), Positives = 85/161 (52%), Gaps = 27/161 (16%)
Query: 12 LVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK----I 61
L H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ + +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHM 122
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPE-----GDKT 115
A+ A G+++LH+ R VI++D N ++D + K++D L++D P GD
Sbjct: 123 AIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + M A E ++ +S SDV+SFGV+L E++T
Sbjct: 180 NRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 46/161 (28%), Positives = 83/161 (51%), Gaps = 17/161 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRM 59
E++ L ++ H N+V+L + + LV+E++ L+ H+ F ++ L +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVS 118
+I +G+A+ H V++RD K N+L+D NA KL+DFGLA+ G
Sbjct: 110 QI----LRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTF 160
Query: 119 TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
T + T Y APE ++ + H ++ D++S G + EM+ +
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L D+ H N+VK + + ++ EFM GSLE L +A
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQ 176
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMG 123
G+A+LH R +++RD K SN+L+++ N K++DFG+++ + D + S +G
Sbjct: 177 ILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VG 230
Query: 124 TYGYAAPEYVMTGHLTSR-----SDVYSFGVVLLEMLTGR 158
T Y +PE + T D++S GV +LE GR
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 14/163 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PL 53
E + + H N++KLIG + RL ++ FM G L L + L
Sbjct: 51 EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL 110
Query: 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
P ++ + A G+ +L + + I+RD N +L+ + ++DFGL+K GD
Sbjct: 111 PLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ A E + T+ SDV++FGV + E++T
Sbjct: 168 YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 39 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 98
L +L +RS PLP + I +GL +LH A+R +I+RD KT NI ++
Sbjct: 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQR-IIHRDVKTENIFINDVDQV 196
Query: 99 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
+ D G A+ P + + GT APE + S++D++S G+VL EML
Sbjct: 197 CIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253
Query: 159 RSMDKNRPNGEHNLVEWARPHL 180
++ ++ P+ V+ HL
Sbjct: 254 STIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
+GL ++H +I+RD K SNI ++ D K+ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 127 YAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE +M H D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 53/177 (29%), Positives = 78/177 (44%), Gaps = 32/177 (18%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLPL 53
E+ L L H N+V LI +E +R VY P G LEN + +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES- 115
Query: 54 PWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---- 107
I+ M L +G+ +LHE +++RD K +NIL+D K++DFGLA+
Sbjct: 116 --QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 108 -----DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
G G T T ++ T Y PE ++ T+ D++ G V EM T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 42/235 (17%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK---- 60
EV + D H N+V + + D+ +V EF+ G+L + + RM
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQI 120
Query: 61 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDK 114
+ L + L++LH + VI+RD K+ +ILL +D KLSDFG ++K+ P+
Sbjct: 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--- 174
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
++GT + APE + + D++S G++++EM+ G
Sbjct: 175 ---RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY------------- 218
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ P L RR + PR++ + + L R+P R E+++
Sbjct: 219 FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 26/165 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E++ L +L H N+V+L+ +++ LV+EF+ L+ + S P L
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLD 97
Query: 65 AA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 114
+G+A+ H V++RD K N+L+D + KL+DFGLA+ G
Sbjct: 98 PPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVP 152
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
T + T Y APE ++ S D++S G + EM+ R
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 44/141 (31%), Positives = 73/141 (51%), Gaps = 15/141 (10%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM---KIALGAAKGLAFLHEEAER 78
Y + + +L L+ +++ G + HL++R +R +I L L LH+
Sbjct: 72 YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLHKLG-- 125
Query: 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV--MTG 136
++YRD K NILLD++ + L+DFGL+K+ +K + GT Y APE + G
Sbjct: 126 -IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGG 183
Query: 137 HLTSRSDVYSFGVVLLEMLTG 157
H D +S G+++ E+LTG
Sbjct: 184 H-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 52/161 (32%), Positives = 73/161 (45%), Gaps = 23/161 (14%)
Query: 68 GLAFL------HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
GL F+ H + +I+RD K++NILL ++ KL DFG +K V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT Y APE + ++D++S GV+L E+LT +R D GE N+ E L
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLA 259
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
R DP L S + ++ LS DPK RP
Sbjct: 260 GR------YDP-LPPSIS----PEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 24/160 (15%)
Query: 16 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGL 69
N+V L Y + +D LV + G L +H+ + L +P W+ M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA---- 100
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYA 128
LH E ++ RD +NILLD + +L+ F + D V Y
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 129 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 168
APE T D +S G +L E+LTG +++ + P+G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 42/235 (17%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK---- 60
EV + D H N+V++ + D+ +V EF+ G+L + + RM
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQI 118
Query: 61 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDK 114
+ L K L+ LH + VI+RD K+ +ILL D KLSDFG ++K+ P
Sbjct: 119 AAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--- 172
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
++GT + APE + D++S G++++EM+ G P ++
Sbjct: 173 ---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI- 228
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
R +L + + + P L+G L RDP R +E+++
Sbjct: 229 --RDNLPPKLKNLHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
E+ L + N++K+ G+ I+ L L+ E+ RG L L + L + ++
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLD 126
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
+A+ KGL L++ +P Y++ + + L+ +Y K+ GL K +V+
Sbjct: 127 MAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184
Query: 121 VMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 158
V Y + + + T + D+YS GVVL E+ TG+
Sbjct: 185 V-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTY 125
+ L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTP 180
Query: 126 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ APE V + D++S G++ +EM+ G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL- 63
E+ + +L + N+V + + D+ +V E++ GSL + + + +IA
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAV 120
Query: 64 --GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTR 120
+ L FLH VI+RD K+ N+LL D + KL+DFG A+ PE K +
Sbjct: 121 CRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RST 174
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
++GT + APE V + D++S G++ +EM+ G
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 56/173 (32%), Positives = 76/173 (43%), Gaps = 26/173 (15%)
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 122
AKG+ FL A R I+RD NILL + K+ DFGLA+D + D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL- 243
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG 181
+ APE + T +SDV+SFGV+L E+ S+ + G E+ R G
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF----SLGASPYPGVKIDEEFCRRLKEG 298
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
R R P + Q C +P RP SE+VE L L
Sbjct: 299 TRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 2 WQ---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 58
WQ EV FL + H N ++ G + + LV E+ GS + L PL
Sbjct: 69 WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEI 127
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
I GA +GLA+LH +I+RD K NILL KL+DFG A +
Sbjct: 128 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS---- 180
Query: 119 TRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 154
+GT + APE ++ G + DV+S G+ +E+
Sbjct: 181 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 50/159 (31%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 2 WQ---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 58
WQ EV FL L H N ++ G + + LV E+ GS + L PL
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEI 117
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+ GA +GLA+LH +I+RD K NILL KL DFG A +
Sbjct: 118 AAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPA 168
Query: 119 TRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 154
+GT + APE ++ G + DV+S G+ +E+
Sbjct: 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 45/161 (27%), Positives = 82/161 (50%), Gaps = 27/161 (16%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 58
H N++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
++ A A G+ +L +E+ I+RD N+L+ + +K++DFGL++ G++ +V
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV 173
Query: 118 STRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ MG + A E + T++SDV+SFGV+L E+++
Sbjct: 174 K-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 38/208 (18%)
Query: 35 EFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 91
E+M GSL+ L+ + +P + +I KGL FL EE +I+RD K +N+L
Sbjct: 79 EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 92 LDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTSR------SDV 144
++ + KL DFG++ + KT++ G Y APE + +G SDV
Sbjct: 136 VNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDV 190
Query: 145 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---PRLEGHFSIK 201
+S G+ +LEM GR P N+ + ++D P L +S
Sbjct: 191 WSLGLSILEMALGRYPYP---PETYANIFA----------QLSAIVDGDPPTLPSGYS-- 235
Query: 202 GAQKAAQLAAHCLSRDPKARPLMSEVVE 229
A A CL++ P RP ++++E
Sbjct: 236 --DDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGAAK 67
H N++ L+G C L E+ P G+L + L R+S L IA L + +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 68 GLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
L F + A ++ I+RD NIL+ +Y AK++DFGL++ G + +V +
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-K 180
Query: 121 VMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 26/145 (17%)
Query: 50 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 109
S PL ++ + A+G+ FL A + I+RD N+LL AK+ DFGLA+D
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD- 261
Query: 110 PEGDKTHVSTRVMGT----YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 165
D +V V G + APE + T +SDV+S+G++L E+ S+ K+
Sbjct: 262 IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGKS- 313
Query: 166 PNGEHNLVEWARPHLGERRRFYRLI 190
P + +FY+++
Sbjct: 314 ----------PYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E+ L L H N++ L I + + V E + + H S PL
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLY 115
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+GL ++H V++RD K SNIL++ + + K+ DFGLA+ +VSTR
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 124 TYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGR 158
Y APE ++T D++S G + EML G+
Sbjct: 171 ---YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-09
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTY 125
+ L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 126 QALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTP 179
Query: 126 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ APE V + D++S G++ +EM+ G
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 35/232 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 57
EV L ++ H N+V+ E+ +V ++ G L LF L W +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
++ +AL +H+ R +++RD K+ NI L D KL DFG+A+ +
Sbjct: 109 QICLAL------KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVEL 157
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ +GT Y +PE ++SD+++ G VL EM T + + + NLV
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV---- 210
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
L R Y P + H+S +QL R+P+ RP ++ ++E
Sbjct: 211 --LKIIRGSY----PPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 45/137 (32%), Positives = 63/137 (45%), Gaps = 7/137 (5%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81
Y + RL V E++ G L HL R + R A L +LH ++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSGK---IV 117
Query: 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 141
YRD K N++LD D + K++DFGL K+G T + GT Y APE +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYGRA 175
Query: 142 SDVYSFGVVLLEMLTGR 158
D + GVV+ EM+ GR
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 45/130 (34%), Positives = 61/130 (46%), Gaps = 6/130 (4%)
Query: 28 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 87
D+ V +++ G L HL R L R A A L +LH ++YRD K
Sbjct: 69 DKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKP 124
Query: 88 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 147
NILLD+ + L+DFGL K+ E + T ++ GT Y APE + D +
Sbjct: 125 ENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182
Query: 148 GVVLLEMLTG 157
G VL EML G
Sbjct: 183 GAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
+GL +LH +++RD K N+L++++ K+ DFGLA+ + H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 127 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
Y APE +M + H TS D++S G + E+L R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 27/161 (16%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 58
H N++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 118 STRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 167 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSL 51
E+ L L H N+V L + L LV+E+M G LE+ L S
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 52 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111
S MK L +GL + H+ + ++RD K SNILL+ KL+DFGLA+
Sbjct: 116 DHIKSF-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
+ + +V+ T Y PE ++ + DV+S G +L E+ T +
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 127 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 127 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ H T D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E N + L + +V++IG C E + +LV E G L L + +I ++
Sbjct: 45 REANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVH 102
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+ G+ +L E ++RD N+LL + AK+SDFGL+K D+ + + G
Sbjct: 103 QVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHG 158
Query: 124 TY--GYAAPEYVMTGHLTSRSDVYSFGVVLLE 153
+ + APE + +S+SDV+SFGV++ E
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 7/155 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
EV+ L DL H N+V L D LV+E++ + L+ ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+GLA+ H R V++RD K N+L++ KL+DFGLA+ KT+ + V T
Sbjct: 113 ILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--T 167
Query: 125 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
Y P+ ++ + +++ D++ G + EM +GR
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWS 56
L H N+V L+G ++ +++ + L L RS L +
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+ I A G+ FL + V+++D T N+L+ N K+SD GL ++ D
Sbjct: 125 DFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + + +PE +M G + SD++S+GVVL E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
GL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 127 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ H D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 125
AKG++FL A + I+RD NILL K+ DFGLA+D V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 126 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 185
+ APE + T SDV+S+G++L E+ + L P + +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325
Query: 186 FYRLIDPRLEGH--FSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVE 229
FY++I EG+ S + A + + C DP RP ++V+
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 29/167 (17%)
Query: 5 EVNFLGDLVHLNLVKL----IGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSI 57
E+N L L H N+V + +G + D+ +V E++ + +E P+
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQ 105
Query: 58 R-----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112
M L G+A LH+ +++RD KTSN+LL+ K+ DFGLA+ G
Sbjct: 106 SEVKCLMLQLL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYG 157
Query: 113 DKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
T+++ T Y APE ++ ++ D++S G + E+LT +
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 52/200 (26%), Positives = 77/200 (38%), Gaps = 60/200 (30%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI- 61
AE + L + + +VKL Y +D+ L L+ E++P G + L ++ R I
Sbjct: 50 AERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA 108
Query: 62 ----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTH 116
A+ + L ++H RD K N+LLDA + KLSDFGL G K+H
Sbjct: 109 ETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSH 155
Query: 117 VST----------------------------------RVM-----GTYGYAAPEYVMTGH 137
+ R + GT Y APE +
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215
Query: 138 LTSRSDVYSFGVVLLEMLTG 157
D +S GV++ EML G
Sbjct: 216 YNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 122
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL- 237
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ APE + T++SDV+SFGV+L E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 41/159 (25%), Positives = 82/159 (51%), Gaps = 18/159 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 57
E + + + ++ +L+G C+ +L + + MP G L ++++ + L L W +
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWCV 116
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
++ AKG+ +L E R +++RD N+L+ + K++DFGLAK +K +
Sbjct: 117 QI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ + A E ++ T +SDV+S+GV + E++T
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 16/144 (11%)
Query: 19 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78
+L+G C+ +L V + MP G L +++ + + + AKG+++L E
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR-- 129
Query: 79 PVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPE--GDKTHVSTRVMGTYGYAAPEY 132
+++RD N+L+ + + K++DFGLA+ D E D V + M A E
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM------ALES 182
Query: 133 VMTGHLTSRSDVYSFGVVLLEMLT 156
++ T +SDV+S+GV + E++T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMG 123
+GL ++H VI+RD K SN+L++ D ++ DFG+A+ P K + T +
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM-TEYVA 173
Query: 124 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSM 161
T Y APE +++ + + D++S G + EML GRR +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 15/166 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+E L + H V L G ++ LV EF+ G L RR+ P +
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG---CF 135
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--- 120
AA+ + ++YRD K N+LLD D K++DFG AK V TR
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYT 187
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 166
+ GT Y APE ++ +D ++ G+ + E+L G N P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 29/157 (18%)
Query: 9 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENH--LFRRSLPLPWSIRMKIALGA 65
+G L LN V ++ +E D + + +G L E H LF L
Sbjct: 82 VGSLTELNSVYIVQEYMETDLANV----LEQGPLSEEHARLFMYQL-------------- 123
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAK--DGPEGDKTHVSTRVM 122
+GL ++H V++RD K +N+ ++ D K+ DFGLA+ D K ++S ++
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 123 GTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
+ Y +P +++ + T D+++ G + EMLTG+
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 7/155 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+GL + H R V++RD K N+L++ KL+DFGLA+ KT+ + V T
Sbjct: 113 LLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--T 167
Query: 125 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
Y P+ ++ + +++ D++ G + EM TGR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 55/174 (31%), Positives = 75/174 (43%), Gaps = 29/174 (16%)
Query: 3 QAEVNFLGDLV-HLNLVKLIGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPL 53
+AE N L L H N+VK G + D Q LV E GS L L L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
++ I GA GL LH +I+RD K +NILL + KL DFG++
Sbjct: 126 DEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ----- 177
Query: 114 KTHVSTRV-----MGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 157
STR+ +GT + APE + +R DV+S G+ +E+ G
Sbjct: 178 --LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGT 124
GL ++H V++RD K N+L++AD K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 125 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNR 165
Y APE +++ +++ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 43/143 (30%), Positives = 62/143 (43%), Gaps = 11/143 (7%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81
Y +D L LV E+ P G L + L R + A+ + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124
Query: 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY--VMTGHLT 139
+RD K N+L+D + KL+DFG A +K S +GT Y APE M G
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 140 SRSDV----YSFGVVLLEMLTGR 158
V +S GV+ EM+ GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALG 64
L H NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACE 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
A GL LH+ I+ D N LL AD K+ D+GL+ + + D ++
Sbjct: 109 IALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165
Query: 125 YGYAAPEYVMTGH-------LTSRSDVYSFGVVLLEML 155
+ APE V H T S+V+S GV + E+
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 7/155 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
EV+ L +L H N+V L + LV+E++ L+ +L +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+GL++ H+ R +++RD K N+L++ KL+DFGLA+ KT+ + V T
Sbjct: 112 LLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--T 166
Query: 125 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
Y P+ ++ + ++ D++ G +L EM TGR
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
+GL ++H V++RD K SN+LL+A+ + K+ DFGLA+ +K T + T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 127 YAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ T+ DV+S G + E+L +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 44/199 (22%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSI 57
E DL+H +V + Y I D VY MP G L + SL +
Sbjct: 52 EAKIAADLIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108
Query: 58 R------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDG 109
+ + I + ++H + V++RD K NILL + D+G A K
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165
Query: 110 PEGDKTHVST--------------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155
E D + +++GT Y APE ++ + +D+Y+ GV+L +ML
Sbjct: 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 156 T---------GRRSMDKNR 165
T GR+ ++
Sbjct: 226 TLSFPYRRKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGA 65
L H N+++ +G C+E LLV+E+ G L+++L R S L + ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEI 108
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 125
A G+ +H+ ++ D N L +D K+ D+G+ + D
Sbjct: 109 AAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165
Query: 126 GYAAPEYV-------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ APE V +T T S+V++ GV L E+ +N +L +
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVL 218
Query: 179 HLGERRRFYRLIDPRLEGHFS 199
+ + + +L P+LE +S
Sbjct: 219 NHVIKDQQVKLFKPQLELPYS 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 29/187 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPL 53
E+ L L H N+V LI C LV+EF G L N + +L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPE 111
+ MK+ L GL ++H +++RD K +NIL+ D KL+DFGLA+ +
Sbjct: 121 IKKV-MKMLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSK 173
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRP 166
K + T + T Y PE + L R D++ G ++ EM T M N
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229
Query: 167 NGEHNLV 173
+ L+
Sbjct: 230 QHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 24/228 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMK 60
+ E L L H N+V + ED +V F G L + L ++ LP + ++
Sbjct: 47 EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
+ A L +LHE+ +++RD KT N+ L K+ D G+A+ ++ +++
Sbjct: 107 WFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMAST 161
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
++GT Y +PE +SDV++ G + EM T + + + N +LV
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV------- 211
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228
YR+I+ +L + + +L A LS+ P+ RP + ++
Sbjct: 212 ------YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 42/169 (24%), Positives = 77/169 (45%), Gaps = 26/169 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLE---NHLFRRSLPLPWSIRM 59
E+ L +L H N+V L+ +E + L++++ + H + + +P S+
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGP--- 110
+ G+ +LH V++RD K +NIL+ + K+ D GLA+ + P
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 111 --EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 156
+ D V+ T Y APE ++ H T D+++ G + E+LT
Sbjct: 169 LADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 14 HLNLVKLIGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAK 67
H N+V+L+ C D+ LV+E + + L +L + P LP + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYG 126
GL FLH +++RD K NIL+ + KL+DFGLA+ ++ T V+ T
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLW 172
Query: 127 YAAPEYVMTGHLTSRSDVYSFGVVLLEML 155
Y APE ++ + D++S G + EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 127 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ H D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 12/98 (12%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVM 122
+ L ++H V +RD K NIL +AD K+ DFGLA+ D P T +
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWTDYV 167
Query: 123 GTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 158
T Y APE + T D++S G + E+LTG+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q E+ + D H N+V G + D+ + EF GSL++ ++ + PL S ++
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVS 112
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+GL +LH + + ++RD K +NILL + + KL+DFG++ S +
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FI 167
Query: 123 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 154
GT + APE G D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 48/174 (27%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-----ALGAAKGLAFLHEEA 76
Y +D + L L+ EF+P G + L ++ + + I A+ A L F+H
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124
Query: 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLA---------------KDGPEGD-------- 113
RD K N+LLDA + KLSDFGL P D
Sbjct: 125 ------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 114 ----------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ ++ +GT Y APE M D +S GV++ EML G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 50/194 (25%), Positives = 76/194 (39%), Gaps = 49/194 (25%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+AE + L + L +VK+ Y +D L L+ EF+P G + L ++ + I
Sbjct: 49 RAERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYI 107
Query: 62 A-----LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT- 115
A + + L F+H RD K N+LLD+ + KLSDFGL + +T
Sbjct: 108 AETVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158
Query: 116 --------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSD 143
++ +GT Y APE M D
Sbjct: 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 144 VYSFGVVLLEMLTG 157
+S GV++ EML G
Sbjct: 219 WWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLP 54
E+ L +L H N+V+L D + LV+E+ G ++ + + +
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM--- 105
Query: 55 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 114
KGLAF H V++RD K N+L++ + KL+DFGLA+ G
Sbjct: 106 --------FQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIP 152
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 159
+ + T Y P+ + L S S D++S G + E+ R
Sbjct: 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 14 HLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAK 67
H N+V+L C + + LV+E + + L +L + P +P + +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
GL FLH V++RD K NIL+ + KL+DFGLA+ T V+ T Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWY 175
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE ++ + D++S G + EM +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 124
A+G+ FL A + ++RD N+LL K+ DFGLA+D D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGSTFLP 302
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 184
+ APE + T+ SDV+S+G++L E+ + L P +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDS 347
Query: 185 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEALKP 233
FY I Q+ + C + +P+ RP +S++VE+L P
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 23/163 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM-- 59
E + L DL H N+V L LV+E++ +++ + M
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHN 104
Query: 60 -KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
++ L +GLA+ H+ R V++RD K N+L+ KL+DFGLA+ KT+
Sbjct: 105 VRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161
Query: 118 STRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 158
+ V T Y P+ ++ T + TS D++ G + EM TGR
Sbjct: 162 NEVV--TLWYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 14/133 (10%)
Query: 32 LVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 88
LV+E++ + ++++ PLP KG+A H+ V++RD K
Sbjct: 83 LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQ 139
Query: 89 NILLDADYNA-KLSDFGLAKDG--PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDV 144
N+L+D K++D GL + P TH + T Y APE ++ H ++ D+
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWYRAPEVLLGSTHYSTPVDI 195
Query: 145 YSFGVVLLEMLTG 157
+S G + EM
Sbjct: 196 WSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 54/172 (31%), Positives = 77/172 (44%), Gaps = 26/172 (15%)
Query: 3 QAEVNFLGDLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLP 52
+ E+N L H N+ G I+ DDQ LV EF GS+ + + +L
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 53 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112
W I +GLA LH VI+RD K N+LL + KL DFG++ +
Sbjct: 120 EDWI--AYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QL 171
Query: 113 DKTHVSTR--VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 157
D+T V R +GT + APE + RSD++S G+ +EM G
Sbjct: 172 DRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 18/165 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGY----CIEDDQRLL----VYEFMPRG--SLENHLFRRSLPLP 54
E+ + +L H+N++ L Y C + +++ + V EF+P+ H R + LP
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168
Query: 55 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGD 113
+ + + LA++H + + +RD K N+L+D + + KL DFG AK+ G
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 114 KTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 157
+ S + + Y APE ++ + T+ D++S G ++ EM+ G
Sbjct: 226 R---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 36/119 (30%), Positives = 47/119 (39%), Gaps = 32/119 (26%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------------DGPEGD 113
L +LH ++YRD K NILL + LSDF L+K G
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 114 KTH----------VSTRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
+ S R GT Y APE + GH S D ++ G++L EML G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE ++ D++S G ++ EM+ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 9/156 (5%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIAL 63
E + L L H N+V L + V+E+M L ++ + L P+++R+
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMF 110
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+GLA++H + +++RD K N+L+ KL+DFGLA+ +T+ S V
Sbjct: 111 QLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-- 165
Query: 124 TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
T Y P+ ++ +S D++ G + +EML G+
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 41/168 (24%), Positives = 67/168 (39%), Gaps = 21/168 (12%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--LPWSIRMK 60
Q E+ L H N++ + I D + +V M GS E+ L + P LP
Sbjct: 47 QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAF 105
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV--- 117
I L ++H + I+R K S+ILL D LS + + K
Sbjct: 106 ILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 118 -----STRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTG 157
S + + + +PE + + G+ +SD+YS G+ E+ G
Sbjct: 163 DFPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 14 HLNLVKLIGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR--MKIAL 63
H N+V+L+ C D+ L LV+E + + L + LP P +I+ M+ L
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKDLMRQLL 117
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+G+ FLH +++RD K NIL+ +D K++DFGLA+ T V+
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVV 168
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154
T Y APE ++ + D++S G + E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 51/185 (27%), Positives = 78/185 (42%), Gaps = 36/185 (19%)
Query: 18 VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 70
+ + Y +D+ L LV ++ G L L + LP + M IA+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 126
++H RD K NIL+D + + +L+DFG L +DG T S+ +GT
Sbjct: 123 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 168
Query: 127 YAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
Y +PE + G D +S GV + EML G P +LVE +
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMN 222
Query: 182 ERRRF 186
+ RF
Sbjct: 223 HKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 42/244 (17%)
Query: 3 QAEVNFLGDLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLP 52
+ E+N L H N+ G I+ DDQ LV EF GS+ + + +L
Sbjct: 50 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 109
Query: 53 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112
W I +GL+ LH+ VI+RD K N+LL + KL DFG++ +
Sbjct: 110 EEWI--AYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QL 161
Query: 113 DKTHVSTR--VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTGRRSMDKNR 165
D+T V R +GT + APE + +SD++S G+ +EM G +
Sbjct: 162 DRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
Query: 166 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
P L+ R PRL+ S K ++K CL ++ RP
Sbjct: 221 PMRALFLIP-------------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTE 264
Query: 226 EVVE 229
++++
Sbjct: 265 QLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ + ++ H N++ L+ +E D LV + M L+ + R + L S I L
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQ 127
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DGPEGDKTH 116
GL LH+ ++RD +NI +++ K++DFGLA+ D D+T
Sbjct: 128 ILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 117 VSTRVMG----TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
M T Y APE +M D++S G + E+LTG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q E+ + + H N+V G + ++ + E+ GSL++ ++ + PL +
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVC 112
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+GLA+LH + + ++RD K +NILL + + KL+DFG+A S +
Sbjct: 113 RETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FI 167
Query: 123 GTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEM 154
GT + APE G D+++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 9 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 68
+ L H +LVKL G C+ D + ++V E++ G L+ L R + ++ +A A
Sbjct: 55 MSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASA 113
Query: 69 LAFLHEEAERPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDGPEGDKTHVSTRV 121
L +L ++ +++ + NIL+ N KLSD G+ + R+
Sbjct: 114 LHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI 168
Query: 122 MGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
+ APE + G LT +D +SFG LLE+ + NGE L +
Sbjct: 169 ----PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS-- 212
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA---HCLSRDPKARP 222
E+ RFY+ + H A+LA C + DP RP
Sbjct: 213 -SEKERFYQ------DQH--RLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 53/169 (31%), Positives = 72/169 (42%), Gaps = 19/169 (11%)
Query: 3 QAEVNFLGDLV-HLNLVKLIG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPL 53
+AE N L L H N+VK G Y +D DQ LV E GS L +R +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
I I A GL LH I+RD K +NILL + KL DFG++
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTS 176
Query: 114 KTHVSTRVMGTYGYAAPEYV-----MTGHLTSRSDVYSFGVVLLEMLTG 157
+GT + APE + + +R DV+S G+ +E+ G
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 11/157 (7%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKI 61
E+ L L N+V+L + LV+E++ + LE +P P +R I
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI 106
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
K + + H+ +++RD K N+L+ + KL DFG A++ EG + T
Sbjct: 107 -YQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEY 161
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
+ T Y +PE ++ D++S G +L E+ G+
Sbjct: 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 124
A G+ FL A + ++RD N+L+ K+ DFGLA+D D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLP 304
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ APE + T+ SDV+SFG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 57
E L + H N+V D +V E+ G L LF L W +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT 115
+M + G+ +HE + V++RD K+ NI L + KL DFG A+ P
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 164
+ T V GT Y PE ++SD++S G +L E+ T + N
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 52/208 (25%), Positives = 79/208 (37%), Gaps = 60/208 (28%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 70
+VKL Y +D L V +++P G + + L F L + + A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------------DGPEGDKTH 116
F+H RD K NIL+D D + KL+DFGL D D
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 117 VSTRV---------------------------MGTYGYAAPEYVM-TGHLTSRSDVYSFG 148
S +GT Y APE ++ TG+ T D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVG 231
Query: 149 VVLLEMLTGRRSMDKNRPNG-EHNLVEW 175
V+L EML G+ + P + ++ W
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
APE ++ D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 128 AAPEYVMTGHLTSRSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 171
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 172 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 221
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 302
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 61/207 (29%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWS 56
+AE + L + + +VKL Y +D L V +++P G + + L R L +
Sbjct: 49 KAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYI 107
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---------- 106
+ +A+ + + F+H RD K NIL+D D + KL+DFGL
Sbjct: 108 AELTLAIESVHKMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158
Query: 107 ---------KDGPE-------------GD----------KTH---VSTRVMGTYGYAAPE 131
+D E GD K H ++ ++GT Y APE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218
Query: 132 YVMTGHLTSRSDVYSFGVVLLEMLTGR 158
++ T D +S GV+L EML G+
Sbjct: 219 VLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVSTRVM 122
K L +H + +RD K NIL+ D KL+DFG + P + ++STR
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--YISTR-- 162
Query: 123 GTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 156
Y APE ++T G+ + D+++ G V E+L+
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 23 YCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSI-RMKIALGAAKGLAFLHEEAERP 79
+C + +R L V E++ G L + LP + RM A L +LH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG--- 121
Query: 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDG--------PEGD-----KTHVSTRVMGTYG 126
+++RD K N+L+ + + KL+DFGL+K G EG + + +V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 127 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
Y APE ++ D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-06
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRM 59
E L L H +VK +E D ++ E+ L+ L ++L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
I L G+ ++H+ R +++RD K NI L + K+ DFG+++ ++T
Sbjct: 112 FIQL--LLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLAT 163
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154
GT Y +PE + S+SD++S G +L EM
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73
H++L + G C+ + ++V EF+ G L+ L + +P + ++ +A A L++L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 74 EEAERPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
+ + +++ + NILL A+ + KLSD G++ ++ RV
Sbjct: 135 D---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-----RV-ERIP 185
Query: 127 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 185
+ APE V G L++ +D +SFG LLE+ +GE L E E+ R
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EKER 232
Query: 186 FY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
FY RL +P ++ A L + CL+ +P RP
Sbjct: 233 FYEKKHRLPEP---------SCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 44/151 (29%), Positives = 65/151 (43%), Gaps = 30/151 (19%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEE 75
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125
Query: 76 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 131
RD K N+LLD + + +L+DFG L DG T S +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPE 173
Query: 132 YVM-----TGHLTSRSDVYSFGVVLLEMLTG 157
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 30/151 (19%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 75
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 76 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 131
RD K N+LLD + + +L+DFG + +DG T S+ +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPE 173
Query: 132 YVMT-----GHLTSRSDVYSFGVVLLEMLTG 157
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 61/207 (29%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHL-----FRRSLPLPWS 56
+AE + L + + +V+L Y +D D V +++P G + + L F L +
Sbjct: 49 KAERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYI 107
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL----------- 105
+ A+ + + F+H RD K NIL+D D + KL+DFGL
Sbjct: 108 AELTCAVESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 106 ---AKDGPEGDKTHVSTR-------------------------------VMGTYGYAAPE 131
+ D D S ++GT Y APE
Sbjct: 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218
Query: 132 YVMTGHLTSRSDVYSFGVVLLEMLTGR 158
++ T D +S GV+L EML G+
Sbjct: 219 VLLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 12/160 (7%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKI 61
E + L + H ++++L G + L+ +PR + + + +R++ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI--CDILAI 187
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + +LHE +I+RD K NI ++ + L DFG A P +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161
GT APE + D++S G+VL EM T S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 46/187 (24%), Positives = 65/187 (34%), Gaps = 62/187 (33%)
Query: 23 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-----LGAAKGLAFLHEEA 76
Y +D Q L L+ EF+P G L L + R +A + A L F+H
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH--- 124
Query: 77 ERPVIYRDFKTSNILLDADYNAKLSDFGL---------------------AKDGPEGDKT 115
RD K NIL+D + KLSDFGL K+ + +
Sbjct: 125 ------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 116 HV-------------------STRVM-----GTYGYAAPEYVMTGHLTSRS-DVYSFGVV 150
+ R+M GT Y APE + + D +S G +
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAI 237
Query: 151 LLEMLTG 157
+ E L G
Sbjct: 238 MFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 5 EVNFLGDLVHLNLVKL--------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 56
E+ LG L H N++K+ Y I +Y FM + + + PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQ 268
Query: 57 IR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 114
R MK L A + ++H+ + +I+RD K NI L+ D L DFG A E ++
Sbjct: 269 TRAIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKER 321
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+GT +PE + +D++S G++LL+ML+
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 25/92 (27%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 126
+GL+++H+ R +++RD K N+L+ KL+DFGLA+ + +H + + T
Sbjct: 114 RGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLW 168
Query: 127 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 157
Y P+ ++ + ++ D++ G + +EM+ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 37/150 (24%), Positives = 72/150 (48%), Gaps = 8/150 (5%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 71
L H +LV G C+ D+ ++V E++ GSL+ +L + + S ++++ AK LA+
Sbjct: 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAW 111
Query: 72 -LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYA 128
LH ++ + + + N+LL + + K + K G V + + +
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 129 APEYVMTG-HLTSRSDVYSFGVVLLEMLTG 157
PE + +L+ +D +SFG L E+ +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 3/115 (2%)
Query: 39 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 98
R L +L R PL + +A + ++H E +I+RD KT N+L++ +
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDI 299
Query: 99 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153
L DFG A T + GT APE + T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 21/136 (15%)
Query: 36 FMPRGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 93
FM GS N L + P + ++ I GA +GL +LH+ I+R+ K S+IL+
Sbjct: 80 FMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 94 ADYNAKLSD----FGLAKDGPEG----DKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 142
D LS + L ++G + D ST V+ + +PE + + G+ +S
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKS 191
Query: 143 DVYSFGVVLLEMLTGR 158
D+YS G+ E+ TGR
Sbjct: 192 DIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 33/188 (17%)
Query: 5 EVNFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRM 59
EVN + +L H N+V+ I + + +Q+L ++ EF G L ++ ++ + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 60 KIALGAAKGLAFLHEEAERP----VIYRDFKTSNILLD----------ADYN-------A 98
I LA+ H + P V++RD K NI L A N A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 99 KLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEML 155
K+ DFGL+K+ G E ++ +GT Y +PE ++ T +SD+++ G ++ E+
Sbjct: 182 KIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 156 TGRRSMDK 163
+G+ K
Sbjct: 238 SGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 31/116 (26%), Positives = 57/116 (49%), Gaps = 11/116 (9%)
Query: 48 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDF 103
++ + LP S+ + G+ +LH V++RD K +NIL+ + K++D
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156
Query: 104 GLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 156
G A+ + P + V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 157 GFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.33 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.09 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.73 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.77 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.39 | |
| PLN02236 | 344 | choline kinase | 96.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.64 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.19 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.18 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.11 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.06 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.44 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.35 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.13 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.79 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.62 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.62 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.47 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.87 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.87 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.78 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.11 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 90.33 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=336.64 Aligned_cols=211 Identities=27% Similarity=0.402 Sum_probs=177.3
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCe-eEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAER 78 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~ 78 (306)
++.+|+++|+.++||+||++||.|..+.. ..|+||||++|||++++.+- +++++.....++.+|++||.|||+ .+
T Consensus 123 Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~-- 199 (364)
T KOG0581|consen 123 QILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK-- 199 (364)
T ss_pred HHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--
Confidence 35799999999999999999999999994 99999999999999988655 579999999999999999999996 66
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||||+||||+..|.|||||||.+...... ....++||..|||||.+.+..|+.++||||||+.++|+++|+
T Consensus 200 -IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~Gr 274 (364)
T KOG0581|consen 200 -IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGR 274 (364)
T ss_pred -eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCC
Confidence 999999999999999999999999999886543 456789999999999999999999999999999999999999
Q ss_pred CCCCCCCC--CCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRP--NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||..... .+...+..+... -..|.+... ..++++.+|+..||++||.+|||+.|+++|..
T Consensus 275 fP~~~~~~~~~~~~~Ll~~Iv~----------~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 275 FPYPPPNPPYLDIFELLCAIVD----------EPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCCCCcCCCCCCHHHHHHHHhc----------CCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 99977521 111122211110 011222221 35789999999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=349.00 Aligned_cols=206 Identities=26% Similarity=0.403 Sum_probs=178.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..+|++|.++|+|||||+++++|++.++.|||+|+|..++|..+++ +.+.+++.++..+++||+.||.|||+.+ |+
T Consensus 65 v~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---Ii 140 (592)
T KOG0575|consen 65 VLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---II 140 (592)
T ss_pred HHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ce
Confidence 4689999999999999999999999999999999999999999997 5568999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||||..|+|++++..|||+|||+|+.+...+. .....|||+.|+|||++.....+..+||||+|||+|-||+|++||
T Consensus 141 HRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPF 218 (592)
T KOG0575|consen 141 HRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPF 218 (592)
T ss_pred ecccchhheeecCcCcEEecccceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCc
Confidence 999999999999999999999999998764422 234579999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+.....+....+.... . .++...+.++.+||.++|+.||.+|||+++|+.|-
T Consensus 219 etk~vkety~~Ik~~~-----------Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 219 ETKTVKETYNKIKLNE-----------Y-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred ccchHHHHHHHHHhcC-----------c-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 8764433222221111 0 12234467899999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=338.04 Aligned_cols=209 Identities=27% Similarity=0.376 Sum_probs=173.7
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
++|++||++|+|||||+++++|...+..|+||||+.||+|.+++..++ .+.+..-+.++.|++.||.|||+.| |+|
T Consensus 224 ~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~H 299 (475)
T KOG0615|consen 224 QNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIH 299 (475)
T ss_pred HHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---ccc
Confidence 699999999999999999999999999999999999999999997665 6888888999999999999999999 999
Q ss_pred ccCCCCCeEEcCC---CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC---CCchhHHHHHHHHHHHHHh
Q 021891 83 RDFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 83 ~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ellt 156 (306)
|||||+|||+..+ ..+||+|||+|+..... ......|||+.|.|||++.+.. +..++||||+||++|-+++
T Consensus 300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs 376 (475)
T KOG0615|consen 300 RDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS 376 (475)
T ss_pred ccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence 9999999999766 67899999999986532 3456689999999999998653 3458999999999999999
Q ss_pred CCCCCCCCCCCC-CcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 157 GRRSMDKNRPNG-EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 157 g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|.+||....... ....+...... +. .....+.+++..+||.+||..||++|||+.|+|+|.+
T Consensus 377 G~pPFS~~~~~~sl~eQI~~G~y~----------f~----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 377 GYPPFSEEYTDPSLKEQILKGRYA----------FG----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred cCCCcccccCCccHHHHHhcCccc----------cc----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 999998654332 11221111110 11 1123456789999999999999999999999999754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=335.07 Aligned_cols=233 Identities=60% Similarity=1.009 Sum_probs=203.7
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
||.+|+++|.+++|||+|+++|||.+.+ ..+||+||++.|+|.+++..... .++|..+.+|+.++|.||+|||+...+
T Consensus 117 eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~ 196 (361)
T KOG1187|consen 117 EFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP 196 (361)
T ss_pred HHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence 5999999999999999999999999998 59999999999999999987765 899999999999999999999998877
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
+|||||||++|||+|+++..||+|||+|+......... .....||.+|+|||++..+..+.|+||||||+++.||+||+
T Consensus 197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr 275 (361)
T KOG1187|consen 197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGR 275 (361)
T ss_pred CEecCCCCHHHeeECCCCCEEccCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCC
Confidence 89999999999999999999999999997654311111 11117999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccC-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE-GHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
.+.......+......|....+... .+.+++|+.+. ..+.. .....+..+..+|++.+|.+||++.|+++.|+.+.
T Consensus 276 ~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 276 KAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9888766666666888887777665 78899999987 55654 67788999999999999999999999999985543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=334.85 Aligned_cols=215 Identities=34% Similarity=0.573 Sum_probs=179.6
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+|.+|+.+|.+|+|||||+++|+|.+.. .+++||||+++|+|.+++.+ ....+++..+..|+.||+.||.|||++++
T Consensus 85 ~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~- 163 (362)
T KOG0192|consen 85 AFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP- 163 (362)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-
Confidence 4899999999999999999999999887 79999999999999999987 46789999999999999999999999874
Q ss_pred CeEeccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcceeeecccccccccCCcchh--cCCCCchhHHHHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell 155 (306)
|||||||++|||++.++ ++||+|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+
T Consensus 164 -iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~ 240 (362)
T KOG0192|consen 164 -IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL 240 (362)
T ss_pred -eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH
Confidence 89999999999999998 99999999998754321 2233367999999999999 569999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
||+.||....... ...... . ....+ .++..++..+..|+.+||..||..||++.+++..|+.+.
T Consensus 241 t~~~Pf~~~~~~~---~~~~v~-~--------~~~Rp----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 241 TGEIPFEDLAPVQ---VASAVV-V--------GGLRP----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HCCCCCCCCCHHH---HHHHHH-h--------cCCCC----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 9999998765411 111110 0 01111 122235678999999999999999999999999987544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=319.03 Aligned_cols=207 Identities=29% Similarity=0.449 Sum_probs=172.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+..|++||+.|+|||||++++++..++.+|+|||||.||+|.++|.+++ .+++..+..++.||+.||++||+++ ||
T Consensus 56 L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---Ii 131 (429)
T KOG0595|consen 56 LLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---II 131 (429)
T ss_pred HHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 4689999999999999999999999999999999999999999997765 7999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCC------CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDAD------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 82 H~dlkp~Nill~~~------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
||||||+|||++.+ -.+||+|||+|+.+..+. .....+|++.|||||++...+|+.|+|+||+|+|+|+|+
T Consensus 132 HRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l 208 (429)
T KOG0595|consen 132 HRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCL 208 (429)
T ss_pred eccCCcceEEeccCCCCCCCceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHH
Confidence 99999999999765 458999999999986443 345689999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|+.||......+....++. +.......+...+..+.+|+...|+.++.+|-++.+-..+
T Consensus 209 ~g~~Pf~a~t~~eL~~~~~k---------------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 209 TGKPPFDAETPKELLLYIKK---------------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hCCCCccccCHHHHHHHHhc---------------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 99999986655433221111 1111222233334556688888888888888877776654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=313.48 Aligned_cols=222 Identities=25% Similarity=0.322 Sum_probs=181.1
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|+++|++|+|+|+|.++++|.....+++|+|||+. ++.+.+.+....++.+.+..++.|++.|+.|+|+++ +||
T Consensus 49 lREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IH 124 (396)
T KOG0593|consen 49 LREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIH 124 (396)
T ss_pred HHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eec
Confidence 5899999999999999999999999999999999976 666667788788999999999999999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||||+||||+.+|.+||||||.|+...... ...+..+.|.||+|||.+.+ .+|+..+||||+||++.||++|.+.|
T Consensus 125 RDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~ 202 (396)
T KOG0593|consen 125 RDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW 202 (396)
T ss_pred ccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence 9999999999999999999999999876422 22345678999999999987 68999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhcc--------ccccccc--cCCccCCCCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGE--------RRRFYRL--IDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
.+..+.+....+......+.. ...|..+ ..+...+... ...+.-+.+|+++||+.||++|++.++++
T Consensus 203 PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 203 PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred CCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 998877766555433322211 1111111 1111111111 13355889999999999999999999999
Q ss_pred HH
Q 021891 229 EA 230 (306)
Q Consensus 229 ~~ 230 (306)
.|
T Consensus 283 ~H 284 (396)
T KOG0593|consen 283 HH 284 (396)
T ss_pred cC
Confidence 75
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=309.21 Aligned_cols=212 Identities=26% Similarity=0.360 Sum_probs=170.0
Q ss_pred HHHHHHHHhcCCCCcccceee-EEEeCCe-eEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIG-YCIEDDQ-RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~-~~~~~~~-~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+..|+.+|++|+|||||++|+ .|.+++. ++||||||.+|+|...+.. ..+.+++..+|+++.|++.||..+|+.-
T Consensus 65 ~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~ 144 (375)
T KOG0591|consen 65 CVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI 144 (375)
T ss_pred HHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc
Confidence 467999999999999999999 4444444 8999999999999998853 4567999999999999999999999943
Q ss_pred CC-CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 77 ER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 77 ~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
++ .|+||||||.|||++.+|.+||+|||+++.+... .......+||+.||+||.+.+.+|+.|+||||+||++|||+
T Consensus 145 ~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc 222 (375)
T KOG0591|consen 145 PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC 222 (375)
T ss_pred cccceeeccCcchheEEcCCCceeeccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 22 2999999999999999999999999999986542 33345689999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.-++||.+.+-......+. + .. -++++ ..-.+.++..||..|+..||+.||+...++..+
T Consensus 223 aL~~PF~g~n~~~L~~KI~-------q-gd-----~~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 223 ALQSPFYGDNLLSLCKKIE-------Q-GD-----YPPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred hcCCCcccccHHHHHHHHH-------c-CC-----CCCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 9999998762211111110 0 00 01111 145678999999999999999999855555443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=317.30 Aligned_cols=216 Identities=30% Similarity=0.424 Sum_probs=173.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC--eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|+++|++|+|||||+++|...... .++++|||+++|+|.+++.+.+..+++..+..+.+||++||.|||+++
T Consensus 61 l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--- 137 (313)
T KOG0198|consen 61 LEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--- 137 (313)
T ss_pred HHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 689999999999999999999855544 689999999999999999877658999999999999999999999998
Q ss_pred eEeccCCCCCeEEcC-CCcEEEeccCCcccCCC-CCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+|||++. ++.+||+|||++..... ...........||+.|||||++..+ ....++|||||||++.||+|
T Consensus 138 ~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 138 IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 999999999999999 79999999999987653 1111223347899999999999853 34459999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|++||... ... ..+...... ......++...+.++.+|+.+|+..||++|||+.++|+|.....
T Consensus 218 g~~PW~~~--~~~---~~~~~~ig~----------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 218 GKPPWSEF--FEE---AEALLLIGR----------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCCcchhh--cch---HHHHHHHhc----------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 99999764 111 111110000 00111344456789999999999999999999999999875433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=324.94 Aligned_cols=214 Identities=33% Similarity=0.479 Sum_probs=177.4
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.|.+|+++|++|+|+|||+++++|..++.++||||||+.|+|.++|.. .+..+...+...++.||++|++||++++
T Consensus 247 ~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--- 323 (468)
T KOG0197|consen 247 AFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--- 323 (468)
T ss_pred HHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---
Confidence 378999999999999999999999998899999999999999999986 4667999999999999999999999999
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
+|||||.+.||||+++..+||+|||+|+...+. .........-...|.|||.+..+.|+.|+|||||||+||||+| |+
T Consensus 324 ~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~ 402 (468)
T KOG0197|consen 324 YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR 402 (468)
T ss_pred ccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence 999999999999999999999999999954433 2222222223557999999999999999999999999999999 77
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
.|+.+....+....+ .+.+++..| ..++..+.+++..||+.+|++|||++.+...|+.+.
T Consensus 403 ~py~~msn~ev~~~l----------e~GyRlp~P-------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 403 VPYPGMSNEEVLELL----------ERGYRLPRP-------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCCHHHHHHHH----------hccCcCCCC-------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 777765433222211 111233333 345789999999999999999999999988876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=320.60 Aligned_cols=221 Identities=25% Similarity=0.323 Sum_probs=180.7
Q ss_pred HHHHHHHhcCC-CCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLV-HLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~-H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.||++-|++|+ |||||++.+++.+.+ .+|+|||||+ .+|.++++.+++.|++..+..|+.||++||+|+|.+| +
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---f 131 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---F 131 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 58999999998 999999999999988 9999999995 6999999999989999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~ 159 (306)
.|||+||+|||+..+..+||+|||+||..... ...+..+.|.||+|||++. ...|+.++|||++|||++|+.+-++
T Consensus 132 FHRDlKPENiLi~~~~~iKiaDFGLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP 208 (538)
T KOG0661|consen 132 FHRDLKPENILISGNDVIKIADFGLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP 208 (538)
T ss_pred ccccCChhheEecccceeEecccccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc
Confidence 99999999999998999999999999986432 2334567899999999987 5688999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhh-----hhcccccccccc--------CCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 160 SMDKNRPNGEHNLVEWARP-----HLGERRRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
.|.+.+..+....+-.+.. .+.+...+...+ ...+..-++ ..+.++.+||.+||.+||++|||+.|
T Consensus 209 LFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 209 LFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred cCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHH
Confidence 9999877665444322221 111111111111 111111122 26789999999999999999999999
Q ss_pred HHHHh
Q 021891 227 VVEAL 231 (306)
Q Consensus 227 ll~~l 231 (306)
++++.
T Consensus 288 al~~p 292 (538)
T KOG0661|consen 288 ALQHP 292 (538)
T ss_pred HhcCc
Confidence 99975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=326.64 Aligned_cols=208 Identities=26% Similarity=0.379 Sum_probs=178.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+|+.++|+|||.+++.|...+.+|+||||++||+|.|.+... .+++.++..+++.++.||+|||.++ |+
T Consensus 317 ilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---Ii 391 (550)
T KOG0578|consen 317 LLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---II 391 (550)
T ss_pred hHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---ee
Confidence 468999999999999999999999999999999999999999988654 4899999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||||.+|||++.+|.+||+|||++..+..... .....+||+.|||||++....|+.|+||||||++++||+-|.+||
T Consensus 392 HrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY 469 (550)
T KOG0578|consen 392 HRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY 469 (550)
T ss_pred eeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc
Confidence 999999999999999999999999988765443 345578999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...++.....++. .. ....-..+...+..+.+|+.+||+.|+++|+++.|||+|-
T Consensus 470 lnE~PlrAlyLIa----~n-----------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 470 LNENPLRALYLIA----TN-----------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred cCCChHHHHHHHh----hc-----------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 8754432222221 10 0011112334578999999999999999999999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=310.04 Aligned_cols=199 Identities=30% Similarity=0.395 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.++|..||.+++||.||+++-.|++.+++|+|+||+.||.|..+|.+.+ .+++..+..++..|+.||.|||+++ ||
T Consensus 72 ~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g---Ii 147 (357)
T KOG0598|consen 72 TKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG---II 147 (357)
T ss_pred HHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3689999999999999999999999999999999999999999996554 7999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||+|.+|+++|+|||+++.....+ .....++||+.|||||++.+..|+..+|.||||+++|||++|.+||
T Consensus 148 yRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF 225 (357)
T KOG0598|consen 148 YRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPF 225 (357)
T ss_pred eccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCC
Confidence 99999999999999999999999998643322 2344589999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
...+.......+ ...+ ....+.-.+.++++++.++|+.||++|..
T Consensus 226 ~~~~~~~~~~~I------~~~k-----------~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 226 YAEDVKKMYDKI------LKGK-----------LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred cCccHHHHHHHH------hcCc-----------CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 876433221111 1111 01111123578899999999999999964
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=290.99 Aligned_cols=221 Identities=24% Similarity=0.350 Sum_probs=180.6
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|++.|+.++|+||+.++|+|.+.+.+.||+||++ .+|...++.+...++...+..++.++++||+|||++. |+|
T Consensus 49 lREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlH 124 (318)
T KOG0659|consen 49 LREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILH 124 (318)
T ss_pred HHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhc
Confidence 589999999999999999999999999999999996 5999999888889999999999999999999999988 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||||+|+|++.+|.+||+|||+|+.+......... .+-|.+|+|||++.| ..|+..+||||+|||+.||+-|.+.|
T Consensus 125 RDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f 202 (318)
T KOG0659|consen 125 RDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF 202 (318)
T ss_pred ccCCccceEEcCCCcEEeecccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence 999999999999999999999999998765544332 256999999999986 57999999999999999999999988
Q ss_pred CCCCCCCCcchHHhhh--h---hh------ccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWAR--P---HL------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~--~---~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.+.++-+....+-... + .| .+...+.....+.. ...-...+.++.+|+.+||..||.+|+|+.|++++
T Consensus 203 pG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 203 PGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 8876655443331111 1 11 11111211111222 22334556788999999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=315.57 Aligned_cols=222 Identities=23% Similarity=0.280 Sum_probs=177.3
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.+||.||++|+||||+++.+...+. ..+|+|+|||+. +|.-++...+..|++.+++.++.||+.||+|||+++ |
T Consensus 164 ~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---v 239 (560)
T KOG0600|consen 164 IREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---V 239 (560)
T ss_pred HHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---e
Confidence 5899999999999999999998876 689999999965 999999888888999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~ 159 (306)
+|||||.+|||||.+|.+||+|||+|+.+....... .+..+-|.||+|||++.|. .|+.++|+||+||||.||++|++
T Consensus 240 lHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 240 LHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 999999999999999999999999999876655443 3344569999999999865 79999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhh-----hhcccccc--ccccCCccC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 160 SMDKNRPNGEHNLVEWARP-----HLGERRRF--YRLIDPRLE-----GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
.|.+....+....+--.-. .|. ...+ ...+.+... .+.-...+....+|+..||..||.+|.|+.++
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a 397 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA 397 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence 9998766554433311100 010 0000 011111110 00112235678899999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
++.
T Consensus 398 L~s 400 (560)
T KOG0600|consen 398 LQS 400 (560)
T ss_pred hcC
Confidence 974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=314.07 Aligned_cols=207 Identities=26% Similarity=0.343 Sum_probs=176.2
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..|-+.|.+| .||.|+++|-.|.++..+|+|+||+++|+|.++|.+.+ .|++.....++.+|+.||+|||+.| ||
T Consensus 121 ~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~G---II 196 (604)
T KOG0592|consen 121 TREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNG---II 196 (604)
T ss_pred hHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcC---ce
Confidence 3677889999 89999999999999999999999999999999997665 7999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-----------eeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-----------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
||||||+|||+|.+|++||+|||.|+.+.+.... .....++||..|.+||++.....+..+|||+||||
T Consensus 197 HRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCi 276 (604)
T KOG0592|consen 197 HRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCI 276 (604)
T ss_pred eccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHH
Confidence 9999999999999999999999999876553322 11144899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|+|+.|.+||.+.+..-..+.+... +-.+ +...++.+.+|+.++|..||.+|+|+++|.+|
T Consensus 277 lyQmlaG~PPFra~NeyliFqkI~~l--------------~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 277 LYQMLAGQPPFRAANEYLIFQKIQAL--------------DYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHhcCCCCCccccHHHHHHHHHHh--------------cccC----CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 99999999999877654332222211 1222 22334788999999999999999999998886
Q ss_pred h
Q 021891 231 L 231 (306)
Q Consensus 231 l 231 (306)
.
T Consensus 339 p 339 (604)
T KOG0592|consen 339 P 339 (604)
T ss_pred c
Confidence 4
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=305.55 Aligned_cols=218 Identities=27% Similarity=0.370 Sum_probs=177.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|++.|+.++||||++++..|..+..+|+||.||.+||+.+++... ...+++..+..+++++++||.|||.+| .
T Consensus 71 l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~ 147 (516)
T KOG0582|consen 71 LRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---H 147 (516)
T ss_pred HHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 689999999999999999999999999999999999999999999754 446999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCC-cceee-ecccccccccCCcchh--cCCCCchhHHHHHHHHHHHHHh
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVS-TRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+.||||+.+|.|||+|||.+..+.+.+ ..... +.+.||++|||||++. ...|+.|+|||||||...||.+
T Consensus 148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 999999999999999999999999886654433 22222 5578999999999965 4589999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|..||....+....-. .+.+... ...-.....+.....+..+.+++..||++||.+|||+++++++
T Consensus 228 G~aPf~k~pPmkvLl~------tLqn~pp--~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 228 GHAPFSKYPPMKVLLL------TLQNDPP--TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCCcccCChHHHHHH------HhcCCCC--CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 9999988765433211 1111111 0000111122233445689999999999999999999999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=314.12 Aligned_cols=209 Identities=26% Similarity=0.354 Sum_probs=174.6
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|+.+++.++ ||||+++++++.....+++|||||.||+|.+++.+ ..++.+..+..++.|++.|++|||+.+ |
T Consensus 66 i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i 141 (370)
T KOG0583|consen 66 IKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---I 141 (370)
T ss_pred hHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---E
Confidence 458999999998 99999999999999999999999999999999988 568999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC-CC-chhHHHHHHHHHHHHHhC
Q 021891 81 IYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LT-SRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~elltg 157 (306)
+||||||+|||++.+ +.+||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+|+++|.|++|
T Consensus 142 ~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G 219 (370)
T KOG0583|consen 142 VHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCG 219 (370)
T ss_pred eeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhC
Confidence 999999999999999 999999999999863 1122345679999999999999877 86 789999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG-AQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
..||...........+. ...- . ++... +.++.+|+.+||..||.+|+|+.+++++-+-.
T Consensus 220 ~~PF~d~~~~~l~~ki~------~~~~--------~----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 220 RLPFDDSNVPNLYRKIR------KGEF--------K----IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred CCCCCCccHHHHHHHHh------cCCc--------c----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 99998733221111100 0000 1 11122 57899999999999999999999999765433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=320.98 Aligned_cols=206 Identities=29% Similarity=0.409 Sum_probs=176.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.++|+-||+-|.||||+++|++++++.++|+|.||++||.|.+++.+++ ++++..+.++++||+.|+.|||..+ |+
T Consensus 59 IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---ic 134 (786)
T KOG0588|consen 59 IEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---IC 134 (786)
T ss_pred hhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ce
Confidence 3689999999999999999999999999999999999999999997776 7999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCC-chhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~p 160 (306)
||||||+|+|+|..+.+||+|||+|..-..+. ....-||++.|.|||++.|.+|+ .++||||.|||||.|+||+.|
T Consensus 135 HRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP 211 (786)
T KOG0588|consen 135 HRDLKPENLLLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP 211 (786)
T ss_pred eccCCchhhhhhcccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC
Confidence 99999999999999999999999998754432 34456899999999999999985 689999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|.+.+.......+. .+.| +++...+.++.+||.+||..||.+|.|++||++|..
T Consensus 212 FdDdNir~LLlKV~--------~G~f----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 212 FDDDNIRVLLLKVQ--------RGVF----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CCCccHHHHHHHHH--------cCcc----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 98543322111111 1111 123345678999999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=308.17 Aligned_cols=205 Identities=27% Similarity=0.363 Sum_probs=177.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++|++.|+|||||.++++|++..++|+|+|||.| +|..++...+ .++++.+..++.|++.||.|||+.+ |+
T Consensus 48 l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~r---il 122 (808)
T KOG0597|consen 48 LRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNR---IL 122 (808)
T ss_pred HHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcC---cc
Confidence 67999999999999999999999999999999999976 9999996554 7999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||+||.|||++.+|.+|+||||+|+.... .+...+...||+.|||||++.+..|+..+|+||||||+|||++|++||
T Consensus 123 hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 123 HRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred cccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence 999999999999999999999999998654 455667788999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...... ..+.... .++. .++...+..+..|+..+|.+||..|.|+.+++.|.
T Consensus 201 ~a~si~------~Lv~~I~---------~d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 201 YARSIT------QLVKSIL---------KDPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred hHHHHH------HHHHHHh---------cCCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 754221 1111111 1111 13446678999999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=288.66 Aligned_cols=212 Identities=28% Similarity=0.373 Sum_probs=176.1
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|..+|+.+.||.++++++.|.+.+.+|+||||++||.|..++++.+ ++++..+..++.||+.||+|||+.+ |++
T Consensus 92 ~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~---iiY 167 (355)
T KOG0616|consen 92 HNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD---IIY 167 (355)
T ss_pred hhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC---eee
Confidence 579999999999999999999999999999999999999999996554 8999999999999999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
|||||+|||+|++|.+||+|||.|+..... .-..|||+.|+|||++....|+.++|.||||+++|||+.|.+||.
T Consensus 168 RDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 168 RDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred ccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999986543 345789999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCCCCCCCCC
Q 021891 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLKDMA 241 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~ell~~l~~~~~~~~~~ 241 (306)
..++....+.+ ..... .++.-.+.++.+|+.++|+.|-.+|. +...=.+.++..+++....
T Consensus 243 ~~~~~~iY~KI------~~~~v------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 243 DDNPIQIYEKI------LEGKV------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred CCChHHHHHHH------HhCcc------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 87663221111 11111 13444457899999999999999994 3333334444455554443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=307.52 Aligned_cols=207 Identities=27% Similarity=0.368 Sum_probs=178.7
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCe-eEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.+|+.+++++.|||||.+++.|..++. ++|||+||+||+|.+.+.+.. ..++++.+..|+.|++.|+.|||++. |
T Consensus 51 ~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---i 127 (426)
T KOG0589|consen 51 IQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---V 127 (426)
T ss_pred HHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---h
Confidence 579999999999999999999999888 999999999999999997654 67999999999999999999999888 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|||||+.|||++.++.|||+|||+|+...... .......||+.||.||++.+.+|+.|+|||||||++|||++-+++
T Consensus 128 LHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~a 205 (426)
T KOG0589|consen 128 LHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPA 205 (426)
T ss_pred hcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccc
Confidence 999999999999999999999999999876543 134457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|...+-......+ ........+...+.++..||+.||..+|..||++.+++.+.
T Consensus 206 F~a~~m~~Li~ki-----------------~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 206 FKASNMSELILKI-----------------NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred cCccchHHHHHHH-----------------hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 9875432211111 11112234556678999999999999999999999999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=289.29 Aligned_cols=222 Identities=23% Similarity=0.276 Sum_probs=178.7
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.+||.+|.+++|||||.+-.+.... +.+|+|||||+. +|..++....++|...+++.++.|++.||+|||.+. |
T Consensus 123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---i 198 (419)
T KOG0663|consen 123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---I 198 (419)
T ss_pred HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---e
Confidence 6899999999999999999987754 479999999965 999999988889999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~ 159 (306)
+|||||++|+|++..|.+||+|||+|+.+....+. .+..+-|.+|+|||++.+ ..|+.++|+||+|||+.||+++++
T Consensus 199 lHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 199 LHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP 276 (419)
T ss_pred EecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence 99999999999999999999999999998765332 344567999999999986 479999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhh-----hhccc--------cccccccCCccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHH
Q 021891 160 SMDKNRPNGEHNLVEWARP-----HLGER--------RRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
.|.+....+..+.+-.... .|... ..+.......+...|... .++..++|+..+|..||.+|.|++
T Consensus 277 lf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 277 LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred CCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence 9998766555443321110 00000 111111111222233322 467889999999999999999999
Q ss_pred HHHHH
Q 021891 226 EVVEA 230 (306)
Q Consensus 226 ell~~ 230 (306)
|.|+|
T Consensus 357 ~~L~h 361 (419)
T KOG0663|consen 357 DGLKH 361 (419)
T ss_pred Hhhcc
Confidence 99985
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=304.37 Aligned_cols=206 Identities=27% Similarity=0.386 Sum_probs=178.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.++|+.+|.+++++||.++|+.+..+..++++||||.||++.+++... ..+.+..+..++++++.||.|||+++ .+
T Consensus 58 iqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~---ki 133 (467)
T KOG0201|consen 58 IQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK---KI 133 (467)
T ss_pred HHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc---ee
Confidence 578999999999999999999999999999999999999999998544 35689999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||||+.|||+..+|.+||+|||++........ ....++||+.|||||++.+..|+.|+||||||++.+||++|.+|+
T Consensus 134 HrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~ 211 (467)
T KOG0201|consen 134 HRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH 211 (467)
T ss_pred cccccccceeEeccCcEEEEecceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC
Confidence 999999999999999999999999988665433 236789999999999999989999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
....+.-....+ .+...|.+.+ ..+..+.+|+..||.+||+.|||+.++++|
T Consensus 212 s~~hPmrvlflI-------------pk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 212 SKLHPMRVLFLI-------------PKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCcceEEEec-------------cCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 887664322221 1122233333 446789999999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=294.65 Aligned_cols=223 Identities=27% Similarity=0.345 Sum_probs=173.9
Q ss_pred HHHHHHHhcCCCCcccceeeEEEe-----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
.+|+++|+.++|+||+.+++++.. -+..|+|+|+| +.+|.+.+.. ++.++...+..++.|++.||.|+|+.+
T Consensus 69 lRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAn- 145 (359)
T KOG0660|consen 69 LRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSAN- 145 (359)
T ss_pred HHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhccc-
Confidence 489999999999999999999876 24789999999 5699888854 446999999999999999999999999
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHh
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+|++++.+..+||+|||+|+...........+..+.|.+|+|||++. ...|+.+.||||+|||+.||++
T Consensus 146 --ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~ 223 (359)
T KOG0660|consen 146 --VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT 223 (359)
T ss_pred --ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc
Confidence 9999999999999999999999999999875432222234566799999999886 5689999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhcc----------cccccccc----CCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
|++.|.+.+.......+......-.+ .....+-. ...+...++ .....+.+|+.+||..||.+|+
T Consensus 224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRi 302 (359)
T KOG0660|consen 224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRI 302 (359)
T ss_pred CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccC
Confidence 99999987665544433222111000 00000000 011111122 3356889999999999999999
Q ss_pred CHHHHHHHh
Q 021891 223 LMSEVVEAL 231 (306)
Q Consensus 223 s~~ell~~l 231 (306)
|++|+++|.
T Consensus 303 ta~eAL~hP 311 (359)
T KOG0660|consen 303 TAEEALAHP 311 (359)
T ss_pred CHHHHhcCh
Confidence 999999974
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=314.04 Aligned_cols=215 Identities=25% Similarity=0.314 Sum_probs=172.0
Q ss_pred HHHHHHHHhcCC-CCcccceee-EEEeC------CeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIG-YCIED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~-~~~~~------~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~L 72 (306)
.++|+++|++|+ |+|||.|+| ..... ..++|+||||.||+|-|++.++ ...|++.++++|+.|+++||.+|
T Consensus 81 v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~m 160 (738)
T KOG1989|consen 81 VKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAM 160 (738)
T ss_pred HHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHH
Confidence 479999999996 999999999 32221 2567999999999999999755 34599999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc-ceee------ecccccccccCCcchh---cCCCCchh
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVS------TRVMGTYGYAAPEYVM---TGHLTSRS 142 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~------~~~~gt~~y~aPE~~~---~~~~~~~~ 142 (306)
|... .+|||||||-+||||+.+|..||||||.++....... .... -....|+.|+|||++. +..+++|+
T Consensus 161 H~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKs 239 (738)
T KOG1989|consen 161 HYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKS 239 (738)
T ss_pred hcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchh
Confidence 9987 7799999999999999999999999999975332221 1000 1134699999999985 67899999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 143 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 143 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
|||+|||+||.|+....||+..... .+++....-.-...++..+.+||..||+.||++||
T Consensus 240 DIWALGclLYkLCy~t~PFe~sg~l--------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 240 DIWALGCLLYKLCYFTTPFEESGKL--------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCcce--------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence 9999999999999999999865322 11222221111235688999999999999999999
Q ss_pred CHHHHHHHhCCCCCC
Q 021891 223 LMSEVVEALKPLPNL 237 (306)
Q Consensus 223 s~~ell~~l~~~~~~ 237 (306)
++-+++.++..+...
T Consensus 300 nI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 300 NIYQVLEEIFELANK 314 (738)
T ss_pred CHHHHHHHHHHHhcC
Confidence 999999988765543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=306.53 Aligned_cols=207 Identities=28% Similarity=0.454 Sum_probs=176.8
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
-+|+.|++|+|+||+.+.|+|....-+|||||||..|-|...|+.. ..+.......|..+||.|+.|||.+. ||||
T Consensus 161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK---IIHR 236 (904)
T KOG4721|consen 161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK---IIHR 236 (904)
T ss_pred hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh---Hhhh
Confidence 4688999999999999999999999999999999999999999554 47899999999999999999999988 9999
Q ss_pred cCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 021891 84 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 163 (306)
Q Consensus 84 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 163 (306)
|||.-||||+.+..|||+|||-++...+. .....++||..|||||++...+-++|+||||||||||||+||..||.+
T Consensus 237 DLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 237 DLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred ccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 99999999999999999999999875443 234568999999999999999999999999999999999999999976
Q ss_pred CCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 164 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
...... .|. .+.. .+.-..+..+++.+.-|++.||+..|.+|||+++++.||..
T Consensus 314 VdssAI----IwG-----VGsN-------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 314 VDSSAI----IWG-----VGSN-------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cchhee----EEe-----ccCC-------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 543221 111 1111 11122345667889999999999999999999999999863
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=283.97 Aligned_cols=209 Identities=26% Similarity=0.402 Sum_probs=175.3
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.+|+.||+++ -||+|+++.|+++++..+++|+|.|+.|.|.|++... ..+++.....+++|+++|++|||..+ |+
T Consensus 70 ~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IV 145 (411)
T KOG0599|consen 70 RQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IV 145 (411)
T ss_pred HHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hh
Confidence 5799999999 6999999999999999999999999999999999544 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc------CCCCchhHHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell 155 (306)
||||||+|||++++..+||+|||.++....+.+ ....|||++|.|||.+.. ..|+..+|+|++|+|+|-|+
T Consensus 146 HRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 146 HRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred hcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999877654 345799999999999864 36888999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.|.+||......-....+.... +++-.+. ..+.+.+..+||.+||+.||.+|.|++|+|+|..
T Consensus 223 aGcpPFwHRkQmlMLR~ImeGk---------yqF~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 223 AGCPPFWHRKQMLMLRMIMEGK---------YQFRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred cCCCchhHHHHHHHHHHHHhcc---------cccCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 9999997543322222221111 1122222 2245678899999999999999999999999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=301.52 Aligned_cols=214 Identities=30% Similarity=0.470 Sum_probs=168.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhcCC-----------------------------
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRS----------------------------- 50 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~----------------------------- 50 (306)
+.+|+++|+++ +||||+++++++...+ .+++||||+++|+|.+++....
T Consensus 57 ~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (338)
T cd05102 57 LMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRR 136 (338)
T ss_pred HHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccc
Confidence 67899999999 8999999999887644 5789999999999999986431
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcE
Q 021891 51 --------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 98 (306)
Q Consensus 51 --------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~ 98 (306)
..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~ 213 (338)
T cd05102 137 IEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVV 213 (338)
T ss_pred cccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcE
Confidence 24778889999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhh
Q 021891 99 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 177 (306)
Q Consensus 99 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 177 (306)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 214 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~--- 288 (338)
T cd05102 214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ--- 288 (338)
T ss_pred EEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH---
Confidence 9999999986543322222223345678999999998899999999999999999997 9999976432211 000
Q ss_pred hhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
....... .. .+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 289 -~~~~~~~------~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 289 -RLKDGTR------MR----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred -HHhcCCC------CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001000 01 1112346789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=295.43 Aligned_cols=209 Identities=21% Similarity=0.351 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-C
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-A 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ 76 (306)
|.+|+++|++++||||+++++++.+ ....++||||+++|+|.+++.+. ..+++.....++.|++.||.|||+. +
T Consensus 65 ~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ 143 (283)
T PHA02988 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN 143 (283)
T ss_pred HHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC
Confidence 6799999999999999999999877 34789999999999999999654 4789999999999999999999984 6
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc--CCCCchhHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el 154 (306)
++||||||+||+++.++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||
T Consensus 144 ---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el 215 (283)
T PHA02988 144 ---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215 (283)
T ss_pred ---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHH
Confidence 8899999999999999999999999988653321 23457889999999976 6899999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
++|..||....... ..... ..... .. ..+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 216 ~~g~~Pf~~~~~~~---~~~~i---~~~~~------~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 216 FTGKIPFENLTTKE---IYDLI---INKNN------SL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHCCCCCCCCCHHH---HHHHH---HhcCC------CC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 99999997643221 11110 00000 01 11223467899999999999999999999999988754
Q ss_pred C
Q 021891 235 P 235 (306)
Q Consensus 235 ~ 235 (306)
.
T Consensus 280 ~ 280 (283)
T PHA02988 280 K 280 (283)
T ss_pred H
Confidence 3
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=316.92 Aligned_cols=216 Identities=29% Similarity=0.463 Sum_probs=183.1
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------CC----CCHHHHHHHHHHHHH
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LP----LPWSIRMKIALGAAK 67 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~----l~~~~~~~~~~qi~~ 67 (306)
+|++|+++|..|+|||||+++|+|..++..++|+|||..|||.++|..+. .. ++..+...|+.|||.
T Consensus 535 dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAa 614 (774)
T KOG1026|consen 535 DFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAA 614 (774)
T ss_pred HHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHH
Confidence 59999999999999999999999999999999999999999999996431 22 888999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHH
Q 021891 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 147 (306)
Q Consensus 68 ~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 147 (306)
|+.||-++. +|||||...|+||+++..|||+|||+++.....+.......-.-..+|||||.+..++|+.++||||+
T Consensus 615 GM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 615 GMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred HHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 999999988 99999999999999999999999999998655554444433344678999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 148 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 148 G~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
||+|||+++ |+.||.+....+....+.... .-..+..++.++++||..||+.+|.+||+++|
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~-----------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ-----------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCC-----------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 999999988 888988766544333322111 12235567889999999999999999999999
Q ss_pred HHHHhCCCCC
Q 021891 227 VVEALKPLPN 236 (306)
Q Consensus 227 ll~~l~~~~~ 236 (306)
|-..|+....
T Consensus 755 I~~~L~~~~~ 764 (774)
T KOG1026|consen 755 IHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHHHh
Confidence 9998875543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=291.07 Aligned_cols=205 Identities=22% Similarity=0.339 Sum_probs=176.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.++|++||+.|+||||+++|.+|+..+.+.|||||..+|.|.|++.+++ .+++..+..+++||..|+.|+|.++ ++
T Consensus 100 IRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr---Vv 175 (668)
T KOG0611|consen 100 IRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR---VV 175 (668)
T ss_pred HHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc---ce
Confidence 4799999999999999999999999999999999999999999997765 7999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 160 (306)
|||||.+|||+|.|+.+||+|||++-.+.+.. ..+.+||++-|.+||++.|.+| .+.+|.||||+++|-|+.|..|
T Consensus 176 HRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMP 252 (668)
T KOG0611|consen 176 HRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMP 252 (668)
T ss_pred ecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccc
Confidence 99999999999999999999999998775543 3456899999999999999988 5789999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|.+.+.......+.. + .+..| ..+.++.-||++||..||++|.|+.+|..|.+
T Consensus 253 FDG~Dhk~lvrQIs~--------G---aYrEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 253 FDGRDHKRLVRQISR--------G---AYREP--------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred cCCchHHHHHHHhhc--------c---cccCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 987644322111110 0 11111 12357789999999999999999999999875
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=311.92 Aligned_cols=209 Identities=26% Similarity=0.360 Sum_probs=171.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+++|+++|+.++|||||++++++..++..|+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+
T Consensus 112 ~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-- 189 (478)
T PTZ00267 112 ARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-- 189 (478)
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 578999999999999999999999999999999999999999987542 346899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 190 -ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~ 268 (478)
T PTZ00267 190 -MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH 268 (478)
T ss_pred -EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998765433323344567999999999999889999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||....... ... ..... ... .++...+..+.+||.+||+.||++||++.+++.+
T Consensus 269 ~Pf~~~~~~~---~~~---~~~~~------~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 269 RPFKGPSQRE---IMQ---QVLYG------KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCCCCHHH---HHH---HHHhC------CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 9996543211 110 00000 000 1112234688999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.92 Aligned_cols=219 Identities=26% Similarity=0.429 Sum_probs=179.1
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.|++|+..|++-+|-||+-+.|+|..... .||+.+|+|.+|+.+|.....+|+..+.+.|++||++|+.|||.++ |
T Consensus 434 aFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---I 509 (678)
T KOG0193|consen 434 AFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---I 509 (678)
T ss_pred HHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---h
Confidence 38999999999999999999999988776 9999999999999999887778999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc---CCCCchhHHHHHHHHHHHHHhC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg 157 (306)
||||||..|||+.++++|||+|||++................|...|||||++.. .+|++.+||||||||+|||++|
T Consensus 510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg 589 (678)
T KOG0193|consen 510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG 589 (678)
T ss_pred hhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence 9999999999999999999999999987544433333334567888999999973 5799999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
..||........ .|. .++.+-..+.. .....+++++.+|+..||.+++++||.+.+|+..|+.+..
T Consensus 590 ~lPysi~~~dqI----ifm------VGrG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 590 ELPYSIQNRDQI----IFM------VGRGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCCcCCCChhhe----EEE------ecccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 999984332211 111 01111111111 1234567899999999999999999999999997765443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=289.67 Aligned_cols=212 Identities=27% Similarity=0.488 Sum_probs=173.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAA 66 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi~ 66 (306)
|.+|++++++++||||+++++++...+..+++|||+++++|.+++.... ..+++..++.++.|++
T Consensus 55 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 134 (283)
T cd05048 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA 134 (283)
T ss_pred HHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHH
Confidence 6889999999999999999999999999999999999999999986532 3578899999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHH
Q 021891 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 146 (306)
Q Consensus 67 ~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 146 (306)
.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||
T Consensus 135 ~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s 211 (283)
T cd05048 135 AGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWS 211 (283)
T ss_pred HHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHH
Confidence 9999999988 9999999999999999999999999997654333222233345678899999998889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 147 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 147 lG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
|||++|||++ |..||.+..... ...... . ......+...+..+.+|+.+||+.||++||++.
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~---~~~~i~----~----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~ 274 (283)
T cd05048 212 FGVVLWEIFSYGLQPYYGFSNQE---VIEMIR----S----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFK 274 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----c----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999999998 999987643321 111100 0 001112234567899999999999999999999
Q ss_pred HHHHHhCC
Q 021891 226 EVVEALKP 233 (306)
Q Consensus 226 ell~~l~~ 233 (306)
+|+++|+.
T Consensus 275 ~i~~~l~~ 282 (283)
T cd05048 275 DIHTRLRS 282 (283)
T ss_pred HHHHHHhc
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=273.03 Aligned_cols=207 Identities=26% Similarity=0.383 Sum_probs=176.9
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
++.+|++|-+.|+||||+++|++|.+....|+++||.++|+|...|.. ....+++...+.++.|++.||.|+|..+
T Consensus 68 qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--- 144 (281)
T KOG0580|consen 68 QLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--- 144 (281)
T ss_pred hhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---
Confidence 478999999999999999999999999999999999999999999864 3457999999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
|+||||||+|+|++.+|.+||+|||.+..... ......+||..|.+||+..+..++.++|+|++|++.||++.|.+
T Consensus 145 VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~p 220 (281)
T KOG0580|consen 145 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLP 220 (281)
T ss_pred cccCCCCHHHhccCCCCCeeccCCCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999987542 23455789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||......+....+... ++. ++...+..+.++|.+||.++|.+|.+..|+++|..
T Consensus 221 pFes~~~~etYkrI~k~-----------~~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 221 PFESQSHSETYKRIRKV-----------DLK-------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred chhhhhhHHHHHHHHHc-----------ccc-------CCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 99876522111111100 111 22344678999999999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=290.94 Aligned_cols=214 Identities=27% Similarity=0.367 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~-l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
.++|+.||++|.|||||+++++..+. +.+|||+|||..|.+.+. ...+. +++.++++++++++.||+|||.++
T Consensus 155 v~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg-- 230 (576)
T KOG0585|consen 155 VRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG-- 230 (576)
T ss_pred HHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC--
Confidence 46899999999999999999998764 589999999999887653 22334 899999999999999999999999
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCC---CcceeeecccccccccCCcchhcC---C-CCchhHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG---DKTHVSTRVMGTYGYAAPEYVMTG---H-LTSRSDVYSFGVVL 151 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~---~-~~~~~DiwslG~il 151 (306)
||||||||+|+||+.+|++||+|||.+.....+ +.........||+.|+|||...++ . -+.+.||||+|++|
T Consensus 231 -iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 231 -IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred -eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 999999999999999999999999999765322 111122336899999999998863 2 35789999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|.|+.|+.||.+....+... .+++..+.-....+..+.+.+||++||++||+.|.+..+|..|+
T Consensus 310 YCllfG~~PF~~~~~~~l~~----------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 310 YCLLFGQLPFFDDFELELFD----------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHhhhccCCcccchHHHHHH----------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 99999999998754322211 12222222112224567899999999999999999999999998
Q ss_pred CCCCC
Q 021891 232 KPLPN 236 (306)
Q Consensus 232 ~~~~~ 236 (306)
+....
T Consensus 374 wvt~~ 378 (576)
T KOG0585|consen 374 WVTRD 378 (576)
T ss_pred eeccC
Confidence 75554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=296.05 Aligned_cols=206 Identities=29% Similarity=0.353 Sum_probs=169.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+
T Consensus 42 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iv 117 (323)
T cd05571 42 TLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VV 117 (323)
T ss_pred HHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 567999999999999999999999999999999999999999988654 47899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 118 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf 195 (323)
T cd05571 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCC
Confidence 99999999999999999999999987532211 1223457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
........ ... .... +. .++...+.++.+||.+||+.||++|| ++.++++|-
T Consensus 196 ~~~~~~~~---~~~---~~~~--------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 196 YNQDHEKL---FEL---ILME--------EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred CCCCHHHH---HHH---HHcC--------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 75432111 000 0000 01 11223357889999999999999999 799998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=283.88 Aligned_cols=221 Identities=27% Similarity=0.321 Sum_probs=176.5
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.|-+||+.++||-++++|+.|+.++..|+|||||+||+|..+..++ ++.+++..+..++..|+.||+|||..| ||
T Consensus 125 ~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---iv 201 (459)
T KOG0610|consen 125 QTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IV 201 (459)
T ss_pred HHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---ee
Confidence 56889999999999999999999999999999999999999988655 567999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCC---------------------------------CCcc-------------
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPE---------------------------------GDKT------------- 115 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~---------------------------------~~~~------------- 115 (306)
+|||||+||||.++|++.|+||.++..+.. ..+.
T Consensus 202 YRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p 281 (459)
T KOG0610|consen 202 YRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLP 281 (459)
T ss_pred eccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccch
Confidence 999999999999999999999998754211 0000
Q ss_pred --------eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccc
Q 021891 116 --------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 187 (306)
Q Consensus 116 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (306)
.....++||-.|.|||++.|..-+.++|.|+|||++|||+.|..||.+.+.......+. .+..
T Consensus 282 ~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv------~~~l--- 352 (459)
T KOG0610|consen 282 ELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV------GQPL--- 352 (459)
T ss_pred hhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh------cCCC---
Confidence 01123679999999999999999999999999999999999999999876543322211 1111
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCCCCC
Q 021891 188 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 242 (306)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 242 (306)
...+ ....+..+.+||+++|.+||.+|.....=..++++.+.++.+.+
T Consensus 353 -----~Fp~--~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 353 -----KFPE--EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred -----cCCC--CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 1111 11346789999999999999999984444445555566555543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=288.63 Aligned_cols=218 Identities=27% Similarity=0.461 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------------------CCCCHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIAL 63 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~l~~~~~~~~~~ 63 (306)
|.+|+++|.+++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..++.++.
T Consensus 66 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 145 (304)
T cd05096 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVAL 145 (304)
T ss_pred HHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHH
Confidence 7789999999999999999999999999999999999999999885421 2467888999999
Q ss_pred HHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhH
Q 021891 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 143 (306)
Q Consensus 64 qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 143 (306)
||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|
T Consensus 146 ~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 222 (304)
T cd05096 146 QIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD 222 (304)
T ss_pred HHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhh
Confidence 9999999999988 9999999999999999999999999998654433322333345578899999998889999999
Q ss_pred HHHHHHHHHHHHh--CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 144 VYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 144 iwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
||||||++|||++ +..||....... .................. ..+..++..+.+|+.+||+.||++|
T Consensus 223 v~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 223 VWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred hHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhC
Confidence 9999999999987 456666543221 111111111100000000 0111235688999999999999999
Q ss_pred CCHHHHHHHhC
Q 021891 222 PLMSEVVEALK 232 (306)
Q Consensus 222 ps~~ell~~l~ 232 (306)
||+.+|.+.|+
T Consensus 293 Ps~~~i~~~l~ 303 (304)
T cd05096 293 PSFSDIHAFLT 303 (304)
T ss_pred cCHHHHHHHHh
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.53 Aligned_cols=209 Identities=26% Similarity=0.346 Sum_probs=170.0
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
+.|-.||....++.||++|-.|++.+++||||||++||++..+|.+.+ .|++..+..++.+++.|+..||..| +||
T Consensus 189 ~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g---yIH 264 (550)
T KOG0605|consen 189 RAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG---YIH 264 (550)
T ss_pred HHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC---ccc
Confidence 568889999999999999999999999999999999999999996665 7999999999999999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCC----------------------CCcce----e-------------------
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPE----------------------GDKTH----V------------------- 117 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~----------------------~~~~~----~------------------- 117 (306)
|||||+|+|||..|++||+||||+.-+.. .+... .
T Consensus 265 RDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~ 344 (550)
T KOG0605|consen 265 RDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQL 344 (550)
T ss_pred ccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhh
Confidence 99999999999999999999999853211 00000 0
Q ss_pred eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCC
Q 021891 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH 197 (306)
Q Consensus 118 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (306)
....+||+.|+|||++.+..|+..+|.||||||+||||.|.+||....+...-..+...+..+.- | .
T Consensus 345 a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------P-~--- 411 (550)
T KOG0605|consen 345 AYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------P-E--- 411 (550)
T ss_pred hhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------C-C---
Confidence 01257999999999999999999999999999999999999999988776543333322222111 1 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 021891 198 FSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 230 (306)
Q Consensus 198 ~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~ 230 (306)
....+.++.+||.+||. ||++|.. ++||.+|
T Consensus 412 -~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 412 -EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred -cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 11224789999999999 9999975 6666654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=294.13 Aligned_cols=221 Identities=23% Similarity=0.361 Sum_probs=170.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~~~~i 80 (306)
|.+|+++|++++||||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |
T Consensus 50 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~---i 125 (331)
T cd06649 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQ---I 125 (331)
T ss_pred HHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCC---E
Confidence 6789999999999999999999999999999999999999999986543 689999999999999999999985 4 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 126 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 201 (331)
T cd06649 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201 (331)
T ss_pred EcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765332 12345689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcccc--------------------------------ccccccCCccCCCCCHHHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERR--------------------------------RFYRLIDPRLEGHFSIKGAQKAAQ 208 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~~~~~ 208 (306)
|............. ........ .+..+.............+.++.+
T Consensus 202 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (331)
T cd06649 202 IPPPDAKELEAIFG--RPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQE 279 (331)
T ss_pred CCCCCHHHHHHHhc--ccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHH
Confidence 96543211100000 00000000 000000000000011124578999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhC
Q 021891 209 LAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 209 li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||.+||+.||++|||+.+|++|..
T Consensus 280 li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 280 FVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred HHHHHccCCcccCCCHHHHhcChH
Confidence 999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.25 Aligned_cols=203 Identities=26% Similarity=0.341 Sum_probs=168.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.+.+ .+++..+..++.|++.||+|||+.+ ++
T Consensus 48 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 123 (291)
T cd05612 48 VHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKE---IV 123 (291)
T ss_pred HHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 5789999999999999999999999999999999999999999986554 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++..... .....|++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 124 H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf 198 (291)
T cd05612 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198 (291)
T ss_pred ecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999865432 12346899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
.......... ...... . .++...+..+.+||.+||+.||.+||+ +.++++|.
T Consensus 199 ~~~~~~~~~~------~i~~~~--------~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 199 FDDNPFGIYE------KILAGK--------L----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CCCCHHHHHH------HHHhCC--------c----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 7643221110 000000 0 111222467899999999999999995 88888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=270.45 Aligned_cols=211 Identities=23% Similarity=0.287 Sum_probs=174.5
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
++++|++|-+.|+|||||++.+.+.+....|+|+|++.|++|..-|.++ ..+++..+..+++||+++|.|+|.++ |
T Consensus 56 ~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---I 131 (355)
T KOG0033|consen 56 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---I 131 (355)
T ss_pred HHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 3689999999999999999999999999999999999999998877666 36789999999999999999999999 9
Q ss_pred EeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 81 IYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 81 iH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
||||+||+|+++.. ..-+||+|||+|....++ ..-..+.||++|||||++...+|+..+|||+-|+|+|-|+.|
T Consensus 132 vHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G 208 (355)
T KOG0033|consen 132 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 208 (355)
T ss_pred eeccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhC
Confidence 99999999999943 345899999999987632 234567899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.+||.+.......+.+.... -.++++.. ...++++.+|+++||..||.+|.|+.|.|+|.+
T Consensus 209 ~~PF~~~~~~rlye~I~~g~----------yd~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 209 YPPFWDEDQHRLYEQIKAGA----------YDYPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CCCCCCccHHHHHHHHhccc----------cCCCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 99998743322111111110 11122122 234578999999999999999999999999865
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=287.59 Aligned_cols=224 Identities=22% Similarity=0.313 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++......+++..+..++.||+.||+|||+.+ |+
T Consensus 50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---iv 125 (288)
T cd07871 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---IL 125 (288)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 56899999999999999999999999999999999975 999988766667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 126 H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p 203 (288)
T cd07871 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM 203 (288)
T ss_pred cCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876432221 1233467899999999875 5689999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhh--------hhhccccccccccCCccCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 161 MDKNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|...........+.... ........+.....+..... .....+.++.+||.+||+.||.+|||++|++
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 204 FPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred CCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 97654322211111000 00000011111111111000 0112346789999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
+|-
T Consensus 284 ~hp 286 (288)
T cd07871 284 RHS 286 (288)
T ss_pred cCC
Confidence 863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=289.07 Aligned_cols=210 Identities=27% Similarity=0.362 Sum_probs=170.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++|+||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |
T Consensus 47 ~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 123 (285)
T cd05631 47 ALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---I 123 (285)
T ss_pred HHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 568999999999999999999999999999999999999999887543 346899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 124 iH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred EeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence 999999999999999999999999998754322 12345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
|............. ..... ....++...+..+.+|+.+||+.||.+||+ ++++++|.
T Consensus 201 f~~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 201 FRKRKERVKREEVD---RRVKE-----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred CCCCCcchhHHHHH---HHhhc-----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 98654322111110 00000 001122234568899999999999999997 78888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=289.05 Aligned_cols=225 Identities=21% Similarity=0.257 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++..++..++||||+++++|..+. +....+++..++.++.|++.||.|||+.+ ++
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~ 122 (287)
T cd07848 47 TLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IV 122 (287)
T ss_pred HHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 578999999999999999999999999999999999887665544 44457999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++......... ......|+..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 123 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf 201 (287)
T cd07848 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201 (287)
T ss_pred cCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999875432211 123356899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhh--------hccccccccccCCcc------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 162 DKNRPNGEHNLVEWARPH--------LGERRRFYRLIDPRL------EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
...........+...... ......+.....+.. ...+....+..+.+||.+||+.||++|||++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred CCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 765432211111100000 000000000000000 001111245679999999999999999999999
Q ss_pred HHHh
Q 021891 228 VEAL 231 (306)
Q Consensus 228 l~~l 231 (306)
++|-
T Consensus 282 l~hp 285 (287)
T cd07848 282 LNHP 285 (287)
T ss_pred hcCC
Confidence 9863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=295.74 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+++..++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+
T Consensus 65 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---iv 140 (329)
T PTZ00263 65 VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---II 140 (329)
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 578999999999999999999999999999999999999999998654 46899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 141 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 215 (329)
T PTZ00263 141 YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215 (329)
T ss_pred ecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC
Confidence 99999999999999999999999998654321 2346899999999999989999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
....... .. ....... .. ++...+..+.+||.+||+.||.+|++ ++++++|.
T Consensus 216 ~~~~~~~---~~---~~i~~~~--------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 216 FDDTPFR---IY---EKILAGR--------LK----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred CCCCHHH---HH---HHHhcCC--------cC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 7543211 00 0000000 00 11123467889999999999999996 67777753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=299.51 Aligned_cols=214 Identities=25% Similarity=0.403 Sum_probs=170.2
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------------------------------
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------------------ 50 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 50 (306)
+.+|+++++.+ +|+||+++++++...+..++|||||++|+|.+++....
T Consensus 88 ~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (374)
T cd05106 88 LMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYI 167 (374)
T ss_pred HHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccc
Confidence 57899999999 89999999999999999999999999999999885321
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 021891 51 ---------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 91 (306)
Q Consensus 51 ---------------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nil 91 (306)
..+++..++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil 244 (374)
T cd05106 168 RSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVL 244 (374)
T ss_pred cccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEE
Confidence 24788899999999999999999988 999999999999
Q ss_pred EcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 021891 92 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 170 (306)
Q Consensus 92 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 170 (306)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 245 ~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~- 323 (374)
T cd05106 245 LTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK- 323 (374)
T ss_pred EeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-
Confidence 99999999999999986544322222222335667999999988899999999999999999997 9999976432211
Q ss_pred chHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 171 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
..... ... .... .+...+.++.+++.+||+.||++|||+.+|++.|+.+
T Consensus 324 -~~~~~----~~~------~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 324 -FYKMV----KRG------YQMS----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred -HHHHH----Hcc------cCcc----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000 000 0000 1111246889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=293.05 Aligned_cols=206 Identities=32% Similarity=0.321 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+
T Consensus 40 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 115 (312)
T cd05585 40 TLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VI 115 (312)
T ss_pred HHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 567999999999999999999999999999999999999999998654 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 116 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf 193 (312)
T cd05585 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193 (312)
T ss_pred eCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCc
Confidence 99999999999999999999999987543221 1233457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~l 231 (306)
....... ......... . .++...+..+.+||.+||+.||.+||+ +.+++.|.
T Consensus 194 ~~~~~~~------~~~~~~~~~--------~----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 194 YDENVNE------MYRKILQEP--------L----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CCCCHHH------HHHHHHcCC--------C----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 7543211 111111100 0 112234568899999999999999974 67777753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=279.69 Aligned_cols=211 Identities=25% Similarity=0.391 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++...+..++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++
T Consensus 40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~ 116 (252)
T cd05084 40 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116 (252)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 688999999999999999999999999999999999999999999766667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 117 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred ccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876433211111111123456999999998889999999999999999998 8888
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|........ .. .... ......+...+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus 197 ~~~~~~~~~---~~----~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 197 YANLSNQQT---RE----AIEQ----------GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccccCHHHH---HH----HHHc----------CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 864322110 00 0000 0001112233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=282.31 Aligned_cols=211 Identities=24% Similarity=0.358 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++..++..++||||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++
T Consensus 53 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---ii 129 (266)
T cd05064 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YV 129 (266)
T ss_pred HHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 678999999999999999999999999999999999999999999776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |..|
T Consensus 130 H~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred eccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999998765432211 11122345678999999999999999999999999999775 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|........ .... ... .... .+...+..+.+++.+||+.+|.+||++++|++.|..
T Consensus 209 ~~~~~~~~~---~~~~----~~~------~~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 209 YWDMSGQDV---IKAV----EDG------FRLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred cCcCCHHHH---HHHH----HCC------CCCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 976533211 1110 000 0011 122345688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=279.14 Aligned_cols=222 Identities=23% Similarity=0.285 Sum_probs=171.5
Q ss_pred HHHHHHHhcCCCCc-ccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHh
Q 021891 3 QAEVNFLGDLVHLN-LVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 3 ~~E~~il~~l~H~n-iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~L 72 (306)
.+|+-+|+.|+|+| ||++++++.+.+ .+++|+||+. -+|.+++.... ..++...++.+++||+.||+||
T Consensus 58 iREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~ 136 (323)
T KOG0594|consen 58 IREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL 136 (323)
T ss_pred hHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 58999999999999 999999999877 7899999995 59999997765 4688899999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVL 151 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il 151 (306)
|+++ |+||||||+||+|+++|.+||+|||+|+.+.-.... ....++|.+|+|||++.+. .|+..+||||+|||+
T Consensus 137 H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf 211 (323)
T KOG0594|consen 137 HSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF 211 (323)
T ss_pred HhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence 9999 999999999999999999999999999976543332 3345689999999999876 799999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhh-----hhcccc---ccccccCCcc-CCCCCHH---HHHHHHHHHHHcccCCCC
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARP-----HLGERR---RFYRLIDPRL-EGHFSIK---GAQKAAQLAAHCLSRDPK 219 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~~-~~~~~~~---~~~~~~~li~~~l~~~p~ 219 (306)
+||+++++.|.+....+....+-.... .|.... .+...+.... ...+... ...+..+++.+||+.+|.
T Consensus 212 aEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~ 291 (323)
T KOG0594|consen 212 AEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA 291 (323)
T ss_pred HHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence 999999999988766332211110000 000000 0000000000 0111111 124788999999999999
Q ss_pred CCCCHHHHHHH
Q 021891 220 ARPLMSEVVEA 230 (306)
Q Consensus 220 ~Rps~~ell~~ 230 (306)
+|.|++.++.|
T Consensus 292 ~R~Sa~~al~h 302 (323)
T KOG0594|consen 292 KRISAKGALTH 302 (323)
T ss_pred cCcCHHHHhcC
Confidence 99999999986
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=295.39 Aligned_cols=203 Identities=26% Similarity=0.293 Sum_probs=168.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++.+.+..++||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.+ |+
T Consensus 78 ~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---iv 153 (340)
T PTZ00426 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLN---IV 153 (340)
T ss_pred HHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 5689999999999999999999999999999999999999999986544 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 154 HrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf 228 (340)
T PTZ00426 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228 (340)
T ss_pred ccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCC
Confidence 9999999999999999999999999865322 22357899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
........ .. ...... . .++...+..+.++|.+||+.||.+|+ +++++++|.
T Consensus 229 ~~~~~~~~---~~---~i~~~~--------~----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 229 YANEPLLI---YQ---KILEGI--------I----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CCCCHHHH---HH---HHhcCC--------C----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 76432110 00 000000 0 01112346788999999999999995 888888764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=294.28 Aligned_cols=224 Identities=20% Similarity=0.213 Sum_probs=168.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++|+||||+++++++..+...++|+|++. ++|..++... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 130 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---Iv 204 (391)
T PHA03212 130 TATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---II 204 (391)
T ss_pred hHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 5789999999999999999999999999999999995 6898888554 36899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 205 HrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 205 HRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred cCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999999975332211 1223457999999999999889999999999999999999999887
Q ss_pred CCCCCCCCc----chHHhhhhhhcc---------ccccc-------c--ccCCccCCC--CCHHHHHHHHHHHHHcccCC
Q 021891 162 DKNRPNGEH----NLVEWARPHLGE---------RRRFY-------R--LIDPRLEGH--FSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 162 ~~~~~~~~~----~~~~~~~~~~~~---------~~~~~-------~--~~~~~~~~~--~~~~~~~~~~~li~~~l~~~ 217 (306)
......... ..+......... ...+. . ...+..... .....+.++.+||.+||+.|
T Consensus 284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363 (391)
T ss_pred CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence 543221110 000000000000 00000 0 000000000 01134568999999999999
Q ss_pred CCCCCCHHHHHHHh
Q 021891 218 PKARPLMSEVVEAL 231 (306)
Q Consensus 218 p~~Rps~~ell~~l 231 (306)
|.+|||++|++++-
T Consensus 364 P~~Rpta~elL~hp 377 (391)
T PHA03212 364 AHHRPSAEALLDFA 377 (391)
T ss_pred hhhCCCHHHHhcCh
Confidence 99999999999854
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.94 Aligned_cols=206 Identities=30% Similarity=0.362 Sum_probs=169.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++...+..|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+
T Consensus 42 ~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---iv 117 (323)
T cd05595 42 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VV 117 (323)
T ss_pred HHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 467999999999999999999999999999999999999999888554 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 118 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf 195 (323)
T cd05595 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195 (323)
T ss_pred ecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCC
Confidence 999999999999999999999999875322111 123356899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
........... ..... .. ++...+..+.+||.+||+.||++|+ ++.++++|-
T Consensus 196 ~~~~~~~~~~~------~~~~~--------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 196 YNQDHERLFEL------ILMEE--------IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCCHHHHHHH------HhcCC--------CC----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 75432211000 00000 01 1122356889999999999999998 899998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=297.73 Aligned_cols=213 Identities=27% Similarity=0.441 Sum_probs=169.8
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------------------------------
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------------------ 50 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 50 (306)
+.+|+++|+.+ +||||++++++|.+.+..++|||||++|+|.+++.+..
T Consensus 85 ~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (375)
T cd05104 85 LMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDS 164 (375)
T ss_pred HHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchh
Confidence 57899999999 89999999999999999999999999999999885432
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 021891 51 --------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 86 (306)
Q Consensus 51 --------------------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlk 86 (306)
..+++..+..++.||+.||.|||+.+ ++|||||
T Consensus 165 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 241 (375)
T cd05104 165 LNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLA 241 (375)
T ss_pred hhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCc
Confidence 24788889999999999999999988 9999999
Q ss_pred CCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 021891 87 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 165 (306)
Q Consensus 87 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 165 (306)
|+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 242 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 242 ARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred hhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999987544332222222345667999999999899999999999999999998 888886543
Q ss_pred CCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 166 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
... ....... ... .... +...+.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 322 ~~~--~~~~~~~----~~~---~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 322 VDS--KFYKMIK----EGY---RMLS-------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred chH--HHHHHHH----hCc---cCCC-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 211 1111111 000 0000 11124688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=294.22 Aligned_cols=211 Identities=23% Similarity=0.268 Sum_probs=171.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++..++||||+++++++.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+
T Consensus 48 ~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iv 123 (333)
T cd05600 48 VLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YI 123 (333)
T ss_pred HHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 568999999999999999999999999999999999999999998654 36899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 124 H~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 198 (333)
T cd05600 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198 (333)
T ss_pred ccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence 999999999999999999999999986533 223457899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...........+.. .. ..+............+.++.+||.+||..+|.+||++.+++++.
T Consensus 199 ~~~~~~~~~~~i~~-------~~---~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 199 SGSTPNETWENLKY-------WK---ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCCCHHHHHHHHHh-------cc---ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 76543221111100 00 00000000000113357889999999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=292.75 Aligned_cols=206 Identities=27% Similarity=0.338 Sum_probs=169.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++...+..++||||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+
T Consensus 42 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---iv 117 (328)
T cd05593 42 TLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IV 117 (328)
T ss_pred HHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 568999999999999999999999999999999999999999888554 46899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 118 HrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf 195 (328)
T cd05593 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195 (328)
T ss_pred ecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCC
Confidence 99999999999999999999999987532211 1123457899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
........ ....... ... ++...+.++.+||.+||+.||++|+ ++.++++|.
T Consensus 196 ~~~~~~~~------~~~~~~~--------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 196 YNQDHEKL------FELILME--------DIK----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCCCHHHH------HHHhccC--------Ccc----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 75432111 0000000 011 1222356889999999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=285.13 Aligned_cols=215 Identities=28% Similarity=0.454 Sum_probs=174.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAA 66 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi~ 66 (306)
|++|++++++++|+||+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+
T Consensus 54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 133 (291)
T cd05094 54 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 133 (291)
T ss_pred HHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999986432 3478999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHH
Q 021891 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 146 (306)
Q Consensus 67 ~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 146 (306)
.||.|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||
T Consensus 134 ~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 210 (291)
T cd05094 134 SGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 210 (291)
T ss_pred HHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHH
Confidence 9999999998 9999999999999999999999999997654433222233345678899999999889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 147 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 147 lG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
|||++|||++ |..||....... ...... .. . ........+..+.+++.+||+.+|++|||+.
T Consensus 211 lG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~-~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 273 (291)
T cd05094 211 FGVILWEIFTYGKQPWFQLSNTE---VIECIT----QG-R---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIK 273 (291)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----CC-C---------CCCCCccCCHHHHHHHHHHcccChhhCcCHH
Confidence 9999999999 999986643321 111100 00 0 0001112356789999999999999999999
Q ss_pred HHHHHhCCCCC
Q 021891 226 EVVEALKPLPN 236 (306)
Q Consensus 226 ell~~l~~~~~ 236 (306)
++++.|+.+..
T Consensus 274 ~v~~~l~~~~~ 284 (291)
T cd05094 274 EIYKILHALGK 284 (291)
T ss_pred HHHHHHHHHHh
Confidence 99999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.63 Aligned_cols=222 Identities=21% Similarity=0.294 Sum_probs=167.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++.+++..++||||+. ++|.+++......+++..+..++.|++.||.|||+.+ |+
T Consensus 50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iv 125 (303)
T cd07869 50 AIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125 (303)
T ss_pred HHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 4689999999999999999999999999999999995 6888888776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 126 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 203 (303)
T cd07869 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203 (303)
T ss_pred cCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875432211 1233567899999999875 4689999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcc-----c---ccccccc-------CC-ccCCCCC-HHHHHHHHHHHHHcccCCCCCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGE-----R---RRFYRLI-------DP-RLEGHFS-IKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~-------~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
|....... ............ . ....... .+ .....+. ...+..+.+|+.+||+.||++|||
T Consensus 204 f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s 281 (303)
T cd07869 204 FPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281 (303)
T ss_pred CCCCccHH--HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC
Confidence 97643211 111110000000 0 0000000 00 0000000 011356889999999999999999
Q ss_pred HHHHHHHh
Q 021891 224 MSEVVEAL 231 (306)
Q Consensus 224 ~~ell~~l 231 (306)
+.|+++|-
T Consensus 282 ~~~~l~h~ 289 (303)
T cd07869 282 AQAALSHE 289 (303)
T ss_pred HHHHhcCc
Confidence 99999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=284.82 Aligned_cols=220 Identities=24% Similarity=0.313 Sum_probs=170.8
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+|++||+.++|||||++.-+|.... ...+||||++. +|.+.+.. .+..++.-.++-+..||+.||.|||+.
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~ 144 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH 144 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence 7999999999999999998887543 23599999975 99998863 356789999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~e 153 (306)
+ |+||||||.|+|+|.+ |.+||||||.|+....+... .....|..|+|||.+.+. .|+.+.||||.|||+.|
T Consensus 145 ~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 145 G---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred C---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 8 9999999999999976 99999999999987655433 234458899999999864 79999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhhh-----hcc------ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARPH-----LGE------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~~-----~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
|+-|++.|.+....+....+...... +.. ...+.++....+...+....+.++.+|+.++|+.+|.+|.
T Consensus 219 Ll~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~ 298 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL 298 (364)
T ss_pred HhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence 99999999987655443333221110 000 0001111111111124445678999999999999999999
Q ss_pred CHHHHHHH
Q 021891 223 LMSEVVEA 230 (306)
Q Consensus 223 s~~ell~~ 230 (306)
++.|+++|
T Consensus 299 ~~~~~l~h 306 (364)
T KOG0658|consen 299 SALEALAH 306 (364)
T ss_pred CHHHHhcc
Confidence 99999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=290.09 Aligned_cols=222 Identities=23% Similarity=0.364 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~~~~i 80 (306)
|.+|++++++++|+||++++++|.+++..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+. + +
T Consensus 50 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~---i 125 (333)
T cd06650 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---I 125 (333)
T ss_pred HHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCC---E
Confidence 6789999999999999999999999999999999999999999986543 689999999999999999999974 5 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 126 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 201 (333)
T cd06650 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201 (333)
T ss_pred EecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998764322 12335689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhh-h-------------------hcccc-------cccc-ccCCccCCCCCHHHHHHHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARP-H-------------------LGERR-------RFYR-LIDPRLEGHFSIKGAQKAAQLAAH 212 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~-~-------------------~~~~~-------~~~~-~~~~~~~~~~~~~~~~~~~~li~~ 212 (306)
|................. . ..... .... ..............+.++.+|+.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 281 (333)
T cd06650 202 IPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNK 281 (333)
T ss_pred CCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHH
Confidence 975432111000000000 0 00000 0000 000000000001134678999999
Q ss_pred cccCCCCCCCCHHHHHHHh
Q 021891 213 CLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 213 ~l~~~p~~Rps~~ell~~l 231 (306)
||+.||++|||+.|++++.
T Consensus 282 ~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 282 CLIKNPAERADLKQLMVHA 300 (333)
T ss_pred hccCCcccCcCHHHHhhCH
Confidence 9999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.44 Aligned_cols=212 Identities=23% Similarity=0.365 Sum_probs=177.5
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.-|++||..++||+||++++.|..++.++|+.|||.||-.+..+..-+..+.+.++..++.|++.||.|||+++ |
T Consensus 75 DylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---i 151 (1187)
T KOG0579|consen 75 DYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---I 151 (1187)
T ss_pred hhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---h
Confidence 3677999999999999999999999999999999999999999999888889999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell 155 (306)
||||||+.|||++.+|.++|+|||.+.... ........+.||+.|||||+.. ..+|+.++||||||+.|.||.
T Consensus 152 IHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA 229 (1187)
T KOG0579|consen 152 IHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA 229 (1187)
T ss_pred hhhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh
Confidence 999999999999999999999999986532 2233456689999999999985 458999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.+.+|....++.-....+ ... -.|.+. .+...+..+.+|+.+||.+||..||++.+|++|..
T Consensus 230 qiEPPHhelnpMRVllKi--aKS-----------ePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 230 QIEPPHHELNPMRVLLKI--AKS-----------EPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred ccCCCccccchHHHHHHH--hhc-----------CCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 999998765543221111 110 011111 23345678899999999999999999999999753
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=291.29 Aligned_cols=206 Identities=29% Similarity=0.372 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|+.++||||+++++++..++..|+||||+++++|.+++.+.+ .+.+..+..++.||+.||.|||+.+ |+
T Consensus 47 ~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iv 122 (323)
T cd05584 47 TKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQG---II 122 (323)
T ss_pred HHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 4689999999999999999999999999999999999999999886544 6888999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf 200 (323)
T cd05584 123 YRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200 (323)
T ss_pred cCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence 999999999999999999999999875432221 223356899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
........ ........ . .++...+..+.+||.+||+.||++|| ++.+++++.
T Consensus 201 ~~~~~~~~------~~~~~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 201 TAENRKKT------IDKILKGK--------L----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCCCHHHH------HHHHHcCC--------C----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 76432111 00000000 0 11112346789999999999999999 888888864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=289.66 Aligned_cols=209 Identities=24% Similarity=0.263 Sum_probs=178.4
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
..+|++||++|+ |||||.++++|++....++|||+|.||.|.+.+.+. .+++..+..++.|++.++.|||+.+ +
T Consensus 82 v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---v 156 (382)
T KOG0032|consen 82 VRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---V 156 (382)
T ss_pred HHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 579999999998 999999999999999999999999999999999777 3999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCC----CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 81 IYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 81 iH~dlkp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
+||||||+|+|+... +.+|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++
T Consensus 157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~ 233 (382)
T KOG0032|consen 157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS 233 (382)
T ss_pred eeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh
Confidence 999999999999543 5799999999998765 224556799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|.+||...........+.... ...........+..+.++|.+||..||.+|+|+.++++|.+
T Consensus 234 G~~PF~~~~~~~~~~~i~~~~--------------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 234 GVPPFWGETEFEIFLAILRGD--------------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCCCCcCCChhHHHHHHHcCC--------------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 999998876544332221111 11222223345788999999999999999999999999854
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=297.36 Aligned_cols=215 Identities=27% Similarity=0.440 Sum_probs=177.7
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|++++++++|||||++||++.....+++|||+|+||+|.++|.+....++..+...++.+.+.||+|||+++ +
T Consensus 207 e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~ 283 (474)
T KOG0194|consen 207 EFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---C 283 (474)
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---C
Confidence 5789999999999999999999999999999999999999999999888778999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeee-cccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
+||||.+.|+|++.++.+||+|||+++.... ..... ...-...|+|||.+....|+.++|||||||++||+++ |.
T Consensus 284 IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~ 360 (474)
T KOG0194|consen 284 IHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGA 360 (474)
T ss_pred cchhHhHHHheecCCCeEEeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCC
Confidence 9999999999999999999999999887431 11111 1123567999999999999999999999999999998 78
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 237 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 237 (306)
.||.+.........+. .....-..+...+..+..++.+||..+|++|||+.++.+.++.+...
T Consensus 361 ~Py~g~~~~~v~~kI~----------------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 361 EPYPGMKNYEVKAKIV----------------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred CCCCCCCHHHHHHHHH----------------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 8998765432211110 00111112224467889999999999999999999999998765543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=296.65 Aligned_cols=207 Identities=23% Similarity=0.347 Sum_probs=168.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCe--eEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQ--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~--~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|..|+.+|+.|+|+||+++|+++.+..+ +.+|+|++.+|+|..|+.+.+ ..+...++.|++||++||.|||++. .+
T Consensus 88 ~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PP 165 (632)
T KOG0584|consen 88 LYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PP 165 (632)
T ss_pred HHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CC
Confidence 6789999999999999999999998665 789999999999999996665 7899999999999999999999988 78
Q ss_pred eEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|||||||-+||||+. .|.|||+|+|+|+..... ......||+.|||||++. ..|++.+||||||+++.||+|+.
T Consensus 166 IIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~e 240 (632)
T KOG0584|consen 166 IIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSE 240 (632)
T ss_pred ccccccccceEEEcCCcCceeecchhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhcc
Confidence 999999999999976 499999999999885432 223368999999999987 78999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
-||........ ..+.+.. -..+..+..-...++.+||.+||.. ..+|+|+.|||++-
T Consensus 241 YPYsEC~n~AQ--IYKKV~S-------------GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 241 YPYSECTNPAQ--IYKKVTS-------------GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred CChhhhCCHHH--HHHHHHc-------------CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 99975533211 1111110 0001111111135788999999999 99999999999863
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.07 Aligned_cols=210 Identities=26% Similarity=0.396 Sum_probs=176.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l--~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+..|+.+.++|+|.|||+++|.+-+++.+-|.||-++||||.+++...-+++ .+.++..+.+||++||.|||.+.
T Consensus 619 LhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--- 695 (1226)
T KOG4279|consen 619 LHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--- 695 (1226)
T ss_pred HHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---
Confidence 5689999999999999999999999998889999999999999998887777 88899999999999999999988
Q ss_pred eEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC--CCCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt 156 (306)
|||||||-+||||+. .|.+||+|||-++.... -+.++..+.||..|||||++..+ .|+.++|||||||.+.||.|
T Consensus 696 IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT 773 (1226)
T KOG4279|consen 696 IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT 773 (1226)
T ss_pred eeeccccCCcEEEeeccceEEecccccchhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc
Confidence 999999999999964 68999999999987653 23456678999999999999743 78999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|++||.........-. . ..++ .....++.+.+.++..+|.+|+..||.+||++.++++..
T Consensus 774 GrPPF~ElgspqAAMF------k----VGmy-----KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 774 GRPPFVELGSPQAAMF------K----VGMY-----KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred CCCCeeecCChhHhhh------h----hcce-----ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 9999975432211000 0 0111 122345677889999999999999999999999999854
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=284.49 Aligned_cols=211 Identities=35% Similarity=0.578 Sum_probs=165.0
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+|.+|++++++++||||++++|++...+..++|||||++|+|.+++... ...+++..++.|+.||+.||.|||+.+
T Consensus 47 ~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--- 123 (259)
T PF07714_consen 47 EFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--- 123 (259)
T ss_dssp HHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred eeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 3789999999999999999999999888899999999999999999877 567999999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
++|++|+++||+++.++.+||+|||++................+...|+|||.+.+..++.++||||||+++|||++ |+
T Consensus 124 iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~ 203 (259)
T PF07714_consen 124 IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGK 203 (259)
T ss_dssp EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999987643333333334456778999999998889999999999999999999 67
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||...... ...... ..... .. .+...+..+.++|..||..||++|||+.+|++.|
T Consensus 204 ~p~~~~~~~---~~~~~~----~~~~~------~~----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 204 FPFSDYDNE---EIIEKL----KQGQR------LP----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp GTTTTSCHH---HHHHHH----HTTEE------TT----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccc---cccccc----ccccc------ce----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 887554221 111111 11111 00 1112346789999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=281.14 Aligned_cols=211 Identities=29% Similarity=0.482 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-------------CCCCHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKG 68 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~l~~~~~~~~~~qi~~~ 68 (306)
|.+|+++|+.++|+||+++++++......++||||+++++|.+++...+ ..+++..+..++.|++.|
T Consensus 55 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~ 134 (280)
T cd05049 55 FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG 134 (280)
T ss_pred HHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999996542 347889999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHH
Q 021891 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 148 (306)
Q Consensus 69 l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 148 (306)
|.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||
T Consensus 135 l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 211 (280)
T cd05049 135 MVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 211 (280)
T ss_pred HHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHH
Confidence 99999988 999999999999999999999999999764332222222233457789999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 149 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 149 ~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|++|||++ |..||........ ..... . .. . ...+...+..+.+++.+||+.||++||++.|+
T Consensus 212 ~il~e~~~~g~~p~~~~~~~~~---~~~~~----~-~~----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 212 VVLWEIFTYGKQPWYGLSNEEV---IECIT----Q-GR----L-----LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred HHHHHHHhcCCCCCCCCCHHHH---HHHHH----c-CC----c-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99999998 9999875433211 11110 0 00 0 00111235688999999999999999999999
Q ss_pred HHHhC
Q 021891 228 VEALK 232 (306)
Q Consensus 228 l~~l~ 232 (306)
++.|+
T Consensus 275 l~~l~ 279 (280)
T cd05049 275 HERLQ 279 (280)
T ss_pred HHHhh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=286.81 Aligned_cols=211 Identities=27% Similarity=0.353 Sum_probs=168.8
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.+ +|+||+++++++..++..++||||+++|+|.+++.++. .+++..+..++.||+.||.|||+.+ |
T Consensus 51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i 126 (332)
T cd05614 51 TRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLG---I 126 (332)
T ss_pred HHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 46799999999 58999999999999999999999999999999986543 6899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~ 159 (306)
+||||||+|||++.++.+||+|||+++........ ......||..|+|||++.+. .++.++|||||||++|||++|..
T Consensus 127 vHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~ 205 (332)
T cd05614 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205 (332)
T ss_pred EecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCC
Confidence 99999999999999999999999999865332221 12345789999999999865 47889999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
||............. .... ..++.. +...+..+.+++.+||+.||++|| +++++++|.
T Consensus 206 pf~~~~~~~~~~~~~--~~~~--------~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 206 PFTLEGERNTQSEVS--RRIL--------KCDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCCCCCCCCCHHHHH--HHHh--------cCCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 997543322111110 0000 011111 122356789999999999999999 778888864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.68 Aligned_cols=226 Identities=22% Similarity=0.240 Sum_probs=169.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++|+|+|||++++++..++..++|||++. ++|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 207 ~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---Iv 282 (461)
T PHA03211 207 SVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---II 282 (461)
T ss_pred HHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 5689999999999999999999999999999999995 6899988776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 283 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 283 HRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99999999999999999999999998754332222233457999999999999999999999999999999999988665
Q ss_pred CCCCCC-CCc----chHHhhhhhhcccccccc----------------ccCCccC-CCCC--HHHHHHHHHHHHHcccCC
Q 021891 162 DKNRPN-GEH----NLVEWARPHLGERRRFYR----------------LIDPRLE-GHFS--IKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 162 ~~~~~~-~~~----~~~~~~~~~~~~~~~~~~----------------~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~ 217 (306)
...... ... ...............+.. ...+... ..+. ...+..+.+||.+||+.|
T Consensus 363 f~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~D 442 (461)
T PHA03211 363 FSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFD 442 (461)
T ss_pred ccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccC
Confidence 432211 110 011111000000000000 0000000 0000 022357889999999999
Q ss_pred CCCCCCHHHHHHHh
Q 021891 218 PKARPLMSEVVEAL 231 (306)
Q Consensus 218 p~~Rps~~ell~~l 231 (306)
|.+|||+.|+++|-
T Consensus 443 P~~RPsa~elL~hp 456 (461)
T PHA03211 443 GARRPSAAELLRLP 456 (461)
T ss_pred hhhCcCHHHHhhCc
Confidence 99999999999963
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.97 Aligned_cols=207 Identities=22% Similarity=0.339 Sum_probs=181.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++.|+-++|||||++|++..+...+|||+|+-.+|+|.|+|.++...+.++.+.++++||+.|+.|+|... +|
T Consensus 64 lfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VV 140 (864)
T KOG4717|consen 64 LFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VV 140 (864)
T ss_pred HHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hh
Confidence 568999999999999999999999999999999999999999999999889999999999999999999999998 99
Q ss_pred eccCCCCCeEE-cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCC-chhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILL-DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~ 159 (306)
||||||+||.+ .+-|-|||+|||++-.+.++.+ .+..+|+..|-|||++.|..|+ +++||||||+|+|-|++|++
T Consensus 141 HRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~ 217 (864)
T KOG4717|consen 141 HRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP 217 (864)
T ss_pred cccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence 99999999877 5578999999999988776654 3457899999999999999996 68999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||+..++.+....+.-... ..+.-.+.++.+||..||..||++|.|.+||..+-+
T Consensus 218 PFqeANDSETLTmImDCKY------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 218 PFQEANDSETLTMIMDCKY------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ccccccchhhhhhhhcccc------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 9998776654443321111 134456789999999999999999999999997654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=283.23 Aligned_cols=214 Identities=29% Similarity=0.472 Sum_probs=172.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------------CCCCHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGL 69 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~l~~~~~~~~~~qi~~~l 69 (306)
|.+|++++++++|+||+++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||
T Consensus 54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL 133 (288)
T cd05093 54 FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGM 133 (288)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999986432 2489999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHH
Q 021891 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 149 (306)
Q Consensus 70 ~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 149 (306)
+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||
T Consensus 134 ~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 210 (288)
T cd05093 134 VYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210 (288)
T ss_pred HHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHH
Confidence 9999988 9999999999999999999999999998654332222222334577899999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 150 VLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 150 il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
++|+|++ |..||........ ..... .. .. ... +...+..+.+|+.+||+.||.+|||+.+++
T Consensus 211 il~~l~t~g~~p~~~~~~~~~---~~~i~----~~-~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 211 VLWEIFTYGKQPWYQLSNNEV---IECIT----QG-RV-----LQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHH---HHHHH----cC-Cc-----CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 9999998 8888865432211 11100 00 00 001 112246789999999999999999999999
Q ss_pred HHhCCCC
Q 021891 229 EALKPLP 235 (306)
Q Consensus 229 ~~l~~~~ 235 (306)
+.|+.+.
T Consensus 274 ~~l~~~~ 280 (288)
T cd05093 274 SLLQNLA 280 (288)
T ss_pred HHHHHHH
Confidence 9887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=279.11 Aligned_cols=213 Identities=26% Similarity=0.441 Sum_probs=173.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.++++++||||+++++++...+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~ 128 (266)
T cd05033 52 FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YV 128 (266)
T ss_pred HHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 678999999999999999999999999999999999999999999776667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 129 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p 208 (266)
T cd05033 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred cCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999987653222222222344678999999998899999999999999999998 9888
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|....... ...... ... .. ..+...+..+.+|+.+||+.+|++||++.+++++|+.+
T Consensus 209 ~~~~~~~~---~~~~~~----~~~---~~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 209 YWDMSNQD---VIKAVE----DGY---RL-------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCHHH---HHHHHH----cCC---CC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 86543211 111110 000 00 01123356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=292.73 Aligned_cols=201 Identities=28% Similarity=0.360 Sum_probs=165.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+++..|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++
T Consensus 45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~ 120 (318)
T cd05582 45 TKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---II 120 (318)
T ss_pred HHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 467999999999999999999999999999999999999999998554 46899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 121 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 198 (318)
T cd05582 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198 (318)
T ss_pred cCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence 999999999999999999999999876543211 223457899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
........ ... ..... . .++...+..+.+||.+||+.||++||++.+
T Consensus 199 ~~~~~~~~---~~~---i~~~~--------~----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 199 QGKDRKET---MTM---ILKAK--------L----GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHH---HHH---HHcCC--------C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 75432111 100 00000 0 111223567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=275.82 Aligned_cols=209 Identities=27% Similarity=0.447 Sum_probs=169.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|+.++||||+++++++...+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 122 (256)
T cd05114 46 FIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122 (256)
T ss_pred HHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 678999999999999999999999999999999999999999998765557899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |+.|
T Consensus 123 H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p 201 (256)
T cd05114 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201 (256)
T ss_pred ccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999886533221 11122334567999999988889999999999999999999 8899
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|........ ..... ... ....+. ..+..+.+++.+||+.+|++|||+.++++.|
T Consensus 202 ~~~~~~~~~---~~~i~----~~~---~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 202 FEKKSNYEV---VEMIS----RGF---RLYRPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHH---HHHHH----CCC---CCCCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 865432111 11110 000 011111 1245789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=280.69 Aligned_cols=211 Identities=25% Similarity=0.418 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~L 72 (306)
|.+|+.+++.++|+||+++++++......++||||+++++|.+++.+.. ..+++..+..++.|++.||.||
T Consensus 56 ~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 135 (277)
T cd05062 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL 135 (277)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999986432 2357788999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 136 H~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 212 (277)
T cd05062 136 NANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212 (277)
T ss_pred HHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHH
Confidence 9988 9999999999999999999999999987654332222222234577899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||++ |..||....... ...... .. . . +. .+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 213 el~~~~~~p~~~~~~~~---~~~~~~----~~-~---~--~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 213 EIATLAEQPYQGMSNEQ---VLRFVM----EG-G---L--LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred HHHcCCCCCCCCCCHHH---HHHHHH----cC-C---c--CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 9999 678886543211 111100 00 0 0 00 1112346789999999999999999999999987
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
+
T Consensus 276 ~ 276 (277)
T cd05062 276 K 276 (277)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=276.49 Aligned_cols=210 Identities=24% Similarity=0.395 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++...+..++||||+.+++|.+++......+++..++.++.||+.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 122 (256)
T cd05113 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FI 122 (256)
T ss_pred HHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999888999999999999999999766557899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.+||+|||.++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 123 H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p 201 (256)
T cd05113 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201 (256)
T ss_pred ccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999876543221 11222345677999999988889999999999999999998 8999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|....... ..... ..... ... +...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 202 ~~~~~~~~---~~~~~----~~~~~------~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 202 YERFNNSE---TVEKV----SQGLR------LYR----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCcCCHHH---HHHHH----hcCCC------CCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 86543211 11100 00000 000 1112468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=281.12 Aligned_cols=210 Identities=25% Similarity=0.362 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+..|+++++.++|+||+++++++..+...++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+
T Consensus 40 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-- 117 (280)
T cd05608 40 AMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117 (280)
T ss_pred HHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46799999999999999999999999999999999999999987743 3346899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|||++|+
T Consensus 118 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~ 194 (280)
T cd05608 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194 (280)
T ss_pred -cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999976543322 123356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~ 230 (306)
.||............ .. ...... ..++...+..+.+++.+||+.||++|| +++++++|
T Consensus 195 ~pf~~~~~~~~~~~~--~~----------~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 195 GPFRARGEKVENKEL--KQ----------RILNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCCCCCcchhHHHH--HH----------hhcccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 999764332111100 00 000000 012223457889999999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=277.61 Aligned_cols=212 Identities=23% Similarity=0.358 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++++.++|+||+++++++..++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ +
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i 125 (263)
T cd05052 49 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125 (263)
T ss_pred HHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 678999999999999999999999999999999999999999998654 345899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 126 ~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~ 204 (263)
T cd05052 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 204 (263)
T ss_pred eecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999875432211 1112234567999999988899999999999999999998 889
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||....... ...... ..... ..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 205 p~~~~~~~~---~~~~~~----------~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 205 PYPGIDLSQ---VYELLE----------KGYRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHH---HHHHHH----------CCCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 987543211 100000 00111 11222357899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=285.81 Aligned_cols=213 Identities=22% Similarity=0.340 Sum_probs=171.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.+++.++||||+++++++... ..++|+||+++|+|.+++.+....+++..++.++.||+.||+|||+.+ ++
T Consensus 56 ~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ii 131 (316)
T cd05108 56 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LV 131 (316)
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---ee
Confidence 67899999999999999999998764 578999999999999999877667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 132 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p 211 (316)
T cd05108 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211 (316)
T ss_pred ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654333222223344678999999998899999999999999999997 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|........ ... ...... .. . +..++.++.+++.+||..+|++||++.+++..+..+.
T Consensus 212 ~~~~~~~~~---~~~----~~~~~~---~~---~----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 212 YDGIPASEI---SSI----LEKGER---LP---Q----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCHHHH---HHH----HhCCCC---CC---C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 865422111 000 000000 00 0 1112457889999999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=292.24 Aligned_cols=225 Identities=23% Similarity=0.264 Sum_probs=172.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++|+||||+++++++......++|||++. ++|.+++ .....+++..++.++.||+.||.|||+.+ |+
T Consensus 133 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---iv 207 (392)
T PHA03207 133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---II 207 (392)
T ss_pred HHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 4689999999999999999999999999999999995 6888888 44457999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.++|+|||+++...............||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 208 HrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 208 HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred ccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999998765443333333467899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccc----------------cccccccCCccC--CC-CCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGER----------------RRFYRLIDPRLE--GH-FSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~--~~-~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
.+.........+.......... ..+.....+... .. .....+.++.++|.+||+.||++||
T Consensus 288 ~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp 367 (392)
T PHA03207 288 FGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367 (392)
T ss_pred CCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC
Confidence 7755433211111111000000 000000000000 00 0011245788999999999999999
Q ss_pred CHHHHHHHh
Q 021891 223 LMSEVVEAL 231 (306)
Q Consensus 223 s~~ell~~l 231 (306)
|+.|++.+.
T Consensus 368 sa~e~l~~p 376 (392)
T PHA03207 368 SAQDILSLP 376 (392)
T ss_pred CHHHHhhCc
Confidence 999999974
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.92 Aligned_cols=211 Identities=24% Similarity=0.341 Sum_probs=174.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+.+|.+| .|.+||++|||-..++.+|+||||= ..+|...|.++....+...++.+..|++.++.++|.++ |
T Consensus 406 y~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---I 481 (677)
T KOG0596|consen 406 YRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---I 481 (677)
T ss_pred HHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---e
Confidence 78999999999 5899999999999999999999986 45999999887766665689999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-----------CCCchhHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----------HLTSRSDVYSFGV 149 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~ 149 (306)
||.||||.|+|+ -.|.+||+|||+|..+............+||..||+||.+... ..+.++|||||||
T Consensus 482 VHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC 560 (677)
T KOG0596|consen 482 VHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC 560 (677)
T ss_pred eecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence 999999999999 5678999999999998887777777889999999999998532 2567999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHH-HHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA-QKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|||+|+.|++||..... ...++..+.+|...-.|+.--. .++.++++.||..||++|||+.|||
T Consensus 561 ILYqMvYgktPf~~~~n---------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 561 ILYQMVYGKTPFGQIIN---------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred HHHHHHhcCCchHHHHH---------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHh
Confidence 99999999999974321 1122334445543333322111 2399999999999999999999999
Q ss_pred HHhC
Q 021891 229 EALK 232 (306)
Q Consensus 229 ~~l~ 232 (306)
+|..
T Consensus 626 qhpF 629 (677)
T KOG0596|consen 626 QHPF 629 (677)
T ss_pred cCcc
Confidence 9753
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=276.31 Aligned_cols=212 Identities=23% Similarity=0.352 Sum_probs=170.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++. .+..++||||+++++|.+++..+...+++..++.++.|++.||.|||+++ ++
T Consensus 42 ~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 117 (257)
T cd05115 42 MMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FV 117 (257)
T ss_pred HHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---ee
Confidence 678999999999999999999885 45789999999999999999766667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+||+++.++.+||+|||++........... .....++..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 118 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 197 (257)
T cd05115 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197 (257)
T ss_pred ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999976543322111 111223568999999988889999999999999999996 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||........ .... .... ....+...+.++.+++.+||..+|++||++.+|++.|+..
T Consensus 198 p~~~~~~~~~---~~~~----~~~~----------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 198 PYKKMKGPEV---MSFI----EQGK----------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CcCcCCHHHH---HHHH----HCCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9976533211 1110 0000 0111223357889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=280.53 Aligned_cols=212 Identities=26% Similarity=0.487 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC----------------CCCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------------SLPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~l~~~~~~~~~~qi 65 (306)
|++|+++++.++||||+++++++...+..++||||+++++|.+++..+ ...+++..+..++.|+
T Consensus 54 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 133 (283)
T cd05090 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133 (283)
T ss_pred HHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999998532 1247888999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 134 ~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 210 (283)
T cd05090 134 AAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIW 210 (283)
T ss_pred HHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhH
Confidence 99999999988 999999999999999999999999999875443322223334456789999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |..||...... ....... ... . .. .+...+..+.+++.+||+.||++||++
T Consensus 211 slG~il~el~~~g~~p~~~~~~~---~~~~~~~----~~~----~--~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (283)
T cd05090 211 SFGVVLWEIFSFGLQPYYGFSNQ---EVIEMVR----KRQ----L--LP----CSEDCPPRMYSLMTECWQEGPSRRPRF 273 (283)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----cCC----c--CC----CCCCCCHHHHHHHHHHcccCcccCcCH
Confidence 99999999998 88888654321 1111110 000 0 00 111234678999999999999999999
Q ss_pred HHHHHHhCC
Q 021891 225 SEVVEALKP 233 (306)
Q Consensus 225 ~ell~~l~~ 233 (306)
.+|+++|..
T Consensus 274 ~~i~~~l~~ 282 (283)
T cd05090 274 KDIHTRLRS 282 (283)
T ss_pred HHHHHHhhc
Confidence 999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=274.26 Aligned_cols=210 Identities=25% Similarity=0.340 Sum_probs=180.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.-+|+.|+++++.|+||++||.+.....+|+|||||..|++.|.++.+++++.+..+..+++..++||+|||... -+
T Consensus 75 IIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KI 151 (502)
T KOG0574|consen 75 IIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KI 151 (502)
T ss_pred HHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HH
Confidence 457999999999999999999999999999999999999999999989999999999999999999999999987 89
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||||..|||++.+|..||+|||.|..+.+.. -..+...||+.|||||++..-.|+.++||||||+...||..|++||
T Consensus 152 HRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPY 229 (502)
T KOG0574|consen 152 HRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPY 229 (502)
T ss_pred HhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCc
Confidence 99999999999999999999999998765432 2245578999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
....+.-..-.+ ..+|..--.-+...+.++-+++++||-++|++|-|+.++++|.
T Consensus 230 sDIHPMRAIFMI---------------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 230 SDIHPMRAIFMI---------------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred ccccccceeEec---------------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 876543221111 1111111223556678999999999999999999999999874
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=289.27 Aligned_cols=224 Identities=25% Similarity=0.329 Sum_probs=164.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++++.++||||+++++++.... ..|+|||||. ++|.+++.+. ..+++..+..++.||+.||.|||+.+
T Consensus 46 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ 123 (338)
T cd07859 46 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN 123 (338)
T ss_pred HHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999999999886532 5799999995 6899988554 36899999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc-ceeeecccccccccCCcchhc--CCCCchhHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e 153 (306)
|+||||||+|||++.++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|+
T Consensus 124 ---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~e 200 (338)
T cd07859 124 ---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 200 (338)
T ss_pred ---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHH
Confidence 99999999999999999999999999986432221 111234568999999999875 678999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhh--------hhhc--cccccccccCCccCCCCC---HHHHHHHHHHHHHcccCCCCC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWAR--------PHLG--ERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~ 220 (306)
|++|+.||...........+.... ..+. ....+...+.......+. ...+..+.+++.+||+.||++
T Consensus 201 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 280 (338)
T cd07859 201 VLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD 280 (338)
T ss_pred HHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence 999999997643221111000000 0000 000000000000000000 012457889999999999999
Q ss_pred CCCHHHHHHH
Q 021891 221 RPLMSEVVEA 230 (306)
Q Consensus 221 Rps~~ell~~ 230 (306)
|||+.|++++
T Consensus 281 Rpt~~e~l~h 290 (338)
T cd07859 281 RPTAEEALAD 290 (338)
T ss_pred CCCHHHHhcC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.09 Aligned_cols=206 Identities=29% Similarity=0.362 Sum_probs=168.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~i 80 (306)
+.+|+++++.++||||+++++++...+..++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+ .+ |
T Consensus 42 ~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---i 117 (325)
T cd05594 42 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---V 117 (325)
T ss_pred HHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---E
Confidence 467899999999999999999999999999999999999999988554 468999999999999999999997 67 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 118 vHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred EecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCC
Confidence 9999999999999999999999999875332211 12335689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
|........... .... ... ++...+.++.+|+.+||+.||++|+ ++.++++|.
T Consensus 196 f~~~~~~~~~~~------i~~~--------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 196 FYNQDHEKLFEL------ILME--------EIR----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCCCHHHHHHH------HhcC--------CCC----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 975432111000 0000 001 1112346789999999999999996 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=279.39 Aligned_cols=217 Identities=24% Similarity=0.332 Sum_probs=172.5
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..|++++++++||||+++++++.++...++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++
T Consensus 41 ~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iv 117 (277)
T cd05607 41 LLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IV 117 (277)
T ss_pred HHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 46999999999999999999999999999999999999999888554 345899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 118 H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~ 194 (277)
T cd05607 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194 (277)
T ss_pred EccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987654322 123346889999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 238 (306)
......... .......... .+.. .....+.++.+|+.+||+.||++||++.|+++++...+.+.
T Consensus 195 ~~~~~~~~~--~~~~~~~~~~------~~~~-----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~ 258 (277)
T cd05607 195 KDHKEKVAK--EELKRRTLED------EVKF-----EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258 (277)
T ss_pred CCCcchhhH--HHHHHHhhcc------cccc-----ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhc
Confidence 754322111 1111110000 0000 00123567899999999999999999988887766555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.68 Aligned_cols=211 Identities=27% Similarity=0.445 Sum_probs=169.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAK 67 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~l~~~~~~~~~~qi~~ 67 (306)
|.+|+++++.++|+||+++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.
T Consensus 54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 133 (280)
T cd05092 54 FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIAS 133 (280)
T ss_pred HHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHH
Confidence 7889999999999999999999999999999999999999999986542 24889999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHH
Q 021891 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 147 (306)
Q Consensus 68 ~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 147 (306)
||.|||+.+ ++||||||+||++++++.+||+|||++................++..|+|||.+.+..++.++|||||
T Consensus 134 al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05092 134 GMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210 (280)
T ss_pred HHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence 999999988 99999999999999999999999999876543222222222345678999999998899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 148 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 148 G~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
||++|+|++ |.+||............ .... ... .+...+..+.+|+.+||+.||.+||++.+
T Consensus 211 G~il~el~~~g~~p~~~~~~~~~~~~~-------~~~~------~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 211 GVVLWEIFTYGKQPWYQLSNTEAIECI-------TQGR------ELE----RPRTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHHHHHHHcCCCCCCccCCHHHHHHHH-------HcCc------cCC----CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999999998 88998654322111000 0000 000 11123467889999999999999999999
Q ss_pred HHHHhC
Q 021891 227 VVEALK 232 (306)
Q Consensus 227 ll~~l~ 232 (306)
|++.|+
T Consensus 274 l~~~l~ 279 (280)
T cd05092 274 IHSRLQ 279 (280)
T ss_pred HHHHHh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=289.95 Aligned_cols=206 Identities=25% Similarity=0.355 Sum_probs=162.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++|+||+++++++...+.+++||||+.+++|.+.. ...+..+..++.||+.||.|||+.+ |+
T Consensus 119 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---iv 190 (353)
T PLN00034 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IV 190 (353)
T ss_pred HHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 678999999999999999999999999999999999999986532 3567888899999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----CCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ellt 156 (306)
||||||+|||++.++.+||+|||+++....... ......||..|+|||++.. ...+.++|||||||++|||++
T Consensus 191 HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~ 268 (353)
T PLN00034 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268 (353)
T ss_pred ecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh
Confidence 999999999999999999999999986543211 1233568999999998743 234568999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|+.||................ .. .. .......+.++.+||.+||+.||++|||+.|+++|-
T Consensus 269 g~~pf~~~~~~~~~~~~~~~~--~~--------~~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 269 GRFPFGVGRQGDWASLMCAIC--MS--------QP----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred CCCCCCCCCCccHHHHHHHHh--cc--------CC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 999997432221111110000 00 00 111223457899999999999999999999999864
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=286.47 Aligned_cols=196 Identities=30% Similarity=0.364 Sum_probs=159.2
Q ss_pred HHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 021891 8 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 87 (306)
Q Consensus 8 il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp 87 (306)
+++.++||||+++++++...+..++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp 124 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKP 124 (323)
T ss_pred HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCH
Confidence 567899999999999999999999999999999999988654 47899999999999999999999998 99999999
Q ss_pred CCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCC
Q 021891 88 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 167 (306)
Q Consensus 88 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 167 (306)
+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 125 ~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 125 ENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred HHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence 99999999999999999987532221 1233457899999999999989999999999999999999999999764321
Q ss_pred CCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 168 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
. . ........ ... ....+..+.++|.+||+.||.+||++.+.
T Consensus 203 ~---~---~~~i~~~~--------~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 203 E---M---YDNILNKP--------LRL----KPNISVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred H---H---HHHHHcCC--------CCC----CCCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 1 1 00000000 011 11225688999999999999999998533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=277.85 Aligned_cols=211 Identities=27% Similarity=0.401 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
|.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++.+.. ..+++..+..++.||+.||.|||+.
T Consensus 56 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 135 (277)
T cd05036 56 FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135 (277)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 6789999999999999999999999999999999999999999986543 2589999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCC---cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+ ++||||||+||+++.++ .+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 136 ~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 212 (277)
T cd05036 136 H---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212 (277)
T ss_pred C---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHH
Confidence 8 99999999999998754 58999999998753322111111223356799999999889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||++ |..||........ .... .... ....+...+..+.+++.+||+.+|++|||+.+|+++|
T Consensus 213 el~~~g~~pf~~~~~~~~---~~~~----~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 213 EIFSLGYMPYPGRTNQEV---MEFV----TGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred HHHcCCCCCCCCCCHHHH---HHHH----HcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 9997 8899875433211 1110 0000 0011222356889999999999999999999999988
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
.
T Consensus 276 ~ 276 (277)
T cd05036 276 Q 276 (277)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=310.40 Aligned_cols=216 Identities=30% Similarity=0.429 Sum_probs=179.5
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+|.+|..+|+.++|||||+++|++.+....+|++|||.||+|..+|++. ...+.......++.|||+|+.||++
T Consensus 741 ~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~ 820 (1025)
T KOG1095|consen 741 DFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES 820 (1025)
T ss_pred HHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh
Confidence 5899999999999999999999999999999999999999999999876 5678999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHH
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 154 (306)
++ +|||||...|+|++....+||+|||+|+.+...+.........-...|||||.+..+.|+.|+|||||||++||+
T Consensus 821 ~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEi 897 (1025)
T KOG1095|consen 821 KH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEI 897 (1025)
T ss_pred CC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHH
Confidence 98 999999999999999999999999999965544433333222334679999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 155 LT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 155 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
+| |..||...+..+.... ..... ++- .+..++..++++|..||+.+|++||++..|++.+..
T Consensus 898 fslG~~PY~~~~n~~v~~~-------~~~gg---RL~-------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 898 FSLGATPYPSRSNFEVLLD-------VLEGG---RLD-------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred HhCCCCCCCCcchHHHHHH-------HHhCC---ccC-------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 99 7789877654322110 11111 111 233557899999999999999999999999997665
Q ss_pred CCC
Q 021891 234 LPN 236 (306)
Q Consensus 234 ~~~ 236 (306)
+.+
T Consensus 961 i~~ 963 (1025)
T KOG1095|consen 961 ISN 963 (1025)
T ss_pred hhh
Confidence 443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.96 Aligned_cols=212 Identities=24% Similarity=0.374 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAA 66 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~~~~qi~ 66 (306)
|.+|+.+++.++||||+++++++.+.+..++++||+.+++|.+++... ...+++..+..++.|++
T Consensus 55 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~ 134 (283)
T cd05091 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIA 134 (283)
T ss_pred HHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999998532 23478889999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHH
Q 021891 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 146 (306)
Q Consensus 67 ~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 146 (306)
.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||
T Consensus 135 ~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05091 135 AGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS 211 (283)
T ss_pred HHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHH
Confidence 9999999988 9999999999999999999999999988654433222223344577899999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 147 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 147 lG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
|||++|||++ |..||....... ...... ... ....+...+..+.+|+..||+.+|++||++.
T Consensus 212 lG~~l~el~~~g~~p~~~~~~~~---~~~~i~----~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~ 274 (283)
T cd05091 212 YGVVLWEVFSYGLQPYCGYSNQD---VIEMIR----NRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFK 274 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----cCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 9999999998 778886543211 111100 000 0011223457789999999999999999999
Q ss_pred HHHHHhCC
Q 021891 226 EVVEALKP 233 (306)
Q Consensus 226 ell~~l~~ 233 (306)
+|++.|+.
T Consensus 275 ~i~~~l~~ 282 (283)
T cd05091 275 DIHSRLRT 282 (283)
T ss_pred HHHHHhhC
Confidence 99998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=278.02 Aligned_cols=213 Identities=26% Similarity=0.401 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+..|+.++++++||||+++++++. ....++|+||+++|+|.+++......+++..+..++.||+.||.|||+.+ ++
T Consensus 56 ~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ii 131 (279)
T cd05111 56 ITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MV 131 (279)
T ss_pred HHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 566778899999999999999875 45678999999999999999776667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 132 H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p 211 (279)
T cd05111 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211 (279)
T ss_pred ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987544333222333456778999999988899999999999999999998 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|........ .... .... ....+. .++..+.+++.+||..||++|||+.|+++.|..+.
T Consensus 212 ~~~~~~~~~---~~~~----~~~~---~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 212 YAGMRPHEV---PDLL----EKGE---RLAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCCHHHH---HHHH----HCCC---cCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 876432211 1110 0100 001111 12357789999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=274.26 Aligned_cols=211 Identities=31% Similarity=0.470 Sum_probs=174.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+++|+++++.++|+||+++++++......++||||+++++|.+++... ...+++..++.++.|++.||.|||
T Consensus 43 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH 122 (262)
T cd00192 43 FLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122 (262)
T ss_pred HHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999999775 467999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
+.+ ++|+||||+||+++.++.+||+|||.+................++..|+|||.+....++.++|||||||++|+
T Consensus 123 ~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 199 (262)
T cd00192 123 SKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199 (262)
T ss_pred cCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHH
Confidence 988 99999999999999999999999999987655432223344567889999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 154 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 154 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|++ |..||....... ...... .. .....+...+.++.+++.+||+.+|.+|||+.+++++|+
T Consensus 200 l~~~g~~p~~~~~~~~---~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 200 IFTLGATPYPGLSNEE---VLEYLR----KG----------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHhcCCCCCCCCCHHH---HHHHHH----cC----------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 999 589987652211 111100 00 001112233578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=282.49 Aligned_cols=213 Identities=28% Similarity=0.414 Sum_probs=171.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~~~~qi 65 (306)
+.+|+++++++ +|+||+++++++..++..++||||+++++|.+++..+ ...+++..++.++.|+
T Consensus 62 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 141 (293)
T cd05053 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141 (293)
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence 56899999999 8999999999999999999999999999999998532 3468899999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||
T Consensus 142 ~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 142 ARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred HHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccccee
Confidence 99999999988 999999999999999999999999999875443222222223346779999999888999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |..||........... .... .....+...+..+.+|+.+||..||++|||+
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 281 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEELFKL-------LKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTF 281 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHHHHH-------HHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence 99999999997 8888865432111110 0000 0001122335688999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.++++.|+.+
T Consensus 282 ~eil~~l~~~ 291 (293)
T cd05053 282 KQLVEDLDRM 291 (293)
T ss_pred HHHHHHHHHh
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=280.39 Aligned_cols=213 Identities=26% Similarity=0.396 Sum_probs=171.7
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++++++ +|+||+++++++...+..++||||+.+++|.+++.... ..+++.++..++.|++.||.|||+.+
T Consensus 85 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--- 161 (302)
T cd05055 85 LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--- 161 (302)
T ss_pred HHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 67899999999 89999999999999999999999999999999986543 34899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 162 ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986544322222223345778999999998889999999999999999998 99
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
.||........ ...... .. ... ..+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus 242 ~p~~~~~~~~~--~~~~~~----~~------~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 242 NPYPGMPVDSK--FYKLIK----EG------YRM----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCcCCCCchHH--HHHHHH----cC------CcC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 99875432211 111000 00 000 0111224689999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=274.79 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=169.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++...+..++||||+++++|.+++..+...+++..++.++.|++.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 122 (256)
T cd05059 46 FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122 (256)
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 678999999999999999999999999999999999999999999776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 123 H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p 201 (256)
T cd05059 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201 (256)
T ss_pred cccccHhhEEECCCCcEEECCcccceecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCC
Confidence 999999999999999999999999876533211 11112223457999999998899999999999999999999 7888
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|........ ..... . ..... .+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 202 ~~~~~~~~~---~~~~~----~------~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 202 YERFSNSEV---VESVS----A------GYRLY----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHH---HHHHH----c------CCcCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 875432211 11000 0 00111 1112356899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=285.65 Aligned_cols=212 Identities=28% Similarity=0.409 Sum_probs=167.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|..++.++ +||||+++++++.+.+..|+|||||++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ +
T Consensus 42 ~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i 117 (329)
T cd05588 42 VQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---I 117 (329)
T ss_pred HHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56889999998 7999999999999999999999999999999988554 47999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 118 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred EecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCC
Confidence 999999999999999999999999987532211 122345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCC--cchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 021891 161 MDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL------MSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~ell~~ 230 (306)
|........ .....+........ ... ++...+..+.++|.+||+.||.+|+| +.++++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~-------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEK-------QIR----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred cccccccccccccchHHHHHHHHcC-------CCC----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 964322211 11111111111000 001 11123467899999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=285.42 Aligned_cols=203 Identities=26% Similarity=0.380 Sum_probs=162.3
Q ss_pred HHHHHHH---hcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 3 QAEVNFL---GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 3 ~~E~~il---~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.+|++++ +.++||||+++++++.+.+..|+||||+++++|...+.. ..+++..+..++.||+.||.|||+.+
T Consensus 47 ~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--- 121 (324)
T cd05589 47 MCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--- 121 (324)
T ss_pred HHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4555544 567899999999999999999999999999999988744 36899999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
++||||||+||+++.++.+||+|||+++...... .......|+..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 122 ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~ 199 (324)
T cd05589 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199 (324)
T ss_pred eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCC
Confidence 9999999999999999999999999987533221 12234678999999999999899999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 230 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~ 230 (306)
||........... ..... .. ++...+..+.++|.+||+.||.+|| ++.+++++
T Consensus 200 pf~~~~~~~~~~~------i~~~~--------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 200 PFPGDDEEEVFDS------IVNDE--------VR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCHHHHHHH------HHhCC--------CC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 9976432211100 00000 01 1122356788999999999999999 56677664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=280.50 Aligned_cols=213 Identities=26% Similarity=0.413 Sum_probs=170.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-----------------------CCCCCHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIR 58 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~~l~~~~~ 58 (306)
|.+|+++++.++||||+++++.+...+..++|+||+.+++|.+++... ...+++..+
T Consensus 50 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (290)
T cd05045 50 LLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDL 129 (290)
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHH
Confidence 678999999999999999999999999999999999999999987532 134788999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC
Q 021891 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 138 (306)
Q Consensus 59 ~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 138 (306)
+.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..+
T Consensus 130 ~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 206 (290)
T cd05045 130 ISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206 (290)
T ss_pred HHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc
Confidence 999999999999999988 99999999999999999999999999986543322222223345678999999988889
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 139 TSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 139 ~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
+.++||||||+++++|++ |..||....... ...... . .... ..+...+..+.+++.+||+.+
T Consensus 207 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~------~~~~----~~~~~~~~~~~~~i~~cl~~~ 269 (290)
T cd05045 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER---LFNLLK----T------GYRM----ERPENCSEEMYNLMLTCWKQE 269 (290)
T ss_pred chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----C------CCCC----CCCCCCCHHHHHHHHHHccCC
Confidence 999999999999999998 999986543211 111100 0 0001 111223568999999999999
Q ss_pred CCCCCCHHHHHHHhCCC
Q 021891 218 PKARPLMSEVVEALKPL 234 (306)
Q Consensus 218 p~~Rps~~ell~~l~~~ 234 (306)
|++||++.++++.|+.+
T Consensus 270 P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 270 PDKRPTFADISKELEKM 286 (290)
T ss_pred cccCCCHHHHHHHHHHH
Confidence 99999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=284.89 Aligned_cols=195 Identities=28% Similarity=0.337 Sum_probs=158.0
Q ss_pred HHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 021891 7 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 86 (306)
Q Consensus 7 ~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlk 86 (306)
.+++.++||||+++++++.+.+..++||||+++++|.+.+.+. ..+++..+..++.||+.||.|||+.+ |+|||||
T Consensus 48 ~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlk 123 (321)
T cd05603 48 VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLK 123 (321)
T ss_pred HHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCC
Confidence 4678899999999999999999999999999999999888544 46899999999999999999999988 9999999
Q ss_pred CCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 021891 87 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 166 (306)
Q Consensus 87 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 166 (306)
|+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 124 p~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (321)
T cd05603 124 PENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201 (321)
T ss_pred HHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence 999999999999999999987532221 122345789999999999988999999999999999999999999976432
Q ss_pred CCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 167 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
.. .. ....... . .++...+..+.+++.+||+.||.+||++.
T Consensus 202 ~~---~~---~~i~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 202 SQ---MY---DNILHKP--------L----QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HH---HH---HHHhcCC--------C----CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 11 1000000 0 01112346788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=285.64 Aligned_cols=222 Identities=23% Similarity=0.315 Sum_probs=165.5
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
..|+.++++++|+||+++++++...+..++|||++. ++|.+++......+++..++.++.||+.||.|||+.+ |+|
T Consensus 105 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 180 (357)
T PHA03209 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIH 180 (357)
T ss_pred HHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 579999999999999999999999999999999995 5899988777778999999999999999999999998 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
|||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 181 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 181 RDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred CCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 9999999999999999999999997532211 1233568999999999999899999999999999999998765554
Q ss_pred CCCCCCCcchHHhh-------hhhhc-cccccc---------cccC------CccCC---CCCHHHHHHHHHHHHHcccC
Q 021891 163 KNRPNGEHNLVEWA-------RPHLG-ERRRFY---------RLID------PRLEG---HFSIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 163 ~~~~~~~~~~~~~~-------~~~~~-~~~~~~---------~~~~------~~~~~---~~~~~~~~~~~~li~~~l~~ 216 (306)
.............. ..... ....+. ..++ ..... ......+.++.+||.+||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 337 (357)
T PHA03209 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF 337 (357)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC
Confidence 33222111000000 00000 000000 0000 00000 00012245667899999999
Q ss_pred CCCCCCCHHHHHHHh
Q 021891 217 DPKARPLMSEVVEAL 231 (306)
Q Consensus 217 ~p~~Rps~~ell~~l 231 (306)
||++|||+.|+++|-
T Consensus 338 dP~~Rpta~e~l~hp 352 (357)
T PHA03209 338 DAAMRPSAEEILNYP 352 (357)
T ss_pred CcccCcCHHHHhcCc
Confidence 999999999999863
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=286.08 Aligned_cols=205 Identities=26% Similarity=0.367 Sum_probs=166.0
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|.+++..+ +||||+++++++.+.+..|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ +
T Consensus 42 ~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---i 117 (320)
T cd05590 42 TMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---I 117 (320)
T ss_pred HHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 45688888776 7999999999999999999999999999999988654 46999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 118 vH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred EeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCC
Confidence 999999999999999999999999987532221 122345789999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ell~~ 230 (306)
|........ ... ..... .. ++...+.++.+|+.+||+.||++||++ +++++|
T Consensus 196 f~~~~~~~~---~~~---i~~~~--------~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 196 FEAENEDDL---FEA---ILNDE--------VV----YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHH---HHH---HhcCC--------CC----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 976532211 110 00000 00 111235688999999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=291.45 Aligned_cols=214 Identities=23% Similarity=0.384 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------------------------------
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------------------ 50 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 50 (306)
|.+|+++|+++. ||||+++++++.+.+..|+|||||++|+|.+++.++.
T Consensus 87 ~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (400)
T cd05105 87 LMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSY 166 (400)
T ss_pred HHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccch
Confidence 678999999996 9999999999999999999999999999999875421
Q ss_pred -----------------------------------------------------------------CCCCHHHHHHHHHHH
Q 021891 51 -----------------------------------------------------------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 51 -----------------------------------------------------------------~~l~~~~~~~~~~qi 65 (306)
..+++..+..++.||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi 246 (400)
T cd05105 167 VILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQV 246 (400)
T ss_pred hhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHH
Confidence 247788889999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 247 ~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred HHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 99999999988 999999999999999999999999999865433222222334567789999999988999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |..||........ ... ..... .... .+...+..+.+++.+||+.||++|||+
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~--~~~----~~~~~------~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDST--FYN----KIKSG------YRMA----KPDHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHH--HHH----HHhcC------CCCC----CCccCCHHHHHHHHHHCccCHhHCcCH
Confidence 99999999997 8899875432111 000 00000 0011 112345788999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.+|.+.|+.+
T Consensus 388 ~~l~~~l~~l 397 (400)
T cd05105 388 LHLSDIVESL 397 (400)
T ss_pred HHHHHHHHHH
Confidence 9999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=292.05 Aligned_cols=212 Identities=24% Similarity=0.324 Sum_probs=165.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++|+||+++++++.+.+.+++|||||++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+
T Consensus 48 ~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---iv 123 (381)
T cd05626 48 VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMG---FI 123 (381)
T ss_pred HHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 5789999999999999999999999999999999999999999986544 6899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc---------------------------------------------e
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------------------------H 116 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------------~ 116 (306)
||||||+|||++.++.+||+|||+++........ .
T Consensus 124 HrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (381)
T cd05626 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC 203 (381)
T ss_pred ecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence 9999999999999999999999997543110000 0
Q ss_pred eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCC
Q 021891 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 196 (306)
Q Consensus 117 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (306)
.....+||..|+|||++.+..++.++|||||||++|||++|..||...........+ ...... . ...
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i------~~~~~~----~--~~~- 270 (381)
T cd05626 204 LAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV------INWENT----L--HIP- 270 (381)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH------Hccccc----c--CCC-
Confidence 012356999999999999889999999999999999999999999765432111000 000000 0 000
Q ss_pred CCCHHHHHHHHHHHHHcc--cCCCCCCCCHHHHHHHh
Q 021891 197 HFSIKGAQKAAQLAAHCL--SRDPKARPLMSEVVEAL 231 (306)
Q Consensus 197 ~~~~~~~~~~~~li~~~l--~~~p~~Rps~~ell~~l 231 (306)
.....+.++.+||.+|+ ..++..|+++.++++|.
T Consensus 271 -~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 271 -PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred -CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 01123467889998854 55666699999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=273.73 Aligned_cols=211 Identities=25% Similarity=0.378 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++|+||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ +
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i 124 (261)
T cd05068 48 FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---Y 124 (261)
T ss_pred HHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 6789999999999999999999999999999999999999999986543 56899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 125 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 203 (261)
T cd05068 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203 (261)
T ss_pred eeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987643211 11111223457999999988899999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ... ..... ... ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 204 p~~~~~~~~---~~~----~~~~~------~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 204 PYPGMTNAE---VLQ----QVDQG------YRM----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCHHH---HHH----HHHcC------CCC----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 986543211 111 00000 000 0111235789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=286.28 Aligned_cols=207 Identities=26% Similarity=0.298 Sum_probs=164.8
Q ss_pred HHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 021891 7 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 86 (306)
Q Consensus 7 ~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlk 86 (306)
.+++.++|+||+++++++...+..++||||+++++|.+++... ..+.+..+..++.||+.||.|||+.+ |+|||||
T Consensus 48 ~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlk 123 (325)
T cd05602 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLK 123 (325)
T ss_pred HHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCC
Confidence 3577899999999999999999999999999999999988654 46888999999999999999999998 9999999
Q ss_pred CCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 021891 87 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 166 (306)
Q Consensus 87 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 166 (306)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 124 p~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 124 PENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred HHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999875432211 22345789999999999999999999999999999999999999975432
Q ss_pred CCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 021891 167 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 237 (306)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 237 (306)
... .... .... .. +....+..+.+++.+||+.||.+|+++.+.+..+.....+
T Consensus 202 ~~~---~~~i---~~~~--------~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 202 AEM---YDNI---LNKP--------LQ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred HHH---HHHH---HhCC--------cC----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence 211 1110 0000 00 1112346789999999999999999987655554444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=289.38 Aligned_cols=211 Identities=25% Similarity=0.336 Sum_probs=164.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++.+++|+||+++++.+.+....|+|||||++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+
T Consensus 48 ~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---iv 123 (363)
T cd05628 48 IRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FI 123 (363)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 568999999999999999999999999999999999999999998654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc---------------------------------eeeeccccccccc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------------HVSTRVMGTYGYA 128 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~ 128 (306)
||||||+|||++.++.+||+|||+++........ ......+||..|+
T Consensus 124 HrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~ 203 (363)
T cd05628 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI 203 (363)
T ss_pred ecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcccc
Confidence 9999999999999999999999998754321100 0012357999999
Q ss_pred CCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHH
Q 021891 129 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 208 (306)
Q Consensus 129 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (306)
|||++.+..++.++|||||||++|||++|..||...........+. ..... ..+.+. ...+.++.+
T Consensus 204 aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~------~~~~~--~~~p~~------~~~s~~~~~ 269 (363)
T cd05628 204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVM------NWKET--LIFPPE------VPISEKAKD 269 (363)
T ss_pred CHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------cCcCc--ccCCCc------CCCCHHHHH
Confidence 9999999999999999999999999999999997654321111100 00000 001110 012467888
Q ss_pred HHHHccc--CCCCCCCCHHHHHHH
Q 021891 209 LAAHCLS--RDPKARPLMSEVVEA 230 (306)
Q Consensus 209 li~~~l~--~~p~~Rps~~ell~~ 230 (306)
+|.+|+. .++..||+++||++|
T Consensus 270 li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 270 LILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHcCChhhcCCCCCHHHHhCC
Confidence 8888664 233456899999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=284.73 Aligned_cols=204 Identities=28% Similarity=0.425 Sum_probs=164.0
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..|..++..+ +||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+
T Consensus 43 ~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~---iv 118 (316)
T cd05592 43 MVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG---II 118 (316)
T ss_pred HHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 3566666654 89999999999999999999999999999999886544 6899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 119 H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf 196 (316)
T cd05592 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred eCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999997643322 2233467899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-ell~~ 230 (306)
........ .. ..... .+ .++...+.++.+|+.+||+.||.+||++. +++++
T Consensus 197 ~~~~~~~~---~~---~i~~~--------~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 197 HGEDEDEL---FD---SILND--------RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCHHHH---HH---HHHcC--------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 76432111 10 00000 01 11222356788999999999999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=286.00 Aligned_cols=211 Identities=23% Similarity=0.259 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+++++.++|+||+++++++.+.+..++||||+++++|.+++.+....+++..+..++.|++.||.|||+.+ |+
T Consensus 48 ~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~ 124 (330)
T cd05601 48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YV 124 (330)
T ss_pred HHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 678999999999999999999999999999999999999999999776568999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh------cCCCCchhHHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell 155 (306)
||||||+||+++.++.+||+|||++......... ......||..|+|||++. ...++.++|||||||++|+|+
T Consensus 125 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 203 (330)
T cd05601 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203 (330)
T ss_pred cccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec
Confidence 9999999999999999999999999875443222 223356899999999986 456789999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|..||........ . .... .......... ....+..+.+|+.+||+ +|.+|||+.++++|.
T Consensus 204 ~g~~Pf~~~~~~~~---~---~~i~-~~~~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 204 YGRSPFHEGTSAKT---Y---NNIM-NFQRFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred cCCCCCCCCCHHHH---H---HHHH-cCCCccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 99999976432111 0 0000 0000000000 01235678999999998 999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.96 Aligned_cols=210 Identities=24% Similarity=0.356 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++.+++..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++
T Consensus 51 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~ 126 (263)
T cd06625 51 LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNM---IV 126 (263)
T ss_pred HHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 5789999999999999999999999999999999999999999886543 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||+|+||+++.++.++|+|||+++.......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 127 H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 206 (263)
T cd06625 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206 (263)
T ss_pred cCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876533211111 1234578899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|........ . ..... ......++...+..+.+++.+||..+|++|||+.+++++.
T Consensus 207 ~~~~~~~~~---~---~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 207 WAEFEAMAA---I---FKIAT----------QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccccchHHH---H---HHHhc----------cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 865422110 0 00000 0001112223456889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.41 Aligned_cols=211 Identities=27% Similarity=0.431 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~L 72 (306)
|.+|+++++.++|+||+++++++......++||||+++++|.+++.... ..+++..++.++.|++.||.||
T Consensus 56 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 135 (277)
T cd05032 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL 135 (277)
T ss_pred HHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999986432 2468889999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|
T Consensus 136 H~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 136 AAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred HhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 9988 9999999999999999999999999987654432222223345678899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||++ |..||........ ..+.. ... ... .+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 213 el~t~g~~p~~~~~~~~~---~~~~~----~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 213 EMATLAEQPYQGLSNEEV---LKFVI----DGG------HLD----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred HhhccCCCCCccCCHHHH---HHHHh----cCC------CCC----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 9998 8888865432211 11111 000 001 1112257889999999999999999999999987
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
+
T Consensus 276 ~ 276 (277)
T cd05032 276 K 276 (277)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=281.11 Aligned_cols=222 Identities=23% Similarity=0.303 Sum_probs=165.0
Q ss_pred HHHHHHHHhcC---CCCcccceeeEEEe-----CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDL---VHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l---~H~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|+++++.+ +||||+++++++.. ....++||||+. ++|.+++... ...+++..++.++.||+.||.||
T Consensus 48 ~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l 126 (290)
T cd07862 48 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126 (290)
T ss_pred HHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45677777766 69999999999863 456899999996 5999988654 34589999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ ++||||||+|||++.++.+||+|||+++..... .......|+..|+|||++.+..++.++|||||||++|
T Consensus 127 H~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (290)
T cd07862 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200 (290)
T ss_pred HHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHH
Confidence 9988 999999999999999999999999999865432 1223456899999999998889999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhh-----hhcccccc-ccccCCcc---CCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARP-----HLGERRRF-YRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
||++|.+||......+....+..... .+.....+ ...+.+.. ........+..+.+|+.+||+.||++|||
T Consensus 201 el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 280 (290)
T cd07862 201 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280 (290)
T ss_pred HHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC
Confidence 99999999987544322111110000 00000000 00000000 00011123567889999999999999999
Q ss_pred HHHHHHH
Q 021891 224 MSEVVEA 230 (306)
Q Consensus 224 ~~ell~~ 230 (306)
+.++++|
T Consensus 281 ~~~~l~h 287 (290)
T cd07862 281 AYSALSH 287 (290)
T ss_pred HHHHhcC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=272.67 Aligned_cols=210 Identities=24% Similarity=0.343 Sum_probs=167.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.+++.++|+||+++++++. .+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 43 ~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~ 117 (257)
T cd05116 43 LLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FV 117 (257)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 678999999999999999999875 45779999999999999998654 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||.||+++.++.+||+|||+++.......... .....++..|+|||.+....++.++|||||||++|||++ |..
T Consensus 118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987544322111 122234578999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... ... .+. .+...+.++.++|.+||+.||++||++.+|.+.|+.
T Consensus 198 p~~~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 198 PYKGMKGNE---VTQMIE----SGE------RME----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHH---HHHHHH----CCC------CCC----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 997543221 111111 000 011 112235688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=290.95 Aligned_cols=211 Identities=24% Similarity=0.299 Sum_probs=166.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++++|+||+++++.+.+++.+++|||||++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+
T Consensus 48 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---iv 123 (376)
T cd05598 48 VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMG---FI 123 (376)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 5789999999999999999999999999999999999999999996554 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCC-----------------------------------------cceeeec
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-----------------------------------------KTHVSTR 120 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------~~~~~~~ 120 (306)
||||||+|||++.++.+||+|||++..+.... .......
T Consensus 124 HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (376)
T cd05598 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS 203 (376)
T ss_pred eCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence 99999999999999999999999975321000 0000113
Q ss_pred ccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCH
Q 021891 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 200 (306)
Q Consensus 121 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (306)
..||+.|+|||++.+..++.++|||||||++|||++|..||...........+ . .... ...... ..
T Consensus 204 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~-~~~~---~~~~~~----~~ 269 (376)
T cd05598 204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV------I-NWET---TLHIPS----QA 269 (376)
T ss_pred cCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH------h-ccCc---cccCCC----CC
Confidence 47999999999999989999999999999999999999999765432111100 0 0000 000000 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCC---CHHHHHHHh
Q 021891 201 KGAQKAAQLAAHCLSRDPKARP---LMSEVVEAL 231 (306)
Q Consensus 201 ~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~l 231 (306)
..+..+.++|.+|+ .+|.+|+ ++.++++|.
T Consensus 270 ~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 270 KLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 23467888999976 5999999 899999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=292.91 Aligned_cols=212 Identities=22% Similarity=0.285 Sum_probs=165.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++.+.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+
T Consensus 48 ~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---iv 123 (377)
T cd05629 48 VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FI 123 (377)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 578999999999999999999999999999999999999999998654 46899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc---------------------------------------------e
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------------------------H 116 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------------~ 116 (306)
||||||+|||++.++.+||+|||+++.+...... .
T Consensus 124 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (377)
T cd05629 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL 203 (377)
T ss_pred ccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence 9999999999999999999999998643211000 0
Q ss_pred eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCC
Q 021891 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 196 (306)
Q Consensus 117 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (306)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+ . .+.. .+ .. +.
T Consensus 204 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i---~-~~~~--~~-~~--p~--- 271 (377)
T cd05629 204 MAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI---I-NWRE--TL-YF--PD--- 271 (377)
T ss_pred cccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH---H-ccCC--cc-CC--CC---
Confidence 001246899999999999889999999999999999999999999764332111000 0 0000 00 00 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHHhC
Q 021891 197 HFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEALK 232 (306)
Q Consensus 197 ~~~~~~~~~~~~li~~~l~~~p~~R---ps~~ell~~l~ 232 (306)
....+.++.+||.+||. +|.+| +|+.++++|..
T Consensus 272 --~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 272 --DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred --CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 01124678899999997 77765 59999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.18 Aligned_cols=205 Identities=28% Similarity=0.378 Sum_probs=164.8
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+..|..++..+ +||||+++++++.+++..|+||||+.+++|.+++... ..+++..+..++.|++.||+|||+.+ |
T Consensus 42 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i 117 (316)
T cd05620 42 TMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---I 117 (316)
T ss_pred HHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 35677777654 8999999999999999999999999999999988654 46899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..|
T Consensus 118 vHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred EecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999987532221 123346789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-ell~~ 230 (306)
|....... ...... ...+.. +...+.++.+||.+||+.||++||++. ++++|
T Consensus 196 f~~~~~~~---~~~~~~-----------~~~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 196 FHGDDEDE---LFESIR-----------VDTPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCHHH---HHHHHH-----------hCCCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 97543211 111000 001111 112346788999999999999999974 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.90 Aligned_cols=218 Identities=27% Similarity=0.425 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~l~~~~~~~~~~qi~~~l~~ 71 (306)
|.+|++++++++||||+++++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|
T Consensus 66 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~ 145 (296)
T cd05051 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY 145 (296)
T ss_pred HHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999986543 268999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
||+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++
T Consensus 146 LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 222 (296)
T cd05051 146 LESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222 (296)
T ss_pred HHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHH
Confidence 99988 999999999999999999999999999865443322333344567789999999888899999999999999
Q ss_pred HHHHh--CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 152 LEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 152 ~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
|||++ +..||....... ............ ........+...+.++.+++.+||+.||.+|||+.+|++
T Consensus 223 ~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 223 WEILTLCREQPYEHLTDQQ---VIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHhcCCCCCCCCcChHH---HHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 99998 667775432211 111111100000 000000111223468999999999999999999999999
Q ss_pred HhC
Q 021891 230 ALK 232 (306)
Q Consensus 230 ~l~ 232 (306)
.|+
T Consensus 293 ~L~ 295 (296)
T cd05051 293 FLQ 295 (296)
T ss_pred Hhc
Confidence 885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=292.80 Aligned_cols=211 Identities=26% Similarity=0.314 Sum_probs=165.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++.+++..++|||||++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+
T Consensus 48 ~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---iv 123 (382)
T cd05625 48 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FI 123 (382)
T ss_pred HHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 578999999999999999999999999999999999999999998655 36899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCC---------------------------------------------cce
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---------------------------------------------KTH 116 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~---------------------------------------------~~~ 116 (306)
||||||+|||++.+|.+||+|||+++...... ...
T Consensus 124 HrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (382)
T cd05625 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRC 203 (382)
T ss_pred cCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence 99999999999999999999999975321000 000
Q ss_pred eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCC
Q 021891 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 196 (306)
Q Consensus 117 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (306)
......||+.|+|||++.+..++.++|||||||++|||++|..||........... ....... ...+
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~------i~~~~~~---~~~p---- 270 (382)
T cd05625 204 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMK------VINWQTS---LHIP---- 270 (382)
T ss_pred cccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHH------HHccCCC---cCCC----
Confidence 01234689999999999998999999999999999999999999976533211000 0000000 0000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHh
Q 021891 197 HFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEAL 231 (306)
Q Consensus 197 ~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~l 231 (306)
.....+.++.++|.+|+ .+|.+|++ +.++++|.
T Consensus 271 -~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 271 -PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred -CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 01123467889998876 59999987 88888763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=273.62 Aligned_cols=210 Identities=30% Similarity=0.450 Sum_probs=171.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.++|+||+++++++.+.+..++||||+++++|.+++... +..+++..+..++.|++.||.|||+.+ +
T Consensus 49 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i 125 (261)
T cd05148 49 FQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---S 125 (261)
T ss_pred HHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 678999999999999999999999999999999999999999999753 456899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.+||+|||++........ ......++..|+|||.+....++.++||||||+++|+|++ |..
T Consensus 126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred eccccCcceEEEcCCceEEEccccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999977543221 1123345678999999988889999999999999999998 889
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... .. ... ..+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 204 p~~~~~~~~---~~~~~~----~~------~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 204 PYPGMNNHE---VYDQIT----AG------YRM----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCcCCHHH---HHHHHH----hC------CcC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 986543211 111111 00 000 1122335788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=291.55 Aligned_cols=211 Identities=24% Similarity=0.330 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|+.++||||+++++++.+++..|+|||||++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+
T Consensus 48 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---iv 123 (364)
T cd05599 48 VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG---YI 123 (364)
T ss_pred HHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 5689999999999999999999999999999999999999999986554 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce------------------------------------eeecccccc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH------------------------------------VSTRVMGTY 125 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~------------------------------------~~~~~~gt~ 125 (306)
||||||+|||++.++.+||+|||++.......... .....+||+
T Consensus 124 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 203 (364)
T cd05599 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP 203 (364)
T ss_pred eccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCc
Confidence 99999999999999999999999987543211000 011246899
Q ss_pred cccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHH
Q 021891 126 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 205 (306)
Q Consensus 126 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (306)
.|+|||++....++.++|||||||++|||++|..||......... . ........ ...+ . ....+..
T Consensus 204 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~---~---~i~~~~~~---~~~~---~--~~~~s~~ 269 (364)
T cd05599 204 DYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETY---R---KIINWKET---LQFP---D--EVPLSPE 269 (364)
T ss_pred cccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHH---H---HHHcCCCc---cCCC---C--CCCCCHH
Confidence 999999999889999999999999999999999999765432110 0 00000000 0000 0 0123468
Q ss_pred HHHHHHHcccCCCCCCCC---HHHHHHHh
Q 021891 206 AAQLAAHCLSRDPKARPL---MSEVVEAL 231 (306)
Q Consensus 206 ~~~li~~~l~~~p~~Rps---~~ell~~l 231 (306)
+.+||.+||. +|.+|++ +.++++|.
T Consensus 270 ~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 270 AKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred HHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 8899999996 9999997 99998864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.57 Aligned_cols=206 Identities=27% Similarity=0.390 Sum_probs=167.4
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|.+++..+ +||||+++++++.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ +
T Consensus 42 ~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i 117 (318)
T cd05570 42 TMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---I 117 (318)
T ss_pred HHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 45788888888 7999999999999999999999999999999988654 36999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 118 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred EccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCC
Confidence 9999999999999999999999999875322111 12335689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~l 231 (306)
|........ .. ..... ... ++...+..+.+||.+||+.||++|||+ .+++++-
T Consensus 196 f~~~~~~~~---~~---~i~~~--------~~~----~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 196 FEGDDEDEL---FQ---SILED--------EVR----YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred CCCCCHHHH---HH---HHHcC--------CCC----CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 975432111 10 00000 001 112235688999999999999999999 8888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.14 Aligned_cols=212 Identities=30% Similarity=0.399 Sum_probs=168.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+.++.++ +||||+++++++.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ +
T Consensus 42 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i 117 (327)
T cd05617 42 VQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---I 117 (327)
T ss_pred HHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56889999888 6999999999999999999999999999999988554 36999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 118 vHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~p 195 (327)
T cd05617 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195 (327)
T ss_pred eccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCC
Confidence 999999999999999999999999987532211 122346789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ell~~ 230 (306)
|.............+........ ... ++...+..+.+++.+||+.||++|+++ .++++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~-------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEK-------PIR----IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhC-------CCC----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 97543332222221111111110 001 112234678899999999999999984 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=277.95 Aligned_cols=210 Identities=28% Similarity=0.365 Sum_probs=170.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.++||||+++++++..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ +
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 123 (285)
T cd05605 47 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---I 123 (285)
T ss_pred HHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 467999999999999999999999999999999999999999888654 346899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||++++++.++|+|||++........ .....|+..|+|||++.+..++.++||||+||++|||++|..|
T Consensus 124 vH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred EecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence 9999999999999999999999999986543221 2234689999999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
|...........+ ...... ....++...+..+.+|+.+||..||++|| ++.+++++.
T Consensus 201 f~~~~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 201 FRQRKEKVKREEV---ERRVKE-----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred CCCCchhhHHHHH---HHHhhh-----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 9764332111111 000000 00112223456789999999999999999 888888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.87 Aligned_cols=215 Identities=25% Similarity=0.391 Sum_probs=171.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
+.+|+++++.+ +||||+++++++......++||||+++++|.+++.+.. ..+++..+..++.||
T Consensus 67 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 146 (304)
T cd05101 67 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQV 146 (304)
T ss_pred HHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHH
Confidence 67899999999 89999999999999999999999999999999986532 247888899999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 147 ~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 147 ARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred HHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 99999999988 999999999999999999999999999876443322222233456789999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
|||+++|+|++ |..||........ .. ....... ...+...+..+.+|+.+||+.+|.+|||+
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~------~~-~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 286 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEEL------FK-LLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTF 286 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHH------HH-HHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCH
Confidence 99999999998 7788765422111 11 0001000 00112335789999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 021891 225 SEVVEALKPLPN 236 (306)
Q Consensus 225 ~ell~~l~~~~~ 236 (306)
.++++.|+.+..
T Consensus 287 ~e~l~~l~~~~~ 298 (304)
T cd05101 287 KQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHHHH
Confidence 999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=281.44 Aligned_cols=204 Identities=27% Similarity=0.414 Sum_probs=164.6
Q ss_pred HHHHHHHhc-CCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..|..+++. ++||||+++++++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++
T Consensus 43 ~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---iv 118 (316)
T cd05619 43 MVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IV 118 (316)
T ss_pred HHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 457777776 49999999999999999999999999999999998654 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 119 Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf 196 (316)
T cd05619 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred eCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 999999999999999999999999875322211 223457899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-ell~~ 230 (306)
....... ...... ...+. ++...+.++.+++.+||+.||++||++. +++++
T Consensus 197 ~~~~~~~---~~~~i~-----------~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 197 HGHDEEE---LFQSIR-----------MDNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCCHHH---HHHHHH-----------hCCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 7643211 111100 00111 1112346788999999999999999997 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=273.24 Aligned_cols=211 Identities=28% Similarity=0.459 Sum_probs=169.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
|.+|+++++.++||||+++++++...+..++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (269)
T cd05044 46 FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM 125 (269)
T ss_pred HHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC
Confidence 678999999999999999999999999999999999999999998642 23478899999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCC-----cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADY-----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
+ ++|+||||+||+++.++ .++|+|||++................++..|+|||.+.+..++.++|||||||+
T Consensus 126 ~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 202 (269)
T cd05044 126 H---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL 202 (269)
T ss_pred C---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHH
Confidence 8 99999999999999887 899999999976543322222223345678999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|+|++ |..||...... ...... .... ....+...+..+.++|.+||..+|.+||++.++++
T Consensus 203 l~ellt~g~~p~~~~~~~---~~~~~~----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 203 MWEILTLGQQPYPALNNQ---EVLQHV----TAGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHcCCCCCcccCHH---HHHHHH----hcCC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999998 99998643221 111110 0000 00112234678899999999999999999999999
Q ss_pred HhC
Q 021891 230 ALK 232 (306)
Q Consensus 230 ~l~ 232 (306)
.|+
T Consensus 266 ~l~ 268 (269)
T cd05044 266 ILQ 268 (269)
T ss_pred HHh
Confidence 875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=284.48 Aligned_cols=206 Identities=26% Similarity=0.366 Sum_probs=167.0
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+..|.+++..+ +||||+++++++.+.+..|+||||+++++|.+.+.+. ..+++..+..++.||+.||.|||+.+ |
T Consensus 42 ~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i 117 (321)
T cd05591 42 TMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---V 117 (321)
T ss_pred HHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 45688888866 8999999999999999999999999999999988654 46899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 118 vHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred eccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCC
Confidence 9999999999999999999999999875432221 22345689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-------LMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~~ell~~l 231 (306)
|........ ... .... ... ++...+.++.+++.+||+.||++|+ ++.++++|.
T Consensus 196 f~~~~~~~~---~~~---i~~~-----~~~-------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 196 FEADNEDDL---FES---ILHD-----DVL-------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCCCHHHH---HHH---HHcC-----CCC-------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 976532211 110 0000 000 1112346889999999999999999 778888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=282.45 Aligned_cols=212 Identities=27% Similarity=0.399 Sum_probs=166.4
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|+.++.++ +||||+++++++.+.+..++||||+++++|..++.+. ..+++..+..++.||+.||.|||+.+ |
T Consensus 42 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---i 117 (329)
T cd05618 42 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---I 117 (329)
T ss_pred HHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 46788888777 8999999999999999999999999999999888554 47999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 118 vH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred eeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCC
Confidence 999999999999999999999999987532211 122345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCC--cchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 021891 161 MDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ell~~ 230 (306)
|........ .....+........ .. .++...+..+.+||.+||+.||++||++ .++++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~-------~~----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEK-------QI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcC-------CC----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 964222111 11111111110000 00 1122335678899999999999999984 677664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=271.49 Aligned_cols=202 Identities=25% Similarity=0.433 Sum_probs=163.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.+++.++||||+++++++..+...++||||+++++|..++.+....+++..++.++.||+.||.|||+.+ ++
T Consensus 51 ~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 127 (262)
T cd05077 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LV 127 (262)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eE
Confidence 577899999999999999999999999999999999999999988766667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCc-------EEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYN-------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 82 H~dlkp~Nill~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~e 153 (306)
||||||+||+++.++. ++++|||++...... ....++..|+|||.+. +..++.++|||||||++||
T Consensus 128 H~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 201 (262)
T cd05077 128 HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201 (262)
T ss_pred CCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHH
Confidence 9999999999987664 899999998754321 2235678899999886 5678999999999999999
Q ss_pred HH-hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 154 ML-TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 154 ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|+ +|..||........ ... ... . .... .....++.+||.+||+.||.+||++.+|++++
T Consensus 202 l~~~~~~p~~~~~~~~~---~~~----~~~--~-~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 202 ICYNGEIPLKDKTLAEK---ERF----YEG--Q-CMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHhCCCCCCCCcchhHH---HHH----Hhc--C-ccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 98 47777764322111 000 000 0 0000 11245788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=293.22 Aligned_cols=204 Identities=28% Similarity=0.398 Sum_probs=176.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..+|++.|++|+|||++.|.|+|..+...||||||| -||-.|++.-..+++.+-.+..|+.+.+.||.|||+.+ .|
T Consensus 73 IlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~I 148 (948)
T KOG0577|consen 73 ILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RI 148 (948)
T ss_pred HHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HH
Confidence 468999999999999999999999999999999999 56999999888889999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
|||||+.|||+++.|.|||+|||.|....+ .+.++||+.|||||++. .+.|+.|+|||||||+..||.-.+
T Consensus 149 HRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERk 222 (948)
T KOG0577|consen 149 HRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 222 (948)
T ss_pred hhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcC
Confidence 999999999999999999999999977543 34688999999999986 578999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|+...+.......+... -.|.+. ..+.+..++.|+..||++-|.+|||.++++.|-
T Consensus 223 PPlFnMNAMSALYHIAQN-------------esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 223 PPLFNMNAMSALYHIAQN-------------ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCccCchHHHHHHHHHhc-------------CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 998876554333222211 112222 335578999999999999999999999999874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=269.25 Aligned_cols=210 Identities=28% Similarity=0.409 Sum_probs=169.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++...+..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ ++
T Consensus 39 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ 115 (250)
T cd05085 39 FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115 (250)
T ss_pred HHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999999999999999999999998766667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 116 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p 194 (250)
T cd05085 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP 194 (250)
T ss_pred ecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999876433211 11112234567999999988889999999999999999998 8899
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|........ .... .. .... ..+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 195 ~~~~~~~~~---~~~~----~~------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 195 YPGMTNQQA---REQV----EK------GYRM----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHH---HHHH----Hc------CCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 865432111 0000 00 0000 111123568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.73 Aligned_cols=211 Identities=22% Similarity=0.361 Sum_probs=171.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ +
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i 124 (261)
T cd05072 48 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---Y 124 (261)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 678999999999999999999999999999999999999999998653 456889999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 125 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~ 203 (261)
T cd05072 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI 203 (261)
T ss_pred eccccchhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCC
Confidence 9999999999999999999999999987543221 11223345678999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... . ........ ..+.++.+++.+||..+|++|||++++++.|+.
T Consensus 204 p~~~~~~~~---~~~~~~----~------~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 204 PYPGMSNSD---VMSALQ----R------GYRMPRME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHH---HHHHHH----c------CCCCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 986543211 111110 0 00011111 234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=273.79 Aligned_cols=212 Identities=25% Similarity=0.413 Sum_probs=166.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~-----~~~~l~~~~~~~~~~qi~~~l~ 70 (306)
|.+|+++++.++|+||+++++++... ...++||||+.+|+|.+++.. ....+++..+..++.|++.||.
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 126 (272)
T cd05075 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126 (272)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHH
Confidence 67899999999999999999987542 246899999999999988742 2345899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+
T Consensus 127 ~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~i 203 (272)
T cd05075 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVT 203 (272)
T ss_pred HHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHH
Confidence 999988 99999999999999999999999999987644332221222345678999999998899999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|||++ |..||...... ....... .... .. .....+..+.++|.+||+.||++|||+.+|++
T Consensus 204 l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 204 MWEIATRGQTPYPGVENS---EIYDYLR----QGNR------LK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred HHHHHcCCCCCCCCCCHH---HHHHHHH----cCCC------CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999 78888653221 1111110 1100 00 11123467899999999999999999999999
Q ss_pred HhCC
Q 021891 230 ALKP 233 (306)
Q Consensus 230 ~l~~ 233 (306)
.|+.
T Consensus 267 ~l~~ 270 (272)
T cd05075 267 ELEK 270 (272)
T ss_pred HHHh
Confidence 8865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.52 Aligned_cols=211 Identities=23% Similarity=0.286 Sum_probs=168.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++||||+++++++.+++..++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+
T Consensus 90 ~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iv 164 (370)
T cd05596 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FI 164 (370)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 568999999999999999999999999999999999999999988543 5889999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC----CCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg 157 (306)
||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 165 HrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG 243 (370)
T cd05596 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243 (370)
T ss_pred ccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhC
Confidence 999999999999999999999999976543221 122345789999999998643 478999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l~ 232 (306)
..||...........+ ...... . .... ....+..+.+||.+||+.+|.+ |+|+.++++|..
T Consensus 244 ~~Pf~~~~~~~~~~~i------~~~~~~---~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 244 DTPFYADSLVGTYSKI------MDHKNS---L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CCCcCCCCHHHHHHHH------HcCCCc---C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 9999765332110000 000000 0 0000 1123578899999999999988 999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=271.21 Aligned_cols=207 Identities=28% Similarity=0.397 Sum_probs=171.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ +
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i 122 (256)
T cd08529 46 AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122 (256)
T ss_pred HHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 678999999999999999999999999999999999999999998764 457899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||||+||+++.++.++|+|||+++....... ......|+..|+|||+..+..++.++|||||||++++|++|..|
T Consensus 123 ~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 200 (256)
T cd08529 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200 (256)
T ss_pred ccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999886543322 12334678899999999988899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|....... .... ... . . ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 201 ~~~~~~~~---~~~~---~~~------~-~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 201 FDANNQGA---LILK---IIR------G-V----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCHHH---HHHH---HHc------C-C----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 97543211 0100 000 0 0 011122345789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=290.25 Aligned_cols=211 Identities=29% Similarity=0.346 Sum_probs=171.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++..++|+||+++++++.+++..++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++
T Consensus 48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ii 123 (350)
T cd05573 48 VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FI 123 (350)
T ss_pred HHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999999765 57999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCC---------------------------cceeeecccccccccCCcchh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYVM 134 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~ 134 (306)
||||||+||+++.++.+||+|||++....... .........||..|+|||++.
T Consensus 124 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (350)
T cd05573 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203 (350)
T ss_pred ccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 99999999999999999999999998654332 001123356899999999999
Q ss_pred cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcc
Q 021891 135 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 214 (306)
Q Consensus 135 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 214 (306)
+..++.++|||||||++|||++|..||...........+ ...... ...+.. . ..+..+.+||.+||
T Consensus 204 ~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~~~---~~~p~~-~----~~~~~~~~li~~ll 269 (350)
T cd05573 204 GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI------INWKES---LRFPPD-P----PVSPEAIDLICRLL 269 (350)
T ss_pred CCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHH------hccCCc---ccCCCC-C----CCCHHHHHHHHHHc
Confidence 999999999999999999999999999765422111000 000000 000000 0 13578899999999
Q ss_pred cCCCCCCCC-HHHHHHHh
Q 021891 215 SRDPKARPL-MSEVVEAL 231 (306)
Q Consensus 215 ~~~p~~Rps-~~ell~~l 231 (306)
. ||.+||+ +.++++|.
T Consensus 270 ~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 270 C-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred c-ChhhcCCCHHHHhcCC
Confidence 7 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=275.97 Aligned_cols=226 Identities=31% Similarity=0.452 Sum_probs=170.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++|+.++||||+++++++... ...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+
T Consensus 53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--- 127 (283)
T cd05080 53 WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--- 127 (283)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 67899999999999999999988764 3678999999999999998653 5899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||||+||+++.++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 128 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998764432211 112233566799999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||......-. .......... ....+....+.......+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 208 ~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 208 DSKQSPPKKFE-EMIGPKQGQM-TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCcchhh-hhhccccccc-chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 99865332110 0000000000 00000111111111111223457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=258.77 Aligned_cols=217 Identities=25% Similarity=0.352 Sum_probs=170.8
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
++|++..++++||||++++++...+. ..||++.|...|+|.+.+... +..+++.++..|+.+|+.||++||+
T Consensus 66 ~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~ 145 (302)
T KOG2345|consen 66 LREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE 145 (302)
T ss_pred HHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc
Confidence 68999999999999999999876554 489999999999999998653 4469999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceee-------ecccccccccCCcchhc---CCCCchhHH
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS-------TRVMGTYGYAAPEYVMT---GHLTSRSDV 144 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~---~~~~~~~Di 144 (306)
.. .++.||||||.||++++.+.++|.|||.++...-....... .....|..|+|||.+.. ...++++||
T Consensus 146 ~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDI 224 (302)
T KOG2345|consen 146 KE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDI 224 (302)
T ss_pred cC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccch
Confidence 87 57999999999999999999999999999864332111110 11345889999999863 457899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 145 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 145 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
|||||++|.|+.|..||...-..+..-. ....++.+...-....++.+.+||++||+.||.+||++
T Consensus 225 WSLGCtLYa~mf~~sPfe~~~~~GgSla--------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i 290 (302)
T KOG2345|consen 225 WSLGCTLYAMMFGESPFERIYQQGGSLA--------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI 290 (302)
T ss_pred hhhhHHHHHHHHcCCcchHHhhcCCeEE--------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH
Confidence 9999999999999999975433221100 01111122111122357899999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.+++..+..+
T Consensus 291 ~~ll~~~d~L 300 (302)
T KOG2345|consen 291 PELLSKLDDL 300 (302)
T ss_pred HHHHHHHHhh
Confidence 9999988654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=285.05 Aligned_cols=221 Identities=23% Similarity=0.311 Sum_probs=172.0
Q ss_pred HHHHHHHhcCC-C-----CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 3 QAEVNFLGDLV-H-----LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 3 ~~E~~il~~l~-H-----~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.|+.||..|+ | -|||+++++|...+++|||+|++ +.+|.++++.+. ..++...+..++.||+.||.+||+.
T Consensus 230 ~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l 308 (586)
T KOG0667|consen 230 QIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL 308 (586)
T ss_pred HHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 57999999996 4 39999999999999999999999 569999998763 5699999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCC--CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDAD--YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
+ |||+||||+|||+... ..+||+|||.++...... ...+.+..|+|||++.|.+|+.+.||||||||++|
T Consensus 309 ~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAE 380 (586)
T KOG0667|consen 309 G---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAE 380 (586)
T ss_pred C---eeeccCChhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHh
Confidence 8 9999999999999653 469999999999754332 24567889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhh--------hhccccccc---------------------------------cccCC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARP--------HLGERRRFY---------------------------------RLIDP 192 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~---------------------------------~~~~~ 192 (306)
|++|.+.|.+.+..+....+.-... .......+. ....|
T Consensus 381 L~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P 460 (586)
T KOG0667|consen 381 LFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGP 460 (586)
T ss_pred HhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCC
Confidence 9999999988766554332211110 000000000 00001
Q ss_pred ----ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 193 ----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 193 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.+...........+.+++++||.+||.+|+|..++++|..
T Consensus 461 ~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 461 PGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPF 504 (586)
T ss_pred CCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcc
Confidence 0011122234567899999999999999999999999864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=280.35 Aligned_cols=213 Identities=27% Similarity=0.407 Sum_probs=169.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
+.+|+++++.+ +|+||+++++++...+..++||||+++++|.+++..+. ..+++..+..++.|+
T Consensus 70 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 149 (307)
T cd05098 70 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQV 149 (307)
T ss_pred HHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHH
Confidence 56799999999 79999999999999999999999999999999996532 247889999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 150 ~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 150 ARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred HHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 99999999988 999999999999999999999999998765432211112222345689999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|+|++ |..||....... ... ..... .....+...+.++.+|+.+||..+|.+|||+
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 289 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVEE---LFK----LLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 289 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHH---HHH----HHHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCH
Confidence 99999999998 888886432211 110 00000 0001122335788999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.++++.|+.+
T Consensus 290 ~evl~~l~~~ 299 (307)
T cd05098 290 KQLVEDLDRI 299 (307)
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=274.98 Aligned_cols=213 Identities=21% Similarity=0.333 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++|+||+++++++.. ...++++||+++|+|.+++..+...+++..+..++.|++.||.|||+.+ ++
T Consensus 56 ~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ii 131 (279)
T cd05109 56 ILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LV 131 (279)
T ss_pred HHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 6789999999999999999999875 4578999999999999999776667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 211 (279)
T cd05109 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654332222222334678999999988899999999999999999998 8888
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|....... ...+.. .... .. .+...+.++.+++.+||+.||++||++.++++.|+.+.
T Consensus 212 ~~~~~~~~---~~~~~~----~~~~------~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 212 YDGIPARE---IPDLLE----KGER------LP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCCCHHH---HHHHHH----CCCc------CC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 86532211 111110 0000 00 11123567899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=290.31 Aligned_cols=203 Identities=26% Similarity=0.374 Sum_probs=168.9
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..|.+|+... +||.++.++.+|++++++|+||||+.||++... .+...|++..+..++..|+.||+|||+++ ||
T Consensus 416 ~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~---II 490 (694)
T KOG0694|consen 416 MCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENG---II 490 (694)
T ss_pred HHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcC---ce
Confidence 4677777777 699999999999999999999999999994332 34457999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||||.+|||+|.+|.+||+|||+++..-..+ ..+.+++||+.|||||++.+..|+.++|.|||||+|||||.|+.||
T Consensus 491 YRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF 568 (694)
T KOG0694|consen 491 YRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF 568 (694)
T ss_pred eeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998744222 2456799999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~ 230 (306)
.+.+..+...-+.. . ...++...+.+..++++++|.+||++|..+ .+|.+|
T Consensus 569 ~gddEee~FdsI~~----------------d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 569 PGDDEEEVFDSIVN----------------D--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred CCCCHHHHHHHHhc----------------C--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 98765433222210 0 112445567899999999999999999854 555543
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=271.96 Aligned_cols=213 Identities=24% Similarity=0.404 Sum_probs=171.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++.+.+..++||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++
T Consensus 53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~ 129 (268)
T cd05063 53 FLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YV 129 (268)
T ss_pred HHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999999776667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceee-ecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
|+||||+||+++.++.+||+|||++............ .....+..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 130 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~ 209 (268)
T cd05063 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209 (268)
T ss_pred ccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999765432221111 11223457999999988889999999999999999997 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||....... ..... .... ..+ .....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 210 p~~~~~~~~---~~~~i----~~~~-----~~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 210 PYWDMSNHE---VMKAI----NDGF-----RLP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCcCCHHH---HHHHH----hcCC-----CCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 986543211 11100 0000 000 1112356789999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=273.96 Aligned_cols=213 Identities=27% Similarity=0.439 Sum_probs=169.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCe------eEEEEEcCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~ 70 (306)
|.+|+++++.++|+||+++++++...+. .++||||+++++|..++... ...+++..+..++.|++.||.
T Consensus 48 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~ 127 (273)
T cd05035 48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127 (273)
T ss_pred HHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHH
Confidence 6789999999999999999998876554 78999999999999988432 236899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+
T Consensus 128 ~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~i 204 (273)
T cd05035 128 YLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 204 (273)
T ss_pred HHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHH
Confidence 999988 99999999999999999999999999987544332222222334678999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|||++ |..||...... ....... ... ... .+...+..+.+++.+||+.||++|||+.++++
T Consensus 205 l~el~~~g~~p~~~~~~~---~~~~~~~----~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 205 MWEIATRGQTPYPGVENH---EIYDYLR----HGN------RLK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred HHHHHhCCCCCCCCCCHH---HHHHHHH----cCC------CCC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999 88888654321 1111111 000 011 11233568999999999999999999999999
Q ss_pred HhCCC
Q 021891 230 ALKPL 234 (306)
Q Consensus 230 ~l~~~ 234 (306)
+|+.+
T Consensus 268 ~l~~~ 272 (273)
T cd05035 268 VLENI 272 (273)
T ss_pred HHHhh
Confidence 98754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=281.43 Aligned_cols=214 Identities=29% Similarity=0.448 Sum_probs=168.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeC-CeeEEEEEcCCCCCHHHHhhcCC-----------------------------
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRS----------------------------- 50 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------------------- 50 (306)
+.+|+++++++ +|+||++++++|... ..++++|||+++++|.+++....
T Consensus 57 ~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (337)
T cd05054 57 LMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSV 136 (337)
T ss_pred HHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccC
Confidence 46799999999 899999999988654 56789999999999999885321
Q ss_pred -------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEE
Q 021891 51 -------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 99 (306)
Q Consensus 51 -------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~k 99 (306)
..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vk 213 (337)
T cd05054 137 SSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVK 213 (337)
T ss_pred CccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEE
Confidence 25789999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhh
Q 021891 100 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 178 (306)
Q Consensus 100 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 178 (306)
|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~---- 287 (337)
T cd05054 214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR---- 287 (337)
T ss_pred EeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----
Confidence 999999987543332222233445678999999999999999999999999999998 9999875432211 000
Q ss_pred hhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
....... . ..+...+.++.+++.+||+.+|++||++.||+++|+.+
T Consensus 288 ~~~~~~~------~----~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 288 RLKEGTR------M----RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHhccCC------C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001000 0 01112346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=278.94 Aligned_cols=214 Identities=25% Similarity=0.407 Sum_probs=169.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++.... ..+++..+..++.|+
T Consensus 64 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 143 (314)
T cd05099 64 LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQV 143 (314)
T ss_pred HHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHH
Confidence 57899999999 69999999999999999999999999999999986532 348889999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 144 ~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 144 ARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred HHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhh
Confidence 99999999988 999999999999999999999999999865432221111222344679999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|+|++ |..||........ ..... .... . ..+...+.++.+++.+||..+|++|||+
T Consensus 221 slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~~------~----~~~~~~~~~l~~li~~cl~~~p~~Rps~ 283 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIPVEEL---FKLLR----EGHR------M----DKPSNCTHELYMLMRECWHAVPTQRPTF 283 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----cCCC------C----CCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 99999999999 8888865432111 11100 0000 0 1112234688899999999999999999
Q ss_pred HHHHHHhCCCC
Q 021891 225 SEVVEALKPLP 235 (306)
Q Consensus 225 ~ell~~l~~~~ 235 (306)
.++++.|+.+.
T Consensus 284 ~~ll~~l~~~~ 294 (314)
T cd05099 284 KQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHHH
Confidence 99999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=277.73 Aligned_cols=212 Identities=24% Similarity=0.349 Sum_probs=168.2
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
|.+|+++++++ +||||+++++++...+..++||||+++++|.+++.+.. ..+++..++.++.|+
T Consensus 49 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 128 (297)
T cd05089 49 FAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128 (297)
T ss_pred HHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHH
Confidence 67899999999 79999999999999999999999999999999986432 248889999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......+..|+|||++.+..++.++|||
T Consensus 129 ~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 202 (297)
T cd05089 129 ATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVW 202 (297)
T ss_pred HHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHH
Confidence 99999999988 9999999999999999999999999986432111 11111234579999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |..||........ .. . .. ...... .+...+..+.+|+.+||+.+|.+|||+
T Consensus 203 SlG~il~el~t~g~~pf~~~~~~~~---~~---~-~~------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~ 265 (297)
T cd05089 203 SFGVLLWEIVSLGGTPYCGMTCAEL---YE---K-LP------QGYRME----KPRNCDDEVYELMRQCWRDRPYERPPF 265 (297)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHH---HH---H-Hh------cCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999997 9999965432211 00 0 00 000111 112234678999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 021891 225 SEVVEALKPLPN 236 (306)
Q Consensus 225 ~ell~~l~~~~~ 236 (306)
.++++.|+.+..
T Consensus 266 ~~i~~~l~~~~~ 277 (297)
T cd05089 266 AQISVQLSRMLE 277 (297)
T ss_pred HHHHHHHHHHHH
Confidence 999998875544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=292.67 Aligned_cols=223 Identities=22% Similarity=0.327 Sum_probs=163.2
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeC--------CeeEEEEEcCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHH
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
.+|+.+|+.++||||+++++++... ..+++||||+++ +|.+++. .....+++..++.++.||+.||.|
T Consensus 107 ~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~y 185 (440)
T PTZ00036 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185 (440)
T ss_pred HHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 5799999999999999999987542 246799999975 7777664 234579999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGV 149 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 149 (306)
||+.+ |+||||||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+. .|+.++|||||||
T Consensus 186 LH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 259 (440)
T PTZ00036 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGC 259 (440)
T ss_pred HHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence 99998 99999999999998664 799999999987543322 2235679999999998754 6899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhh--hcc----cccc-----ccccCCccCCCCCHHHHHHHHHHHHHcccCCC
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPH--LGE----RRRF-----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 218 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 218 (306)
++|||++|.+||.+.........+...... ... ...+ .......+...++...+.++.+||.+||++||
T Consensus 260 il~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 260 IIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 999999999999765432211111100000 000 0000 00000011111222345789999999999999
Q ss_pred CCCCCHHHHHHHhC
Q 021891 219 KARPLMSEVVEALK 232 (306)
Q Consensus 219 ~~Rps~~ell~~l~ 232 (306)
.+|||+.|+++|..
T Consensus 340 ~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 340 LKRLNPIEALADPF 353 (440)
T ss_pred hHCcCHHHHhCChh
Confidence 99999999998743
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=271.08 Aligned_cols=212 Identities=28% Similarity=0.451 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++. .+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++
T Consensus 43 ~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~ 117 (257)
T cd05060 43 FLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FV 117 (257)
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---ee
Confidence 678999999999999999999876 456899999999999999996654 7899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
|+||||+||+++.++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~ 197 (257)
T cd05060 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197 (257)
T ss_pred ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987543322211 111223467999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
||...... ........ .. .. . .+...+..+.++|.+||..+|++||++.++++.|+...
T Consensus 198 p~~~~~~~---~~~~~~~~----~~---~~---~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 198 PYGEMKGA---EVIAMLES----GE---RL---P----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CcccCCHH---HHHHHHHc----CC---cC---C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 98654321 11111110 00 00 0 11123468899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.25 Aligned_cols=211 Identities=28% Similarity=0.438 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++.+.+..++||||+++++|.+++......+++..+..++.+++.||.|||+++ ++
T Consensus 39 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~ 115 (251)
T cd05041 39 FLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115 (251)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 678999999999999999999999999999999999999999999766667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 116 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p 195 (251)
T cd05041 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP 195 (251)
T ss_pred hhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCC
Confidence 999999999999999999999999976542211111112233567999999988889999999999999999999 7888
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|...........+ .... . ...+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 196 ~~~~~~~~~~~~~-------~~~~---~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 196 YPGMSNQQTRERI-------ESGY---R-------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHH-------hcCC---C-------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 8654321111110 0000 0 0112233568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=272.07 Aligned_cols=203 Identities=24% Similarity=0.439 Sum_probs=163.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.++++++||||+++++++.+....++||||+++++|..++.+....+++..+..++.||+.||+|||+.+ |+
T Consensus 63 ~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ii 139 (274)
T cd05076 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LV 139 (274)
T ss_pred HHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---cc
Confidence 678899999999999999999999999999999999999999998766667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCC-------cEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADY-------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 82 H~dlkp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~e 153 (306)
||||||+||+++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||
T Consensus 140 H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~e 213 (274)
T cd05076 140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213 (274)
T ss_pred CCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHH
Confidence 999999999997643 4899999988653221 12346778999998875 568999999999999999
Q ss_pred HH-hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 154 ML-TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 154 ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|+ +|..||.......... .. .... .... .....+.++|.+||+.+|++|||+.+++++|.
T Consensus 214 l~~~g~~p~~~~~~~~~~~---~~----~~~~--------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 214 ICFDGEVPLKERTPSEKER---FY----EKKH--------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHhCCCCCccccChHHHHH---HH----Hhcc--------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 85 6888887543322111 00 0000 0001 11347889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.60 Aligned_cols=218 Identities=26% Similarity=0.451 Sum_probs=168.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~l~~~~~~~~~~qi~~~l~ 70 (306)
|.+|++++++++|+||+++++++...+..++||||+.+++|.+++.... ..+++..++.++.|++.||.
T Consensus 64 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 143 (295)
T cd05097 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK 143 (295)
T ss_pred HHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999885432 23688899999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
|||+.+ ++|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||+
T Consensus 144 ~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~ 220 (295)
T cd05097 144 YLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220 (295)
T ss_pred HHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHH
Confidence 999988 99999999999999999999999999976543332222233345678999999988889999999999999
Q ss_pred HHHHHh--CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 151 LLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 151 l~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
+|+|++ +..||....... .+............ ... . ..+...+..+.+|+.+||+.||++|||+.+|+
T Consensus 221 l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~--~~~-~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 221 LWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQGR--QIY-L----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred HHHHHHcCCCCCCcccChHH---HHHHHHHhhhhccc--ccc-C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 999998 556766533211 11111100100000 000 0 00112346899999999999999999999999
Q ss_pred HHhC
Q 021891 229 EALK 232 (306)
Q Consensus 229 ~~l~ 232 (306)
+.|+
T Consensus 291 ~~l~ 294 (295)
T cd05097 291 HFLR 294 (295)
T ss_pred HHHh
Confidence 9885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.00 Aligned_cols=210 Identities=24% Similarity=0.348 Sum_probs=173.1
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|++++++++|+||+++++++.+....++++||+.+++|.+++......+++..++.++.|++.||.|||+.+ +
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i 120 (256)
T cd06612 44 EIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---K 120 (256)
T ss_pred HHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 3789999999999999999999999999999999999999999999766678999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 121 ~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred ccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987544321 22334578899999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|............ . ....+ ....+...+..+.++|.+||+.||++|||+.+++++
T Consensus 199 ~~~~~~~~~~~~~-------~------~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 199 YSDIHPMRAIFMI-------P------NKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCcchhhhhhhh-------c------cCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 9754332111000 0 00000 001122345688999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=275.37 Aligned_cols=211 Identities=27% Similarity=0.467 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------------CCCCHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMK 60 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------~~l~~~~~~~ 60 (306)
|.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ..+++..++.
T Consensus 55 ~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 134 (288)
T cd05050 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLC 134 (288)
T ss_pred HHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHH
Confidence 6789999999999999999999999999999999999999999986421 2478889999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCc
Q 021891 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS 140 (306)
Q Consensus 61 ~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 140 (306)
++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.
T Consensus 135 ~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 211 (288)
T cd05050 135 IAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT 211 (288)
T ss_pred HHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc
Confidence 9999999999999988 9999999999999999999999999987643322211122233466799999998889999
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCC
Q 021891 141 RSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 219 (306)
Q Consensus 141 ~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 219 (306)
++|||||||++|+|++ |..||....... ..... .... .. ..+...+..+.+|+.+||+.+|.
T Consensus 212 ~~Dv~slG~il~el~~~~~~p~~~~~~~~---~~~~~----~~~~----~~------~~~~~~~~~l~~li~~~l~~~p~ 274 (288)
T cd05050 212 ESDVWAYGVVLWEIFSYGMQPYYGMAHEE---VIYYV----RDGN----VL------SCPDNCPLELYNLMRLCWSKLPS 274 (288)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCC----CC------CCCCCCCHHHHHHHHHHcccCcc
Confidence 9999999999999997 778886543211 11100 0000 00 01112356889999999999999
Q ss_pred CCCCHHHHHHHhC
Q 021891 220 ARPLMSEVVEALK 232 (306)
Q Consensus 220 ~Rps~~ell~~l~ 232 (306)
+|||+.|+++.|+
T Consensus 275 ~Rpt~~el~~~l~ 287 (288)
T cd05050 275 DRPSFASINRILQ 287 (288)
T ss_pred cCCCHHHHHHHhh
Confidence 9999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=280.35 Aligned_cols=212 Identities=28% Similarity=0.340 Sum_probs=167.1
Q ss_pred HHHH-HHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 4 AEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 4 ~E~~-il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
+|.. +++.++||||+++++++..++..++||||+++++|..++.+. ..+++..+..++.||+.||.|||+.+ |+|
T Consensus 44 ~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivH 119 (325)
T cd05604 44 AERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN---IVY 119 (325)
T ss_pred HHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 4443 577899999999999999999999999999999999888544 47899999999999999999999988 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
|||||+|||++.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 120 ~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence 9999999999999999999999987532211 12234578999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCC
Q 021891 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 239 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 239 (306)
....... . ....... ..+. ...+..+.+++.+||+.+|.+||++.+.++.+...+.+..
T Consensus 198 ~~~~~~~---~---~~~~~~~----~~~~--------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 198 CRDVAEM---Y---DNILHKP----LVLR--------PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CCCHHHH---H---HHHHcCC----ccCC--------CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 6432211 0 0000000 0011 1234678899999999999999988755555555555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=272.84 Aligned_cols=210 Identities=25% Similarity=0.385 Sum_probs=166.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
|.+|+++++++ +||||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|+
T Consensus 42 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i 121 (270)
T cd05047 42 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121 (270)
T ss_pred HHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHH
Confidence 56899999999 89999999999999999999999999999999986432 247899999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......+..|+|||++....++.++|||
T Consensus 122 ~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 195 (270)
T cd05047 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVW 195 (270)
T ss_pred HHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHH
Confidence 99999999988 9999999999999999999999999986422111 11112235679999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |..||........ ... .... ... ..+...+..+.+|+.+||..||.+|||+
T Consensus 196 slG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~ 258 (270)
T cd05047 196 SYGVLLWEIVSLGGTPYCGMTCAEL---YEK----LPQG------YRL----EKPLNCDDEVYDLMRQCWREKPYERPSF 258 (270)
T ss_pred HHHHHHHHHHcCCCCCccccCHHHH---HHH----HhCC------CCC----CCCCcCCHHHHHHHHHHcccChhhCCCH
Confidence 99999999997 9999865322111 100 0000 000 1111234678999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.++++.|+.+
T Consensus 259 ~~il~~l~~~ 268 (270)
T cd05047 259 AQILVSLNRM 268 (270)
T ss_pred HHHHHHHHHh
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=284.53 Aligned_cols=211 Identities=23% Similarity=0.268 Sum_probs=166.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++||||+++++++.+++..|+|||||++|+|.+++... .+++..+..++.||+.||+|||+.+ |+
T Consensus 90 ~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---Iv 164 (370)
T cd05621 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LI 164 (370)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 568999999999999999999999999999999999999999998543 5899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC----CCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg 157 (306)
||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 165 HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G 243 (370)
T cd05621 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243 (370)
T ss_pred ecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhC
Confidence 999999999999999999999999987543221 122345799999999998754 378899999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l~ 232 (306)
..||........... ....... .... .....+..+.+++.+||+.++.+ |+++.|+++|..
T Consensus 244 ~~Pf~~~~~~~~~~~------i~~~~~~------~~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 244 DTPFYADSLVGTYSK------IMDHKNS------LNFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred CCCCCCCCHHHHHHH------HHhCCcc------cCCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 999976532111000 0000000 0000 01123567889999999855544 889999999743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=270.14 Aligned_cols=211 Identities=27% Similarity=0.410 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++|+||+++++++.. ...++||||+++++|.+.+.+.. ..+++..++.++.|++.||.|||+.+ +
T Consensus 43 ~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i 118 (257)
T cd05040 43 FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---F 118 (257)
T ss_pred HHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 6789999999999999999999988 88999999999999999997654 57899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
+|+||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 119 ~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~ 198 (257)
T cd05040 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE 198 (257)
T ss_pred cccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998765432211 1223456788999999988899999999999999999998 99
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||........ ...... ... . ...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 199 ~p~~~~~~~~~---~~~~~~---~~~---~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 199 EPWAGLSGSQI---LKKIDK---EGE---R-------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCCCCHHHH---HHHHHh---cCC---c-------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 99865432211 111000 000 0 0011123568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=270.93 Aligned_cols=203 Identities=22% Similarity=0.395 Sum_probs=163.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.+++.++||||+++++++..++..++||||+++|+|.+++..+...+++..+..++.||+.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ii 122 (258)
T cd05078 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LT 122 (258)
T ss_pred HHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999999776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCc--------EEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 82 H~dlkp~Nill~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ 152 (306)
||||||+||+++.++. ++++|||++...... ....++..|+|||++.+ ..++.++|||||||++|
T Consensus 123 H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 196 (258)
T cd05078 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196 (258)
T ss_pred cCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence 9999999999987664 699999998654321 22457888999999976 45799999999999999
Q ss_pred HHHhCC-CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++|. .||........ .. ...... . ++.....++.+|+.+||+.||++|||++++++.|
T Consensus 197 ~l~~g~~~~~~~~~~~~~---~~----~~~~~~--------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 197 EIFSGGDKPLSALDSQKK---LQ----FYEDRH--------Q----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHcCCCCChhhccHHHH---HH----HHHccc--------c----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 999985 55543221110 00 000000 0 1111235789999999999999999999999976
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
+
T Consensus 258 ~ 258 (258)
T cd05078 258 N 258 (258)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.96 Aligned_cols=218 Identities=25% Similarity=0.454 Sum_probs=169.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~l~~~~~~~~~~qi~~~l~~ 71 (306)
|.+|+++++.++|+||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|
T Consensus 66 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~ 145 (296)
T cd05095 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKY 145 (296)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999986532 246778999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
||+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||...+..++.++|||||||++
T Consensus 146 lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l 222 (296)
T cd05095 146 LSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222 (296)
T ss_pred HHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHH
Confidence 99988 999999999999999999999999999865433222222223446789999998888899999999999999
Q ss_pred HHHHh--CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 152 LEMLT--GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 152 ~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
|||++ |..||........ +............ ....+ .+..++..+.+|+.+||+.||++||++.+|++
T Consensus 223 ~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 223 WEILTLCKEQPYSQLSDEQV---IENTGEFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHhCCCCCccccChHHH---HHHHHHHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99998 6678765433211 1111000000000 00000 01123468899999999999999999999999
Q ss_pred HhC
Q 021891 230 ALK 232 (306)
Q Consensus 230 ~l~ 232 (306)
.|+
T Consensus 293 ~l~ 295 (296)
T cd05095 293 TLL 295 (296)
T ss_pred HHh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.46 Aligned_cols=214 Identities=23% Similarity=0.330 Sum_probs=172.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|.+|+++++.++||||+++++++.+.+..++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+.+
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-- 126 (267)
T cd08228 49 CVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-- 126 (267)
T ss_pred HHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 67899999999999999999999999999999999999999988743 3345899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 127 -i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 203 (267)
T cd08228 127 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred -eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999886543221 122346788999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||....... ..+.... . ....+. ......+..+.+++.+||+.+|++||++.++++.++.+
T Consensus 204 ~p~~~~~~~~----~~~~~~~-~------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 204 SPFYGDKMNL----FSLCQKI-E------QCDYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCccccccH----HHHHHHH-h------cCCCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 9986532211 1111100 0 000111 11223457899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.90 Aligned_cols=225 Identities=21% Similarity=0.303 Sum_probs=161.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~--------~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
+.+|+++|++++||||+++++++.. +...++||||+. ++|.+++... ...+++..+..++.||+.||.|
T Consensus 45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 123 (317)
T cd07868 45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123 (317)
T ss_pred HHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHH
Confidence 5689999999999999999999864 456889999995 5888877432 2358999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEE----cCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhc-CCCCchhHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVY 145 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 145 (306)
||+.+ |+||||||+|||+ +.++.+||+|||+++........ .......||..|+|||++.+ ..++.++|||
T Consensus 124 LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07868 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence 99998 9999999999999 45678999999999875432211 11234578999999999876 4689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcc------hHHhhhhhh--------cccc------ccccccCCccC---------C
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEHN------LVEWARPHL--------GERR------RFYRLIDPRLE---------G 196 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~~------~~~~~~~~~--------~~~~------~~~~~~~~~~~---------~ 196 (306)
|+||++|+|++|.+||.......... ......... .... ........... .
T Consensus 201 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (317)
T cd07868 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 280 (317)
T ss_pred HHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHH
Confidence 99999999999999997544321100 000000000 0000 00000000000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 197 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 197 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.........+.+||.+||+.||.+|||++|+++|
T Consensus 281 ~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 281 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000113468899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=272.08 Aligned_cols=213 Identities=24% Similarity=0.396 Sum_probs=170.6
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|++++++++||||+++++++.+++..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ +
T Consensus 51 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~ 127 (269)
T cd05065 51 DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---Y 127 (269)
T ss_pred HHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 3778999999999999999999999999999999999999999999776667899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeec-c--cccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-V--MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT- 156 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt- 156 (306)
+|+||||+||+++.++.+||+|||++.............. . ..+..|+|||.+.+..++.++|||||||++|||++
T Consensus 128 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~ 207 (269)
T cd05065 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 207 (269)
T ss_pred eecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcC
Confidence 9999999999999999999999999876543222111111 1 12457999999998899999999999999999886
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|..||....... ...+... ..... .+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 208 g~~p~~~~~~~~---~~~~i~~----------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 208 GERPYWDMSNQD---VINAIEQ----------DYRLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CCCCCCCCCHHH---HHHHHHc----------CCcCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 999986543221 1111110 00000 111235678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.61 Aligned_cols=212 Identities=24% Similarity=0.399 Sum_probs=171.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.++++++||||+++++++.+++..++||||+++++|.+++.+....+++..+..++.|++.||.|||+.+ ++
T Consensus 52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~ 128 (267)
T cd05066 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YV 128 (267)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 678999999999999999999999999999999999999999999776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+|||||++|++++ |..
T Consensus 129 h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~ 208 (267)
T cd05066 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208 (267)
T ss_pred ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999987644322111 111223567999999998889999999999999999886 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ ..... ... ... .+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 209 p~~~~~~~~~---~~~~~----~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 209 PYWEMSNQDV---IKAIE----EGY------RLP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CcccCCHHHH---HHHHh----CCC------cCC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 9876533211 11110 000 000 111235678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=294.55 Aligned_cols=209 Identities=26% Similarity=0.316 Sum_probs=168.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC--------eeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ 70 (306)
+++|+.++..++|+||+++++.+...+ .+++||||+++|+|.+++..+ ...+++..+..++.|++.||.
T Consensus 78 ~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~ 157 (496)
T PTZ00283 78 AQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVH 157 (496)
T ss_pred HHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 578999999999999999988775432 368999999999999988643 346899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
|||+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvi 234 (496)
T PTZ00283 158 HVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVL 234 (496)
T ss_pred HHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHH
Confidence 999988 99999999999999999999999999987544333333345679999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|||++|..||....... ........ ... .++...+.++.+|+.+||+.||.+||++.+++++
T Consensus 235 lyeLltG~~Pf~~~~~~~------~~~~~~~~------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 235 LYELLTLKRPFDGENMEE------VMHKTLAG------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHCCCCCCCCCHHH------HHHHHhcC------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 999999999997542211 11110000 000 1122335789999999999999999999999976
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.38 Aligned_cols=211 Identities=27% Similarity=0.378 Sum_probs=171.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 47 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~ 123 (262)
T cd06613 47 IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KI 123 (262)
T ss_pred HHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ce
Confidence 678999999999999999999999999999999999999999998776567999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC---CCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~ 158 (306)
|+||+|+||+++.++.+||+|||++....... .......++..|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus 124 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~ 201 (262)
T cd06613 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201 (262)
T ss_pred ecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999987654321 122335678899999998776 8899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||............ . .. . +.+.. .......+.++.+++.+||..+|.+|||+.+++.+
T Consensus 202 ~p~~~~~~~~~~~~~--~------~~---~-~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 202 PPMFDLHPMRALFLI--S------KS---N-FPPPK-LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCCCCCCHHHHHHHH--H------hc---c-CCCcc-ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999754322111000 0 00 0 00000 01123456789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.78 Aligned_cols=225 Identities=20% Similarity=0.238 Sum_probs=166.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|+++++.++||||+++++++..++..++||||+++++|.+++..+ ...+++..++.++.|++.||.|||+.+ +
T Consensus 46 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---i 122 (327)
T cd08227 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---Y 122 (327)
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567999999999999999999999999999999999999999998654 345899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-----eeecccccccccCCcchhc--CCCCchhHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e 153 (306)
+||||||+||+++.++.++++||+............ ......++..|+|||++.+ ..++.++|||||||++||
T Consensus 123 iH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 202 (327)
T cd08227 123 VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202 (327)
T ss_pred ecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999998654432111100 0112346778999999875 468999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhhhhcc---------------------cccccc---------ccCCccCCCCCHHHH
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARPHLGE---------------------RRRFYR---------LIDPRLEGHFSIKGA 203 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~---------~~~~~~~~~~~~~~~ 203 (306)
|++|..||........ ........... ...+.. ..............+
T Consensus 203 l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (327)
T cd08227 203 LANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFS 280 (327)
T ss_pred HHHCCCCCCCcchhHH--HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccC
Confidence 9999999975332110 00000000000 000000 000000011222345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 204 QKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 204 ~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
..+.+|+.+||+.||++|||+++++++.
T Consensus 281 ~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 281 PHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred HHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 6899999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.66 Aligned_cols=214 Identities=25% Similarity=0.344 Sum_probs=172.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|.+|+++++.++|+||+++++++..++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+
T Consensus 49 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-- 126 (267)
T cd08229 49 CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-- 126 (267)
T ss_pred HHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 67899999999999999999999999999999999999999998853 2346899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 127 -i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~ 203 (267)
T cd08229 127 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred -eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876543221 123356888999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||....... ....... .....+.. .....+..+.+++.+||..||++|||+.+|++.++.+
T Consensus 204 ~p~~~~~~~~-~~~~~~~----------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 204 SPFYGDKMNL-YSLCKKI----------EQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcccccchH-HHHhhhh----------hcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 9986532210 0000000 00001111 1123457899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.93 Aligned_cols=220 Identities=25% Similarity=0.377 Sum_probs=170.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~i 80 (306)
+.+|++++++++||||+++++++.+++..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+ +
T Consensus 46 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i 121 (308)
T cd06615 46 IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---I 121 (308)
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---E
Confidence 578999999999999999999999999999999999999999998655 468999999999999999999997 46 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||||+||+++.++.+||+|||++....... .....|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 122 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 197 (308)
T cd06615 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197 (308)
T ss_pred EECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987643321 2345688999999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcccc-------------------c-cccc---cCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERR-------------------R-FYRL---IDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~-------------------~-~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
|....................... . .... ..+... ....+.++.+|+.+||..|
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~ 274 (308)
T cd06615 198 IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKN 274 (308)
T ss_pred CCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCC
Confidence 865432211111100000000000 0 0000 000000 0013567899999999999
Q ss_pred CCCCCCHHHHHHHhC
Q 021891 218 PKARPLMSEVVEALK 232 (306)
Q Consensus 218 p~~Rps~~ell~~l~ 232 (306)
|++|||+.+++++..
T Consensus 275 P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 275 PKERADLKELTKHPF 289 (308)
T ss_pred hhhCcCHHHHhcChh
Confidence 999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=280.14 Aligned_cols=199 Identities=27% Similarity=0.372 Sum_probs=160.8
Q ss_pred HHHHHHHHhcCCCC-cccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+..|++++..++|+ +|+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |
T Consensus 47 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---i 122 (324)
T cd05587 47 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKG---I 122 (324)
T ss_pred HHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 45788899999765 58889999999999999999999999999886543 6899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 123 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (324)
T cd05587 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200 (324)
T ss_pred EecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 9999999999999999999999999875322211 22345789999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
|........ .... ... .. .++...+..+.+++.+||+.||.+|++.
T Consensus 201 f~~~~~~~~---~~~i---~~~--------~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 201 FDGEDEDEL---FQSI---MEH--------NV----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHHHH---HHHH---HcC--------CC----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 975432111 1100 000 01 1112235678999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.25 Aligned_cols=215 Identities=27% Similarity=0.388 Sum_probs=165.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|.+|+.++++++||||+++++++.+....++||||+++|+|.+++.... ...++..+..++.|++.||.|||+.+
T Consensus 42 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~- 120 (269)
T cd05087 42 FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120 (269)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 6789999999999999999999999999999999999999999986432 24567788899999999999999988
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-------CCCchhHHHHHHHH
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTSRSDVYSFGVV 150 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~i 150 (306)
++|+||||+||+++.++.+||+|||++................++..|+|||++.+. .++.++||||||++
T Consensus 121 --i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05087 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198 (269)
T ss_pred --EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHH
Confidence 999999999999999999999999999764433222222335577889999998632 35789999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|||++ |..||........ ...... ........+... ...+..+.+++..|+ .+|++|||+++|++
T Consensus 199 l~el~~~g~~p~~~~~~~~~---~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 199 IWELFELGSQPYRHLSDEQV---LTYTVR-----EQQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHhCCCCCCCCCChHHH---HHHHhh-----cccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 999996 9999965432211 111000 000111122211 122456889999999 68999999999998
Q ss_pred HhC
Q 021891 230 ALK 232 (306)
Q Consensus 230 ~l~ 232 (306)
.|.
T Consensus 266 ~l~ 268 (269)
T cd05087 266 LLS 268 (269)
T ss_pred Hhc
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=280.32 Aligned_cols=215 Identities=26% Similarity=0.394 Sum_probs=171.2
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
|.+|+++++++ +|+||+++++++...+..++||||+++++|.+++.++. ..+++..+..++.|+
T Consensus 64 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 143 (334)
T cd05100 64 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQV 143 (334)
T ss_pred HHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHH
Confidence 67899999999 89999999999999999999999999999999986532 247888999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 144 ~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 220 (334)
T cd05100 144 ARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220 (334)
T ss_pred HHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhH
Confidence 99999999988 999999999999999999999999999865433222222223345679999999988999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |..||........ ... ..... ....+...+..+.+++.+||+.+|++|||+
T Consensus 221 slG~il~el~~~g~~p~~~~~~~~~------~~~-~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 283 (334)
T cd05100 221 SFGVLLWEIFTLGGSPYPGIPVEEL------FKL-LKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTF 283 (334)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHH------HHH-HHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCH
Confidence 99999999998 7888865432111 100 00000 001112234688999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 021891 225 SEVVEALKPLPN 236 (306)
Q Consensus 225 ~ell~~l~~~~~ 236 (306)
.++++.|+.+..
T Consensus 284 ~ell~~l~~~~~ 295 (334)
T cd05100 284 KQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHHHhh
Confidence 999999976654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.54 Aligned_cols=224 Identities=23% Similarity=0.336 Sum_probs=169.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++..++..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+ |+
T Consensus 51 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---iv 126 (309)
T cd07872 51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VL 126 (309)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 56899999999999999999999999999999999965 898888776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 127 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p 204 (309)
T cd07872 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL 204 (309)
T ss_pred cCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876433221 1223457889999999865 4689999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhh--------hhhccccccccccCCccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 161 MDKNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|......+....+.... ........+...-.+.... ......+.++.+||.+||+.||.+|||+.|++
T Consensus 205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 205 FPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 97654432211111100 0000000000000000000 00112356789999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
++.
T Consensus 285 ~h~ 287 (309)
T cd07872 285 KHA 287 (309)
T ss_pred cCh
Confidence 854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.69 Aligned_cols=214 Identities=29% Similarity=0.412 Sum_probs=163.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|.+|+++++.++|+||+++++.+.+....++||||+++|+|.+++.... ...++..+..++.||+.||+|||+.+
T Consensus 42 ~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 120 (269)
T cd05042 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120 (269)
T ss_pred HHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 6789999999999999999999999999999999999999999986543 23467888999999999999999988
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-------CCCCchhHHHHHHHH
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVV 150 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~i 150 (306)
|+||||||+||+++.++.+||+|||++................++..|+|||++.. ..++.++|||||||+
T Consensus 121 --ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 198 (269)
T cd05042 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT 198 (269)
T ss_pred --EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHH
Confidence 99999999999999999999999999876433222222223345677999998753 356889999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|||++ |..||....... .... .... .......+.. ....+..+.+++..|| .||++|||+++|++
T Consensus 199 l~el~~~~~~p~~~~~~~~---~~~~---~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 199 MWELFTAADQPYPDLSDEQ---VLKQ---VVRE--QDIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHhCCCCCCCcCCHHH---HHHH---Hhhc--cCccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 999999 777886543211 1100 0000 0001112222 2233467778999998 59999999999998
Q ss_pred Hh
Q 021891 230 AL 231 (306)
Q Consensus 230 ~l 231 (306)
.|
T Consensus 266 ~l 267 (269)
T cd05042 266 LL 267 (269)
T ss_pred Hh
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=277.04 Aligned_cols=210 Identities=25% Similarity=0.385 Sum_probs=167.3
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
|.+|++++.++ +|+||+++++++.+++..++||||+++++|.+++.+.. ..+++..++.++.|+
T Consensus 54 ~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 133 (303)
T cd05088 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133 (303)
T ss_pred HHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHH
Confidence 67899999999 89999999999999999999999999999999986432 257899999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.++|||
T Consensus 134 ~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 207 (303)
T cd05088 134 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVW 207 (303)
T ss_pred HHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccch
Confidence 99999999988 9999999999999999999999999986422111 11112335679999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||+| |..||........ ... .... ... ..+...+..+.+|+.+||+.+|++||++
T Consensus 208 slG~il~ellt~g~~p~~~~~~~~~---~~~----~~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 270 (303)
T cd05088 208 SYGVLLWEIVSLGGTPYCGMTCAEL---YEK----LPQG------YRL----EKPLNCDDEVYDLMRQCWREKPYERPSF 270 (303)
T ss_pred hhhhHHHHHHhcCCCCcccCChHHH---HHH----HhcC------CcC----CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999998 9999865432211 100 0000 000 0111234678999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.++++.|+.+
T Consensus 271 ~~il~~l~~~ 280 (303)
T cd05088 271 AQILVSLNRM 280 (303)
T ss_pred HHHHHHHHHH
Confidence 9999988654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=283.26 Aligned_cols=205 Identities=27% Similarity=0.303 Sum_probs=160.5
Q ss_pred HHHHHHHhcC---CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 3 QAEVNFLGDL---VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 3 ~~E~~il~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.+|..++..+ .||||+++++++.+.+..|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+
T Consensus 41 ~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--- 116 (330)
T cd05586 41 IGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--- 116 (330)
T ss_pred HHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3456666655 6999999999999999999999999999999988654 46899999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+|||++.++.+||+|||++........ ......||..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 117 ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~ 194 (330)
T cd05586 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW 194 (330)
T ss_pred eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCC
Confidence 99999999999999999999999999875332221 22345789999999998754 5899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~ell~~ 230 (306)
.||...........+ .... ..+.. ...+..+.+|+.+||+.||.+|| ++.++++|
T Consensus 195 ~Pf~~~~~~~~~~~i------~~~~--------~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 195 SPFYAEDTQQMYRNI------AFGK--------VRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCCCCCHHHHHHHH------HcCC--------CCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 999764321110000 0000 00000 01246788999999999999998 46666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=271.45 Aligned_cols=211 Identities=25% Similarity=0.381 Sum_probs=169.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++|+||+++++++..++..++||||+++++|..++.+....+++..+..++.|++.||.|||+.+ ++
T Consensus 49 ~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~ 125 (282)
T cd06643 49 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---II 125 (282)
T ss_pred HHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999988665567999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+||+++.++.+||+|||++....... .......++..|+|||++. +..++.++|||||||++|+|++
T Consensus 126 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred ecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 99999999999999999999999987643221 1223356889999999974 3457889999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|.+||........ ...... . ..+.. ..+...+..+.+||.+||+.||.+||++.+++++..
T Consensus 204 g~~p~~~~~~~~~--~~~~~~----~-------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 204 IEPPHHELNPMRV--LLKIAK----S-------EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred CCCCccccCHHHH--HHHHhh----c-------CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 9999875432111 010000 0 00000 011223568899999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=272.04 Aligned_cols=212 Identities=25% Similarity=0.413 Sum_probs=168.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~L 72 (306)
|.+|+.+++.++|+||+++++++.+.+..++||||+++|+|.+++.+.. ..++...+..++.|++.||.||
T Consensus 56 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 135 (288)
T cd05061 56 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 135 (288)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 5689999999999999999999999999999999999999999996421 2356778899999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|
T Consensus 136 H~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~ 212 (288)
T cd05061 136 NAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212 (288)
T ss_pred HhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHH
Confidence 9988 9999999999999999999999999988654332222222234567899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||++ |..||....... ...... .... . ..+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 213 el~~~~~~p~~~~~~~~---~~~~~~----~~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 213 EITSLAEQPYQGLSNEQ---VLKFVM----DGGY------L----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred HHHhCCCCCCCCCCHHH---HHHHHH----cCCC------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 678886532211 111100 0000 0 01112346899999999999999999999999988
Q ss_pred CC
Q 021891 232 KP 233 (306)
Q Consensus 232 ~~ 233 (306)
+.
T Consensus 276 ~~ 277 (288)
T cd05061 276 KD 277 (288)
T ss_pred Hh
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=267.58 Aligned_cols=207 Identities=27% Similarity=0.407 Sum_probs=166.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEE-eCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+.++++++|+||+++++++. .++..++||||+++++|.+++.++. ..+++..++.++.|++.||+|||+.+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 122 (256)
T cd05082 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--- 122 (256)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 678999999999999999999765 4567899999999999999987654 34889999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
++||||||+||+++.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 123 i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~ 197 (256)
T cd05082 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987643221 12234567999999988889999999999999999998 88
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
.||....... ...... . ...+. .....+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 198 ~p~~~~~~~~---~~~~~~----~------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 198 VPYPRIPLKD---VVPRVE----K------GYKMD----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHH---HHHHHh----c------CCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 8886432211 111100 0 00111 112235688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=267.56 Aligned_cols=210 Identities=29% Similarity=0.489 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++......++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~ 122 (256)
T cd05112 46 FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122 (256)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 678999999999999999999999999999999999999999999766667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 123 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 201 (256)
T cd05112 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201 (256)
T ss_pred ccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999876533211 11122334668999999988889999999999999999998 8999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|....... .... .... .....+. ..+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 202 ~~~~~~~~---~~~~----~~~~---~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 202 YENRSNSE---VVET----INAG---FRLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCcCCHHH---HHHH----HhCC---CCCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 86533211 1110 0000 0111111 12468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=270.61 Aligned_cols=212 Identities=24% Similarity=0.371 Sum_probs=171.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++.. ...++||||+++|+|.+++......+++..+..++.|++.||.|||+.+ ++
T Consensus 56 ~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~ 131 (279)
T cd05057 56 ILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LV 131 (279)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 6789999999999999999999987 7889999999999999999876667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.+||+|||+++...............++..|+|||.+....++.++|||||||++||+++ |..|
T Consensus 132 H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 211 (279)
T cd05057 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999987654332222222233567999999988889999999999999999998 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|........... ...... .. .+...+..+.+++.+||..||++||++.++++.|..+
T Consensus 212 ~~~~~~~~~~~~-------~~~~~~---~~-------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 212 YEGIPAVEIPDL-------LEKGER---LP-------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCCCCHHHHHHH-------HhCCCC---CC-------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 876432211110 000000 00 0111235788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=271.64 Aligned_cols=226 Identities=25% Similarity=0.348 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|++++++++||||+++++++... ...++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+
T Consensus 52 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--- 128 (284)
T cd05081 52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--- 128 (284)
T ss_pred HHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 67899999999999999999987543 4688999999999999999766557899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||||+||+++.++.+||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++|.
T Consensus 129 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 208 (284)
T cd05081 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208 (284)
T ss_pred ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcC
Confidence 99999999999999999999999999987644322211 11122345699999998888999999999999999999987
Q ss_pred CCCCCCCCCCCcchHHhhhhhhc---cccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLG---ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.++......- ......... ....+...+............+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 209 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 209 DKSCSPPAEF----MRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCcchhh----hhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 7654321100 000000000 00000000000000001122346899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=268.25 Aligned_cols=213 Identities=25% Similarity=0.405 Sum_probs=165.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+.+++.++||||+++++++.. ++..++||||+.+++|.+++.+....+++..+..++.|++.||.|||+.+ +
T Consensus 43 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i 119 (262)
T cd05058 43 FLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---F 119 (262)
T ss_pred HHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5689999999999999999998764 55678999999999999999766556788888999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC-
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG- 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg- 157 (306)
+||||||+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++|
T Consensus 120 ~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred cccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999764332111 111223456789999999888899999999999999999995
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.+||...... ...... .. . ...... ...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 200 ~~~~~~~~~~---~~~~~~---~~-~------~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 200 APPYPDVDSF---DITVYL---LQ-G------RRLLQP----EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCCCHH---HHHHHH---hc-C------CCCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 5556443211 111111 00 0 001111 12246789999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=268.99 Aligned_cols=211 Identities=24% Similarity=0.356 Sum_probs=167.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+.++++++||||+++++++..++..++||||+++++|.+++.++ ..+++..+..++.|++.||.|||+.+ |+
T Consensus 53 ~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 128 (267)
T cd06646 53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KM 128 (267)
T ss_pred HHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 578999999999999999999999999999999999999999988654 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++.++.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|.
T Consensus 129 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~ 206 (267)
T cd06646 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ 206 (267)
T ss_pred ccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999986532211 122346788999999874 345788999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||............ .... ...+... .....+..+.+++.+||+.+|++|||+++++++|
T Consensus 207 ~p~~~~~~~~~~~~~--------~~~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 207 PPMFDLHPMRALFLM--------SKSN---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCccccchhhhheee--------ecCC---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 998654322111000 0000 0001110 0112356889999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.68 Aligned_cols=208 Identities=25% Similarity=0.408 Sum_probs=169.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++
T Consensus 53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---iv 128 (267)
T cd06628 53 LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---II 128 (267)
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cc
Confidence 678999999999999999999999999999999999999999999654 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCc----ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
|+||+|+||+++.++.++|+|||+++....... ........|+..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 129 H~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 129 HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred cccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhC
Confidence 999999999999999999999999887642211 1111234578899999999888899999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
..||....... .+. . . .....+. .+...+..+.++|.+||+.||.+||++.+++++
T Consensus 209 ~~p~~~~~~~~---~~~--~--~------~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 209 KHPFPDCTQLQ---AIF--K--I------GENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCCCCCccHHH---HHH--H--H------hccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 99997542211 000 0 0 0011111 222345788999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.10 Aligned_cols=208 Identities=25% Similarity=0.363 Sum_probs=171.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ +
T Consensus 46 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (256)
T cd08221 46 ALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---I 122 (256)
T ss_pred HHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 678999999999999999999999999999999999999999999765 456899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||+|+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 123 ~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08221 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200 (256)
T ss_pred cccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999976543321 22345688999999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|........ ...... .. ..+ .....+.++.+++.+||+.+|++||++.++++++
T Consensus 201 ~~~~~~~~~------~~~~~~--~~----~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 201 FDATNPLNL------VVKIVQ--GN----YTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCCHHHH------HHHHHc--CC----CCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 865432111 000000 00 000 1123356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=283.57 Aligned_cols=211 Identities=23% Similarity=0.252 Sum_probs=165.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++.+++..++|||||++|+|.+++... .+++..+..++.||+.||.|||+.+ |+
T Consensus 90 ~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---iv 164 (371)
T cd05622 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FI 164 (371)
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 568999999999999999999999999999999999999999988543 4889999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC----CCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg 157 (306)
||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 165 HrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G 243 (371)
T cd05622 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243 (371)
T ss_pred eCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhC
Confidence 999999999999999999999999987543221 122345799999999998754 378999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l~ 232 (306)
..||........... ....... .... .....+..+.++|.+||..++.+ |+++.++++|..
T Consensus 244 ~~Pf~~~~~~~~~~~------i~~~~~~-~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 244 DTPFYADSLVGTYSK------IMNHKNS-LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCCCCCCCHHHHHHH------HHcCCCc-ccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 999976432111000 0000000 0000 01123568889999999844433 789999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.64 Aligned_cols=218 Identities=28% Similarity=0.430 Sum_probs=169.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++++.++||||+++++++... ...++||||+++++|.+++.+....+++..+..++.|++.||.|||+.+
T Consensus 53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--- 129 (284)
T cd05079 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--- 129 (284)
T ss_pred HHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 67899999999999999999998875 5688999999999999998766557899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|+++.
T Consensus 130 i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~ 209 (284)
T cd05079 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209 (284)
T ss_pred eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCC
Confidence 999999999999999999999999999876443221 1122345677899999998888999999999999999999987
Q ss_pred CCCCCCCCC---------CCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 159 RSMDKNRPN---------GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 159 ~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
.|+...... ......... ....... ... .....+..+.+|+.+||+.||++|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 210 DSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEEGK------RLP----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred CCCccccchhhhhcccccccccHHHHH-HHHHcCc------cCC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 654321110 000000000 0000000 000 11123578999999999999999999999999
Q ss_pred HhCC
Q 021891 230 ALKP 233 (306)
Q Consensus 230 ~l~~ 233 (306)
.++.
T Consensus 279 ~l~~ 282 (284)
T cd05079 279 GFEA 282 (284)
T ss_pred HHHh
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.97 Aligned_cols=210 Identities=26% Similarity=0.349 Sum_probs=165.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++.+++|+||+++++.+.+.+..|+|||||++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+
T Consensus 48 ~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---iv 123 (360)
T cd05627 48 IRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FI 123 (360)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 567999999999999999999999999999999999999999998654 36899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc---------------------------------eeeeccccccccc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------------HVSTRVMGTYGYA 128 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~ 128 (306)
||||||+||+++.++.+||+|||++......... ......+||..|+
T Consensus 124 HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 203 (360)
T cd05627 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI 203 (360)
T ss_pred ccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcccc
Confidence 9999999999999999999999998754321100 0011346899999
Q ss_pred CCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHH
Q 021891 129 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 208 (306)
Q Consensus 129 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (306)
|||++.+..++.++|||||||++|||++|..||...........+ ...... ..+.+. ...+.++.+
T Consensus 204 APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i------~~~~~~--~~~p~~------~~~s~~~~~ 269 (360)
T cd05627 204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV------MNWKET--LVFPPE------VPISEKAKD 269 (360)
T ss_pred CHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHH------HcCCCc--eecCCC------CCCCHHHHH
Confidence 999999999999999999999999999999999765432211110 000000 001110 012467889
Q ss_pred HHHHcccCCCCCCCC---HHHHHHH
Q 021891 209 LAAHCLSRDPKARPL---MSEVVEA 230 (306)
Q Consensus 209 li~~~l~~~p~~Rps---~~ell~~ 230 (306)
||.+|+ .||.+|++ +.++++|
T Consensus 270 li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 270 LILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHhc-cChhhcCCCCCHHHHhcC
Confidence 999977 49999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.74 Aligned_cols=224 Identities=24% Similarity=0.316 Sum_probs=167.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++|+.++|+||+++++++...+ ..|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+
T Consensus 46 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ 123 (372)
T cd07853 46 VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG 123 (372)
T ss_pred HHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999999999998776 7899999996 5888877544 47999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell 155 (306)
++||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+. .++.++|||||||++|||+
T Consensus 124 ---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 199 (372)
T cd07853 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199 (372)
T ss_pred ---eeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH
Confidence 999999999999999999999999999865432211 12334578899999998864 5799999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhh---------hhcc-ccccc-cccCCc-cC--CCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARP---------HLGE-RRRFY-RLIDPR-LE--GHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~---------~~~~-~~~~~-~~~~~~-~~--~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
+|+.||...........+..... .... ...+. ....+. .. .......+.++.+||.+||+.||++|
T Consensus 200 ~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 279 (372)
T cd07853 200 GRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR 279 (372)
T ss_pred cCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhC
Confidence 99999976543322111110000 0000 00000 000000 00 00111235688999999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
||+.|+++|.
T Consensus 280 ~t~~e~l~hp 289 (372)
T cd07853 280 ISAADALAHP 289 (372)
T ss_pred cCHHHHhcCH
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.91 Aligned_cols=207 Identities=22% Similarity=0.307 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.++|+||+++++.+.+++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ +
T Consensus 45 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i 121 (255)
T cd08219 45 SRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---V 121 (255)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---c
Confidence 568999999999999999999999999999999999999999988653 456899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 122 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p 199 (255)
T cd08219 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199 (255)
T ss_pred ccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCC
Confidence 9999999999999999999999999876543221 12335688899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|........ . ...... . . ...+...+..+.+|+.+||+.||++|||+.+++..
T Consensus 200 ~~~~~~~~~---~---~~~~~~--~----~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 200 FQANSWKNL---I---LKVCQG--S----Y-----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCHHHH---H---HHHhcC--C----C-----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 975422111 0 000000 0 0 01122235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=264.86 Aligned_cols=202 Identities=25% Similarity=0.431 Sum_probs=163.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++.. ...++||||+++++|.+++......+++..+..++.||+.||.|||+.+ ++
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~ 123 (259)
T cd05037 48 FFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LV 123 (259)
T ss_pred HHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---ee
Confidence 6789999999999999999999988 7789999999999999999766557899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCC-------cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC--CCCchhHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADY-------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLL 152 (306)
Q Consensus 82 H~dlkp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ 152 (306)
||||||+||+++.++ .+||+|||++..... .....++..|+|||++.+. .++.++|||||||++|
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~ 197 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLL 197 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHH
Confidence 999999999999887 799999999986433 1223456789999998876 7899999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++ |..||........ ..+.. ... .... .....+.+++.+||..+|.+|||+.++++.|
T Consensus 198 ~l~~~~~~p~~~~~~~~~---~~~~~----~~~---~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 198 EICSNGEEPLSTLSSSEK---ERFYQ----DQH---RLPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHhCCCCCcccCCchhH---HHHHh----cCC---CCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999 4677755432111 11100 000 0000 0116888999999999999999999999876
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
.
T Consensus 259 ~ 259 (259)
T cd05037 259 N 259 (259)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=265.99 Aligned_cols=210 Identities=25% Similarity=0.384 Sum_probs=168.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|++|+++++.++|+||+++++++. .+..++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ +
T Consensus 48 ~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i 123 (262)
T cd05071 48 FLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---Y 123 (262)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 688999999999999999999875 45689999999999999999753 345899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.++|+|||.++........ ......++..|+|||+..+..++.++|||||||++|+|++ |..
T Consensus 124 ~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~ 202 (262)
T cd05071 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 202 (262)
T ss_pred cccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999765433221 1222345678999999988889999999999999999999 788
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ ... .... ... ......+..+.+|+.+||+.||++||++.++++.|+.
T Consensus 203 p~~~~~~~~~---~~~----~~~~------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 203 PYPGMVNREV---LDQ----VERG------YRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCCCChHHH---HHH----HhcC------CCC----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 8865432111 100 0000 000 1122345788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.07 Aligned_cols=210 Identities=30% Similarity=0.392 Sum_probs=169.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+.++++++|+||+++++.+.+.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ +
T Consensus 47 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i 123 (285)
T cd05630 47 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---I 123 (285)
T ss_pred HHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 467999999999999999999999999999999999999999988543 346899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 124 iH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred EeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876433221 1234689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
|.............. .... ... .+....+..+.+|+.+||+.||++||| ++|+++|.
T Consensus 201 f~~~~~~~~~~~~~~---~~~~-------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 201 FQQRKKKIKREEVER---LVKE-------VQE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred CCCCCccchHHHHHh---hhhh-------hhh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 976432211111100 0000 000 111223467899999999999999999 88998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=265.16 Aligned_cols=210 Identities=27% Similarity=0.383 Sum_probs=167.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++++.++|+||+++++++. .+..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ +
T Consensus 48 ~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i 123 (260)
T cd05069 48 FLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---Y 123 (260)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 678999999999999999999875 45688999999999999999654 345889999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||++++++.++|+|||+++........ ......++..|+|||...+..++.++||||||+++|+|++ |..
T Consensus 124 ~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~ 202 (260)
T cd05069 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred eecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999765432211 1122345678999999988889999999999999999999 888
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ ..... . ..... .+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 203 p~~~~~~~~~---~~~~~----~------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 203 PYPGMVNREV---LEQVE----R------GYRMP----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCHHHH---HHHHH----c------CCCCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9875432111 11100 0 00011 112335789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=278.92 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=161.2
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+..|..++..+ .|++|+++++++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |
T Consensus 47 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---i 122 (323)
T cd05616 47 TMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKG---I 122 (323)
T ss_pred HHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 34577777777 68999999999999999999999999999999886543 6899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 123 vHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~P 200 (323)
T cd05616 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200 (323)
T ss_pred EecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCC
Confidence 9999999999999999999999999875432211 22345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
|........ ..... .. .. .++...+.++.+++.+||+.||.+|+++
T Consensus 201 f~~~~~~~~---~~~i~---~~--------~~----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 201 FEGEDEDEL---FQSIM---EH--------NV----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCHHHH---HHHHH---hC--------CC----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 976432211 11000 00 00 1122335788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=265.43 Aligned_cols=207 Identities=29% Similarity=0.487 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ +
T Consensus 47 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i 123 (256)
T cd05039 47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---F 123 (256)
T ss_pred HHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 6789999999999999999999998899999999999999999986553 36899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.+||+|||+++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 124 ~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~ 198 (256)
T cd05039 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred cchhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999998753221 12234567999999988889999999999999999997 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ... ..... ... ..+...+..+.++|.+||..+|++|||+.++++.|+.
T Consensus 199 p~~~~~~~~---~~~----~~~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 199 PYPRIPLKD---VVP----HVEKG------YRM----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCCHHH---HHH----HHhcC------CCC----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 886542211 110 00000 000 1112235788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.78 Aligned_cols=212 Identities=23% Similarity=0.383 Sum_probs=169.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.+++.++||||+++++++... ..++|+||+++|+|.+++......+++..+..++.|++.||.|||+.+ ++
T Consensus 56 ~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iv 131 (303)
T cd05110 56 FMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LV 131 (303)
T ss_pred HHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---ee
Confidence 67899999999999999999998754 567899999999999999776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 132 H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987644332222223345678999999988899999999999999999997 8888
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|....... ...+. ..... .. . +...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 212 ~~~~~~~~---~~~~~----~~~~~---~~---~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 212 YDGIPTRE---IPDLL----EKGER---LP---Q----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCCCCHHH---HHHHH----HCCCC---CC---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 86542211 11111 01000 00 0 111245788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=269.52 Aligned_cols=209 Identities=24% Similarity=0.376 Sum_probs=166.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++...+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ ++
T Consensus 46 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 117 (279)
T cd06619 46 IMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---IL 117 (279)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 678999999999999999999999999999999999999997542 4788899999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||||+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 118 H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 193 (279)
T cd06619 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193 (279)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999999999765332 123357899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcc-hHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 162 DKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.......... ........... ..+... ....+.++.+++.+||+.+|++||++++++++..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 194 PQIQKNQGSLMPLQLLQCIVDE-------DPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred hhhcccccccchHHHHHHHhcc-------CCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 7543222111 01110000000 001100 1123467899999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=268.71 Aligned_cols=210 Identities=25% Similarity=0.389 Sum_probs=167.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+.+++.++||||+++++++...+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++
T Consensus 53 ~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 128 (267)
T cd06645 53 VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG---KM 128 (267)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 5789999999999999999999999999999999999999999886544 7899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||+||+++.++.++|+|||++...... ........|+..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 129 H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~ 206 (267)
T cd06645 129 HRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ 206 (267)
T ss_pred cCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCC
Confidence 9999999999999999999999998764322 11223456899999999874 456889999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||............. . . ....+.... ....+..+.++|.+||+.+|++|||+.+|+++
T Consensus 207 ~p~~~~~~~~~~~~~~--~------~---~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 207 PPMFDLHPMRALFLMT--K------S---NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCcccccchhhHHhhh--c------c---CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 9986543221110000 0 0 000011100 01224578899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=270.57 Aligned_cols=222 Identities=21% Similarity=0.255 Sum_probs=166.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++.+.+..++|+||+. ++|.+++......+++..++.++.||++||.|||+.+ ++
T Consensus 46 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~ 121 (284)
T cd07839 46 ALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VL 121 (284)
T ss_pred hhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 5689999999999999999999999999999999996 5888887665667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 122 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p 199 (284)
T cd07839 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199 (284)
T ss_pred cCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999976533221 12234568899999998764 478999999999999999999988
Q ss_pred CCCCCCCCCcchHHhhhh-----------hhccccccc--cccCCccC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 161 MDKNRPNGEHNLVEWARP-----------HLGERRRFY--RLIDPRLE-GHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~-----------~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
|........ ....... ......... ........ .......+.++.+||.+||+.||.+|||+.+
T Consensus 200 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 200 LFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred CcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 654322110 0000000 000000000 00000000 0011123578899999999999999999999
Q ss_pred HHHHh
Q 021891 227 VVEAL 231 (306)
Q Consensus 227 ll~~l 231 (306)
+++|.
T Consensus 278 il~h~ 282 (284)
T cd07839 278 ALQHP 282 (284)
T ss_pred HhcCC
Confidence 99863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=265.84 Aligned_cols=210 Identities=26% Similarity=0.402 Sum_probs=167.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++|+||+++++++. ....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ +
T Consensus 48 ~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i 123 (260)
T cd05070 48 FLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---Y 123 (260)
T ss_pred HHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 679999999999999999999875 45689999999999999998654 345899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 124 ~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 202 (260)
T cd05070 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred ccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999765432211 1122335667999999988889999999999999999999 888
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... .. ... ..+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 203 p~~~~~~~~---~~~~~~----~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 203 PYPGMNNRE---VLEQVE----RG------YRM----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCHHH---HHHHHH----cC------CCC----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 886543211 111110 00 001 1122335689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=268.64 Aligned_cols=213 Identities=25% Similarity=0.413 Sum_probs=170.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-------~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+++++.++|+||+++++++.. +...++++||+++++|.+++.... ..+++..++.++.|++.||.|||
T Consensus 55 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 134 (280)
T cd05043 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134 (280)
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999998776 467899999999999999986532 45899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
+.+ ++|+||||+||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++||
T Consensus 135 ~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~e 211 (280)
T cd05043 135 KRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWE 211 (280)
T ss_pred HCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHH
Confidence 988 99999999999999999999999999986544332222223345678999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 154 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 154 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
+++ |..||....... ...+.. ... ... .....+..+.+++.+||..||++|||+.++++.|+
T Consensus 212 l~~~g~~p~~~~~~~~---~~~~~~----~~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 212 LMTLGQTPYVEIDPFE---MAAYLK----DGY------RLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred HhcCCCCCcCcCCHHH---HHHHHH----cCC------CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 999 999997543221 111111 000 000 11123467899999999999999999999999886
Q ss_pred CC
Q 021891 233 PL 234 (306)
Q Consensus 233 ~~ 234 (306)
.+
T Consensus 275 ~~ 276 (280)
T cd05043 275 DF 276 (280)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=282.42 Aligned_cols=214 Identities=24% Similarity=0.382 Sum_probs=169.2
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------------------------------
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------------------ 50 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 50 (306)
|.+|+++|.++. ||||+++++++...+..++|||||.+|+|.+++.+..
T Consensus 87 ~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (401)
T cd05107 87 LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKS 166 (401)
T ss_pred HHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccccc
Confidence 578999999997 9999999999999999999999999999999985432
Q ss_pred -------------------------------------------------------------------CCCCHHHHHHHHH
Q 021891 51 -------------------------------------------------------------------LPLPWSIRMKIAL 63 (306)
Q Consensus 51 -------------------------------------------------------------------~~l~~~~~~~~~~ 63 (306)
..+++..+..++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 246 (401)
T cd05107 167 HVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSY 246 (401)
T ss_pred chhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHH
Confidence 1356778889999
Q ss_pred HHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhH
Q 021891 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 143 (306)
Q Consensus 64 qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 143 (306)
|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|
T Consensus 247 qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 323 (401)
T cd05107 247 QVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSD 323 (401)
T ss_pred HHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence 9999999999988 9999999999999999999999999998653322211222345678899999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 144 VYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 144 iwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
||||||++|||++ |..||......... ........ .+. .+...+.++.+|+.+||..+|.+||
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~------~~~~~~~~------~~~----~p~~~~~~l~~li~~cl~~~P~~RP 387 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQF------YNAIKRGY------RMA----KPAHASDEIYEIMQKCWEEKFEIRP 387 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHH------HHHHHcCC------CCC----CCCCCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999998 88888654321110 00000000 001 1112356899999999999999999
Q ss_pred CHHHHHHHhCCC
Q 021891 223 LMSEVVEALKPL 234 (306)
Q Consensus 223 s~~ell~~l~~~ 234 (306)
++++|++.|+.+
T Consensus 388 s~~ell~~L~~~ 399 (401)
T cd05107 388 DFSQLVHLVGDL 399 (401)
T ss_pred CHHHHHHHHHHH
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=265.68 Aligned_cols=215 Identities=21% Similarity=0.337 Sum_probs=163.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|.+|+.+++.++||||+++++++.+....++||||+++|+|.+++.+. ....++..+..++.||+.||.|||+.+
T Consensus 42 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-- 119 (268)
T cd05086 42 FLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119 (268)
T ss_pred HHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 678999999999999999999999999999999999999999998654 234677788899999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-------CCCCchhHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVL 151 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il 151 (306)
++||||||+||+++.++.++|+|||++................++..|+|||++.. ..++.++|||||||++
T Consensus 120 -i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 198 (268)
T cd05086 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTL 198 (268)
T ss_pred -eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHH
Confidence 99999999999999999999999999864322211122234567889999998743 2457899999999999
Q ss_pred HHHHhC-CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 152 LEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 152 ~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|||+++ ..||....... ... .... .......++..... .+..+.+++..|| .+|++||++.+|++.
T Consensus 199 ~el~~~~~~p~~~~~~~~---~~~---~~~~--~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 199 WELFENAAQPYSHLSDRE---VLN---HVIK--DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred HHHHhCCCCCCCCCCHHH---HHH---HHHh--hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 999974 66775432211 111 0110 11112223332222 3467888999999 689999999999987
Q ss_pred hC
Q 021891 231 LK 232 (306)
Q Consensus 231 l~ 232 (306)
|.
T Consensus 266 l~ 267 (268)
T cd05086 266 LT 267 (268)
T ss_pred hc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=265.01 Aligned_cols=214 Identities=24% Similarity=0.363 Sum_probs=172.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|++++++++|+||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+
T Consensus 49 ~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-- 126 (267)
T cd08224 49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-- 126 (267)
T ss_pred HHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 67899999999999999999999999999999999999999998853 2445899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 127 -i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~ 203 (267)
T cd08224 127 -IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred -EecCCcChhhEEECCCCcEEEeccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999876533221 122346788999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||...... ......... . ... +.. .....+..+.++|.+||..+|++|||+.+|++.|+.+
T Consensus 204 ~p~~~~~~~----~~~~~~~~~-~-----~~~-~~~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 204 SPFYGDKMN----LYSLCKKIE-K-----CDY-PPL---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCcccCCcc----HHHHHhhhh-c-----CCC-CCC---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 998654311 111100000 0 000 000 0113456889999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=270.76 Aligned_cols=207 Identities=23% Similarity=0.325 Sum_probs=168.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++|+||+++++++..+...++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++
T Consensus 64 ~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g---i~ 138 (296)
T cd06654 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VI 138 (296)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 568999999999999999999999999999999999999999988543 5789999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 139 H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf 216 (296)
T cd06654 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (296)
T ss_pred cCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876433221 122346788999999998888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.......... . ..... .+. ...+...+..+.+++.+||..+|++|||+.+++++
T Consensus 217 ~~~~~~~~~~--~----~~~~~-------~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 217 LNENPLRALY--L----IATNG-------TPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCHHHhHH--H----HhcCC-------CCC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 7543311100 0 00000 000 01122345678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.84 Aligned_cols=214 Identities=20% Similarity=0.248 Sum_probs=166.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+.+++.++|+||+++++++.+++..|+||||+++|+|.+++.+....+++..+..++.||+.||+|||+.+ |+
T Consensus 48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 124 (331)
T cd05597 48 FREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YV 124 (331)
T ss_pred HHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 678999999999999999999999999999999999999999999766667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----CCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ellt 156 (306)
||||||+|||++.++.+||+|||++........ .......||+.|+|||++.. ..++.++|||||||++|+|++
T Consensus 125 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (331)
T cd05597 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred ECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh
Confidence 999999999999999999999999876543222 11223468999999999863 457889999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 232 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l~ 232 (306)
|+.||........ ..........+ . +.+. ....+..+.++|.+||..++++ |+++.++++|..
T Consensus 204 g~~Pf~~~~~~~~------~~~i~~~~~~~-~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 204 GETPFYAESLVET------YGKIMNHKEHF-Q-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred CCCCCCCCCHHHH------HHHHHcCCCcc-c-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 9999975432111 00000000000 0 0010 0123567889999988654443 789999999743
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=308.64 Aligned_cols=209 Identities=30% Similarity=0.422 Sum_probs=171.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..+|.++|..|+|||+|++||+-.+.+..+|.||||.+|+|.+++ +.+.-.++.....+..|++.|+.|||+.| ||
T Consensus 1281 i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IV 1356 (1509)
T KOG4645|consen 1281 IAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IV 1356 (1509)
T ss_pred hHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ce
Confidence 578999999999999999999999999999999999999999988 44445777777889999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCc--ceeeecccccccccCCcchhcC---CCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ellt 156 (306)
||||||+||+++.+|.+|++|||.|........ ....+..+||+.|||||++.+. .-..++||||||||+.||+|
T Consensus 1357 HRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1357 HRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred ecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec
Confidence 999999999999999999999999987655421 1222457899999999999753 45678999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhh-hhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARP-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|+.||...+.+ |... +.+- ...| .++...+.+..++|..||+.||++|+++.||+++=
T Consensus 1437 GkrPW~~~dne-------~aIMy~V~~------gh~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1437 GKRPWAELDNE-------WAIMYHVAA------GHKP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCCchhhccch-------hHHHhHHhc------cCCC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 99999764331 1111 1111 1112 23444678899999999999999999999999863
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=273.99 Aligned_cols=226 Identities=22% Similarity=0.323 Sum_probs=161.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~--------~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
+.+|+++|++++||||+++++++.. +...++||||+. ++|.+++... ...+++..++.++.||+.||.|
T Consensus 45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 123 (317)
T cd07867 45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123 (317)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999998854 457899999996 4887776421 2358899999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEE----cCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhc-CCCCchhHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVY 145 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 145 (306)
||+.+ ++||||||+||++ +.++.+||+|||+++........ .......||..|+|||++.+ ..++.++|||
T Consensus 124 lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07867 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence 99988 9999999999999 56678999999999875433221 11233568999999999876 4589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcc------hHHhhhhhhc--------c---cccc---cccc------CCcc---CC
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEHN------LVEWARPHLG--------E---RRRF---YRLI------DPRL---EG 196 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~~------~~~~~~~~~~--------~---~~~~---~~~~------~~~~---~~ 196 (306)
||||++|||+||.+||.......... .......... . ...+ .... .... ..
T Consensus 201 SlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (317)
T cd07867 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYME 280 (317)
T ss_pred hHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhh
Confidence 99999999999999997543221100 0000000000 0 0000 0000 0000 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 197 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 197 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.........+.+|+.+||+.||.+|||+.|+++|.
T Consensus 281 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 281 KHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred cccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 00111235688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=270.87 Aligned_cols=229 Identities=26% Similarity=0.354 Sum_probs=172.8
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+|++|+++++.++|+||+++++++.. ....++||||+++++|.+++......+++..+..++.|++.||.|||+.+
T Consensus 52 ~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~-- 129 (284)
T cd05038 52 DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR-- 129 (284)
T ss_pred HHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 37899999999999999999999887 55789999999999999999776657999999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
++|+||||+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|||||||+++||++|
T Consensus 130 -i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg 208 (284)
T cd05038 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208 (284)
T ss_pred -eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeecc
Confidence 99999999999999999999999999987653322211 1123345679999999888899999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
..|+............. .... .....+...+........+..++..+.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 209 ~~p~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 209 GDPSQSPPAEFLRMIGI-AQGQ-MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCCcccccchhcccccc-cccc-ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 99886532211100000 0000 000000000000001111123346899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=267.99 Aligned_cols=212 Identities=24% Similarity=0.356 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+ +..++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++
T Consensus 54 ~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~ 129 (270)
T cd05056 54 FLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FV 129 (270)
T ss_pred HHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 6789999999999999999998875 4578999999999999999776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|+||||+||+++.++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..|
T Consensus 130 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 208 (270)
T cd05056 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208 (270)
T ss_pred ccccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999876544321 11222234567999999988889999999999999999986 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|...........+ .... ... .+...+..+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 209 f~~~~~~~~~~~~-------~~~~------~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 209 FQGVKNNDVIGRI-------ENGE------RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CCCCCHHHHHHHH-------HcCC------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9765332111110 0000 001 11223568999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=269.38 Aligned_cols=223 Identities=21% Similarity=0.251 Sum_probs=165.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++||||+++++++.+++..++||||+. ++|.+++... +..+++..++.++.||+.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--- 121 (285)
T cd07861 46 AIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--- 121 (285)
T ss_pred HHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5789999999999999999999999999999999997 5898887543 256899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 122 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 199 (285)
T cd07861 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199 (285)
T ss_pred eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999876433211 12234568899999988654 5789999999999999999999
Q ss_pred CCCCCCCCCCCcchH-Hhh----hhhhc---cccccccccCC---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 159 RSMDKNRPNGEHNLV-EWA----RPHLG---ERRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~-~~~----~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
.||............ ... ...+. ....+...... ..........+.++.++|.+||+.||.+|||+.+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l 279 (285)
T cd07861 200 PLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279 (285)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 999764321110000 000 00000 00000000000 00000011235678899999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
+.+
T Consensus 280 l~~ 282 (285)
T cd07861 280 LNH 282 (285)
T ss_pred hcC
Confidence 975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=271.22 Aligned_cols=225 Identities=22% Similarity=0.305 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++..++..++||||+. ++|.+++......+++..+..++.|++.||.|||+.+ ++
T Consensus 51 ~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~ 126 (301)
T cd07873 51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126 (301)
T ss_pred HHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 5689999999999999999999999999999999996 5999988776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 127 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~ 204 (301)
T cd07873 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL 204 (301)
T ss_pred CCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999976433221 1223356889999999875 4578999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhh--------hhhccccccccccCCccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 161 MDKNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|...........+.... ........+...-.+.... ......+..+.+||.+||+.||.+|||+.|++
T Consensus 205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 205 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred CCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 97654321110000000 0000000000000000000 01112356788999999999999999999999
Q ss_pred HHhC
Q 021891 229 EALK 232 (306)
Q Consensus 229 ~~l~ 232 (306)
+|..
T Consensus 285 ~h~~ 288 (301)
T cd07873 285 KHPY 288 (301)
T ss_pred cCcc
Confidence 8643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=267.59 Aligned_cols=206 Identities=24% Similarity=0.373 Sum_probs=169.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---iv 123 (277)
T cd06642 49 IQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KI 123 (277)
T ss_pred HHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---ee
Confidence 67899999999999999999999999999999999999999998854 36899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 124 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 201 (277)
T cd06642 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201 (277)
T ss_pred ccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976543221 122345788999999999888999999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
........... .. ....+ ......+..+.+++.+||+.+|++||++.+++++.
T Consensus 202 ~~~~~~~~~~~-------~~------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 202 SDLHPMRVLFL-------IP------KNSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred cccchhhHHhh-------hh------cCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 65432211100 00 00011 11223456789999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=277.57 Aligned_cols=221 Identities=24% Similarity=0.297 Sum_probs=163.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+.+++.++||||+++++++...+ ..|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.
T Consensus 67 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~ 142 (359)
T cd07876 67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA 142 (359)
T ss_pred HHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC
Confidence 568999999999999999999987543 47999999965 67766632 478999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ |+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|+
T Consensus 143 ~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 216 (359)
T cd07876 143 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216 (359)
T ss_pred C---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH
Confidence 8 9999999999999999999999999997643221 123356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchH------------Hh----hhhhhcccccc-----ccccCCcc---CCCCCHHHHHHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLV------------EW----ARPHLGERRRF-----YRLIDPRL---EGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~------------~~----~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~li~ 211 (306)
+|..||............ .. ........... .+...... ........+..+.+||.
T Consensus 217 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 296 (359)
T cd07876 217 KGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLS 296 (359)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHH
Confidence 999999865322110000 00 00000000000 00000000 00011122467899999
Q ss_pred HcccCCCCCCCCHHHHHHHhC
Q 021891 212 HCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l~ 232 (306)
+||+.||++|||+.|+++|..
T Consensus 297 ~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 297 KMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHhccCcccCCCHHHHhcCch
Confidence 999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=264.74 Aligned_cols=207 Identities=24% Similarity=0.341 Sum_probs=172.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++++.|+||+++++++.+++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---iv 123 (277)
T cd06640 49 IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KI 123 (277)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 67899999999999999999999999999999999999999998854 35889999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|||++|..||
T Consensus 124 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 201 (277)
T cd06640 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201 (277)
T ss_pred CcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999976543221 223345788899999998888999999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
...........+ ............+..+.+++.+||+.+|++||++.+++++..
T Consensus 202 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 202 SDMHPMRVLFLI-----------------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCcChHhHhhhh-----------------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 754332111100 001112233456778999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=275.42 Aligned_cols=213 Identities=20% Similarity=0.258 Sum_probs=167.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+.++..++|+||+++++++.+.+..++||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+
T Consensus 48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ii 124 (332)
T cd05623 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YV 124 (332)
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 678999999999999999999999999999999999999999999776667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+||+++.++.+||+|||++........ .......||+.|+|||++. ...++.++|||||||++|||++
T Consensus 125 HrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~ 203 (332)
T cd05623 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203 (332)
T ss_pred ecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc
Confidence 999999999999999999999999876433221 2223357899999999986 3468899999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l 231 (306)
|+.||........ . .........+ . + +. .....+.++.+|+.+||..++++ |+++.++++|-
T Consensus 204 g~~Pf~~~~~~~~---~---~~i~~~~~~~-~-~-p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 204 GETPFYAESLVET---Y---GKIMNHKERF-Q-F-PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred CCCCCCCCCHHHH---H---HHHhCCCccc-c-C-CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 9999975432111 0 0000000000 0 0 00 01123578899999999765544 68999999873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=269.59 Aligned_cols=209 Identities=28% Similarity=0.372 Sum_probs=167.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|+.++|+||+++++++..++..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |
T Consensus 47 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i 123 (285)
T cd05632 47 ALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---T 123 (285)
T ss_pred HHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 567999999999999999999999999999999999999999888654 346999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 124 iH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P 200 (285)
T cd05632 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200 (285)
T ss_pred eecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876433211 1234689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~ 230 (306)
|...........+. ...... . ..+....+..+.+|+.+||+.||++||+ +.+++++
T Consensus 201 ~~~~~~~~~~~~~~---~~~~~~-------~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 201 FRGRKEKVKREEVD---RRVLET-------E----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCCCCHHHHHHHHH---Hhhhcc-------c----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 97543221111110 000000 0 0112223467889999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.81 Aligned_cols=209 Identities=25% Similarity=0.386 Sum_probs=167.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++|+||+++++++..++..++||||+++++|..++.+....+++..+..++.|++.||.|||+.+ ++
T Consensus 56 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~ 132 (292)
T cd06644 56 YMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---II 132 (292)
T ss_pred HHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---ee
Confidence 678999999999999999999999999999999999999999888766667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+||+++.++.++|+|||++...... ........++..|+|||++. ...++.++|||||||++|+|++
T Consensus 133 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~ 210 (292)
T cd06644 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ 210 (292)
T ss_pred ecCCCcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc
Confidence 9999999999999999999999998753322 11123346788999999985 3457889999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|..||........ .... . ....+.. ..+...+.++.++|.+||+.||++||++.+++++
T Consensus 211 g~~p~~~~~~~~~--~~~~----~-------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 211 IEPPHHELNPMRV--LLKI----A-------KSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCCCccccHHHH--HHHH----h-------cCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999865432110 0000 0 0000000 0112234678899999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.80 Aligned_cols=209 Identities=23% Similarity=0.359 Sum_probs=162.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|.+|+.+|++|+|||||+++++|... ..+||||||+++++|.++|... ...+++..++.|+.||+.||.|||+.+
T Consensus 59 ~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g 138 (1021)
T PTZ00266 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138 (1021)
T ss_pred HHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcc
Confidence 67899999999999999999988653 5689999999999999998643 346999999999999999999999843
Q ss_pred C----CCeEeccCCCCCeEEcC-----------------CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc
Q 021891 77 E----RPVIYRDFKTSNILLDA-----------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 135 (306)
Q Consensus 77 ~----~~iiH~dlkp~Nill~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 135 (306)
. .+|+||||||+||||+. .+.+||+|||++....... ......||+.|+|||++.+
T Consensus 139 ~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred cccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhc
Confidence 1 33999999999999964 2358999999998654322 1234568999999999864
Q ss_pred --CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHc
Q 021891 136 --GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 213 (306)
Q Consensus 136 --~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 213 (306)
..++.++||||||||+|+|++|..||....... .++ ..+... ..... ...+.++.+||..|
T Consensus 216 e~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~--qli----~~lk~~------p~lpi-----~~~S~eL~dLI~~~ 278 (1021)
T PTZ00266 216 ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS--QLI----SELKRG------PDLPI-----KGKSKELNILIKNL 278 (1021)
T ss_pred cCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH--HHH----HHHhcC------CCCCc-----CCCCHHHHHHHHHH
Confidence 458899999999999999999999997543211 111 011000 00000 11246889999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021891 214 LSRDPKARPLMSEVVEA 230 (306)
Q Consensus 214 l~~~p~~Rps~~ell~~ 230 (306)
|..+|.+||++.+++.+
T Consensus 279 L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 279 LNLSAKERPSALQCLGY 295 (1021)
T ss_pred hcCChhHCcCHHHHhcc
Confidence 99999999999999964
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.99 Aligned_cols=209 Identities=32% Similarity=0.498 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.++|+||+++++++.+.+..++||||+++++|.+++...... +++..++.++.|++.||.|||+.+ +
T Consensus 48 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~ 124 (258)
T smart00219 48 FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---F 124 (258)
T ss_pred HHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 678999999999999999999999999999999999999999998765433 899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.++|+|||++............ ...++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 125 ~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~ 203 (258)
T smart00219 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGES 203 (258)
T ss_pred eecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543222211 2336788999999988889999999999999999998 778
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||....... ...... ... . . ......+.++.+++.+||..||++|||+.++++.|
T Consensus 204 p~~~~~~~~---~~~~~~----~~~---~---~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 204 PYPGMSNEE---VLEYLK----KGY---R---L----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCHHH---HHHHHh----cCC---C---C----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 876532211 111100 000 0 0 01112457899999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=264.66 Aligned_cols=211 Identities=27% Similarity=0.407 Sum_probs=170.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ +
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i 124 (261)
T cd05034 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---Y 124 (261)
T ss_pred HHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 6789999999999999999999998889999999999999999997653 56899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |+.
T Consensus 125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 203 (261)
T cd05034 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203 (261)
T ss_pred ccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987654321 111122234567999999998889999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... . ...... +...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 204 p~~~~~~~~---~~~~~~----~------~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 204 PYPGMTNRE---VLEQVE----R------GYRMPR----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHH---HHHHHH----c------CCCCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 986543211 111100 0 000011 11225688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=266.51 Aligned_cols=210 Identities=30% Similarity=0.479 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++|+||+++++++.+.+..++|+||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++
T Consensus 49 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 124 (265)
T cd06631 49 LQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNC---VV 124 (265)
T ss_pred HHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 6789999999999999999999999999999999999999999996543 6899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCC----cceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
|+||+|+||+++.++.++|+|||++....... .........|+..|+|||++.+..++.++|||||||++|+|++|
T Consensus 125 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred cCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999987642211 11112234688899999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
..||......... .. .... ....+.. +...+..+.++|.+||+.+|.+||++.+++++
T Consensus 205 ~~p~~~~~~~~~~-----~~--~~~~----~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 205 KPPLASMDRLAAM-----FY--IGAH----RGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCccccCChHHHH-----HH--hhhc----cCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999654221110 00 0000 0001111 22235678999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=278.48 Aligned_cols=221 Identities=24% Similarity=0.289 Sum_probs=163.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+.+++.++||||+++++++.... ..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.
T Consensus 63 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~ 138 (355)
T cd07874 63 AYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 138 (355)
T ss_pred HHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC
Confidence 467999999999999999999886543 57999999965 77776632 478999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ |+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|+
T Consensus 139 g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 212 (355)
T cd07874 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212 (355)
T ss_pred C---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999998653321 223456899999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHH----------------hhhhhhccccccc-----cccCCcc---CCCCCHHHHHHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVE----------------WARPHLGERRRFY-----RLIDPRL---EGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~----------------~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~li~ 211 (306)
+|..||............. ............. ....... ........+..+.+||.
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 292 (355)
T cd07874 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292 (355)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHH
Confidence 9999997643221100000 0000000000000 0000000 00111123467899999
Q ss_pred HcccCCCCCCCCHHHHHHHhC
Q 021891 212 HCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l~ 232 (306)
+||+.||++|||+.|+++|..
T Consensus 293 ~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 293 KMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HHhcCCchhcCCHHHHhcCcc
Confidence 999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=270.34 Aligned_cols=222 Identities=25% Similarity=0.296 Sum_probs=163.3
Q ss_pred HHHHHHHHhcC---CCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDL---VHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l---~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|+++++.+ +||||+++++++... ...++||||+. ++|.+++... ...+++..+..++.|++.||.||
T Consensus 46 ~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 124 (288)
T cd07863 46 TVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124 (288)
T ss_pred HHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35678777765 799999999988652 45799999997 4898888654 34589999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ ++||||||+||+++.++.+||+|||+++....... .....|+..|+|||++.+..++.++|||||||++|
T Consensus 125 H~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 198 (288)
T cd07863 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198 (288)
T ss_pred HhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHH
Confidence 9998 99999999999999999999999999986543221 22346788999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhh-----hhhcccccc-ccccCCc---cCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWAR-----PHLGERRRF-YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
+|++|.+||...........+.... ..+...... ...+.+. .........+..+.+|+.+||+.||++|||
T Consensus 199 ~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 199 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred HHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 9999999997543322111110000 000000000 0000000 000111234567899999999999999999
Q ss_pred HHHHHHH
Q 021891 224 MSEVVEA 230 (306)
Q Consensus 224 ~~ell~~ 230 (306)
+.|++.|
T Consensus 279 ~~~~l~h 285 (288)
T cd07863 279 AFRALQH 285 (288)
T ss_pred HHHHhcC
Confidence 9999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=279.46 Aligned_cols=220 Identities=27% Similarity=0.448 Sum_probs=180.4
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCC-CHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l-~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+|.+|+++|.+|+|||||+++|+|..++.+++|+||++.|+|.+++.++..+. ..+.-..++.||+.||+||.+.+
T Consensus 581 ~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--- 657 (807)
T KOG1094|consen 581 DFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--- 657 (807)
T ss_pred HHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---
Confidence 48999999999999999999999999999999999999999999998774333 55666789999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh--C
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--G 157 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g 157 (306)
+|||||.+.|+|++.++++||+|||+++.+..++........+-..+|||+|.+.-++++.++|||+||+++||+++ .
T Consensus 658 fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~ 737 (807)
T KOG1094|consen 658 FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR 737 (807)
T ss_pred hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999998766666666656666789999999999999999999999999999755 6
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
..||....... .++.....+..... ...-..+..++..+.++|.+||..+-++|||++++..+|..
T Consensus 738 e~Py~~lt~e~---vven~~~~~~~~~~-------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 738 EQPYSQLTDEQ---VVENAGEFFRDQGR-------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred hCchhhhhHHH---HHHhhhhhcCCCCc-------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 67887654332 22222222211111 11112234557899999999999999999999999988764
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=266.23 Aligned_cols=207 Identities=27% Similarity=0.398 Sum_probs=170.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++.++...++|+||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~ 120 (274)
T cd06609 46 IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KI 120 (274)
T ss_pred HHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 678999999999999999999999999999999999999999998654 7899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus 121 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~ 198 (274)
T cd06609 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198 (274)
T ss_pred cCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999999999999999999998764332 1223456788999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
........... .. ....+..... ..+..+.+++.+||..+|++|||+++++++-
T Consensus 199 ~~~~~~~~~~~---~~----------~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 199 SDLHPMRVLFL---IP----------KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred ccCchHHHHHH---hh----------hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 75432111000 00 0011111111 1356789999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=268.73 Aligned_cols=210 Identities=25% Similarity=0.381 Sum_probs=169.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++..+...++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~ 125 (280)
T cd06611 49 FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125 (280)
T ss_pred HHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 678999999999999999999999999999999999999999999776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
|+||||+||+++.++.++|+|||++........ ......|+..|+|||++. ...++.++|||||||++|+|++
T Consensus 126 h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~ 203 (280)
T cd06611 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ 203 (280)
T ss_pred cCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999876433211 223356888999999975 3457789999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||........ .... .. ...+.. ..+...+.++.+++.+||+.+|.+||++.+++++-
T Consensus 204 g~~p~~~~~~~~~--~~~~-----~~------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 204 MEPPHHELNPMRV--LLKI-----LK------SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred CCCCcccCCHHHH--HHHH-----hc------CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 9999975432111 0000 00 000000 01112346788999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.42 Aligned_cols=214 Identities=26% Similarity=0.437 Sum_probs=171.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~i 80 (306)
|.+|+++++.++||||+++++++...+..++||||+++++|.+++.+. ..+++..+..++.+++.||.|||+ .+ +
T Consensus 50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~---i 125 (284)
T cd06620 50 ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR---I 125 (284)
T ss_pred HHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC---e
Confidence 678999999999999999999999999999999999999999988554 468999999999999999999997 46 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||||+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 126 ~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p 201 (284)
T cd06620 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201 (284)
T ss_pred eccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998654222 12235689999999999888899999999999999999999999
Q ss_pred CCCCCCCCC-----cchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 161 MDKNRPNGE-----HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 161 f~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|........ ............. ..+... ....+..+.+|+.+||+.||++|||+.|++++..-
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 202 FAFSNIDDDGQDDPMGILDLLQQIVQE-------PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred CcccchhhhhhhhhhHHHHHHHHHhhc-------cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 986543211 1111111111100 001110 11245678999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=278.44 Aligned_cols=221 Identities=23% Similarity=0.278 Sum_probs=163.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+.+++.++||||+++++++... ...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.
T Consensus 70 ~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~ 145 (364)
T cd07875 70 AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 145 (364)
T ss_pred HHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC
Confidence 56899999999999999999987643 357999999964 78777742 478999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ |+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 219 (364)
T cd07875 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219 (364)
T ss_pred C---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH
Confidence 8 9999999999999999999999999998653321 123356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHh------------h----hhhhccccccc-----cccCC---ccCCCCCHHHHHHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEW------------A----RPHLGERRRFY-----RLIDP---RLEGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~------------~----~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~~~~~~li~ 211 (306)
+|+.||...........+.. . .........+. ..... .............+.+||.
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 299 (364)
T cd07875 220 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299 (364)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHH
Confidence 99999976543211110000 0 00000000000 00000 0000111122457899999
Q ss_pred HcccCCCCCCCCHHHHHHHhC
Q 021891 212 HCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l~ 232 (306)
+||+.||.+|||+.++++|..
T Consensus 300 ~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 300 KMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HhcCcCcccCCCHHHHhcCcc
Confidence 999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=286.53 Aligned_cols=225 Identities=19% Similarity=0.224 Sum_probs=163.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|++|+++|++++|+|||++++++...+..|+|++++. ++|.+++.... .......+..++.||+.||.|||+.+
T Consensus 210 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g- 287 (501)
T PHA03210 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK- 287 (501)
T ss_pred HHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 6789999999999999999999999999999999995 57777765432 22345677889999999999999988
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
|+||||||+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|
T Consensus 288 --IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~ 364 (501)
T PHA03210 288 --LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364 (501)
T ss_pred --eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999999999999999987644322 122345789999999999999999999999999999999998
Q ss_pred CCC-CCCCCCCCCcchHHhhhhhhcccc-------ccccccCCc----cCCCC-----CHHHHHHHHHHHHHcccCCCCC
Q 021891 158 RRS-MDKNRPNGEHNLVEWARPHLGERR-------RFYRLIDPR----LEGHF-----SIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 158 ~~p-f~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~----~~~~~-----~~~~~~~~~~li~~~l~~~p~~ 220 (306)
..+ +....................... .+...++.. ....+ ....+.++.++|.+||+.||.+
T Consensus 365 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~ 444 (501)
T PHA03210 365 DFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHL 444 (501)
T ss_pred CCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCccc
Confidence 754 433222111111111110000000 000000000 00000 0012356788999999999999
Q ss_pred CCCHHHHHHHh
Q 021891 221 RPLMSEVVEAL 231 (306)
Q Consensus 221 Rps~~ell~~l 231 (306)
|||+.|++++.
T Consensus 445 Rpsa~elL~hp 455 (501)
T PHA03210 445 RPGAAELLALP 455 (501)
T ss_pred CcCHHHHhhCh
Confidence 99999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=259.71 Aligned_cols=224 Identities=24% Similarity=0.315 Sum_probs=167.7
Q ss_pred HHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+|+.+++.|+||||+.+..+|.. +...++++||++. +|...|.- ..+.++...+..++.||+.|+.|||++-
T Consensus 76 REiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-- 152 (438)
T KOG0666|consen 76 REIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-- 152 (438)
T ss_pred HHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--
Confidence 79999999999999999999988 7789999999976 89888853 2356999999999999999999999977
Q ss_pred CeEeccCCCCCeEEcCC----CcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcC-CCCchhHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 152 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 152 (306)
|+||||||.||++..+ |.|||+|||+++.+...-... .....+-|.+|+|||++.|. .|+.+.|||++|||+.
T Consensus 153 -vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 153 -VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred -eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence 9999999999999877 999999999999876654443 23446679999999999864 7999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcc------hHHhhhhhh-----ccccccccc---------cCCccCCCCC--------HHHHH
Q 021891 153 EMLTGRRSMDKNRPNGEHN------LVEWARPHL-----GERRRFYRL---------IDPRLEGHFS--------IKGAQ 204 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~------~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~--------~~~~~ 204 (306)
||+|..+.|.+........ .+......+ ..+..+..+ +........+ ..-++
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 9999999887643322111 000000000 000000000 0000000000 00123
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 205 KAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 205 ~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...+|+.+||+.||.+|.|+++.+++.
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhccc
Confidence 478999999999999999999999875
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=286.37 Aligned_cols=222 Identities=18% Similarity=0.249 Sum_probs=161.1
Q ss_pred HHHHHHHHhcCCCC------cccceeeEEEeC-CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHL------NLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~------niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
++.|+++++.++|. +|+++++++... ++.|+|||++ +++|.+++.+. ..+++..+..++.||+.||.|||+
T Consensus 172 ~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~ 249 (467)
T PTZ00284 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT 249 (467)
T ss_pred HHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45688888877554 588899988764 4789999998 67899888655 369999999999999999999997
Q ss_pred -CCCCCeEeccCCCCCeEEcCCC----------------cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC
Q 021891 75 -EAERPVIYRDFKTSNILLDADY----------------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 137 (306)
Q Consensus 75 -~~~~~iiH~dlkp~Nill~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 137 (306)
.+ |+||||||+|||++.++ .+||+|||.+..... ......||..|+|||++.+..
T Consensus 250 ~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~ 321 (467)
T PTZ00284 250 ELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLG 321 (467)
T ss_pred cCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCC
Confidence 47 99999999999998765 499999998864322 123467899999999999999
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhh----hc-------------cccccccccCCccC-----
Q 021891 138 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH----LG-------------ERRRFYRLIDPRLE----- 195 (306)
Q Consensus 138 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----~~-------------~~~~~~~~~~~~~~----- 195 (306)
|+.++|||||||++|||++|+.||......+....+...... +. ....+....++...
T Consensus 322 ~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (467)
T PTZ00284 322 WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401 (467)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhc
Confidence 999999999999999999999999765432221111110000 00 00000000000000
Q ss_pred --CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 196 --GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 196 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
..........+.+||.+||++||++|||++|+++|..-
T Consensus 402 ~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred ccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 00001123568899999999999999999999997543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.48 Aligned_cols=212 Identities=23% Similarity=0.395 Sum_probs=170.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+++++.++|+||+++++++.+.+..++|+||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 50 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~ 125 (268)
T cd06630 50 LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---II 125 (268)
T ss_pred HHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999999999999999999999998654 36899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC-cEEEeccCCcccCCCCCc--ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||+|+||+++.++ .+||+|||++........ ........|+..|+|||.+.+..++.++|||||||++++|++|.
T Consensus 126 H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 205 (268)
T cd06630 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205 (268)
T ss_pred cCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCC
Confidence 999999999998776 599999999877543211 11123356788999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||...........+.. ..........+...+.++.+++.+||..+|++||++.+++++
T Consensus 206 ~p~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 206 PPWNAEKHSNHLALIFK-------------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCCCCcchHHHHHH-------------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 99965432211111100 000001112333456789999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=255.89 Aligned_cols=214 Identities=23% Similarity=0.266 Sum_probs=170.3
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
++|+++.-.. .|||||+++++|+. .+-+.+|||.++||.|...+..++ +.+++.++..|++||..|+.|||+.+
T Consensus 102 RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n 181 (400)
T KOG0604|consen 102 RREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN 181 (400)
T ss_pred HhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc
Confidence 5788887777 69999999998874 245679999999999999997764 56999999999999999999999999
Q ss_pred CCCeEeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
|.||||||+|+|... |..+||+|||.|+...... .....+-|+.|.|||++....|+..+|+||+|+++|-
T Consensus 182 ---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYI 255 (400)
T KOG0604|consen 182 ---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255 (400)
T ss_pred ---hhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHH
Confidence 999999999999954 5578999999998754322 2334567999999999998899999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|++|.+||..........-+.... +...+.+.++. ....++...++|+++|..+|.+|.|+.++++|.+
T Consensus 256 lLCGyPPFYS~hg~aispgMk~rI-----~~gqy~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 256 LLCGYPPFYSNHGLAISPGMKRRI-----RTGQYEFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred hhcCCCcccccCCccCChhHHhHh-----hccCccCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 999999998654322111111000 00112222222 2356889999999999999999999999999865
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=262.68 Aligned_cols=207 Identities=24% Similarity=0.350 Sum_probs=167.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++|+||+++++.+.. +...++||||+++++|.+.+... ...+++.+++.++.|++.||.+||+.+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--- 122 (257)
T cd08223 46 AEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--- 122 (257)
T ss_pred HHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5789999999999999999998764 44678999999999999998764 446899999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++++|++|..
T Consensus 123 i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08223 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200 (257)
T ss_pred eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999876533211 2233567889999999998899999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
||...... ......... .. + ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 201 ~~~~~~~~------~~~~~~~~~------~~-~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 201 AFNAKDMN------SLVYRIIEG------KL-P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCCHH------HHHHHHHhc------CC-C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 98643211 111100000 00 0 1122345789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.97 Aligned_cols=210 Identities=26% Similarity=0.388 Sum_probs=168.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++|+||+++++++. .+..++||||+.+++|.+++... +..+++..+..++.|++.||+|||+.+ +
T Consensus 48 ~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i 123 (260)
T cd05067 48 FLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---Y 123 (260)
T ss_pred HHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 678999999999999999999874 56789999999999999988653 456899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus 124 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~ 202 (260)
T cd05067 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202 (260)
T ss_pred ecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999976543221 11222345678999999988889999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ .... .. ..... .+...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus 203 p~~~~~~~~~---~~~~----~~------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 203 PYPGMTNPEV---IQNL----ER------GYRMP----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCChHHH---HHHH----Hc------CCCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9975432111 1100 00 00011 111234689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=273.76 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=160.5
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+..|.+++..+. |++|+++++++.+.+..|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ +
T Consensus 47 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---i 122 (323)
T cd05615 47 TMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---I 122 (323)
T ss_pred HHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 457888888885 577889999999999999999999999999988554 36999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 123 vHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (323)
T cd05615 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200 (323)
T ss_pred eccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCC
Confidence 9999999999999999999999999875432211 22345689999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
|........ ..... .. .. .++...+.++.+++.+||+.+|.+|++.
T Consensus 201 f~~~~~~~~---~~~i~---~~--------~~----~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 201 FDGEDEDEL---FQSIM---EH--------NV----SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCHHHH---HHHHH---hC--------CC----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 976432111 11000 00 00 1112234678999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.12 Aligned_cols=208 Identities=24% Similarity=0.362 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++...+..++|+||+++++|.+++... .+++.++..++.|++.||.|||+.+ ++
T Consensus 63 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~ 137 (296)
T cd06655 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VI 137 (296)
T ss_pred HHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 578999999999999999999999999999999999999999988543 5899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus 138 H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf 215 (296)
T cd06655 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (296)
T ss_pred cCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876543221 122346788999999998888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
........... .. .... +.. ..+...+..+.++|.+||..||.+|||+.+++++-
T Consensus 216 ~~~~~~~~~~~---~~---~~~~-------~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 216 LNENPLRALYL---IA---TNGT-------PEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CCCCHHHHHHH---HH---hcCC-------ccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 76433211100 00 0000 000 01122346788999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.80 Aligned_cols=210 Identities=24% Similarity=0.374 Sum_probs=166.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l--~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++++.++|+||+++++++..++..++|+||+++++|.+++......+ ++..+..++.||+.||.|||+.+
T Consensus 52 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 128 (268)
T cd06624 52 LHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--- 128 (268)
T ss_pred HHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---
Confidence 6789999999999999999999999999999999999999999997654445 88889999999999999999988
Q ss_pred eEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC--CCCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+||+++. ++.++|+|||++........ ......|+..|+|||++... .++.++||||||+++|+|++
T Consensus 129 i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~ 206 (268)
T cd06624 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206 (268)
T ss_pred EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh
Confidence 999999999999976 67999999999876533221 12234578899999998654 47899999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||........ ..+..... . ..+ .++...+.++.+++.+||+.+|.+|||+.+++++.
T Consensus 207 g~~p~~~~~~~~~---~~~~~~~~-------~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 207 GKPPFIELGEPQA---AMFKVGMF-------K-IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred CCCCCccccChhh---hHhhhhhh-------c-cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 9999865322111 00000000 0 011 12223456889999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.93 Aligned_cols=223 Identities=26% Similarity=0.318 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++......++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++
T Consensus 47 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~ 122 (286)
T cd07847 47 ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN---CI 122 (286)
T ss_pred HHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 56899999999999999999999999999999999998888776643 346899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 123 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p 200 (286)
T cd07847 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200 (286)
T ss_pred ecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987644322 1223457888999999875 4678999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhh-c------cccccc-cccCCccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHL-G------ERRRFY-RLIDPRLEGH-----FSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~-~------~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|......+....+....... . ....+. ....+..... .....+..+.+|+.+||+.+|++|||+.|+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 201 WPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 97654322111110000000 0 000000 0000000000 001235678999999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
+.+
T Consensus 281 l~~ 283 (286)
T cd07847 281 LEH 283 (286)
T ss_pred hcC
Confidence 975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.17 Aligned_cols=208 Identities=28% Similarity=0.380 Sum_probs=164.7
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+.+++++ +|+||+++++++... ...++||||+++++|.+++... ...+++..+..++.|++.||.|||
T Consensus 49 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH 128 (272)
T cd06637 49 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128 (272)
T ss_pred HHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 57899999998 799999999998763 4689999999999999998764 346899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFG 148 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG 148 (306)
+.+ ++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++. ...++.++||||||
T Consensus 129 ~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 203 (272)
T cd06637 129 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203 (272)
T ss_pred HCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence 988 99999999999999999999999999876433211 223456889999999986 34688899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|++|||++|..||......... .... .. ..... .....+..+.+|+.+||..||.+|||+.+++
T Consensus 204 v~l~el~~g~~p~~~~~~~~~~-----~~~~---~~-----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 204 ITAIEMAEGAPPLCDMHPMRAL-----FLIP---RN-----PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred HHHHHHHhCCCCccccCHHHHH-----HHHh---cC-----CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 9999999999999654321110 0000 00 00000 1112346789999999999999999999999
Q ss_pred HH
Q 021891 229 EA 230 (306)
Q Consensus 229 ~~ 230 (306)
++
T Consensus 268 ~~ 269 (272)
T cd06637 268 KH 269 (272)
T ss_pred hC
Confidence 85
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=264.17 Aligned_cols=214 Identities=27% Similarity=0.463 Sum_probs=169.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++|+||+++++++...+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 55 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~ 130 (272)
T cd06629 55 LRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---IL 130 (272)
T ss_pred HHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---ee
Confidence 567999999999999999999999999999999999999999998665 47899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC--CCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~ 159 (306)
|+||+|+||+++.++.++|+|||++................|+..|+|||.+.... ++.++|+||||+++|+|++|..
T Consensus 131 H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 210 (272)
T cd06629 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210 (272)
T ss_pred ecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999997654322222223356788999999987654 7899999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||....... .... .... ..............+..+.+++.+||..+|++|||+.+++++.
T Consensus 211 p~~~~~~~~-----~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 211 PWSDEEAIA-----AMFK--LGNK-----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred CCcCcchHH-----HHHH--hhcc-----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 986432211 0000 0000 0011111112223457899999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=262.07 Aligned_cols=210 Identities=26% Similarity=0.400 Sum_probs=168.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++++.++|+||+++++++.+ ...++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ +
T Consensus 48 ~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i 123 (260)
T cd05073 48 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 123 (260)
T ss_pred HHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 6789999999999999999999887 7789999999999999999653 446788999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+|+||||+||+++.++.+||+|||++........ .......++..|+|||++....++.++|+|||||++|+|++ |..
T Consensus 124 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~ 202 (260)
T cd05073 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 202 (260)
T ss_pred cccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999976543221 12222345677999999988889999999999999999999 899
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ ..... .. .... .....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 203 p~~~~~~~~~---~~~~~----~~------~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 203 PYPGMSNPEV---IRALE----RG------YRMP----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCHHHH---HHHHh----CC------CCCC----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9875432111 11100 00 0000 111234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=275.45 Aligned_cols=219 Identities=22% Similarity=0.304 Sum_probs=161.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|++++|+||+++++++... ...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.
T Consensus 61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~ 137 (343)
T cd07878 61 TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA 137 (343)
T ss_pred HHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 56899999999999999999987643 3568999998 7799887743 3599999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ |+||||||+||+++.++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 138 ~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 138 G---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred C---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence 8 999999999999999999999999999865432 223468999999999876 5789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhh--------hhh--ccccccccccCCccC---CCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWAR--------PHL--GERRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+.... ... .....+...+..... .......+..+.+|+.+||+.||++|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 99999997643211110000000 000 000000000000000 00000123467899999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
||+.|+++|-
T Consensus 290 ~s~~ell~hp 299 (343)
T cd07878 290 ISASEALAHP 299 (343)
T ss_pred CCHHHHhcCc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.74 Aligned_cols=211 Identities=25% Similarity=0.409 Sum_probs=168.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
|.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||
T Consensus 55 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred HHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 7889999999999999999999999899999999999999999986543 15899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
+.+ ++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+
T Consensus 135 ~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 210 (275)
T cd05046 135 NAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210 (275)
T ss_pred hcC---cccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHH
Confidence 988 99999999999999999999999999875432211 11223345677999999988888999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 154 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 154 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|++ |..||....... ...... . .... .......+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 211 l~~~~~~p~~~~~~~~---~~~~~~----~-~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 211 VFTQGELPFYGLSDEE---VLNRLQ----A-GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHhCCCCCccccchHH---HHHHHH----c-CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 999 778886433211 111100 0 0000 0011123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=264.66 Aligned_cols=211 Identities=30% Similarity=0.427 Sum_probs=170.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~i 80 (306)
+.+|++++++++||||+++++++...+..++|+||+++++|.+++......+++..+..++.|++.||.|||+ .+ +
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i 122 (265)
T cd06605 46 ILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---I 122 (265)
T ss_pred HHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---e
Confidence 6789999999999999999999999999999999999999999997665689999999999999999999999 88 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 123 ~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 198 (265)
T cd06605 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198 (265)
T ss_pred ecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876432211 125678899999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|......... .......... ...+... ....+..+.++|.+||..||++|||+.+++.+
T Consensus 199 ~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 199 YPPENDPPDG-IFELLQYIVN-------EPPPRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCcccccccc-HHHHHHHHhc-------CCCCCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 9754321111 1111111000 0001111 11145779999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.14 Aligned_cols=209 Identities=26% Similarity=0.419 Sum_probs=167.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhc-CCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHE-EAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~ 78 (306)
|.+|++++++++|+||+++++.+...+..++||||+++++|..++... ...+++..+..++.|++.||.|||+ .+
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-- 123 (286)
T cd06622 46 IIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123 (286)
T ss_pred HHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--
Confidence 678999999999999999999999999999999999999999988653 2368999999999999999999996 46
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC------CCCchhHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLL 152 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ 152 (306)
++|+||||+||+++.++.+||+|||++....... .....++..|+|||.+.+. .++.++|||||||++|
T Consensus 124 -i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred -EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 9999999999999999999999999987653221 2234578899999998643 3588999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++|..||............. .... ......+...+.++.+||.+||+.+|++||++.+++++.
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~-------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLS-------------AIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHH-------------HHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 9999999996543211111100 0000 001112233567889999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=266.63 Aligned_cols=207 Identities=23% Similarity=0.342 Sum_probs=168.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++
T Consensus 63 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~---i~ 137 (297)
T cd06656 63 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ---VI 137 (297)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 568999999999999999999999999999999999999999998543 5789999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus 138 H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf 215 (297)
T cd06656 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (297)
T ss_pred cCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876543221 122346788999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
............. ... .+. ...+...+..+.+|+.+||+.+|++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~------~~~-------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 216 LNENPLRALYLIA------TNG-------TPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCcchheeeec------cCC-------CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 7643322111000 000 000 00122335678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=274.34 Aligned_cols=211 Identities=25% Similarity=0.403 Sum_probs=179.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|..|+-+|++++|||||+++|+|.+. ..|||||+++-|.|..++..+...++......++.||..||.|||+.. +|
T Consensus 438 flqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fV 513 (974)
T KOG4257|consen 438 FLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FV 513 (974)
T ss_pred HHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hh
Confidence 78999999999999999999999754 689999999999999999998888999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||...|||+.....+||+|||+++...+....... ...-...|||||-+....++.++|||.||+++||++. |..|
T Consensus 514 HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkP 592 (974)
T KOG4257|consen 514 HRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKP 592 (974)
T ss_pred hhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999998776544333 2233567999999999999999999999999999865 8899
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|.+....+..-.++ ++. .-..+..++..++.|+.+||.++|.+||.+.+|...|..+
T Consensus 593 fqgvkNsDVI~~iE-------nGe----------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 593 FQGVKNSDVIGHIE-------NGE----------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred cccccccceEEEec-------CCC----------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 98876554432221 111 1123445678999999999999999999999999887543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=272.65 Aligned_cols=213 Identities=20% Similarity=0.254 Sum_probs=167.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.++..++|+||+++++++.+++..|+||||+++|+|.+++.+....+++..+..++.|++.||.|||+.+ |+
T Consensus 48 ~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---ii 124 (331)
T cd05624 48 FREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YV 124 (331)
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678899999999999999999999999999999999999999999775567999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----CCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ellt 156 (306)
||||||+||+++.++.+||+|||++........ .......||..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 125 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 203 (331)
T cd05624 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred eccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh
Confidence 999999999999999999999999976543322 12233568999999999875 467899999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l 231 (306)
|+.||........ .. .......+ . ..... ....+..+.+++.+||..++.+ |++++++++|.
T Consensus 204 g~~Pf~~~~~~~~---~~---~i~~~~~~---~---~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 204 GETPFYAESLVET---YG---KIMNHEER---F---QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CCCCccCCCHHHH---HH---HHHcCCCc---c---cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 9999975432111 00 00000000 0 00000 1123568899999999876554 46888888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=267.47 Aligned_cols=225 Identities=22% Similarity=0.299 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|+++++.++|+||+++++++.+.+..+++|||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |
T Consensus 46 ~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i 122 (314)
T cd08216 46 LQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---F 122 (314)
T ss_pred HHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 678999999999999999999999999999999999999999998754 446899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhc--CCCCchhHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e 153 (306)
+||||||+||+++.++.+||+|||.+......... .......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 123 vH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~e 202 (314)
T cd08216 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACE 202 (314)
T ss_pred ecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHH
Confidence 99999999999999999999999988754322111 11123456778999999875 458899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhhhhc---cc-------ccccc----ccC----CccCCCCCHHHHHHHHHHHHHccc
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARPHLG---ER-------RRFYR----LID----PRLEGHFSIKGAQKAAQLAAHCLS 215 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~----~~~----~~~~~~~~~~~~~~~~~li~~~l~ 215 (306)
|++|..||........ .......... .. ..... ... ...........+.++.+|+.+||+
T Consensus 203 l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 280 (314)
T cd08216 203 LANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280 (314)
T ss_pred HHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhh
Confidence 9999999976432211 0000000000 00 00000 000 001111233456789999999999
Q ss_pred CCCCCCCCHHHHHHHh
Q 021891 216 RDPKARPLMSEVVEAL 231 (306)
Q Consensus 216 ~~p~~Rps~~ell~~l 231 (306)
.||++|||+.+++++.
T Consensus 281 ~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 281 RDPESRPSASQLLNHS 296 (314)
T ss_pred cCCCcCcCHHHHhcCc
Confidence 9999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.60 Aligned_cols=222 Identities=24% Similarity=0.318 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++......++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 121 (286)
T cd07832 46 ALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121 (286)
T ss_pred HHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999 99999998766677999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.++|+|||++........ .......|+..|+|||++.+. .++.++|||||||++|+|++|.++
T Consensus 122 H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~ 200 (286)
T cd07832 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL 200 (286)
T ss_pred cCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcC
Confidence 999999999999999999999999987644321 112234678899999998654 468999999999999999999888
Q ss_pred CCCCCCCCCcchHHhhhhhhccc-----c------ccccccCCcc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGER-----R------RFYRLIDPRL----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~-----~------~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
|........ ........... . .......+.. ........+..+.+++.+||+.||++|||++
T Consensus 201 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 277 (286)
T cd07832 201 FPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA 277 (286)
T ss_pred cCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHH
Confidence 865432111 11111000000 0 0000000000 0001112347899999999999999999999
Q ss_pred HHHHHh
Q 021891 226 EVVEAL 231 (306)
Q Consensus 226 ell~~l 231 (306)
++++|.
T Consensus 278 ~~l~h~ 283 (286)
T cd07832 278 EALRHP 283 (286)
T ss_pred HHhhCc
Confidence 999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=261.89 Aligned_cols=209 Identities=24% Similarity=0.358 Sum_probs=164.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++||||+++++++.+. +..++++||+++++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 51 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--- 126 (266)
T cd06651 51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM--- 126 (266)
T ss_pred HHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57899999999999999999988763 57889999999999999986544 5899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 127 i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~ 206 (266)
T cd06651 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206 (266)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCC
Confidence 999999999999999999999999998764321111 1112345788999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||....... .+ ..... .... ..++...+..+.+++ +||..+|++||+++||++|-
T Consensus 207 ~pf~~~~~~~---~~---~~~~~------~~~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 207 PPWAEYEAMA---AI---FKIAT------QPTN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred CCccccchHH---HH---HHHhc------CCCC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 9997542211 00 00000 0001 122233456677888 68889999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=265.81 Aligned_cols=221 Identities=24% Similarity=0.330 Sum_probs=164.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++.+++..++||||+.+ +|.+++.+....+++..++.++.|+++||.|||+.+ ++
T Consensus 50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~ 125 (291)
T cd07844 50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VL 125 (291)
T ss_pred HHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 46799999999999999999999999999999999974 999988776667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++........ .....++..|+|||++.+ ..++.++||||+|+++|+|++|..|
T Consensus 126 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred cccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998754322111 122346788999999875 4589999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcc--cc------c---cc----cccC-CccCCCC-CHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGE--RR------R---FY----RLID-PRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~--~~------~---~~----~~~~-~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
|........ ........... .. . .. .... ....... .......+.+++.+||+.+|++|||
T Consensus 204 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps 281 (291)
T cd07844 204 FPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281 (291)
T ss_pred CCCCccHHH--HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC
Confidence 965431110 00000000000 00 0 00 0000 0000000 0001267889999999999999999
Q ss_pred HHHHHHH
Q 021891 224 MSEVVEA 230 (306)
Q Consensus 224 ~~ell~~ 230 (306)
+.+++++
T Consensus 282 ~~e~l~~ 288 (291)
T cd07844 282 AAEAMKH 288 (291)
T ss_pred HHHHhcC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=278.85 Aligned_cols=213 Identities=23% Similarity=0.372 Sum_probs=174.5
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
||..|+.+|+.++|||+|+++|+|..+..+|||+|||..|+|.++|.+.++ .++.-....++-||..|++||..++
T Consensus 309 EFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--- 385 (1157)
T KOG4278|consen 309 EFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--- 385 (1157)
T ss_pred HHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---
Confidence 699999999999999999999999999999999999999999999987643 4666777899999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
+|||||...|+|+.++..+|++|||+++.+.... ........-...|.|||-+....++.|+|||+||++|||+.| |.
T Consensus 386 FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGM 464 (1157)
T KOG4278|consen 386 FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGM 464 (1157)
T ss_pred hhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999875532 222211122457999999999999999999999999999988 77
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||.+...... +.++.....-+-+..++..+++|++.||+++|.+||++.|+-+.++.+
T Consensus 465 sPYPGidlSqV-----------------Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 465 SPYPGIDLSQV-----------------YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred CCCCCccHHHH-----------------HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 88876432111 112222222222345678999999999999999999999999877643
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.11 Aligned_cols=224 Identities=26% Similarity=0.341 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++..++..++||||++++.+..+. .....+++..++.++.||+.||.|||..+ ++
T Consensus 47 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~ 122 (288)
T cd07833 47 ALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---II 122 (288)
T ss_pred HHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999886666554 44456899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||+|+||+++.++.+||+|||++......... ......++..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus 123 H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 201 (288)
T cd07833 123 HRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201 (288)
T ss_pred cCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543321 12335678899999999887 889999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhh--------ccccccc--cccCCc----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHL--------GERRRFY--RLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
|......+............ .....+. +..+.. ....++...+.++.+||.+||..+|++|||+++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 281 (288)
T cd07833 202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281 (288)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence 97543221111100000000 0000000 000000 000112223678999999999999999999999
Q ss_pred HHHH
Q 021891 227 VVEA 230 (306)
Q Consensus 227 ll~~ 230 (306)
++++
T Consensus 282 il~~ 285 (288)
T cd07833 282 LLQH 285 (288)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=259.72 Aligned_cols=206 Identities=30% Similarity=0.453 Sum_probs=165.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+.+++.++||||+++++++..+ ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+ +
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~ 121 (254)
T cd05083 46 FLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---L 121 (254)
T ss_pred HHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 67899999999999999999998654 5799999999999999997553 35899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+||+++.++.+||+|||++....... .....+..|+|||.+.+..++.++|+|||||++|+|++ |..
T Consensus 122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 196 (254)
T cd05083 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196 (254)
T ss_pred eccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987643211 11233567999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ ... ..... . .. .....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 197 p~~~~~~~~~---~~~----~~~~~---~---~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 197 PYPKMSLKEV---KEC----VEKGY---R---ME----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCccCCHHHH---HHH----HhCCC---C---CC----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9875432211 110 00000 0 00 111235688899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=264.17 Aligned_cols=212 Identities=30% Similarity=0.473 Sum_probs=168.4
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|+.++++++|+||+++++++.+.+..++||||+.+++|.+++. ....+++..++.++.|++.||.+||+.+ ++|
T Consensus 46 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H 121 (260)
T PF00069_consen 46 IREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVH 121 (260)
T ss_dssp HHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred hhhhhcccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccc---ccc
Confidence 358999999999999999999999999999999999999999997 3346899999999999999999999998 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
+||||+||+++.++.++|+|||.+..... .........++..|+|||++. +..++.++||||||+++|+|++|..||
T Consensus 122 ~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~ 199 (260)
T PF00069_consen 122 RDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPF 199 (260)
T ss_dssp SSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSS
T ss_pred ccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999976411 122334467899999999998 788999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
................. . ........ .......+.+++.+||+.||++|||+.+++++.
T Consensus 200 ~~~~~~~~~~~~~~~~~---~--~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 200 EESNSDDQLEIIEKILK---R--PLPSSSQQ------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp TTSSHHHHHHHHHHHHH---T--HHHHHTTS------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred ccccchhhhhhhhhccc---c--cccccccc------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 86511111111110000 0 00000000 000127899999999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=265.75 Aligned_cols=202 Identities=29% Similarity=0.400 Sum_probs=167.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~ 123 (290)
T cd05580 48 VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IV 123 (290)
T ss_pred HHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 568999999999999999999999999999999999999999998655 47899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.+||+|||++...... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 124 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 198 (290)
T cd05580 124 YRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198 (290)
T ss_pred cCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999875443 23346889999999998888899999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~ 230 (306)
....... .... .... ... ++...+..+.+++.+||+.||.+|+ +++|++++
T Consensus 199 ~~~~~~~---~~~~---~~~~--------~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 199 FDDNPIQ---IYEK---ILEG--------KVR----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCCCHHH---HHHH---HhcC--------Ccc----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 7543110 0000 0000 001 1112256889999999999999999 77777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.12 Aligned_cols=207 Identities=26% Similarity=0.392 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++|+||+++++.+...+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ ++
T Consensus 66 ~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---iv 140 (292)
T cd06658 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VI 140 (292)
T ss_pred HHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 67899999999999999999999999999999999999999998743 25899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||++|..||
T Consensus 141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 218 (292)
T cd06658 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218 (292)
T ss_pred ecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876433221 122346788999999998888999999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
........ ..... ....+.... ....+..+.+++.+||..||.+|||+++++++
T Consensus 219 ~~~~~~~~---~~~~~----------~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 219 FNEPPLQA---MRRIR----------DNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCCHHHH---HHHHH----------hcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 75432111 00000 011111111 11234678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.27 Aligned_cols=214 Identities=30% Similarity=0.429 Sum_probs=165.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeC-CeeEEEEEcCCCCCHHHHhhcCC-----------------------------
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRS----------------------------- 50 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------------------- 50 (306)
+.+|+++|.++ +|+||+++++++... ...++|||||++|+|.+++....
T Consensus 57 ~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (343)
T cd05103 57 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKR 136 (343)
T ss_pred HHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhh
Confidence 56899999999 689999999988654 46789999999999999885421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEc
Q 021891 51 -------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 93 (306)
Q Consensus 51 -------------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~ 93 (306)
..+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~ 213 (343)
T cd05103 137 RLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 213 (343)
T ss_pred hccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEc
Confidence 23677888999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 021891 94 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 172 (306)
Q Consensus 94 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 172 (306)
.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .
T Consensus 214 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~ 291 (343)
T cd05103 214 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F 291 (343)
T ss_pred CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H
Confidence 999999999999986533222111222345677999999988899999999999999999997 8888865422110 0
Q ss_pred HHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.. ....... ... +...+..+.+++..||+.||++|||+.+|+++|+.+
T Consensus 292 ~~----~~~~~~~------~~~----~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 292 CR----RLKEGTR------MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HH----HHhccCC------CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 0001000 000 111235789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=267.36 Aligned_cols=203 Identities=28% Similarity=0.377 Sum_probs=172.1
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.+|-+||++++.+.||.+--.|++.+.+|+|+..|+||+|.-+|.+.+ ..|++..+..++.+|+.||++||..+ ||
T Consensus 233 LnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iV 309 (591)
T KOG0986|consen 233 LNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IV 309 (591)
T ss_pred hHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---ee
Confidence 689999999999999999888999999999999999999999998764 46999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
+|||||+|||+|+.|+++|+|+|+|..+..+.. ....+||.+|||||++..+.|+...|.|||||++|||+.|..||
T Consensus 310 YRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF 386 (591)
T KOG0986|consen 310 YRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF 386 (591)
T ss_pred eccCChhheeeccCCCeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence 999999999999999999999999998876543 33448999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
..........-++... . ....+++...++++.+|.+.+|++||.+|...+
T Consensus 387 r~~KeKvk~eEvdrr~------------~--~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 387 RQRKEKVKREEVDRRT------------L--EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhhhhhhhHHHHHHHH------------h--cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 7654433221111110 0 111234556678999999999999999997544
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=260.67 Aligned_cols=213 Identities=28% Similarity=0.408 Sum_probs=171.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|+++++.++|+||+++++.+...+..++|||++++++|.+++... ...+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--- 122 (267)
T cd06610 46 LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--- 122 (267)
T ss_pred HHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 678999999999999999999999999999999999999999999654 246899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt 156 (306)
++|+||+|+||++++++.++|+|||++.......... ......|+..|+|||++... .++.++|+|||||++++|++
T Consensus 123 i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~ 202 (267)
T cd06610 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202 (267)
T ss_pred eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh
Confidence 9999999999999999999999999987755433221 22345688999999998866 78999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|..||........ ....... . .+..... .....+..+.+++.+||+.||++|||+.+|++|
T Consensus 203 g~~p~~~~~~~~~--~~~~~~~---~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 203 GAAPYSKYPPMKV--LMLTLQN---D--------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCCccccChhhh--HHHHhcC---C--------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9999975433211 1111000 0 0001000 012345788999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=260.81 Aligned_cols=208 Identities=25% Similarity=0.333 Sum_probs=169.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++||||+++++++.+++..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++
T Consensus 40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~ 115 (262)
T cd05572 40 IFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---II 115 (262)
T ss_pred HHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cc
Confidence 678999999999999999999999999999999999999999998654 35899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||
T Consensus 116 h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 192 (262)
T cd05572 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192 (262)
T ss_pred cCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCc
Confidence 99999999999999999999999998764432 122346788999999998888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~ 230 (306)
....... .... .... .......++...+..+.++|.+||+.+|++||+ +.|++++
T Consensus 193 ~~~~~~~-~~~~---~~~~----------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 193 GEDDEDP-MEIY---NDIL----------KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCCCH-HHHH---HHHh----------ccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 7654311 1111 0000 000001112222578999999999999999999 7787774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=267.18 Aligned_cols=210 Identities=27% Similarity=0.307 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.++|+||+++++++...+..++||||+.+++|.+++.+. ...+++..+..++.|++.||.|||+.+ +
T Consensus 48 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i 124 (316)
T cd05574 48 VLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---I 124 (316)
T ss_pred HHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578999999999999999999999999999999999999999998654 356899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc---------------------------eeeecccccccccCCcch
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEYV 133 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~ 133 (306)
+|+||||+||+++.++.++|+|||++......... .......|+..|+|||++
T Consensus 125 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 204 (316)
T cd05574 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI 204 (316)
T ss_pred eccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH
Confidence 99999999999999999999999998754322110 011234678899999999
Q ss_pred hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHc
Q 021891 134 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 213 (306)
Q Consensus 134 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 213 (306)
.+..++.++||||||+++|+|++|..||........... ...... ... .....+..+.+++.+|
T Consensus 205 ~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~------~~~~~~--------~~~--~~~~~~~~~~~li~~~ 268 (316)
T cd05574 205 SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN------ILKKEV--------TFP--GSPPVSSSARDLIRKL 268 (316)
T ss_pred cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHH------HhcCCc--------cCC--CccccCHHHHHHHHHH
Confidence 988899999999999999999999999975432211000 000000 000 0111467899999999
Q ss_pred ccCCCCCCCC----HHHHHHH
Q 021891 214 LSRDPKARPL----MSEVVEA 230 (306)
Q Consensus 214 l~~~p~~Rps----~~ell~~ 230 (306)
|+.||++||| +.+++++
T Consensus 269 l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 269 LVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ccCCHhHCCCchhhHHHHHcC
Confidence 9999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=267.74 Aligned_cols=208 Identities=24% Similarity=0.381 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++
T Consensus 65 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iv 139 (297)
T cd06659 65 LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VI 139 (297)
T ss_pred HHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 56899999999999999999999999999999999999999997744 35899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 140 H~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred cCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999875433211 123356889999999998888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
........ ..... .. ..+.. ......+..+.+++.+||+.+|++||++.+++++-
T Consensus 218 ~~~~~~~~---~~~~~----~~------~~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 218 FSDSPVQA---MKRLR----DS------PPPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCCCHHHH---HHHHh----cc------CCCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 75432111 11000 00 00000 00112246788999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=289.90 Aligned_cols=214 Identities=21% Similarity=0.317 Sum_probs=166.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
|.+|++++++++||||+++++++.+++..++||||++|++|.+++... ...+++..+..++.||+.||+|
T Consensus 49 flrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~y 128 (932)
T PRK13184 49 FLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128 (932)
T ss_pred HHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999999999999999999999999988531 1235667788999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc----------------ceeeecccccccccCCcchhc
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVMT 135 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~ 135 (306)
||+.+ |+||||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+
T Consensus 129 LHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g 205 (932)
T PRK13184 129 VHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205 (932)
T ss_pred HHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence 99988 99999999999999999999999999986521100 011123568999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHccc
Q 021891 136 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 215 (306)
Q Consensus 136 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 215 (306)
..++.++|||||||++|||+||..||......... .. . ...++.... .....+..+.+++.+||+
T Consensus 206 ~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~----~~-~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~ 270 (932)
T PRK13184 206 VPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS----YR-D---------VILSPIEVA-PYREIPPFLSQIAMKALA 270 (932)
T ss_pred CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh----hh-h---------hccChhhcc-ccccCCHHHHHHHHHHcc
Confidence 99999999999999999999999999763321110 00 0 000000000 011234678899999999
Q ss_pred CCCCCCC-CHHHHHHHhCC
Q 021891 216 RDPKARP-LMSEVVEALKP 233 (306)
Q Consensus 216 ~~p~~Rp-s~~ell~~l~~ 233 (306)
.||++|+ +++++++.|+.
T Consensus 271 ~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 271 VDPAERYSSVQELKQDLEP 289 (932)
T ss_pred CChhhCcCHHHHHHHHHHH
Confidence 9999997 56667666543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=264.97 Aligned_cols=223 Identities=25% Similarity=0.343 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++||||+++++++... +..++||||+. ++|.+++......+++..++.++.||+.||.|||+.+
T Consensus 51 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 126 (293)
T cd07843 51 SLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--- 126 (293)
T ss_pred HHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46799999999999999999999887 88999999997 4999988766657999999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus 127 i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987544321 11234568889999988754 4689999999999999999999
Q ss_pred CCCCCCCCCCCcchHH----------hhhh-hhc--cccccccccCCccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCH
Q 021891 159 RSMDKNRPNGEHNLVE----------WARP-HLG--ERRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~----------~~~~-~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
.||...........+. |... ... ....+.......+...++.. .++.+.++|.+||+.||++|||+
T Consensus 205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~ 284 (293)
T cd07843 205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284 (293)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence 9997654322111100 0000 000 00000000011111112211 35678999999999999999999
Q ss_pred HHHHHH
Q 021891 225 SEVVEA 230 (306)
Q Consensus 225 ~ell~~ 230 (306)
.|++++
T Consensus 285 ~ell~~ 290 (293)
T cd07843 285 EDALKH 290 (293)
T ss_pred HHHhcC
Confidence 999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=263.82 Aligned_cols=210 Identities=28% Similarity=0.373 Sum_probs=163.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEE-----eCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|+.+++.+ +|+||+++++++. .++..++||||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 61 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 140 (286)
T cd06638 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140 (286)
T ss_pred HHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH
Confidence 57899999999 7999999999874 34578999999999999998753 334689999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----CCCCchhHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSF 147 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Diwsl 147 (306)
|+.+ ++||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.. ..++.++|||||
T Consensus 141 H~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 215 (286)
T cd06638 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215 (286)
T ss_pred HhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhH
Confidence 9988 99999999999999999999999999876543211 1223468899999998753 457889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 148 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 148 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
||++|+|++|+.||......... .. ... ........+ ...+..+.+||.+||+.||++|||+.|+
T Consensus 216 Gvi~~el~~g~~p~~~~~~~~~~--~~-----~~~-~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~el 280 (286)
T cd06638 216 GITAIELGDGDPPLADLHPMRAL--FK-----IPR-NPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDL 280 (286)
T ss_pred HHHHHHHhcCCCCCCCCchhHHH--hh-----ccc-cCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence 99999999999998754322110 00 000 000001111 1124578999999999999999999999
Q ss_pred HHHh
Q 021891 228 VEAL 231 (306)
Q Consensus 228 l~~l 231 (306)
++++
T Consensus 281 l~~~ 284 (286)
T cd06638 281 LQHV 284 (286)
T ss_pred hhcc
Confidence 9875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.92 Aligned_cols=216 Identities=26% Similarity=0.344 Sum_probs=168.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|.+|++++++++||||+++++++.+. +.+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ 125 (287)
T cd06621 46 ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125 (287)
T ss_pred HHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 67899999999999999999988654 468999999999999887643 3456899999999999999999999988
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 126 ---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 126 ---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred ---cccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999987643221 123457888999999988899999999999999999999
Q ss_pred CCCCCCCCCCC--CCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 157 GRRSMDKNRPN--GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 157 g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|..||...... .......+... . .. .. +..... .....+..+.+++.+||+.+|.+|||+.|++++-.
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~---~-~~-~~-~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 199 NRFPFPPEGEPPLGPIELLSYIVN---M-PN-PE-LKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCCCCCcccCCCCChHHHHHHHhc---C-Cc-hh-hccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 99999765331 11111111111 0 00 00 000000 01123578899999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=262.00 Aligned_cols=209 Identities=28% Similarity=0.383 Sum_probs=167.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|++++||||+++++++...+..|+||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ +
T Consensus 40 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i 116 (277)
T cd05577 40 ALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116 (277)
T ss_pred HHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 4679999999999999999999999999999999999999999986643 36899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 117 ~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 193 (277)
T cd05577 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193 (277)
T ss_pred ccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCC
Confidence 999999999999999999999999987654321 12234567889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~ 230 (306)
|...........+. ..... .....+...+..+.++|.+||+.||.+|| ++.++++|
T Consensus 194 ~~~~~~~~~~~~~~--~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 194 FRQRKEKVEKEELK--RRTLE------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCCCcccccHHHHH--hcccc------------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 97654321111110 00000 00111222357889999999999999999 55556653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=259.59 Aligned_cols=207 Identities=25% Similarity=0.338 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhh---
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH--- 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH--- 73 (306)
+.+|++++++++|+||+++++++.. ....+++|||+++++|.+++... ...+++..++.++.|++.||.|||
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 125 (265)
T cd08217 46 LVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125 (265)
T ss_pred HHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCc
Confidence 5679999999999999999998764 34678999999999999998653 457899999999999999999999
Q ss_pred --cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 74 --EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 74 --~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
+.+ ++|+||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++|+||||+++
T Consensus 126 ~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il 200 (265)
T cd08217 126 DPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200 (265)
T ss_pred cccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHH
Confidence 666 99999999999999999999999999987654322 12234688999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
++|++|..||...... ....... . .....++...+..+.+++.+||+.+|++||++.+|+++
T Consensus 201 ~~l~~g~~p~~~~~~~---~~~~~~~----~----------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 201 YELCALSPPFTARNQL---QLASKIK----E----------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHCCCcccCcCHH---HHHHHHh----c----------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999764311 1111100 0 00111222345789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=262.80 Aligned_cols=223 Identities=24% Similarity=0.313 Sum_probs=167.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++.+.+..++||||+ +++|.+++......+++..++.++.||++||.|||+.+ ++
T Consensus 49 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 124 (298)
T cd07841 49 ALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---IL 124 (298)
T ss_pred HHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 457999999999999999999999999999999999 88999999665547999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|.++
T Consensus 125 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~ 202 (298)
T cd07841 125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPF 202 (298)
T ss_pred ecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcc
Confidence 999999999999999999999999987544321 1222346778999998864 4678999999999999999999888
Q ss_pred CCCCCCCCCcchHHhhh--h---hhccccccccccC-----CccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWAR--P---HLGERRRFYRLID-----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|................ . .+........... +..........+..+.++|.+||+.||++|||+.|++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 203 LPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 76543321110000000 0 0000000000000 000000112235788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=258.77 Aligned_cols=206 Identities=27% Similarity=0.371 Sum_probs=167.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|++|+++|+.++||||+++++.+..++..++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ +
T Consensus 46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i 122 (256)
T cd08220 46 AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---I 122 (256)
T ss_pred HHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 678999999999999999999999999999999999999999999764 345899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
+|+||+|+||+++.+ +.+||+|||.+........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 199 (256)
T cd08220 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCC
Confidence 999999999999865 4689999999987543321 223467889999999988888999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
||........ ...... .. ... .+...+..+.+++.+||+.+|++|||+.|++++
T Consensus 200 ~~~~~~~~~~---~~~~~~-----~~-----~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 200 AFEAANLPAL---VLKIMS-----GT-----FAP----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CcccCchHHH---HHHHHh-----cC-----CCC----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 9865432211 110000 00 000 111235688999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=263.84 Aligned_cols=207 Identities=27% Similarity=0.403 Sum_probs=168.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++|+||+++++++...+..++|+||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++
T Consensus 63 ~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~ 137 (285)
T cd06648 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VI 137 (285)
T ss_pred HHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 56899999999999999999999999999999999999999999866 46899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 138 H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~ 215 (285)
T cd06648 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215 (285)
T ss_pred cCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998875433211 122346889999999998888999999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
........ ..... ....+... .....+..+.+++.+||+.+|++|||+.+++++
T Consensus 216 ~~~~~~~~---~~~~~----------~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 216 FNEPPLQA---MKRIR----------DNLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCCHHHH---HHHHH----------hcCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 65432111 11000 00001110 011234689999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=260.25 Aligned_cols=207 Identities=23% Similarity=0.359 Sum_probs=169.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++|+||+++++++...+..++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ +
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (256)
T cd08218 46 SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---I 122 (256)
T ss_pred HHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 678999999999999999999999999999999999999999988654 346899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+|||||++++|++|..|
T Consensus 123 ~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08218 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999976543221 12234578889999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|....... ........ . .+ ..+...+.++.++|.+||+.+|++||++.+++++
T Consensus 201 ~~~~~~~~------~~~~~~~~------~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 201 FEAGNMKN------LVLKIIRG------S-YP----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCCHHH------HHHHHhcC------C-CC----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 86532211 11000000 0 00 1122335688999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=266.21 Aligned_cols=210 Identities=23% Similarity=0.283 Sum_probs=164.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++.+..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++
T Consensus 48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 123 (305)
T cd05609 48 VFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IV 123 (305)
T ss_pred HHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 568999999999999999999999999999999999999999999655 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCc-------------ceeeecccccccccCCcchhcCCCCchhHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 148 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 148 (306)
||||||+||+++.++.+||+|||+++....... ........|+..|+|||.+.+..++.++||||||
T Consensus 124 H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 203 (305)
T cd05609 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 203 (305)
T ss_pred ccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHH
Confidence 999999999999999999999999864211100 0011124578889999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH---H
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---S 225 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~ 225 (306)
|++|||++|..||.+..... .. ...... ....+... ...+..+.++|.+||+.||++||++ .
T Consensus 204 ~vl~el~~g~~pf~~~~~~~---~~---~~~~~~-----~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 268 (305)
T cd05609 204 IILYEFLVGCVPFFGDTPEE---LF---GQVISD-----DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAF 268 (305)
T ss_pred HHHHHHHhCCCCCCCCCHHH---HH---HHHHhc-----ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHH
Confidence 99999999999997543211 11 000000 00001110 1235678999999999999999985 5
Q ss_pred HHHHH
Q 021891 226 EVVEA 230 (306)
Q Consensus 226 ell~~ 230 (306)
+++++
T Consensus 269 ~ll~~ 273 (305)
T cd05609 269 EVKQH 273 (305)
T ss_pred HHHhC
Confidence 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=288.30 Aligned_cols=215 Identities=25% Similarity=0.407 Sum_probs=180.7
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|+.|+.||.+++||||+++.|+....+..+||+|||+.|+|+.+|+++...|...+...+++.|+.|+.||-+.+ +
T Consensus 676 dFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---Y 752 (996)
T KOG0196|consen 676 DFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---Y 752 (996)
T ss_pred hhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---c
Confidence 5899999999999999999999999999999999999999999999999888999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
|||||.+.|||++.+-.+|++|||+++.+.+.... .......-..+|.|||.+...+++.++||||+|+++||.++ |.
T Consensus 753 VHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 753 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred hhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 99999999999999999999999999987554322 11122222568999999999999999999999999999766 88
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
.||-.....+. +..+. .-+++. -+.+++..|.+|+..||++|..+||.+.+|+..|.++.
T Consensus 833 RPYWdmSNQdV---IkaIe-------~gyRLP-------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 833 RPYWDMSNQDV---IKAIE-------QGYRLP-------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred CcccccchHHH---HHHHH-------hccCCC-------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 89876544322 22111 111222 23456789999999999999999999999999987654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=258.71 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=165.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++|+||+++++++.+. ..+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+
T Consensus 51 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--- 126 (265)
T cd06652 51 LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--- 126 (265)
T ss_pred HHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57799999999999999999998764 4678999999999999998654 35889999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.++|+|||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 127 i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 206 (265)
T cd06652 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206 (265)
T ss_pred EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCC
Confidence 999999999999999999999999998764321111 1122345788999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||....... ..... .........+...+..+.+++.+||. +|++||++++++++.
T Consensus 207 ~p~~~~~~~~-----~~~~~-----------~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 207 PPWAEFEAMA-----AIFKI-----------ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred CCCCccchHH-----HHHHH-----------hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 9996432111 00000 00001112334456788899999994 999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=258.32 Aligned_cols=206 Identities=28% Similarity=0.440 Sum_probs=168.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++|+||+++++++...+..++|+||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++
T Consensus 49 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 124 (258)
T cd06632 49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRN---TV 124 (258)
T ss_pred HHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 6789999999999999999999999999999999999999999986543 6899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC-CCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p 160 (306)
|+||+|+||+++.++.+||+|||++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..|
T Consensus 125 H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p 201 (258)
T cd06632 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201 (258)
T ss_pred cCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654322 223456888999999987666 89999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|........ ... .. .... .+ ..+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 202 f~~~~~~~~--~~~--~~---~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 202 WSQLEGVAA--VFK--IG---RSKE-----LP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cccCcHHHH--HHH--HH---hccc-----CC----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 975431110 000 00 0000 01 1112235688899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=259.82 Aligned_cols=213 Identities=23% Similarity=0.422 Sum_probs=165.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~ 70 (306)
+.+|++++++++||||+++++++...+ ..+++++|+.+|+|.+++... ...+++..++.++.|++.||+
T Consensus 48 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 127 (273)
T cd05074 48 FLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGME 127 (273)
T ss_pred HHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH
Confidence 678999999999999999999886542 247889999999998887432 224788999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|++||.+....++.++|||||||+
T Consensus 128 ~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~i 204 (273)
T cd05074 128 YLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVT 204 (273)
T ss_pred HHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHH
Confidence 999988 99999999999999999999999999987543322222223345677999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|+|++ |..||....... ...+.. .... .. .+...+..+.+++.+||+.+|++|||+.++++
T Consensus 205 l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 205 MWEIMTRGQTPYAGVENSE---IYNYLI----KGNR------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HHHHhhCCCCCCCCCCHHH---HHHHHH----cCCc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999 888886542211 111110 0000 00 11123468999999999999999999999999
Q ss_pred HhCCC
Q 021891 230 ALKPL 234 (306)
Q Consensus 230 ~l~~~ 234 (306)
.|+.+
T Consensus 268 ~l~~~ 272 (273)
T cd05074 268 QLELI 272 (273)
T ss_pred HHHhh
Confidence 98753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=260.96 Aligned_cols=209 Identities=29% Similarity=0.400 Sum_probs=164.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
|++|+++++++ +|+||+++++++.... ..++||||+++++|.+++... ...+++..++.++.|++.||.|
T Consensus 49 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~ 128 (275)
T cd06608 49 IKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128 (275)
T ss_pred HHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 67899999999 7999999999997644 489999999999999988542 3578999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----CCCCchhHHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYS 146 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Diws 146 (306)
||+.+ ++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||++.. ..++.++||||
T Consensus 129 lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 203 (275)
T cd06608 129 LHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203 (275)
T ss_pred HhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHH
Confidence 99988 9999999999999999999999999987643322 12233568889999998753 34678999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 147 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 147 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
|||++|+|++|..||........ ... .. ....+.. ..+...+..+.+||.+||..||++|||+.+
T Consensus 204 lG~il~~l~~g~~p~~~~~~~~~--~~~----~~-------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 268 (275)
T cd06608 204 LGITAIELADGKPPLCDMHPMRA--LFK----IP-------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEE 268 (275)
T ss_pred hHHHHHHHHhCCCCccccchHHH--HHH----hh-------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence 99999999999999964322111 000 00 0000111 111234578999999999999999999999
Q ss_pred HHHH
Q 021891 227 VVEA 230 (306)
Q Consensus 227 ll~~ 230 (306)
++++
T Consensus 269 ll~~ 272 (275)
T cd06608 269 LLEH 272 (275)
T ss_pred HhcC
Confidence 9985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=266.91 Aligned_cols=225 Identities=21% Similarity=0.257 Sum_probs=166.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|++|+.+++.++||||++++++|..++..++||||+.+++|.+++.+. ...+++..+..++.|++.||+|||+.+ +
T Consensus 46 ~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i 122 (328)
T cd08226 46 LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---Y 122 (328)
T ss_pred HHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 678999999999999999999999999999999999999999988654 345899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-----eeecccccccccCCcchhc--CCCCchhHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e 153 (306)
+||||||+||+++.++.++++||+.+.......... ......++..|+|||++.+ ..++.++|||||||++|+
T Consensus 123 vHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~e 202 (328)
T cd08226 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202 (328)
T ss_pred ecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999999998654322111100 0011234567999999876 357899999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhh----------------hhc-ccccc--------------ccccCCccCCCCCHHH
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARP----------------HLG-ERRRF--------------YRLIDPRLEGHFSIKG 202 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~----------------~~~-~~~~~--------------~~~~~~~~~~~~~~~~ 202 (306)
|++|..||......... ...... ... ..... .......+........
T Consensus 203 l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (328)
T cd08226 203 LATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280 (328)
T ss_pred HHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhh
Confidence 99999999764321110 000000 000 00000 0000111111223345
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 203 AQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 203 ~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+..+.+|+.+||+.||++|||+.+++++.
T Consensus 281 ~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 281 SPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 67899999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=262.99 Aligned_cols=208 Identities=29% Similarity=0.389 Sum_probs=164.0
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEe------CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
++.|+.+++++ +|+||+++++++.. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||
T Consensus 59 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 138 (282)
T cd06636 59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138 (282)
T ss_pred HHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 57889999998 79999999999853 45789999999999999988653 345889999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFG 148 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG 148 (306)
+.+ ++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++. ...++.++||||||
T Consensus 139 ~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG 213 (282)
T cd06636 139 AHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213 (282)
T ss_pred HCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHH
Confidence 988 99999999999999999999999999876432111 123356888999999875 34678899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|++|+|++|..||............ .....+.. .....+..+.+||.+||+.||.+|||+.||+
T Consensus 214 ~~l~el~~g~~p~~~~~~~~~~~~~-------------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 214 ITAIEMAEGAPPLCDMHPMRALFLI-------------PRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred HHHHHHHhCCCCccccCHHhhhhhH-------------hhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 9999999999999654322111100 00000111 1112456899999999999999999999998
Q ss_pred HH
Q 021891 229 EA 230 (306)
Q Consensus 229 ~~ 230 (306)
++
T Consensus 278 ~~ 279 (282)
T cd06636 278 KH 279 (282)
T ss_pred cC
Confidence 75
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.58 Aligned_cols=209 Identities=25% Similarity=0.384 Sum_probs=174.9
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+|.+|+.+|-+|+|+|++++||+..+ ....+|||+++.|||.+.|.+ ....|.......++.|||.||.||.+++
T Consensus 157 dflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--- 232 (1039)
T KOG0199|consen 157 DFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--- 232 (1039)
T ss_pred HHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---
Confidence 48999999999999999999999887 678899999999999999987 4556889999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeec-ccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-C
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 157 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g 157 (306)
+|||||...|+++.....|||+|||+.+.+...+....... ..-...|+|||.+....++.++|||++|+++|||+| |
T Consensus 233 lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyG 312 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYG 312 (1039)
T ss_pred hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccC
Confidence 99999999999999999999999999998776554443332 223557999999999999999999999999999998 6
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
..||.+......+.. +|....-.-+..++++++++++.||..+|.+|||+..|.+.
T Consensus 313 EePW~G~~g~qIL~~-----------------iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 313 EEPWVGCRGIQILKN-----------------IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCCCCHHHHHHh-----------------ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 789987654322222 22111112244678999999999999999999999999744
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=256.61 Aligned_cols=209 Identities=24% Similarity=0.390 Sum_probs=167.5
Q ss_pred HHHHHHHHhc-CCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhc-CC
Q 021891 2 WQAEVNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EA 76 (306)
Q Consensus 2 ~~~E~~il~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ 76 (306)
+.+|++++.+ ++|+||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+
T Consensus 55 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~ 134 (269)
T cd08528 55 IVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR 134 (269)
T ss_pred HHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc
Confidence 4568887765 7999999999999999999999999999999988743 34568999999999999999999996 56
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
++|+||+|+||+++.++.++|+|||.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 135 ---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~ 208 (269)
T cd08528 135 ---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208 (269)
T ss_pred ---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998754432 2334568889999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|..||........ .. ... . ....+.. ....+..+.+++.+||+.||++||++.|+.++++
T Consensus 209 g~~p~~~~~~~~~---~~---~~~-~-----~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 209 LQPPFYSTNMLSL---AT---KIV-E-----AVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCCcccccCHHHH---HH---HHh-h-----ccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999864322111 00 000 0 0000100 1123468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.82 Aligned_cols=206 Identities=23% Similarity=0.316 Sum_probs=174.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|+.|+|||||+++.+......+|+||||+.+|.+.+++.+++ ...+..+..++.|+..|++|||+++ |+
T Consensus 102 ~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---iv 177 (596)
T KOG0586|consen 102 LGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IV 177 (596)
T ss_pred HHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---ee
Confidence 4689999999999999999999999999999999999999999998877 4555899999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 160 (306)
|||||++|||++.+..+||+|||++..+..+ ......+|++.|.|||++.+..| .+.+|+||+|+++|-|+.|..|
T Consensus 178 HrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLP 254 (596)
T KOG0586|consen 178 HRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLP 254 (596)
T ss_pred ccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccc
Confidence 9999999999999999999999999887543 34566899999999999998877 5799999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|.+..-.+...... ...- .++...+.++.++|.++|..+|.+|++++++.++-+
T Consensus 255 FDG~~lk~Lr~rvl------~gk~------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 255 FDGQNLKELRPRVL------RGKY------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cCCcccccccchhe------eeee------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 98765443221110 0000 112233567889999999999999999999998644
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=262.71 Aligned_cols=223 Identities=27% Similarity=0.321 Sum_probs=166.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++..++..++||||+++++|.++.... ..+++..++.++.||+.||.|||+.+ ++
T Consensus 47 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~ 122 (286)
T cd07846 47 AMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN---II 122 (286)
T ss_pred HHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 578999999999999999999999999999999999998888876443 45899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|.+|
T Consensus 123 h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~ 200 (286)
T cd07846 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL 200 (286)
T ss_pred ccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999876543321 1223457889999999875 4578899999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcc--------ccccccccCCccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGE--------RRRFYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|...........+......... .........+.... ......+..+.+|+.+||+.+|++||++.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 280 (286)
T cd07846 201 FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280 (286)
T ss_pred CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence 8654321110000000000000 00000000000000 0011235789999999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
+++
T Consensus 281 l~~ 283 (286)
T cd07846 281 LHH 283 (286)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=259.88 Aligned_cols=207 Identities=25% Similarity=0.329 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+++..++|+||+.+++|.+++... ..+++..+..++.|+++||.|||+.+ ++
T Consensus 47 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~ 122 (258)
T cd05578 47 VLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---II 122 (258)
T ss_pred HHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 578999999999999999999999999999999999999999999665 47899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 123 h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 199 (258)
T cd05578 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199 (258)
T ss_pred ccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCC
Confidence 99999999999999999999999988754332 123356788999999998888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM--SEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~ell~~ 230 (306)
........... ...... .....+...+..+.++|.+||+.||.+||++ +|++++
T Consensus 200 ~~~~~~~~~~~----~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 200 RGHSRTIRDQI----RAKQET-----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred CCCCccHHHHH----HHHhcc-----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 86543211111 100000 0111222345789999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=262.32 Aligned_cols=205 Identities=29% Similarity=0.403 Sum_probs=166.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++.+++..++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ ++
T Consensus 62 ~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~ 137 (307)
T cd06607 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RI 137 (307)
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 5789999999999999999999999999999999996 5888877665567999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||+|+||+++.++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++|||++|.
T Consensus 138 H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~ 211 (307)
T cd06607 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (307)
T ss_pred ecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCC
Confidence 9999999999999999999999998764322 2345788899999874 456889999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||.......... ..... ..+.. .....+..+.+++.+||..+|++||++.+++.+..
T Consensus 212 ~p~~~~~~~~~~~-------~~~~~------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 212 PPLFNMNAMSALY-------HIAQN------DSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CCCCCccHHHHHH-------HHhcC------CCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 9986543211100 00000 00111 11234578999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.29 Aligned_cols=200 Identities=26% Similarity=0.334 Sum_probs=159.9
Q ss_pred HhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 021891 9 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 88 (306)
Q Consensus 9 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~ 88 (306)
+....||||+.+++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~ 126 (279)
T cd05633 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPA 126 (279)
T ss_pred HhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHH
Confidence 334479999999999999999999999999999999886544 6999999999999999999999998 999999999
Q ss_pred CeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCC
Q 021891 89 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 167 (306)
Q Consensus 89 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 167 (306)
||+++.++.++|+|||++....... .....|+..|+|||.+. +..++.++||||+||++|+|++|..||......
T Consensus 127 Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 202 (279)
T cd05633 127 NILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (279)
T ss_pred HEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc
Confidence 9999999999999999987543321 12346899999999986 456899999999999999999999999765332
Q ss_pred CCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 168 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
....... ... ... ..++...+.++.++|.+||..||.+|| |++++++|.
T Consensus 203 ~~~~~~~---~~~--------~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 203 DKHEIDR---MTL--------TVN----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CHHHHHH---Hhh--------cCC----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 2111100 000 001 112223457889999999999999999 599998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=258.47 Aligned_cols=206 Identities=26% Similarity=0.391 Sum_probs=166.8
Q ss_pred HHHHHHHHhcCC---CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+++|++++++++ ||||+++++++..+...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~-- 121 (277)
T cd06917 46 IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG-- 121 (277)
T ss_pred HHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 678999999996 999999999999999999999999999999988543 6899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg 157 (306)
++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|
T Consensus 122 -i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g 198 (277)
T cd06917 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198 (277)
T ss_pred -cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987654331 1233468889999998874 4578999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
..||............ . ....+.+... ..+.++.+++.+||+.||++||++.+++.+
T Consensus 199 ~~p~~~~~~~~~~~~~-------~------~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 199 NPPYSDVDAFRAMMLI-------P------KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCCCChhhhhhcc-------c------cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 9999754322111000 0 0001111111 134688999999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=259.90 Aligned_cols=223 Identities=22% Similarity=0.287 Sum_probs=164.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++..++..++||||+. ++|.+.+......+++..+..++.|++.||.|||+.+ ++
T Consensus 50 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~ 125 (291)
T cd07870 50 AIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---IL 125 (291)
T ss_pred HHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 5689999999999999999999999999999999995 6887777665556888999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.+||+|||+++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 126 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred cCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876432211 1223456889999999875 4578999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhh---------hcccccc-ccccCCccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 161 MDKNRPNGEHNLVEWARPH---------LGERRRF-YRLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
|.............+.... ....... ............ ....+..+.+++.+||..||.+|||+.
T Consensus 204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~ 283 (291)
T cd07870 204 FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ 283 (291)
T ss_pred CCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence 9754432110000000000 0000000 000000000000 001145788999999999999999999
Q ss_pred HHHHH
Q 021891 226 EVVEA 230 (306)
Q Consensus 226 ell~~ 230 (306)
|++.|
T Consensus 284 ~~l~h 288 (291)
T cd07870 284 DALLH 288 (291)
T ss_pred HHhcC
Confidence 99875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.61 Aligned_cols=209 Identities=26% Similarity=0.373 Sum_probs=171.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~i 80 (306)
|.+|++++.+++|+||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+ +
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~ 121 (264)
T cd06623 46 LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---I 121 (264)
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---C
Confidence 678999999999999999999999999999999999999999999665 478999999999999999999999 88 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 122 ~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p 199 (264)
T cd06623 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199 (264)
T ss_pred ccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998875432221 1234578899999999888899999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|................ ....+. .+.. .+..+.++|.+||..+|++|||+.+++++
T Consensus 200 ~~~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 200 FLPPGQPSFFELMQAIC----------DGPPPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CccccccCHHHHHHHHh----------cCCCCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 97654311111111111 000011 1112 45789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=260.32 Aligned_cols=210 Identities=27% Similarity=0.400 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++...+..++|+||+++++|.+++......+++..+..++.|++.||.|||+.+ ++
T Consensus 62 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~ 138 (286)
T cd06614 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VI 138 (286)
T ss_pred HHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999999999999999999999999776557999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 139 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~ 216 (286)
T cd06614 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216 (286)
T ss_pred eCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876433211 122345788999999998888999999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.......... ... . .. . +... .....+..+.++|.+||+.+|.+|||+.+++++.
T Consensus 217 ~~~~~~~~~~--~~~-----~-~~----~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 217 LREPPLRALF--LIT-----T-KG----I-PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CCCCHHHHHH--HHH-----h-cC----C-CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 6543221100 000 0 00 0 0000 0112356889999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=259.39 Aligned_cols=207 Identities=25% Similarity=0.365 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++||||+++++++...+..++|+||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++
T Consensus 63 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~ 137 (293)
T cd06647 63 IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VI 137 (293)
T ss_pred HHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 578999999999999999999999999999999999999999998653 4789999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||||+||+++.++.++|+|||++........ ......|+..|+|||.+....++.++||||||+++|+|++|..||
T Consensus 138 H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf 215 (293)
T cd06647 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (293)
T ss_pred eccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998876543322 223346788999999998888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
............. ... .+.. ......+..+.+++.+||..+|++||++.+++.|
T Consensus 216 ~~~~~~~~~~~~~------~~~-------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 216 LNENPLRALYLIA------TNG-------TPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCChhhheeehh------cCC-------CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 7654322111000 000 0000 0122235678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=254.19 Aligned_cols=211 Identities=27% Similarity=0.397 Sum_probs=172.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++|+||+++++++... +..++|+||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--- 121 (260)
T cd06606 46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--- 121 (260)
T ss_pred HHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 67899999999999999999999988 88999999999999999987655 8999999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++++|++|..
T Consensus 122 ~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 201 (260)
T cd06606 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201 (260)
T ss_pred ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999987654432111234567889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||..... ....... ..........+...+..+.+++.+||+.||++||++.+++++-
T Consensus 202 p~~~~~~-----~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 202 PWSELGN-----PMAALYK----------IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred CCCCCCc-----hHHHHHh----------ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 9976541 0000000 0000111112223367899999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=256.83 Aligned_cols=205 Identities=25% Similarity=0.387 Sum_probs=168.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++
T Consensus 49 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~ 123 (277)
T cd06641 49 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK---KI 123 (277)
T ss_pred HHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC---ee
Confidence 678999999999999999999999999999999999999999988543 5899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus 124 h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (277)
T cd06641 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201 (277)
T ss_pred cCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999876543221 122346788999999998888899999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
........ ... .... ..+ .+....+..+.+++.+||+.+|.+||++.+++++
T Consensus 202 ~~~~~~~~---~~~----~~~~------~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 202 SELHPMKV---LFL----IPKN------NPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CccchHHH---HHH----HhcC------CCC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 65332110 000 0000 001 1122335678899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=253.33 Aligned_cols=208 Identities=26% Similarity=0.401 Sum_probs=171.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++..+...++++||+++++|.+++......+++..+..++.|++.||.+||..+ ++
T Consensus 44 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~ 120 (253)
T cd05122 44 IINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---II 120 (253)
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---Ee
Confidence 678999999999999999999999999999999999999999998776567999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus 121 h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 197 (253)
T cd05122 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY 197 (253)
T ss_pred cCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654322 23456788999999998888999999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
............ . . ........ ....+..+.++|.+||+.||++|||+.+++++
T Consensus 198 ~~~~~~~~~~~~---~---~--~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 198 SELPPMKALFKI---A---T--NGPPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCchHHHHHHH---H---h--cCCCCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 754321111000 0 0 00000000 11124679999999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=261.27 Aligned_cols=220 Identities=25% Similarity=0.357 Sum_probs=164.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.+ +
T Consensus 46 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i 121 (284)
T cd07860 46 AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---V 121 (284)
T ss_pred HHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 6789999999999999999999999999999999996 5898888543 456899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC-CCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~ 159 (306)
+|+||+|+||+++.++.+||+|||++......... .....++..|+|||++.+.. ++.++|||||||++|+|+||+.
T Consensus 122 ~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 199 (284)
T cd07860 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199 (284)
T ss_pred ecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998765332211 12234678899999887644 6889999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhh----------hcc----ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 160 SMDKNRPNGEHNLVEWARPH----------LGE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~----------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
||........ ........ ... ...+........ .......+..+.++|.+||+.||.+|||+.
T Consensus 200 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 276 (284)
T cd07860 200 LFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276 (284)
T ss_pred CCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence 9975432111 00000000 000 000000000000 000112346788999999999999999999
Q ss_pred HHHHH
Q 021891 226 EVVEA 230 (306)
Q Consensus 226 ell~~ 230 (306)
+++++
T Consensus 277 ~~l~~ 281 (284)
T cd07860 277 AALAH 281 (284)
T ss_pred HHhcC
Confidence 99975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=262.50 Aligned_cols=225 Identities=24% Similarity=0.314 Sum_probs=164.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC--------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|++++++++||||+++++++...+ ..++||||+. ++|.+.+......+++..++.++.||+.||.|||
T Consensus 58 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH 136 (310)
T cd07865 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136 (310)
T ss_pred HHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999999999987654 4599999996 5888888766667999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhcC-CCCchhHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVV 150 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~i 150 (306)
+.+ ++|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+. .++.++||||||++
T Consensus 137 ~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 213 (310)
T cd07865 137 RNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCI 213 (310)
T ss_pred HCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHH
Confidence 988 999999999999999999999999999765432221 112234578889999988654 47889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhc-----cccc---cccccCCc-cCCCC-----CHHHHHHHHHHHHHcccC
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-----ERRR---FYRLIDPR-LEGHF-----SIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~-~~~~~-----~~~~~~~~~~li~~~l~~ 216 (306)
+|+|++|..||...........+........ .... +.....+. ..... ....+..+.+||.+||..
T Consensus 214 l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~ 293 (310)
T cd07865 214 MAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293 (310)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcC
Confidence 9999999999976543221111111100000 0000 00000000 00000 001135678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021891 217 DPKARPLMSEVVEA 230 (306)
Q Consensus 217 ~p~~Rps~~ell~~ 230 (306)
||.+|||+.++++|
T Consensus 294 ~P~~R~t~~e~l~h 307 (310)
T cd07865 294 DPAKRIDADTALNH 307 (310)
T ss_pred ChhhccCHHHHhcC
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=261.70 Aligned_cols=225 Identities=23% Similarity=0.293 Sum_probs=165.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|++++++++||||+++++++.+. +..++||||+++ +|.+.+... ...+++..++.++.|++.||.|||+.
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 127 (316)
T cd07842 49 ACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127 (316)
T ss_pred HHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 46799999999999999999999988 789999999965 777766422 23689999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcC----CCcEEEeccCCcccCCCCCc-ceeeecccccccccCCcchhc-CCCCchhHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGV 149 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~----~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 149 (306)
+ ++||||||+||+++. ++.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||
T Consensus 128 ~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 204 (316)
T cd07842 128 W---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC 204 (316)
T ss_pred C---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence 8 999999999999999 89999999999987543322 112233467889999998875 46899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcc------hHHhhhhhhc-----------ccccccc---ccC-CccC-CC----CCH--H
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHN------LVEWARPHLG-----------ERRRFYR---LID-PRLE-GH----FSI--K 201 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~------~~~~~~~~~~-----------~~~~~~~---~~~-~~~~-~~----~~~--~ 201 (306)
++|+|++|.+||.......... ........+. ....+.. ... .... .. +.. .
T Consensus 205 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd07842 205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284 (316)
T ss_pred HHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccC
Confidence 9999999999997654432100 0000000000 0000000 000 0000 00 000 2
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 202 GAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 202 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.+..+.+++.+||+.||++|||+.|++++
T Consensus 285 ~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 285 PDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 34578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=259.57 Aligned_cols=209 Identities=29% Similarity=0.377 Sum_probs=163.4
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|+.+++++ +||||+++++++... +..++||||+++++|.+++.. ....+++..++.++.|++.||.||
T Consensus 65 ~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 144 (291)
T cd06639 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144 (291)
T ss_pred HHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 56799999999 899999999998754 358999999999999998753 345689999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-----CCCchhHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSF 147 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Diwsl 147 (306)
|+.+ ++|+||||+||+++.++.+||+|||++........ ......|+..|+|||.+... .++.++|||||
T Consensus 145 H~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 145 HNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred HhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 9988 99999999999999999999999999876543221 12234678899999987643 36889999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 148 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 148 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
||++|+|++|+.||........ ...+. . .......+ +......+.+||.+||+.+|++||++.++
T Consensus 220 Gvi~~el~~g~~p~~~~~~~~~--~~~~~-----~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~i 284 (291)
T cd06639 220 GITAIELGDGDPPLFDMHPVKT--LFKIP-----R-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHL 284 (291)
T ss_pred HHHHHHHhhCCCCCCCCcHHHH--HHHHh-----c-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 9999999999999975432111 10000 0 00000011 11234578999999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
++|
T Consensus 285 l~~ 287 (291)
T cd06639 285 LEH 287 (291)
T ss_pred hcC
Confidence 986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=260.08 Aligned_cols=209 Identities=27% Similarity=0.384 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+|++++++++.+++..++||||+.+ +|.+.+......+++..+..++.|++.||.|||+.+ ++
T Consensus 72 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~ 147 (317)
T cd06635 72 IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 147 (317)
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 56899999999999999999999999999999999964 888887666667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||+|+||+++.++.++|+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 148 H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 221 (317)
T cd06635 148 HRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221 (317)
T ss_pred cCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999875432 12346788999999974 456889999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
.||........... +. ... .+. ......+..+.+++.+||+.+|.+||++.++++++.....
T Consensus 222 ~p~~~~~~~~~~~~--~~----~~~-------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 222 PPLFNMNAMSALYH--IA----QNE-------SPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CCCCCccHHHHHHH--HH----hcc-------CCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 99865422111000 00 000 000 0111234678999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.50 Aligned_cols=220 Identities=25% Similarity=0.335 Sum_probs=170.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++.+++..++|+||+++ +|.+++......+++..+..++.|++.||.|||+.+ ++
T Consensus 45 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~ 120 (283)
T cd05118 45 ALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120 (283)
T ss_pred HHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 56899999999999999999999999999999999965 898888776668999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.|
T Consensus 121 H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~ 198 (283)
T cd05118 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198 (283)
T ss_pred ecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999977644321 12234578889999998876 789999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcc-----cccccc--------cc--CCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGE-----RRRFYR--------LI--DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--------~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
|......+..... ...... ...+.. .. ............+.++.++|.+||+.||.+||++.
T Consensus 199 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 275 (283)
T cd05118 199 FPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE 275 (283)
T ss_pred CCCCCHHHHHHHH---HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHH
Confidence 9765432211110 000000 000000 00 00000111223567899999999999999999999
Q ss_pred HHHHH
Q 021891 226 EVVEA 230 (306)
Q Consensus 226 ell~~ 230 (306)
+++.+
T Consensus 276 ~ll~~ 280 (283)
T cd05118 276 QALAH 280 (283)
T ss_pred HHhhC
Confidence 99985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.34 Aligned_cols=217 Identities=24% Similarity=0.314 Sum_probs=164.1
Q ss_pred HHHHHHHhcCC-CCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 3 QAEVNFLGDLV-HLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 3 ~~E~~il~~l~-H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.+|+.++.++. |+||+++++++.+. +..++||||+. ++|.+.+......+++..++.++.|++.||.|||+.+
T Consensus 45 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--- 120 (282)
T cd07831 45 LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--- 120 (282)
T ss_pred HHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46888899885 99999999999987 88999999996 5888888765567999999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||+|+||+++. +.+||+|||+++....... .....++..|+|||++. +..++.++|||||||++|||++|.
T Consensus 121 i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~ 196 (282)
T cd07831 121 IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196 (282)
T ss_pred ceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCC
Confidence 999999999999999 9999999999986543221 12245788999999765 456788999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccc-c------ccccccCCccC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGER-R------RFYRLIDPRLE-------GHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
.||......+. ........... . ......+.... .......+..+.+||.+||+.+|++||++
T Consensus 197 ~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 273 (282)
T cd07831 197 PLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273 (282)
T ss_pred cCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence 99976543221 11111000000 0 00000000000 00112346789999999999999999999
Q ss_pred HHHHHH
Q 021891 225 SEVVEA 230 (306)
Q Consensus 225 ~ell~~ 230 (306)
.+++++
T Consensus 274 ~~~l~~ 279 (282)
T cd07831 274 KQALRH 279 (282)
T ss_pred HHHhhC
Confidence 999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=271.58 Aligned_cols=202 Identities=26% Similarity=0.272 Sum_probs=165.1
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.+|+.++... +|+||+++.+.+.++.+.|+|||.+.|+-|.+.+.... .....+..|+++|+.|+.|||++| ++
T Consensus 363 ~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vv 437 (612)
T KOG0603|consen 363 QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VV 437 (612)
T ss_pred ccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---ee
Confidence 4566666555 89999999999999999999999999998888875543 233777889999999999999999 99
Q ss_pred eccCCCCCeEE-cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILL-DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+|||+ +..|.++|+|||.++..... ....+-|..|.|||++...+|++++|+||||++||+|++|+.|
T Consensus 438 hRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp 512 (612)
T KOG0603|consen 438 HRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTL 512 (612)
T ss_pred ecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCc
Confidence 99999999999 68899999999999876543 2223457889999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|....... +.. . ....+.+....+..+.+|+.+||+.||.+|+++.++..|-..
T Consensus 513 ~~~~P~~~--ei~--------------~---~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 513 FAAHPAGI--EIH--------------T---RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cccCCchH--HHH--------------H---hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 97654330 000 0 011122234557899999999999999999999999987654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=255.01 Aligned_cols=207 Identities=22% Similarity=0.366 Sum_probs=167.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|+++++.++|+||+++++.+......++|+||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ +
T Consensus 46 ~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i 122 (257)
T cd08225 46 SKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---I 122 (257)
T ss_pred HHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 5789999999999999999999999999999999999999999986543 35899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
+|+||||+||+++.++ .+||+|||.+........ ......|+..|+|||+..+..++.++|+||||+++++|++|..
T Consensus 123 ~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08225 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH 200 (257)
T ss_pred ccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999998886 469999999876543221 1223457889999999988889999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
||...... ......... ... ......+.++.+++.+||..+|++|||+.+++++
T Consensus 201 p~~~~~~~------~~~~~~~~~------~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 201 PFEGNNLH------QLVLKICQG------YFA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCccHH------HHHHHHhcc------cCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 98654321 111111100 000 0111234679999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=261.50 Aligned_cols=224 Identities=25% Similarity=0.302 Sum_probs=165.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++|+||+++++++... +..++||||+. ++|.+++......+++..++.++.|++.||.|||+.+
T Consensus 53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--- 128 (309)
T cd07845 53 SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128 (309)
T ss_pred hhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 45799999999999999999998765 46899999996 4898888766567999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||||+||+++.++.+||+|||++......... .....++..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 129 i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 206 (309)
T cd07845 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206 (309)
T ss_pred eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999875433211 122345778999999875 56799999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhh--------hhccccccccc-cCCccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARP--------HLGERRRFYRL-IDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
+||...........+..... ........... ......... ....+..+.++|.+||+.||++|||+.+
T Consensus 207 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~ 286 (309)
T cd07845 207 PLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286 (309)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 99976543222111110000 00000000000 000000000 0113567889999999999999999999
Q ss_pred HHHHh
Q 021891 227 VVEAL 231 (306)
Q Consensus 227 ll~~l 231 (306)
+++|.
T Consensus 287 il~h~ 291 (309)
T cd07845 287 ALESS 291 (309)
T ss_pred HhcCh
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=254.17 Aligned_cols=206 Identities=24% Similarity=0.331 Sum_probs=170.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|++++++++|+||+++++++.+....++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-- 123 (256)
T cd08530 46 AVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-- 123 (256)
T ss_pred HHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 568999999999999999999999999999999999999999988652 346899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||+|+||+++.++.+||+|||++...... ......++..|++||.+.+..++.++|+||||+++|+|++|.
T Consensus 124 -i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 198 (256)
T cd08530 124 -ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198 (256)
T ss_pred -cccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876543 122345788999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||....... ..... ........+...+.++.+++.+||+.+|++||++.+++++.
T Consensus 199 ~p~~~~~~~~---~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 199 PPFEARSMQD---LRYKV--------------QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred CCCCCCCHHH---HHHHH--------------hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 9997543211 00000 00011112224567899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=265.64 Aligned_cols=220 Identities=23% Similarity=0.275 Sum_probs=164.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++++.++|+||+++++++... ...++||||+. ++|.+.+... +++..+..++.|++.||.|||+.
T Consensus 62 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~ 137 (353)
T cd07850 62 AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA 137 (353)
T ss_pred HHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC
Confidence 45799999999999999999988654 35799999995 5888877543 88999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ ++||||||+||+++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|+
T Consensus 138 g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 211 (353)
T cd07850 138 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211 (353)
T ss_pred C---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence 8 99999999999999999999999999987543221 22345788999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchH------------Hhhh----hhhccc-----cccccccCCc----cCCCCCHHHHHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLV------------EWAR----PHLGER-----RRFYRLIDPR----LEGHFSIKGAQKAAQLA 210 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~------------~~~~----~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~~~~~li 210 (306)
+|..||...........+ .... ...... ..+....... .........+..+.++|
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (353)
T cd07850 212 RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291 (353)
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHH
Confidence 999999754321110000 0000 000000 0000111000 00001123456789999
Q ss_pred HHcccCCCCCCCCHHHHHHHh
Q 021891 211 AHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 211 ~~~l~~~p~~Rps~~ell~~l 231 (306)
.+||+.||++|||+.|++++-
T Consensus 292 ~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 292 SKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHcCCChhhCcCHHHHhcCh
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=253.55 Aligned_cols=211 Identities=30% Similarity=0.440 Sum_probs=168.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++...+..++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++
T Consensus 46 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~ 121 (264)
T cd06626 46 IADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IV 121 (264)
T ss_pred HHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 678999999999999999999999999999999999999999998654 35889999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee--eecccccccccCCcchhcCC---CCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV--STRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ellt 156 (306)
|+||+|+||+++.++.+||+|||++........... .....++..|+|||++.+.. ++.++||||||+++|+|++
T Consensus 122 H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~ 201 (264)
T cd06626 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT 201 (264)
T ss_pred cCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence 999999999999999999999999987544322111 11345788999999998765 8899999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|..||....... ...+.... . ..+.... ....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 202 g~~pf~~~~~~~---~~~~~~~~-~--------~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 202 GKRPWSELDNEF---QIMFHVGA-G--------HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCccCCcchH---HHHHHHhc-C--------CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 999997543111 11110000 0 0111111 11225678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.19 Aligned_cols=221 Identities=23% Similarity=0.306 Sum_probs=165.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++|+||+++++++.+.+..++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+.+ +
T Consensus 45 ~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~ 120 (283)
T cd07835 45 AIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---V 120 (283)
T ss_pred HHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5689999999999999999999999999999999995 68999886543 46899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~ 159 (306)
+|+||+|+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.++||||||+++|+|++|+.
T Consensus 121 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 198 (283)
T cd07835 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198 (283)
T ss_pred eCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999764332111 1223467889999987654 57899999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhh----------hccccccccccC---CccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 160 SMDKNRPNGEHNLVEWARPH----------LGERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
||........ ........ ......+...+. ...........+..+.++|.+||+.||.+|||++|
T Consensus 199 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 199 LFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred CCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 9976433211 00000000 000000000000 00000111123467889999999999999999999
Q ss_pred HHHH
Q 021891 227 VVEA 230 (306)
Q Consensus 227 ll~~ 230 (306)
++++
T Consensus 277 il~~ 280 (283)
T cd07835 277 ALQH 280 (283)
T ss_pred HhcC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=258.23 Aligned_cols=207 Identities=26% Similarity=0.386 Sum_probs=167.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.+++.++|+||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++
T Consensus 64 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g---iv 138 (292)
T cd06657 64 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG---VI 138 (292)
T ss_pred HHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999977433 5899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 139 H~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~ 216 (292)
T cd06657 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216 (292)
T ss_pred cCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987643321 1123356788999999998888899999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
........ ...... ........ ....+..+.+++.+||+.+|.+||++.+++++
T Consensus 217 ~~~~~~~~---~~~~~~----------~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 217 FNEPPLKA---MKMIRD----------NLPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCCCHHHH---HHHHHh----------hCCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 75432111 110000 00111000 01224578899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=257.81 Aligned_cols=211 Identities=28% Similarity=0.365 Sum_probs=162.7
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHh---h-cCCCCCCHHHHHHHHHHHHHHHHHhhcC-
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---F-RRSLPLPWSIRMKIALGAAKGLAFLHEE- 75 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l---~-~~~~~l~~~~~~~~~~qi~~~l~~LH~~- 75 (306)
+.+|+.++.++. |+||+++++++..++..+++|||+. ++|.++. . .....+++..+..++.|++.||+|||+.
T Consensus 49 ~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~ 127 (288)
T cd06616 49 LLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127 (288)
T ss_pred HHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 678999999995 9999999999999999999999995 4665543 2 2235799999999999999999999974
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC---CCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ 152 (306)
+ ++||||||+||+++.++.+||+|||+++....... .....|+..|+|||++.+. .++.++|||||||++|
T Consensus 128 ~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 201 (288)
T cd06616 128 K---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201 (288)
T ss_pred C---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHH
Confidence 6 99999999999999999999999999976533211 1233578899999998765 6899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++|+.||..... ......... ....+..........+..+.+|+.+||+.||++|||+.+|+++-
T Consensus 202 el~~g~~p~~~~~~-----~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 202 EVATGKFPYPKWNS-----VFDQLTQVV-------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred HHHhCCCCchhcch-----HHHHHhhhc-------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 99999999975431 111000000 00011111111123457899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=252.68 Aligned_cols=207 Identities=26% Similarity=0.386 Sum_probs=171.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|++++++++|+|++++++.+...+..++|+||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-- 123 (258)
T cd08215 46 ALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123 (258)
T ss_pred HHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 578999999999999999999999999999999999999999999765 367999999999999999999999998
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||+|+||+++.++.++|+|||.+....... .......|+..|+|||...+..++.++|+||+|+++++|++|.
T Consensus 124 -~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~ 200 (258)
T cd08215 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK 200 (258)
T ss_pred -EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999998754432 1233356888999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||....... . ....... . .+. .+...+..+.+++.+||..+|++|||+.+++++
T Consensus 201 ~p~~~~~~~~---~---~~~~~~~------~-~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 201 HPFEGENLLE---L---ALKILKG------Q-YPP----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCcHHH---H---HHHHhcC------C-CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9986543211 1 1000000 0 011 111335688999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=253.57 Aligned_cols=203 Identities=26% Similarity=0.326 Sum_probs=159.5
Q ss_pred HHHHH-HhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 4 AEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 4 ~E~~i-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.|..+ ...++|+||+++++++..++..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|
T Consensus 45 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H 120 (260)
T cd05611 45 AERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIH 120 (260)
T ss_pred HHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 34443 44558999999999999999999999999999999998654 36899999999999999999999988 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
+||+|+||+++.++.++|+|||++..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 121 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred CCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999875432 223457889999999988889999999999999999999999996
Q ss_pred CCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH---HHHHHH
Q 021891 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---SEVVEA 230 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~ell~~ 230 (306)
....... .. . ....... .........+..+.+++.+||+.||++||++ .|++.|
T Consensus 195 ~~~~~~~---~~--~-~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 195 AETPDAV---FD--N-ILSRRIN--------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCCHHHH---HH--H-HHhcccC--------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 5432111 00 0 0000000 0011111235789999999999999999966 465554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.65 Aligned_cols=194 Identities=22% Similarity=0.280 Sum_probs=158.5
Q ss_pred CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 021891 13 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 92 (306)
Q Consensus 13 ~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill 92 (306)
+|+||+++++++...+..++||||+++++|.+++..+. .+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 79999999999999999999999999999999986654 7999999999999999999999998 9999999999999
Q ss_pred cCCC-cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 021891 93 DADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 171 (306)
Q Consensus 93 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 171 (306)
+.++ .++|+|||+++..... ....|+..|+|||++.+..++.++||||||+++|+|++|..||....... ..
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~ 215 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD 215 (267)
T ss_pred eCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh
Confidence 9988 9999999998765322 12357889999999998899999999999999999999999997443221 11
Q ss_pred hHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 021891 172 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 230 (306)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~ell~~ 230 (306)
...+.... .. ........+..+.++|.+||+.+|.+||+ ++++++|
T Consensus 216 ~~~~~~~~-~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 216 LESLLKRQ-QK------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHhh-cc------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11111100 00 00111234578999999999999999996 6999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=256.17 Aligned_cols=208 Identities=27% Similarity=0.370 Sum_probs=166.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++.+..++..|+||||+.+++|.+++.+.+ .+++..++.++.||+.||.|||+.+ ++
T Consensus 40 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~ 115 (265)
T cd05579 40 VLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---II 115 (265)
T ss_pred HHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---ee
Confidence 5789999999999999999999999999999999999999999986654 7899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCc------ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
|+||+|+||+++.++.++|+|||++........ ........++..|+|||......++.++||||||+++|+|+
T Consensus 116 H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~ 195 (265)
T cd05579 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL 195 (265)
T ss_pred cCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 999999999999999999999999876433211 11223345788899999998888999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH---HHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---SEVVE 229 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~ell~ 229 (306)
+|..||........... ..... ... .... ..+..+.+++.+||+.+|++|||+ .++++
T Consensus 196 ~g~~p~~~~~~~~~~~~------~~~~~------~~~--~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 196 VGIPPFHGETPEEIFQN------ILNGK------IEW--PEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred hCCCCCCCCCHHHHHHH------HhcCC------cCC--Cccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 99999975432211000 00000 000 0000 125788999999999999999999 65555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=252.33 Aligned_cols=209 Identities=22% Similarity=0.300 Sum_probs=166.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|++|++++++++|+||+++++++.+. +.+++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 51 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--- 126 (264)
T cd06653 51 LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM--- 126 (264)
T ss_pred HHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 67899999999999999999998764 46889999999999999986544 5889999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc-ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.++|+|||+++....... ........|+..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 127 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 206 (264)
T cd06653 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206 (264)
T ss_pred EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532111 11112346788999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||........ . ... ........++...+..+.+++.+||+ +|..||++.+++.|.
T Consensus 207 ~p~~~~~~~~~---~---~~~----------~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 207 PPWAEYEAMAA---I---FKI----------ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred CCCCccCHHHH---H---HHH----------HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 99965322110 0 000 00011112233445789999999999 579999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=255.32 Aligned_cols=202 Identities=25% Similarity=0.324 Sum_probs=161.5
Q ss_pred HHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 021891 7 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 86 (306)
Q Consensus 7 ~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlk 86 (306)
++++...||||+++++++...+..++||||+.|++|.+++... ..+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~ 124 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLK 124 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCC
Confidence 3445568999999999999999999999999999999988554 47999999999999999999999988 9999999
Q ss_pred CCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 021891 87 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNR 165 (306)
Q Consensus 87 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 165 (306)
|+||+++.++.++|+|||++....... .....|+..|+|||++.++ .++.++||||+||++|+|++|..||....
T Consensus 125 p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 125 PANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred HHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999987653321 2234689999999998744 68999999999999999999999997653
Q ss_pred CCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 166 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
.......... . ...... ++...+..+.+++.+||..+|.+|| ++.+++++.
T Consensus 201 ~~~~~~~~~~---~--------~~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 201 TKDKHEIDRM---T--------LTMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred ccchHHHHHH---h--------hccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 3221111000 0 000111 1222357899999999999999999 999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=255.57 Aligned_cols=223 Identities=22% Similarity=0.305 Sum_probs=166.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++|+||+++++++.+.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+
T Consensus 45 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 120 (284)
T cd07836 45 AIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--- 120 (284)
T ss_pred HHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46799999999999999999999999999999999975 8888886543 46899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||||+||+++.++.++|+|||++........ ......++..|++||++.+ ..++.++|||||||++|+|++|.
T Consensus 121 i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 198 (284)
T cd07836 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198 (284)
T ss_pred eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999976433211 1123456888999998865 45789999999999999999999
Q ss_pred CCCCCCCCCCCcchHH-hh-------hhhhccccccccccCC---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 159 RSMDKNRPNGEHNLVE-WA-------RPHLGERRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
.||......+....+. .. ...+.....+...... .....+....+..+.+++.+||+.||.+||++.++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 199 PLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred CCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 9997654322111100 00 0000000000000000 00001111235678999999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
+++
T Consensus 279 l~~ 281 (284)
T cd07836 279 LQH 281 (284)
T ss_pred hcC
Confidence 975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=242.12 Aligned_cols=226 Identities=25% Similarity=0.317 Sum_probs=172.6
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeC--------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
.+|+++|..|+|+|++.+++.|... ..+|+||++|+. +|..++.....+++...+.+++.++..||.|+|.
T Consensus 64 lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 64 LREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred HHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999988753 358999999965 9999998887889999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhc-CCCCchhHHHHHHHHH
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVL 151 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il 151 (306)
.. |+|||+|++|+||+.+|.+||+|||+++.+....... ..+..+-|.+|++||.+.| ..|+.+.|||+.|||+
T Consensus 143 ~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 143 NK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM 219 (376)
T ss_pred hh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence 88 9999999999999999999999999998765432221 1123445999999999986 5799999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhh-----hccccc--ccccc-CCccCCCC---------CHHHHHHHHHHHHHcc
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPH-----LGERRR--FYRLI-DPRLEGHF---------SIKGAQKAAQLAAHCL 214 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~-~~~~~~~~---------~~~~~~~~~~li~~~l 214 (306)
.||+|+.+.++++........+...-.. |.+... +++.+ .+.+.... +-.-.++..+|+.++|
T Consensus 220 aeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 220 AEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 9999999999887655444333322211 111100 11111 00011000 0001247889999999
Q ss_pred cCCCCCCCCHHHHHHHhC
Q 021891 215 SRDPKARPLMSEVVEALK 232 (306)
Q Consensus 215 ~~~p~~Rps~~ell~~l~ 232 (306)
..||.+|+++.+++.|-.
T Consensus 300 ~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 300 KLDPTKRIDADQALNHDF 317 (376)
T ss_pred ccCcccCcchHhhhchhh
Confidence 999999999999998753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.80 Aligned_cols=204 Identities=28% Similarity=0.419 Sum_probs=164.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+|++++++++.+.+..++||||+. ++|.+.+......+++..+..++.|++.||.|||+.+ ++
T Consensus 68 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~ 143 (313)
T cd06633 68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143 (313)
T ss_pred HHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 5689999999999999999999999999999999996 5888888766667999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||+|+||+++.++.+||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|.
T Consensus 144 H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~ 217 (313)
T cd06633 144 HRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217 (313)
T ss_pred cCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999864321 22356788999999984 456889999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||............. . .. .+.. .....+..+.+|+.+||+.+|.+||++.+++.+-
T Consensus 218 ~p~~~~~~~~~~~~~~------~--~~-----~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 218 PPLFNMNAMSALYHIA------Q--ND-----SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred CCCCCCChHHHHHHHH------h--cC-----CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 9987653321111000 0 00 0000 0112235688999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=257.46 Aligned_cols=208 Identities=28% Similarity=0.388 Sum_probs=166.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+|++++++++......++||||+. |+|.+.+......+++..+..++.|++.||.|||+.+ ++
T Consensus 62 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~ 137 (308)
T cd06634 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MI 137 (308)
T ss_pred HHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 5689999999999999999999999999999999996 5888877665667899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||+|+||+++.++.++|+|||++...... ....|+..|+|||.+. ...++.++|||||||++|+|++|.
T Consensus 138 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 211 (308)
T cd06634 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (308)
T ss_pred cCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence 9999999999999999999999998764321 2345788999999975 356788999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
.||.......... .... . ..+.. .....+..+.+||.+||+.+|++||++.+++++.....
T Consensus 212 ~p~~~~~~~~~~~-------~~~~-~-----~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 212 PPLFNMNAMSALY-------HIAQ-N-----ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCCccccHHHHHH-------HHhh-c-----CCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 9986542211100 0000 0 00100 11133567899999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=262.31 Aligned_cols=223 Identities=28% Similarity=0.337 Sum_probs=164.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|+.+++++ +|+||+++++++... ...++||||+. ++|.+++... .+++..++.++.||+.||.|||+.+
T Consensus 53 ~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~-- 127 (337)
T cd07852 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN-- 127 (337)
T ss_pred hhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 56799999999 999999999998654 36899999996 5999988554 6889999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc---eeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
++|+||||+||+++.++.+||+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 128 -i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el 206 (337)
T cd07852 128 -VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206 (337)
T ss_pred -eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence 999999999999999999999999999875443221 12233568899999998764 4678999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhh--------hh--ccccccccccCC---ccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARP--------HL--GERRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|+.||...........+..... .+ .....+...... ..........+..+.++|.+||+.||++|
T Consensus 207 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 286 (337)
T cd07852 207 LLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286 (337)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence 999999975433221111000000 00 000000000000 00000111135788999999999999999
Q ss_pred CCHHHHHHH
Q 021891 222 PLMSEVVEA 230 (306)
Q Consensus 222 ps~~ell~~ 230 (306)
||+.+++++
T Consensus 287 ps~~~il~~ 295 (337)
T cd07852 287 LTAEEALEH 295 (337)
T ss_pred cCHHHHhhC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=257.02 Aligned_cols=223 Identities=22% Similarity=0.297 Sum_probs=162.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++|+||+++++++.+.+..++||||++ ++|.+++... ...+++..++.++.||+.||+|||+.+ +
T Consensus 48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i 123 (294)
T PLN00009 48 AIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---V 123 (294)
T ss_pred HHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5789999999999999999999999999999999996 5888877554 334688899999999999999999988 9
Q ss_pred EeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCC
Q 021891 81 IYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~ 158 (306)
+|+||+|+||+++. ++.+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 124 ~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~ 201 (294)
T PLN00009 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201 (294)
T ss_pred eCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999985 56799999999976433211 1122356889999998875 45789999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhh-h-h---hhc---ccccccccc---CCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWA-R-P---HLG---ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~-~-~---~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
.||......+........ . . .+. ....+.... ............+..+.+++.+||+.+|++||++.++
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~ 281 (294)
T PLN00009 202 PLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281 (294)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence 999764332111100000 0 0 000 000000000 0000000011234678999999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
+++
T Consensus 282 l~~ 284 (294)
T PLN00009 282 LEH 284 (294)
T ss_pred hcC
Confidence 984
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=249.54 Aligned_cols=198 Identities=22% Similarity=0.249 Sum_probs=158.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|...+....||||+++++++.+.+..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~---i~ 107 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREG---IV 107 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3456666666789999999999999999999999999999999986543 5899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.++||||+|+++|||++|..|+
T Consensus 108 H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~ 182 (237)
T cd05576 108 CRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182 (237)
T ss_pred ccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchh
Confidence 9999999999999999999999987654332 12234567899999998888999999999999999999999887
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~ 230 (306)
........ . ... ...+...+..+.++|.+||+.||++||++ +++++|
T Consensus 183 ~~~~~~~~------------~------~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 183 ECHPSGIN------------T------HTT----LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred hcCchhcc------------c------ccc----cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 53211100 0 000 01112234678999999999999999986 666654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=256.23 Aligned_cols=224 Identities=24% Similarity=0.285 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|++++++++|+||+++++++... +..++||||++ ++|.+++......+++..++.++.||+.||+|||+.+
T Consensus 45 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--- 120 (287)
T cd07840 45 AIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--- 120 (287)
T ss_pred HHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56899999999999999999999988 88999999997 4999988766567999999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 121 ~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~ 199 (287)
T cd07840 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199 (287)
T ss_pred ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876443211 1223356788999998764 46789999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhh--hcccccccc-----cc------CCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPH--LGERRRFYR-----LI------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~-----~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
.||...........+...... ......+.. .. .......+...++..+.+++.+||..+|.+||++.
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 279 (287)
T cd07840 200 PIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD 279 (287)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999765432111110000000 000000000 00 00000011111267889999999999999999999
Q ss_pred HHHHH
Q 021891 226 EVVEA 230 (306)
Q Consensus 226 ell~~ 230 (306)
+++++
T Consensus 280 ~~l~~ 284 (287)
T cd07840 280 QALQH 284 (287)
T ss_pred HHhhC
Confidence 99975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=255.35 Aligned_cols=207 Identities=26% Similarity=0.396 Sum_probs=159.6
Q ss_pred HHHHHH-HhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcC-CC
Q 021891 3 QAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AE 77 (306)
Q Consensus 3 ~~E~~i-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~-~~ 77 (306)
..|+.+ ++.++||||+++++++..++..++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ +
T Consensus 47 ~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~- 124 (283)
T cd06617 47 LMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS- 124 (283)
T ss_pred HHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-
Confidence 345554 666799999999999999999999999996 688877643 334689999999999999999999986 7
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc----CCCCchhHHHHHHHHHHH
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~e 153 (306)
++||||||+||+++.++.+||+|||++....... ......|+..|+|||++.+ ..++.++|+|||||++|+
T Consensus 125 --i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 125 --VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred --eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 9999999999999999999999999998653321 1223457889999998864 456889999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|++|..||...... ....... .. ...+... ....+.++.++|.+||..+|++||++.+++++-
T Consensus 200 l~~g~~p~~~~~~~--~~~~~~~---~~-------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 200 LATGRFPYDSWKTP--FQQLKQV---VE-------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred HHhCCCCCCccccC--HHHHHHH---Hh-------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 99999998643211 0111000 00 0001110 112357899999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=256.01 Aligned_cols=221 Identities=21% Similarity=0.283 Sum_probs=162.4
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCe-----eEEEEEcCCCCCHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
+.+|+.+++.+. |+||+++++++...+. .|+||||+++ +|.+++... ...+++..++.++.||+.||.|
T Consensus 47 ~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~ 125 (295)
T cd07837 47 ALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125 (295)
T ss_pred HHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 578999999995 6999999999987665 8999999975 898887543 2458999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGV 149 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 149 (306)
||+.+ ++||||||+||+++. ++.+||+|||++......... .....++..|+|||++.+ ..++.++||||||+
T Consensus 126 LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred HHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 99988 999999999999998 889999999998765332111 122346788999998865 46799999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhh-hccc---------cccccc--cCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPH-LGER---------RRFYRL--IDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~---------~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
++|+|++|..||......... ....... .... ...... ..+..........+..+.++|.+||..|
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 278 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYD 278 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCC
Confidence 999999999999764322111 0000000 0000 000000 0000000011124577899999999999
Q ss_pred CCCCCCHHHHHHH
Q 021891 218 PKARPLMSEVVEA 230 (306)
Q Consensus 218 p~~Rps~~ell~~ 230 (306)
|.+||++.|++.+
T Consensus 279 P~~R~~~~eil~~ 291 (295)
T cd07837 279 PAKRISAKAALTH 291 (295)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=290.36 Aligned_cols=221 Identities=32% Similarity=0.546 Sum_probs=173.0
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|++++++++|||||+++++|.+.+..++||||+++|+|.+++. .+++..+..++.|++.||+|||.....+|+|
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 467999999999999999999999999999999999999999984 3789999999999999999999553344999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
|||||+||+++.++..++. ||....... .....|+..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 9999999999998888775 665543211 112357899999999999899999999999999999999999995
Q ss_pred CCCCCCCcchHHhhhhhhccccccccccCCccCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
.... .......|....... ......+++.... ........++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 880 ~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 880 AEFG-VHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccC-CCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4322 223344444432211 1222334444322 2344556678999999999999999999999999976543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=245.24 Aligned_cols=219 Identities=26% Similarity=0.308 Sum_probs=169.4
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.+|++++.++ .|+||++++++|+++..+|||||.|.||+|..+|.++. .|++..+..+..+|+.||.|||.+| |.
T Consensus 123 fREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg---IA 198 (463)
T KOG0607|consen 123 FREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG---IA 198 (463)
T ss_pred HHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC---cc
Confidence 5899999999 69999999999999999999999999999999996654 7999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCc---EEEeccCCcccCCCC-----CcceeeecccccccccCCcchh-----cCCCCchhHHHHHH
Q 021891 82 YRDFKTSNILLDADYN---AKLSDFGLAKDGPEG-----DKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFG 148 (306)
Q Consensus 82 H~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG 148 (306)
||||||+|||....+. +|||||.+..-.... ..+......+|+..|||||+.. ...|+.++|.||||
T Consensus 199 HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 199 HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 9999999999976654 699999987542211 1111223467899999999874 23689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCC--------cchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 021891 149 VVLLEMLTGRRSMDKNRPNGE--------HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
+|+|-|++|.+||.+.-..+. ..........+.++ -+++.+.. ....+.+..+++.++|..|+.+
T Consensus 279 vIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG--kYeFPdkd-----WahIS~eakdlisnLlvrda~~ 351 (463)
T KOG0607|consen 279 VILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG--KYEFPDKD-----WAHISSEAKDLISNLLVRDAKQ 351 (463)
T ss_pred HHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc--CCcCChhh-----hHHhhHHHHHHHHHHHhccHHh
Confidence 999999999999987543221 00111111111111 11222221 2245778999999999999999
Q ss_pred CCCHHHHHHHhC
Q 021891 221 RPLMSEVVEALK 232 (306)
Q Consensus 221 Rps~~ell~~l~ 232 (306)
|.++.++++|.+
T Consensus 352 rlsa~~vlnhPw 363 (463)
T KOG0607|consen 352 RLSAAQVLNHPW 363 (463)
T ss_pred hhhhhhccCCcc
Confidence 999999998654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=248.81 Aligned_cols=206 Identities=29% Similarity=0.450 Sum_probs=169.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+|++++++++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~ 121 (254)
T cd06627 46 IMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VI 121 (254)
T ss_pred HHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cc
Confidence 678999999999999999999999999999999999999999998655 47999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++......... .....++..|+|||...+..++.++|||+||+++|+|++|..||
T Consensus 122 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~ 199 (254)
T cd06627 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199 (254)
T ss_pred cCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999876543321 23346788999999998878899999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
....... ..+.. .. . ..+. ++...+..+.+++.+||..+|++|||+.+++.+
T Consensus 200 ~~~~~~~----~~~~~-~~---~-----~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 200 YDLNPMA----ALFRI-VQ---D-----DHPP----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCccHHH----HHHHH-hc---c-----CCCC----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 7543110 00100 00 0 0011 122235688999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=243.23 Aligned_cols=200 Identities=30% Similarity=0.439 Sum_probs=161.1
Q ss_pred CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 021891 13 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 92 (306)
Q Consensus 13 ~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill 92 (306)
..|.||+.+|+|..+...++.||.| +..++.++.+-.+++++..+-++...+++||.||.++.. |+|||+||+|||+
T Consensus 149 dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILl 225 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL 225 (391)
T ss_pred CCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEE
Confidence 4699999999999999999999999 456777776667789999999999999999999987643 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 021891 93 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 169 (306)
Q Consensus 93 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 169 (306)
|+.|.+||||||++-.+.+.. ......|.+.|||||-+. ...|+..+||||||+.++||.||+.||.+....
T Consensus 226 De~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-- 300 (391)
T KOG0983|consen 226 DERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-- 300 (391)
T ss_pred ccCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--
Confidence 999999999999998765532 334567899999999986 347899999999999999999999999875321
Q ss_pred cchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
......+.. -..|.+.... ..+.++.+|+..||++|+.+||...++++|-.
T Consensus 301 Fe~ltkvln----------~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 301 FEVLTKVLN----------EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred HHHHHHHHh----------cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 112211111 1112222222 14689999999999999999999999998743
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=248.75 Aligned_cols=203 Identities=28% Similarity=0.355 Sum_probs=169.8
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
-|-++|+..+||.+..+.-.|+..+.+|+||||+.||.|.-++.+ ...+++.....+...|+.||.|||+++ ||+|
T Consensus 217 TE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYR 292 (516)
T KOG0690|consen 217 TENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYR 292 (516)
T ss_pred hHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeee
Confidence 466789999999999888889999999999999999999999854 457999999999999999999999988 9999
Q ss_pred cCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 021891 84 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 163 (306)
Q Consensus 84 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 163 (306)
|||.+|+++|.+|++||+|||+++.--.. ......+|||+.|.|||++....|+.++|.|.+|+++|||++|+.||..
T Consensus 293 DlKLENLlLDkDGHIKitDFGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 293 DLKLENLLLDKDGHIKITDFGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred echhhhheeccCCceEeeecccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 99999999999999999999999863222 1234568999999999999999999999999999999999999999987
Q ss_pred CCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 021891 164 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 230 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~ 230 (306)
........++.. + .-.++...++++..|+.-+|.+||++|. .+.||.++
T Consensus 371 ~dh~kLFeLIl~------e------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 371 KDHEKLFELILM------E------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred cchhHHHHHHHh------h------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 654332222211 1 0124445567899999999999999994 46666654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=250.65 Aligned_cols=210 Identities=17% Similarity=0.175 Sum_probs=156.3
Q ss_pred HHHhcCCCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 7 NFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 7 ~il~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
..+..+.|+||+++++++.... ..+++++++. .++.+.+... ...++..+..++.|++.||.|||+.+ ++|
T Consensus 75 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH 149 (294)
T PHA02882 75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG---ISH 149 (294)
T ss_pred HHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4456679999999999876544 3478888874 4777766443 34678889999999999999999988 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
|||||+|||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999865432211 112234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
..||............ ...... .++...... ....+..+.+++..|++.+|++||++.++++.+
T Consensus 230 ~~P~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 230 KLPWKGFGHNGNLIHA--AKCDFI-----KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCccccchHHHHH--hHHHHH-----HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999866332211110 000000 000000000 011247899999999999999999999999865
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=258.06 Aligned_cols=226 Identities=23% Similarity=0.292 Sum_probs=166.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++++..++..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++
T Consensus 67 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---i~ 141 (335)
T PTZ00024 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY---FM 141 (335)
T ss_pred HHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 5689999999999999999999999999999999996 5999988544 46899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCC------------cceeeecccccccccCCcchhcC-CCCchhHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGD------------KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFG 148 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG 148 (306)
|+||+|+||+++.++.++|+|||++....... .........++..|+|||.+.+. .++.++||||||
T Consensus 142 H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 221 (335)
T PTZ00024 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221 (335)
T ss_pred cccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence 99999999999999999999999987654110 00111223467889999998764 478999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhh-----hhcccccc--ccccCCccCC---CCCHHHHHHHHHHHHHcccCCC
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARP-----HLGERRRF--YRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDP 218 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p 218 (306)
|++|+|++|..||...........+..... .+.....+ .......... ......+.++.++|.+||+.+|
T Consensus 222 ~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 301 (335)
T PTZ00024 222 CIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301 (335)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence 999999999999976543221110000000 00000000 0000000000 0011225678899999999999
Q ss_pred CCCCCHHHHHHHhC
Q 021891 219 KARPLMSEVVEALK 232 (306)
Q Consensus 219 ~~Rps~~ell~~l~ 232 (306)
++|||+.+++.+..
T Consensus 302 ~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 302 LERISAKEALKHEY 315 (335)
T ss_pred hhccCHHHHhcCcc
Confidence 99999999998654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=261.66 Aligned_cols=226 Identities=22% Similarity=0.296 Sum_probs=165.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
+.+|+.+|++++||||+++++++.. ....++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+
T Consensus 51 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~- 127 (334)
T cd07855 51 TLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN- 127 (334)
T ss_pred HHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5679999999999999999998764 346899999995 5899888554 45999999999999999999999988
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
++||||||+||+++.++.+||+|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 128 --ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el 205 (334)
T cd07855 128 --VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205 (334)
T ss_pred --eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHH
Confidence 999999999999999999999999998765332211 11223468889999999865 4689999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhh-----h--ccccccccc---cCCccC---CCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPH-----L--GERRRFYRL---IDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+...... . .......+. ...... ..+....+.++.++|.+||+.+|.+|
T Consensus 206 ~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred HcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 9999999764332111000000000 0 000000000 000000 00111235789999999999999999
Q ss_pred CCHHHHHHHhC
Q 021891 222 PLMSEVVEALK 232 (306)
Q Consensus 222 ps~~ell~~l~ 232 (306)
||+.+++++..
T Consensus 286 pt~~~~l~~~~ 296 (334)
T cd07855 286 ITVEQALQHPF 296 (334)
T ss_pred cCHHHHHhChh
Confidence 99999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=256.47 Aligned_cols=224 Identities=27% Similarity=0.317 Sum_probs=163.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC--------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+++++.++|+||+++++++.... .+++||||+.+ +|...+......+++..+..++.|+++||.|||
T Consensus 54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH 132 (311)
T cd07866 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH 132 (311)
T ss_pred HHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 468999999999999999999876543 46999999964 788777666667999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce---------eeecccccccccCCcchhc-CCCCchhH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH---------VSTRVMGTYGYAAPEYVMT-GHLTSRSD 143 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~D 143 (306)
+.+ ++|+||||+||+++.++.++|+|||+++......... ......++..|+|||.+.+ ..++.++|
T Consensus 133 ~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 209 (311)
T cd07866 133 ENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVD 209 (311)
T ss_pred hCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhH
Confidence 998 9999999999999999999999999997654322111 1122456788999998865 45899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhh-----hhcccccccc--------ccCCccCCCCCHHHHHHHHHHH
Q 021891 144 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-----HLGERRRFYR--------LIDPRLEGHFSIKGAQKAAQLA 210 (306)
Q Consensus 144 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li 210 (306)
||||||++|+|++|.+||.+.........+..... .+........ ...+.....+ ......+.++|
T Consensus 210 v~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i 288 (311)
T cd07866 210 IWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLL 288 (311)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHH
Confidence 99999999999999999976543221111100000 0000000000 0000000000 11235788999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 021891 211 AHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 211 ~~~l~~~p~~Rps~~ell~~ 230 (306)
.+||+.||.+|||+.+++.+
T Consensus 289 ~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 289 SKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHcccCcccCcCHHHHhcC
Confidence 99999999999999999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.75 Aligned_cols=220 Identities=23% Similarity=0.316 Sum_probs=161.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+.++++++|+||+++++++.... ..++|+||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ 126 (336)
T cd07849 50 TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN 126 (336)
T ss_pred HHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 567999999999999999999876543 5799999996 588887743 36899999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
++||||||+||+++.++.+||+|||++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 127 ---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el 203 (336)
T cd07849 127 ---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203 (336)
T ss_pred ---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987654322111 1123467899999998754 5689999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhcc-------------ccccccccCCccCCC---CCHHHHHHHHHHHHHcccCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGE-------------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDP 218 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p 218 (306)
++|+.||........ .......... ............... .....+..+.+++.+||+.+|
T Consensus 204 ~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 280 (336)
T cd07849 204 LSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNP 280 (336)
T ss_pred HhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCCh
Confidence 999999965432110 0000000000 000000000000000 001224678999999999999
Q ss_pred CCCCCHHHHHHH
Q 021891 219 KARPLMSEVVEA 230 (306)
Q Consensus 219 ~~Rps~~ell~~ 230 (306)
++|||+.+++++
T Consensus 281 ~~Rpt~~e~l~h 292 (336)
T cd07849 281 HKRITVEEALAH 292 (336)
T ss_pred hhCcCHHHHhcC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.88 Aligned_cols=206 Identities=24% Similarity=0.309 Sum_probs=176.9
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
-.|-+||.++..|.||++|--|.+++..|++||-|-||.|...+..++ .|++.+...++..+++|++|||+++ ||+
T Consensus 468 ~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~---iIY 543 (732)
T KOG0614|consen 468 FSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG---IIY 543 (732)
T ss_pred HhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC---cee
Confidence 357889999999999999999999999999999999999999996665 7999999999999999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
|||||+|++++.+|-+||.|||.|+....+.++. .++||+.|.|||++....-+.++|.||||+++|||++|.+||.
T Consensus 544 RDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 544 RDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred ccCChhheeeccCCceEEeehhhHHHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999999987665543 5799999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
+.++....+.+..... ...++........+||++++..+|.+|.. +.+|.+|-
T Consensus 621 ~~dpmktYn~ILkGid----------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 621 GVDPMKTYNLILKGID----------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred CCchHHHHHHHHhhhh----------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 8876544333321111 12344555678899999999999999974 55555543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=251.19 Aligned_cols=210 Identities=28% Similarity=0.358 Sum_probs=165.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++++ +|+||+++++++..+...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ +
T Consensus 51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i 126 (290)
T cd05613 51 TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---I 126 (290)
T ss_pred HHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 56799999999 6999999999999999999999999999999998655 36889999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC--CCCchhHHHHHHHHHHHHHhCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~ 158 (306)
+||||+|+||+++.++.+||+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus 127 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~ 205 (290)
T cd05613 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA 205 (290)
T ss_pred eccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999765432211 12235688899999998753 4678999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~ 230 (306)
.||........ ........... .+. ++...+..+.+++.+||+.||++|| ++.+++++
T Consensus 206 ~p~~~~~~~~~--~~~~~~~~~~~--------~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 206 SPFTVDGEKNS--QAEISRRILKS--------EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCcCCcccc--HHHHHHHhhcc--------CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 99864322211 11111111000 011 1222356788999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.24 Aligned_cols=207 Identities=27% Similarity=0.352 Sum_probs=169.5
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++++. |+||+++++++..++..++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.+ +
T Consensus 48 ~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~---~ 123 (280)
T cd05581 48 VKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG---I 123 (280)
T ss_pred HHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 578899999998 9999999999999999999999999999999996654 7999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc------------------eeeecccccccccCCcchhcCCCCchh
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSRS 142 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 142 (306)
+|+||+|+||+++.++.++|+|||++......... .......++..|+|||+..+..++.++
T Consensus 124 ~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~ 203 (280)
T cd05581 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS 203 (280)
T ss_pred eecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhh
Confidence 99999999999999999999999998865433211 122334578899999999888899999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 143 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 143 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
||||||++++++++|..||........ .... .. ....++...++.+.+++.+||+.+|.+||
T Consensus 204 Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~---~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 265 (280)
T cd05581 204 DLWALGCIIYQMLTGKPPFRGSNEYLT---FQKI---LK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265 (280)
T ss_pred hHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH---Hh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCC
Confidence 999999999999999999976542110 0000 00 00111222357889999999999999999
Q ss_pred CH----HHHHHH
Q 021891 223 LM----SEVVEA 230 (306)
Q Consensus 223 s~----~ell~~ 230 (306)
|+ +++++|
T Consensus 266 ~~~~~~~~ll~~ 277 (280)
T cd05581 266 GVNEGYDELKAH 277 (280)
T ss_pred CcccCHHHHhcC
Confidence 99 888875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=253.91 Aligned_cols=223 Identities=26% Similarity=0.316 Sum_probs=164.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC----------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~----------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
+.+|++++++++||||+++++++.+.. .+++|+||+++ +|.+.+......+++..+..++.|++.||.|
T Consensus 53 ~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~ 131 (302)
T cd07864 53 AIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131 (302)
T ss_pred HHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 568999999999999999999987655 78999999975 7878776665679999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 150 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~i 150 (306)
||+.+ ++|+||||+||+++.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||+
T Consensus 132 LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 207 (302)
T cd07864 132 CHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 207 (302)
T ss_pred HHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHH
Confidence 99988 999999999999999999999999999875443221 1122345778999998864 457899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhh--ccccccccc-----cC------CccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYRL-----ID------PRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-----~~------~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
+++|++|++||...........+....... .....+... .+ ......+. ..+..+.+++.+||+.|
T Consensus 208 ~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~ 286 (302)
T cd07864 208 LGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLD 286 (302)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCC
Confidence 999999999997543321111111000000 000000000 00 00000011 13568899999999999
Q ss_pred CCCCCCHHHHHHH
Q 021891 218 PKARPLMSEVVEA 230 (306)
Q Consensus 218 p~~Rps~~ell~~ 230 (306)
|.+|||+.+++.+
T Consensus 287 P~~Rp~~~~il~~ 299 (302)
T cd07864 287 PSKRCTAEEALNS 299 (302)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.96 Aligned_cols=206 Identities=22% Similarity=0.313 Sum_probs=166.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-- 126 (260)
T cd08222 49 ANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-- 126 (260)
T ss_pred HHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 45788999999999999999999999999999999999999998853 3456899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++|+||+|+||+++. +.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 127 -i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 127 -ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred -ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999975 5799999999876543221 223355788999999998888899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||..... ........ ....+ ..+...+.++.++|.+||+.+|++||++.+++++
T Consensus 203 ~~~~~~~~------~~~~~~~~-------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 203 HAFEGQNF------LSVVLRIV-------EGPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCccH------HHHHHHHH-------cCCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 99864321 11111000 00011 1233456789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=226.05 Aligned_cols=222 Identities=23% Similarity=0.271 Sum_probs=173.1
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|+-+|+.|+|.|||+++++...++.+-+|+||| ..+|+.+...-+..++.+.+..++.|++.||.|+|+++ +.|
T Consensus 49 lreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlh 124 (292)
T KOG0662|consen 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLH 124 (292)
T ss_pred HHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhh
Confidence 58999999999999999999999999999999999 56999999877788999999999999999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt-g~~p 160 (306)
|||||.|++|+.+|.+|++|||+++.+.-.. .+....+-|.+|++|.++.+. -|+...|+||.|||+.|+.. |.+.
T Consensus 125 rdlkpqnllin~ngelkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 125 RDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred ccCCcceEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 9999999999999999999999999865432 233445669999999999875 58999999999999999987 6666
Q ss_pred CCCCCCCCCcchHHhhhhhh--ccccccccccCCccCCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHL--GERRRFYRLIDPRLEGHF---------SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
|.+.+..+....+-+..... .++..+..+.|-.....+ -......-++|+.++|.-+|..|.++++.++
T Consensus 203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 77665544433332222111 111122222221111111 1122345579999999999999999999998
Q ss_pred H
Q 021891 230 A 230 (306)
Q Consensus 230 ~ 230 (306)
+
T Consensus 283 h 283 (292)
T KOG0662|consen 283 H 283 (292)
T ss_pred C
Confidence 5
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.68 Aligned_cols=225 Identities=24% Similarity=0.308 Sum_probs=168.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|.+|++++++++|+||+++++++...+ ..|+||||++ ++|.+++.+.. .+++..++.++.|++.||.|||+.+
T Consensus 46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g 123 (330)
T cd07834 46 ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN 123 (330)
T ss_pred HHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 678999999999999999999998775 7899999997 58998886544 7999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el 154 (306)
++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|
T Consensus 124 ---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l 200 (330)
T cd07834 124 ---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200 (330)
T ss_pred ---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence 999999999999999999999999999876543210 112334578899999999877 889999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhc-------ccccccccc---CCcc---CCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLG-------ERRRFYRLI---DPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+........ ........+ .... ........+..+.++|.+||+.+|++|
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 280 (330)
T cd07834 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280 (330)
T ss_pred HcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence 999999976543211111000000000 000000000 0000 000111235688999999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
||+.+++++.
T Consensus 281 pt~~~ll~~~ 290 (330)
T cd07834 281 ITADEALAHP 290 (330)
T ss_pred CCHHHHHhCc
Confidence 9999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=246.27 Aligned_cols=205 Identities=31% Similarity=0.390 Sum_probs=167.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++|+||+++++.+..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++
T Consensus 40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~---~~ 115 (250)
T cd05123 40 TLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG---II 115 (250)
T ss_pred HHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 5789999999999999999999999999999999999999999986553 6899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+..++.++|+||||+++|+|++|..||
T Consensus 116 H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~ 193 (250)
T cd05123 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF 193 (250)
T ss_pred ecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987754321 1223456788999999998888899999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH---HHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---SEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~ell~~ 230 (306)
...... ....... .. .. .++...+..+.+++.+||..||++||++ ++++++
T Consensus 194 ~~~~~~---~~~~~~~---~~--------~~----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 194 YAEDRK---EIYEKIL---KD--------PL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCCHH---HHHHHHh---cC--------CC----CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 654321 1111000 00 00 1122225788999999999999999999 666654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=250.30 Aligned_cols=212 Identities=28% Similarity=0.353 Sum_probs=166.3
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++.++ +|+||+++++.+..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ +
T Consensus 51 ~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~ 126 (288)
T cd05583 51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---I 126 (288)
T ss_pred HHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56899999999 6999999999999999999999999999999998654 46899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC--CCchhHHHHHHHHHHHHHhCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~ 158 (306)
+|+||||+||+++.++.++|+|||+++....... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|.
T Consensus 127 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~ 205 (288)
T cd05583 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA 205 (288)
T ss_pred eccCCCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCC
Confidence 9999999999999999999999999876543321 1122346788999999987654 788999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||........ ........... .+. .+...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 206 ~p~~~~~~~~~--~~~~~~~~~~~--------~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 206 SPFTVDGEQNS--QSEISRRILKS--------KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCcccCcccch--HHHHHHHHHcc--------CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 99964322111 11111111100 011 11223467889999999999999999777766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=255.89 Aligned_cols=221 Identities=24% Similarity=0.334 Sum_probs=163.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+.+++.++|+||+++++++... ...++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+
T Consensus 51 ~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ 128 (337)
T cd07858 51 TLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN 128 (337)
T ss_pred HHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45799999999999999999988654 35799999995 6898888654 47999999999999999999999988
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell 155 (306)
++||||||+||+++.++.+||+|||++....... .......++..|+|||.+.. ..++.++|||||||++|+|+
T Consensus 129 ---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 129 ---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred ---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence 9999999999999999999999999998754322 11233457889999998864 46899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhh--------hh--cccccccc----ccCCccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARP--------HL--GERRRFYR----LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~--------~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
+|..||...........+..... .. ........ ...+... ......+..+.++|.+||+.+|++|
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R 282 (337)
T cd07858 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKR 282 (337)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhc
Confidence 99999975432110000000000 00 00000000 0000000 0111245778999999999999999
Q ss_pred CCHHHHHHH
Q 021891 222 PLMSEVVEA 230 (306)
Q Consensus 222 ps~~ell~~ 230 (306)
||++++++|
T Consensus 283 ps~~ell~h 291 (337)
T cd07858 283 ITVEEALAH 291 (337)
T ss_pred cCHHHHHcC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=251.38 Aligned_cols=222 Identities=26% Similarity=0.355 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++.+.+..++||||++ ++|.+++.+....+++..+..++.|++.||.|||+.+ ++
T Consensus 45 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~ 120 (282)
T cd07829 45 ALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---IL 120 (282)
T ss_pred HHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 5679999999999999999999999999999999997 5999999776557999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|||||||+++||++|..|
T Consensus 121 H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 198 (282)
T cd07829 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPL 198 (282)
T ss_pred cCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876543222 12223457789999998766 789999999999999999999999
Q ss_pred CCCCCCCCCcchHHhh--------hhhhccc----cccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 161 MDKNRPNGEHNLVEWA--------RPHLGER----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~--------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|...........+... ....... ..+...........+ ...+..+.++|.+||..||++||++.+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 199 FPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred CCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 9764422111100000 0000000 000000000000001 11256899999999999999999999999
Q ss_pred HH
Q 021891 229 EA 230 (306)
Q Consensus 229 ~~ 230 (306)
.+
T Consensus 278 ~~ 279 (282)
T cd07829 278 KH 279 (282)
T ss_pred hC
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=248.22 Aligned_cols=221 Identities=24% Similarity=0.300 Sum_probs=164.9
Q ss_pred HHHHHHHHhcC---CCCcccceeeEEEeCCe-----eEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDL---VHLNLVKLIGYCIEDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l---~H~niv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|+.+++++ +|+||+++++++...+. .+++|||+. ++|.+++.... ..+++..++.++.|++.||.||
T Consensus 45 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L 123 (287)
T cd07838 45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123 (287)
T ss_pred HHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45687777666 69999999999998776 899999996 48998886543 3689999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ ++|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+..++.++|||||||++|
T Consensus 124 H~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~ 197 (287)
T cd07838 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197 (287)
T ss_pred HHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence 9988 99999999999999999999999999977543321 12234688899999999888999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhh-----hhcc-----ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARP-----HLGE-----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
+|++|.+||......+....+..... .+.. ...+...... .........+..+.++|.+||+.||.+||
T Consensus 198 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 198 ELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPR-SFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccccccc-chhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 99999999876443221110000000 0000 0000000000 00111223457889999999999999999
Q ss_pred CHHHHHHH
Q 021891 223 LMSEVVEA 230 (306)
Q Consensus 223 s~~ell~~ 230 (306)
++.+++++
T Consensus 277 ~~~~il~~ 284 (287)
T cd07838 277 SAFEALQH 284 (287)
T ss_pred CHHHHhcC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=261.12 Aligned_cols=223 Identities=26% Similarity=0.311 Sum_probs=168.6
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
-+|+++|++|+|+|||+++|+-++.. ...+|||||.||||...+.+ +...+++..+..++.++..||.|||+
T Consensus 59 ~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE 138 (732)
T KOG4250|consen 59 CREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE 138 (732)
T ss_pred HHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999765443 45799999999999999965 35679999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEc--CCCc--EEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHH
Q 021891 75 EAERPVIYRDFKTSNILLD--ADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGV 149 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~--~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ 149 (306)
++ |+||||||.||++- .+|+ -||+|||.|+...++. ....++||..|.+||++. .+.|+..+|.|||||
T Consensus 139 n~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 139 NG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred cC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 88 99999999999993 3343 5999999999887654 456789999999999998 488999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccc-----------cccccccCCccCCCCCHHHHHHHHHHHHHcccCCC
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-----------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 218 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 218 (306)
++|+.+||..||...........+.|....-... ..+..-..-.............+-.++..+|..+|
T Consensus 213 tlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~ 292 (732)
T KOG4250|consen 213 TLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNP 292 (732)
T ss_pred HHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhH
Confidence 9999999999997543332212222222111000 00000000111233445556677788999999999
Q ss_pred CCCC--CHHHHHHHh
Q 021891 219 KARP--LMSEVVEAL 231 (306)
Q Consensus 219 ~~Rp--s~~ell~~l 231 (306)
.+|. .+.+..+.+
T Consensus 293 ~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 293 RKRGHEGFDRFFAEV 307 (732)
T ss_pred HHhCCCCcchHHHHH
Confidence 9998 655555544
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=253.76 Aligned_cols=225 Identities=24% Similarity=0.299 Sum_probs=161.7
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeC----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++++++ +||||+++++++... ...++++||+. ++|.+.+... ..+++..++.++.||+.||.|||+.+
T Consensus 48 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g 125 (332)
T cd07857 48 ALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN 125 (332)
T ss_pred HHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46799999999 599999999975432 45789999995 6899888543 47899999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~e 153 (306)
++||||||+||+++.++.+||+|||+++........ .......|+..|+|||.+.+ ..++.++|||||||++|+
T Consensus 126 ---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~ 202 (332)
T cd07857 126 ---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE 202 (332)
T ss_pred ---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999865432211 11223568899999998765 468999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhh--------hhhcc--cccccccc---CCccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWAR--------PHLGE--RRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
|++|.+||...........+.... ..... ...+.... ............+..+.+|+.+||+.||.+
T Consensus 203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 282 (332)
T cd07857 203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282 (332)
T ss_pred HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence 999999997643211110000000 00000 00000000 000000000112467899999999999999
Q ss_pred CCCHHHHHHHh
Q 021891 221 RPLMSEVVEAL 231 (306)
Q Consensus 221 Rps~~ell~~l 231 (306)
|||+.+++++-
T Consensus 283 R~t~~~ll~~~ 293 (332)
T cd07857 283 RISVEEALEHP 293 (332)
T ss_pred CCCHHHHhcCh
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=251.43 Aligned_cols=210 Identities=30% Similarity=0.432 Sum_probs=161.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCC
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~ 79 (306)
+.+|+.++..+ .|+||+++++++.+....++||||+. ++|.+++......+++..+..++.|++.||.|||+ .+
T Consensus 60 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--- 135 (296)
T cd06618 60 ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--- 135 (296)
T ss_pred HHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---
Confidence 34567666666 59999999999999999999999995 58888776655579999999999999999999997 46
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC----CCchhHHHHHHHHHHHHH
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell 155 (306)
++||||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|+
T Consensus 136 i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~ 212 (296)
T cd06618 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212 (296)
T ss_pred EecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH
Confidence 99999999999999999999999999876543221 12235678899999987543 788999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
+|+.||...... ....... .... .+.... ....+..+.+|+.+||..||.+||++.+++++..
T Consensus 213 ~g~~p~~~~~~~--~~~~~~~---~~~~-------~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 213 TGQFPYKNCKTE--FEVLTKI---LQEE-------PPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred hCCCCCCcchhH--HHHHHHH---hcCC-------CCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 999999653211 0111100 0000 000000 0123467899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=247.30 Aligned_cols=220 Identities=26% Similarity=0.355 Sum_probs=165.4
Q ss_pred HHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.+|+..+++++ |+||+++++++.+++..++||||+ +++|.+++.... ..+++..+..++.|++.+|.|||+.+ +
T Consensus 45 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i 120 (283)
T cd07830 45 LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---F 120 (283)
T ss_pred HHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 46889999998 999999999999999999999999 779999886653 57899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~ 159 (306)
+|+||+|+||+++.++.++|+|||++........ .....++..|+|||++. ...++.++|+||||+++++|++|..
T Consensus 121 ~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~ 197 (283)
T cd07830 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197 (283)
T ss_pred ccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence 9999999999999999999999999976543221 12345788899999875 4567899999999999999999999
Q ss_pred CCCCCCCCCCcchHH----------hhhhhhccccccccccCCcc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 160 SMDKNRPNGEHNLVE----------WARPHLGERRRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 160 pf~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
||............. |..... ........+.... ........+..+.++|.+||+.+|++|||+.|
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 198 LFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred ccCCCChHHHHHHHHHhcCCCChhhhhhHhh-hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 997654322111000 000000 0000000000000 00000111467999999999999999999999
Q ss_pred HHHH
Q 021891 227 VVEA 230 (306)
Q Consensus 227 ll~~ 230 (306)
++.+
T Consensus 277 i~~~ 280 (283)
T cd07830 277 ALQH 280 (283)
T ss_pred HhhC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.39 Aligned_cols=213 Identities=30% Similarity=0.477 Sum_probs=172.7
Q ss_pred CHHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHH
Q 021891 1 MWQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALG 64 (306)
Q Consensus 1 ~~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~q 64 (306)
+|..|+++|+.+ +|+||+.++|+|...+..++|+|||..|+|.+++.++. ..+.......++.|
T Consensus 347 ~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~Q 426 (609)
T KOG0200|consen 347 DLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQ 426 (609)
T ss_pred HHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHH
Confidence 368899999999 79999999999999999999999999999999997665 34888999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccc--cccccCCcchhcCCCCchh
Q 021891 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTGHLTSRS 142 (306)
Q Consensus 65 i~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~ 142 (306)
|+.|++||++.. ++||||...|||+..+..+||+|||+++........... ...| ...|||||.+....|+.++
T Consensus 427 Ia~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kS 502 (609)
T KOG0200|consen 427 IANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKS 502 (609)
T ss_pred HHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccc
Confidence 999999999988 999999999999999999999999999975544333212 1122 3459999999999999999
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 143 DVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 143 DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
||||||+++|||+| |..||.+..... .+.+ .+..+. + -..+..++.+++++++.||+.+|++|
T Consensus 503 DVWSfGI~L~EifsLG~~PYp~~~~~~--~l~~----~l~~G~---r-------~~~P~~c~~eiY~iM~~CW~~~p~~R 566 (609)
T KOG0200|consen 503 DVWSFGILLWEIFTLGGTPYPGIPPTE--ELLE----FLKEGN---R-------MEQPEHCSDEIYDLMKSCWNADPEDR 566 (609)
T ss_pred hhhHHHHHHHHHhhCCCCCCCCCCcHH--HHHH----HHhcCC---C-------CCCCCCCCHHHHHHHHHHhCCCcccC
Confidence 99999999999998 778887632111 1111 111111 1 12233446789999999999999999
Q ss_pred CCHHHHHHHhCC
Q 021891 222 PLMSEVVEALKP 233 (306)
Q Consensus 222 ps~~ell~~l~~ 233 (306)
|++.++.+.+..
T Consensus 567 P~F~~~~~~~~~ 578 (609)
T KOG0200|consen 567 PTFSECVEFFEK 578 (609)
T ss_pred CCHHHHHHHHHH
Confidence 999999998876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.93 Aligned_cols=211 Identities=28% Similarity=0.348 Sum_probs=174.7
Q ss_pred CHHHHHHHHhcC-CCCcccceeeEEEe-----CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 1 MWQAEVNFLGDL-VHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 1 ~~~~E~~il~~l-~H~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
|.+.|++||+.+ .|||++.+|++|.. ++.+|||||||.|||..|++..- +..+.|+.+..|++.++.||.+||
T Consensus 61 EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH 140 (953)
T KOG0587|consen 61 EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH 140 (953)
T ss_pred HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh
Confidence 356788899988 79999999999875 45899999999999999998643 567999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-----CCCchhHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFG 148 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG 148 (306)
... ++|||||-.|||++.++.|||+|||++...+.. ....+...||+.|||||++... .|+..+|+||||
T Consensus 141 ~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 141 NNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLG 215 (953)
T ss_pred hcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhcc
Confidence 988 999999999999999999999999999876532 3345567899999999999743 477899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
++..||.-|.+|+....+.-..-. ..-+|...-.-+...++++.++|..||.+|..+||++.+++
T Consensus 216 ITaIEladG~PPl~DmHPmraLF~---------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 216 ITAIEMAEGAPPLCDMHPMRALFL---------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred ceeehhcCCCCCccCcchhhhhcc---------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 999999999999987655322111 11122222233566789999999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
+|.
T Consensus 281 ~hp 283 (953)
T KOG0587|consen 281 KHP 283 (953)
T ss_pred cCC
Confidence 864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.59 Aligned_cols=217 Identities=24% Similarity=0.345 Sum_probs=159.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++++.++|+||+++++++.... ..++|+||+. .+|...+ +..+++..+..++.|++.||+|||+.
T Consensus 61 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~ 136 (342)
T cd07879 61 AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA 136 (342)
T ss_pred HHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 568999999999999999999987543 4689999995 4777765 23589999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ ++||||||+||+++.++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||
T Consensus 137 ~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el 208 (342)
T cd07879 137 G---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208 (342)
T ss_pred C---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHH
Confidence 8 999999999999999999999999998764322 123456888999999875 4689999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhh--------hhhcc--ccccccccCCccCCCC---CHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWAR--------PHLGE--RRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|+.||...........+.... ..... ...............+ ....+..+.+||.+||+.||++|
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 288 (342)
T cd07879 209 LTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKR 288 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhC
Confidence 99999997643211110000000 00000 0000000000000000 01134578899999999999999
Q ss_pred CCHHHHHHH
Q 021891 222 PLMSEVVEA 230 (306)
Q Consensus 222 ps~~ell~~ 230 (306)
|++.+++.|
T Consensus 289 ~~~~e~l~h 297 (342)
T cd07879 289 LTATEALEH 297 (342)
T ss_pred cCHHHHhcC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=247.39 Aligned_cols=220 Identities=21% Similarity=0.260 Sum_probs=166.5
Q ss_pred HHHHHHHhcCCC--C----cccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 3 QAEVNFLGDLVH--L----NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 3 ~~E~~il~~l~H--~----niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+-|+++|+++.+ | -+|++.++|.-.++.|||+|.+ |-|+.+++.++ ..+++...+..++.|++++++|||+.
T Consensus 133 ~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~ 211 (415)
T KOG0671|consen 133 LIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL 211 (415)
T ss_pred HHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc
Confidence 358899999933 3 3788889999999999999999 56999999775 46799999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcC--------------------CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc
Q 021891 76 AERPVIYRDFKTSNILLDA--------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 135 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~--------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 135 (306)
+ ++|-||||+|||+-+ +..++|+|||.|+...... ...+.|..|+|||++.+
T Consensus 212 k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 212 K---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILG 283 (415)
T ss_pred c---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheec
Confidence 8 999999999999931 2348999999998744332 34567899999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccc------------------------cccccccC
Q 021891 136 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER------------------------RRFYRLID 191 (306)
Q Consensus 136 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~ 191 (306)
-+++..+||||+||||+|+.||...|+.....+....++......... +......+
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~ 363 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFE 363 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhc
Confidence 999999999999999999999999998765443322222221111000 00000000
Q ss_pred CccC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 192 PRLE----GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 192 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+... -.....+..++++|+++||..||.+|+|+.|++.|.
T Consensus 364 ~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 364 PCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred CCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCH
Confidence 0000 011223456899999999999999999999999863
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=256.87 Aligned_cols=219 Identities=24% Similarity=0.316 Sum_probs=163.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCe------eEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+.++++++|+||+++++++...+. .++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~ 137 (343)
T cd07851 61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA 137 (343)
T ss_pred HHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4579999999999999999998876654 89999999 6799998854 3689999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ ++|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 138 g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 138 G---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred C---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence 8 999999999999999999999999999875432 223457888999999865 4678999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhh----hh------ccccccccccCCccCCCC---CHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARP----HL------GERRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+..... .+ .....+...+.......+ ....+..+.++|.+||+.||++|
T Consensus 210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R 289 (343)
T cd07851 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289 (343)
T ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence 999999975433211110000000 00 000000000000000000 01125789999999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
||+.+|+++-
T Consensus 290 pt~~ell~h~ 299 (343)
T cd07851 290 ITAAEALAHP 299 (343)
T ss_pred CCHHHHhcCC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=253.51 Aligned_cols=224 Identities=22% Similarity=0.292 Sum_probs=159.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--------------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 67 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~ 67 (306)
+.+|++++++++||||+++++++... ...++||||++ ++|.+++... .+++..++.++.||+.
T Consensus 49 ~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~ 125 (342)
T cd07854 49 ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLR 125 (342)
T ss_pred HHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHH
Confidence 57899999999999999999876654 35789999996 5898887543 5899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhc-CCCCchhHH
Q 021891 68 GLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDV 144 (306)
Q Consensus 68 ~l~~LH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 144 (306)
||.|||+.+ ++||||||+||+++. ++.+||+|||+++........ .......++..|+|||++.+ ..++.++||
T Consensus 126 aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 202 (342)
T cd07854 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM 202 (342)
T ss_pred HHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhH
Confidence 999999988 999999999999974 567899999999764322111 11122357888999998754 568899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhc--cccccccc----cC-CccCC-----CCCHHHHHHHHHHHHH
Q 021891 145 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--ERRRFYRL----ID-PRLEG-----HFSIKGAQKAAQLAAH 212 (306)
Q Consensus 145 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~----~~-~~~~~-----~~~~~~~~~~~~li~~ 212 (306)
|||||++|+|++|+.||.................... ....+... .. ..... ......+.++.+|+.+
T Consensus 203 wSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (342)
T cd07854 203 WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ 282 (342)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHH
Confidence 9999999999999999976543221111000000000 00000000 00 00000 0011234678899999
Q ss_pred cccCCCCCCCCHHHHHHHh
Q 021891 213 CLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 213 ~l~~~p~~Rps~~ell~~l 231 (306)
||+.||.+|||+.+++++-
T Consensus 283 ~L~~dP~~R~t~~ell~h~ 301 (342)
T cd07854 283 ILTFNPMDRLTAEEALMHP 301 (342)
T ss_pred HhCCCchhccCHHHHhCCC
Confidence 9999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=248.59 Aligned_cols=219 Identities=25% Similarity=0.341 Sum_probs=161.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++++++||||+++++++.. .+..++|+||+ +++|.+++... .+++..+..++.|+++||.|||+.+ +
T Consensus 56 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i 129 (328)
T cd07856 56 TYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG---V 129 (328)
T ss_pred HHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 5689999999999999999999876 55789999999 56898887533 5788899999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~ 159 (306)
+||||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..
T Consensus 130 iH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred ccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754321 123456788999998765 578999999999999999999999
Q ss_pred CCCCCCCCCCcchHH---------hhhhhh-ccccccccccCCccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 160 SMDKNRPNGEHNLVE---------WARPHL-GERRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 160 pf~~~~~~~~~~~~~---------~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
||...........+. +..... .....+......... .......+..+.++|.+||+.+|++|||+.+
T Consensus 205 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 205 LFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 997543211100000 000000 000000000000000 0000113468899999999999999999999
Q ss_pred HHHHh
Q 021891 227 VVEAL 231 (306)
Q Consensus 227 ll~~l 231 (306)
++.+-
T Consensus 285 ll~~~ 289 (328)
T cd07856 285 ALAHP 289 (328)
T ss_pred HhcCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=252.06 Aligned_cols=219 Identities=23% Similarity=0.330 Sum_probs=160.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|++++++++|+||+++++++... ...+++++++ +++|.+++... .+++..++.++.|++.||.|||+.
T Consensus 63 ~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~ 139 (345)
T cd07877 63 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA 139 (345)
T ss_pred HHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 56799999999999999999988643 3467888887 77998877443 589999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ ++||||||+||+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 140 ~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el 211 (345)
T cd07877 140 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211 (345)
T ss_pred C---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHH
Confidence 8 999999999999999999999999998764322 223467889999998876 5688999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhh--------hhhcc--ccccccccCCccC---CCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWAR--------PHLGE--RRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+.... ..... ...+...+..... .......+.++.+||.+||+.||.+|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 99999996543221111000000 00000 0000000000000 00000124678999999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
|++.+++.+-
T Consensus 292 ~t~~e~l~h~ 301 (345)
T cd07877 292 ITAAQALAHA 301 (345)
T ss_pred CCHHHHhcCh
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=244.26 Aligned_cols=213 Identities=24% Similarity=0.353 Sum_probs=166.2
Q ss_pred HHHHHHhcCCCCcccceeeEEE-eCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
+|.+|.+.|+||-||++|++|. +.+.+|-|+|||+|.+|+-+|+.+ +.+++..+..|+.||+.||.||.+.. .+|||
T Consensus 516 REyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEik-pPIIH 593 (775)
T KOG1151|consen 516 REYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIK-PPIIH 593 (775)
T ss_pred HHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccC-CCeee
Confidence 7899999999999999999986 456789999999999999988655 47999999999999999999999877 78999
Q ss_pred ccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcC----CCCchhHHHHHHHH
Q 021891 83 RDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVV 150 (306)
Q Consensus 83 ~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~i 150 (306)
-||||.|||+-. -|.+||+|||+++.+.+.... .......||.||++||++.-+ .++.|+||||+|+|
T Consensus 594 YDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI 673 (775)
T KOG1151|consen 594 YDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI 673 (775)
T ss_pred eccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence 999999999943 477999999999987654332 233457899999999998633 56889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|..+.|+.||..+..... .+.. ..+-... +.--|.. .-.+.++.+||++||++.-++|....++..+
T Consensus 674 FyQClYGrKPFGhnqsQQd--ILqe--NTIlkAt---EVqFP~K-----PvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 674 FYQCLYGRKPFGHNQSQQD--ILQE--NTILKAT---EVQFPPK-----PVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhhhhccCCCCCCchhHHH--HHhh--hchhcce---eccCCCC-----CccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 9999999999986543211 0000 0000000 0000100 1224688899999999999999998888764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=252.55 Aligned_cols=218 Identities=22% Similarity=0.302 Sum_probs=161.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|++++|+||+++++++..+. ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.
T Consensus 61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~ 137 (343)
T cd07880 61 AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA 137 (343)
T ss_pred HHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 568999999999999999999987654 358999999 6799988754 3689999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ |+||||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|
T Consensus 138 g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 138 G---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred C---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 8 999999999999999999999999999865332 123456889999999875 4688999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchH-H--------hhhhhh-ccccccccccCCc---cCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLV-E--------WARPHL-GERRRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~-~--------~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+ . +..... .....+...+... .........+..+.++|.+||+.||++|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 9999999754321110000 0 000000 0000000000000 0000111234578899999999999999
Q ss_pred CCHHHHHHH
Q 021891 222 PLMSEVVEA 230 (306)
Q Consensus 222 ps~~ell~~ 230 (306)
||+.+++++
T Consensus 290 ~t~~~~l~~ 298 (343)
T cd07880 290 ITAAEALAH 298 (343)
T ss_pred CCHHHHhcC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=237.77 Aligned_cols=219 Identities=23% Similarity=0.306 Sum_probs=167.0
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
.+|+.++..++|+||++++.+|.-.+ ..|+|||+|. .+|...+. -.++-..+..++.|++.|+.|||+.+
T Consensus 63 ~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~ 138 (369)
T KOG0665|consen 63 YRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG 138 (369)
T ss_pred hhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc
Confidence 47999999999999999999987543 5699999995 59999886 35788999999999999999999999
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+||++..++.+||.|||+|+..... ...+..+.|..|+|||++.+-.|.+.+||||+||++.||++
T Consensus 139 ---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~ 212 (369)
T KOG0665|consen 139 ---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL 212 (369)
T ss_pred ---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh
Confidence 999999999999999999999999999874332 34455678899999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHH----------------hhhhhhccc-----cccccccCC-ccCC--CCCHHHHHHHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVE----------------WARPHLGER-----RRFYRLIDP-RLEG--HFSIKGAQKAAQLAAH 212 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~----------------~~~~~~~~~-----~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~ 212 (306)
|...|.+...-+.-..+. .++...... ..+.+.+.. .+.. +.+......+.+++.+
T Consensus 213 ~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~ 292 (369)
T KOG0665|consen 213 GTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSK 292 (369)
T ss_pred ceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHH
Confidence 999988643322111110 000000000 111111111 1111 1112234678999999
Q ss_pred cccCCCCCCCCHHHHHHHh
Q 021891 213 CLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 213 ~l~~~p~~Rps~~ell~~l 231 (306)
||..||++|.|++++|.|.
T Consensus 293 MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 293 MLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hhccChhhcccHHHHhcCC
Confidence 9999999999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=266.61 Aligned_cols=102 Identities=28% Similarity=0.333 Sum_probs=95.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|+||+++++++...+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||..+ |+
T Consensus 51 ~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---Ii 126 (669)
T cd05610 51 VQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---II 126 (669)
T ss_pred HHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 678999999999999999999999999999999999999999998654 36899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAK 107 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~ 107 (306)
||||||+|||++.++.+||+|||+++
T Consensus 127 HrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 127 HRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=241.82 Aligned_cols=194 Identities=26% Similarity=0.387 Sum_probs=162.2
Q ss_pred HHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 5 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 5 E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
|-++|.-. +-|.+++++.+|++-+.+|+||||+.||+|.-++.+-+ ++.+..+..++..|+.||-+||+++ ||+|
T Consensus 399 EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---IiYR 474 (683)
T KOG0696|consen 399 EKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---IIYR 474 (683)
T ss_pred hhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---eeee
Confidence 44555444 45788999999999999999999999999999886655 6889999999999999999999999 9999
Q ss_pred cCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 021891 84 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 163 (306)
Q Consensus 84 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 163 (306)
|||.+||+++.+|++||+|||+++.-...+. .+..++||+.|+|||++...+|+.++|.||+|++||||+.|++||.+
T Consensus 475 DLKLDNvmLd~eGHiKi~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 475 DLKLDNVMLDSEGHIKIADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred eccccceEeccCCceEeeecccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999986433322 34568999999999999999999999999999999999999999998
Q ss_pred CCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 164 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
.+..+....+. + ..-.++...+.++.++++..|.++|.+|.
T Consensus 553 eDE~elF~aI~----------------e--hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 553 EDEDELFQAIM----------------E--HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CCHHHHHHHHH----------------H--ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 65543221111 0 01124556678999999999999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=233.55 Aligned_cols=208 Identities=31% Similarity=0.399 Sum_probs=168.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++.+++++|+||+++++++......++++||+.+++|.+++.... .+++..++.++.+++.++.+||+.+ ++
T Consensus 34 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~ 109 (244)
T smart00220 34 ILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---II 109 (244)
T ss_pred HHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---ee
Confidence 6789999999999999999999999999999999999999999986544 3899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||+|+||+++.++.++|+|||.+....... ......++..|++||...+..++.++|||+||+++++|++|..||
T Consensus 110 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~ 186 (244)
T smart00220 110 HRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPF 186 (244)
T ss_pred cCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998764432 223456788999999998888999999999999999999999998
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
....... ....... ... .... ......+.++.+++.+||..+|++||++.+++++
T Consensus 187 ~~~~~~~--~~~~~~~---~~~------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 187 PGDDQLL--ELFKKIG---KPK------PPFP---PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CCCCcHH--HHHHHHh---ccC------CCCc---cccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 6531111 1111000 000 0000 0000034688999999999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=265.24 Aligned_cols=210 Identities=22% Similarity=0.258 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|..|-.+|..-+.+-|++++-.|.+++++|+||||++||+|-.++.+.. ++++..+..++..|+.||.-||+.| +|
T Consensus 122 F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yV 197 (1317)
T KOG0612|consen 122 FREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YV 197 (1317)
T ss_pred HHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ce
Confidence 6788889988889999999999999999999999999999999998877 8999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh----c-CCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----T-GHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~ellt 156 (306)
||||||+|||+|..|++||+|||.+-.+...+.. .....+|||.|++||++. + +.|+..+|.||+||++|||+.
T Consensus 198 HRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly 276 (1317)
T KOG0612|consen 198 HRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY 276 (1317)
T ss_pred eccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc
Confidence 9999999999999999999999998776654433 344568999999999996 3 578999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~l 231 (306)
|..||....-.+....+. .-+....+. . ..+.+.++.+||.+.+ -+|+.|.. ++++..|.
T Consensus 277 G~TPFYadslveTY~KIm-------~hk~~l~FP-----~--~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 277 GETPFYADSLVETYGKIM-------NHKESLSFP-----D--ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred CCCcchHHHHHHHHHHHh-------chhhhcCCC-----c--ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence 999997643221111110 000000111 0 1235789999999988 47888887 88888865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=242.27 Aligned_cols=201 Identities=26% Similarity=0.365 Sum_probs=161.6
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
+.|-.||..-+.+-||++|-.|.+++.+|+||+|++||++..+|.+.+ -|++..+..++..+..|+++.|..| +||
T Consensus 677 KAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIH 752 (1034)
T KOG0608|consen 677 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIH 752 (1034)
T ss_pred hhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---cee
Confidence 578899999999999999999999999999999999999999998776 6899999999999999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCccc---------CCCCCcce-------------------------------eeeccc
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKD---------GPEGDKTH-------------------------------VSTRVM 122 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~---------~~~~~~~~-------------------------------~~~~~~ 122 (306)
|||||+|||||.+|++||+||||++- +..++... .....+
T Consensus 753 RDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv 832 (1034)
T KOG0608|consen 753 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLV 832 (1034)
T ss_pred cccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence 99999999999999999999999852 11110000 011257
Q ss_pred ccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHH
Q 021891 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 202 (306)
Q Consensus 123 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (306)
||..|+|||++....|+..+|.||.|+|||||+.|++||....+.+....+...+ ..++-.... +.
T Consensus 833 gt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~----------~~l~~~~~~----~l 898 (1034)
T KOG0608|consen 833 GTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR----------NFLHIPYQG----NL 898 (1034)
T ss_pred CCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh----------hcccccccc----cc
Confidence 9999999999999999999999999999999999999999887766543332211 122222222 33
Q ss_pred HHHHHHHHHHcccCCCCCCC
Q 021891 203 AQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 203 ~~~~~~li~~~l~~~p~~Rp 222 (306)
+.++.+||.+++ -+++.|.
T Consensus 899 s~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 899 SKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred CHHHHHHHHHHh-cChhhhh
Confidence 567778887754 3567775
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=232.07 Aligned_cols=212 Identities=26% Similarity=0.311 Sum_probs=161.5
Q ss_pred HHHHHHHHh-cCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~-~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|+.|.+... .=+.||||++||.+..++..|+.||+| ..||+.+... ....+++..+-.+....+.||.||.+.-
T Consensus 109 ll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l 187 (361)
T KOG1006|consen 109 LLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL 187 (361)
T ss_pred HHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh
Confidence 455555433 346899999999999999999999999 4588776532 3456999999999999999999998754
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh--cCCCCchhHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el 154 (306)
. |||||+||+|||++..|.+||||||++-.+.+. ...+...|...|||||-+. +..|+.++||||||+++||+
T Consensus 188 k--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~Ev 262 (361)
T KOG1006|consen 188 K--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEV 262 (361)
T ss_pred h--hhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeee
Confidence 3 999999999999999999999999999775432 2234457888999999986 34699999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||..|+.++.. +.+....... +....+..+ .-....+..+..+|..||.+|...||...+++++
T Consensus 263 AtG~fPyr~w~s-----vfeql~~Vv~--gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 263 ATGNFPYRKWDS-----VFEQLCQVVI--GDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCCCCcchHHH-----HHHHHHHHHc--CCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 999999987643 1111111110 010111111 1123356789999999999999999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=247.06 Aligned_cols=210 Identities=23% Similarity=0.268 Sum_probs=171.4
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
++++|+.||+++.||.||.+...|++.+..+.|||.+.|.=|.-.+.....++++..-..++.||+.||.|||.++ |
T Consensus 609 qlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---I 685 (888)
T KOG4236|consen 609 QLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---I 685 (888)
T ss_pred HHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---e
Confidence 3789999999999999999999999999999999999654444444455668999999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCC---CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 81 IYRDFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
+|+||||+|||+... -.+||||||.|+.+.... -....+||+.|.|||++..+.|+..-|+||+|+|+|.-++|
T Consensus 686 vHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG 762 (888)
T KOG4236|consen 686 VHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 762 (888)
T ss_pred eeccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc
Confidence 999999999999654 468999999999976533 24457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
-.||....+.. +.+..+ .-+..+.. ..+.+..+++||..+|+..-.+|.|.++.+.|.+
T Consensus 763 TFPFNEdEdIn--dQIQNA----------aFMyPp~P----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 763 TFPFNEDEDIN--DQIQNA----------AFMYPPNP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred cccCCCccchh--HHhhcc----------ccccCCCc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 99997543221 111110 01122222 2345678999999999999999999999998754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=255.88 Aligned_cols=208 Identities=27% Similarity=0.382 Sum_probs=161.3
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCH---HHHHHHHHHHHHHHHHhhcCCCC
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW---SIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~---~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
++|+++|+.- +|||||++|+.-.+....||..|.|. .+|.+++......... ...+.++.|+++||++||+.+
T Consensus 550 ~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-- 626 (903)
T KOG1027|consen 550 QREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK-- 626 (903)
T ss_pred HHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--
Confidence 6899999988 79999999999888999999999995 5999999774211111 345778999999999999988
Q ss_pred CeEeccCCCCCeEEcC---C--CcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDA---D--YNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~---~--~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
||||||||.||||+. + .+++|+|||+++....+... .......||.+|+|||++....-..++|||||||++|
T Consensus 627 -iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfy 705 (903)
T KOG1027|consen 627 -IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFY 705 (903)
T ss_pred -cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEE
Confidence 999999999999976 3 46899999999987654332 2234567999999999999888888999999999999
Q ss_pred HHHhC-CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+.++| ..||......+..-+ .....+..+. + ....++.+||.+|+..+|..||++.+|+.|.
T Consensus 706 YvltgG~HpFGd~~~R~~NIl--------~~~~~L~~L~-~--------~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 706 YVLTGGSHPFGDSLERQANIL--------TGNYTLVHLE-P--------LPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred EEecCCccCCCchHHhhhhhh--------cCccceeeec-c--------CchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 99886 799986533211000 0000000000 0 0011788999999999999999999999874
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=254.04 Aligned_cols=211 Identities=26% Similarity=0.352 Sum_probs=179.5
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|+-+|.+|+|||+++++++|.... +.||++|+++|+|.|+++.+...+-....+.|..||++||.|||.+. +
T Consensus 744 e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---l 819 (1177)
T KOG1025|consen 744 ELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---L 819 (1177)
T ss_pred HHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---h
Confidence 5789999999999999999999998776 88999999999999999988888999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||...||||..-..+||.|||+++...............-.+.|||-|.+....|+.++||||||+.+||++| |..
T Consensus 820 VHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~ 899 (1177)
T KOG1025|consen 820 VHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAK 899 (1177)
T ss_pred hhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCC
Confidence 9999999999999999999999999998776655544444444667999999999999999999999999999887 889
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|+.+....+..+..+.. . + -..+..++.+++.++.+||..|++.||+++++...+.
T Consensus 900 Py~gi~~~eI~dlle~g-------e---R-------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 900 PYDGIPAEEIPDLLEKG-------E---R-------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred ccCCCCHHHhhHHHhcc-------c---c-------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 98876554443332211 1 1 1233456789999999999999999999999998764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-33 Score=267.96 Aligned_cols=201 Identities=19% Similarity=0.226 Sum_probs=145.4
Q ss_pred HhcCCC-CcccceeeEE-------EeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 9 LGDLVH-LNLVKLIGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 9 l~~l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.+.++| .||++++++| ...+.+++++||+ +++|.+++......+++..++.++.||+.||.|||+++ |
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 345677 6888999987 3334677889988 56999999766667999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCC-------------------CcEEEeccCCcccCCCCCc--------------ceeeecccccccc
Q 021891 81 IYRDFKTSNILLDAD-------------------YNAKLSDFGLAKDGPEGDK--------------THVSTRVMGTYGY 127 (306)
Q Consensus 81 iH~dlkp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y 127 (306)
+||||||+||||+.. +.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999653 4456666666653211000 0001124578899
Q ss_pred cCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHH
Q 021891 128 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 207 (306)
Q Consensus 128 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (306)
||||++.+..|+.++|||||||++|||++|.+|+..... ...... . ....+... .......
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~----~-----~~~~~~~~-----~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR----H-----RVLPPQIL-----LNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH----H-----hhcChhhh-----hcCHHHH
Confidence 999999999999999999999999999998887643210 000000 0 01111111 1123456
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 208 QLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 208 ~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
+++.+||+.+|.+||++.|++++..
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchh
Confidence 8899999999999999999998653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=228.39 Aligned_cols=228 Identities=29% Similarity=0.420 Sum_probs=168.1
Q ss_pred HHHHHHHHhcC--CCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDL--VHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l--~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
|++|-+|.+.. +|+||+++++.-+... .++||++|-+.|+|.++|..+ .++|.....++..++.||+|||+.
T Consensus 249 ~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee 326 (534)
T KOG3653|consen 249 FQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEE 326 (534)
T ss_pred HHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhccc
Confidence 77888888764 8999999999877665 789999999999999999766 489999999999999999999987
Q ss_pred CC------CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCC-----chhH
Q 021891 76 AE------RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SRSD 143 (306)
Q Consensus 76 ~~------~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~D 143 (306)
-+ .+|+|||||..||||..++++.|+|||+|..+..+.........+||.+|||||++.+. .+. ...|
T Consensus 327 ~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~D 406 (534)
T KOG3653|consen 327 LPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRID 406 (534)
T ss_pred CCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHH
Confidence 53 35999999999999999999999999999987765444334457899999999999764 222 3699
Q ss_pred HHHHHHHHHHHHhCCCCCC-CCCCCCCcch---------HHhhhhhhccccccccccCCccCCCC-CHHHHHHHHHHHHH
Q 021891 144 VYSFGVVLLEMLTGRRSMD-KNRPNGEHNL---------VEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAH 212 (306)
Q Consensus 144 iwslG~il~elltg~~pf~-~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ 212 (306)
|||+|.|+|||++...-+. +..+...... .+..+..... +...|.+...+ .......+.+.+..
T Consensus 407 vYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~-----kK~RP~~p~~W~~h~~~~~l~et~Ee 481 (534)
T KOG3653|consen 407 VYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR-----KKQRPKIPDAWRKHAGMAVLCETIEE 481 (534)
T ss_pred HHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh-----hccCCCChhhhhcCccHHHHHHHHHH
Confidence 9999999999999655443 1111111100 1100000000 01111111111 01335678999999
Q ss_pred cccCCCCCCCCHHHHHHHhCCCCC
Q 021891 213 CLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 213 ~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
||..|++.|.|+.=+-+.+..+..
T Consensus 482 CWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 482 CWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HcCCchhhhhhhHHHHHHHHHHhc
Confidence 999999999998887777665544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=226.67 Aligned_cols=225 Identities=21% Similarity=0.301 Sum_probs=168.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+-+|+++|..++|.|++..++...-.. .+|.|+|++.. +|.+.|.. .+.++...++-++.||+.||.|||+.+
T Consensus 99 vFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ 176 (449)
T KOG0664|consen 99 VFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN 176 (449)
T ss_pred HHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc
Confidence 468999999999999999998765432 46789999954 88887754 457999999999999999999999999
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell 155 (306)
|.||||||.|+|++.|..+||||||+++.-...+... .+..+-|..|+|||++.| ..|+.++||||+|||+.||+
T Consensus 177 ---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELL 252 (449)
T KOG0664|consen 177 ---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELL 252 (449)
T ss_pred ---hhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHH
Confidence 9999999999999999999999999999755443333 334456889999999986 47999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhh--------ccccc---ccccc-CCccCC--CC--CHHHHHHHHHHHHHcccCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHL--------GERRR---FYRLI-DPRLEG--HF--SIKGAQKAAQLAAHCLSRDPK 219 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~~-~~~~~~--~~--~~~~~~~~~~li~~~l~~~p~ 219 (306)
..+..|+...+....+++.-....- -++.+ +.... .|...- .+ +.....+...++.++|..||+
T Consensus 253 gRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 253 QRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred hhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 9999998877665554443221100 00000 00000 000000 00 112234677899999999999
Q ss_pred CCCCHHHHHHHhC
Q 021891 220 ARPLMSEVVEALK 232 (306)
Q Consensus 220 ~Rps~~ell~~l~ 232 (306)
+|.+..+.+.++-
T Consensus 333 kris~~~A~~~~~ 345 (449)
T KOG0664|consen 333 KRISVEEALQHRY 345 (449)
T ss_pred ccccHhhhccccc
Confidence 9999999998763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=220.97 Aligned_cols=203 Identities=28% Similarity=0.407 Sum_probs=159.9
Q ss_pred HHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 4 AEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 4 ~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
-|-.+..+- +||.+|-+..+|.++..+++|.||++||+|.-++.+ .++++++.+..+...|..||.|||+.| ||+
T Consensus 299 tek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg---iiy 374 (593)
T KOG0695|consen 299 TEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG---IIY 374 (593)
T ss_pred hhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC---eee
Confidence 344555555 799999999999999999999999999999888844 457999999999999999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
||||.+|+|+|..|.+||+|+|+++.-... ...+..++||+.|.|||++.+..|...+|.|+||++++||+.|+.||.
T Consensus 375 rdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 375 RDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred eeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 999999999999999999999999863322 223456899999999999999999999999999999999999999997
Q ss_pred CCCCCC-CcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 163 KNRPNG-EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 163 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
-..-.+ ..+...+....+-++ .+ .++...+-.+..+++.-|.+||.+|..
T Consensus 453 ivgm~n~d~ntedylfqvilek---------qi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 453 IVGMDNPDMNTEDYLFQVILEK---------QI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred eecCCCcccchhHHHHHHHhhh---------cc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 432211 122222222211111 11 112223445668899999999999953
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=208.69 Aligned_cols=215 Identities=19% Similarity=0.268 Sum_probs=165.0
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
.++|++||..|. ||||++++++..+. ....+|+||++..+...+. ..++.-.+..++.+++.||.|||+.|
T Consensus 79 IkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G-- 152 (338)
T KOG0668|consen 79 IKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG-- 152 (338)
T ss_pred HHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC--
Confidence 479999999996 99999999998875 4678999999988877765 35778889999999999999999999
Q ss_pred CeEeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHh
Q 021891 79 PVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt 156 (306)
|+|||+||.|++||.. ..++|+|+|+|..+..+.... ..+.+..|.-||++.. ..|+.+-|+|||||++..|++
T Consensus 153 -ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF 228 (338)
T KOG0668|consen 153 -IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228 (338)
T ss_pred -cccccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHh
Confidence 9999999999999865 569999999999876654332 2345778899999874 578999999999999999999
Q ss_pred CCCCCCCCCCCCCc-chHHhhh-----------hhh------------ccccccccccCCccCCCCCHHHHHHHHHHHHH
Q 021891 157 GRRSMDKNRPNGEH-NLVEWAR-----------PHL------------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 212 (306)
Q Consensus 157 g~~pf~~~~~~~~~-~~~~~~~-----------~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 212 (306)
.+.||.....+... ..+..+. ..+ ..++.+..++.+.... -.+.++.+|+.+
T Consensus 229 rkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldk 304 (338)
T KOG0668|consen 229 RKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDK 304 (338)
T ss_pred ccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHH
Confidence 99999766554321 1111110 000 1112222222222111 124688999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 021891 213 CLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 213 ~l~~~p~~Rps~~ell~~ 230 (306)
+|..|..+|+|++|+++|
T Consensus 305 lLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 305 LLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHhhccccccchHHHhcC
Confidence 999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=235.84 Aligned_cols=221 Identities=23% Similarity=0.260 Sum_probs=170.1
Q ss_pred HHHHHHHhcCCC------CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 3 QAEVNFLGDLVH------LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 3 ~~E~~il~~l~H------~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+.|++||++|+. -|+++++-.|...+++|||+|-+ .-+|.+.|.+.+ ..|....+..++.|++.||..|-.
T Consensus 476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~ 554 (752)
T KOG0670|consen 476 LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK 554 (752)
T ss_pred hHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh
Confidence 579999999953 38999999999999999999999 569999997654 457888999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 75 EAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
.+ |+|.||||+|||+++. ..+||||||.|........+ ...-+..|+|||++.|..|+...|+||+||+|||
T Consensus 555 c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYE 627 (752)
T KOG0670|consen 555 CG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYE 627 (752)
T ss_pred cC---eeecccCccceEeccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEE
Confidence 88 9999999999999875 56799999999876544322 2234667999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhh---------------hhhcccccc----------------ccccCC------ccCC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWAR---------------PHLGERRRF----------------YRLIDP------RLEG 196 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~---------------~~~~~~~~~----------------~~~~~~------~~~~ 196 (306)
|.||+..|.+...+.++.+..-.. .++.....| ...+.| .+..
T Consensus 628 lYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~ 707 (752)
T KOG0670|consen 628 LYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA 707 (752)
T ss_pred eeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc
Confidence 999999999876654433221111 111111111 011111 0000
Q ss_pred --CC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 197 --HF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 197 --~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.+ ......++.+|+.+||..||++|.|..++|+|.
T Consensus 708 ~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 708 VQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred cCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 01 223456889999999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=206.39 Aligned_cols=156 Identities=27% Similarity=0.366 Sum_probs=132.3
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
.+|+.+.... ..|.+|.+||........++.||.|. .||+.+.. +.+..+++..+-+++..++.||.|||++-+
T Consensus 92 L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~- 169 (282)
T KOG0984|consen 92 LMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS- 169 (282)
T ss_pred HHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh-
Confidence 4566654444 68999999999999999999999994 58877653 457789999999999999999999999754
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc----CCCCchhHHHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el 154 (306)
++|||+||+||||+.+|++|+||||++-.+.+.. ..+...|...|||||.+.. ..|+-|+||||||+.++||
T Consensus 170 -vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiEl 245 (282)
T KOG0984|consen 170 -VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEM 245 (282)
T ss_pred -hhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhh
Confidence 9999999999999999999999999998765432 2233568889999999863 4799999999999999999
Q ss_pred HhCCCCCCCC
Q 021891 155 LTGRRSMDKN 164 (306)
Q Consensus 155 ltg~~pf~~~ 164 (306)
.+++.||..+
T Consensus 246 A~lr~PY~~w 255 (282)
T KOG0984|consen 246 AILRFPYESW 255 (282)
T ss_pred hhcccccccc
Confidence 9999999765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=246.93 Aligned_cols=183 Identities=28% Similarity=0.431 Sum_probs=134.3
Q ss_pred eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 29 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 29 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.+||=||||+...|.+++.++...-.....|.++++|++||.|+|+.| +|||||||.|||++.++.|||+|||+|+.
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 357889999987777777655422257888999999999999999999 99999999999999999999999999986
Q ss_pred CC------C----------CCcceeeecccccccccCCcchhcC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 021891 109 GP------E----------GDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 169 (306)
Q Consensus 109 ~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 169 (306)
.. + +......+..+||.-|+|||++.+. .|+.|+|+||||+|+|||+. ||... .+.
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MER 821 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MER 821 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHH
Confidence 11 0 1111133557899999999999754 59999999999999999985 35432 111
Q ss_pred cchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
...+...+ ...+ ... ..+.......-..+|.+|++.||.+|||+.|+|+.
T Consensus 822 a~iL~~LR-----~g~i----P~~--~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 822 ASILTNLR-----KGSI----PEP--ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHhcc-----cCCC----CCC--cccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 11111111 0000 000 11222333456789999999999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=206.33 Aligned_cols=166 Identities=25% Similarity=0.240 Sum_probs=126.2
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeee
Q 021891 40 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119 (306)
Q Consensus 40 ~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 119 (306)
|+|.+++..++..+++..++.++.||+.||.|||+.+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999876777999999999999999999999854 999999999999999 99987653321
Q ss_pred cccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCC
Q 021891 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 199 (306)
Q Consensus 120 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (306)
..||+.|+|||++.+..++.++|||||||++|||++|..||....... ............ ..+.. ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~-------~~~~~-~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA-------DDPRD-RSNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc-------CCccc-cccH
Confidence 257899999999999999999999999999999999999996542211 111111100000 00000 0011
Q ss_pred HHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 200 IKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 200 ~~~~~--~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
..... .+.+++.+||..||++||++.++++++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 22233 68999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=219.43 Aligned_cols=211 Identities=25% Similarity=0.333 Sum_probs=171.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-CeeEEEEEcCCCCCHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~-------~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
|..|.-+|..+.|||+..+.+++.++ ...+.++.++..|+|+.++.. ..+.++..+...++.|++.|++|||
T Consensus 334 ~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh 413 (563)
T KOG1024|consen 334 LLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH 413 (563)
T ss_pred HHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH
Confidence 56777788889999999999988764 467888999999999999972 2345777788899999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
+.+ +||.||...|++|++.-.+||+|=.+++..-+.+..-..........||++|.+....|+.++||||||+++||
T Consensus 414 ~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWE 490 (563)
T KOG1024|consen 414 NHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWE 490 (563)
T ss_pred hcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHH
Confidence 999 99999999999999999999999999988655544333333344667999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 154 MLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 154 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|+| |+.|+...++.+....+. ++. .-..+..++++++.++.-||...|++||+++++..-|.
T Consensus 491 Lmtlg~~PyaeIDPfEm~~ylk-------dGy----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 491 LMTLGKLPYAEIDPFEMEHYLK-------DGY----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred HHhcCCCCccccCHHHHHHHHh-------ccc----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 988 788887665544322221 111 11234457899999999999999999999999998774
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=221.87 Aligned_cols=223 Identities=21% Similarity=0.277 Sum_probs=165.6
Q ss_pred HHHHHHHhcCC-----C---CcccceeeEEEeC----CeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHH
Q 021891 3 QAEVNFLGDLV-----H---LNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGL 69 (306)
Q Consensus 3 ~~E~~il~~l~-----H---~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l 69 (306)
..||++|+++. | .+||+++++|... .++|+|+|++ |.+|..+|... .+.++...++.|++||+.||
T Consensus 122 lDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GL 200 (590)
T KOG1290|consen 122 LDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGL 200 (590)
T ss_pred HHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHH
Confidence 47999999982 3 3799999999874 4899999999 66888888654 56799999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEEc--------------------------------------------------------
Q 021891 70 AFLHEEAERPVIYRDFKTSNILLD-------------------------------------------------------- 93 (306)
Q Consensus 70 ~~LH~~~~~~iiH~dlkp~Nill~-------------------------------------------------------- 93 (306)
.|||.+.. |||-||||+|||+.
T Consensus 201 dYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~ 278 (590)
T KOG1290|consen 201 DYLHRECG--IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLK 278 (590)
T ss_pred HHHHHhcC--ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHh
Confidence 99998754 99999999999994
Q ss_pred ----------------------------------------------------------CC--------------------
Q 021891 94 ----------------------------------------------------------AD-------------------- 95 (306)
Q Consensus 94 ----------------------------------------------------------~~-------------------- 95 (306)
.+
T Consensus 279 r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~ 358 (590)
T KOG1290|consen 279 RQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSA 358 (590)
T ss_pred hhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhccccc
Confidence 00
Q ss_pred --------------------------------CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhH
Q 021891 96 --------------------------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 143 (306)
Q Consensus 96 --------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 143 (306)
-++||+|||-|++.... .+....|..|+|||++.+..|+..+|
T Consensus 359 t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~AD 433 (590)
T KOG1290|consen 359 TPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSAD 433 (590)
T ss_pred ccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchh
Confidence 01577777777664322 12235688999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCC---CcchHHhhh------------------hhhccccccccccCCccC-------
Q 021891 144 VYSFGVVLLEMLTGRRSMDKNRPNG---EHNLVEWAR------------------PHLGERRRFYRLIDPRLE------- 195 (306)
Q Consensus 144 iwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~------- 195 (306)
|||++|++|||+||...|......+ ....+.... ..+...+.+..+-.-...
T Consensus 434 iWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~ 513 (590)
T KOG1290|consen 434 IWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLI 513 (590)
T ss_pred HHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHH
Confidence 9999999999999998886533222 111111111 111112222111111111
Q ss_pred --CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 196 --GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 196 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
-.++.+.+.++.+|+.-||+.+|++|||+.++++|.+-
T Consensus 514 eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 514 EKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL 553 (590)
T ss_pred HHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence 13677889999999999999999999999999998653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=220.31 Aligned_cols=226 Identities=27% Similarity=0.360 Sum_probs=169.7
Q ss_pred HHHHHHHHhcC--CCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDL--VHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l--~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
|.+|.+|.+.+ +|+||+.+++.-..++ .+|||++|-+.|||.|+|.+ ..++.+...+++..+|.||++||..
T Consensus 250 WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~e 327 (513)
T KOG2052|consen 250 WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHME 327 (513)
T ss_pred hhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHH
Confidence 67899999875 9999999999765543 67899999999999999966 3689999999999999999999964
Q ss_pred -----CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc--ceeeecccccccccCCcchhcC----CC--Cchh
Q 021891 76 -----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTG----HL--TSRS 142 (306)
Q Consensus 76 -----~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~ 142 (306)
|+..|.|||||..||||.++|.+-|+|+|+|........ ....+..+||.+|||||++... .+ -..+
T Consensus 328 I~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~A 407 (513)
T KOG2052|consen 328 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRA 407 (513)
T ss_pred HhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHH
Confidence 445699999999999999999999999999987544321 1223457899999999998642 22 2369
Q ss_pred HHHHHHHHHHHHHhC----------CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHHH
Q 021891 143 DVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAA 211 (306)
Q Consensus 143 DiwslG~il~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 211 (306)
||||||.++||++-. +.||.+..+.+...-.. ...-.. +.+.|.+... .+.+.-..+.+||+
T Consensus 408 DIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM---rkVVCv----~~~RP~ipnrW~s~~~l~~m~klMk 480 (513)
T KOG2052|consen 408 DIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM---RKVVCV----QKLRPNIPNRWKSDPALRVMAKLMK 480 (513)
T ss_pred HHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH---hcceee----cccCCCCCcccccCHHHHHHHHHHH
Confidence 999999999999863 46776655443311100 000011 1122222222 23345567889999
Q ss_pred HcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 212 HCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
.||..||.-|.|+-.|.+.|..+.+
T Consensus 481 eCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 481 ECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HhhcCCchhhhHHHHHHHHHHHHhc
Confidence 9999999999999999998876654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=238.54 Aligned_cols=200 Identities=21% Similarity=0.256 Sum_probs=132.9
Q ss_pred EeCCeeEEEEEcCCCCCHHHHhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 021891 25 IEDDQRLLVYEFMPRGSLENHLFRRSLP-------------------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 85 (306)
Q Consensus 25 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dl 85 (306)
......++|+||+.+++|.+++...... .....+..++.||+.||.|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 3456789999999999999988654311 123456789999999999999988 999999
Q ss_pred CCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC----------------------CCCchh
Q 021891 86 KTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----------------------HLTSRS 142 (306)
Q Consensus 86 kp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 142 (306)
||+|||++. ++.+||+|||+++....... .......+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 58999999999986543222 223446789999999976422 234567
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCC----C--CHHHHHHHHHHHHHcccC
Q 021891 143 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH----F--SIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 143 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~~~~li~~~l~~ 216 (306)
|||||||++|||+++..++.... ................+.....+..... + .........+||.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999998765533210 0000000000000000001111110000 0 000123456899999999
Q ss_pred CCCCCCCHHHHHHHhC
Q 021891 217 DPKARPLMSEVVEALK 232 (306)
Q Consensus 217 ~p~~Rps~~ell~~l~ 232 (306)
||.+|||+.++++|..
T Consensus 437 dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 437 KGRQRISAKAALAHPY 452 (566)
T ss_pred CcccCCCHHHHhCCcC
Confidence 9999999999999754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=203.86 Aligned_cols=176 Identities=35% Similarity=0.549 Sum_probs=155.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++.++.++|++|+++++++......++++|++.+++|.+++......+++..++.++.+++.+|.+||+.+ ++
T Consensus 38 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~ 114 (215)
T cd00180 38 LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---II 114 (215)
T ss_pred HHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 679999999999999999999999989999999999989999998765456899999999999999999999998 99
Q ss_pred eccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~ 159 (306)
|+||+|.||+++. ++.++|+|||.+........ ......+...|++||..... .++.++|+|++|+++++|
T Consensus 115 H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----- 187 (215)
T cd00180 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----- 187 (215)
T ss_pred ccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----
Confidence 9999999999999 89999999999987544321 12234567889999998876 888999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
..+.+++.+|++.||++||++.++++++
T Consensus 188 --------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2566999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=226.73 Aligned_cols=214 Identities=20% Similarity=0.266 Sum_probs=149.3
Q ss_pred HHHHHHhcCCCCcc-----cceeeEEEe--------CCeeEEEEEcCCCCCHHHHhhcCC--------------------
Q 021891 4 AEVNFLGDLVHLNL-----VKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS-------------------- 50 (306)
Q Consensus 4 ~E~~il~~l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~-------------------- 50 (306)
.|+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777778876654 677777653 356899999999999999885321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccc
Q 021891 51 ---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127 (306)
Q Consensus 51 ---~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 127 (306)
..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........ ......+++.|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y 376 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRY 376 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcce
Confidence 12456788899999999999999988 999999999999999999999999999764332211 11123347899
Q ss_pred cCCcchhcCC--------------------C--CchhHHHHHHHHHHHHHhCCC-CCCCCCCCCC------cchHHhhhh
Q 021891 128 AAPEYVMTGH--------------------L--TSRSDVYSFGVVLLEMLTGRR-SMDKNRPNGE------HNLVEWARP 178 (306)
Q Consensus 128 ~aPE~~~~~~--------------------~--~~~~DiwslG~il~elltg~~-pf~~~~~~~~------~~~~~~~~~ 178 (306)
+|||.+.... | ..+.||||+||++|+|++|.. ||........ .....|...
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999875322 1 235799999999999999875 6643221110 001111110
Q ss_pred hhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHHhC
Q 021891 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP---KARPLMSEVVEALK 232 (306)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~ell~~l~ 232 (306)
. .. ..+- ......+....+|+.+||..+| .+|+|+.|+++|..
T Consensus 457 ~-~~------~~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 457 K-GQ------KYDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred c-cc------CCCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 0 00 0000 0112235788999999999876 68999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-31 Score=233.40 Aligned_cols=210 Identities=24% Similarity=0.347 Sum_probs=169.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.++|+-+++..+|||||.|++.+...+.+++.||||.||+|.+.. .-..++++.++...++..+.||.|||+.+ -+
T Consensus 59 iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~g---k~ 134 (829)
T KOG0576|consen 59 IQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQG---KI 134 (829)
T ss_pred cccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCC---cc
Confidence 367888999999999999999999999999999999999999965 34458999999999999999999999999 89
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
|||||-.||++++.|.+|++|||.+..+.... -....+.||+.|||||+.. .+.|..++|||++|+...|+--.+
T Consensus 135 hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLq 212 (829)
T KOG0576|consen 135 HRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQ 212 (829)
T ss_pred cccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcC
Confidence 99999999999999999999999998765432 2345588999999999874 568999999999999999999888
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|.....+.....++. . ..+++....+ .-..++.+.+|++.+|.++|++|||++.++.|
T Consensus 213 pplfdlhpmr~l~LmT--------k----S~~qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 213 PPLFDLHPMRALFLMT--------K----SGFQPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CcccccchHHHHHHhh--------c----cCCCCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 8866544332211111 0 1111111111 11235678899999999999999999998875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=205.81 Aligned_cols=211 Identities=25% Similarity=0.358 Sum_probs=153.7
Q ss_pred CHHHHHHHHhcC-CCCcccceeeE-EEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 1 MWQAEVNFLGDL-VHLNLVKLIGY-CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 1 ~~~~E~~il~~l-~H~niv~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+|.+|+.---.| .|.||+.-|++ |++.+.+++++||++.|+|...+... .+-+..-..++.|+++|+.|+|+++
T Consensus 66 dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn-- 141 (378)
T KOG1345|consen 66 DFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN-- 141 (378)
T ss_pred HHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc--
Confidence 477777766666 58899987764 67778888999999999999988654 4788888999999999999999999
Q ss_pred CeEeccCCCCCeEEcC--CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc---C--CCCchhHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---G--HLTSRSDVYSFGVVL 151 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il 151 (306)
+||||||.+||||-. .-++||||||+.+..... ......+..|.+||.... + ...+.+|||.||+++
T Consensus 142 -lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 142 -LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred -hhhcccccceEEEecCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeee
Confidence 999999999999932 347999999998864321 222234567999998753 2 346789999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHH
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVV 228 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~ell 228 (306)
|.++||..||+.....+. ....|.. +..+. .+.....+. ..++.+..+.++-|..++++| .++....
T Consensus 216 f~cltG~~PWQka~~~d~-~Y~~~~~--w~~rk------~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 216 FYCLTGKFPWQKASIMDK-PYWEWEQ--WLKRK------NPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred eeeecCCCcchhhhccCc-hHHHHHH--Hhccc------CccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 999999999985544333 2222222 21111 112222221 235678899999999999999 4444444
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
..+
T Consensus 286 k~~ 288 (378)
T KOG1345|consen 286 KCL 288 (378)
T ss_pred HHH
Confidence 433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=221.95 Aligned_cols=151 Identities=25% Similarity=0.359 Sum_probs=134.4
Q ss_pred HHHHHHhcCC---CCcccceeeEEEeCCeeEEEEEcCC-CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 4 AEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMP-RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 4 ~E~~il~~l~---H~niv~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.|++||..|+ |+||++++++|++++.+||+||--. |-+|.++|..+ ..+++..+..|++||+.|+++||+.+
T Consensus 615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--- 690 (772)
T KOG1152|consen 615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--- 690 (772)
T ss_pred hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---
Confidence 5999999997 9999999999999999999999753 34999999554 47999999999999999999999999
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~ 158 (306)
|||||||-+||.++.+|.+||+|||.+.....+ .-..++||..|.|||++.|..| ...-|||+||+++|-++...
T Consensus 691 ivhrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred ceecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 999999999999999999999999999875333 2345789999999999999888 55689999999999999888
Q ss_pred CCCC
Q 021891 159 RSMD 162 (306)
Q Consensus 159 ~pf~ 162 (306)
.||.
T Consensus 767 npyy 770 (772)
T KOG1152|consen 767 NPYY 770 (772)
T ss_pred CCCc
Confidence 8875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=191.00 Aligned_cols=158 Identities=31% Similarity=0.380 Sum_probs=138.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++.++.++|+|++++++++......++++|++++++|.+++......+++..+..++.+++.++.+||+.+ ++
T Consensus 44 ~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~ 120 (225)
T smart00221 44 FLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IV 120 (225)
T ss_pred HHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999999999999999999999998665433899999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcch-hcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||+|.||+++.++.++|+|||.+........ .......++..|++||.+ ....++.++|+|+||+++++|++|+.|
T Consensus 121 h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~p 199 (225)
T smart00221 121 HRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEP 199 (225)
T ss_pred cCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999987654320 012334677889999998 666788899999999999999999999
Q ss_pred CCC
Q 021891 161 MDK 163 (306)
Q Consensus 161 f~~ 163 (306)
|..
T Consensus 200 f~~ 202 (225)
T smart00221 200 FSG 202 (225)
T ss_pred ccc
Confidence 965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=197.86 Aligned_cols=223 Identities=24% Similarity=0.281 Sum_probs=162.0
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
..+|+++|..+ -+.||+++.+++..++..++|+||++.....++.. .++...+..+++.++.||.++|.+| |
T Consensus 81 i~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---I 153 (418)
T KOG1167|consen 81 ILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---I 153 (418)
T ss_pred HHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---c
Confidence 36899999999 68999999999999999999999999999988873 4678899999999999999999999 9
Q ss_pred EeccCCCCCeEEcC-CCcEEEeccCCcccCCCC------------------------------------------Cccee
Q 021891 81 IYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEG------------------------------------------DKTHV 117 (306)
Q Consensus 81 iH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~------------------------------------------~~~~~ 117 (306)
|||||||+|++.+. .+.-.|.|||+|...... .....
T Consensus 154 vHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~ 233 (418)
T KOG1167|consen 154 VHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSE 233 (418)
T ss_pred cccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccce
Confidence 99999999999975 467789999998721100 00000
Q ss_pred eecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC-cchHH---------hhhhhhcc----
Q 021891 118 STRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVE---------WARPHLGE---- 182 (306)
Q Consensus 118 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~---------~~~~~~~~---- 182 (306)
.-...||++|+|||++.. ...+.++||||.|+|+.-++++..||........ ...+. ......+.
T Consensus 234 ~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~ 313 (418)
T KOG1167|consen 234 RANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW 313 (418)
T ss_pred ecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence 112569999999999974 5678999999999999999999999876433211 10000 00000000
Q ss_pred ----------c-cccccc----cCC-----ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 183 ----------R-RRFYRL----IDP-----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 183 ----------~-~~~~~~----~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
. ..+... +.+ ..........+..+++|+.+||+.||.+|.|+++.|+|.
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0 000000 101 011111222345789999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-27 Score=218.07 Aligned_cols=213 Identities=20% Similarity=0.210 Sum_probs=166.6
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
.|+-+-..|+|+|++..+..+.+.....-+||||++ +|..++... ..+....+-.++.|++.||.|+|+.| +.||
T Consensus 370 sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahr 444 (601)
T KOG0590|consen 370 SEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHR 444 (601)
T ss_pred hheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceec
Confidence 355566678999999888877776666666999999 999998665 36888899999999999999999999 9999
Q ss_pred cCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhcCCCCc-hhHHHHHHHHHHHHHhCCCC
Q 021891 84 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 84 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~p 160 (306)
|||++|+++..+|.+||+|||.+......... ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.|
T Consensus 445 dlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 445 DLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred cCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence 99999999999999999999999876544333 4556688999999999999999976 69999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|......+...... .... ..-...-........+...+.+|.+||+.||.+|.|+++|++.
T Consensus 525 Wk~a~~~~~~~~~~-------~~~~--~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 525 WKVAKKSDNSFKTN-------NYSD--QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccccccchhhh-------cccc--ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 97654443321000 0000 0000001112334456788899999999999999999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=187.74 Aligned_cols=218 Identities=25% Similarity=0.397 Sum_probs=167.9
Q ss_pred HhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-EeccCCC
Q 021891 9 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV-IYRDFKT 87 (306)
Q Consensus 9 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i-iH~dlkp 87 (306)
|+++.|.|+.+++|.+.++...++|.+||..|+|.|.+......+++.....++++|+.||.|||+.. | .|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 56889999999999999999999999999999999999888888999999999999999999999866 4 9999999
Q ss_pred CCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC---C----CCchhHHHHHHHHHHHHHhCCCC
Q 021891 88 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---H----LTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 88 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DiwslG~il~elltg~~p 160 (306)
.|++++....+||+|||+.................-..-|.|||.+.+. . .+.+.||||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776431111111222235569999999753 1 46679999999999999999999
Q ss_pred CCCCCCCCCc-chHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 021891 161 MDKNRPNGEH-NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 237 (306)
Q Consensus 161 f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 237 (306)
|......... ..+..... .....+.|.+.... +...++..++..||..+|.+||+++++-..++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9875443332 22222111 01112222222111 3344789999999999999999999999988766553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-22 Score=175.65 Aligned_cols=220 Identities=31% Similarity=0.427 Sum_probs=167.3
Q ss_pred HHHHHHHHhcCCCC-cccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|.+|+.+++.+.|+ +|+++++++......+++++++.+++|.+++.... ..+....+..++.|++.++.|+|+.+
T Consensus 44 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~-- 121 (384)
T COG0515 44 FLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG-- 121 (384)
T ss_pred HHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 67899999999988 79999999977777899999999999997775544 26899999999999999999999999
Q ss_pred CeEeccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcce----eeecccccccccCCcchhc---CCCCchhHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVV 150 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~i 150 (306)
++|||+||+||+++..+ .++++|||.++......... ......|+..|+|||.+.+ ..++...|+|++|++
T Consensus 122 -~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~ 200 (384)
T COG0515 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200 (384)
T ss_pred -eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHH
Confidence 99999999999999988 79999999998654433221 2355789999999999987 578999999999999
Q ss_pred HHHHHhCCCCCCCCCCC-CCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLTGRRSMDKNRPN-GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
++++++|..||...... ............. .. .................+.+++..|+..+|..|.+..+...
T Consensus 201 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 201 LYELLTGLPPFEGEKNSSATSQTLKIILELP---TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHHhCCCCCCCCCccccHHHHHHHHHhcC---Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 99999999997654431 0011111111000 00 00000110000122357889999999999999998888776
Q ss_pred H
Q 021891 230 A 230 (306)
Q Consensus 230 ~ 230 (306)
.
T Consensus 275 ~ 275 (384)
T COG0515 275 H 275 (384)
T ss_pred c
Confidence 4
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=172.16 Aligned_cols=208 Identities=22% Similarity=0.347 Sum_probs=161.2
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+|..|.--|+.+.||||+.+++.|....++.++..||+.|||...+.+.. ...+..++.+++.+++.|++|||+..+ -
T Consensus 233 dfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ 311 (448)
T KOG0195|consen 233 DFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-M 311 (448)
T ss_pred hhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-h
Confidence 47778888888999999999999999999999999999999999997653 347888999999999999999999873 2
Q ss_pred eEeccCCCCCeEEcCCCcEEEe--ccCCcccCCCCCcceeeecccccccccCCcchhcCCC---CchhHHHHHHHHHHHH
Q 021891 80 VIYRDFKTSNILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEM 154 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el 154 (306)
|..-.|....++||++.+.+|. |--.+.. .....-.+.||+||.++..+- -.++|+|||++++|||
T Consensus 312 ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel 382 (448)
T KOG0195|consen 312 IPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL 382 (448)
T ss_pred hhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence 4445688999999998777663 3222111 122334778999999986543 3589999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.|...||....+.+.--.+. -..+.-.++...+..+.+|+.-|+..||.+||.+..++-.|+.+
T Consensus 383 ~trevpfadlspmecgmkia----------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 383 NTREVPFADLSPMECGMKIA----------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hccccccccCCchhhhhhhh----------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 99999998876654322211 01112223444567889999999999999999999998877654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=176.54 Aligned_cols=215 Identities=23% Similarity=0.238 Sum_probs=164.6
Q ss_pred HHHHHHHHhcCCC----CcccceeeEE-EeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVH----LNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H----~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
++.|..++..+.. +++..+++.+ ..+...|+||+.+ |.+|.++..... +.++..++..++.|++.+|++||+.
T Consensus 63 l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~ 141 (322)
T KOG1164|consen 63 LKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK 141 (322)
T ss_pred chhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc
Confidence 6789999999973 6899999999 4777889999999 789999886554 7899999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCC-----CcEEEeccCCcc--cCCCCCcc---ee---eecccccccccCCcchhcCCCCchh
Q 021891 76 AERPVIYRDFKTSNILLDAD-----YNAKLSDFGLAK--DGPEGDKT---HV---STRVMGTYGYAAPEYVMTGHLTSRS 142 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~-----~~~kl~Dfg~a~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~~~ 142 (306)
| ++||||||+|+.+... ..+.|.|||+++ .+...... .. ...+.||..|+++.++.+...+.+.
T Consensus 142 G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~D 218 (322)
T KOG1164|consen 142 G---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRD 218 (322)
T ss_pred C---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCch
Confidence 9 9999999999999765 468999999999 43222211 11 1235699999999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 143 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 143 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
|+||++.++.+++.|..||.................. ..... +....+..+.++...+-..+..++|
T Consensus 219 Dles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~P 285 (322)
T KOG1164|consen 219 DLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK--------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKP 285 (322)
T ss_pred hhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh--------hcccc-----ccCCChHHHHHHHHHhhccCCcCCC
Confidence 9999999999999999999665433221111110000 00000 1112245677777777789999999
Q ss_pred CHHHHHHHhCC
Q 021891 223 LMSEVVEALKP 233 (306)
Q Consensus 223 s~~ell~~l~~ 233 (306)
....+...++.
T Consensus 286 dy~~~~~~l~~ 296 (322)
T KOG1164|consen 286 DYEKLAELLKD 296 (322)
T ss_pred CHHHHHHHHHH
Confidence 99999887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=165.10 Aligned_cols=217 Identities=18% Similarity=0.201 Sum_probs=172.4
Q ss_pred CHHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+++.|.+..+.|. .++|..+|-+...+.+-.||+|++ |.||.|++.-.++.|+..++..++.|++.-++|+|++.
T Consensus 69 QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--- 144 (449)
T KOG1165|consen 69 QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--- 144 (449)
T ss_pred hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---
Confidence 4788999999995 589999998888888888999999 78999999888889999999999999999999999999
Q ss_pred eEeccCCCCCeEEcCC-----CcEEEeccCCcccCCCCCcce-----eeecccccccccCCcchhcCCCCchhHHHHHHH
Q 021891 80 VIYRDFKTSNILLDAD-----YNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 149 (306)
Q Consensus 80 iiH~dlkp~Nill~~~-----~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 149 (306)
+|+|||||+|+||... ..+.|+|||+|+.+.+..+.. ......||.+||+-..+.+.+.+...|+-|||-
T Consensus 145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 9999999999999643 458999999999887654332 234567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
++++.+-|..||++..........+ .+++.++.. -...+....+.++...+...-..+..+-|..+-+..
T Consensus 225 vFmYFLRGsLPWQGLKA~tnK~kYe----KIGe~Kr~T------~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~ 294 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLKADTNKEKYE----KIGETKRST------PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRK 294 (449)
T ss_pred hhhhhccCCCccccccCcchHHHHH----HhccccccC------CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999876554433222 222222110 011122234677888888888888888898776655
Q ss_pred Hh
Q 021891 230 AL 231 (306)
Q Consensus 230 ~l 231 (306)
.+
T Consensus 295 Lf 296 (449)
T KOG1165|consen 295 LF 296 (449)
T ss_pred HH
Confidence 43
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=165.34 Aligned_cols=197 Identities=21% Similarity=0.257 Sum_probs=140.3
Q ss_pred CCCcccceeeEEEeC---------------------------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHH
Q 021891 13 VHLNLVKLIGYCIED---------------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 65 (306)
Q Consensus 13 ~H~niv~~~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi 65 (306)
+|||||++.++|.+. ..+|+||.-.. .+|..++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence 799999999887642 36789999885 59999996654 5667778899999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEc--CCC--cEEEeccCCcccCCCCCc--c--eeeecccccccccCCcchhcCC
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLD--ADY--NAKLSDFGLAKDGPEGDK--T--HVSTRVMGTYGYAAPEYVMTGH 137 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~--~~~--~~kl~Dfg~a~~~~~~~~--~--~~~~~~~gt~~y~aPE~~~~~~ 137 (306)
++|+.|||.++ |.|||||.+|||+. +++ .+.|+|||.+-......- . ......-|...-||||+....+
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 99999999999993 333 478999997643221100 0 0011234566789999986321
Q ss_pred ------CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHH
Q 021891 138 ------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 138 ------~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 211 (306)
--.|+|.|+.|.+.||+++...||.+..... .....+.... -| .++..++..+.+|+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~q-----------LP----alp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQ-----------LP----ALPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhh-----------CC----CCcccCChHHHHHHH
Confidence 1358999999999999999999998732211 1111111111 11 234455678899999
Q ss_pred HcccCCCCCCCCHHHHHHHh
Q 021891 212 HCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l 231 (306)
.+|+.||.+|++..=....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876555544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-23 Score=190.36 Aligned_cols=208 Identities=22% Similarity=0.266 Sum_probs=149.7
Q ss_pred HHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 021891 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 84 (306)
Q Consensus 5 E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~d 84 (306)
|++ ...++|||++.+.-+...++..|||-+|.. .+|.|.+..+. .+...+.+.|+.|++.||..+|+.| |+|+|
T Consensus 72 ~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g---VcHGD 145 (1431)
T KOG1240|consen 72 EIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG---VCHGD 145 (1431)
T ss_pred HHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 344 445699999999998888889999999995 49999997664 5777888899999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEeccCCcccC-CCCCcce----eeecccccccccCCcchhcC----------C-CCchhHHHHHH
Q 021891 85 FKTSNILLDADYNAKLSDFGLAKDG-PEGDKTH----VSTRVMGTYGYAAPEYVMTG----------H-LTSRSDVYSFG 148 (306)
Q Consensus 85 lkp~Nill~~~~~~kl~Dfg~a~~~-~~~~~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG 148 (306)
||.+||||+.-+.+.|+||..-+.. .+.+... --..-..-.+|.|||-+... . .+++-||||+|
T Consensus 146 IKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 146 IKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred cccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 9999999999999999999876532 1111111 01111122369999987531 2 56789999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 149 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 149 ~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|+++||++ |+++|.-. ++..+............+.+ ....++.||..|++.||.+|.|+++.
T Consensus 226 CViaELf~Eg~PlF~LS------QL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedy 288 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFTLS------QLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDY 288 (1431)
T ss_pred HHHHHHHhcCCCcccHH------HHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHH
Confidence 99999988 57777521 12222221111111111111 12367799999999999999999999
Q ss_pred HHHhCCCC
Q 021891 228 VEALKPLP 235 (306)
Q Consensus 228 l~~l~~~~ 235 (306)
|+.-.+..
T Consensus 289 L~~yrG~~ 296 (1431)
T KOG1240|consen 289 LQKYRGLV 296 (1431)
T ss_pred HHhhhccc
Confidence 99765544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-23 Score=178.94 Aligned_cols=173 Identities=25% Similarity=0.404 Sum_probs=130.5
Q ss_pred eeEEEEEcCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCc
Q 021891 29 QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 106 (306)
Q Consensus 29 ~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a 106 (306)
.+||.|++|...+|.+.|.++ ....++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999644 3457888899999999999999 56 999999999999999999999999999
Q ss_pred ccCCCCC----cceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhc
Q 021891 107 KDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 181 (306)
Q Consensus 107 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 181 (306)
....... .....+...||.+||+||.+.+..|+.|+||||||+|++|++. -...|....... .+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~----------d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT----------DIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh----------hhh
Confidence 8765543 1223445789999999999999999999999999999999998 233222110000 000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
...+++....++ ..-..|+.+++...|.+||++.+.
T Consensus 474 -----~g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 -----DGIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -----cCCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 011222222222 234589999999999999955444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=154.87 Aligned_cols=218 Identities=19% Similarity=0.161 Sum_probs=170.5
Q ss_pred CHHHHHHHHhcCCC-CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
++..|.++.+.|++ ..|..+..+..+...-.+||+++ |.||.+++.-..+.++..++.-++-|++.-++|+|.++
T Consensus 56 qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--- 131 (341)
T KOG1163|consen 56 QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--- 131 (341)
T ss_pred chhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---
Confidence 35678999999976 57778888888888889999999 78999988666778999999999999999999999999
Q ss_pred eEeccCCCCCeEEcCC---CcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 80 VIYRDFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 80 iiH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
++||||||+|+|..-+ ..+.++|||+|+.+.+.... .......||..|.+-....+.+.+...|+-|+|.++
T Consensus 132 fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 132 FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 9999999999999644 46899999999887554322 223446899999999888888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.++.-|..||++.......+..+....... ....+.+....|.++.-.+..|-..--++-|...-+.+..
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~EkK~----------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISEKKM----------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHHhhc----------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 999999999998876655444332221100 0001112223356788899999999999999877766654
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
.
T Consensus 282 r 282 (341)
T KOG1163|consen 282 R 282 (341)
T ss_pred H
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=173.97 Aligned_cols=188 Identities=29% Similarity=0.363 Sum_probs=156.8
Q ss_pred HHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..|..++..++ ||.+|++.-.++.+...++++++..+|.|...+.+.. .+.+..+..+...++.+++++|+.+ ++
T Consensus 44 ~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~---ii 119 (612)
T KOG0603|consen 44 KQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG---IA 119 (612)
T ss_pred ccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH---HH
Confidence 35778888886 9999999999999999999999999999998885554 6788888889999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|||+|++||+++.+|++++.|||+++........ +||..|||||++. .....+|.||||+++|||+||-.||
T Consensus 120 yrd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf 191 (612)
T KOG0603|consen 120 YRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPF 191 (612)
T ss_pred HhcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCC
Confidence 9999999999999999999999999875443221 8999999999997 5688999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
... ... .+.. ..-.++...+..+.+++..++..+|.+|...
T Consensus 192 ~~~-------~~~-------------~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 192 GGD-------TMK-------------RILK--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chH-------HHH-------------HHhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 761 110 0000 1112455667788999999999999999744
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=148.84 Aligned_cols=149 Identities=19% Similarity=0.147 Sum_probs=113.9
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|++|+++|++|. |++|++++++ +..+++|||+.|.+|...+.. . ...++.|++.+|.++|+.| |
T Consensus 48 ~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G---I 112 (218)
T PRK12274 48 ARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG---V 112 (218)
T ss_pred HHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc---C
Confidence 689999999995 5889999986 356999999999998764311 1 1357889999999999999 9
Q ss_pred EeccC-CCCCeEEcCCCcEEEeccCCcccCCCCCcc---ee--------eecccccccccCCcchhcC-CCC-chhHHHH
Q 021891 81 IYRDF-KTSNILLDADYNAKLSDFGLAKDGPEGDKT---HV--------STRVMGTYGYAAPEYVMTG-HLT-SRSDVYS 146 (306)
Q Consensus 81 iH~dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Diws 146 (306)
+|||| ||+||+++.+|.++|+|||++......... .. ......++.|+.|+..... ..+ ...+.++
T Consensus 113 vHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~ 192 (218)
T PRK12274 113 AHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFA 192 (218)
T ss_pred ccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHH
Confidence 99999 799999999999999999999865433210 00 1112357778888765432 334 5678889
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 021891 147 FGVVLLEMLTGRRSMDKNR 165 (306)
Q Consensus 147 lG~il~elltg~~pf~~~~ 165 (306)
.|+.+|.++|+..++....
T Consensus 193 ~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 193 TGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hcchHHHHHhccCCccccC
Confidence 9999999999998765443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-21 Score=165.57 Aligned_cols=119 Identities=19% Similarity=0.135 Sum_probs=94.4
Q ss_pred HHHHHHHHhcCCCCcccc-eeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVK-LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~-~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|++|+++|++|+|+||+. ++++ +..|+|||||+|++|.. +... . ...++.|++.||.|||+.+ |
T Consensus 68 ~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH~~g---I 132 (365)
T PRK09188 68 AAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLHRAG---I 132 (365)
T ss_pred HHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHHHCC---C
Confidence 789999999999999985 5442 46799999999999973 2111 1 1467899999999999988 9
Q ss_pred EeccC-CCCCeEEcCCCcEEEeccCCcccCCCCCccee------eecccccccccCCcchhc
Q 021891 81 IYRDF-KTSNILLDADYNAKLSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVMT 135 (306)
Q Consensus 81 iH~dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 135 (306)
+|||| ||+|||++.++.+||+|||+++.+........ .....++..|+|||.+..
T Consensus 133 iHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 133 THNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999 99999999999999999999987654321111 134567888999999863
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=151.54 Aligned_cols=128 Identities=10% Similarity=0.179 Sum_probs=101.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
|++|++.+.+|.|++|..+.+++... +..++||||++|.+|.+.. .+++ ....+++.+|..+|
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH 152 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLH 152 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHH
Confidence 68999999999999999999986643 3478999999999998863 2333 24569999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
..+ ++|||+||+||+++.+| ++|+|||............ .++....|+.++|+|+||+.+..
T Consensus 153 ~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~ 214 (232)
T PRK10359 153 QHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLI 214 (232)
T ss_pred HcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehH
Confidence 999 99999999999999988 9999999887643211100 03345567789999999999876
Q ss_pred HHh
Q 021891 154 MLT 156 (306)
Q Consensus 154 llt 156 (306)
+..
T Consensus 215 ~~~ 217 (232)
T PRK10359 215 YKK 217 (232)
T ss_pred HHH
Confidence 653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-20 Score=153.09 Aligned_cols=161 Identities=22% Similarity=0.321 Sum_probs=108.2
Q ss_pred eEEEEEcCCCCCHHHHhhc---CCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEecc
Q 021891 30 RLLVYEFMPRGSLENHLFR---RSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 103 (306)
Q Consensus 30 ~~lv~e~~~~~sL~~~l~~---~~~---~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Df 103 (306)
.+++|+-+. ++|.+++.. ... .+....+..+..|++..+++||+.| ++|+||+|+|++++.+|.++|+||
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 467888884 599887642 221 2334455677799999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCCcchhcC--------CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHh
Q 021891 104 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 175 (306)
Q Consensus 104 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 175 (306)
+....... .... ...+..|.+||..... .++.+.|.|+||+++|.|+++..||...........
T Consensus 190 ~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 190 SSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred HHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 98876432 1121 2345779999977532 478899999999999999999999986533222111
Q ss_pred hhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 176 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
....+. ..++.+..||..+|+.||.+|
T Consensus 262 ------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 112234 668899999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-18 Score=138.16 Aligned_cols=99 Identities=15% Similarity=0.126 Sum_probs=80.7
Q ss_pred HHHHHHHHhcC-----CCCcccceeeEEEeCC---eeE-EEEEc--CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHH-
Q 021891 2 WQAEVNFLGDL-----VHLNLVKLIGYCIEDD---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL- 69 (306)
Q Consensus 2 ~~~E~~il~~l-----~H~niv~~~~~~~~~~---~~~-lv~e~--~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l- 69 (306)
+.+|++++++| +||||+++||+++++. ..+ +|+|| +.+++|.+++.+. .+++. ..++.|++.++
T Consensus 43 ~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~ 118 (210)
T PRK10345 43 IRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLK 118 (210)
T ss_pred HHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHH
Confidence 67999999999 5799999999999874 333 78999 5578999999553 36655 35678888887
Q ss_pred HHhhcCCCCCeEeccCCCCCeEEcCC----CcEEEeccCCcc
Q 021891 70 AFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAK 107 (306)
Q Consensus 70 ~~LH~~~~~~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~ 107 (306)
+|||+++ |+||||||+||+++.+ +.++|+||+.+.
T Consensus 119 ~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 119 RYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 9999999 9999999999999743 479999965443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-18 Score=136.43 Aligned_cols=99 Identities=18% Similarity=0.202 Sum_probs=80.5
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEe
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIY 82 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~L-H~~~~~~iiH 82 (306)
+|+++|.+|.++++.....+.. . ..+|||||++|++|...+.+. ..++...+..++.|++.+|.++ |+.+ |+|
T Consensus 68 ~E~~~l~~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiH 141 (190)
T cd05147 68 KEMRNLKRLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCR---LVH 141 (190)
T ss_pred HHHHHHHHHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 4999999999888754443322 2 238999999988776554333 4689999999999999999999 6888 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
|||||+||+++ ++.++|+|||++...
T Consensus 142 rDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 142 ADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.7e-19 Score=163.56 Aligned_cols=139 Identities=26% Similarity=0.362 Sum_probs=107.4
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-------------eeeecccccccccCCcc
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-------------HVSTRVMGTYGYAAPEY 132 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~ 132 (306)
+.+++|||+.+ |+|||+||+|++|..-|++|++|||+++.......+ ....+.+||+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 67899999998 999999999999999999999999998753221111 11234689999999999
Q ss_pred hhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHH
Q 021891 133 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 212 (306)
Q Consensus 133 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 212 (306)
+....|...+|.|++|+|+||.+-|..||.+..+.+...........+. +- ....+.++.++|.+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp------E~---------dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP------EE---------DEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc------cc---------CcCCCHHHHHHHHH
Confidence 9999999999999999999999999999998766543322211111111 11 11234688999999
Q ss_pred cccCCCCCCC
Q 021891 213 CLSRDPKARP 222 (306)
Q Consensus 213 ~l~~~p~~Rp 222 (306)
+|+.+|..|-
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999995
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=133.79 Aligned_cols=101 Identities=17% Similarity=0.159 Sum_probs=82.2
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeE
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~ii 81 (306)
++|++.+.++.|++|.....+... ..++||||++|+++....... ..++...+..++.|++.+|.++|+ .+ |+
T Consensus 67 ~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~g---iv 140 (190)
T cd05145 67 EKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAG---LV 140 (190)
T ss_pred HHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 578999999999988654444333 248999999887554432222 357888999999999999999999 88 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGP 110 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 110 (306)
||||||+||+++ ++.++|+|||+++...
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999998 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-19 Score=163.27 Aligned_cols=210 Identities=28% Similarity=0.319 Sum_probs=163.5
Q ss_pred HHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeE
Q 021891 5 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVI 81 (306)
Q Consensus 5 E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l-~~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~~~~ii 81 (306)
|..+-+.+. |+|++.+++.....+..+++++|..|+++.+.+ .......+...+..++.|+..++.|+| ..+ +.
T Consensus 70 e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~ 146 (601)
T KOG0590|consen 70 ETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VT 146 (601)
T ss_pred cccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cc
Confidence 555556665 999999999999999999999999999999988 443336777888899999999999999 877 99
Q ss_pred eccCCCCCeEEcCCC-cEEEeccCCcccCCC-CCcceeeecccc-cccccCCcchhcC-CCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADY-NAKLSDFGLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg 157 (306)
||||||+|.+++..+ .++++|||+|..+.. .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|
T Consensus 147 h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 147 HRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred cCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence 999999999999999 999999999998776 444444556778 9999999999875 457889999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
..|+......... ...|.... ..+ . ............+++.+++..+|..|.+.+++-..
T Consensus 227 ~~p~~~~~~~~~~-~~~~~~~~----~~~----~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 227 ELPWDFPSRKDGR-YSSWKSNK----GRF----T----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred CCCcccccccccc-ceeecccc----ccc----c----cCccccCChhhhhcccccccCCchhcccccccccc
Confidence 9998765443311 01111100 000 0 01112234577899999999999999998888764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-17 Score=138.42 Aligned_cols=201 Identities=22% Similarity=0.272 Sum_probs=141.4
Q ss_pred HHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 8 FLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 8 il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
-|-++.|.|||+++.|+.+.+ ...+++||+..|+|..+|++ +.+.+....-.+|+-||+.||.|||+.. .+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 455778999999999987654 46789999999999999965 3456777888899999999999999987 78
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCC---CcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG---DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
|+|+++..+.|++..+|-+|++- +........ ..........+.++|.+||.-.....+.++|||+||.+..+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999999853 211111000 00011122356788999998766677889999999999999988
Q ss_pred CCCCC-CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSM-DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+..-- ...........+..... .+-+. .-++++.+|++..|..||++++++-|.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~---------~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVII---------GLENG------------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhhhhhhhee---------eccCc------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 76421 11111111111100000 00011 113688999999999999999999764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=149.85 Aligned_cols=149 Identities=19% Similarity=0.178 Sum_probs=122.0
Q ss_pred HHHhcCC---CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 7 NFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 7 ~il~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
+++.+|+ -+-|..+...+.-.+.-+||+||.+.|+|.+++- ..+.+++..++.+..|++..|+.||..+ |||+
T Consensus 743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHg 818 (974)
T KOG1166|consen 743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHG 818 (974)
T ss_pred HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecc
Confidence 4555665 2345556666666788899999999999999984 5667999999999999999999999999 9999
Q ss_pred cCCCCCeEEcC-------CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 84 DFKTSNILLDA-------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 84 dlkp~Nill~~-------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
||||+|++|.. .-.++|+|||.+-.+.--.....-...++|-.+-.+|+..|..++..+|.|.|+.+++-|++
T Consensus 819 DiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF 898 (974)
T KOG1166|consen 819 DIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF 898 (974)
T ss_pred cCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH
Confidence 99999999942 34589999999865432222223445678889999999999999999999999999999999
Q ss_pred CCC
Q 021891 157 GRR 159 (306)
Q Consensus 157 g~~ 159 (306)
|+.
T Consensus 899 G~y 901 (974)
T KOG1166|consen 899 GKY 901 (974)
T ss_pred HHH
Confidence 964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=124.98 Aligned_cols=98 Identities=19% Similarity=0.292 Sum_probs=87.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++..+.|++|.....++...+..++||||++|++|.+.+.... . .+..++.+++.+|.++|..+ ++
T Consensus 46 ~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~ 117 (211)
T PRK14879 46 TRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---II 117 (211)
T ss_pred HHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cc
Confidence 5689999999999999887777777888899999999999999885432 2 78899999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
|+|++|.||+++ ++.++|+|||.+..
T Consensus 118 H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 118 HGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred cCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999 78899999999865
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-15 Score=141.16 Aligned_cols=94 Identities=23% Similarity=0.332 Sum_probs=85.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|++|+..+.++.+....++||||+++++|.+++. ....++.+++.+|.+||+.+ ++
T Consensus 383 ~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---ii 450 (535)
T PRK09605 383 TRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IV 450 (535)
T ss_pred HHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---Cc
Confidence 6789999999999999988887777778899999999999999884 35678999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
||||||+||++ .++.++|+|||+++.
T Consensus 451 HrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 451 HGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999 678899999999876
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=122.77 Aligned_cols=95 Identities=22% Similarity=0.330 Sum_probs=81.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++..+.|+++.....++...+..++||||++|++|.+.+..... .++.+++.+|.+||+.+ ++
T Consensus 44 ~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~ 112 (199)
T TIGR03724 44 TRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IV 112 (199)
T ss_pred HHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---ee
Confidence 46799999999998776655566667778999999999999998754321 78999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
|+|++|+||+++ ++.++++|||++..
T Consensus 113 H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 113 HGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred cCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.8e-15 Score=123.13 Aligned_cols=99 Identities=24% Similarity=0.199 Sum_probs=80.3
Q ss_pred HHHHHHHHhcCCCCcc--cceeeEEEeCCe----eEEEEEcCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHLNL--VKLIGYCIEDDQ----RLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~ni--v~~~~~~~~~~~----~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+++|++++.+|.|++| ++.+++...... .++|||+++| .+|.+++... .+++.. +.+|+.+|.+||.
T Consensus 87 ~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~ 160 (239)
T PRK01723 87 AFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHD 160 (239)
T ss_pred HHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHH
Confidence 4679999999998875 677776544322 3599999997 6999887543 355443 5789999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
.| |+||||||+|||++.++.++|+|||.++..
T Consensus 161 ~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 161 AG---VYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred CC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 99 999999999999999999999999998763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.2e-15 Score=121.87 Aligned_cols=100 Identities=19% Similarity=0.207 Sum_probs=78.8
Q ss_pred HHHHHHHHhcCCCCc--ccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+++|+++++++.+.+ +.+++++ . ..++||||++|++|....... ..+....+..++.|++.+|.+||..+.
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~-- 169 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGE-- 169 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCC--
Confidence 468999999997632 3444442 2 358999999998887654333 346666778999999999999998653
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
++||||||+||+++ ++.++|+|||.+...
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-14 Score=129.22 Aligned_cols=204 Identities=25% Similarity=0.306 Sum_probs=155.0
Q ss_pred HHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCC
Q 021891 5 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAERP 79 (306)
Q Consensus 5 E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~----~l~~LH~~~~~~ 79 (306)
|+.....+ .|+|.++.+..+...+..|+-+|+| +.+|..+.......++...++..+.+... ||.++|+.+
T Consensus 167 ~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--- 242 (524)
T KOG0601|consen 167 EFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--- 242 (524)
T ss_pred hhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---
Confidence 44444455 5899999999999999999999999 57999998877777899999999999999 999999988
Q ss_pred eEeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcc---eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 80 VIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 80 iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
++|-|+||.||+...+ ..++++|||+...+...... .......|...|++||... .-++.+.|||++|.++.+-.
T Consensus 243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~ 321 (524)
T KOG0601|consen 243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAI 321 (524)
T ss_pred ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhH
Confidence 9999999999999999 88999999999887665422 2222336778899999875 46789999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
++.......... .|. +... .. +..++....+..+...+..|++.+|..|++++.+.++
T Consensus 322 l~~~~~~~g~~~------~W~-----~~r~---~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 322 LGSHLPSVGKNS------SWS-----QLRQ---GY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhcccccCCCCC------Ccc-----cccc---cc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 987665432111 010 0000 00 1111222223456669999999999999999888764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.1e-14 Score=115.33 Aligned_cols=96 Identities=18% Similarity=0.106 Sum_probs=77.9
Q ss_pred HHHHHHHHhcCCCCc--ccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+++|+.++..+.|++ +...++ ....++||||++|++|.+.... .....++.+++.++.++|..+
T Consensus 80 ~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--- 145 (198)
T cd05144 80 AQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--- 145 (198)
T ss_pred HHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---
Confidence 467889999998874 445544 2455899999999998775421 335678899999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 111 (306)
++|+||||+||+++.++.++|+|||++.....
T Consensus 146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 146 IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.1e-14 Score=125.84 Aligned_cols=143 Identities=17% Similarity=0.216 Sum_probs=113.3
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
++-++-|+.|+||||++|++.++.++..|||+|-+ ..|..++.+.+ ...+..-+.||+.||.|||..++ ++|
T Consensus 57 ~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~Gl~qIl~AL~FL~~d~~--lvH 128 (690)
T KOG1243|consen 57 KRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCLGLFQILAALSFLNDDCN--LVH 128 (690)
T ss_pred HHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHHHHHHHHHHHHHHhccCC--eee
Confidence 46678899999999999999999999999999998 57888875543 67777789999999999986554 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
++|.-..|+|+..|..||++|.++........ ......--..|..|+.+.... ...|.|.|||++++++.|
T Consensus 129 gNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 129 GNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999999998876443322 111112223466777553322 467999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-13 Score=106.14 Aligned_cols=99 Identities=24% Similarity=0.211 Sum_probs=85.4
Q ss_pred HHHHHHHHhcCCC--CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|+.+++.+.| .+++++++++...+..+++|||+.++.+..+ +......++.+++.+|.++|.....+
T Consensus 38 ~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~ 109 (155)
T cd05120 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLV 109 (155)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceE
Confidence 6889999999976 5899999988887889999999988777654 55666788999999999999864334
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
++|+||+|+||++++.+.+++.|||.++.
T Consensus 110 i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999999999999989999999999865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-12 Score=123.09 Aligned_cols=192 Identities=23% Similarity=0.240 Sum_probs=139.3
Q ss_pred CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcC
Q 021891 15 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 94 (306)
Q Consensus 15 ~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~ 94 (306)
|-+++..--+.-....++|++|+.+++|...+...+ ..+.+-....+..+..+++|||+.. +.|+|++|.|+++..
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAY 939 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcc
Confidence 444433333344567899999999999999886554 4566666667777889999999977 899999999999999
Q ss_pred CCcEEEeccCCcccCCCC---------------------C--------cceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 95 DYNAKLSDFGLAKDGPEG---------------------D--------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 95 ~~~~kl~Dfg~a~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+|..+++|||........ . .........||..|.+||...+..-...+|.|
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 999999999843221100 0 00112235689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
++|++++|.++|.+||...........+......+ ..-+...+..+.+++...+..++.+|-.+.
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~---------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPW---------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCC---------------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999999998765543322211111111 111233456788999999999999998766
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.8e-12 Score=102.07 Aligned_cols=98 Identities=20% Similarity=0.171 Sum_probs=71.0
Q ss_pred HHHHHHHhcCCCCc--ccceeeEEEeCCeeEEEEEcCCCCCHHHH-hhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCC
Q 021891 3 QAEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENH-LFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAER 78 (306)
Q Consensus 3 ~~E~~il~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~ 78 (306)
+.|.+.+.++.+.. +.+.+++ ...++||||++++.+... +.... .. ..+..++.+++.++.++|. .+
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~-- 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG-- 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--
Confidence 35666666664433 4455543 246899999998543211 11111 11 6678899999999999999 88
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 111 (306)
++|+||||+||+++ ++.++|+|||.+.....
T Consensus 136 -ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 136 -LVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -cCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence 99999999999999 89999999999976433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=3e-11 Score=96.38 Aligned_cols=99 Identities=13% Similarity=0.134 Sum_probs=75.2
Q ss_pred HHHHHHHhcCCC--CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCC
Q 021891 3 QAEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERP 79 (306)
Q Consensus 3 ~~E~~il~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~L-H~~~~~~ 79 (306)
++|++.|+++.. -++.+.+++ ..-+|||||+.++.+..-..+. ..++......+..+++.+|..| |..+
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g--- 145 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN--- 145 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 489999999953 567777765 4568899999765442211111 1355566778889999999999 8888
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGP 110 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 110 (306)
++|+||++.||+++ ++.+.|+|||.+....
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999996 4679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-11 Score=95.84 Aligned_cols=95 Identities=22% Similarity=0.118 Sum_probs=71.7
Q ss_pred HHHHHHHHhcCCCCccc-ceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CC
Q 021891 2 WQAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--ER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--~~ 78 (306)
+++|+++++.+.+.+++ +++.+. ....++||||++|.++.+.- .....++.+++.+|..||+.+ ..
T Consensus 39 ~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~ 107 (170)
T cd05151 39 RENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDL 107 (170)
T ss_pred HHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCc
Confidence 67899999999765554 565543 33458999999998876530 111345678999999999976 12
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++|+|++|.||+++ ++.++++|||.+..
T Consensus 108 ~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 108 VPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred eeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 249999999999998 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.2e-11 Score=91.34 Aligned_cols=94 Identities=24% Similarity=0.347 Sum_probs=75.5
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|++++.++.--.|..-+=+..+.+...|+|||++|..|++.+... ...++..+-.-+.-||..+ |+|
T Consensus 47 ~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivH 115 (204)
T COG3642 47 RREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVH 115 (204)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eec
Confidence 57999999986655554444456677788999999999999888554 2456677777788899999 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
+||.++||+++..+ +.++|||++..
T Consensus 116 GDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 116 GDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999997765 88999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=5e-11 Score=107.57 Aligned_cols=105 Identities=19% Similarity=0.132 Sum_probs=73.5
Q ss_pred CHHHHHHHHhcCC----CCcccceeeEEE-eCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHhhc
Q 021891 1 MWQAEVNFLGDLV----HLNLVKLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK-GLAFLHE 74 (306)
Q Consensus 1 ~~~~E~~il~~l~----H~niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~-~l~~LH~ 74 (306)
+|.+|++.+.++. |.+-+.+-.++. .....++||||++|++|.+.........+ ...++.+++. .+..+|.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 3677888777762 333233322222 23456899999999999887643221222 2345555555 4678898
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCC
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 111 (306)
.| ++|+|+||.||+++.++.++++|||++.....
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88 99999999999999999999999999977543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-11 Score=109.86 Aligned_cols=198 Identities=22% Similarity=0.164 Sum_probs=141.5
Q ss_pred HHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 5 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 5 E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
|+.+...+ .|.+++.++..+...++.|+=-|||.++++...+ .-...+++..++.+..|++.++.++|+.. ++|+
T Consensus 315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~ 390 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHL 390 (524)
T ss_pred hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcc
Confidence 45555555 6889999888888788888999999999887766 22335788899999999999999999988 9999
Q ss_pred cCCCCCeEEcCC-CcEEEeccCCcccCCCCCcceeeeccccccccc--CCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 84 DFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA--APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 84 dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
|+||+||++..+ +..+++|||..+.+..... ...+.-++. +++......+..++|++|||.-+.+..++...
T Consensus 391 d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 391 DVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccceeeccchhhhhccccccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCccc
Confidence 999999999886 7789999998865322111 112223344 45444566788999999999999999998653
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
-..... | ..+..-.-+. .+ ....++..+.+.++..++..||++.++..+.+
T Consensus 466 s~~~~~--------~--------~~i~~~~~p~----~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 466 SESGVQ--------S--------LTIRSGDTPN----LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred Cccccc--------c--------eeeecccccC----CC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 222110 0 0000000011 11 11267788999999999999999998877654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-09 Score=95.88 Aligned_cols=180 Identities=16% Similarity=0.244 Sum_probs=129.7
Q ss_pred HHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCC-CHHHHhhcC--------------CCCCCHHHHHHHHHHHH
Q 021891 6 VNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRG-SLENHLFRR--------------SLPLPWSIRMKIALGAA 66 (306)
Q Consensus 6 ~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~-sL~~~l~~~--------------~~~l~~~~~~~~~~qi~ 66 (306)
+++++++.|.|||++.++|.. +..+++|++|.++. +|.++.... +...+++.+|.++.|+.
T Consensus 324 ve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLt 403 (655)
T KOG3741|consen 324 VEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLT 403 (655)
T ss_pred HHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHH
Confidence 678999999999999998873 34678999998864 888766432 23578899999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHH
Q 021891 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 146 (306)
Q Consensus 67 ~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 146 (306)
.||.++|+.| +.-+-|.+.+|+++.+.+++|...|+......... |.+. --.+-|.=.
T Consensus 404 aaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~le---~~Qq~D~~~ 461 (655)
T KOG3741|consen 404 AALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EPLE---SQQQNDLRD 461 (655)
T ss_pred HHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cchh---HHhhhhHHH
Confidence 9999999999 88899999999999998999988887655433210 1121 134678889
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 147 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 147 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
||.+++.|.||..--... ... .... ........+.++++++......++++ -++.+
T Consensus 462 lG~ll~aLAt~~~ns~~~-d~~----~~s~------------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 462 LGLLLLALATGTENSNRT-DST----QSSH------------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred HHHHHHHHhhcccccccc-cch----HHHH------------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 999999999985421000 000 0000 00112244678888888888888887 67777
Q ss_pred HHHHh
Q 021891 227 VVEAL 231 (306)
Q Consensus 227 ll~~l 231 (306)
++.++
T Consensus 518 llp~~ 522 (655)
T KOG3741|consen 518 LLPMI 522 (655)
T ss_pred HHHHH
Confidence 77653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=92.17 Aligned_cols=104 Identities=15% Similarity=0.131 Sum_probs=81.4
Q ss_pred HHHHHHHHhcCCCCcc--cceeeEEEe-----CCeeEEEEEcCCCC-CHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLVHLNL--VKLIGYCIE-----DDQRLLVYEFMPRG-SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~H~ni--v~~~~~~~~-----~~~~~lv~e~~~~~-sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|.+.+..|..-+| ++.+++++. ....+||||++++. +|.+++... ....+......++.+++..+.-|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 5689998888854443 455666543 23468999999876 899987532 23456677889999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcC-------CCcEEEeccCCccc
Q 021891 73 HEEAERPVIYRDFKTSNILLDA-------DYNAKLSDFGLAKD 108 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~-------~~~~kl~Dfg~a~~ 108 (306)
|..| |+|+||+++|||++. ++.+.|+||+.++.
T Consensus 155 H~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 155 HAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999 999999999999975 46789999998854
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.8e-11 Score=106.62 Aligned_cols=161 Identities=21% Similarity=0.278 Sum_probs=109.6
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeec-------cccccc
Q 021891 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-------VMGTYG 126 (306)
Q Consensus 54 ~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-------~~gt~~ 126 (306)
..+....=+.+++.|+.|+|..-. +||++|.|++|.++.++.+||+.|+.+.............. ..-...
T Consensus 97 aTe~~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~ 174 (700)
T KOG2137|consen 97 ATEDGFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLN 174 (700)
T ss_pred cccHhhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcc
Confidence 334445556677899999998643 99999999999999999999999998866444221111111 123457
Q ss_pred ccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHH
Q 021891 127 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 205 (306)
Q Consensus 127 y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (306)
|.|||++.+..-+.++|+||+|+++|.+.. |+.-+........ .... ...+..-...++...+.+
T Consensus 175 f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~~~-----------~~~~~~~~~~~s~~~p~e 240 (700)
T KOG2137|consen 175 FLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YSFS-----------RNLLNAGAFGYSNNLPSE 240 (700)
T ss_pred cccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcch---hhhh-----------hcccccccccccccCcHH
Confidence 999999998888899999999999999984 4444433211110 0000 001111111223455788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 206 AAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 206 ~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+.+=+.+++..+..-||++.++...
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcc
Confidence 9999999999999999988777653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-09 Score=83.49 Aligned_cols=103 Identities=22% Similarity=0.243 Sum_probs=78.1
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCC-CCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~-l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
++|+++|.++.--.|.--.-++.+...-.|+|||++| .++.+++...... ........++..|-+.+.-||.++ +
T Consensus 58 ~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---i 134 (229)
T KOG3087|consen 58 KQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---I 134 (229)
T ss_pred HHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---e
Confidence 6789999888655555444455666777899999976 3888888654322 333333788999999999999999 9
Q ss_pred EeccCCCCCeEEcCCC-c--EEEeccCCccc
Q 021891 81 IYRDFKTSNILLDADY-N--AKLSDFGLAKD 108 (306)
Q Consensus 81 iH~dlkp~Nill~~~~-~--~kl~Dfg~a~~ 108 (306)
+|+||..+||++..++ . +.++|||++..
T Consensus 135 iHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 135 IHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999999999996544 2 48999999865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.3e-09 Score=85.61 Aligned_cols=104 Identities=24% Similarity=0.227 Sum_probs=83.5
Q ss_pred HHHHHHHHhcCCCC--cccceeeEEEeCC----eeEEEEEcCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHL--NLVKLIGYCIEDD----QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~--niv~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
..+|.+.+..|..- .+.+.+++..... ..+||+|++++. +|.+++..... .+......++.+++..+.-||.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHH
Confidence 35788888888543 3456777766533 347999999874 89998865332 6777788999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCC---cEEEeccCCcccC
Q 021891 75 EAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 109 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~ 109 (306)
.| |+|+|+++.|||++.++ .+.++||+.++..
T Consensus 137 ~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 137 AG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred Cc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 99999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.4e-08 Score=86.53 Aligned_cols=195 Identities=16% Similarity=0.179 Sum_probs=126.6
Q ss_pred eEEEEEcCCCC-CHHHHhh-----cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEecc
Q 021891 30 RLLVYEFMPRG-SLENHLF-----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 103 (306)
Q Consensus 30 ~~lv~e~~~~~-sL~~~l~-----~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Df 103 (306)
..++|..+.+. ...+++. +......|......++.++.+.+-||+.| .+-+|++++|+|+++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 56788888765 2233221 11234789999999999999999999999 999999999999999999999985
Q ss_pred CCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCCCCc----c-h
Q 021891 104 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEH----N-L 172 (306)
Q Consensus 104 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~----~-~ 172 (306)
........+ ......+|...|.+||.-. +..-+...|.|.||+++|+++.| ..||.+....... + -
T Consensus 162 Dsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 544333221 1122346888999999754 33456789999999999999887 8999764322111 0 1
Q ss_pred HHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHhC
Q 021891 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR--DPKARPLMSEVVEALK 232 (306)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~p~~Rps~~ell~~l~ 232 (306)
+.......... .......+.....+ ...+.++..|..+|+.. ++.-|||++..+..|.
T Consensus 239 Ia~g~f~ya~~-~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 239 IAHGRFAYASD-QRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred hhcceeeechh-ccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 11111000000 10111112111111 23456788899999854 3678999988776654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.3e-09 Score=85.99 Aligned_cols=106 Identities=23% Similarity=0.260 Sum_probs=81.8
Q ss_pred CHHHHHHHHhcCCCC--cccceeeEEEeCC---eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 1 MWQAEVNFLGDLVHL--NLVKLIGYCIEDD---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 1 ~~~~E~~il~~l~H~--niv~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
++++|+++++.+.+. ++.+++.+..... ..++||||++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 41 ~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~ 118 (223)
T cd05154 41 DVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSV 118 (223)
T ss_pred cHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 368999999999764 4577887766542 56899999999888775532 2467777778888888888888853
Q ss_pred C-----------------------------------------------------CCCeEeccCCCCCeEEcC--CCcEEE
Q 021891 76 A-----------------------------------------------------ERPVIYRDFKTSNILLDA--DYNAKL 100 (306)
Q Consensus 76 ~-----------------------------------------------------~~~iiH~dlkp~Nill~~--~~~~kl 100 (306)
. ...++|+|+++.||+++. ++.+.|
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~i 198 (223)
T cd05154 119 DPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAV 198 (223)
T ss_pred ChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEE
Confidence 1 123799999999999988 667899
Q ss_pred eccCCccc
Q 021891 101 SDFGLAKD 108 (306)
Q Consensus 101 ~Dfg~a~~ 108 (306)
+||+.+..
T Consensus 199 ID~e~~~~ 206 (223)
T cd05154 199 LDWELATL 206 (223)
T ss_pred Eecccccc
Confidence 99998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.8e-09 Score=96.85 Aligned_cols=101 Identities=13% Similarity=0.036 Sum_probs=68.0
Q ss_pred HHHHHHHHhcCC----CCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHh--hcCCC---CCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLV----HLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l--~~~~~---~l~~~~~~~~~~qi~~~l~~ 71 (306)
|.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.+.+.- .+.+. .+....+..++.|++
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 566776666652 4444444444332 34568999999999998742 22221 233444445555554
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCC----cEEEeccCCcccCCCC
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAKDGPEG 112 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~ 112 (306)
..| ++|+|+||.||+++.+| .++++|||++......
T Consensus 278 --~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 --RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred --hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 356 99999999999999888 9999999999876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=5e-09 Score=83.28 Aligned_cols=98 Identities=21% Similarity=0.233 Sum_probs=65.5
Q ss_pred HHHHHHHHhcCCCC--cccceeeEEEeCCeeEEEEEcCC--CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhcCC
Q 021891 2 WQAEVNFLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~--niv~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~-LH~~~ 76 (306)
.++|++.|.++..- ++.+.+++. .-+|||||++ |..+..+.... ++.+....++.+++..+.. +|..|
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g 127 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG 127 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC
Confidence 36899999999765 567777653 3479999998 55554433211 1234456677777775555 57888
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCC
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 110 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 110 (306)
++|+||.+.||+++.+ .+.|+|||.+....
T Consensus 128 ---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 128 ---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999999877 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.7e-07 Score=72.29 Aligned_cols=102 Identities=28% Similarity=0.270 Sum_probs=82.5
Q ss_pred HHHHHHHhcCCC-CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 3 QAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 3 ~~E~~il~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.+|.-+|+.+.+ +++.+++|+| ..++|.||...+++...-. ..-...+|..+.+++.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 6999999999 3477999998776643210 11124689999999999999999999865555
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
+.-.|++++|+-++++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.6e-07 Score=74.13 Aligned_cols=104 Identities=16% Similarity=0.099 Sum_probs=79.7
Q ss_pred HHHHHHHHhcCCC--CcccceeeEEEeC----CeeEEEEEcCCC-CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVH--LNLVKLIGYCIED----DQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H--~niv~~~~~~~~~----~~~~lv~e~~~~-~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
|.+|+..|.+|.. -.+.+........ ...+||+|-++| .+|.+.+.+.. .+.+......++.+++..+.-||
T Consensus 66 f~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH 145 (216)
T PRK09902 66 IVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH 145 (216)
T ss_pred HHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH
Confidence 7899999999953 2344555222221 135799997753 48988875542 35677888899999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCc--EEEeccCCccc
Q 021891 74 EEAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKD 108 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~--~kl~Dfg~a~~ 108 (306)
..+ +.|+|+.+.||+++.+|. ++++||.-++.
T Consensus 146 ~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 146 SVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999 999999999999987777 89999987765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.5e-09 Score=93.83 Aligned_cols=149 Identities=20% Similarity=0.185 Sum_probs=113.9
Q ss_pred HHHHHHHhcCCCCc-ccceeeEEEeCCeeEEEEEcCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.-++++|.+++||| .+.+++-+..++..+++++++.++ +-..........+..-+...+.+.-+.++++||+.. -
T Consensus 281 rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~ 357 (829)
T KOG0576|consen 281 RLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---K 357 (829)
T ss_pred HHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---c
Confidence 45789999999999 778888777788899999999877 222222111122444455667777888999999965 5
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+|+| ||+..+ +..+.+||+....+.... ......+++.|+|||+.....+..+.|+|++|.-..+|.-|.+|
T Consensus 358 ~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 358 VHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 8998 776654 678999999988765443 34456789999999999999999999999999877788777776
Q ss_pred CC
Q 021891 161 MD 162 (306)
Q Consensus 161 f~ 162 (306)
-.
T Consensus 430 r~ 431 (829)
T KOG0576|consen 430 RS 431 (829)
T ss_pred CC
Confidence 54
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.2e-07 Score=86.78 Aligned_cols=196 Identities=20% Similarity=0.238 Sum_probs=138.7
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCee----EEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~----~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+-|++.+..+.|+|++.++.|....... .+..++|..-++...+.. -..++.++...+..++.+||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~-- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS-- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence 4577788889999999999987765433 355678888888887744 347899999999999999999999986
Q ss_pred CeEeccCCCC---CeEEcCCCcEEEe--ccCCcccCCCCCcceeeecccccccccCCcchhcCCCCc--hhHHHHHHHHH
Q 021891 79 PVIYRDFKTS---NILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS--RSDVYSFGVVL 151 (306)
Q Consensus 79 ~iiH~dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~il 151 (306)
..|.-|..+ +.-.+..+.+.++ ||+.+....+..... ...-...|.++|......+.. ..|+|.+|...
T Consensus 307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 667666665 5555666777777 998887765443221 122344578888877655544 47999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
..+..|..+-...... ..+.+. .......+...+|+.-+.++|+++.+++.+.
T Consensus 383 ~~~~~~~~i~~~~~~~-------------------~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVP-------------------VSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccch-------------------hhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9998876542211000 000110 0111567889999999999999999999875
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
.
T Consensus 436 f 436 (1351)
T KOG1035|consen 436 F 436 (1351)
T ss_pred h
Confidence 3
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1e-06 Score=72.63 Aligned_cols=94 Identities=18% Similarity=0.131 Sum_probs=68.5
Q ss_pred HHHHHHHhcCCCC--cccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
++|++.|..|.-. .|.+-+++ +.-++|||+++|-.|...- ++.+....++..|+.-+.-+-..| +
T Consensus 157 ~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G---i 223 (304)
T COG0478 157 EREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG---I 223 (304)
T ss_pred HHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC---c
Confidence 6899999999654 77787775 3447899999886665432 123334444555555555444667 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
+|+|+.+-||+++++|.+.++||--+...
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999999999766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.5e-06 Score=68.86 Aligned_cols=67 Identities=15% Similarity=0.165 Sum_probs=52.5
Q ss_pred eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 29 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 29 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++||||++|..|.+.. .+++ .+...+.+++.-||..| +.|+|.+|.|++++.++ ++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECccccc
Confidence 456899999998887653 1232 24456778899999999 99999999999998655 89999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=66.30 Aligned_cols=106 Identities=15% Similarity=0.145 Sum_probs=62.7
Q ss_pred HHHHHHHHhcCCCCc--ccceeeEEEeCCeeEEEEEcCCCCC-HHHHh--------------hc-----CC---CCCCHH
Q 021891 2 WQAEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGS-LENHL--------------FR-----RS---LPLPWS 56 (306)
Q Consensus 2 ~~~E~~il~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~~s-L~~~l--------------~~-----~~---~~l~~~ 56 (306)
.++|.++++.+..-. +.+.+++....+...+|||+++|.+ +...+ .+ +. ......
T Consensus 39 i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~ 118 (226)
T TIGR02172 39 IKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQ 118 (226)
T ss_pred HHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHH
Confidence 468999999986443 4688888888888889999998863 21111 00 00 011111
Q ss_pred HH-HHHHH----------HHHH-HHHHhhcC-CCCCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 57 IR-MKIAL----------GAAK-GLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 57 ~~-~~~~~----------qi~~-~l~~LH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.. ..+.. .+.. ...+|... ....++|+|+.|.||++++++ +.|+||+.+..
T Consensus 119 ~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 119 SYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred HHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 00 00000 0001 11222211 123478999999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.2e-05 Score=67.18 Aligned_cols=107 Identities=20% Similarity=0.142 Sum_probs=64.7
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhh-------------------cC---CCCCCHH--
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-------------------RR---SLPLPWS-- 56 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-------------------~~---~~~l~~~-- 56 (306)
+.+|+++++.+. +--+.+++++....+..++|||+++|.+|..... .- ...+...
T Consensus 38 ~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~ 117 (244)
T cd05150 38 LEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLD 117 (244)
T ss_pred hHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHH
Confidence 578999999884 4345678888777667899999999987764321 00 0011100
Q ss_pred HHHHH-----------------------HHHHHHHHHHhh-cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 57 IRMKI-----------------------ALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 57 ~~~~~-----------------------~~qi~~~l~~LH-~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..... ..++...|.... ......++|+|+.|.||++++++.+.|+||+.+..
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 118 RRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 00000 111111111111 01123389999999999999987788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=5.5e-06 Score=75.83 Aligned_cols=106 Identities=16% Similarity=0.110 Sum_probs=70.9
Q ss_pred CHHHHHHHHhcCC-----CCcccceeeEE-EeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 1 MWQAEVNFLGDLV-----HLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 1 ~~~~E~~il~~l~-----H~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+|.+|...+.++. .++ +++=.++ +-.....|+|||+.|-.+.+...-....++...+.....++.-- .+-.
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~--q~~~ 283 (517)
T COG0661 207 DYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLR--QLLR 283 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHH--HHHh
Confidence 4677888777762 233 2222222 22456689999999998888753333456655554444443322 2222
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCC
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 112 (306)
.| +.|.|.+|.||+++.+|.+.+.|||+.......
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 45 999999999999999999999999999876553
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.2e-05 Score=73.49 Aligned_cols=104 Identities=15% Similarity=0.073 Sum_probs=70.5
Q ss_pred CHHHHHHHHhcC----CCCc------ccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 021891 1 MWQAEVNFLGDL----VHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 1 ~~~~E~~il~~l----~H~n------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~ 70 (306)
+|.+|++-..++ .|-+ |.++|-.+ .....|+||||+|..+.|+-.-....++...+..-+.+...-+-
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qI 317 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQI 317 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHH
Confidence 366677655443 4544 45555433 34678999999998776654333334666666665555554444
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcC----CCcEEEeccCCcccCCC
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDGPE 111 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~----~~~~kl~Dfg~a~~~~~ 111 (306)
+.| | ++|+|=+|.||+++. ++.+.+.|||+......
T Consensus 318 f~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred Hhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 444 4 999999999999984 67899999999987544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.1e-05 Score=60.97 Aligned_cols=92 Identities=18% Similarity=0.210 Sum_probs=67.0
Q ss_pred HHHHHHHHhcCC------CCcccceeeEEEeCCeeEEEEEcCCC------CCHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLV------HLNLVKLIGYCIEDDQRLLVYEFMPR------GSLENHLFRRSLPLPWSIRMKIALGAAKGL 69 (306)
Q Consensus 2 ~~~E~~il~~l~------H~niv~~~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l 69 (306)
+.+|+.-..++. +.+|.++||+.+++....+|+|.+.+ .+|.+++.+. .++. .....+.++.
T Consensus 58 ~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~~f~--- 131 (199)
T PF10707_consen 58 NRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALDEFK--- 131 (199)
T ss_pred HHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHHHHH---
Confidence 566777666665 78999999999999999999998654 2788888544 3555 4444444444
Q ss_pred HHhhcCCCCCeEeccCCCCCeEEcCCC----cEEEec
Q 021891 70 AFLHEEAERPVIYRDFKTSNILLDADY----NAKLSD 102 (306)
Q Consensus 70 ~~LH~~~~~~iiH~dlkp~Nill~~~~----~~kl~D 102 (306)
.||-..+ |+.+||+|.||++..+. .+.|+|
T Consensus 132 ~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 132 RYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 5555556 99999999999995432 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=6.4e-05 Score=62.47 Aligned_cols=30 Identities=20% Similarity=0.233 Sum_probs=25.5
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++|+|+.+.||+++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 389999999999998776567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0001 Score=72.33 Aligned_cols=41 Identities=17% Similarity=0.337 Sum_probs=32.3
Q ss_pred HHHHHHHHhcCC-CCcc--cceeeEEEeC---CeeEEEEEcCCCCCH
Q 021891 2 WQAEVNFLGDLV-HLNL--VKLIGYCIED---DQRLLVYEFMPRGSL 42 (306)
Q Consensus 2 ~~~E~~il~~l~-H~ni--v~~~~~~~~~---~~~~lv~e~~~~~sL 42 (306)
+.+|+++|+.|. |.+| .+++.+|.+. +..|+||||++|..+
T Consensus 85 ~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 85 VEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 679999999995 6665 7888887764 467899999988643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00012 Score=59.92 Aligned_cols=98 Identities=19% Similarity=0.206 Sum_probs=67.3
Q ss_pred HHHHHHHhcCC--CCcccceeeEEEeCCeeEEEEEcCCCCCH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCC
Q 021891 3 QAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAER 78 (306)
Q Consensus 3 ~~E~~il~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~ 78 (306)
.+|+.-|+++. +-.+.+-+++. +-.|||||+....+ .-.|. ...+.......+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~-- 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAG-- 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence 46888888874 33445555543 34789999955311 01111 1123333567778888888887776 66
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 110 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 110 (306)
+||+||..-|||+. ++.+.|+|||-|....
T Consensus 188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999998 8889999999887643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=5.1e-06 Score=82.74 Aligned_cols=156 Identities=14% Similarity=0.009 Sum_probs=114.1
Q ss_pred HHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcCCC-
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAE- 77 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~~- 77 (306)
.|...+++..|+++...+.-... ....+.+++|+.+|.+.+.|.+.. ..+...-+.....+.+.+..-+|+..+
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 44455666789998877765543 335689999999999999987643 234555555555554666666555432
Q ss_pred -CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 78 -RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 78 -~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
.-.+|++||+-|.+|..+-.+|++++|+.+...+. ........+++-|+.+++...-.++.++|+|..|+-+|+..-
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 33789999999999999999999999999832221 111233556778899998888889999999999999999988
Q ss_pred CCCCC
Q 021891 157 GRRSM 161 (306)
Q Consensus 157 g~~pf 161 (306)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 87665
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=7.5e-05 Score=67.12 Aligned_cols=45 Identities=24% Similarity=0.345 Sum_probs=36.0
Q ss_pred HHHHHhcCCCCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhcCC
Q 021891 5 EVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRS 50 (306)
Q Consensus 5 E~~il~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~ 50 (306)
.+++++.+.|+|...++++.+... ...+|||++ +.||.+.+..+.
T Consensus 32 r~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 32 RFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred hhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 467888999999999999877543 456889999 569999886554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00068 Score=55.85 Aligned_cols=106 Identities=20% Similarity=0.209 Sum_probs=55.5
Q ss_pred HHHHHHHHhcCCCC--cccceeeEEEe---CCeeEEEEEcCCCCCHHH----------------Hhh---cC---CCCCC
Q 021891 2 WQAEVNFLGDLVHL--NLVKLIGYCIE---DDQRLLVYEFMPRGSLEN----------------HLF---RR---SLPLP 54 (306)
Q Consensus 2 ~~~E~~il~~l~H~--niv~~~~~~~~---~~~~~lv~e~~~~~sL~~----------------~l~---~~---~~~l~ 54 (306)
+.+|..+++.|... .+.+++.+... ....+++|++++|..+.. .+. +. ...+.
T Consensus 37 ~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~ 116 (239)
T PF01636_consen 37 LRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFA 116 (239)
T ss_dssp HHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHT
T ss_pred HHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccc
Confidence 46788888888533 35677765433 335689999999988777 110 01 01111
Q ss_pred HHH---------HHHH------------HHHHHH-HHHHhhc----CCCCCeEeccCCCCCeEEc-CCCcEEEeccCCcc
Q 021891 55 WSI---------RMKI------------ALGAAK-GLAFLHE----EAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAK 107 (306)
Q Consensus 55 ~~~---------~~~~------------~~qi~~-~l~~LH~----~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~ 107 (306)
... .... ...+.. .+..++. .....++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 117 DWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 100 0000 111222 2333332 1223499999999999999 66777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0011 Score=54.98 Aligned_cols=30 Identities=20% Similarity=0.286 Sum_probs=26.4
Q ss_pred CeEeccCCCCCeEEcC-CCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~ 108 (306)
.++|+|+.+.||+++. ++.+.|+||..+..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 4999999999999998 57899999988754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0015 Score=56.29 Aligned_cols=42 Identities=19% Similarity=0.192 Sum_probs=33.0
Q ss_pred CHHHHHHHHhcCCC---CcccceeeEEEeC---CeeEEEEEcCCCCCH
Q 021891 1 MWQAEVNFLGDLVH---LNLVKLIGYCIED---DQRLLVYEFMPRGSL 42 (306)
Q Consensus 1 ~~~~E~~il~~l~H---~niv~~~~~~~~~---~~~~lv~e~~~~~sL 42 (306)
+|.+|++.|+.|.- -.+.++++++... +..+||||+++|+++
T Consensus 53 ~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 53 VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred HHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 47899999999943 3678899887653 568999999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00096 Score=56.16 Aligned_cols=29 Identities=24% Similarity=0.321 Sum_probs=25.7
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 389999999999999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0081 Score=52.91 Aligned_cols=30 Identities=20% Similarity=0.304 Sum_probs=26.0
Q ss_pred CeEeccCCCCCeEEcC-CCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~ 108 (306)
.++|+|+++.||++++ ++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 4899999999999976 46799999988754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0088 Score=51.62 Aligned_cols=31 Identities=23% Similarity=0.467 Sum_probs=28.0
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
.++|+|+++.|++++.++-+-+.||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4899999999999999888999999998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.011 Score=50.72 Aligned_cols=31 Identities=35% Similarity=0.408 Sum_probs=26.8
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|++|.||+++.++.+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999887778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.017 Score=50.66 Aligned_cols=30 Identities=17% Similarity=0.255 Sum_probs=25.9
Q ss_pred CeEeccCCCCCeEEcC-CCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~ 108 (306)
.++|+|+.+.||++++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 57899999998854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.02 Score=46.54 Aligned_cols=86 Identities=15% Similarity=0.084 Sum_probs=53.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.++++++.++. .|+++.. ...-.+.++.|.|-.... ... .++..=+++|.-.|+.. ...+
T Consensus 105 y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i----------~~~----N~i~agi~~L~~fH~~~-~~~l 165 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI----------NFS----NFITAGIKDLMDFHSEN-QHCL 165 (308)
T ss_pred hhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc----------chh----HHHHHhHHHHHHhhccC-CCee
Confidence 445566665553 2455542 123355688898843211 111 11111136778889655 4599
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCc
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLA 106 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a 106 (306)
|+|..|+||+.|..|.+||.|-+..
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCCCEEecChhhh
Confidence 9999999999999999999996643
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.095 Score=42.92 Aligned_cols=43 Identities=33% Similarity=0.539 Sum_probs=34.8
Q ss_pred CHHHHHHHHhcCCC---CcccceeeEEEeCCeeEEEEEcCCCCCHH
Q 021891 1 MWQAEVNFLGDLVH---LNLVKLIGYCIEDDQRLLVYEFMPRGSLE 43 (306)
Q Consensus 1 ~~~~E~~il~~l~H---~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 43 (306)
+|..|+.-|..|.- -+|.+++.+..+.++.|+||||++-+.+.
T Consensus 54 ~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 54 MFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 47788887777743 46778999999999999999999886655
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.032 Score=48.69 Aligned_cols=73 Identities=19% Similarity=0.187 Sum_probs=55.4
Q ss_pred eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 29 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 29 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..|++|++- |++|.- + +...++++..++.+.+..+.-+..+- +.-|||+.-.||+|+ +|.+.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 456777775 445432 2 12457888889998888777776654 388999999999999 99999999999985
Q ss_pred CC
Q 021891 109 GP 110 (306)
Q Consensus 109 ~~ 110 (306)
..
T Consensus 371 ~~ 372 (488)
T COG5072 371 SY 372 (488)
T ss_pred cc
Confidence 43
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.01 Score=50.99 Aligned_cols=93 Identities=19% Similarity=0.174 Sum_probs=62.8
Q ss_pred HHHHHHHhcCCC--CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 3 QAEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 3 ~~E~~il~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.+|+..|+.|.- --|.+.+++. .-++|||++.|-.|...-. ..+..++..-+.. -+--|-.+| +
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~----v~d~~~ly~~lm~---~Iv~la~~G---l 223 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH----VEDPPTLYDDLMG---LIVRLANHG---L 223 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee----cCChHHHHHHHHH---HHHHHHHcC---c
Confidence 478888888843 2355666654 3478999998877765321 1233333333332 334455566 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
||+|..-=||++++++.++++||--....
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhhcc
Confidence 99999999999999999999999765443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.045 Score=48.87 Aligned_cols=29 Identities=24% Similarity=0.084 Sum_probs=24.0
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..+|.|+-+.||+.+. +.+.++||..|..
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 4899999999999755 4599999988753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.051 Score=42.56 Aligned_cols=91 Identities=15% Similarity=0.153 Sum_probs=62.1
Q ss_pred HHHHHHHHhcCCCCccc-ceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|+.|+++|..++--++- ++|.|..+ ++.|||+.|-.|.+..... +-. -+..+++.-.-|-..| |
T Consensus 62 l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~----~rk----~l~~vlE~a~~LD~~G---I 126 (201)
T COG2112 62 LEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG----DRK----HLLRVLEKAYKLDRLG---I 126 (201)
T ss_pred HHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc----cHH----HHHHHHHHHHHHHHhc---c
Confidence 67899999999877765 56665432 4559999988888765321 222 2334555545555666 8
Q ss_pred EeccCCC--CCeEEcCCCcEEEeccCCccc
Q 021891 81 IYRDFKT--SNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 81 iH~dlkp--~Nill~~~~~~kl~Dfg~a~~ 108 (306)
-|..|.- .||++. ++.+.|+||..|+.
T Consensus 127 ~H~El~~~~k~vlv~-~~~~~iIDFd~At~ 155 (201)
T COG2112 127 EHGELSRPWKNVLVN-DRDVYIIDFDSATF 155 (201)
T ss_pred chhhhcCCceeEEec-CCcEEEEEccchhh
Confidence 8888874 456664 44899999999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.028 Score=48.47 Aligned_cols=31 Identities=29% Similarity=0.230 Sum_probs=27.0
Q ss_pred CCeEeccCCCCCeEEcCC----CcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~~ 108 (306)
..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 458999999999999875 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.061 Score=47.16 Aligned_cols=101 Identities=16% Similarity=0.151 Sum_probs=67.9
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
+.|++-|++|....|.----+.. ..-.|||+|+.....-.-. -+...++...+..+-.|++.-+.-|..... +||
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVH 288 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCR--LVH 288 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhc--eec
Confidence 46888888887766442221111 1236899999543221111 112346777788888888888888876543 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
.||.--|+|+ .+|.+.|+|.+-+...
T Consensus 289 ADLSEfN~Ly-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 289 ADLSEFNLLY-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred cchhhhhheE-ECCEEEEEEccccccC
Confidence 9999999999 5678999998877653
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.014 Score=46.28 Aligned_cols=28 Identities=25% Similarity=0.318 Sum_probs=25.4
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.+|+|+.|.|++++++| ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 79999999999998877 88999999865
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.038 Score=46.84 Aligned_cols=49 Identities=18% Similarity=0.097 Sum_probs=36.8
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 59 ~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
...+..+-.++.-.+... .-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 334555555555555541 2389999999999999989999999998865
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.031 Score=48.36 Aligned_cols=31 Identities=35% Similarity=0.412 Sum_probs=27.1
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 4599999999999999888778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.049 Score=47.36 Aligned_cols=31 Identities=32% Similarity=0.421 Sum_probs=26.2
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..+||+|+++.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4599999999999998766568999998754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.071 Score=46.13 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.3
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+++.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 34899999999999987 6688999987653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.02 Score=46.57 Aligned_cols=30 Identities=33% Similarity=0.403 Sum_probs=21.2
Q ss_pred CeEeccCCCCCeEE-cCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILL-DADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill-~~~~~~kl~Dfg~a~~ 108 (306)
.++|+||.+.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.17 Score=40.70 Aligned_cols=83 Identities=30% Similarity=0.434 Sum_probs=55.4
Q ss_pred HHHHHHHHhcC---CCCcc--cceeeEEEeC------------------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHH
Q 021891 2 WQAEVNFLGDL---VHLNL--VKLIGYCIED------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 58 (306)
Q Consensus 2 ~~~E~~il~~l---~H~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~ 58 (306)
|-.|-+-..+| .+.++ |+++||..-. ....||.||++... .+....
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~- 169 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD- 169 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH-
Confidence 44555544444 45566 8899887432 12357888776543 122233
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCc
Q 021891 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 106 (306)
Q Consensus 59 ~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a 106 (306)
+.++..-|..+|..+ |+-+|+++.|.. + =||+|||.+
T Consensus 170 ---~~~~~~dl~~~~k~g---I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 170 ---IPQMLRDLKILHKLG---IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred ---HHHHHHHHHHHHHCC---eeeccCcccccc---C--CEEEecccC
Confidence 456777788999999 999999999986 2 378899864
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.06 Score=46.42 Aligned_cols=80 Identities=18% Similarity=0.104 Sum_probs=45.4
Q ss_pred eeEEEEEcCCCCCHHHH----hhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCCeEeccCCCCCeEEcCCC-------
Q 021891 29 QRLLVYEFMPRGSLENH----LFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-ERPVIYRDFKTSNILLDADY------- 96 (306)
Q Consensus 29 ~~~lv~e~~~~~sL~~~----l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-~~~iiH~dlkp~Nill~~~~------- 96 (306)
.-.+|+.++.+ +-.+. ..+.+-.--.+-++.++.||+.-.-..-+.. ....+|.||||+|||+-+..
T Consensus 249 GnIIIfPLArc-Sadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 327 (444)
T PHA03111 249 GNIIIFPLARC-SADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITL 327 (444)
T ss_pred CcEEEEehhhc-ccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEE
Confidence 34577887643 22221 1122322234567788888865442332211 12389999999999994332
Q ss_pred -----------cEEEeccCCcccC
Q 021891 97 -----------NAKLSDFGLAKDG 109 (306)
Q Consensus 97 -----------~~kl~Dfg~a~~~ 109 (306)
.++|.||.+++..
T Consensus 328 ~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 328 KDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred CCeEEEeccchhhhhcccCHHHHc
Confidence 2567777777653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.16 Score=44.38 Aligned_cols=29 Identities=31% Similarity=0.468 Sum_probs=25.5
Q ss_pred eEeccCCCCCeEEcCCCc-EEEeccCCccc
Q 021891 80 VIYRDFKTSNILLDADYN-AKLSDFGLAKD 108 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~-~kl~Dfg~a~~ 108 (306)
+||+|+.|.||+++.+.. +.+.||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 899999999999998874 88999997653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.088 Score=45.64 Aligned_cols=76 Identities=17% Similarity=0.160 Sum_probs=44.4
Q ss_pred EEEEEcCCCCCHHHH---hh-cCCCCCCHHHHHHHHHHHHHHHHH--hhcC-CCCCeEeccCCCCCeEEcCCC-------
Q 021891 31 LLVYEFMPRGSLENH---LF-RRSLPLPWSIRMKIALGAAKGLAF--LHEE-AERPVIYRDFKTSNILLDADY------- 96 (306)
Q Consensus 31 ~lv~e~~~~~sL~~~---l~-~~~~~l~~~~~~~~~~qi~~~l~~--LH~~-~~~~iiH~dlkp~Nill~~~~------- 96 (306)
.+|+.++.+ +-.+. .. +.+-..-.+-++.++.||+. -| .-+. +....+|.||||+|||+-+..
T Consensus 247 IIIfPLA~~-Sadkv~~~~~~e~GF~s~~~YvkfifLQiaL--LyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~ 323 (434)
T PF05445_consen 247 IIIFPLARC-SADKVTESNAAELGFKSNVEYVKFIFLQIAL--LYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKF 323 (434)
T ss_pred EEEEehhhc-chhhcCHHHHHhcCchhHHHHHHHHHHHHHH--HHeeeecCCCcceeeecccCcCcEEEecCCCceEEEE
Confidence 478887643 32221 11 12222334566778888854 44 2222 112389999999999994321
Q ss_pred -----------cEEEeccCCcccC
Q 021891 97 -----------NAKLSDFGLAKDG 109 (306)
Q Consensus 97 -----------~~kl~Dfg~a~~~ 109 (306)
.++|.||.+++..
T Consensus 324 ~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 324 GNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred CCeEEEecccceeeecccCHHHhc
Confidence 2678888888764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.2 Score=40.21 Aligned_cols=30 Identities=27% Similarity=0.326 Sum_probs=25.1
Q ss_pred CeEeccCCCCCeEEcCCC-----cEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADY-----NAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~-----~~kl~Dfg~a~~ 108 (306)
.++|+|+.+.||++..++ .+.+.||..++.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 489999999999997543 589999988764
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.23 E-value=0.14 Score=44.40 Aligned_cols=31 Identities=16% Similarity=0.170 Sum_probs=27.7
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+.+.|++++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3499999999999999999999999988765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.80 E-value=0.091 Score=44.97 Aligned_cols=40 Identities=30% Similarity=0.517 Sum_probs=26.4
Q ss_pred CHHHHHHHHhcCC--C-CcccceeeEEEeCCeeEEEEEcCCCC
Q 021891 1 MWQAEVNFLGDLV--H-LNLVKLIGYCIEDDQRLLVYEFMPRG 40 (306)
Q Consensus 1 ~~~~E~~il~~l~--H-~niv~~~~~~~~~~~~~lv~e~~~~~ 40 (306)
+|+.|++-|+.|. . -.+.+++++....+..+|||||++.+
T Consensus 55 ~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 55 MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4788999999883 3 35779999988888889999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.096 Score=44.62 Aligned_cols=30 Identities=30% Similarity=0.401 Sum_probs=25.1
Q ss_pred CeEeccCCCCCeEEcCCCc-EEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYN-AKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~-~kl~Dfg~a~~ 108 (306)
.++|+|+++.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999987555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.11 E-value=0.33 Score=49.18 Aligned_cols=31 Identities=45% Similarity=0.493 Sum_probs=25.9
Q ss_pred CCeEeccCCCCCeEEcCCC--cEE-EeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADY--NAK-LSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~--~~k-l~Dfg~a~~ 108 (306)
..+||+|+++.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4499999999999998775 554 999998764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.33 E-value=0.51 Score=41.24 Aligned_cols=29 Identities=24% Similarity=0.241 Sum_probs=23.8
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..+||+|+.+.||+++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3489999999999995 4 578899997753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 306 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 453 bits (1168), Expect = e-162
Identities = 85/235 (36%), Positives = 133/235 (56%), Gaps = 9/235 (3%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRM 59
+ E+ + H NLV+L+G+ + D LVY +MP GSL + L + PL W +R
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
KIA GAA G+ FLHE I+RD K++NILLD + AK+SDFGLA+ + +T +++
Sbjct: 137 KIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
R++GT Y APE + G +T +SD+YSFGVVLLE++TG ++D++R L++
Sbjct: 194 RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEI 250
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
E + ID ++ + +A+ CL RP + +V + L+ +
Sbjct: 251 EDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 427 bits (1100), Expect = e-152
Identities = 91/243 (37%), Positives = 144/243 (59%), Gaps = 7/243 (2%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIR 58
++ E+ L H +LV LIG+C E ++ +L+Y++M G+L+ HL+ ++ + W R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
++I +GAA+GL +LH +I+RD K+ NILLD ++ K++DFG++K G E D+TH+S
Sbjct: 142 LEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
T V GT GY PEY + G LT +SDVYSFGVVL E+L R ++ ++ P NL EWA
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238
+ +++DP L + +K A CL+ + RP M +V+ L+ L+
Sbjct: 259 SH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 239 DMA 241
+
Sbjct: 318 ESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-135
Identities = 96/235 (40%), Positives = 146/235 (62%), Gaps = 7/235 (2%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRM 59
Q EV + VH NL++L G+C+ +RLLVY +M GS+ + L R PL W R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK D THV+T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTT 193
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWAR 177
V GT G+ APEY+ TG + ++DV+ +GV+LLE++TG+R+ D R + L++W +
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
L + ++ L+D L+G++ + ++ Q+A C P RP MSEVV L+
Sbjct: 254 GLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-75
Identities = 63/257 (24%), Positives = 103/257 (40%), Gaps = 23/257 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
EV L + H N+++ IG L+ F +GSL + L + W+
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCH 125
Query: 61 IALGAAKGLAFLHEEAER-------PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
IA A+GLA+LHE+ + +RD K+ N+LL + A ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTS-----RSDVYSFGVVLLEMLTGRRSMDKNRPNG 168
+ +GT Y APE + R D+Y+ G+VL E+ + + D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 169 EHNLVE--WARPHLGERRRF--YRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPL 223
E P L + + ++ P L ++ G + C D +AR
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 224 MSEVVEALKPLPNLKDM 240
V E + + L ++
Sbjct: 306 AGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-54
Identities = 55/268 (20%), Positives = 98/268 (36%), Gaps = 38/268 (14%)
Query: 2 WQAEVN--FLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRSLPLP 54
+ E N + + H N+ + I + LLV E+ P GSL +L +
Sbjct: 52 FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-- 109
Query: 55 WSIRMKIALGAAKGLAFLHEEAER------PVIYRDFKTSNILLDADYNAKLSDFGLAK- 107
W ++A +GLA+LH E R + +RD + N+L+ D +SDFGL+
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 108 -----DGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEML 155
G++ + + +GT Y APE + + D+Y+ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 156 TGRRSMDKNRPNGEHNL----VEWARPHLGERRRF-----YRLIDPRLEGHFSIKGAQKA 206
+ E+ + P + + R P S+ +
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSL 288
Query: 207 AQLAAHCLSRDPKARPLMSEVVEALKPL 234
+ C +D +AR E + L
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-54
Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 31/236 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIA 62
E+ L + H N+VKL G C+ LV E+ GSL N H + M
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVSTRV 121
L ++G+A+LH + +I+RD K N+LL A K+ DFG A D T
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNN 163
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--- 178
G+ + APE + + + DV+S+G++L E++T R +P E +
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAV 217
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
H G R + + + L C S+DP RP M E+V+ + L
Sbjct: 218 HNGTRPPLIKNLPKPI------------ESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIA 62
EV + L H N+V +G + +V E++ RGSL L + L R+ +A
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
AKG+ +LH P+++R+ K+ N+L+D Y K+ DFGL++ + S
Sbjct: 144 YDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAA 200
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--WARPHL 180
GT + APE + +SDVYSFGV+L E+ T + +P G N + A
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFK 254
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
+R R ++P++ A + C + +P RP + +++ L+PL
Sbjct: 255 CKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-53
Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 39/244 (15%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q EV + +L H N+VKL G +V EF+P G L + L ++ P+ WS+++++
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKLSDFGLAKDGPEGDKTHV 117
L A G+ ++ + P+++RD ++ NI L A AK++DFGL++ H
Sbjct: 129 LDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHS 182
Query: 118 STRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRP----NGEH 170
+ ++G + + APE + T ++D YSF ++L +LTG P +
Sbjct: 183 VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGK 235
Query: 171 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230
G R PRL + C S DPK RP S +V+
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKE 283
Query: 231 LKPL 234
L L
Sbjct: 284 LSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-51
Identities = 57/249 (22%), Positives = 97/249 (38%), Gaps = 40/249 (16%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------DGP 110
A G+A+LH +I+RD + N L+ + N ++DFGLA+
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 111 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 170
+ V+G + APE + + DV+SFG+VL E++ + P+
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLP 227
Query: 171 NLVEWARPHLGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
+++ R F P + C DP+ RP
Sbjct: 228 RTMDFGLNV----RGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFV 271
Query: 226 EVVEALKPL 234
++ L+ L
Sbjct: 272 KLEHWLETL 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-50
Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 34/240 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E L H N++ L G C+++ LV EF G L L + +P I + A+
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQ 113
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLD--------ADYNAKLSDFGLAKDGPEGDKTH 116
A+G+ +LH+EA P+I+RD K+SNIL+ ++ K++DFGLA+ E +T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTT 170
Query: 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL-VE 174
+ G Y + APE + + SDV+S+GV+L E+LTG P G L V
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVA 223
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
+ A+L C + DP +RP + +++ L +
Sbjct: 224 YGVAMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-50
Identities = 54/245 (22%), Positives = 95/245 (38%), Gaps = 48/245 (19%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLPWSIRMKI 61
E L H N++ ++G C + +MP GSL N L + + S +K
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
AL A+G+AFLH E + + ++++D D A++S + + S
Sbjct: 117 ALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGR 168
Query: 122 MGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA- 176
M + APE + +D++SF V+L E++T P + + +E
Sbjct: 169 MYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGM 221
Query: 177 -------RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
RP + I P + ++L C++ DP RP +V
Sbjct: 222 KVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRPKFDMIVP 263
Query: 230 ALKPL 234
L+ +
Sbjct: 264 ILEKM 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-50
Identities = 56/260 (21%), Positives = 103/260 (39%), Gaps = 27/260 (10%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
E+ + H N++ I I+ Q L+ ++ GSL ++L +S L +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSML 137
Query: 60 KIALGAAKGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEG 112
K+A + GL LH E + +RD K+ NIL+ + ++D GLA
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNR 165
+ +GT Y PE V+ L +D+YSFG++L E+ R
Sbjct: 198 EVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIV 255
Query: 166 PNGE--HNLVEWARPHLGERRRF--YRLIDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKA 220
+ ++ + + P + R + + P +S + +L C + +P +
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 221 RPLMSEVVEALKPLPNLKDM 240
R V + L + +D+
Sbjct: 316 RLTALRVKKTLAKMSESQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-49
Identities = 58/258 (22%), Positives = 94/258 (36%), Gaps = 35/258 (13%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
E+ L H N++ I + Q L+ + GSL ++L + L +
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCL 108
Query: 60 KIALGAAKGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEG 112
+I L A GLA LH E + +RD K+ NIL+ + ++D GLA
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNR 165
+ +GT Y APE V+ + R D+++FG+VL E+ S
Sbjct: 169 QLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 166 P--------NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSR 216
E R + ++ R I R A+L C +
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQ--RPNIPNRWFSD---PTLTSLAKLMKECWYQ 282
Query: 217 DPKARPLMSEVVEALKPL 234
+P AR + + L +
Sbjct: 283 NPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-49
Identities = 43/255 (16%), Positives = 90/255 (35%), Gaps = 40/255 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
EV H N+V +G C+ ++ +L + + + L + +IA
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRV 121
KG+ +LH + ++++D K+ N+ D + ++DFGL G +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 122 MGTYGYAAPEYVMTG---------HLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGE 169
G + APE + + SDV++ G + E+ ++
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---- 250
Query: 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ W + ++ I + C + + + RP +++++
Sbjct: 251 ---IIWQ------MGTGMKPNLSQIGMGKEIS------DILLFCWAFEQEERPTFTKLMD 295
Query: 230 ALKPLPNLKDMASSS 244
L+ LP K S
Sbjct: 296 MLEKLP--KRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-49
Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 19/236 (8%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ EV L H+N++ +GY Q +V ++ SL +HL + IA
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
A+G+ +LH + +I+RD K++NI L D K+ DFGLA + +H ++
Sbjct: 127 RQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 123 GTYGYAAPE---YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
G+ + APE + + +SDVY+FG+VL E++TG+ P N +
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEM 237
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235
+G ++ + ++ +L A CL + RP ++ ++ L
Sbjct: 238 VGRGSL--SPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 61/264 (23%), Positives = 103/264 (39%), Gaps = 35/264 (13%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
AE+ L H N++ I +D+ Q LV ++ GSL ++L + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMI 142
Query: 60 KIALGAAKGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEG 112
K+AL A GLA LH E + +RD K+ NIL+ + ++D GLA D
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNR 165
+GT Y APE V+ + R+D+Y+ G+V E+ +
Sbjct: 203 TIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 166 P--------NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSR 216
VE R + E++ R I R + +++ A++ C
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKL--RPNIPNRWQSCEALR---VMAKIMRECWYA 316
Query: 217 DPKARPLMSEVVEALKPLPNLKDM 240
+ AR + + L L + +
Sbjct: 317 NGAARLTALRIKKTLSQLSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 21/232 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E L H N+V+LIG C + +V E + G L L +++
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
AA G+ +L + I+RD N L+ K+SDFG++++ +G
Sbjct: 221 DAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGE 182
+ APE + G +S SDV+SFG++L E + S N N + VE
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------- 329
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
+ RL P E +L C + +P RP S + + L+ +
Sbjct: 330 --KGGRL--PCPELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 31/228 (13%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 71
L H N+V +I EDD LV E++ +L ++ PL + G+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKH 126
Query: 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 131
H+ +++RD K NIL+D++ K+ DFG+AK E T + V+GT Y +PE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPE 182
Query: 132 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGE-----RRR 185
+D+YS G+VL EML G P NGE V A H+ +
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQDSVPNVTTD 235
Query: 186 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 232
+ I L + +D R + E+ + L
Sbjct: 236 VRKDIPQSLS------------NVILRATEKDKANRYKTIQEMKDDLS 271
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 68/248 (27%), Positives = 101/248 (40%), Gaps = 38/248 (15%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
W+ E++ L L H +++K G C + LV E++P GSL ++L R S+ L +
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF 139
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
A +G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + +
Sbjct: 140 --AQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 194
Query: 120 -------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 171
APE + SDV+SFGV L E+LT S E
Sbjct: 195 EDGDSPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
Query: 172 LVEWARPHLGERRRF----YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224
+ + + RL P E + L +C + RP
Sbjct: 249 GIAQGQMTVLRLTELLERGERLPRPDKCPAEVY----------HLMKNCWETEASFRPTF 298
Query: 225 SEVVEALK 232
++ LK
Sbjct: 299 ENLIPILK 306
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-29
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 27/225 (12%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIR 58
+ E L L H N+V+ + + +++ E M G+L+ +L +R + +
Sbjct: 73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVL 131
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHV 117
KGL FLH P+I+RD K NI + + K+ D GLA +
Sbjct: 132 RSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASF 186
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ V+GT + APE + DVY+FG+ +LEM T E+ E
Sbjct: 187 AKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMAT-----------SEYPYSECQN 234
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
RR + + + ++ C+ ++ R
Sbjct: 235 AAQIYRRVTSGVKPASFDKVAI----PEVKEIIEGCIRQNKDERY 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 56/257 (21%), Positives = 109/257 (42%), Gaps = 29/257 (11%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIA 62
E + ++ H NLV+L+G C + ++ EFM G+L ++L + + + +A
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+ + +L ++ I+R+ N L+ ++ K++DFGL++ GD
Sbjct: 325 TQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAK 380
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLG 181
+ APE + + +SDV++FGV+L E+ T S + + L+E
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------- 433
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
+ YR+ P G + +L C +P RP +E+ +A + +
Sbjct: 434 ---KDYRMERPE--------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ---- 478
Query: 241 ASSSYYFQTMQAERIGS 257
SS + + G+
Sbjct: 479 ESSISDEVEKELGKRGT 495
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 52/258 (20%), Positives = 93/258 (36%), Gaps = 59/258 (22%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-------------LVYEFMPRGSLENHLFRR 49
+EV L L H +V+ +E + + E+ G+L + +
Sbjct: 50 LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109
Query: 50 SLPLP----WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 105
+L W + +I L+++H + +I+RD K NI +D N K+ DFGL
Sbjct: 110 NLNQQRDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGL 162
Query: 106 AK-------------DGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVV 150
AK G ++++ + GT Y A E V+ TGH + D+YS G++
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGII 220
Query: 151 LLEMLTGRRSMDKNRPNGEHNLVE-WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 209
EM+ + V + P + + + ++
Sbjct: 221 FFEMIYP--------FSTGMERVNILKKLRSVSIE-----FPPDFDDNKM----KVEKKI 263
Query: 210 AAHCLSRDPKARPLMSEV 227
+ DP RP +
Sbjct: 264 IRLLIDHDPNKRPGARTL 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 52/229 (22%), Positives = 76/229 (33%), Gaps = 32/229 (13%)
Query: 4 AEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
AEV + H V+L E L E SL+ H LP +
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYL 163
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
LA LH + +++ D K +NI L KL DFGL + V
Sbjct: 164 RDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QE 217
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
G Y APE + + + +DV+S G+ +LE+ PH GE
Sbjct: 218 GDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNME-----------------LPHGGE 259
Query: 183 RRR--FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ + P S + + L DPK R ++
Sbjct: 260 GWQQLRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 60/253 (23%), Positives = 91/253 (35%), Gaps = 45/253 (17%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL----------------LVYEFMPRGSLENHL-F 47
EV L L H+N+V G D + EF +G+LE +
Sbjct: 54 EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 48 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 107
RR L + +++ KG+ ++H + +I RD K SNI L K+ DFGL
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 108 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 167
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 171 ---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAF 222
Query: 168 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227
F L D + F +K L LS+ P+ RP SE+
Sbjct: 223 ETSKF-------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
Query: 228 VEALKPLPNLKDM 240
+ L +
Sbjct: 266 LRTLTVWKKSPEK 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 26/292 (8%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 61
+ EV L ++ H N+V+ E+ +V ++ G L + ++ + +
Sbjct: 71 RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ L +H+ R +++RD K+ NI L D +L DFG+A+ +
Sbjct: 131 FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI 186
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT Y +PE ++SD+++ G VL E+ T + + + +
Sbjct: 187 -GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--- 242
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE---ALKPLPNLK 238
P + H+S L + R+P+ RP ++ ++E K +
Sbjct: 243 ----------PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL 288
Query: 239 DMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 290
+ F + GS P + S+S + ++ P Y P
Sbjct: 289 SPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-28
Identities = 62/250 (24%), Positives = 98/250 (39%), Gaps = 36/250 (14%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
+ E+ L +L H N+VK G C ED L+ EF+P GSL+ +L + + ++
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
K A+ KG+ +L R ++RD N+L+++++ K+ DFGL K + +
Sbjct: 130 KYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186
Query: 120 -------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 171
APE +M SDV+SFGV L E+LT +
Sbjct: 187 DDRDSPVFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
Query: 172 LV---EWARPHLGER-RRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224
+ L + RL P E + QL C P R
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSF 290
Query: 225 SEVVEALKPL 234
++E + L
Sbjct: 291 QNLIEGFEAL 300
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 45/148 (30%), Positives = 61/148 (41%), Gaps = 5/148 (3%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 71
L ++V + + D Q + + L L RR PL + I L
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDA 149
Query: 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 131
H +RD K NIL+ AD A L DFG+A + T + +GT Y APE
Sbjct: 150 AHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPE 205
Query: 132 YVMTGHLTSRSDVYSFGVVLLEMLTGRR 159
H T R+D+Y+ VL E LTG
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + + + ++ +L+G C+ L+ + MP G L +++ + + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
AKG+ +L +R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 125 QIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ A E ++ T +SDV+S+GV + E++T G +
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-27
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKI 61
E + L H LVK G C ++ +V E++ G L N+L + L + M
Sbjct: 52 QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-- 109
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+G+AFL I+RD N L+D D K+SDFG+ + +
Sbjct: 110 CYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSS 162
Query: 122 MGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+GT ++APE +S+SDV++FG+++ E+ + G+
Sbjct: 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 21/166 (12%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSLPLPWS 56
E+ + D+ + + G I + + ++YE+M S+ + +P
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KT 115
+ I +++H E+ + +RD K SNIL+D + KLSDFG ++ + K
Sbjct: 152 VIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 158
GTY + PE + + ++ D++S G+ L M
Sbjct: 210 -----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 26/234 (11%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIA 62
E + L H LV+L E+ +V E+M +GSL + L L + +A
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
A G+A++ ++RD + +NIL+ + K++DFGLA+ E ++
Sbjct: 287 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 342
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLG 181
+ APE + G T +SDV+SFG++L E+ T R N E + VE
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------- 395
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 234
R YR+ P ++ L C ++P+ RP + L+
Sbjct: 396 ---RGYRMPCPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKI 61
E + L H LV+L G C+E LV EFM G L ++L R + M
Sbjct: 52 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-- 109
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTR 120
L +G+A+L E VI+RD N L+ + K+SDFG+ + + + T+
Sbjct: 110 CLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166
Query: 121 V----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+PE +S+SDV+SFGV++ E+ + G+
Sbjct: 167 FPVKWA------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 18/164 (10%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
++ E+ L L H N+VK G C +R L+ E++P GSL ++L + + +
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+ KG+ +L + I+RD T NIL++ + K+ DFGL K P+ +
Sbjct: 118 QYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK 174
Query: 120 -------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
APE + + SDV+SFGVVL E+ T
Sbjct: 175 EPGESPIFWY------APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 58/257 (22%), Positives = 90/257 (35%), Gaps = 39/257 (15%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L +V L G E + E + GSL L ++ LP +
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYL 156
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAK---DGPEGDKTHVS 118
A +GL +LH +++ D K N+LL +D A L DFG A G
Sbjct: 157 GQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 119 TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ GT + APE VM ++ D++S ++L ML G P W
Sbjct: 214 DYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH------P--------WT- 257
Query: 178 PHLGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVV 228
++ + + AQ L ++P R L +V
Sbjct: 258 -QYFRGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVG 312
Query: 229 EALKPLPNLKDMASSSY 245
+AL+ + LK Y
Sbjct: 313 KALQEVGGLKSPWKGEY 329
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 24/167 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPW 55
E + + + ++V+L+G + L++ E M RG L+++L P
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
S +++A A G+A+L ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 138 SKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 116 HVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ M +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 195 RKGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 5/158 (3%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+E + +G H N+++L G ++V E+M GSL+ L + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 122
G G+ +L ++ ++RD N+L+D++ K+SDFGL++ + D + +T
Sbjct: 159 GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + +S SDV+SFGVV+ E+L G R
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 66/250 (26%), Positives = 99/250 (39%), Gaps = 36/250 (14%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
+Q E+ L L +VK G ++ LV E++P G L + L R L S +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+ KG+ +L R ++RD NIL++++ + K++DFGLAK P +V
Sbjct: 131 LYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 120 -------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 171
APE + + +SDV+SFGVVL E+ T +S +
Sbjct: 188 EPGQSPIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 172 LVEWARPHLGERRRF----YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224
E P L RL P E H +L C + P+ RP
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVH----------ELMKLCWAPSPQDRPSF 291
Query: 225 SEVVEALKPL 234
S + L L
Sbjct: 292 SALGPQLDML 301
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-26
Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKI 61
E + +L H LV+L G C + ++ E+M G L N+L R + M
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-- 125
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + +L + ++RD N L++ K+SDFGL++ + + T
Sbjct: 126 CKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSS 178
Query: 122 MGT---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+G+ ++ PE +M +S+SD+++FGV++ E+ + G+
Sbjct: 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRM 59
++ E+ L L H N+VK G C +R L+ E++P GSL ++L + + +
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+ KG+ +L + I+RD T NIL++ + K+ DFGL K P+ + +
Sbjct: 149 QYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205
Query: 120 -------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
APE + + SDV+SFGVVL E+ T
Sbjct: 206 EPGESPIFWY------APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 38/236 (16%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRM 59
E++ L L H N++K IED++ +V E G L + ++ +P
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
K + L +H R V++RD K +N+ + A KL D GL + T +
Sbjct: 140 KYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHS 195
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
V GT Y +PE + +SD++S G +L EM + P
Sbjct: 196 LV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPF 236
Query: 180 LGERRRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227
G++ Y L P H+S ++ QL C++ DP+ RP ++ V
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYV 288
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + L + +V+LIG C + + +LV E G L L + +P S ++
Sbjct: 59 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+ G+ +L E+ ++RD N+LL + AK+SDFGL+K D + +
Sbjct: 118 QVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--- 171
Query: 124 TYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + +SRSDV+S+GV + E L+ G++
Sbjct: 172 --AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 30/235 (12%)
Query: 12 LVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 67
L H +V + + +V E++ +L + + P+ +++ A +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQ 127
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGTYG 126
L F H+ +I+RD K +NI++ A K+ DFG+A+ + + T V+GT
Sbjct: 128 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 127 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRR 185
Y +PE + +RSDVYS G VL E+LTG P G+ + V A H+ E
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SPVSVAYQHVREDPI 237
Query: 186 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLP 235
L + + L+++P+ R + +++V P
Sbjct: 238 PPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 52/253 (20%), Positives = 90/253 (35%), Gaps = 54/253 (21%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR--S 50
EV L L H +V+ +E + ++ +Y + + +L++ + R
Sbjct: 53 EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 51 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 107
S+ + I L A+ + FLH + +++RD K SNI D K+ DFGL
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 108 -------DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160
T +GT Y +PE + + + D++S G++L E+L
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---- 225
Query: 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSR 216
+ + ER R + P L + LS
Sbjct: 226 ----PFSTQM-----------ERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDMLSP 266
Query: 217 DPKARPLMSEVVE 229
P RP ++E
Sbjct: 267 SPMERPEAINIIE 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + D H N++ L+G C+ + L+V +M G L N + + + L
Sbjct: 76 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 135
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
AKG+ +L A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 136 QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 124 ------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
A E + T T++SDV+SFGV+L E++T
Sbjct: 193 KLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 11/159 (6%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 61
AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+L + + +L ++RD N+L+ D AK+SDFGL K+ T + ++
Sbjct: 295 SLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKL 348
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + +++SDV+SFG++L E+ + GR
Sbjct: 349 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 44/157 (28%), Positives = 81/157 (51%), Gaps = 5/157 (3%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
+ +G L H ++V+L+G C LV +++P GSL +H+ + L + + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
AKG+ +L E +++R+ N+LL + +++DFG+A P DK + +
Sbjct: 123 QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ A E + G T +SDV+S+GV + E++T G
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 5/156 (3%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + + + ++ +L+G C+ L+ + MP G L +++ + + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
AKG+ +L +R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 126 IAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ A E ++ T +SDV+S+GV + E++T G +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 59/255 (23%), Positives = 91/255 (35%), Gaps = 39/255 (15%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLPW 55
Q E + H N+++L+ YC+ + L+ F RG+L N + R L
Sbjct: 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
+ + LG +GL +H + +RD K +NILL + L D G +
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 116 HVSTRVM-------GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 165
+ T Y APE + R+DV+S G VL M+ G D
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
Query: 166 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP--- 222
G+ L + + P S QL ++ DP RP
Sbjct: 251 QKGDSVA-------LAVQNQLSIPQSP----RHS----SALWQLLNSMMTVDPHQRPHIP 295
Query: 223 -LMSEVVEALKPLPN 236
L+S++ P P
Sbjct: 296 LLLSQLEALQPPAPG 310
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 48/172 (27%), Positives = 70/172 (40%), Gaps = 29/172 (16%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------ 58
E L L H ++V+ G C E L+V+E+M G L L
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 59 --------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 110
+ +A A G+ +L A ++RD T N L+ K+ DFG+++D
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 111 EGDKTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
D V R M PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 210 STDYYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 10/160 (6%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
EVN + L H NL++L G + +V E P GSL + L + + A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 129 QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--H 183
Query: 124 T---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ + APE + T + SD + FGV L EM T G+
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 33/229 (14%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS---IRM 59
E+ L H N+V+ +G E+ + E +P GSL L + PL + I
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG- 125
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVS 118
+GL +LH+ +++RD K N+L++ K+SDFG +K + +
Sbjct: 126 FYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 119 TRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 175
GT Y APE + G+ +D++S G ++EM TG+ P + L E
Sbjct: 183 --FTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK------PPF--YELGEP 231
Query: 176 ARP--HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
+G + + P + S +A C DP R
Sbjct: 232 QAAMFKVGMFK-----VHPEIPESMS----AEAKAFILKCFEPDPDKRA 271
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + +G H N+++L G + ++V E+M GSL++ L + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTR 120
G A G+ +L ++ ++RD NIL++++ K+SDFGL +D PE T +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 121 V----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ +PE + TS SDV+S+G+VL E+++ G R
Sbjct: 212 IPIRWT------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 26/234 (11%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIA 62
E + L H LV+L E+ +V E+M +GSL + L L + +A
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 369
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
A G+A++ ++RD + +NIL+ + K++DFGLA+ E ++
Sbjct: 370 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAK 425
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLG 181
+ APE + G T +SDV+SFG++L E+ T R N E + VE
Sbjct: 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------- 478
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 234
R YR+ P ++ L C ++P+ RP + L+
Sbjct: 479 ---RGYRMPCPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMK 60
E + L H N++ LIG + + ++ +M G L + +R+ + I
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF- 129
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
L A+G+ +L AE+ ++RD N +LD + K++DFGLA+D + + V
Sbjct: 130 -GLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 121 VMG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
T A E + T T++SDV+SFGV+L E+LT
Sbjct: 186 RHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 19/163 (11%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKI 61
AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+L + + +L ++RD N+L+ D AK+SDFGL K+ T + ++
Sbjct: 123 SLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKL 176
Query: 122 ----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
APE + +++SDV+SFG++L E+ + GR
Sbjct: 177 PVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + D H N++ L+G C+ + L+V +M G L N + + + L
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
AKG+ FL A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 200 QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 124 ------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
A E + T T++SDV+SFGV+L E++T
Sbjct: 257 KLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWSIR 58
E + D H N+++L+G CIE + +++ FM G L +L + R P I
Sbjct: 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 59 MK----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD- 113
++ + A G+ +L + R ++RD N +L D ++DFGL+K GD
Sbjct: 146 LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 114 -KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ ++ + A E + TS+SDV++FGV + E+ T
Sbjct: 203 YRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIA 62
AE N + L + +V++IG C E + +LV E G L +L R + I +
Sbjct: 67 AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL--V 123
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+ G+ +L E ++RD N+LL + AK+SDFGL+K + + +
Sbjct: 124 HQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-- 178
Query: 123 GTYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + +S+SDV+SFGV++ E + G++
Sbjct: 179 ---HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIA 62
AE N + L H LV+L ++ ++ E+M GSL + L + L + + +A
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV 121
A+G+AF+ ER I+RD + +NIL+ + K++DFGLA+ + + +
Sbjct: 116 AQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + G T +SDV+SFG++L E++T GR
Sbjct: 173 P--IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTR 120
G A G+ +L A ++RD NIL++++ K+SDFGL+ +D PE T +
Sbjct: 155 GIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 121 V----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + TS SDV+SFG+V+ E++T G R
Sbjct: 212 IPIRWT------APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 30/175 (17%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---- 58
Q E L +L H ++VK G C + D ++V+E+M G L L +
Sbjct: 65 QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 59 -----------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 107
+ IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 108 DGPEGDKTHVSTRV------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
D D V M PE +M T+ SDV+SFGV+L E+ T
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 40/163 (24%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIA 62
E + ++ H NLV+L+G C + ++ EFM G+L ++L + + + +A
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV 121
+ + +L ++ I+RD N L+ ++ K++DFGL++ H +
Sbjct: 118 TQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 122 ----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
APE + + +SDV++FGV+L E+ T G
Sbjct: 175 PIKWT------APESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKI 61
+ + L H +LV G C+ D+ +LV EF+ GSL+ +L + + + W + +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-- 118
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDGPEGD 113
A A + FL E +I+ + NILL + + KLSD G++ D
Sbjct: 119 AKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 114 KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRR 159
+ PE + +L +D +SFG L E+ + G +
Sbjct: 176 ILQERIPWV------PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 52/158 (32%), Positives = 83/158 (52%), Gaps = 7/158 (4%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 62
AE N + L H LVKL ++ ++ EFM +GSL + L P + +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
A+G+AF+ +R I+RD + +NIL+ A K++DFGLA+ E ++
Sbjct: 291 AQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAK 346
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + G T +SDV+SFG++L+E++T GR
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKI 61
+E + +L H ++VKLIG E+ ++ E P G L ++L + SL + +
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-- 118
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-- 119
+L K +A+L ++RD NIL+ + KL DFGL++ + D S
Sbjct: 119 SLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 120 ---RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ M +PE + T+ SDV+ F V + E+L+ G++
Sbjct: 176 LPIKWM------SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 39/169 (23%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSI 57
E + + H ++ KL+G + + +++ FM G L L R P+++
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 58 RMK----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
++ + A G+ +L + R I+RD N +L D ++DFGL++ GD
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 114 --KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ ++++ + A E + T SDV++FGV + E++T
Sbjct: 192 YYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 54/161 (33%), Positives = 69/161 (42%), Gaps = 17/161 (10%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK-- 60
E L + +V L Y E L LV M G L+ H++ R
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 61 ---IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
I G L LH E ++YRD K NILLD + ++SD GLA PEG
Sbjct: 292 AAEICCG----LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK- 343
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
RV GT GY APE V T D ++ G +L EM+ G+
Sbjct: 344 -GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + L + +V+LIG C + + +LV E G L L + +P S ++
Sbjct: 385 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
+ G+ +L E+ ++R+ N+LL + AK+SDFGL+K D + +
Sbjct: 444 QVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--A 498
Query: 124 T---YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ APE + +SRSDV+S+GV + E L+ G++
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 50/236 (21%), Positives = 87/236 (36%), Gaps = 44/236 (18%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSI 57
AE FL ++VH ++V++ + D+ +V E++ SL+ + LP+ +I
Sbjct: 127 MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAI 185
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
L L++LH ++Y D K NI+L + KL D G
Sbjct: 186 A--YLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSF 234
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ GT G+ APE ++ T +D+Y+ G L + + + +G
Sbjct: 235 GY-LYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD---- 288
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 232
P L + RL+ + DP+ R E+ L
Sbjct: 289 PVLKTYDSYGRLL--------------------RRAIDPDPRQRFTTAEEMSAQLT 324
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------ 58
E L H N+V L+G +D +++ + G L L RS
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 59 ---------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 109
+ + A G+ +L + V+++D T N+L+ N K+SD GL ++
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 110 PEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
D K ++ + M APE +M G + SD++S+GVVL E+ +
Sbjct: 179 YAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 26/234 (11%)
Query: 3 QAEVNFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSI 57
+EVN L +L H N+V+ + L +V E+ G L + + + L
Sbjct: 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 58 RMKIALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
+++ L H + V++RD K +N+ LD N KL DFGLA+ D +
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTS 171
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 175
T V GT Y +PE + +SD++S G +L E+ +
Sbjct: 172 FAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 176 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ R+ +S + ++ L+ RP + E++E
Sbjct: 231 GKF-------------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-24
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKI 61
E + H ++VKLIG E+ ++ E G L + L + SL L I
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY-- 121
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-- 119
A + LA+L + ++RD N+L+ ++ KL DFGL++ + S
Sbjct: 122 AYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 120 ---RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159
+ M APE + TS SDV+ FGV + E+L G +
Sbjct: 179 LPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 48/150 (32%), Positives = 68/150 (45%), Gaps = 23/150 (15%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 69
+V + Y +L + + M G L HL + M+ I LG L
Sbjct: 254 IVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----L 305
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 129
+H V+YRD K +NILLD + ++SD GLA D + K H V GT+GY A
Sbjct: 306 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYMA 358
Query: 130 PEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
PE + G S D +S G +L ++L G
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 30/164 (18%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 58
H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTH 116
+ A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 117 VSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 217 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 28/162 (17%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 60
H N+V L+G C L++ E+ G L N L R+S L +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 119
+ A+G+AFL A + I+RD N+LL + AK+ DFGLA+D V
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 120 -----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ M APE + T +SDV+S+G++L E+ +
Sbjct: 226 ARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 38/181 (20%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------ 58
E + + + N+VKL+G C L++E+M G L L S S+
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 59 -----------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 101
+ IA A G+A+L +ER ++RD T N L+ + K++
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIA 216
Query: 102 DFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155
DFGL+++ D K + + M PE + T+ SDV+++GVVL E+
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 156 T 156
+
Sbjct: 271 S 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E + H ++VKLIG ++ ++ E G L + L R L + + A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--- 120
+ LA+L + ++RD N+L+ ++ KL DFGL++ + S
Sbjct: 499 QLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ APE + TS SDV+ FGV + E+L
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 14/162 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSI 57
E + H N+V+ IG ++ R ++ E M G L++ L R + P L
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLD 141
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDK 114
+ +A A G +L E I+RD N LL AK+ DFG+A+D
Sbjct: 142 LLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
M + PE M G TS++D +SFGV+L E+ +
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 4e-24
Identities = 46/246 (18%), Positives = 87/246 (35%), Gaps = 44/246 (17%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------ 54
++ + N V + + + + +L++ + RR
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 55 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------ 108
I ++IA + FLH + +++RD K SNI D K+ DFGL
Sbjct: 167 LHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 109 ----GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 164
T +GT Y +PE + + + + D++S G++L E+L +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-- 277
Query: 165 RPNGEHNLVEWARPHLGERRRFYRLI-DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223
ER R + + + F+ K + + LS P RP
Sbjct: 278 -----------------ERVRIITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTERPE 319
Query: 224 MSEVVE 229
++++E
Sbjct: 320 ATDIIE 325
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-24
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 30/164 (18%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 58
H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTH 116
+ A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 117 VSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 263 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 58
H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ K
Sbjct: 144 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT- 199
Query: 118 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
R+ M A E + T+ SDV+S+GV+L E+++
Sbjct: 200 MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-24
Identities = 49/234 (20%), Positives = 84/234 (35%), Gaps = 30/234 (12%)
Query: 5 EVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
EV L + H N+++ + + + E +L+ ++ ++ + +
Sbjct: 67 EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ 125
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAK--DGPEGDKTH 116
GLA LH +++RD K NIL+ A +SDFGL K +
Sbjct: 126 QTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 117 VSTRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 173
S GT G+ APE + + T D++S G V +++ P G+
Sbjct: 183 RSGVP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQR 236
Query: 174 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227
+ L E H A +L ++ DP+ RP V
Sbjct: 237 Q-----ANILLGACSLDCLHPEKHED----VIARELIEKMIAMDPQKRPSAKHV 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-24
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
EV L H N+++L GY D R+ L+ E+ P G++ L ++
Sbjct: 59 EVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 116
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
A L++ H + VI+RD K N+LL + K++DFG + P + G
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---G 169
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 183
T Y PE + + D++S GV+ E L G+ P + E
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQE--------- 214
Query: 184 RRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
Y+ I + + +GA+ L + L +P RP++ EV+E
Sbjct: 215 --TYKRISRVEFTFPDFVT-EGARD---LISRLLKHNPSQRPMLREVLE 257
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-24
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 14/162 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR- 58
E + H N+V+ IG ++ R ++ E M G L++ L R + P ++
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLD 182
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDK 114
+ +A A G +L E I+RD N LL AK+ DFG+A+D
Sbjct: 183 LLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
M + PE M G TS++D +SFGV+L E+ +
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 51/168 (30%), Positives = 68/168 (40%), Gaps = 26/168 (15%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWS 56
E L + +V L Y E L LV M G + H++ P
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-- 289
Query: 57 IRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111
R I G L LH+ +IYRD K N+LLD D N ++SD GLA +
Sbjct: 290 -RAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
G GT G+ APE ++ G S D ++ GV L EM+ R
Sbjct: 342 GQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 39/241 (16%), Positives = 71/241 (29%), Gaps = 52/241 (21%)
Query: 11 DLVHLNLVKLIGYCIEDDQRLLV---YEFMPRGSLENHLFRRSL--------PLPWSIRM 59
DLV K + D++ + V + PR F L L R+
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
++ L + LA LH +++ + +I+LD L+ F +G S
Sbjct: 215 QLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----SA 265
Query: 120 RVMGTYGYAAPEYVM----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 169
G+A PE +T D ++ G+ + + PN +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------LPNTD 319
Query: 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ + + P+ L L + R L + +E
Sbjct: 320 DAALGGSEWIFRSCKNI-----PQP-----------VRALLEGFLRYPKEDRLLPLQAME 363
Query: 230 A 230
Sbjct: 364 T 364
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 30/164 (18%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK-- 60
H N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 61 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTH 116
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D K
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 117 VSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ R+ M APE + T +SDV+SFGV+L E+ T
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 31/216 (14%), Positives = 60/216 (27%), Gaps = 47/216 (21%)
Query: 30 RLLVYEFMP-----RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 84
R +Y M G + L R+++ L + LA LH +++
Sbjct: 175 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTY 231
Query: 85 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------- 135
+ +I+LD L+ F + + G+ PE
Sbjct: 232 LRPVDIVLDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRD 285
Query: 136 --GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 193
+T D ++ G+V+ + P + + + R
Sbjct: 286 RRTLMTFSFDAWALGLVIYWIWCAD------LPITKDAALGGSEWIF------------R 327
Query: 194 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ Q L L + R L + +E
Sbjct: 328 SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 10/155 (6%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E+ L H N++++ Y D +R+ L+ EF PRG L L ++
Sbjct: 64 EIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFME 121
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 123
A L + HE R VI+RD K N+L+ K++DFG + P + G
Sbjct: 122 ELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---G 174
Query: 124 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
T Y PE + + D++ GV+ E L G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 52/182 (28%), Positives = 80/182 (43%), Gaps = 40/182 (21%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------ 58
E N L + H +++KL G C +D LL+ E+ GSL L R S +
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSR 134
Query: 59 ------------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 100
+ A ++G+ +L AE +++RD NIL+ K+
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 101 SDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154
SDFGL++D E D R+ M A E + T++SDV+SFGV+L E+
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 155 LT 156
+T
Sbjct: 246 VT 247
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-23
Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 7/154 (4%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L + +V G D + + E M GSL+ + +++ +P I K+++
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 139
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
KGL +L E+ +++RD K SNIL+++ KL DFG++ + + ++ V GT
Sbjct: 140 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GT 193
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 48/166 (28%), Positives = 69/166 (41%), Gaps = 32/166 (19%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 58
H+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 59 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 117 VST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
V + M APE + T SDV+S+G+ L E+ +
Sbjct: 203 VKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-23
Identities = 49/166 (29%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 14 HLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------- 58
HLN+V L+G C + +++ EF G+L +L R +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 59 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--K 114
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 149 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 115 THVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
R+ M APE + T +SDV+SFGV+L E+ +
Sbjct: 206 RKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 8e-23
Identities = 56/248 (22%), Positives = 84/248 (33%), Gaps = 33/248 (13%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSL 51
W E+ + L H N+V + D + LL E+ G L +L +
Sbjct: 59 WCLEIQIMKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116
Query: 52 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKD 108
L + + L +LHE +I+RD K NI+L K+ D G AK+
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173
Query: 109 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR--------- 159
+G+ V GT Y APE + T D +SFG + E +TG R
Sbjct: 174 LDQGELCT--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230
Query: 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 219
+ + G + L P H S A K + L +
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQR 287
Query: 220 ARPLMSEV 227
R +
Sbjct: 288 QRGTDPQN 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 30/226 (13%), Positives = 56/226 (24%), Gaps = 26/226 (11%)
Query: 29 QRLLVYEFM-----PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83
LL+ S + ++ + + A L + +++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHG 218
Query: 84 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSR 141
F N+ + D L D YA E++ T
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHA 273
Query: 142 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 201
+ + G+ + + P + W RP L +
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKG---SWKRPSLRVPGTDS--LAFGSCTPLP-- 326
Query: 202 GAQKAAQLAAHCLSRDPKARPLMSEVVE--ALKPLPNLKDMASSSY 245
L L+ D + R L E +E L N + S+
Sbjct: 327 --DFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTG 370
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK- 60
E+ + L H LV L Y +D++ + +V + + G L HL + +K
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKL 119
Query: 61 ----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+ + L +L + +I+RD K NILLD + ++DF +A P +
Sbjct: 120 FICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI- 171
Query: 117 VSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLTGRR 159
T + GT Y APE G+ + D +S GV E+L GRR
Sbjct: 172 --TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 37/171 (21%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 58
H N+V L+G C L++E+ G L N+L +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 59 -------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 111
+ A AKG+ FL + ++RD N+L+ K+ DFGLA+D
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 112 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
+ R+ M APE + G T +SDV+S+G++L E+ +
Sbjct: 225 DSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 4e-22
Identities = 55/292 (18%), Positives = 90/292 (30%), Gaps = 41/292 (14%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPW 55
+ E L L H N+VKL E+ EF P GSL L + LP
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPE 111
S + + G+ L E +++R+ K NI+ D KL+DFG A++ +
Sbjct: 112 SEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS--------DVYSFGVVLLEMLTGRR---- 159
++ + GT Y P+ L D++S GV TG
Sbjct: 169 DEQFV--SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 160 ---------SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 210
M K + + + D + S +
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVL 283
Query: 211 AHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 262
A+ L D + + + + + + Q M A +I
Sbjct: 284 ANILEADQEKCWGFDQFFAETSDILHRMVIH--VFSLQQMTAHKIYIHSYNT 333
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 38/238 (15%)
Query: 5 EVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
E+ +L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSY 132
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + +H+ +++ D K +N L+ D KL DFG+A + V
Sbjct: 133 WKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 122 MGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGE 169
+GT Y PE + ++ +SDV+S G +L M G+ P
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQI 242
Query: 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227
N + + + +IDP E F + + CL RDPK R + E+
Sbjct: 243 INQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 42/296 (14%)
Query: 5 EVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
E+ +L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 57 EIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSY 113
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + +H+ +++ D K +N L+ D KL DFG+A + V
Sbjct: 114 WKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 122 MGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGE 169
+GT Y PE + ++ +SDV+S G +L M G+ P
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQI 223
Query: 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
N + + + +IDP E F + + CL RDPK R + E++
Sbjct: 224 INQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
Query: 230 ----ALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLS 281
++ P + ++ + + + +G + A+ +G S +
Sbjct: 274 HPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 329
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-22
Identities = 69/232 (29%), Positives = 93/232 (40%), Gaps = 50/232 (21%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 60
E L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RAR 108
Query: 61 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
I L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 109 FYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 116 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 173
+ GT Y APE V+ + R+ D + GVV+ EM+ G R
Sbjct: 162 ---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCG-------RL------- 203
Query: 174 EWARPHLGE-RRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221
P + R + LI + R S +A L A L +DPK R
Sbjct: 204 ----PFYNQDHERLFELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQR 247
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 38/238 (15%)
Query: 5 EVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
E+ +L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSY 160
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + +H+ +++ D K +N L+ D KL DFG+A + V
Sbjct: 161 WKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 122 MGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGE 169
+G Y PE + ++ +SDV+S G +L M G+ P
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQI 270
Query: 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227
N + + + +IDP E F + + CL RDPK R + E+
Sbjct: 271 INQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 50/224 (22%), Positives = 82/224 (36%), Gaps = 44/224 (19%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAKGLA 70
V G + + E M SL+ + + +P I KIA+ K L
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 130
LH + VI+RD K SN+L++A K+ DFG++ G Y AP
Sbjct: 124 HLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAP 178
Query: 131 EYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 186
E + + +SD++S G+ ++E+ R W P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR-----------FPYDSWGTP-------- 219
Query: 187 YRLID-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 222
++ + P+L FS + + CL ++ K RP
Sbjct: 220 FQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
EV L H ++++L Y ED + LV E G + +L R P +
Sbjct: 61 EVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVM 122
G+ +LH +++RD SN+LL + N K++DFGLA + +K +
Sbjct: 120 QIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--- 173
Query: 123 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
GT Y +PE + H SDV+S G + +L GR
Sbjct: 174 GTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 55/164 (33%), Positives = 82/164 (50%), Gaps = 24/164 (14%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK- 60
E + L ++ H +VKL Y + + +L L+ +F+ G L L + +K
Sbjct: 75 MERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKF 130
Query: 61 ----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+AL L LH +IYRD K NILLD + + KL+DFGL+K+ + +K
Sbjct: 131 YLAELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 182
Query: 117 VSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
GT Y APE V+ ++S D +SFGV++ EMLTG
Sbjct: 183 --AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 30/169 (17%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRMK 60
+ L + +K + + +LV E G+L N + +P + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL-----------DADYNAKLSDFGLAKDG 109
A+ + +H+ +I+ D K N +L D L D G + D
Sbjct: 177 FAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 110 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
K + T T G+ E + + D + + ML G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 54/161 (33%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 60
E L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RAR 251
Query: 61 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T
Sbjct: 252 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---M 306
Query: 120 RVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
+ GT Y APE V+ + R+ D + GVV+ EM+ GR
Sbjct: 307 KTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-21
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK 60
+AE N L ++ H +V LI Y + +L L+ E++ G L L R
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TAC 124
Query: 61 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 115
I++ L LH++ +IYRD K NI+L+ + KL+DFGL K+
Sbjct: 125 FYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 116 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
T GT Y APE ++ +R+ D +S G ++ +MLTG
Sbjct: 178 ---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-21
Identities = 51/251 (20%), Positives = 81/251 (32%), Gaps = 39/251 (15%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPW 55
+ E L L H N+VKL E+ EF P GSL L + LP
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPE 111
S + + G+ L E +++R+ K NI+ D KL+DFG A++ +
Sbjct: 112 SEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHL--------TSRSDVYSFGVVLLEMLTGRR---- 159
++ + GT Y P+ L + D++S GV TG
Sbjct: 169 DEQFV--SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 160 ---------SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 210
M K + + + D + S +
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVL 283
Query: 211 AHCLSRDPKAR 221
A+ L D +
Sbjct: 284 ANILEADQEKC 294
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAF 71
LV L C + + RL V E++ G L H+ R R LP + R +I+L L +
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLA----LNY 125
Query: 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAP 130
LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT Y AP
Sbjct: 126 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAP 179
Query: 131 EYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLGERRR 185
E ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 180 E-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------------TEDY 226
Query: 186 FYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221
+++I R+ S KAA + L++DPK R
Sbjct: 227 LFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-21
Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 49/221 (22%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 69
LV L Y + + +L L+ +++ G L HL + ++ I L L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLA----L 172
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 129
LH+ +IYRD K NILLD++ + L+DFGL+K+ + GT Y A
Sbjct: 173 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 228
Query: 130 PEYVM---TGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGER 183
P+ V +GH + D +S GV++ E+LTG + E
Sbjct: 229 PDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAE-------------- 273
Query: 184 RRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221
R I +P S A L L +DPK R
Sbjct: 274 --ISRRILKSEPPYPQEMS----ALAKDLIQRLLMKDPKKR 308
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E++ L H ++V G+ ED+ + +V E R SL RR R
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLR 122
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVM 122
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V
Sbjct: 123 QIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 176
Query: 123 GTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT Y APE V++ S DV+S G ++ +L G+ P L E
Sbjct: 177 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE------- 222
Query: 182 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
Y I + + H + AA L L DP ARP ++E++
Sbjct: 223 ----TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 52/151 (34%), Positives = 72/151 (47%), Gaps = 24/151 (15%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 69
L + + + L V E++ G L H+ L R I LG L
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG----L 131
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 128
FLH + ++YRD K NILLD D + K++DFG+ K+ GD T GT Y
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYI 185
Query: 129 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
APE ++ G + S D +SFGV+L EML G+
Sbjct: 186 APE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 24/151 (15%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 69
L +L C + RL V E++ G L H+ + P IA+G L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG----L 134
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 128
FL + +IYRD K N++LD++ + K++DFG+ K+ T T+ GT Y
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYI 188
Query: 129 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
APE ++ +S D ++FGV+L EML G+
Sbjct: 189 APE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 20/163 (12%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK- 60
E + + L H VKL + +DD++L + G L ++ + S +
Sbjct: 79 RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRF 134
Query: 61 ----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
I L +LH + +I+RD K NILL+ D + +++DFG AK K
Sbjct: 135 YTAEIVSA----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 117 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
+ +GT Y +PE + SD+++ G ++ +++ G
Sbjct: 188 RANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 52/151 (34%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 69
LV L + + +L V +++ G L HL R R P R + IA L
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----L 152
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 128
+LH ++YRD K NILLD+ + L+DFGL K+ E + T T GT Y
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYL 206
Query: 129 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
APE V+ R+ D + G VL EML G
Sbjct: 207 APE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 29/216 (13%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73
+V+ G I + + E M E R P+P I K+ + K L +L
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 133
E+ VI+RD K SNILLD KL DFG++ R G Y APE +
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERI 196
Query: 134 MTGHL-----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRF 186
R+DV+S G+ L+E+ TG+ + + E +++ P L
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG---- 252
Query: 187 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
FS CL++D + RP
Sbjct: 253 --------HMGFS----GDFQSFVKDCLTKDHRKRP 276
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 47/221 (21%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 69
LV L C + + RL V E++ G L H+ R R LP + I+L L
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA----L 166
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 128
+LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT Y
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYI 220
Query: 129 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLGER 183
APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 221 APE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------------TE 267
Query: 184 RRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221
+++I R+ S KAA + L++DPK R
Sbjct: 268 DYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 304
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E++ L H ++V G+ ED+ + +V E R SL RR R
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLR 148
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVM 122
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V
Sbjct: 149 QIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 202
Query: 123 GTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT Y APE V++ S DV+S G ++ +L G+ P L E
Sbjct: 203 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE------- 248
Query: 182 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
Y I + + H + AA L L DP ARP ++E++
Sbjct: 249 ----TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 61/262 (23%), Positives = 101/262 (38%), Gaps = 66/262 (25%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q E+ L + K G ++D + ++ E++ GS + L L IA
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IA 122
Query: 63 L---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
KGL +LH E I+RD K +N+LL KL+DFG+A G T
Sbjct: 123 TILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQI 174
Query: 120 R---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---------RSM---DKN 164
+ +GT + APE + S++D++S G+ +E+ G + + KN
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234
Query: 165 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224
P P LEG++S + + CL+++P RP
Sbjct: 235 NP-------------------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTA 265
Query: 225 SE------VVEALKPLPNLKDM 240
E ++ K L ++
Sbjct: 266 KELLKHKFILRNAKKTSYLTEL 287
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 19/153 (12%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRMKIA-LGAAKGLAFL 72
+ +L + +D+ L LV E+ G L L + +P + R +A + A + +
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSV 178
Query: 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 132
H ++RD K NILLD + +L+DFG V GT Y +PE
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEI 234
Query: 133 VMTGHLTSRSDVY-------SFGVVLLEMLTGR 158
+ + Y + GV EM G+
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 51/151 (33%), Positives = 72/151 (47%), Gaps = 24/151 (15%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGL 69
L +L C + RL V EF+ G L H+ + R R + I L
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIISA----L 137
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYA 128
FLH+ + +IYRD K N+LLD + + KL+DFG+ K+G T T GT Y
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYI 191
Query: 129 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
APE ++ L + D ++ GV+L EML G
Sbjct: 192 APE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-20
Identities = 45/243 (18%), Positives = 78/243 (32%), Gaps = 55/243 (22%)
Query: 5 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMK 60
EV L H ++V+ EDD L+ E+ GSL + + +R +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-------------------YNAKLS 101
+ L +GL ++H +++ D K SNI + K+
Sbjct: 120 LLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 102 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRR 159
D G V G + A E + HL +D+++ + ++
Sbjct: 177 DLGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEP 229
Query: 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 219
P +W G PR+ S Q+ +L + DP+
Sbjct: 230 L-----PRNGD---QWHEIRQGRL--------PRIPQVLS----QEFTELLKVMIHPDPE 269
Query: 220 ARP 222
RP
Sbjct: 270 RRP 272
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 51/161 (31%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E + + +V+L Y +DD+ L +V E+MP G L N + +P W+ R A
Sbjct: 118 EERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTA 175
Query: 63 -LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ A L +H I+RD K N+LLD + KL+DFG + T V
Sbjct: 176 EVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 122 MGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTGR 158
GT Y +PE + + G+ D +S GV L EML G
Sbjct: 231 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 48/147 (32%), Positives = 73/147 (49%), Gaps = 16/147 (10%)
Query: 17 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGLAFLH 73
L +L C + RL V E++ G L H+ + P A A GL FL
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQ 459
Query: 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEY 132
+ +IYRD K N++LD++ + K++DFG+ K+ T T+ GT Y APE
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE- 512
Query: 133 VMTGHLTSRS-DVYSFGVVLLEMLTGR 158
++ +S D ++FGV+L EML G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-19
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 27/164 (16%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK- 60
E L + H ++++ +D Q++ ++ +++ G L + L + + P P K
Sbjct: 55 DERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKF 110
Query: 61 ----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+ L L +LH + +IYRD K NILLD + + K++DFG AK P+ T
Sbjct: 111 YAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT- 162
Query: 117 VSTRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 158
+ GT Y APE V T + ++S D +SFG+++ EML G
Sbjct: 163 ----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 56/288 (19%), Positives = 103/288 (35%), Gaps = 53/288 (18%)
Query: 3 QAEVNFLGDLV-HLNLVKLIGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--P 52
EV F+ L H N+V+ + L+ + +G L L + P
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 53 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDG 109
L +KI + + +H + P+I+RD K N+LL KL DFG A
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 110 PEGDKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSRSDVYSFGVVLLEMLTGRR 159
P+ + ++ T Y PE + + + + D+++ G +L + +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ- 250
Query: 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLS 215
P + + I + G +SI L L
Sbjct: 251 -----HPFEDGAKLR---------------I---VNGKYSIPPHDTQYTVFHSLIRAMLQ 287
Query: 216 RDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM-QAERIGSSPNTR 262
+P+ R ++EVV L+ + +++ S + + Q GS+ +R
Sbjct: 288 VNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 59/262 (22%), Positives = 92/262 (35%), Gaps = 65/262 (24%)
Query: 5 EVNFLGDLV-HLNLVKLIGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWS 56
E+ L + H N+++ YC E R + E +L ++ +L L
Sbjct: 58 EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKE 114
Query: 57 IRMKIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLD-------------ADYNAKLSD 102
L A G+A LH +I+RD K NIL+ + +SD
Sbjct: 115 YNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 103 FGLAK---DGPEGDKTHVSTRVMGTYGYAAPE-------YVMTGHLTSRSDVYSFGVVLL 152
FGL K G +T+++ GT G+ APE LT D++S G V
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 153 EMLTG-------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK 205
+L+ + S + N G +L E H + +
Sbjct: 231 YILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLH---------------DRSLI----AE 271
Query: 206 AAQLAAHCLSRDPKARPLMSEV 227
A L + + DP RP +V
Sbjct: 272 ATDLISQMIDHDPLKRPTAMKV 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 59/228 (25%), Positives = 80/228 (35%), Gaps = 48/228 (21%)
Query: 14 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWSIRMKIALGAAKGL 69
+V+ G + + E M S + +P I KI L K L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 70 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 129
L E +I+RD K SNILLD N KL DFG++ + + TR G Y A
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMA 193
Query: 130 PEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 185
PE + RSDV+S G+ L E+ TGR K
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------------------- 234
Query: 186 FYRLID-------PRL----EGHFSIKGAQKAAQLAAHCLSRDPKARP 222
+ + P+L E FS CL++D RP
Sbjct: 235 VFDQLTQVVKGDPPQLSNSEEREFS----PSFINFVNLCLTKDESKRP 278
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL--FRRSLPLPWSIRMK 60
E + L + + L Y +DD L LV ++ G L L F LP + R
Sbjct: 123 EERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFY 180
Query: 61 IA-LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
+A + A + +H+ ++RD K NIL+D + + +L+DFG E S
Sbjct: 181 LAEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 120 RVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 158
V GT Y +PE + D +S GV + EML G
Sbjct: 236 AV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 7e-19
Identities = 50/263 (19%), Positives = 82/263 (31%), Gaps = 53/263 (20%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
Q E++ H N+V I D++ +V FM GS + L + + IA
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIA 131
Query: 63 L---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHV- 117
G K L ++H ++R K S+IL+ D LS G + V
Sbjct: 132 YILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 118 ---STRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGR------------- 158
+ + +PE V+ +L ++SD+YS G+ E+ G
Sbjct: 189 HDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247
Query: 159 -------------------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 199
+ ++ + + R FS
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
Query: 200 IKGAQKAAQLAAHCLSRDPKARP 222
CL R+P ARP
Sbjct: 308 ----PHFHHFVEQCLQRNPDARP 326
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 38/229 (16%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E++ + ++VK G ++ +V E+ GS+ + + R+ L I
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATIL 131
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRV 121
KGL +LH I+RD K NILL+ + +AKL+DFG+ + K + V
Sbjct: 132 QSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---V 185
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+GT + APE + +D++S G+ +EM G +P P+
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG-------KP-----------PYAD 227
Query: 182 ER--RRFYRLID----PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 222
R + +I P +S CL + P+ R
Sbjct: 228 IHPMRAIF-MIPTNPPPTFRKPELWS----DNFTDFVKQCLVKSPEQRA 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-18
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 38/228 (16%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ + + + N+V + + D+ +V E++ GSL + + + I +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVC 122
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRV 121
+ L FLH VI+RD K+ NILL D + KL+DFG A+ PE K T V
Sbjct: 123 RECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV 177
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT + APE V + D++S G++ +EM+ G P P+L
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLN 218
Query: 182 ER--RRFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 222
E R Y + P L+ S CL D + R
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRG 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 23/162 (14%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM-- 59
E L + LVKL + +D+ L +V E++ G + +HL R P + R
Sbjct: 90 NEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYA 147
Query: 60 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+I L +LH +IYRD K N+L+D +++DFG AK T
Sbjct: 148 AQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT--- 197
Query: 119 TRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 158
+ GT APE +++ G+ +++ D ++ GV++ EM G
Sbjct: 198 --LCGTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGY 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-18
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L L H NLV L+ + LV+E+ ++ + L R +P + I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 121
+ + F H+ I+RD K NIL+ KL DFG A+ GP V+TR
Sbjct: 111 TLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166
Query: 122 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
Y +PE ++ DV++ G V E+L+G
Sbjct: 167 ----WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-18
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
EV + D H N+V++ + ++ ++ EF+ G+L + + + L +
Sbjct: 90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVC 147
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRV 121
+ LA+LH + VI+RD K+ +ILL D KLSDFG A+ + K + V
Sbjct: 148 EAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV 202
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT + APE + + D++S G++++EM+ G P P+
Sbjct: 203 -GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFS 243
Query: 182 ER--RRFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 222
+ + RL D P+L+ S L RDP+ R
Sbjct: 244 DSPVQAMKRLRDSPPPKLKNSHKVS----PVLRDFLERMLVRDPQERA 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 51/239 (21%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
E++ L L H N++KL ED + LV EF G L + R +
Sbjct: 96 EISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANI 151
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 115
MK L + +LH + +++RD K NILL ++ N K+ DFGL+ + K
Sbjct: 152 MKQILSG---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVE 174
+GT Y APE V+ + DV+S GV++ +L G P G+++
Sbjct: 206 R---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY------PPFGGQND--- 252
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 227
+ + + +G + +A +L L+ D R E
Sbjct: 253 ---------QDIIKKV---EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 52/237 (21%), Positives = 90/237 (37%), Gaps = 49/237 (20%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L H +VKL+G D + ++ EF P G+++ + L +
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 120
+ L FLH + +I+RD K N+L+ + + +L+DFG++ +
Sbjct: 124 RQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRD 175
Query: 121 -VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
+GT + APE VM + ++D++S G+ L+EM P
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-------EP-------- 220
Query: 175 WARPHLGE---RRRFYRLID----PRLE--GHFSIKGAQKAAQLAAHCLSRDPKARP 222
PH R I P L +S + L ++P+ RP
Sbjct: 221 ---PHHELNPMRVLL--KIAKSDPPTLLTPSKWS----VEFRDFLKIALDKNPETRP 268
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 42/241 (17%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK-- 60
E+ + H N+V + D+ LV + + GS+ + + +
Sbjct: 61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLD 119
Query: 61 ---IAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGD 113
IA +GL +LH+ I+RD K NILL D + +++DFG+ A GD
Sbjct: 120 ESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 114 KTHVSTR--VMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 170
T R +GT + APE + ++D++SFG+ +E+ TG K P
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--- 233
Query: 171 NLVEWARPHLGERRRFYRLI----DPRLEGHFSIKGAQKA-----AQLAAHCLSRDPKAR 221
+ L P LE K K ++ + CL +DP+ R
Sbjct: 234 --------------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 222 P 222
P
Sbjct: 280 P 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L L H NLV L+ C + + LV+EF+ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 121
G+ F H +I+RD K NIL+ KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 122 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ DV++ G ++ EM G
Sbjct: 189 ----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 51/239 (21%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
EV L L H N++KL + ED + LV E G L + + R ++
Sbjct: 86 EVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVI 141
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 115
+K L + +LH+ +++RD K N+LL + D K+ DFGL+ K
Sbjct: 142 IKQVLSG---VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVE 174
+GT Y APE V+ + DV+S GV+L +L G P G+ +
Sbjct: 196 K---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------PPFGGQTD--- 242
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 227
+ R + +G ++ + A L L D + R +
Sbjct: 243 ---------QEILRKV---EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 51/239 (21%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
EV L L H N++KL + ED LV E G L + + R +S
Sbjct: 76 EVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARI 131
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 115
++ L + ++H+ +++RD K N+LL D N ++ DFGL+ K
Sbjct: 132 IRQVLSG---ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 175
+GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 186 K---DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC----------------- 224
Query: 176 ARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 227
P G + + +G ++ + + A L L+ P R +
Sbjct: 225 -PPFNGANEYDILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L +L H N+V+L D + LV+EF + L+ + + L I
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVM 122
KGL F H R V++RD K N+L++ + KL++FGLA+ P + V+
Sbjct: 110 LLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV 163
Query: 123 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRR 159
T Y P+ V+ G ++ D++S G + E+ R
Sbjct: 164 -TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 5 EVNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
EV + L H N+VKL + IE ++ L L+ E+ G + ++L RMK
Sbjct: 64 EVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEK 114
Query: 63 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+K + + H+ + +++RD K N+LLDAD N K++DFG + + G K
Sbjct: 115 EARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171
Query: 117 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
G YAAPE + G DV+S GV+L +++G D NL E
Sbjct: 172 AFC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE 221
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ L G + I + L L +P R + ++++
Sbjct: 222 -----------LRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E++ L +L H N+VKL + +LV+E + + L+ L L L
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVM 122
G+A+ H+ R V++RD K N+L++ + K++DFGLA+ P TH ++
Sbjct: 109 LLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV 162
Query: 123 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
T Y AP+ V+ G ++ D++S G + EM+ G
Sbjct: 163 -TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E++ L +L H N+V LI + LV+EFM + L+ L L S
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVM 122
+G+A H+ +++RD K N+L+++D KL+DFGLA+ P TH V+
Sbjct: 128 LLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV 181
Query: 123 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
T Y AP+ V+ G ++ D++S G + EM+TG+
Sbjct: 182 -TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVM 122
+GLA+ H + V++RD K N+L++ KL+DFGLA K P + V+
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 123 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
T Y P+ ++ G +++ D++ G + EM TGR
Sbjct: 163 -TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 51/239 (21%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
EV L L H N++KL ED +V E G L + + +R +S
Sbjct: 71 EVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARI 126
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 115
+K + ++H+ +++RD K NILL + D + K+ DFGL+ + K
Sbjct: 127 IKQVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 175
+GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 181 K---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT----------------- 219
Query: 176 ARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 227
P G+ + + G ++ A L L+ P R ++
Sbjct: 220 -PPFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-16
Identities = 65/254 (25%), Positives = 97/254 (38%), Gaps = 50/254 (19%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
EV FL L H N ++ G + + LV E+ GS + L PL +
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVT 160
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-- 120
GA +GLA+LH +I+RD K NILL KL DFG A + ++
Sbjct: 161 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANS 209
Query: 121 VMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+GT + APE ++ G + DV+S G+ +E+ +P
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-------KP----------- 251
Query: 178 PHLGER-RRFYRLID----PRLE-GHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSE 226
P I P L+ GH+S + CL + P+ RP L
Sbjct: 252 PLFNMNAMSALYHIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHR 307
Query: 227 VVEALKPLPNLKDM 240
V +P + D+
Sbjct: 308 FVLRERPPTVIMDL 321
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L +L H N++ L+ LV++FM LE + SL L S L
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRV 121
+GL +LH+ +++RD K +N+LLD + KL+DFGLAK P TH V TR
Sbjct: 121 TLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR- 176
Query: 122 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 158
Y APE + + D+++ G +L E+L
Sbjct: 177 ----WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMK 60
E++ + +L H N+V+L +++ LV+EFM + +++ + L ++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVS 118
+GLAF HE +++RD K N+L++ KL DFGLA P +
Sbjct: 113 FQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-- 167
Query: 119 TRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
V+ T Y AP+ V+ G ++ D++S G +L EM+TG+
Sbjct: 168 -EVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 43 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 102
E L + + AKG+ FL A R I+RD NILL K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 103 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156
FGLA+D + + APE + T +SDV+SFGV+L E+ +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 54/240 (22%)
Query: 5 EVNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L H +++KL Y I +V E++ G L +++ + R++
Sbjct: 61 EIQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEM 111
Query: 63 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+ + H V++RD K N+LLDA NAK++DFGL+ +G+
Sbjct: 112 EARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 117 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
S G+ YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 169 TSC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHV-- 216
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
++ I G F I + L H L DP R + ++ E
Sbjct: 217 ---------PTLFKKI---RGGVFYIPEYLNRSVAT---LLMHMLQVDPLKRATIKDIRE 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 43/252 (17%)
Query: 5 EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 58
EV L H N+++LI + E++ R LV+E M GS+ +H+ +R ++
Sbjct: 60 EVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASV 115
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-GPEGD 113
++ A L FLH + + +RD K NIL + K+ DF L GD
Sbjct: 116 VVQDVASA---LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 114 KTHVSTRVM----GTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKN 164
+ +ST + G+ Y APE V + D++S GV+L +L+G
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------ 223
Query: 165 RP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRD 217
P G L + EG + A L + L RD
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283
Query: 218 PKARPLMSEVVE 229
K R ++V++
Sbjct: 284 AKQRLSAAQVLQ 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 48/242 (19%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SI 57
E + L H ++V+L+ D L +V+EFM L + +R+ S
Sbjct: 76 EASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 114
M+ L A L + H + +I+RD K +LL + KL FG+A E
Sbjct: 135 YMRQILEA---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 173
RV GT + APE V+ + DV+ GV+L +L+G
Sbjct: 189 V-AGGRV-GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC--------------- 230
Query: 174 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQ------KAAQLAAHCLSRDPKARPLMSEV 227
P G + R + I ++G + + Q A L L DP R + E
Sbjct: 231 ---LPFYGTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
Query: 228 VE 229
+
Sbjct: 285 LN 286
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 19/164 (11%)
Query: 5 EVNFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMK 60
E+ L L H N+++L+ E+ Q++ +V E+ G E + + + P+ +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHV 117
L GL +LH + ++++D K N+LL K+S G+A D
Sbjct: 116 CQL--IDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 118 STRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 158
S G+ + PE + G T + D++S GV L + TG
Sbjct: 171 SQ---GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 9e-15
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E+ L H N+VK G + L E+ G L + + I M
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD 106
Query: 64 GAAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
A + G+ +LH + +RD K N+LLD N K+SDFGLA ++
Sbjct: 107 -AQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 117 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 158
+ ++ GT Y APE ++ DV+S G+VL ML G
Sbjct: 163 LLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 20/163 (12%)
Query: 5 EVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM- 59
E+ L L H N+VKL + +D +V+E + +G + + L +
Sbjct: 86 EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF 143
Query: 60 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+ G + +LH + +I+RD K SN+L+ D + K++DFG++ + +G +S
Sbjct: 144 QDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLS 195
Query: 119 TRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 158
V GT + APE + DV++ GV L + G+
Sbjct: 196 NTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 36/172 (20%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ E+ L L H ++K+ + + + +V E M G E LF + +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKR 235
Query: 63 LG---AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDG 109
L + +LHE +I+RD K N+LL + D K++DFG +K
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 110 PEGDKTHVSTRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTG 157
E T GT Y APE V+ D +S GV+L L+G
Sbjct: 293 GETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 57/303 (18%), Positives = 100/303 (33%), Gaps = 60/303 (19%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRMKIA 62
E+ L + H N++K++ E+ LV E G L + R R+
Sbjct: 79 EIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RLDEP 130
Query: 63 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
L + + +L + +I+RD K NI++ D+ KL DFG A G +
Sbjct: 131 LASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187
Query: 117 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNL 172
GT Y APE V+ G+ +++S GV L ++ +
Sbjct: 188 TFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA--- 240
Query: 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA-- 230
P S ++ L + L P+ R + ++V
Sbjct: 241 --------------IHP--PY---LVS----KELMSLVSGLLQPVPERRTTLEKLVTDPW 277
Query: 231 LKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 290
+ NL D Y ++ + S G + ++ + G
Sbjct: 278 VTQPVNLAD-----YTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHH 332
Query: 291 YHH 293
+HH
Sbjct: 333 HHH 335
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 64/253 (25%), Positives = 92/253 (36%), Gaps = 66/253 (26%)
Query: 3 QAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGSLE---NHLFRRSLP 52
+ E+N L H N+ G DDQ LV EF GS+ + +L
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 53 LPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 109
W IA +GL+ LH+ VI+RD K N+LL + KL DFG++
Sbjct: 128 EEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--- 176
Query: 110 PEGDKTHVSTR---VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSM 161
R +GT + APE + +SD++S G+ +EM G
Sbjct: 177 --AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG---- 230
Query: 162 DKNRPNGEHNLVEWARPHLGE---RRRFYRLID----PRLEG-HFSIKGAQKAAQLAAHC 213
P P R F LI PRL+ +S +K C
Sbjct: 231 ---AP-----------PLCDMHPMRALF--LIPRNPAPRLKSKKWS----KKFQSFIESC 270
Query: 214 LSRDPKARPLMSE 226
L ++ RP +
Sbjct: 271 LVKNHSQRPATEQ 283
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 66/355 (18%), Positives = 120/355 (33%), Gaps = 71/355 (20%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPW 55
E+ L +L H N++ L + D+++ L++++ ++ H ++ + LP
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DG 109
+ + G+ +LH V++RD K +NIL+ + K++D G A+ +
Sbjct: 128 GMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 110 PEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR-----RSMD 162
P + V+ T+ Y APE ++ G H T D+++ G + E+LT R D
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 163 KNRPNGEH--------------NLVEW-----------ARPHLGERRRFYRLIDPRLEGH 197
N H +W + +E H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 198 FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-------PLPNLKDMASSSYYFQTM 250
+ KA L L+ DP R +A++ PLP A +
Sbjct: 303 KVKPDS-KAFHLLQKLLTMDPIKRITSE---QAMQDPYFLEDPLPTSDVFAGCQIPYP-K 357
Query: 251 QAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPKPNGK 305
+ P+ + + Q N P + H P K
Sbjct: 358 REFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPG-------NQDSSHTQGPPLKK 405
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
E+ L H N+VK G + L E+ G L + + I M
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD 106
Query: 64 GAAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
A + G+ +LH + +RD K N+LLD N K+SDFGLA ++
Sbjct: 107 -AQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 117 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 158
+ ++ GT Y APE ++ DV+S G+VL ML G
Sbjct: 163 LLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 19/163 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
EV+ L +L H N+++L + + L++E+ L+ ++ ++ + +
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQ 140
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--GPEGDKTHV 117
G+ F H R ++RD K N+LL + K+ DFGLA+ P TH
Sbjct: 141 LINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH- 196
Query: 118 STRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
++ T Y PE ++ G H ++ D++S + EML
Sbjct: 197 --EII-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 54/202 (26%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 63
EV + L H N+ +L ED+Q + LV E G L + L M +
Sbjct: 78 EVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 64 G--------------------------------AAK-------GLAFLHEEAERPVIYRD 84
+ L +LH + + +RD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRD 193
Query: 85 FKTSNILLDADYNA--KLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 139
K N L + + KL DFGL+K G+ ++T+ GT + APE V+
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNE 251
Query: 140 S---RSDVYSFGVVLLEMLTGR 158
S + D +S GV+L +L G
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGA 273
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPW 55
E+ + + H N+V L +D+ L LV E++P H + +P
Sbjct: 82 ELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK 114
+ + LA++H + +RD K N+LLD KL DFG AK G+
Sbjct: 141 LLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 115 -TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
+ +R Y Y APE ++ G + T+ D++S G V+ E++ G+
Sbjct: 198 NVSYICSR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 41/241 (17%)
Query: 5 EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 58
E+ L H N+VKL D LV E + G L + ++ +S
Sbjct: 55 EITALKLCEGHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASY 110
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 114
M+ + A ++ +H+ V++RD K N+L + + K+ DFG A+ P ++
Sbjct: 111 IMRKLVSA---VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
+ T T YAAPE + D++S GV+L ML+G+ P
Sbjct: 165 P-LKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF------- 209
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVV 228
+ ++ +G FS +G Q+A L L+ DP R MS +
Sbjct: 210 QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269
Query: 229 E 229
Sbjct: 270 Y 270
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 9 LGDLVHLNLVKLI------GYCIEDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRM 59
L L H N+V+L G D L +V E++P + +RR + P +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKD-GPEGDKTH- 116
+ + LH + V +RD K N+L++ AD KL DFG AK P
Sbjct: 133 VFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 117 VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
+ +R Y Y APE ++ G H T+ D++S G + EM+ G
Sbjct: 192 ICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 46/170 (27%), Positives = 70/170 (41%), Gaps = 36/170 (21%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLK 112
Query: 65 ---AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPE 111
+ +LHE +I+RD K N+LL + D K++DFG +K E
Sbjct: 113 EATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 112 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSR----SDVYSFGVVLLEMLTG 157
T GT Y APE V+ T+ D +S GV+L L+G
Sbjct: 170 TSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 38/172 (22%)
Query: 5 EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
EV+ L + H N+++L E + LV++ M +G E LF + K+
Sbjct: 73 EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY-------LTEKVT 120
Query: 63 LG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112
L K + LH+ +++RD K NILLD D N KL+DFG + G
Sbjct: 121 LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 157
+K GT Y APE ++ + D++S GV++ +L G
Sbjct: 178 EKL--REVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL------LVYEFMPR--GSLENHLFRRSLPLPWS 56
E+ + L H N+V+L + ++ LV +++P + H R LP
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK- 114
+ LA++H + +RD K N+LLD D KL DFG AK G+
Sbjct: 157 YVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 115 TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158
+ +R Y Y APE ++ G TS DV+S G VL E+L G+
Sbjct: 214 VSYICSR----Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 48/237 (20%)
Query: 5 EVNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L H +++KL Y I + +V E++ G L +++ + R+
Sbjct: 66 EIQNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEK 116
Query: 63 LGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
G+ + H V++RD K N+LLDA NAK++DFGL+ +G+
Sbjct: 117 ESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173
Query: 117 VSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
S G+ YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 174 TSC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHV-- 221
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 229
++ I +G F L H L DP R + ++ E
Sbjct: 222 ---------PTLFKKI---CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 37/169 (21%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 127
+ + H +++RD K N+LLD + N K++DFGL+ +G+ S G+ Y
Sbjct: 120 AIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 173
Query: 128 AAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 185
AAPE V+ G L DV+S G+VL ML GR D + +
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFI-----------PN 215
Query: 186 FYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
++ + + + GAQ L + DP R + E+
Sbjct: 216 LFKKV---NSCVYVMPDFLSPGAQS---LIRRMIVADPMQRITIQEIRR 258
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPL 53
E+ L L H N+V LI C LV++F G L N L + +L
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------K 107
+ M++ L GL ++H +++RD K +N+L+ D KL+DFGLA K
Sbjct: 126 IKRV-MQMLL---NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 108 DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 158
+ T+ RV+ T Y PE ++ D++ G ++ EM T
Sbjct: 179 NSQPNRYTN---RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 59/249 (23%), Positives = 91/249 (36%), Gaps = 67/249 (26%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
EV L L H N++KL ED +V E G E LF I
Sbjct: 71 EVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRF 118
Query: 59 --------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 107
+K + ++H+ +++RD K NILL + D + K+ DFGL+
Sbjct: 119 SEHDAARIIKQVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 108 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 167
+ K R+ GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 173 CFQQNTKM--KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT--------- 219
Query: 168 GEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKA 220
P G+ + + G ++ A L L+ P
Sbjct: 220 ---------PPFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 221 RPLMSEVVE 229
R ++ +E
Sbjct: 268 RITATQCLE 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 58/243 (23%), Positives = 90/243 (37%), Gaps = 56/243 (23%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
E+ L L H N++K+ ED + +V E G E L R + +
Sbjct: 70 EIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEG 124
Query: 59 -----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGP 110
MK + A LA+ H + V+++D K NIL K+ DFGLA+
Sbjct: 125 YVAELMKQMMNA---LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 111 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 170
+ + GT Y APE V +T + D++S GVV+ +LTG
Sbjct: 179 SDEH--STNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------ 222
Query: 171 NLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA-----QKAAQLAAHCLSRDPKARPLM 224
P G + + +A L L++DP+ RP
Sbjct: 223 ------LPFTGTSLEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273
Query: 225 SEV 227
++V
Sbjct: 274 AQV 276
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 22/166 (13%)
Query: 5 EVNFLGDL---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPL 53
EV L L H N+V+L + + +L LV+E + L+ +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGV 117
Query: 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEG 112
P + +GL FLH V++RD K NIL+ + KL+DFGLA+ +
Sbjct: 118 PTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
T V+ T Y APE ++ + D++S G + EM +
Sbjct: 175 ALTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGT 124
G+ LH +I+RD K SNI++ +D K+ DFGLA+ +V TR
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 228
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ D++S G ++ EM+ +
Sbjct: 229 --YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGT 124
G+ LH +I+RD K SNI++ +D K+ DFGLA+ +V TR
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 191
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ D++S G ++ EM+ G
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 8e-13
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 22/166 (13%)
Query: 5 EVNFLGDL---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPL 53
EV L L H N+V+L+ + + ++ LV+E + R L+ L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGL 117
Query: 54 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEG 112
P + +GL FLH +++RD K NIL+ + KL+DFGLA+ +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
T V+ T Y APE ++ + D++S G + EM +
Sbjct: 175 ALTP---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-13
Identities = 61/247 (24%), Positives = 87/247 (35%), Gaps = 67/247 (27%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
E+ + L H N+++L ED+ + LV E G E LF R +
Sbjct: 56 EIEIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVF 103
Query: 59 --------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 107
MK L A +A+ H+ V +RD K N L D KL DFGLA
Sbjct: 104 RESDAARIMKDVLSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157
Query: 108 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 167
G + T+V GT Y +P+ V+ G D +S GV++ +L G
Sbjct: 158 RFKPGKM--MRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY--------- 204
Query: 168 GEHNLVEWARPHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKA 220
P I EG F+ +A L L++ PK
Sbjct: 205 ---------PPFSAPTDSEVMLKI---REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252
Query: 221 RPLMSEV 227
R +
Sbjct: 253 RITSLQA 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 49/235 (20%), Positives = 84/235 (35%), Gaps = 47/235 (20%)
Query: 14 HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIAL 63
++V ++ E+ L++ E M G L + + R ++ R M+
Sbjct: 81 GPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIG 138
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTR 120
A + FLH + +RD K N+L + D KL+DFG AK+ + + T
Sbjct: 139 TA---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTP 189
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
T Y APE + D++S GV++ +L G ++
Sbjct: 190 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------------YSNTGQ 235
Query: 181 GERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 229
R I G + + A QL L DP R +++ +
Sbjct: 236 AISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 57
EV+ L ++H N++ L E+ + L+ E + G L + L +
Sbjct: 65 EVSILRQVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TS 119
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 113
+K L G+ +LH + + + D K NI+L + KL DFGLA + +G
Sbjct: 120 FIKQILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 39/174 (22%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 59
+ E+ L + H N+V L E LV + + G E LF R I
Sbjct: 52 SLENEIAVLKKIKHENIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I-- 97
Query: 60 KIALG------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 103
+ G A+ + +LHE +++RD K N+L + + ++DF
Sbjct: 98 -LERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDF 153
Query: 104 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
GL+K G + + GT GY APE + + D +S GV+ +L G
Sbjct: 154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 38/172 (22%)
Query: 5 EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E + L + H +++ LI E + LV++ M +G E LF + K+A
Sbjct: 149 ETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG--E--LFDY-------LTEKVA 196
Query: 63 LG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112
L ++FLH +++RD K NILLD + +LSDFG + G
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 157
+K GT GY APE ++ + D+++ GV+L +L G
Sbjct: 254 EKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 29/224 (12%), Positives = 60/224 (26%), Gaps = 47/224 (20%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 71
+ + +++ L+V E++ GSL+ + P P ++ A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAMQSLAAAADA 144
Query: 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 131
H V S + + D + L+
Sbjct: 145 AHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA 179
Query: 132 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 191
+ D+ G L +L R + + G + + A + ID
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTAGQPIEPADID 229
Query: 192 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235
+ S +AA + D R S ++ ++
Sbjct: 230 RDIPFQIS--------AVAARSVQGDGGIRSA-STLLNLMQQAT 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 36/168 (21%), Positives = 60/168 (35%), Gaps = 41/168 (24%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLA---KDGPEGDKTHVSTRVMG 123
+ H V++RD K NIL+D + KL DFG KD G
Sbjct: 161 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-----G 210
Query: 124 TYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
T Y+ PE++ H + V+S G++L +M+ G + + ++
Sbjct: 211 TRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRG------ 258
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
++ + S + L CL+ P RP E+
Sbjct: 259 ------QVFFRQ---RVS----SECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 39/169 (23%), Positives = 60/169 (35%), Gaps = 43/169 (25%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLA---KDGPEGDKTHVSTRVMG 123
+ H R V++RD K NIL+D KL DFG D P G
Sbjct: 151 AIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFD-----G 200
Query: 124 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
T Y+ PE++ + V+S G++L +M+ G P +
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD------------------IPFERD 242
Query: 183 RRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ I LE + L CL+ P +RP + E++
Sbjct: 243 QE-----I---LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 57
EV+ L ++H N++ L E+ + L+ E + G L + L +
Sbjct: 65 EVSILRQVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TS 119
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 113
+K L G+ +LH + + + D K NI+L + KL DFGLA + +G
Sbjct: 120 FIKQILD---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ + L H LV L +D++ +++YEFM G E LF + + A+
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKMSEDEAVE 259
Query: 65 AAK----GLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVS 118
+ GL +HE ++ D K NI+ KL DFGL V
Sbjct: 260 YMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 315
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
GT +AAPE + +D++S GV+ +L+G
Sbjct: 316 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 31/95 (32%), Positives = 43/95 (45%), Gaps = 11/95 (11%)
Query: 68 GLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTHVSTRVMGTY 125
G+++ H + +RD K N LLD K+ DFG +K + + V GT
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTP 181
Query: 126 GYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 158
Y APE V+ +DV+S GV L ML G
Sbjct: 182 AYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKT-HVSTRVMGT 124
GL LHE A V++RD NILL + + + DF LA +D + +KT +V+ R
Sbjct: 145 LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW--- 198
Query: 125 YGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE VM T D++S G V+ EM +
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 16/159 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMK 60
E++ + L H L+ L ED + L+ EF+ G L + + + M+
Sbjct: 98 EISIMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVS 118
A GL +HE +++ D K NI+ + K+ DFGLA + V
Sbjct: 157 QACE---GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV- 209
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
T +AAPE V + +D+++ GV+ +L+G
Sbjct: 210 --TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 32/159 (20%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMK 60
E++ L H N++ L E + L +++EF+ + + + L +
Sbjct: 51 EISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVS 118
+ L FLH + + D + NI+ ++ K+ +FG A+ GD +
Sbjct: 110 QVC---EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL- 162
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ Y APE +++ +D++S G ++ +L+G
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 58/246 (23%), Positives = 89/246 (36%), Gaps = 54/246 (21%)
Query: 5 EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 58
E+ L H N++ L +D + + +V E M G L + + R+ +S R
Sbjct: 65 EIEILLRYGQHPNIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASA 120
Query: 59 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDGPEGD 113
+ + +LH + V++RD K SNIL D N ++ DFG AK +
Sbjct: 121 VLFTITKT---VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG----RRSMDKNRPNGE 169
+ T T + APE + + D++S GV+L MLTG D
Sbjct: 175 GL-LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--- 229
Query: 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPL 223
I G FS+ G A L + L DP R
Sbjct: 230 ---------------EILARI---GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
Query: 224 MSEVVE 229
+ V+
Sbjct: 272 AALVLR 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 9e-12
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 38/170 (22%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E L H N+V+L E+ LV++ + G E LF I +A
Sbjct: 55 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFED-------I---VARE 100
Query: 65 ------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD 108
A+ +A+ H +++R+ K N+LL KL+DFGLA +
Sbjct: 101 FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 109 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 157
+ + H GT GY +PE V+ + D+++ GV+L +L G
Sbjct: 158 VNDSEAWH--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTY 125
KGL ++H V++RD K N+ ++ D K+ DFGLA+ + + T V TR
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRW---- 188
Query: 126 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE +++ H D++S G ++ EMLTG+
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 57
EVN L ++ H N++ L E+ + L+ E + G L + L +
Sbjct: 58 EVNILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEA----TQ 112
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 113
+K L G+ +LH + + + D K NI+L + KL DFG+A G+
Sbjct: 113 FLKQILD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 167 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTY 125
+GL ++H A+ +I+RD K SN+ ++ D K+ DFGLA+ + T +V+TR
Sbjct: 143 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATRW---- 194
Query: 126 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 11/94 (11%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTY 125
KGL ++H A +I+RD K N+ ++ D K+ DFGLA+ + + T +V TR
Sbjct: 139 KGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVVTRW---- 190
Query: 126 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ T D++S G ++ EM+TG+
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
E L H N+V+L I+++ LV++ + G L + R +S
Sbjct: 78 EARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHC 133
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 115
++ L + +A+ H +++R+ K N+LL KL+DFGLA + + +
Sbjct: 134 IQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 116 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
H GT GY +PE + + D+++ GV+L +L G
Sbjct: 188 H--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 37/165 (22%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 5 EVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW-------- 55
E+ L ++ L + +L+ E+ G E +F LP
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDV 133
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEG 112
+K L G+ +LH + +++ D K NILL + K+ DFG+++
Sbjct: 134 IRLIKQILE---GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ +MGT Y APE + +T+ +D+++ G++ +LT
Sbjct: 188 CELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 26/164 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLF--RRSLPLPW 55
E++ + L H NL++L E + LV E++ G L E++ ++
Sbjct: 136 EISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-- 192
Query: 56 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEGD 113
MK G+ +H+ +++ D K NIL K+ DFGLA+ +
Sbjct: 193 ---MKQICE---GIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
K V GT + APE V ++ +D++S GV+ +L+G
Sbjct: 244 KLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 58/252 (23%), Positives = 87/252 (34%), Gaps = 63/252 (25%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 59
+ + E+ L L H N++KL E + LV E + G L F R I
Sbjct: 94 IVRTEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I-- 139
Query: 60 KIALG------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 103
+ G AA +A+LHE +++RD K N+L D K++DF
Sbjct: 140 -VEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 104 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 163
GL+K V GT GY APE + D++S G++ +L G
Sbjct: 196 GLSKIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF----- 247
Query: 164 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRD 217
P ER + L + A L + D
Sbjct: 248 -------------EPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293
Query: 218 PKARPLMSEVVE 229
PK R + ++
Sbjct: 294 PKKRLTTFQALQ 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 18/135 (13%)
Query: 32 LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAERPVIYRDFKTS 88
++ E++P + R +P + I + + + F+H + +RD K
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQ 170
Query: 89 NILLDA-DYNAKLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSD 143
N+L+++ D KL DFG AK + + +R + Y APE +M G T D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTPSID 224
Query: 144 VYSFGVVLLEMLTGR 158
++S G V E++ G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 25/164 (15%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSI 57
EV+ L ++ H N++ L E+ + L+ E + G L + L +
Sbjct: 64 EVSILKEIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TE 118
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGD 113
+K L + +LH + + D K NI+L K+ DFGLA G+
Sbjct: 119 FLKQILNG---VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157
+ + GT + APE V L +D++S GV+ +L+G
Sbjct: 173 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 125
+GL ++H A V++RD K SN+LL+ + K+ DFGLA+ P+ D T T + T
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 126 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y APE ++ T D++S G +L EML+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 51/245 (20%), Positives = 89/245 (36%), Gaps = 47/245 (19%)
Query: 5 EVNFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR 58
EV ++V+++ E+ L+V E + G L + + R ++ R
Sbjct: 104 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTER 161
Query: 59 -----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDGP 110
MK A + +LH + +RD K N+L NA KL+DFG AK+
Sbjct: 162 EASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 111 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 170
+ ++T T Y APE + D++S GV++ +L G P
Sbjct: 216 SHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF--- 263
Query: 171 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLM 224
++ L I G + ++ L + L +P R +
Sbjct: 264 ----YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316
Query: 225 SEVVE 229
+E +
Sbjct: 317 TEFMN 321
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 23/163 (14%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----- 58
E L H N+V+L I ++ L+++ + G L + R +S
Sbjct: 60 EARICRLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHC 115
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 115
++ L A + H+ V++R+ K N+LL KL+DFGLA + EG++
Sbjct: 116 IQQILEA---VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQ 168
Query: 116 HVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 157
GT GY +PE V+ D+++ GV+L +L G
Sbjct: 169 AWFGFA-GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPEGDKTHVSTRVM 122
+ + LH + VI+RD K SN+L++++ + K+ DFGLA + + + M
Sbjct: 123 RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 123 GTY----GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 158
+ Y APE ++T + DV+S G +L E+ R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 24/97 (24%), Positives = 48/97 (49%), Gaps = 12/97 (12%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG-PEGDKTH-VSTRVMG 123
K L + H +++RD K N+++D ++ +L D+GLA+ P + V++R
Sbjct: 141 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 124 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 159
+ PE ++ + S D++S G +L M+ +
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAK-DGPEGDKTHVSTRVMGT 124
+GL ++H A V++RD K +N+ ++ D K+ DFGLA+ P + + T
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 125 YGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 158
Y +P +++ + T D+++ G + EMLTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 23/112 (20%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMG 123
K + +LH +++RD K SNILL+A+ + K++DFGL+ + +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 124 TYGYAAPEYVMTGH------------LTSRS-----DVYSFGVVLLEMLTGR 158
T + + ++T + L S D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 28/122 (22%), Positives = 48/122 (39%), Gaps = 24/122 (19%)
Query: 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPEGDKTHVSTRVM 122
G F+HE + +I+RD K +N LL+ D + K+ DFGLA + +
Sbjct: 140 LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 123 GTYGYAAPEYVMTGHLTSR-----------------SDVYSFGVVLLEMLTGRRSMDKNR 165
+ +T H+ +R D++S G + E+L +S +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 166 PN 167
N
Sbjct: 257 TN 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 31/153 (20%), Positives = 64/153 (41%), Gaps = 24/153 (15%)
Query: 32 LVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 88
+V+E + +L + + R +PL ++ +I+ GL ++H +I+ D K
Sbjct: 107 MVFEVL-GENLLALIKKYEHRGIPLI-YVK-QISKQLLLGLDYMHRRCG--IIHTDIKPE 161
Query: 89 NILLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 142
N+L++ K++D G A E + TR Y +PE ++ +
Sbjct: 162 NVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGA 216
Query: 143 DVYSFGVVLLEMLTGR-----RSMDKNRPNGEH 170
D++S ++ E++TG + +H
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 38/205 (18%), Positives = 69/205 (33%), Gaps = 56/205 (27%)
Query: 5 EVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 59
E+ L L H ++VK+ I +E L +V E ++ + R
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------LFRT 149
Query: 60 KIALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--- 106
+ L G+ ++H A +++RD K +N L++ D + K+ DFGLA
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 107 ------KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH------------LTSRS-----D 143
++ + +TGH L + D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266
Query: 144 VYSFGVVLLEMLTGRRSMDKNRPNG 168
V+S G + E+L + +
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADR 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 41/278 (14%), Positives = 76/278 (27%), Gaps = 88/278 (31%)
Query: 32 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 90
+V+E + L + + LP KI +GL +LH + +I+ D K NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 91 LLDAD-------------------------------------------------YNAKLS 101
LL + K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 102 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161
D G A + + TR Y + E ++ + +D++S + E+ TG
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 162 DKNRPNGEHN-------------------LVEWARPHL-----GERRRFYRLIDPRLEG- 196
+ + +V G+ + +L L
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 197 -----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+S + A L P+ R +E +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 18/128 (14%)
Query: 33 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 92
+YE + + + LP +R K A + L LH+ +I+ D K NILL
Sbjct: 185 LYELIKKNKF------QGFSLP-LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILL 233
Query: 93 -DADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150
+ K+ DFG + + T++ +R Y APE ++ D++S G +
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCI 288
Query: 151 LLEMLTGR 158
L E+LTG
Sbjct: 289 LAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 35/129 (27%), Positives = 56/129 (43%), Gaps = 18/129 (13%)
Query: 33 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 92
+Y+ L N FR + ++ K A L FL +I+ D K NILL
Sbjct: 142 LYDL-----LRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILL 192
Query: 93 DADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGV 149
+ K+ DFG + + ++ +R Y +PE V+ G + D++S G
Sbjct: 193 CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGC 246
Query: 150 VLLEMLTGR 158
+L+EM TG
Sbjct: 247 ILVEMHTGE 255
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 45/253 (17%), Positives = 80/253 (31%), Gaps = 84/253 (33%)
Query: 5 EVNFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR 58
EV ++V+++ E+ L+V E + G E LF R I+
Sbjct: 60 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQ 107
Query: 59 MKIALG-----AA-------KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 103
+ A+ + + +LH + +RD K N+L + KL+DF
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 104 GLAKDGPEGDKTHVSTRVMGT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162
G A E G Y + D++S GV++ +L G
Sbjct: 165 GFA---KE---------TTGEKYDKSC-------------DMWSLGVIMYILLCGY---- 195
Query: 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSR 216
P ++ L I G + ++ L + L
Sbjct: 196 --PPF-------YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKT 243
Query: 217 DPKARPLMSEVVE 229
+P R ++E +
Sbjct: 244 EPTQRMTITEFMN 256
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 32/159 (20%)
Query: 19 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 75
+ + E +LV + + SLE L R + ++ M A + +HE
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQMLARVQSIHE- 124
Query: 76 AERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHVSTR----VMG 123
+ ++YRD K N L+ + + DFG+ K D K H+ R + G
Sbjct: 125 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQHIPYREKKNLSG 180
Query: 124 TYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 158
T Y + + HL + R D+ + G V + L G
Sbjct: 181 TARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 40/155 (25%), Positives = 62/155 (40%), Gaps = 26/155 (16%)
Query: 19 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 75
+ E D ++V E + SLE LF R L ++ + +A + ++H
Sbjct: 69 TIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQMISRIEYIHS- 123
Query: 76 AERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR----VMGTYGY 127
+ I+RD K N L+ + DFGLAK H+ R + GT Y
Sbjct: 124 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 128 AAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 158
A+ + HL + R D+ S G VL+ G
Sbjct: 182 AS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 35/170 (20%)
Query: 9 LGDLVHLNLVKLIGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPWSIRM--KIAL 63
L L + +G+ +D R LV +P SL+ S S R ++A
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVLSERSVLQVAC 166
Query: 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK---DGPEGDKTHVS 118
L FLHE ++ + NI +D + ++ L+ +G A HV+
Sbjct: 167 RLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP----SGKHVA 219
Query: 119 TR------VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 158
G + + M H + RSD+ S G +L+ L G
Sbjct: 220 YVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 32/159 (20%)
Query: 19 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE 75
++ + +V E + SLE LF R+ L ++ M IA+ + ++H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQLISRMEYVHS- 123
Query: 76 AERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHVSTR----VMG 123
+ +IYRD K N L+ N + DF LAK D K H+ R + G
Sbjct: 124 --KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHIPYREHKSLTG 179
Query: 124 TYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 158
T Y + + HL + R D+ + G + + L G
Sbjct: 180 TARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 1e-04
Identities = 18/82 (21%), Positives = 25/82 (30%), Gaps = 4/82 (4%)
Query: 26 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 85
+DDQ +V EF G + + + I LA +RD
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLR--FEHRDL 188
Query: 86 KTSNILLDADYNAKLSDFGLAK 107
N+LL KL K
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGK 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 39/144 (27%), Positives = 55/144 (38%), Gaps = 35/144 (24%)
Query: 33 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 92
Y+F ++ + F P K+A K + FLH + + D K NIL
Sbjct: 103 TYDF-----IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILF 151
Query: 93 -DADYNA------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 133
+DY K+ DFG A E T VSTR Y APE +
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVI 206
Query: 134 MTGHLTSRSDVYSFGVVLLEMLTG 157
+ + DV+S G +L+E G
Sbjct: 207 LALGWSQPCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 37/145 (25%), Positives = 55/145 (37%), Gaps = 37/145 (25%)
Query: 33 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 92
+EF L+ + F+ P P +A L FLHE + + D K NIL
Sbjct: 108 TFEF-----LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILF 156
Query: 93 -DADYNA------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 133
++++ +++DFG A E T V+TR Y PE V
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-V 210
Query: 134 MTGHL-TSRSDVYSFGVVLLEMLTG 157
+ DV+S G +L E G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRG 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 30/144 (20%), Positives = 57/144 (39%), Gaps = 20/144 (13%)
Query: 26 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 85
R +V E + L+ + ++ S +++ + L ++HE ++ D
Sbjct: 123 GRSYRFMVMERLGI-DLQ-KISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDI 177
Query: 86 KTSNILLDADYNAK--LSDFGLAKD-GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHL 138
K +N+LL + L+D+GL+ P G+ GT + + + H
Sbjct: 178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS----LDAHK 233
Query: 139 ----TSRSDVYSFGVVLLEMLTGR 158
+ RSDV G +L L G+
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGK 257
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 18/101 (17%)
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD-GPEGDKTHVSTR----V 121
L ++HE ++ D K SN+LL+ + L D+GLA PEG +
Sbjct: 165 LEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 122 MGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 158
GT + + + H + R D+ G +++ LTG
Sbjct: 222 DGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 24/154 (15%)
Query: 19 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM--KIALGAAKGLAFLHEEA 76
+ + +E D +LV + + SLE LF S++ +A + F+H
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLE-DLFN-FCSRKLSLKTVLMLADQMINRVEFVHS-- 121
Query: 77 ERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR----VMGTYGYA 128
+ ++RD K N L+ A + DFGLAK H+ R + GT YA
Sbjct: 122 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 129 APEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 158
+ + HL + R D+ S G VL+ L G
Sbjct: 181 S----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.86 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.24 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.58 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.71 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.61 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.55 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 91.34 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.06 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 85.89 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-56 Score=378.88 Aligned_cols=218 Identities=26% Similarity=0.471 Sum_probs=172.4
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|++|+++|++|+|||||++++++. ++.++||||||++|+|.+++......+++..+..++.||+.||+|||+++ |
T Consensus 78 ~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---I 153 (307)
T 3omv_A 78 AFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---I 153 (307)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 3789999999999999999999875 45789999999999999999877778999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc---CCCCchhHHHHHHHHHHHHHhC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg 157 (306)
|||||||+|||++.++.+||+|||+|+..............+||+.|||||++.+ ..|+.++|||||||++|||+||
T Consensus 154 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg 233 (307)
T 3omv_A 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233 (307)
T ss_dssp BCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHC
Confidence 9999999999999999999999999987654444444456789999999999974 3689999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
+.||........ +... ... ....+.. ...+..++..+.+||.+||+.||++|||+.||+++|+.+
T Consensus 234 ~~Pf~~~~~~~~---~~~~---~~~-----~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 234 ELPYSHINNRDQ---IIFM---VGR-----GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTTTCCCHHH---HHHH---HHT-----TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCChHHH---HHHH---Hhc-----CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999976433211 1111 100 0111111 112234467899999999999999999999999988644
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-56 Score=385.32 Aligned_cols=208 Identities=22% Similarity=0.362 Sum_probs=174.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|++|+++|++|+|||||++++++.+++.+|||||||+||+|.++|..+ +..+++..++.++.||+.||.|||+++ |
T Consensus 70 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---I 146 (350)
T 4b9d_A 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---I 146 (350)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 789999999999999999999999999999999999999999999754 446899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+|+..... .......+||+.|||||++.+..|+.++|||||||++|||++|+.|
T Consensus 147 iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~P 224 (350)
T 4b9d_A 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224 (350)
T ss_dssp EETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999999875422 1223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|...+... ..... ... . . +.. +...+.++.+||.+||+.||++|||+.|+++|-
T Consensus 225 F~~~~~~~---~~~~i---~~~--~----~-~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 225 FEAGSMKN---LVLKI---ISG--S----F-PPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp CCCSSHHH---HHHHH---HHT--C----C-CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCCcCHHH---HHHHH---HcC--C----C-CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 97653221 11110 000 0 0 111 122357899999999999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=379.61 Aligned_cols=217 Identities=22% Similarity=0.284 Sum_probs=179.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+
T Consensus 79 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---Ii 154 (311)
T 4aw0_A 79 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG---II 154 (311)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 6799999999999999999999999999999999999999999997654 7999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||++|..||
T Consensus 155 HRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 234 (311)
T 4aw0_A 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234 (311)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999999876544444455678999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hCCCCCCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 239 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~--l~~~~~~~~ 239 (306)
...+... ..... ... ...+ +...+.++.+||.+||++||++|||++|++.+ +...+++.+
T Consensus 235 ~~~~~~~---~~~~i---~~~--------~~~~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 235 RAGNEGL---IFAKI---IKL--------EYDF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp CCSSHHH---HHHHH---HHT--------CCCC----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CCCCHHH---HHHHH---HcC--------CCCC----CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 7643221 11111 000 0111 12235688999999999999999999997543 334444443
Q ss_pred C
Q 021891 240 M 240 (306)
Q Consensus 240 ~ 240 (306)
.
T Consensus 297 i 297 (311)
T 4aw0_A 297 V 297 (311)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-56 Score=380.44 Aligned_cols=216 Identities=25% Similarity=0.384 Sum_probs=181.0
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
+|++|+++|++|+|||||+++|+|.+++.++||||||++|+|.++|..+. ..+++..+..++.||
T Consensus 75 ~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 154 (308)
T 4gt4_A 75 EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 154 (308)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHH
Confidence 38899999999999999999999999999999999999999999996432 358999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....+.........||+.|||||++.+..|+.++|||
T Consensus 155 a~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVw 231 (308)
T 4gt4_A 155 AAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 231 (308)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhh
Confidence 99999999988 999999999999999999999999999875443333334456799999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||+| |..||.+..... ...... .... +. .+..++..+.+|+.+||+.||++|||+
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~~~---~~~~i~----~~~~------~~----~p~~~~~~~~~li~~C~~~dP~~RPs~ 294 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSNQD---VVEMIR----NRQV------LP----CPDDCPAWVYALMIECWNEFPSRRPRF 294 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCHHH---HHHHHH----TTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCC------CC----CcccchHHHHHHHHHHcCCChhHCcCH
Confidence 99999999998 899997654321 111111 1110 11 122345789999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 021891 225 SEVVEALKPLPN 236 (306)
Q Consensus 225 ~ell~~l~~~~~ 236 (306)
.||+++|+...+
T Consensus 295 ~ei~~~L~a~~n 306 (308)
T 4gt4_A 295 KDIHSRLRAWGN 306 (308)
T ss_dssp HHHHHHHHTSCC
T ss_pred HHHHHHHHhccC
Confidence 999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=379.73 Aligned_cols=214 Identities=29% Similarity=0.466 Sum_probs=178.7
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC------------CCCCCHHHHHHHHHHHHHH
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALGAAKG 68 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------~~~l~~~~~~~~~~qi~~~ 68 (306)
+|.+|+++|++|+|||||+++|+|.+++.++||||||++|+|.++|.+. ...+++..+..++.||+.|
T Consensus 61 ~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 140 (299)
T 4asz_A 61 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140 (299)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence 3889999999999999999999999999999999999999999999653 2469999999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHH
Q 021891 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 148 (306)
Q Consensus 69 l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 148 (306)
|.|||+++ |+||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++||||||
T Consensus 141 l~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~G 217 (299)
T 4asz_A 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217 (299)
T ss_dssp HHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHH
Confidence 99999988 999999999999999999999999999875443333333445789999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 149 VVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 149 ~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|++|||+| |+.||....... ...... .... +. .+..++.++.+||.+||+.||++|||+.+|
T Consensus 218 vvl~Ellt~G~~Pf~~~~~~~---~~~~i~----~~~~------~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 218 VVLWEIFTYGKQPWYQLSNNE---VIECIT----QGRV------LQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HHHHHHHTTTCCTTTTSCHHH---HHHHHH----HTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCCCCCCCCHHH---HHHHHH----cCCC------CC----CCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999998 899997653221 111111 1100 11 122345789999999999999999999999
Q ss_pred HHHhCCC
Q 021891 228 VEALKPL 234 (306)
Q Consensus 228 l~~l~~~ 234 (306)
++.|+.+
T Consensus 281 ~~~L~~~ 287 (299)
T 4asz_A 281 HTLLQNL 287 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9888643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=380.04 Aligned_cols=214 Identities=28% Similarity=0.450 Sum_probs=170.4
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHH
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAA 66 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~l~~~~~~~~~~qi~ 66 (306)
+|++|+++|++|+|||||+++++|.+.+.+|||||||++|+|.+++.+.. .++++.++..++.||+
T Consensus 89 ~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 168 (329)
T 4aoj_A 89 DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168 (329)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHH
Confidence 38899999999999999999999999999999999999999999996532 3589999999999999
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHH
Q 021891 67 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 146 (306)
Q Consensus 67 ~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 146 (306)
.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............||+.|||||++.+..|+.++||||
T Consensus 169 ~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS 245 (329)
T 4aoj_A 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245 (329)
T ss_dssp HHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccc
Confidence 9999999988 9999999999999999999999999998765544444445567999999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 021891 147 FGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225 (306)
Q Consensus 147 lG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 225 (306)
|||++|||+| |+.||....... ...... ... .+. .+..++.++.+||.+||+.||++|||+.
T Consensus 246 ~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~----~g~------~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ 308 (329)
T 4aoj_A 246 FGVVLWEIFTYGKQPWYQLSNTE---AIDCIT----QGR------ELE----RPRACPPEVYAIMRGCWQREPQQRHSIK 308 (329)
T ss_dssp HHHHHHHHHTTSCCTTCSSCHHH---HHHHHH----HTC------CCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred hHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----cCC------CCC----CcccccHHHHHHHHHHcCcChhHCcCHH
Confidence 9999999999 899997653221 111111 111 111 1223457899999999999999999999
Q ss_pred HHHHHhCCC
Q 021891 226 EVVEALKPL 234 (306)
Q Consensus 226 ell~~l~~~ 234 (306)
||+++|+.+
T Consensus 309 ei~~~L~~l 317 (329)
T 4aoj_A 309 DVHARLQAL 317 (329)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-55 Score=376.12 Aligned_cols=211 Identities=24% Similarity=0.228 Sum_probs=173.9
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|+++|++|+|||||++++++.+++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+|
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiH 173 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR---ILH 173 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 589999999999999999999999999999999999999999997654 7999999999999999999999998 999
Q ss_pred ccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcc---eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 83 RDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 83 ~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|||||+|||++.+| .+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||+||.
T Consensus 174 RDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 253 (336)
T 4g3f_A 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253 (336)
T ss_dssp SCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence 99999999999987 6999999999876543221 1223467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||...........+.. ....+ ..++...+..+.+||.+||++||++|||+.||+++|.
T Consensus 254 ~Pf~~~~~~~~~~~i~~------~~~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 254 HPWTQYFRGPLCLKIAS------EPPPI---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp CSSTTTCCSCCHHHHHH------SCCGG---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHc------CCCCc---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 99987654433222111 10000 0112234578999999999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=379.33 Aligned_cols=208 Identities=26% Similarity=0.375 Sum_probs=174.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++|+|||||+++++|.+++.+|||||||+||+|.+++.+. .+++..+..++.||+.||+|||+++ |+
T Consensus 118 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---Ii 192 (346)
T 4fih_A 118 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VI 192 (346)
T ss_dssp GHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 689999999999999999999999999999999999999999998653 5999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|..||
T Consensus 193 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 270 (346)
T 4fih_A 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270 (346)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999987654322 234578999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.+...... ...... ...+.. ......+.++.+||.+||+.||++|||+.|+++|-
T Consensus 271 ~~~~~~~~---~~~i~~----------~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 271 FNEPPLKA---MKMIRD----------NLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp TTSCHHHH---HHHHHH----------SSCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCcCHHHH---HHHHHc----------CCCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 76432211 111110 011111 01123357899999999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=368.92 Aligned_cols=208 Identities=24% Similarity=0.371 Sum_probs=167.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|.+|+++|++|+|||||+++++|.+ ++.+|||||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++
T Consensus 72 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~- 149 (290)
T 3fpq_A 72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT- 149 (290)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 7899999999999999999999875 34689999999999999999654 47999999999999999999999976
Q ss_pred CCeEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 78 RPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
.+|+||||||+|||++. +|.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+|
T Consensus 150 ~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyellt 224 (290)
T 3fpq_A 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH
T ss_pred CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHH
Confidence 45999999999999974 799999999999864332 2345689999999998865 69999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|+.||....... ..... ..... ..+.. +...+.++.+||.+||+.||++|||+.|+++|.
T Consensus 225 g~~Pf~~~~~~~--~~~~~----i~~~~-----~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 225 SEYPYSECQNAA--QIYRR----VTSGV-----KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp SSCTTTTCSSHH--HHHHH----HTTTC-----CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCCCCcHH--HHHHH----HHcCC-----CCCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 999997543211 11110 00000 00111 111235789999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=380.66 Aligned_cols=208 Identities=26% Similarity=0.376 Sum_probs=174.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++|+|||||+++++|.+++.+|||||||+||+|.+++... .+++..+..++.||+.||.|||+++ |+
T Consensus 195 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---Ii 269 (423)
T 4fie_A 195 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VI 269 (423)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 679999999999999999999999999999999999999999998653 5999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||||+.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|..||
T Consensus 270 HRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 347 (423)
T 4fie_A 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347 (423)
T ss_dssp CCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999987654322 234578999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.+...... ...... ...+... .....+.++.+||.+||+.||++|||+.|+++|-
T Consensus 348 ~~~~~~~~---~~~i~~----------~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 348 FNEPPLKA---MKMIRD----------NLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp TTSCHHHH---HHHHHH----------SCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCcCHHHH---HHHHHc----------CCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 76432211 111110 0111110 1112357899999999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=359.07 Aligned_cols=204 Identities=25% Similarity=0.339 Sum_probs=162.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++|+|||||++++++.+++.+|+||||| +|+|.+++.+++ .+++..+..++.||+.||+|||+++ |+
T Consensus 60 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---Ii 134 (275)
T 3hyh_A 60 IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHK---IV 134 (275)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 679999999999999999999999999999999999 679999997654 7999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 160 (306)
||||||+|||++.++.+||+|||+|+...... .....+||+.|||||++.+..| +.++|||||||++|+|+||+.|
T Consensus 135 HRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~P 211 (275)
T 3hyh_A 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 211 (275)
T ss_dssp CCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998754332 2334689999999999998876 5799999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|....... ..... .... ..+ +...+.++.+||.+||+.||++|||++|+++|-
T Consensus 212 F~~~~~~~---~~~~i---~~~~--------~~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 212 FDDESIPV---LFKNI---SNGV--------YTL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp SCCSSHHH---HHHHH---HHTC--------CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred CCCCCHHH---HHHHH---HcCC--------CCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 97543211 11110 0000 111 112357889999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=368.26 Aligned_cols=205 Identities=28% Similarity=0.352 Sum_probs=165.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++|+|||||++++++.+++.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+
T Consensus 73 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---Ii 148 (304)
T 3ubd_A 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG---II 148 (304)
T ss_dssp -----CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 6789999999999999999999999999999999999999999996654 7999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||+||..||
T Consensus 149 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF 226 (304)
T 3ubd_A 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226 (304)
T ss_dssp CSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCC
Confidence 999999999999999999999999987543322 234568999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~ 230 (306)
.+.+.... .... .... .. ++...+.++.+||.+||+.||++|||+ +|+++|
T Consensus 227 ~~~~~~~~---~~~i---~~~~--------~~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 227 QGKDRKET---MTMI---LKAK--------LG----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCSSHHHH---HHHH---HHCC--------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCcCHHHH---HHHH---HcCC--------CC----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 76432211 1111 1010 11 112235789999999999999999984 677764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=368.11 Aligned_cols=214 Identities=29% Similarity=0.405 Sum_probs=176.6
Q ss_pred HHHHHHHHhcCCC-CcccceeeEEEeC-CeeEEEEEcCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVH-LNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALG 64 (306)
Q Consensus 2 ~~~E~~il~~l~H-~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~~~~q 64 (306)
|.+|+++|++++| ||||+++++|.+. +.++||||||++|+|.++|.+. ...+++..+..++.|
T Consensus 114 ~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 193 (353)
T 4ase_A 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 193 (353)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHH
Confidence 7899999999965 8999999999764 5689999999999999999653 234899999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHH
Q 021891 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 144 (306)
Q Consensus 65 i~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 144 (306)
|+.||.|||+++ ||||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++||
T Consensus 194 ia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV 270 (353)
T 4ase_A 194 VAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270 (353)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccE
Confidence 999999999998 99999999999999999999999999997655544444556789999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 145 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 145 wslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
|||||++|||+| |..||.+...... .... +.... .+.. +..++.++.+||.+||+.||++|||
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~--~~~~----i~~g~------~~~~----p~~~~~~~~~li~~c~~~dP~~RPt 334 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEE--FCRR----LKEGT------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPT 334 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHH--HHHH----HHHTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHH--HHHH----HHcCC------CCCC----CccCCHHHHHHHHHHcCcChhHCcC
Confidence 999999999998 8999986543221 1111 11111 1111 2223578999999999999999999
Q ss_pred HHHHHHHhCCC
Q 021891 224 MSEVVEALKPL 234 (306)
Q Consensus 224 ~~ell~~l~~~ 234 (306)
+.||+++|+.+
T Consensus 335 ~~eil~~L~~l 345 (353)
T 4ase_A 335 FSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=346.34 Aligned_cols=207 Identities=23% Similarity=0.353 Sum_probs=156.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------------eeEEEEEcCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------------QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAK 67 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------------~~~lv~e~~~~~sL~~~l~~~~~--~l~~~~~~~~~~qi~~ 67 (306)
|.+|+++|++|+|||||++++++.+.+ .+|+|||||++|+|.+++..+.. ..++..++.++.||+.
T Consensus 50 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~ 129 (299)
T 4g31_A 50 VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129 (299)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHH
Confidence 679999999999999999999987654 36899999999999999976542 3556778999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc----------eeeecccccccccCCcchhcCC
Q 021891 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGH 137 (306)
Q Consensus 68 ~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~ 137 (306)
||+|||+++ |+||||||+|||++.+|.+||+|||+|+........ ......+||+.|||||++.+..
T Consensus 130 al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp HHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred HHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 999999998 999999999999999999999999999876443211 1123467999999999999999
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 138 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 138 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
|+.++|||||||++|||++ ||.... ....... .. ...... ......+..+.+||.+||+.|
T Consensus 207 y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~~~~-~~---------~~~~~p-~~~~~~~~~~~~li~~~L~~d 267 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY---PFSTQM-----ERVRTLT-DV---------RNLKFP-PLFTQKYPCEYVMVQDMLSPS 267 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHH-HH---------HTTCCC-HHHHHHCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHHHHH-HH---------hcCCCC-CCCcccCHHHHHHHHHHcCCC
Confidence 9999999999999999996 664211 0110000 00 000000 011223456789999999999
Q ss_pred CCCCCCHHHHHHH
Q 021891 218 PKARPLMSEVVEA 230 (306)
Q Consensus 218 p~~Rps~~ell~~ 230 (306)
|++|||+.|+++|
T Consensus 268 P~~Rps~~eil~h 280 (299)
T 4g31_A 268 PMERPEAINIIEN 280 (299)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=347.71 Aligned_cols=225 Identities=26% Similarity=0.314 Sum_probs=167.7
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-- 76 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-- 76 (306)
+.|+..+.+++|||||++++++.+++ .+|||||||++|+|.+++.+. .++++.+..++.|++.||+|||++.
T Consensus 45 e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~ 122 (303)
T 3hmm_A 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 45666677899999999999998764 579999999999999999654 5899999999999999999999871
Q ss_pred ---CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhcC------CCCchhHHH
Q 021891 77 ---ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVY 145 (306)
Q Consensus 77 ---~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Diw 145 (306)
..+|+||||||+|||++.++.+||+|||+++......... .....+||+.|||||++.+. .|+.++|||
T Consensus 123 ~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVw 202 (303)
T 3hmm_A 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202 (303)
T ss_dssp TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred ccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhh
Confidence 1239999999999999999999999999998754432221 22346799999999999754 367899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcc--------hHHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHHHHHcccC
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEHN--------LVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~ 216 (306)
||||++|||+||.+||.......... ......... .....++.+... ...+.+..+.+|+.+||+.
T Consensus 203 S~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 203 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS
T ss_pred hHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHccc
Confidence 99999999999988875433221100 000000000 011122222221 1235667899999999999
Q ss_pred CCCCCCCHHHHHHHhCCC
Q 021891 217 DPKARPLMSEVVEALKPL 234 (306)
Q Consensus 217 ~p~~Rps~~ell~~l~~~ 234 (306)
||++|||+.||++.|+.+
T Consensus 278 dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 278 NGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHH
Confidence 999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=351.57 Aligned_cols=225 Identities=22% Similarity=0.292 Sum_probs=169.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|++|+|||||++++++... +.+|||||||+ |+|.+++.++ ..+++..+..++.||+.||.|||++
T Consensus 100 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~ 177 (398)
T 4b99_A 100 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSA 177 (398)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 56899999999999999999997643 57899999995 6899998654 4799999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCC--cceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 152 (306)
+ |+||||||+|||++.+|.+||+|||+|+...... ........+||+.|||||++.+. .|+.++||||+||++|
T Consensus 178 ~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ 254 (398)
T 4b99_A 178 Q---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 254 (398)
T ss_dssp T---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred c---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHH
Confidence 9 9999999999999999999999999998754322 12223457899999999998875 5699999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhcc----------ccccccccCCccCCC---CCHHHHHHHHHHHHHcccCCCC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPK 219 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~ 219 (306)
||++|++||.+.+.......+......... .......+.+..... .....+.++.+||.+||+.||+
T Consensus 255 ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 334 (398)
T 4b99_A 255 EMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS 334 (398)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence 999999999875443222222111100000 000000000000000 0011246889999999999999
Q ss_pred CCCCHHHHHHHh
Q 021891 220 ARPLMSEVVEAL 231 (306)
Q Consensus 220 ~Rps~~ell~~l 231 (306)
+|||+.|+++|.
T Consensus 335 ~R~ta~e~L~Hp 346 (398)
T 4b99_A 335 ARISAAAALRHP 346 (398)
T ss_dssp TSCCHHHHTTSG
T ss_pred HCcCHHHHhcCH
Confidence 999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=342.31 Aligned_cols=223 Identities=23% Similarity=0.269 Sum_probs=165.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|+.+ +|||||++++++.+.+++|+|||||++|+|.+++. .+++..+..++.||+.||.|||+++ |
T Consensus 66 ~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---I 138 (361)
T 4f9c_A 66 IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---I 138 (361)
T ss_dssp HHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 56899999998 69999999999999999999999999999999983 5899999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcc--------------------------eeeecccccccccCCcch
Q 021891 81 IYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKT--------------------------HVSTRVMGTYGYAAPEYV 133 (306)
Q Consensus 81 iH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~ 133 (306)
+||||||+|||++.+ +.+||+|||+|+........ ......+||+.|+|||++
T Consensus 139 iHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 218 (361)
T 4f9c_A 139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL 218 (361)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred EeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 999999999999876 89999999999865432110 112335799999999999
Q ss_pred hcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCC-cchHHhhhhh---------hcc------------cccccc--
Q 021891 134 MTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPH---------LGE------------RRRFYR-- 188 (306)
Q Consensus 134 ~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~---------~~~------------~~~~~~-- 188 (306)
.+. .|+.++||||+||++|||++|+.||........ ...+...... ... .....+
T Consensus 219 ~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 298 (361)
T 4f9c_A 219 TKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERL 298 (361)
T ss_dssp TTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHH
T ss_pred cCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhh
Confidence 875 589999999999999999999999975433211 0000000000 000 000000
Q ss_pred ----ccCCccC---------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 189 ----LIDPRLE---------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 189 ----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...+... .......+.++.+||.+||+.||++|+|++|+++|.
T Consensus 299 ~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 299 RGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp C----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0000000 000112356789999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=363.58 Aligned_cols=211 Identities=22% Similarity=0.290 Sum_probs=176.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++|+|||||+++++|.+++.+|||||||+||+|.+++.+....+++..+..++.||+.||.|||+++ |+
T Consensus 201 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---ii 277 (573)
T 3uto_A 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 277 (573)
T ss_dssp HHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 578999999999999999999999999999999999999999999777668999999999999999999999999 99
Q ss_pred eccCCCCCeEEcCC--CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLDAD--YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||+|||++.+ +.+||+|||+++...... .....+||+.|||||++.+..|+.++|||||||++|||++|..
T Consensus 278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~ 354 (573)
T 3uto_A 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354 (573)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred eccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999854 899999999999875433 2344689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||.+.........+. .... .+.... ....+.++.+||.+||+.||.+|||+.|+++|-.
T Consensus 355 Pf~~~~~~~~~~~i~------~~~~----~~~~~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 355 PFGGENDDETLRNVK------SCDW----NMDDSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp SSCCSSHHHHHHHHH------TTCC----CCCSGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCCCcCHHHHHHHHH------hCCC----CCCccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 997654321111110 0000 011111 1123578899999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=357.85 Aligned_cols=205 Identities=25% Similarity=0.313 Sum_probs=169.7
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
+++++++.++|||||+++++|.+.+.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||.|||+++ ||||
T Consensus 241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~g---IiHR 316 (689)
T 3v5w_A 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF---VVYR 316 (689)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTT---EECC
T ss_pred HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 45677888999999999999999999999999999999999997654 7999999999999999999999999 9999
Q ss_pred cCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 84 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 84 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
||||+||||+.+|.+||+|||+|+...... ....+||+.|||||++. +..|+.++|||||||++|||++|.+||.
T Consensus 317 DLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 317 DLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998764432 33468999999999996 4689999999999999999999999997
Q ss_pred CCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
.............. ... ... ++...+.++.+||.+||+.||.+|++ ++||++|.
T Consensus 393 ~~~~~~~~~i~~~i---~~~--------~~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 393 QHKTKDKHEIDRMT---LTM--------AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp GGGCCCHHHHHHHH---HHC--------CCC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred CCChHHHHHHHHhh---cCC--------CCC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 65433221111111 111 111 12223578999999999999999998 68888764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=320.05 Aligned_cols=229 Identities=40% Similarity=0.731 Sum_probs=195.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|++|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+
T Consensus 82 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-- 159 (321)
T 2qkw_B 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-- 159 (321)
T ss_dssp HHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--
Confidence 6899999999999999999999999999999999999999999986543 35899999999999999999999988
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|+|++|+
T Consensus 160 -ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 238 (321)
T 2qkw_B 160 -IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238 (321)
T ss_dssp -EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCC
T ss_pred -eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCC
Confidence 9999999999999999999999999998754433333334456899999999999889999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||.............|..... ....+...+++..........+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 239 SAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TTCSCSSSSSCCCHHHHTHHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccccCcHHHHHHHHHhhhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 9998877666655555543322 22334455666666677888999999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=321.90 Aligned_cols=213 Identities=24% Similarity=0.387 Sum_probs=176.3
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
|.+|+++|+.+ +||||+++++++.+.+..|+||||+++|+|.+++.... ..+++..++.++.||
T Consensus 133 ~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 212 (370)
T 2psq_A 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212 (370)
T ss_dssp HHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHH
Confidence 67999999999 89999999999999999999999999999999997643 348899999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||
T Consensus 213 ~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw 289 (370)
T 2psq_A 213 ARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289 (370)
T ss_dssp HHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHH
Confidence 99999999998 999999999999999999999999999876544333333445678899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |..||........ ..... .. ..+ ..+..++..+.+||.+||+.||.+|||+
T Consensus 290 slG~il~ellt~g~~p~~~~~~~~~---~~~~~----~~------~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 352 (370)
T 2psq_A 290 SFGVLMWEIFTLGGSPYPGIPVEEL---FKLLK----EG------HRM----DKPANCTNELYMMMRDCWHAVPSQRPTF 352 (370)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH----TT------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHH---HHHHh----cC------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999999 9999976432211 11110 00 001 1122335689999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.|++++|+.+
T Consensus 353 ~ell~~L~~i 362 (370)
T 2psq_A 353 KQLVEDLDRI 362 (370)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=312.51 Aligned_cols=230 Identities=41% Similarity=0.727 Sum_probs=191.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcC---
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEE--- 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~--- 75 (306)
|++|++++++++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 74 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 153 (326)
T 3uim_A 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153 (326)
T ss_dssp HHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred HHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6899999999999999999999999999999999999999999997643 3499999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ |+||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 229 (326)
T 3uim_A 154 K---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 229 (326)
T ss_dssp C---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH
T ss_pred C---eEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHH
Confidence 7 99999999999999999999999999987654332 2234456999999999999889999999999999999999
Q ss_pred hCCCCCCCCC--CCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 156 TGRRSMDKNR--PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 156 tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
+|..||.... .........|..... .........+......+....+..+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 230 TGQRAFDLARLANDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HCCCSBCHHHHTTTSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hCCCcccccccccccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 9999996321 112222333333222 2233345556666667788889999999999999999999999999999986
Q ss_pred CCC
Q 021891 234 LPN 236 (306)
Q Consensus 234 ~~~ 236 (306)
...
T Consensus 309 ~~~ 311 (326)
T 3uim_A 309 DGL 311 (326)
T ss_dssp SSC
T ss_pred cch
Confidence 443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=315.08 Aligned_cols=213 Identities=26% Similarity=0.379 Sum_probs=174.0
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.+++|+.+++.++||||+++++++.+++..++|||||++++|.+++... ..+++..++.++.||+.||.|||+.+ |
T Consensus 51 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g---i 126 (323)
T 3tki_A 51 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---I 126 (323)
T ss_dssp CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 3689999999999999999999999999999999999999999988544 46999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~ 159 (306)
+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus 127 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (323)
T 3tki_A 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (323)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987544333333445679999999999987765 779999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||........ ....+... . ....+ ....+..+.+||.+||+.||++|||+.|++++..
T Consensus 207 pf~~~~~~~~-~~~~~~~~-----~---~~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 207 PWDQPSDSCQ-EYSDWKEK-----K---TYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp SCSSSCTTSH-HHHHHHTT-----C---TTSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCCCCchHHH-HHHHHhcc-----c---ccCCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 9976543221 11111100 0 00000 1123467889999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=310.38 Aligned_cols=216 Identities=25% Similarity=0.391 Sum_probs=175.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+++..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+
T Consensus 54 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iv 130 (310)
T 3s95_A 54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130 (310)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 689999999999999999999999999999999999999999999887778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee------------eecccccccccCCcchhcCCCCchhHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV------------STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 149 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 149 (306)
||||||+||+++.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||
T Consensus 131 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 210 (310)
T 3s95_A 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGI 210 (310)
T ss_dssp CSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred CCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHH
Confidence 999999999999999999999999987544322110 11457899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
++|+|++|..||................ . ..... +...+..+.+|+.+||+.||++|||+.++++
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~~~~~~~~-~------~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMDFGLNVRG-F------LDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTTSSBCHHH-H------HHHTC--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCcchhhhHHHHhhhhhc-c------ccccC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999987654432211110000 0 00001 1122357889999999999999999999999
Q ss_pred HhCCCC
Q 021891 230 ALKPLP 235 (306)
Q Consensus 230 ~l~~~~ 235 (306)
.|+.+.
T Consensus 276 ~L~~l~ 281 (310)
T 3s95_A 276 WLETLR 281 (310)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=309.34 Aligned_cols=208 Identities=24% Similarity=0.327 Sum_probs=172.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.++++++||||+++++++...+..++||||+++++|.+++.+. .+++..++.++.|++.||.|||+.+ |+
T Consensus 64 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 138 (297)
T 3fxz_A 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VI 138 (297)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ce
Confidence 678999999999999999999999999999999999999999999664 5899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 139 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 216 (297)
T 3fxz_A 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (297)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654322 233467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
........... ...... ... ..+...+..+.+||.+||+.||++|||+.|++++.
T Consensus 217 ~~~~~~~~~~~------~~~~~~--~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 217 LNENPLRALYL------IATNGT--PEL-------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp TTSCHHHHHHH------HHHHCS--CCC-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCCCHHHHHHH------HHhCCC--CCC-------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 75432111000 000000 000 11123356789999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.24 Aligned_cols=206 Identities=24% Similarity=0.343 Sum_probs=172.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|+.++||||+++++++.+.+..++||||+++++|.+++.+.+ .+++..++.++.|++.||.|||+.+ |+
T Consensus 61 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---iv 136 (328)
T 3fe3_A 61 LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR---IV 136 (328)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 5789999999999999999999999999999999999999999996654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCC-chhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ....+||+.|+|||++.+..+. .++|||||||++|+|++|..|
T Consensus 137 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 213 (328)
T 3fe3_A 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213 (328)
T ss_dssp CSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999987544322 3446799999999999988775 799999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|........ ........ .. .+...+.++.+|+.+||+.||.+|||++|+++|..
T Consensus 214 f~~~~~~~~------~~~i~~~~--------~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 214 FDGQNLKEL------RERVLRGK--------YR----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp SCCSSHHHH------HHHHHHCC--------CC----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred CCCCCHHHH------HHHHHhCC--------CC----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 976432111 11000000 01 11123568899999999999999999999998743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=317.03 Aligned_cols=210 Identities=22% Similarity=0.316 Sum_probs=172.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+
T Consensus 62 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iv 137 (361)
T 2yab_A 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IA 137 (361)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 679999999999999999999999999999999999999999999654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC----cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
||||||+||+++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 138 HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g 214 (361)
T 2yab_A 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214 (361)
T ss_dssp CCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhC
Confidence 999999999998877 799999999987654322 2345799999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
..||.+.........+ ...... +++.... ..+..+.+||.+||..||.+|||+.|+++|..
T Consensus 215 ~~Pf~~~~~~~~~~~i------~~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 215 ASPFLGDTKQETLANI------TAVSYD----FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp CCSSCCSSHHHHHHHH------HTTCCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCCCCCCCHHHHHHHH------HhcCCC----CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 9999764322111100 000000 0111111 22467899999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=312.82 Aligned_cols=229 Identities=27% Similarity=0.343 Sum_probs=175.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC--
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-- 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-- 75 (306)
+++|+.+|++++||||+++++++.... .+++|||||++|+|.+++... .+++..++.++.|++.||.|||+.
T Consensus 65 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~ 142 (322)
T 3soc_A 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIP 142 (322)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEE
T ss_pred HHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhcc
Confidence 457889999999999999999998754 469999999999999999664 489999999999999999999998
Q ss_pred --------CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-----CCCchh
Q 021891 76 --------AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRS 142 (306)
Q Consensus 76 --------~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~ 142 (306)
+ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+. .++.++
T Consensus 143 ~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 219 (322)
T 3soc_A 143 GLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219 (322)
T ss_dssp EETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHH
T ss_pred ccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccc
Confidence 7 999999999999999999999999999876544333333446789999999999863 456789
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhh--ccc--cccccccCCccCCC-CCHHHHHHHHHHHHHcccCC
Q 021891 143 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GER--RRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 143 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~ 217 (306)
|||||||++|||++|..||................... ... ........+..... .....+..+.+||.+||+.|
T Consensus 220 DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (322)
T 3soc_A 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299 (322)
T ss_dssp HHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSS
T ss_pred hhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCC
Confidence 99999999999999999998765443322221110000 000 00000111111111 12245677999999999999
Q ss_pred CCCCCCHHHHHHHhCCCC
Q 021891 218 PKARPLMSEVVEALKPLP 235 (306)
Q Consensus 218 p~~Rps~~ell~~l~~~~ 235 (306)
|++|||+.|+++.|+.+.
T Consensus 300 P~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 300 AEARLSAGCVGERITQMQ 317 (322)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=314.11 Aligned_cols=211 Identities=18% Similarity=0.245 Sum_probs=174.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|+.++||||+++++++.+.+..++|||||++++|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 48 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---iv 124 (321)
T 1tki_A 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124 (321)
T ss_dssp HHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CC
Confidence 678999999999999999999999999999999999999999999776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcC--CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 125 H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 201 (321)
T 1tki_A 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999987 7899999999998765433 2334578999999999998889999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||....... ...... ..... .+..... ..+.++.+||.+||+.||.+|||+.|+++|..
T Consensus 202 pf~~~~~~~---~~~~i~---~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 202 PFLAETNQQ---IIENIM---NAEYT----FDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp TTCCSSHHH---HHHHHH---HTCCC----CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCcCCCHHH---HHHHHH---cCCCC----CChhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 997643211 111100 00000 0000001 12468899999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=313.45 Aligned_cols=213 Identities=26% Similarity=0.407 Sum_probs=174.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 97 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---iv 173 (325)
T 3kul_A 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173 (325)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999999777678999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCc-ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+||+++.++.+||+|||+++....... ........+|..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987654322 222233456788999999998999999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||........ ..... .. .... .+...+..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus 254 p~~~~~~~~~---~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 254 PYWNMTNRDV---ISSVE----EG------YRLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp TTTTSCHHHH---HHHHH----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccCCHHHH---HHHHH----cC------CCCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9965432211 11000 00 0111 1223357899999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=313.64 Aligned_cols=212 Identities=20% Similarity=0.329 Sum_probs=173.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.. .++|+||+.+|+|.+++.+....+++..++.++.||+.||.|||+.+ |+
T Consensus 64 ~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---iv 139 (327)
T 3poz_A 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LV 139 (327)
T ss_dssp HHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---ee
Confidence 688999999999999999999998754 78899999999999999887778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 140 H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 999999999999999999999999987654444333444567889999999999999999999999999999999 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|...........+ . ... .. ..+...+..+.+|+.+||+.||.+|||+.+++++|+.+
T Consensus 220 ~~~~~~~~~~~~~---~----~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 220 YDGIPASEISSIL---E----KGE------RL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TTTCCGGGHHHHH---H----TTC------CC----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHH---H----cCC------CC----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 9765432211111 0 000 00 11122346889999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=322.71 Aligned_cols=214 Identities=24% Similarity=0.400 Sum_probs=174.3
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|+++|++++||||+++++++...+..++||||+++|+|.+++...+..+++..+..++.||+.||.|||+.+ +
T Consensus 158 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i 234 (377)
T 3cbl_A 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234 (377)
T ss_dssp TTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 3678999999999999999999999999999999999999999999776667999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 235 vHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~ 314 (377)
T 3cbl_A 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314 (377)
T ss_dssp ECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986543221111122235778999999998899999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||....... ..... .... . .. .+..++..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus 315 p~~~~~~~~---~~~~~----~~~~---~---~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 315 PYPNLSNQQ---TREFV----EKGG---R---LP----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp SSTTSCHHH---HHHHH----HTTC---C---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHH---HHHHH----HcCC---C---CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 997643211 11111 0100 0 01 1122356889999999999999999999999988643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.09 Aligned_cols=211 Identities=21% Similarity=0.264 Sum_probs=173.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++.+.+..++|||||.+|+|.+.+..+. .+++..+..++.||+.||.|||+.+ |+
T Consensus 57 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~g---iv 132 (444)
T 3soa_A 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMG---VV 132 (444)
T ss_dssp HHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 6799999999999999999999999999999999999999999997654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEc---CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+|||++ .++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus 133 HrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~ 210 (444)
T 3soa_A 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY 210 (444)
T ss_dssp CCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence 999999999998 568899999999987654322 223467999999999999989999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||........ ..... .... ....+ .. ...+..+.+||.+||+.||++|||+.|+++|..
T Consensus 211 ~Pf~~~~~~~~---~~~i~---~~~~---~~~~~-~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 211 PPFWDEDQHRL---YQQIK---AGAY---DFPSP-EW----DTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp CSCCCSSHHHH---HHHHH---HTCC---CCCTT-TT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred CCCCCccHHHH---HHHHH---hCCC---CCCcc-cc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 99976432111 11100 0000 00111 11 123468899999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=305.79 Aligned_cols=217 Identities=26% Similarity=0.389 Sum_probs=171.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++.+.+ .+++..++.++.|++.||.|||+.+ |+
T Consensus 58 ~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 133 (294)
T 4eqm_A 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR---IV 133 (294)
T ss_dssp HHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 6789999999999999999999999999999999999999999996554 7999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 134 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf 212 (294)
T 4eqm_A 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212 (294)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987643322 2233457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPN 236 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~ell~~l~~~~~ 236 (306)
....... ......... .+..........+..+.++|.+||+.||.+|| +++++.+.|+.+..
T Consensus 213 ~~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 213 NGETAVS------IAIKHIQDS-------VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CSSCHHH------HHHHHHSSC-------CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCCChHH------HHHHHhhcc-------CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 7643211 000000000 00000011122357899999999999999999 89999998876654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=311.99 Aligned_cols=213 Identities=25% Similarity=0.418 Sum_probs=173.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.++++++||||+++++++. ++..++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 62 ~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 137 (325)
T 3kex_A 62 VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MV 137 (325)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CC
Confidence 568999999999999999999886 56689999999999999999877667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+|||++.++.+||+|||+++...............|+..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 138 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp CSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 999999999999999999999999998765544444455678889999999999999999999999999999999 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|...........+. ... .... +...+..+.+||.+||+.||.+|||+.+++++|+.+.
T Consensus 218 ~~~~~~~~~~~~~~-------~~~---~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 218 YAGLRLAEVPDLLE-------KGE---RLAQ-------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTTSCTTHHHHHHH-------TTC---BCCC-------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ccccCHHHHHHHHH-------cCC---CCCC-------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 98654332211111 000 0000 1112346779999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=315.44 Aligned_cols=211 Identities=20% Similarity=0.286 Sum_probs=174.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++++||||+++++++.+.+..++|||||.+++|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 95 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iv 171 (387)
T 1kob_A 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 171 (387)
T ss_dssp HHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999999999999999999999999777667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcC--CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 172 HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 248 (387)
T 1kob_A 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 248 (387)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred ecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCC
Confidence 9999999999974 57799999999987654322 233478999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||....... ...... ... ...+... ....+..+.+||.+||+.||.+|||+.|++++..
T Consensus 249 Pf~~~~~~~---~~~~i~---~~~----~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 249 PFAGEDDLE---TLQNVK---RCD----WEFDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp SSCCSSHHH---HHHHHH---HCC----CCCCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CCCCCCHHH---HHHHHH---hCC----CCCCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 997643211 111000 000 0011111 1123568899999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.41 Aligned_cols=224 Identities=23% Similarity=0.284 Sum_probs=172.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+++..++||||++ ++|.+.+......+++..++.++.||+.||.|||+.+ |+
T Consensus 66 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---iv 141 (311)
T 3niz_A 66 AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---IL 141 (311)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 5789999999999999999999999999999999997 4898988777777999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 142 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 219 (311)
T 3niz_A 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219 (311)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987543222 2233568999999999876 5689999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhh-----hccccc-------cccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPH-----LGERRR-------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~-----~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|...........+...... +..... .................+.++.+||.+||+.||++|||+.|++
T Consensus 220 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp CCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9876554332221111000 000000 0000000000001112346789999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
+|.
T Consensus 300 ~hp 302 (311)
T 3niz_A 300 NHP 302 (311)
T ss_dssp TSG
T ss_pred cCc
Confidence 863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=308.18 Aligned_cols=213 Identities=27% Similarity=0.416 Sum_probs=176.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-----------------------CCCCHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIR 58 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~l~~~~~ 58 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..+
T Consensus 73 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (314)
T 2ivs_A 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152 (314)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHH
T ss_pred HHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHH
Confidence 6789999999999999999999999999999999999999999997643 23899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC
Q 021891 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 138 (306)
Q Consensus 59 ~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 138 (306)
+.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..+
T Consensus 153 ~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 153 ISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence 999999999999999998 99999999999999999999999999987655444333344567889999999999899
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 139 TSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 139 ~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
+.++|||||||++|+|++ |..||........... .. .. .... .+...+..+.+|+.+||+.|
T Consensus 230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---~~----~~------~~~~----~~~~~~~~~~~li~~~l~~d 292 (314)
T 2ivs_A 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL---LK----TG------HRME----RPDNCSEEMYRLMLQCWKQE 292 (314)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HH----TT------CCCC----CCTTCCHHHHHHHHHHTCSS
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---hh----cC------CcCC----CCccCCHHHHHHHHHHccCC
Confidence 999999999999999999 9999976543221111 10 00 0011 11233578999999999999
Q ss_pred CCCCCCHHHHHHHhCCC
Q 021891 218 PKARPLMSEVVEALKPL 234 (306)
Q Consensus 218 p~~Rps~~ell~~l~~~ 234 (306)
|++|||+.+++++|+.+
T Consensus 293 p~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 293 PDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHH
Confidence 99999999999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=307.90 Aligned_cols=206 Identities=31% Similarity=0.367 Sum_probs=171.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|+.++||||+++++++.+.+..|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+
T Consensus 52 ~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---iv 127 (337)
T 1o6l_A 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VV 127 (337)
T ss_dssp HHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 568999999999999999999999999999999999999999998654 36999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 128 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 205 (337)
T 1o6l_A 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205 (337)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCC
Confidence 999999999999999999999999986432221 234467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
....... ... ...... .. ++...+.++.+||.+||+.||++|| ++.|+++|.
T Consensus 206 ~~~~~~~---~~~---~i~~~~--------~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 206 YNQDHER---LFE---LILMEE--------IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp CCSSHHH---HHH---HHHHCC--------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCCCHHH---HHH---HHHcCC--------CC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 7543211 111 000010 01 1122357889999999999999999 899999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=310.22 Aligned_cols=210 Identities=22% Similarity=0.301 Sum_probs=171.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 61 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iv 136 (326)
T 2y0a_A 61 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IA 136 (326)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 679999999999999999999999999999999999999999999654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC----cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
||||||+||+++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 213 (326)
T 2y0a_A 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213 (326)
T ss_dssp CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999998887 799999999987643322 2345789999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
..||........ ..... ..... ..... ....+..+.+||.+||+.||++|||+.|+++|..
T Consensus 214 ~~pf~~~~~~~~---~~~~~---~~~~~----~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 214 ASPFLGDTKQET---LANVS---AVNYE----FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp CCSSCCSSHHHH---HHHHH---HTCCC----CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred cCCCCCCCHHHH---HHHHH---hcCCC----cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 999976432111 10000 00000 00000 0112467899999999999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=301.16 Aligned_cols=226 Identities=37% Similarity=0.616 Sum_probs=183.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+
T Consensus 77 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--- 153 (307)
T 2nru_A 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--- 153 (307)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---
Confidence 678999999999999999999999999999999999999999998643 346999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
++||||||+||+++.++.+||+|||+++...............||..|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999999987654433333445678999999998865 58999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||...........+ ..........+...++... .......+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 233 p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 233 AVDEHREPQLLLDI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SBCTTBSSSBTTHH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCcchHHHHHH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 99875543322211 1111111122223333332 334667788999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=307.84 Aligned_cols=215 Identities=28% Similarity=0.450 Sum_probs=167.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++|++++||||+++++++.+.+..++||||+++++|.+++.+... .+++..++.++.||+.||.|||+.+ .+
T Consensus 81 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ 159 (309)
T 3p86_A 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PP 159 (309)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CC
Confidence 67899999999999999999999999999999999999999999976542 3899999999999999999999976 45
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 160 ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 237 (309)
T 3p86_A 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237 (309)
T ss_dssp CCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCC
T ss_pred EECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999997643321 12334578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
||........ ...... . ..... .+...+..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 238 Pf~~~~~~~~---~~~~~~---~------~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 238 PWGNLNPAQV---VAAVGF---K------CKRLE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp TTTTSCHHHH---HHHHHH---S------CCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHH---HHHHHh---c------CCCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9976432211 110000 0 00011 12233468899999999999999999999999886543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=301.99 Aligned_cols=214 Identities=25% Similarity=0.393 Sum_probs=177.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 126 (268)
T 3sxs_A 50 FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FI 126 (268)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 679999999999999999999999999999999999999999999776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||++........ .......+|..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 127 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 205 (268)
T 3sxs_A 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205 (268)
T ss_dssp ESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654332 22333456778999999998899999999999999999999 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
|........... ..... .... +...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 206 ~~~~~~~~~~~~-------~~~~~---~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 206 YDLYTNSEVVLK-------VSQGH---RLYR-------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTTSCHHHHHHH-------HHTTC---CCCC-------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ccccChHHHHHH-------HHcCC---CCCC-------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 965432211000 00000 0111 11124678999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=316.43 Aligned_cols=215 Identities=26% Similarity=0.391 Sum_probs=177.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
+.+|+++++++ +||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||
T Consensus 121 ~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 200 (382)
T 3tt0_A 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200 (382)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHH
Confidence 67899999999 99999999999999999999999999999999997653 359999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|||
T Consensus 201 ~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 277 (382)
T 3tt0_A 201 ARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 277 (382)
T ss_dssp HHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHH
T ss_pred HHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHH
Confidence 99999999998 999999999999999999999999999876544333334445678899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|+|++ |..||....... ...... .. ..... +...+.++.+||.+||+.||++|||+
T Consensus 278 slG~il~ellt~g~~p~~~~~~~~---~~~~~~----~~------~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~ 340 (382)
T 3tt0_A 278 SFGVLLWEIFTLGGSPYPGVPVEE---LFKLLK----EG------HRMDK----PSNCTNELYMMMRDCWHAVPSQRPTF 340 (382)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH----TT------CCCCC----CSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC------CCCCC----CccCCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999999 999997543211 111110 00 01111 11234689999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 021891 225 SEVVEALKPLPN 236 (306)
Q Consensus 225 ~ell~~l~~~~~ 236 (306)
.||+++|+.+..
T Consensus 341 ~ell~~L~~~~~ 352 (382)
T 3tt0_A 341 KQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999976543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=302.40 Aligned_cols=212 Identities=27% Similarity=0.428 Sum_probs=175.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 52 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~ 128 (269)
T 4hcu_A 52 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128 (269)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 689999999999999999999999999999999999999999999877778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 129 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p 207 (269)
T 4hcu_A 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 207 (269)
T ss_dssp CSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999998654321 112233456778999999999999999999999999999999 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|........ .... ... .... .+...+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 208 ~~~~~~~~~---~~~~----~~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 208 YENRSNSEV---VEDI----STG------FRLY----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TTTCCHHHH---HHHH----HTT------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHH---HHHH----hcC------ccCC----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 976432111 1100 000 0011 1112246889999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=301.16 Aligned_cols=226 Identities=23% Similarity=0.246 Sum_probs=177.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC--eeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
+.+|+++|++++||||+++++++...+ ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+
T Consensus 54 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~- 132 (319)
T 4euu_A 54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132 (319)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 568999999999999999999998765 7899999999999999997643 23999999999999999999999998
Q ss_pred CCeEeccCCCCCeEE----cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh--------cCCCCchhHHH
Q 021891 78 RPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TGHLTSRSDVY 145 (306)
Q Consensus 78 ~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Diw 145 (306)
|+||||||+||++ +.++.+||+|||+++....... .....||..|+|||++. +..++.++|||
T Consensus 133 --ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diw 207 (319)
T 4euu_A 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207 (319)
T ss_dssp --EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHH
T ss_pred --EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHH
Confidence 9999999999999 7888899999999987654332 23356899999999986 46889999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccc---ccc--------ccCCccCCCCCHHHHHHHHHHHHHcc
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR---FYR--------LIDPRLEGHFSIKGAQKAAQLAAHCL 214 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l 214 (306)
||||++|||++|..||........................ ... .-.......+....+..+.+||.+||
T Consensus 208 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L 287 (319)
T 4euu_A 208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287 (319)
T ss_dssp HHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhc
Confidence 9999999999999999754432221111111100000000 000 00111223456788899999999999
Q ss_pred cCCCCCCCCHHHHHHHhCC
Q 021891 215 SRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 215 ~~~p~~Rps~~ell~~l~~ 233 (306)
+.||++|||++|++++...
T Consensus 288 ~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 288 EADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp CCCTTTSCCHHHHHHHHHH
T ss_pred cCChhhhccHHHhhhccHH
Confidence 9999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.44 Aligned_cols=209 Identities=22% Similarity=0.302 Sum_probs=170.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++|+||||+++++++.+.+..++|||||.+|+|.+.+..+ ..+++..++.++.||+.||.|||+.+ |+
T Consensus 75 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iv 150 (362)
T 2bdw_A 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IV 150 (362)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 678999999999999999999999999999999999999999998655 46999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCC---CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++.+ +.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 151 H~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227 (362)
T ss_dssp CCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999765 4599999999987654322 23467999999999999989999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||....... ...... .... .. .... ....+..+.+||.+||+.||++|||+.++++|.
T Consensus 228 ~Pf~~~~~~~---~~~~i~---~~~~---~~-~~~~----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 228 PPFWDEDQHR---LYAQIK---AGAY---DY-PSPE----WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp CSSCCSSHHH---HHHHHH---HTCC---CC-CTTG----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred CCCCCCCHHH---HHHHHH---hCCC---CC-Cccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 9997643211 111100 0000 00 0000 112346889999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=311.25 Aligned_cols=216 Identities=24% Similarity=0.367 Sum_probs=177.3
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCC----------------------CCCHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIR 58 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------------~l~~~~~ 58 (306)
|.+|+++|+++ +||||+++++++...+..++||||+++|+|.+++..... .+++..+
T Consensus 95 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 174 (344)
T 1rjb_A 95 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174 (344)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHH
Confidence 67999999999 999999999999999999999999999999999976542 3789999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC
Q 021891 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 138 (306)
Q Consensus 59 ~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 138 (306)
+.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++................||+.|+|||++.+..+
T Consensus 175 ~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 175 LCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp HHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 999999999999999998 99999999999999999999999999987654443334445667889999999999999
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 139 TSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 139 ~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
+.++|||||||++|+|++ |..||........ ...... .. .... .+...+..+.+||.+||+.|
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~d 315 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--FYKLIQ----NG------FKMD----QPFYATEEIYIIMQSCWAFD 315 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHH----TT------CCCC----CCTTCCHHHHHHHHHHTCSS
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH--HHHHHh----cC------CCCC----CCCCCCHHHHHHHHHHcCCC
Confidence 999999999999999998 9999976543211 111111 00 0111 11223578999999999999
Q ss_pred CCCCCCHHHHHHHhCCCCC
Q 021891 218 PKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 218 p~~Rps~~ell~~l~~~~~ 236 (306)
|.+|||+.+++++|+.+..
T Consensus 316 p~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 316 SRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp GGGSCCHHHHHHHHHHHC-
T ss_pred chhCcCHHHHHHHHHHHHH
Confidence 9999999999999975443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=315.19 Aligned_cols=213 Identities=25% Similarity=0.431 Sum_probs=164.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++||||+++++++.+.+..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+
T Consensus 93 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 169 (373)
T 2qol_A 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169 (373)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 789999999999999999999999999999999999999999999877778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 170 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp CSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred CCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876443221 11222345778999999999999999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||....... ...... ... .. ..+...+..+.+||.+||+.||.+||++.++++.|+.+
T Consensus 250 P~~~~~~~~---~~~~i~----~~~---~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 250 PYWEMSNQD---VIKAVD----EGY---RL-------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp TTTTCCHHH---HHHHHH----TTE---EC-------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHH---HHHHHH----cCC---CC-------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 997543211 111110 100 00 01112357899999999999999999999999988654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=311.31 Aligned_cols=207 Identities=24% Similarity=0.324 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|+.++|||||++++++.+.+..|+||||+.||+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+
T Consensus 62 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iv 137 (384)
T 4fr4_A 62 VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR---II 137 (384)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 568999999999999999999999999999999999999999999654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc---CCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+|||++.+|.+||+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.
T Consensus 138 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~ 214 (384)
T 4fr4_A 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214 (384)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred eccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCC
Confidence 99999999999999999999999998764432 2345679999999999863 46899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~ell~~ 230 (306)
.||................. . ... ++...+..+.+||.+||+.||.+||+ ++++++|
T Consensus 215 ~Pf~~~~~~~~~~~~~~~~~---~--------~~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 215 RPYHIRSSTSSKEIVHTFET---T--------VVT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp CSSCCCTTSCHHHHHHHHHH---C--------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CCCCCCCCccHHHHHHHHhh---c--------ccC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 99976544332222111110 0 001 12223578999999999999999998 7777764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=313.11 Aligned_cols=215 Identities=26% Similarity=0.415 Sum_probs=175.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-----------------------CCCCHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIR 58 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~l~~~~~ 58 (306)
|++|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..+
T Consensus 97 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 176 (343)
T 1luf_A 97 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176 (343)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHH
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHH
Confidence 6899999999999999999999999999999999999999999997642 56899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC
Q 021891 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 138 (306)
Q Consensus 59 ~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 138 (306)
+.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............||..|+|||++.+..+
T Consensus 177 ~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 253 (343)
T 1luf_A 177 LCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253 (343)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc
Confidence 999999999999999998 99999999999999999999999999976543322223334567899999999999999
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 139 TSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 139 ~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
+.++|||||||++|+|++ |..||....... ...... .. . ... .+...+..+.+||.+||+.|
T Consensus 254 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~~-~-----~~~----~~~~~~~~l~~li~~~l~~~ 316 (343)
T 1luf_A 254 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---VIYYVR----DG-N-----ILA----CPENCPLELYNLMRLCWSKL 316 (343)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH----TT-C-----CCC----CCTTCCHHHHHHHHHHTCSS
T ss_pred CcccccHHHHHHHHHHHhcCCCcCCCCChHH---HHHHHh----CC-C-----cCC----CCCCCCHHHHHHHHHHcccC
Confidence 999999999999999999 999997543211 111000 00 0 001 11223568999999999999
Q ss_pred CCCCCCHHHHHHHhCCCCC
Q 021891 218 PKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 218 p~~Rps~~ell~~l~~~~~ 236 (306)
|.+|||+.+++++|+.+..
T Consensus 317 p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 317 PADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp GGGSCCHHHHHHHHHHTTC
T ss_pred cccCCCHHHHHHHHHHHHh
Confidence 9999999999999986654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=308.38 Aligned_cols=205 Identities=24% Similarity=0.320 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++.+.+..++||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||+.+ |+
T Consensus 56 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g---iv 130 (336)
T 3h4j_B 56 VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHK---IV 130 (336)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT---CC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 678999999999999999999999999999999999 679999886554 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 131 H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~P 207 (336)
T 3h4j_B 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207 (336)
T ss_dssp CCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987654322 234579999999999988776 7899999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|...........+. . ... ..+...+..+.+||.+||+.||.+|||+.|++++..
T Consensus 208 f~~~~~~~~~~~i~-------------~-~~~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 208 FDDEFIPNLFKKVN-------------S-CVY----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp SBCSSSTTCBCCCC-------------S-SCC----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred CCCccHHHHHHHHH-------------c-CCC----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 97654332211110 0 000 112223568899999999999999999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=318.49 Aligned_cols=213 Identities=24% Similarity=0.377 Sum_probs=172.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
|.+|+.++++++||||+++++++.+.+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.
T Consensus 121 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 200 (367)
T 3l9p_A 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200 (367)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 6789999999999999999999999999999999999999999996532 4589999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCC---cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+ |+||||||+|||++.++ .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|
T Consensus 201 ~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 277 (367)
T 3l9p_A 201 H---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277 (367)
T ss_dssp T---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred C---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHH
Confidence 8 99999999999998555 59999999997532222222233456789999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||++ |..||....... ...... ... ... .+...+..+.+||.+||+.||.+|||+.+|+++|
T Consensus 278 ellt~g~~pf~~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 278 EIFSLGYMPYPSKSNQE---VLEFVT----SGG------RMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp HHHTTSCCSSTTCCHHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHH---HHHHHH----cCC------CCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9998 999997643211 111110 000 011 1122346789999999999999999999999998
Q ss_pred CCC
Q 021891 232 KPL 234 (306)
Q Consensus 232 ~~~ 234 (306)
+.+
T Consensus 341 ~~~ 343 (367)
T 3l9p_A 341 EYC 343 (367)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=314.28 Aligned_cols=214 Identities=29% Similarity=0.403 Sum_probs=174.3
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCe-eEEEEEcCCCCCHHHHhhcCCC----------------------------
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSL---------------------------- 51 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~---------------------------- 51 (306)
|.+|+++++++ +||||+++++++.+.+. .++|||||++|+|.+++.....
T Consensus 72 ~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (359)
T 3vhe_A 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKR 151 (359)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------
T ss_pred HHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhc
Confidence 68999999999 88999999999987654 8999999999999999976432
Q ss_pred -------------------------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcC
Q 021891 52 -------------------------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 94 (306)
Q Consensus 52 -------------------------------------~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~ 94 (306)
.+++..++.++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~ 228 (359)
T 3vhe_A 152 RLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 228 (359)
T ss_dssp --------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred cccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcC
Confidence 1899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchH
Q 021891 95 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 173 (306)
Q Consensus 95 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~ 173 (306)
++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++ |..||........ ..
T Consensus 229 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~ 306 (359)
T 3vhe_A 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC 306 (359)
T ss_dssp GGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH
T ss_pred CCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HH
Confidence 99999999999987655444444455678999999999999999999999999999999998 9999976543221 11
Q ss_pred HhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 174 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.... .. .... .+...+..+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 307 ~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 307 RRLK----EG------TRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HHHH----HT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----cC------CCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1000 00 0011 1112346899999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=313.63 Aligned_cols=210 Identities=22% Similarity=0.290 Sum_probs=173.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+++|++|+||||+++++++.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 133 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 209 (373)
T 2x4f_A 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---IL 209 (373)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 789999999999999999999999999999999999999999999777667999999999999999999999998 99
Q ss_pred eccCCCCCeEE--cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 210 H~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 286 (373)
T 2x4f_A 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286 (373)
T ss_dssp CCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 99999999999 5678999999999987654332 233468999999999998899999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||.......... ........ +...... ..+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 287 pf~~~~~~~~~~------~i~~~~~~----~~~~~~~----~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 287 PFLGDNDAETLN------NILACRWD----LEDEEFQ----DISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp TTCCSSHHHHHH------HHHHTCCC----SCSGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCCCCHHHHHH------HHHhccCC----CChhhhc----cCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 997653221110 00000000 0111111 2346889999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.97 Aligned_cols=213 Identities=20% Similarity=0.327 Sum_probs=168.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.... .++|+||+.+|+|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 64 ~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 139 (327)
T 3lzb_A 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LV 139 (327)
T ss_dssp HHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---Cc
Confidence 678999999999999999999998754 78899999999999999887778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 140 H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 219 (327)
T 3lzb_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999987655444333444567889999999999999999999999999999999 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|...........+ . ... ... .+...+..+.+||.+||+.||.+|||+.|+++.|+.+.
T Consensus 220 ~~~~~~~~~~~~~---~----~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 220 YDGIPASEISSIL---E----KGE------RLP----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTTCCGGGHHHHH---H----TTC------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHH---H----cCC------CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9765432211111 0 000 001 11123467899999999999999999999999987544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=302.76 Aligned_cols=219 Identities=16% Similarity=0.180 Sum_probs=177.4
Q ss_pred CHHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.|.+|++++++| +||||+++++++...+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+
T Consensus 50 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--- 125 (330)
T 2izr_A 50 QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--- 125 (330)
T ss_dssp CHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 478999999999 9999999999999999999999999 89999999876668999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCc-----EEEeccCCcccCCCCCcce-----eeecccccccccCCcchhcCCCCchhHHHHHHH
Q 021891 80 VIYRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 149 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 149 (306)
|+||||||+|||++.++. +||+|||+++......... ......||+.|+|||++.+..++.++|||||||
T Consensus 126 iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 205 (330)
T 2izr_A 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGH 205 (330)
T ss_dssp EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHH
Confidence 999999999999998887 9999999998754432211 123567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
++|||++|..||.................... ...... .....+ ++.+|+..||+.||.+||++.+|++
T Consensus 206 il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-------~~~~~~---~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 206 MFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-------ATPIEV---LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-------HSCHHH---HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhcCCCCccccccccHHHHHHHHHhhhc-------cCCHHH---HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999999999987654433222211111000 000000 000123 8999999999999999999999999
Q ss_pred HhCCC
Q 021891 230 ALKPL 234 (306)
Q Consensus 230 ~l~~~ 234 (306)
.|+.+
T Consensus 275 ~l~~~ 279 (330)
T 2izr_A 275 LFTDL 279 (330)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=302.78 Aligned_cols=203 Identities=27% Similarity=0.378 Sum_probs=170.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+++.++||||+++++++.+.+..|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+.+ |+
T Consensus 53 ~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---iv 128 (318)
T 1fot_A 53 TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD---II 128 (318)
T ss_dssp HHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred HHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 4679999999999999999999999999999999999999999996654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 129 HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 203 (318)
T 1fot_A 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203 (318)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 9999999999999999999999999875432 23457999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
....... ......... .. ++...+.++.+||.+||+.||.+|| +++++++|.
T Consensus 204 ~~~~~~~------~~~~i~~~~--------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 204 YDSNTMK------TYEKILNAE--------LR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CCSSHHH------HHHHHHHCC--------CC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCHHH------HHHHHHhCC--------CC----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 7643211 111111110 01 1112346889999999999999999 889998864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=310.69 Aligned_cols=206 Identities=25% Similarity=0.358 Sum_probs=166.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|.++|+.+ +||||+++++++.+.+..|+|||||++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |
T Consensus 70 ~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---i 145 (353)
T 3txo_A 70 TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---I 145 (353)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 46899999988 7999999999999999999999999999999999655 36999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..|
T Consensus 146 vHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 223 (353)
T 3txo_A 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223 (353)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCC
Confidence 999999999999999999999999998643222 223456899999999999988999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ell~~l 231 (306)
|...........+ .... .. ++...+..+.+||.+||+.||.+||++ .++++|.
T Consensus 224 f~~~~~~~~~~~i------~~~~--------~~----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 224 FEAENEDDLFEAI------LNDE--------VV----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp SCCSSHHHHHHHH------HHCC--------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred CCCCCHHHHHHHH------HcCC--------CC----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 9765322111110 0000 00 111234678999999999999999998 7888754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=302.33 Aligned_cols=218 Identities=27% Similarity=0.488 Sum_probs=163.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++||||+++++++ ..+..++||||+.+++|.+++......+++..++.++.|++.||.|||+.+ |+
T Consensus 67 ~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~ 142 (289)
T 3og7_A 67 FKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 142 (289)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 68999999999999999999965 556789999999999999999777778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++.++.+||+|||+++...............||..|+|||++. +..++.++|||||||++|+|++|.
T Consensus 143 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (289)
T 3og7_A 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222 (289)
T ss_dssp CSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred cccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence 99999999999999999999999998654433333334467899999999986 567899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
.||........ ....... . ...+. .......++..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 223 ~p~~~~~~~~~--~~~~~~~-----~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 223 LPYSNINNRDQ--IIEMVGR-----G----SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSSCCCHHH--HHHHHHH-----T----SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCccccchHHH--HHHHhcc-----c----ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 99976433211 1111100 0 00111 11112234578999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=300.73 Aligned_cols=211 Identities=24% Similarity=0.363 Sum_probs=162.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.++++++||||+++++++. ++..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 63 ~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 138 (281)
T 1mp8_A 63 FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138 (281)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999974 56789999999999999999877667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p 217 (281)
T 1mp8_A 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217 (281)
T ss_dssp CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999987644322 12233456788999999999999999999999999999997 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|........ ..... ... ... .+...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 218 f~~~~~~~~---~~~i~----~~~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 218 FQGVKNNDV---IGRIE----NGE------RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp TTTCCGGGH---HHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCHHHH---HHHHH----cCC------CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 976543221 11110 000 011 1123357889999999999999999999999988643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=305.09 Aligned_cols=213 Identities=27% Similarity=0.413 Sum_probs=176.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCC-----------------CCCHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIAL 63 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------------~l~~~~~~~~~~ 63 (306)
|.+|+++++++ +||||+++++++.+.+..++||||+++|+|.+++..... .+++..++.++.
T Consensus 73 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (313)
T 1t46_A 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152 (313)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred HHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHH
Confidence 67999999999 999999999999999999999999999999999976542 489999999999
Q ss_pred HHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhH
Q 021891 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 143 (306)
Q Consensus 64 qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 143 (306)
||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++|
T Consensus 153 qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 229 (313)
T 1t46_A 153 QVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229 (313)
T ss_dssp HHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHH
Confidence 9999999999998 9999999999999999999999999998776554433344456788999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 144 VYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 144 iwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
||||||++|+|++ |..||........ ...... .. ..... +...+..+.+||.+||+.||.+||
T Consensus 230 i~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~----~~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 230 VWSYGIFLWELFSLGSSPYPGMPVDSK--FYKMIK----EG------FRMLS----PEHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHH--HHHHHH----HT------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHhCCCCCCCcccchhH--HHHHhc----cC------CCCCC----cccCCHHHHHHHHHHcCCCchhCc
Confidence 9999999999999 9999976543211 111110 00 01111 112346889999999999999999
Q ss_pred CHHHHHHHhCC
Q 021891 223 LMSEVVEALKP 233 (306)
Q Consensus 223 s~~ell~~l~~ 233 (306)
|+.+++++|+.
T Consensus 294 s~~ell~~L~~ 304 (313)
T 1t46_A 294 TFKQIVQLIEK 304 (313)
T ss_dssp CHHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 99999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.25 Aligned_cols=210 Identities=25% Similarity=0.332 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|.+|+++++.++||||+++++++.+++..++|||||++++|.+.+.+. +..+++..++.++.||+.||.|||+.+
T Consensus 73 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-- 150 (351)
T 3c0i_A 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-- 150 (351)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 679999999999999999999999999999999999999998887543 345899999999999999999999998
Q ss_pred CeEeccCCCCCeEEcCCCc---EEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
|+||||||+||+++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 151 -ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (351)
T 3c0i_A 151 -IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227 (351)
T ss_dssp -EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred -ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH
Confidence 999999999999976654 99999999987654322 233457999999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|..||..... ...... ..... ...+.... ..+..+.+||.+||+.||++|||+.++++|.
T Consensus 228 ~g~~pf~~~~~----~~~~~i---~~~~~----~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 228 SGCLPFYGTKE----RLFEGI---IKGKY----KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp HSSCSSCSSHH----HHHHHH---HHTCC----CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HCCCCCCCcHH----HHHHHH---HcCCC----CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 99999976321 111100 00000 00110001 1246889999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=299.39 Aligned_cols=222 Identities=22% Similarity=0.263 Sum_probs=169.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+++..++||||+++ +|.+.+......+++..++.++.||+.||.|||+.+ |+
T Consensus 48 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---iv 123 (292)
T 3o0g_A 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123 (292)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 57899999999999999999999999999999999975 777777666668999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC-CCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 124 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p 201 (292)
T 3o0g_A 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred cCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987543222 233457899999999998765 89999999999999999998888
Q ss_pred CCCCCCCCCcchHHhhhhhhcc-----ccccccc---------cCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGE-----RRRFYRL---------IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
|....... ............ ....... .............+..+.+||.+||+.||++|||++|
T Consensus 202 ~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 279 (292)
T 3o0g_A 202 LFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp SCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence 65432211 111111000000 0000000 0000011112234578899999999999999999999
Q ss_pred HHHHh
Q 021891 227 VVEAL 231 (306)
Q Consensus 227 ll~~l 231 (306)
+++|.
T Consensus 280 ~l~hp 284 (292)
T 3o0g_A 280 ALQHP 284 (292)
T ss_dssp HHTSG
T ss_pred HhcCc
Confidence 99864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.94 Aligned_cols=213 Identities=27% Similarity=0.397 Sum_probs=170.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|..+|.++ +||||+++++++.+.+.+++|||||++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |
T Consensus 99 ~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---i 174 (396)
T 4dc2_A 99 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---I 174 (396)
T ss_dssp HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 57899999887 8999999999999999999999999999999998654 36999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 175 vHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~P 252 (396)
T 4dc2_A 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252 (396)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998633222 223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCc--chHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHh
Q 021891 161 MDKNRPNGEH--NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ell~~l 231 (306)
|......... ............. ... ++...+.++.+||.+||+.||.+||++ .|+++|.
T Consensus 253 f~~~~~~~~~~~~~~~~~~~~i~~~-------~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 253 FDIVGSSDNPDQNTEDYLFQVILEK-------QIR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp STTTTC------CCHHHHHHHHHHC-------CCC----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred CcccccccccchhhHHHHHHHHhcc-------ccC----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 9754322111 0011111000000 011 122235688999999999999999985 6888764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=306.15 Aligned_cols=203 Identities=23% Similarity=0.286 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|+.++||||+++++++.+.+..|+||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||+.+ |+
T Consensus 88 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---iv 163 (350)
T 1rdq_E 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LI 163 (350)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 5689999999999999999999999999999999999999999996654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 164 HrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 238 (350)
T 1rdq_E 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCC
Confidence 9999999999999999999999999875432 23457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
....... ... ...... .. ++...+..+.+||.+||+.||.+||+ +++|++|.
T Consensus 239 ~~~~~~~---~~~---~i~~~~--------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 239 FADQPIQ---IYE---KIVSGK--------VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CCSSHHH---HHH---HHHHCC--------CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCHHH---HHH---HHHcCC--------CC----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 7643211 111 000000 01 11123568899999999999999998 88888764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=300.72 Aligned_cols=224 Identities=22% Similarity=0.275 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+ |+
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 122 (288)
T 1ob3_A 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122 (288)
T ss_dssp HHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 57899999999999999999999999999999999975 999999777678999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (288)
T 1ob3_A 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (288)
T ss_dssp CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999976432211 1233568999999999976 4589999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhh-----hhccccccc------cccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARP-----HLGERRRFY------RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~-----~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
|...........+..... .+....... ....+.....+....+..+.+||.+||+.||++|||+.|+++
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 976432211111000000 000000000 000000001111223578899999999999999999999998
Q ss_pred Hh
Q 021891 230 AL 231 (306)
Q Consensus 230 ~l 231 (306)
|.
T Consensus 281 hp 282 (288)
T 1ob3_A 281 HA 282 (288)
T ss_dssp SG
T ss_pred Cc
Confidence 63
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=314.45 Aligned_cols=213 Identities=20% Similarity=0.235 Sum_probs=174.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+.++..++||||++++++|.+.+.+|+|||||++|+|.+++.+....+++..++.++.||+.||.|||+.+ |+
T Consensus 121 ~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---ii 197 (437)
T 4aw2_A 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YV 197 (437)
T ss_dssp HHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 789999999999999999999999999999999999999999999876668999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+|||++.+|.+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++
T Consensus 198 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt 276 (437)
T 4aw2_A 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276 (437)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH
T ss_pred ecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh
Confidence 999999999999999999999999987654322 2234468999999999997 4578999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l 231 (306)
|..||...........+. .... ...-+.... ..+.++.+||.+||+.+|++ |++++|+++|.
T Consensus 277 G~~Pf~~~~~~~~~~~i~------~~~~---~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 277 GETPFYAESLVETYGKIM------NHKE---RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp SSCTTCCSSHHHHHHHHH------THHH---HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred CCCCCCCCChhHHHHhhh------hccc---cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 999997643221111110 0000 001111111 12468899999999998888 99999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=300.28 Aligned_cols=211 Identities=19% Similarity=0.353 Sum_probs=174.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 66 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 142 (283)
T 3gen_A 66 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FL 142 (283)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 679999999999999999999999999999999999999999999776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++...... ........+|..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 143 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p 221 (283)
T 3gen_A 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221 (283)
T ss_dssp CSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654321 111223456778999999998899999999999999999998 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|........... ... ...... +...+..+.+|+.+||+.||.+|||+.+++++|+.
T Consensus 222 ~~~~~~~~~~~~-------~~~------~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 222 YERFTNSETAEH-------IAQ------GLRLYR----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TTTSCHHHHHHH-------HHT------TCCCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccChhHHHHH-------Hhc------ccCCCC----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 976432211100 000 000111 11224688999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=304.82 Aligned_cols=213 Identities=23% Similarity=0.375 Sum_probs=162.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCee------EEEEEcCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~ 70 (306)
|.+|++++++++||||+++++++...+.. ++||||+.+++|.+++... ...+++..++.++.||+.||.
T Consensus 72 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 151 (323)
T 3qup_A 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151 (323)
T ss_dssp HHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH
Confidence 67999999999999999999999887655 9999999999999998542 225899999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+
T Consensus 152 ~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 228 (323)
T 3qup_A 152 YLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228 (323)
T ss_dssp HHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHH
Confidence 999998 99999999999999999999999999987654433333344557888999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|+|++ |..||......... .... ... ... .+...+..+.+|+.+||+.||++|||+.++++
T Consensus 229 l~ell~~g~~p~~~~~~~~~~---~~~~----~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 229 MWEIMTRGQTPYAGIENAEIY---NYLI----GGN------RLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp HHHHHTTSCCTTTTCCGGGHH---HHHH----TTC------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCccccChHHHH---HHHh----cCC------CCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999 89999765432211 1100 000 001 11223468999999999999999999999998
Q ss_pred HhCCC
Q 021891 230 ALKPL 234 (306)
Q Consensus 230 ~l~~~ 234 (306)
.|+.+
T Consensus 292 ~l~~~ 296 (323)
T 3qup_A 292 ELENI 296 (323)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=296.73 Aligned_cols=210 Identities=29% Similarity=0.547 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|++++++++||||+++++++.+.. ++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ .+++
T Consensus 70 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~iv 146 (287)
T 4f0f_A 70 FQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIV 146 (287)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCB
T ss_pred HHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCee
Confidence 678999999999999999999986554 7999999999999999887778999999999999999999999976 4599
Q ss_pred eccCCCCCeEEcCCCc-----EEEeccCCcccCCCCCcceeeecccccccccCCcchh--cCCCCchhHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 82 H~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el 154 (306)
||||||+||+++.++. +||+|||+++.... ......||..|+|||++. ...++.++|||||||++|+|
T Consensus 147 H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l 221 (287)
T 4f0f_A 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221 (287)
T ss_dssp CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHH
T ss_pred cCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHH
Confidence 9999999999988776 99999999985432 233457899999999984 45678999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
++|..||........... ... .. ....+. ++...+..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 222 ~~g~~pf~~~~~~~~~~~-~~~---~~------~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 222 LTGEGPFDEYSYGKIKFI-NMI---RE------EGLRPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHSSCTTTTCCCCHHHHH-HHH---HH------SCCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HcCCCCCccccccHHHHH-HHH---hc------cCCCCC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 999999976543221101 000 00 011111 122335789999999999999999999999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.94 Aligned_cols=208 Identities=25% Similarity=0.393 Sum_probs=171.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.++++++||||+++++++...+..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+
T Consensus 89 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iv 163 (321)
T 2c30_A 89 LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VI 163 (321)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 67999999999999999999999999999999999999999998854 35999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987644322 223457999999999999989999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
....... ...... ....+... .....+..+.+||.+||+.||++|||+.+++++.
T Consensus 242 ~~~~~~~---~~~~~~----------~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 242 FSDSPVQ---AMKRLR----------DSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp TTSCHHH---HHHHHH----------HSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCCHHH---HHHHHh----------cCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 7543211 111110 00011110 1112346789999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=294.55 Aligned_cols=221 Identities=16% Similarity=0.132 Sum_probs=178.2
Q ss_pred CHHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.+.+|+++++.+ +|+||+++++++.+....++||||+ +++|.+++...+..+++..++.++.||+.||.|||+.+
T Consensus 51 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--- 126 (298)
T 1csn_A 51 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 126 (298)
T ss_dssp CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 378999999999 8999999999999999999999999 89999999877767999999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCc-----EEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHH
Q 021891 80 VIYRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 149 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 149 (306)
|+||||||+||+++.++. +||+|||+++........ .......||..|+|||++.+..++.++|||||||
T Consensus 127 ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 206 (298)
T 1csn_A 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 206 (298)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHH
Confidence 999999999999987766 999999999876543221 1234467899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
++|+|++|..||..................... ... +.... ..+..+.+|+.+||+.||++|||+.+|++
T Consensus 207 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 207 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPL-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCH-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHcCCCCcchhhccccHHHHHHHHhhccC-ccH-----HHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 999999999999876543332222111110000 000 00001 22468999999999999999999999999
Q ss_pred HhCCCC
Q 021891 230 ALKPLP 235 (306)
Q Consensus 230 ~l~~~~ 235 (306)
.|+.+.
T Consensus 277 ~l~~~~ 282 (298)
T 1csn_A 277 LFSKVL 282 (298)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=308.04 Aligned_cols=212 Identities=22% Similarity=0.300 Sum_probs=161.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+.+++.++||||+++++++.+.+..++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+
T Consensus 63 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~---iv 138 (361)
T 3uc3_A 63 VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQ---IC 138 (361)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 6799999999999999999999999999999999999999999986544 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCc--EEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCch-hHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~ 158 (306)
||||||+||+++.++. +||+|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|.
T Consensus 139 H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 215 (361)
T 3uc3_A 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215 (361)
T ss_dssp SCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC
Confidence 9999999999987765 9999999997533221 2234578999999999998888765 89999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||............ .......... +.. ....+..+.+||.+||+.||++|||+.|+++|..
T Consensus 216 ~Pf~~~~~~~~~~~~--~~~~~~~~~~----~~~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 216 YPFEDPEEPRDYRKT--IQRILSVKYS----IPD------DIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CSCC----CCCHHHH--HHHHHTTCCC----CCT------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCCCCccHHHHHHH--HHHHhcCCCC----CCC------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 999865443221111 1111100000 000 0112468899999999999999999999999743
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=310.15 Aligned_cols=225 Identities=19% Similarity=0.223 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|++++++++|||||++++++.+.+..++|||||++++|.+++... ...+++..++.++.||+.||.|||+.+ |
T Consensus 73 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i 149 (389)
T 3gni_B 73 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149 (389)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 578999999999999999999999999999999999999999999765 356999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhc--CCCCchhHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e 153 (306)
+||||||+|||++.++.+||+|||.+......... .......||..|+|||++.+ ..++.++|||||||++|+
T Consensus 150 vHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 229 (389)
T 3gni_B 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229 (389)
T ss_dssp ECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHH
Confidence 99999999999999999999999988654322111 11122468999999999987 679999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhhhhccc--------cc-------------ccccc---------CCccCCCCCHHHH
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARPHLGER--------RR-------------FYRLI---------DPRLEGHFSIKGA 203 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~-------------~~~~~---------~~~~~~~~~~~~~ 203 (306)
|++|..||............ ........ .. ..... .......+....+
T Consensus 230 l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 307 (389)
T 3gni_B 230 LANGHVPFKDMPATQMLLEK--LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307 (389)
T ss_dssp HHHSSCTTTTCCSTTHHHHC----------------------------------------------------------CC
T ss_pred HHHCCCCCCCCCHHHHHHHH--hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccC
Confidence 99999999765443221100 00000000 00 00000 0000001223345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 204 QKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 204 ~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
..+.+||.+||+.||++|||+.|+++|.
T Consensus 308 ~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 308 PHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 7899999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=321.56 Aligned_cols=214 Identities=22% Similarity=0.351 Sum_probs=177.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++|++++||||+++++++.+.+..++|||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |
T Consensus 263 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i 339 (495)
T 1opk_A 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339 (495)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 789999999999999999999999999999999999999999999764 356899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 340 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~ 418 (495)
T 1opk_A 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418 (495)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCC
Confidence 999999999999999999999999998764332 222233456778999999998899999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
||....... ...... .. ... ..+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 419 p~~~~~~~~---~~~~~~----~~------~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 419 PYPGIDLSQ---VYELLE----KD------YRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp SSTTCCGGG---HHHHHH----TT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCHHH---HHHHHH----cC------CCC----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 997654321 111111 00 001 1122335789999999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=308.67 Aligned_cols=214 Identities=21% Similarity=0.262 Sum_probs=164.6
Q ss_pred HHHHHHHHhc-CCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGD-LVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~-l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|++++.+ ++||||+++++++.. .+.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.
T Consensus 101 ~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 180 (400)
T 1nxk_A 101 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180 (400)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 5789998754 589999999999876 567899999999999999997653 4699999999999999999999998
Q ss_pred CCCCeEeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+ |+||||||+|||++. ++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 181 ~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 254 (400)
T 1nxk_A 181 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254 (400)
T ss_dssp T---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHH
T ss_pred C---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHH
Confidence 8 999999999999987 7899999999998754322 223467899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchH-HhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTGRRSMDKNRPNGEHNLV-EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++|..||............ ..... . . .....+ . ....+.++.+||.+||+.||++|||+.|+++|.
T Consensus 255 ell~g~~pf~~~~~~~~~~~~~~~i~~---~--~-~~~~~~-~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 255 ILLCGYPPFYSNHGLAISPGMKTRIRM---G--Q-YEFPNP-E----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHHHSSCSCCCCTTCSSCCSHHHHHHH---T--C-CCCCTT-T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHhCCCCCCCCccccccHHHHHHHHc---C--c-ccCCCc-c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 999999999875543321111 11100 0 0 000011 0 112356889999999999999999999999975
Q ss_pred C
Q 021891 232 K 232 (306)
Q Consensus 232 ~ 232 (306)
.
T Consensus 324 ~ 324 (400)
T 1nxk_A 324 W 324 (400)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=295.18 Aligned_cols=210 Identities=30% Similarity=0.488 Sum_probs=164.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++++.++||||+++++++.+.+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+++
T Consensus 53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~ 130 (271)
T 3dtc_A 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPII 130 (271)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCC
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Confidence 67899999999999999999999999999999999999999998853 3699999999999999999999998744488
Q ss_pred eccCCCCCeEEcC--------CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDA--------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 82 H~dlkp~Nill~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
||||||+||+++. ++.+||+|||+++...... .....||..|+|||++.+..++.++||||||+++|+
T Consensus 131 H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 206 (271)
T 3dtc_A 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206 (271)
T ss_dssp CSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred ecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHH
Confidence 9999999999986 7789999999998654322 223568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|++|..||........ ....... ......+...+..+.+++.+||+.||.+|||+.|++++|+.
T Consensus 207 l~~g~~p~~~~~~~~~------~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 207 LLTGEVPFRGIDGLAV------AYGVAMN----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHCCCTTTTSCHHHH------HHHHHTS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHhCCCCCCCCCHHHH------HHhhhcC----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999999975432110 0000000 00111122335789999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=306.94 Aligned_cols=205 Identities=28% Similarity=0.402 Sum_probs=169.2
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|.++|+.+ +||||+++++++.+.+..|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||+.+ |
T Consensus 64 ~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---i 139 (345)
T 1xjd_A 64 TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG---I 139 (345)
T ss_dssp HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 46788899877 99999999999999999999999999999999996543 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 140 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 217 (345)
T 1xjd_A 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217 (345)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999986433221 23456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-ell~~ 230 (306)
|....... ...... .. .+.. +...+..+.+||.+||+.||++||++. ++++|
T Consensus 218 f~~~~~~~---~~~~i~---~~--------~~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 218 FHGQDEEE---LFHSIR---MD--------NPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp SCCSSHHH---HHHHHH---HC--------CCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCCCHHH---HHHHHH---hC--------CCCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 97643211 111000 00 0111 112346889999999999999999997 77664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=305.74 Aligned_cols=210 Identities=24% Similarity=0.376 Sum_probs=163.2
Q ss_pred HHHHHHHHhcCCC--CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|++|+++|++++| +||+++++++.+.+..++|||+ .+++|.+++.+. ..+++..+..++.||+.||.|||+.+
T Consensus 54 ~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--- 128 (343)
T 3dbq_A 54 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--- 128 (343)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6789999999977 9999999999999999999995 478999999765 47999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----------CCCCchhHHHHHH
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFG 148 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG 148 (306)
|+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||
T Consensus 129 iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG 207 (343)
T 3dbq_A 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207 (343)
T ss_dssp CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHH
T ss_pred eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHH
Confidence 99999999999997 67899999999987655433333445679999999999865 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|++|+|++|..||...... ..... ..+++.....++...+..+.+||.+||+.||.+|||+.|++
T Consensus 208 ~il~ell~g~~pf~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 208 CILYYMTYGKTPFQQIINQ-----ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp HHHHHHHHSSCTTTTCCSH-----HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHhCCCcchhhhhH-----HHHHH----------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 9999999999999653221 11111 11111111112222246789999999999999999999999
Q ss_pred HHhC
Q 021891 229 EALK 232 (306)
Q Consensus 229 ~~l~ 232 (306)
+|..
T Consensus 273 ~hp~ 276 (343)
T 3dbq_A 273 AHPY 276 (343)
T ss_dssp TSHH
T ss_pred hCcc
Confidence 8753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=304.21 Aligned_cols=215 Identities=25% Similarity=0.405 Sum_probs=174.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~L 72 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.||
T Consensus 75 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 154 (322)
T 1p4o_A 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154 (322)
T ss_dssp HHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999986421 4578999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ |+||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|
T Consensus 155 H~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 231 (322)
T 1p4o_A 155 NANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231 (322)
T ss_dssp HHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHH
Confidence 9998 9999999999999999999999999998654332222233345688999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++ |..||....... ...... ... . .. .+...+..+.+||.+||+.||.+|||+.+++++|
T Consensus 232 el~~~g~~p~~~~~~~~---~~~~~~----~~~----~--~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 232 EIATLAEQPYQGLSNEQ---VLRFVM----EGG----L--LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp HHHHTSCCTTTTSCHHH---HHHHHH----TTC----C--CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCccccCCHHH---HHHHHH----cCC----c--CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999 888887543211 111100 000 0 00 1122356889999999999999999999999999
Q ss_pred CCCCC
Q 021891 232 KPLPN 236 (306)
Q Consensus 232 ~~~~~ 236 (306)
+....
T Consensus 295 ~~~~~ 299 (322)
T 1p4o_A 295 KEEME 299 (322)
T ss_dssp GGGSC
T ss_pred HHhhc
Confidence 86543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=303.13 Aligned_cols=218 Identities=24% Similarity=0.286 Sum_probs=153.2
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+++|+++++.+. ||||+++++++.+.+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |
T Consensus 52 ~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i 127 (325)
T 3kn6_A 52 TQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---V 127 (325)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 578999999997 999999999999999999999999999999999765 47999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCC---cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 81 IYRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
+||||||+||+++.++ .+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 128 vH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 205 (325)
T 3kn6_A 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205 (325)
T ss_dssp ECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHS
T ss_pred eecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence 9999999999997765 899999999986543322 22345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
..||...................... ............+.++.+||.+||+.||.+|||+.++++|..
T Consensus 206 ~~pf~~~~~~~~~~~~~~~~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 206 QVPFQSHDRSLTCTSAVEIMKKIKKG-------DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp SCTTC-------CCCHHHHHHHHTTT-------CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CCCCCCCccccccccHHHHHHHHHcC-------CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 99998654322111111111111000 000000001123578999999999999999999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=298.23 Aligned_cols=206 Identities=24% Similarity=0.333 Sum_probs=165.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++|++++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.||+.||.|||+.+
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 6789999999999999999999987 568899999999999988653 346999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC---CCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ellt 156 (306)
|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 99999999999999999999999999987654322 233457899999999997654 3789999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|..||...... .......... ....... ..+..+.+||.+||+.||++|||+.|+++|
T Consensus 236 g~~pf~~~~~~------~~~~~~~~~~------~~~~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 236 GQCPFMDERIM------CLHSKIKSQA------LEFPDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSCSSCCSSHH------HHHHHHHHCC------CCCCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCCCccHH------HHHHHHhccc------CCCCCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999754221 1110000000 0000011 224688999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=306.63 Aligned_cols=221 Identities=18% Similarity=0.206 Sum_probs=171.1
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeC----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
..|+..++.++||||+++++++... ...++||||+ +++|.+++......+++..++.++.||+.||.|||+.+
T Consensus 96 ~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-- 172 (364)
T 3op5_A 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE-- 172 (364)
T ss_dssp HHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3566677888999999999998875 4589999999 99999999887678999999999999999999999998
Q ss_pred CeEeccCCCCCeEEc--CCCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 79 ~iiH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
|+||||||+|||++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++
T Consensus 173 -iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 251 (364)
T 3op5_A 173 -YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM 251 (364)
T ss_dssp -EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHH
Confidence 99999999999998 8899999999999765432211 111334599999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|||++|..||........ ......... ...+...+++.+. ....+.++.+|+..||+.||.+||++.+|++.|
T Consensus 252 ~el~~g~~Pf~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 252 IQWLTGHLPWEDNLKDPK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp HHHHHSCCTTGGGTTCHH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHhCCCCccccccCHH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 999999999985432211 111111110 0111111111110 011246889999999999999999999999988
Q ss_pred CCC
Q 021891 232 KPL 234 (306)
Q Consensus 232 ~~~ 234 (306)
+.+
T Consensus 325 ~~~ 327 (364)
T 3op5_A 325 LQG 327 (364)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=297.68 Aligned_cols=212 Identities=25% Similarity=0.376 Sum_probs=174.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++ ..+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 57 ~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 132 (287)
T 1u59_A 57 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 132 (287)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 67899999999999999999999 566799999999999999999777677999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+||+++.++.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765433221 1223456889999999998899999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||....... ...... ... .+. ++...+..+.++|.+||+.||.+|||+.+++++|+.+
T Consensus 213 p~~~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 213 PYKKMKGPE---VMAFIE----QGK------RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TTTTCCTHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccCCHHH---HHHHHh----cCC------cCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 997654321 111110 000 011 1223357899999999999999999999999998654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=302.98 Aligned_cols=213 Identities=23% Similarity=0.399 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 93 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 169 (333)
T 1mqb_A 93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YV 169 (333)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999999999999999999999999877678999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 170 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999875443211 11223446788999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||....... .... ..... ... .+...+..+.+|+.+||+.||++||++.+++++|+.+
T Consensus 250 pf~~~~~~~---~~~~----~~~~~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 250 PYWELSNHE---VMKA----INDGF------RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp TTTTCCHHH---HHHH----HHTTC------CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCCHHH---HHHH----HHCCC------cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 996543211 1111 00000 001 1112356889999999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=308.24 Aligned_cols=213 Identities=27% Similarity=0.431 Sum_probs=164.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++||||+++++++.. ++..++||||+++|+|.+++.+....+++..++.++.||+.||.|||+.+ |
T Consensus 137 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 213 (373)
T 3c1x_A 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---F 213 (373)
T ss_dssp HHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 6789999999999999999998754 45789999999999999999877777999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-C
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g 157 (306)
+||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 214 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~ 293 (373)
T 3c1x_A 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293 (373)
T ss_dssp CCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999865432211 11233457788999999999999999999999999999999 6
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.+||........... .. ... .... +...+..+.++|.+||+.||++|||+.++++.|+.+
T Consensus 294 ~~p~~~~~~~~~~~~---~~----~~~---~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 294 APPYPDVNTFDITVY---LL----QGR---RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CCSCTTSCSSCHHHH---HH----TTC---CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHH---HH----cCC---CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 777765543321111 11 000 0111 112346899999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.01 Aligned_cols=206 Identities=27% Similarity=0.357 Sum_probs=165.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+.+..|+||||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ |+
T Consensus 68 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---iv 143 (327)
T 3a62_A 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKG---II 143 (327)
T ss_dssp ---HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 5689999999999999999999999999999999999999999986543 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 144 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp CCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence 99999999999999999999999997643222 1233467999999999999989999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
....... ... ...... .. ++...+..+.+||.+||+.||.+|| ++.++++|.
T Consensus 222 ~~~~~~~---~~~---~i~~~~--------~~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 222 TGENRKK---TID---KILKCK--------LN----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp CCSSHHH---HHH---HHHHTC--------CC----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred CCCCHHH---HHH---HHHhCC--------CC----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 7643211 111 000000 01 1112346889999999999999999 788999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.46 Aligned_cols=224 Identities=23% Similarity=0.303 Sum_probs=169.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|++++++++||||+++++++.+++..++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+
T Consensus 50 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 128 (317)
T 2pmi_A 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128 (317)
T ss_dssp HHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5789999999999999999999999999999999997 5999988643 245899999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell 155 (306)
|+||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 129 ---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 203 (317)
T 2pmi_A 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203 (317)
T ss_dssp ---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999987543221 1234568999999999976 46899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhh-----hcccc---ccccccCCcc--------CCCCCHHHHHHHHHHHHHcccCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPH-----LGERR---RFYRLIDPRL--------EGHFSIKGAQKAAQLAAHCLSRDPK 219 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~ 219 (306)
+|..||...........+...... +.... .+...+.... ........+..+.+||.+||+.||+
T Consensus 204 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 283 (317)
T 2pmi_A 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283 (317)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc
Confidence 999999765432211111000000 00000 0000000000 0000112346899999999999999
Q ss_pred CCCCHHHHHHHh
Q 021891 220 ARPLMSEVVEAL 231 (306)
Q Consensus 220 ~Rps~~ell~~l 231 (306)
+|||+.|+++|.
T Consensus 284 ~Rpt~~e~l~hp 295 (317)
T 2pmi_A 284 MRLSAKQALHHP 295 (317)
T ss_dssp GSCCHHHHTTSG
T ss_pred cCCCHHHHhCCh
Confidence 999999999853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=303.60 Aligned_cols=223 Identities=19% Similarity=0.179 Sum_probs=172.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
+.+|+.+++.++||||+++++++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+
T Consensus 95 ~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~- 171 (345)
T 2v62_A 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE- 171 (345)
T ss_dssp HHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4578889999999999999999988 67899999999 899999986655 7999999999999999999999998
Q ss_pred CCeEeccCCCCCeEEcCCC--cEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 78 RPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
|+||||||+||+++.++ .+||+|||+++........ .......||..|+|||++.+..++.++|||||||+
T Consensus 172 --ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 249 (345)
T 2v62_A 172 --YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYC 249 (345)
T ss_dssp --EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHH
T ss_pred --eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHH
Confidence 99999999999998877 9999999999865432111 11134578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|||++|..||........ .......... ..+...+..... ....+..+.+||.+||+.||++|||+.+|++.
T Consensus 250 l~ell~g~~pf~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 250 MLRWLCGKLPWEQNLKDPV--AVQTAKTNLL--DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHSSCTTGGGTTCHH--HHHHHHHHHH--HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhCCCCccccccccH--HHHHHHHhhc--ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 9999999999964322111 0111000000 000000000000 00224689999999999999999999999999
Q ss_pred hCCCCC
Q 021891 231 LKPLPN 236 (306)
Q Consensus 231 l~~~~~ 236 (306)
|+.+..
T Consensus 323 L~~~~~ 328 (345)
T 2v62_A 323 LNPHGI 328 (345)
T ss_dssp HCTTCC
T ss_pred HhccCC
Confidence 987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.23 Aligned_cols=211 Identities=24% Similarity=0.292 Sum_probs=160.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 95 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---iv 170 (349)
T 2w4o_A 95 VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IV 170 (349)
T ss_dssp ----CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 678999999999999999999999999999999999999999998654 46999999999999999999999998 99
Q ss_pred eccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 247 (349)
T 2w4o_A 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF 247 (349)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 9999999999975 8899999999998654321 223457899999999999989999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||........ .... ...... ... .. .....+..+.+||.+||+.||++|||+.|++++..
T Consensus 248 ~pf~~~~~~~~--~~~~---i~~~~~---~~~-~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 248 EPFYDERGDQF--MFRR---ILNCEY---YFI-SP----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp CTTCCTTCHHH--HHHH---HHTTCC---CCC-TT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCCCCCcccHH--HHHH---HHhCCC---ccC-Cc----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 99975432210 1000 000000 000 11 11123568899999999999999999999999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=304.10 Aligned_cols=213 Identities=24% Similarity=0.396 Sum_probs=175.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.||
T Consensus 87 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 166 (334)
T 2pvf_A 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166 (334)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHH
Confidence 67899999999 99999999999999999999999999999999997653 248999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||
T Consensus 167 ~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 243 (334)
T 2pvf_A 167 ARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243 (334)
T ss_dssp HHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHH
Confidence 99999999998 999999999999999999999999999876554333333445678899999999988999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|+|++ |..||....... ...... .. .... .+...+..+.+||.+||+.||.+|||+
T Consensus 244 slG~il~ellt~g~~p~~~~~~~~---~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~ 306 (334)
T 2pvf_A 244 SFGVLMWEIFTLGGSPYPGIPVEE---LFKLLK----EG------HRMD----KPANCTNELYMMMRDCWHAVPSQRPTF 306 (334)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH----HT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhCCCCCcCcCCHHH---HHHHHh----cC------CCCC----CCccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999999999 999997643211 111100 00 0011 112234688999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.+++++|+.+
T Consensus 307 ~ell~~L~~l 316 (334)
T 2pvf_A 307 KQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=313.33 Aligned_cols=205 Identities=25% Similarity=0.341 Sum_probs=171.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|+.++||||+++++++.+.+..++|||||++|+|.+++.++ ..+++..++.++.||+.||.|||+.+ |+
T Consensus 63 ~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iv 138 (476)
T 2y94_A 63 IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VV 138 (476)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CC
Confidence 578999999999999999999999999999999999999999999654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 139 HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P 215 (476)
T 2y94_A 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215 (476)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence 999999999999999999999999987654322 234579999999999988765 6899999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|....... ...... ... . . .+...+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 216 f~~~~~~~---~~~~i~---~~~------~--~----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 216 FDDDHVPT---LFKKIC---DGI------F--Y----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp SCCSSSHH---HHHHHH---TTC------C--C----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CCCCCHHH---HHHHHh---cCC------c--C----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 97643211 111000 000 0 0 1112246789999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=311.51 Aligned_cols=212 Identities=21% Similarity=0.229 Sum_probs=171.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|.++|..++||||+++++++.+.+..|+|||||++|+|.+++.+.+..+++..++.++.||+.||.|||+.+ |+
T Consensus 108 ~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ii 184 (412)
T 2vd5_A 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YV 184 (412)
T ss_dssp HHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999999776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-------cCCCCchhHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el 154 (306)
||||||+|||++.+|.+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||
T Consensus 185 HrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyel 263 (412)
T 2vd5_A 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263 (412)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHH
T ss_pred ecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHH
Confidence 999999999999999999999999987654322 2233468999999999997 35689999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHHh
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEAL 231 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~ell~~l 231 (306)
++|..||...........+.... . ....+.. ....+.++.+||.+||+ +|.+| |+++|+++|-
T Consensus 264 ltG~~Pf~~~~~~~~~~~i~~~~----~-----~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 264 FYGQTPFYADSTAETYGKIVHYK----E-----HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHH----H-----HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HhCCCCCCCCCHHHHHHHHHhcc----c-----CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 99999997643221111110000 0 0000111 11235789999999999 99998 5999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=298.99 Aligned_cols=220 Identities=24% Similarity=0.354 Sum_probs=169.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++|++++||||+++++++... ...++||||+++++|.+++......+++..++.++.|++.||.|||+.+
T Consensus 58 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 134 (295)
T 3ugc_A 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134 (295)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---
Confidence 67999999999999999999998653 5689999999999999999877667999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 135 ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999876443221 2223345677899999999999999999999999999999999
Q ss_pred CCCCCCCCC--------CCcch-HHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 159 RSMDKNRPN--------GEHNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 159 ~pf~~~~~~--------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
.||...... ..... .......... ......+..++..+.+||.+||+.||++|||+.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCChHHHHhhhcCccccchhHHHHHHHHhc----------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 988642110 00000 0000000000 0011112234578999999999999999999999999
Q ss_pred HhCCC
Q 021891 230 ALKPL 234 (306)
Q Consensus 230 ~l~~~ 234 (306)
.|+.+
T Consensus 285 ~L~~l 289 (295)
T 3ugc_A 285 RVDQI 289 (295)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.94 Aligned_cols=210 Identities=24% Similarity=0.374 Sum_probs=163.8
Q ss_pred HHHHHHHHhcCC--CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|++|+++|++|+ ||||+++++++...+..++||| +.+++|.+++.+.. .+++..++.++.||+.||.|||+.+
T Consensus 101 ~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--- 175 (390)
T 2zmd_A 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--- 175 (390)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 689999999996 5999999999999999999999 45789999997654 7899999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----------CCCCchhHHHHHH
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFG 148 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG 148 (306)
|+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||
T Consensus 176 ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG 254 (390)
T 2zmd_A 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254 (390)
T ss_dssp CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence 99999999999995 58899999999987654433333445679999999999875 3689999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|++|||++|..||...... ..... ..+++.....++...+..+.+||.+||+.||.+|||+.|++
T Consensus 255 vil~ell~G~~Pf~~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 255 CILYYMTYGKTPFQQIINQ-----ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp HHHHHHHHSSCTTTTCCCH-----HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHCCCcchhhhHH-----HHHHH----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 9999999999999753221 11111 11111111111111246789999999999999999999999
Q ss_pred HHhC
Q 021891 229 EALK 232 (306)
Q Consensus 229 ~~l~ 232 (306)
++..
T Consensus 320 ~hp~ 323 (390)
T 2zmd_A 320 AHPY 323 (390)
T ss_dssp TSHH
T ss_pred hCcC
Confidence 8753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=299.87 Aligned_cols=213 Identities=27% Similarity=0.400 Sum_probs=169.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++++ +||||+++++++.+.+..|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+.+ |
T Consensus 56 ~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---i 131 (345)
T 3a8x_A 56 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG---I 131 (345)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 56899999988 89999999999999999999999999999999986543 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 132 vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 209 (345)
T 3a8x_A 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209 (345)
T ss_dssp BCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998643222 123456799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCc--chHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHh
Q 021891 161 MDKNRPNGEH--NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~ell~~l 231 (306)
|......... ............. ... ++...+..+.+||.+||+.||.+||++ .++++|.
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~i~~~-------~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 210 FDIVGSSDNPDQNTEDYLFQVILEK-------QIR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp TTTTTC-------CHHHHHHHHHHC-------CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred cCCcccccccccccHHHHHHHHHcC-------CCC----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 9753221110 0001111000000 011 122235688999999999999999995 6777653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=308.60 Aligned_cols=211 Identities=24% Similarity=0.275 Sum_probs=172.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++|||||++++++.+.+.+|+|||||+||+|.+++.+. .+++..++.++.||+.||.|||+.+ |+
T Consensus 116 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---iv 190 (410)
T 3v8s_A 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FI 190 (410)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 678999999999999999999999999999999999999999998654 5899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC----CCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg 157 (306)
||||||+|||++.+|.+||+|||+++...... .......+||+.|+|||++.+.. |+.++|||||||++|||++|
T Consensus 191 HrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G 269 (410)
T 3v8s_A 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269 (410)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHS
T ss_pred eccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhC
Confidence 99999999999999999999999998765432 22234568999999999998665 78999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~ell~~l~ 232 (306)
..||...........+.. .... ..-+. .. ..+.++.+||.+||+.+|.+ ||+++||++|..
T Consensus 270 ~~Pf~~~~~~~~~~~i~~------~~~~---~~~p~-~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 270 DTPFYADSLVGTYSKIMN------HKNS---LTFPD-DN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp SCTTCCSSHHHHHHHHHT------HHHH---CCCCT-TC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred CCCCCCCChhhHHHHHHh------cccc---ccCCC-cc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 999976432211111100 0000 00010 01 12468899999999999988 999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=312.51 Aligned_cols=208 Identities=26% Similarity=0.409 Sum_probs=171.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++|++++||||+++++++...+ ..++|||||++|+|.+++.+.+. .+++..++.++.||+.||.|||+++
T Consensus 233 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--- 309 (450)
T 1k9a_A 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 309 (450)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 789999999999999999999987765 78999999999999999976543 4799999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
|+||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 310 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 384 (450)
T 1k9a_A 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384 (450)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999864322 122356889999999999999999999999999999998 99
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||...........+ . .. .... .+..++..+.+||.+||+.||++|||+.++++.|+.+
T Consensus 385 ~P~~~~~~~~~~~~i---~----~~------~~~~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 385 VPYPRIPLKDVVPRV---E----KG------YKMD----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CSSTTSCTTTHHHHH---H----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHH---H----cC------CCCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 999865443221111 1 00 0011 1223357899999999999999999999999988643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=293.48 Aligned_cols=207 Identities=27% Similarity=0.380 Sum_probs=152.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 58 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 134 (278)
T 3cok_A 58 VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134 (278)
T ss_dssp HHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 678999999999999999999999999999999999999999999877678999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 135 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 212 (278)
T 3cok_A 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212 (278)
T ss_dssp CSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987543221 122356899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
............. ..+.. .+...+.++.+||.+||+.||++|||+.+++++.
T Consensus 213 ~~~~~~~~~~~~~--------------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 213 DTDTVKNTLNKVV--------------LADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CCCSCC-----CC--------------SSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred CChhHHHHHHHHh--------------hcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 7654322111000 00001 1112346889999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.07 Aligned_cols=213 Identities=25% Similarity=0.384 Sum_probs=174.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-------------CCCCCHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAK 67 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------~~~l~~~~~~~~~~qi~~ 67 (306)
|.+|+++++++ +||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.||+.
T Consensus 96 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 175 (333)
T 2i1m_A 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175 (333)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHH
Confidence 67999999999 8999999999999999999999999999999998643 345899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHH
Q 021891 68 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 147 (306)
Q Consensus 68 ~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 147 (306)
||.|||+.+ |+||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++|||||
T Consensus 176 ~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 252 (333)
T 2i1m_A 176 GMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252 (333)
T ss_dssp HHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH
Confidence 999999998 99999999999999999999999999986544333333344567889999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 148 GVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 148 G~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
||++|+|++ |..||........ ....... . .... .+...+..+.+||.+||+.||.+|||+.+
T Consensus 253 G~il~el~t~g~~p~~~~~~~~~--~~~~~~~----~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 316 (333)
T 2i1m_A 253 GILLWEIFSLGLNPYPGILVNSK--FYKLVKD----G------YQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQ 316 (333)
T ss_dssp HHHHHHHTTTSCCSSTTCCSSHH--HHHHHHH----T------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCCcccchhHH--HHHHHhc----C------CCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 999999998 8999976543211 1111110 0 0011 11122468899999999999999999999
Q ss_pred HHHHhCC
Q 021891 227 VVEALKP 233 (306)
Q Consensus 227 ll~~l~~ 233 (306)
++++|+.
T Consensus 317 l~~~L~~ 323 (333)
T 2i1m_A 317 ICSFLQE 323 (333)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=298.73 Aligned_cols=208 Identities=24% Similarity=0.375 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+++..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+
T Consensus 59 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---iv 135 (289)
T 4fvq_A 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LI 135 (289)
T ss_dssp HHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eE
Confidence 678999999999999999999999999999999999999999999877666999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCc--------EEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 82 H~dlkp~Nill~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ 152 (306)
||||||+||+++.++. +||+|||++..... .....||..|+|||++.+ ..++.++|||||||++|
T Consensus 136 H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 209 (289)
T 4fvq_A 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209 (289)
T ss_dssp CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred CCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence 9999999999988887 99999999876432 123457889999999987 67999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
+|++|..|+....... .... ....... ... ..+..+.+|+.+||+.||++|||+.+++++|+
T Consensus 210 el~~g~~~~~~~~~~~--~~~~----~~~~~~~----~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 210 EICSGGDKPLSALDSQ--RKLQ----FYEDRHQ----LPA--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp HHHTTTCCTTTTSCHH--HHHH----HHHTTCC----CCC--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCccccchH--HHHH----HhhccCC----CCC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999655443322111 0000 0001000 111 11346789999999999999999999999998
Q ss_pred CCCC
Q 021891 233 PLPN 236 (306)
Q Consensus 233 ~~~~ 236 (306)
.+..
T Consensus 272 ~l~~ 275 (289)
T 4fvq_A 272 SLFT 275 (289)
T ss_dssp TCC-
T ss_pred HhcC
Confidence 7655
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=296.46 Aligned_cols=213 Identities=26% Similarity=0.432 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEE-eCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++||||+++++++. .++..++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ +
T Consensus 73 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i 149 (298)
T 3f66_A 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---F 149 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 678999999999999999999865 456789999999999999999877778999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc--ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-C
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 157 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g 157 (306)
+||||||+||+++.++.+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 150 ~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~ 229 (298)
T 3f66_A 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 229 (298)
T ss_dssp CCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987644321 112233567889999999999999999999999999999999 5
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.+||............ .. . . .... +...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~---~~---~-~---~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 230 APPYPDVNTFDITVYL---LQ---G-R---RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CCSSTTSCTTTHHHHH---HT---T-C---CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHH---hc---C-C---CCCC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5666554332211111 00 0 0 0011 112246799999999999999999999999998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.73 Aligned_cols=206 Identities=24% Similarity=0.338 Sum_probs=169.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|.++|..+ +||||+++++++.+.+..|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||+.+ |
T Consensus 67 ~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---i 142 (353)
T 2i0e_A 67 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---I 142 (353)
T ss_dssp HHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 46799999988 89999999999999999999999999999999996544 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 143 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 220 (353)
T 2i0e_A 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220 (353)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCC
Confidence 9999999999999999999999999986432221 23456799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
|....... .... ..... .. ++...+.++.+||.+||+.||.+||+ ++++++|.
T Consensus 221 f~~~~~~~---~~~~---i~~~~--------~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 221 FEGEDEDE---LFQS---IMEHN--------VA----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp SCCSSHHH---HHHH---HHHCC--------CC----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred CCCCCHHH---HHHH---HHhCC--------CC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 97643211 1110 00000 01 11223578999999999999999995 57888763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=324.04 Aligned_cols=211 Identities=25% Similarity=0.379 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++|||||++++++.. +..++|||||.+|+|.+++......+++..++.++.||+.||.|||+++ |+
T Consensus 383 ~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ii 458 (613)
T 2ozo_A 383 MMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 458 (613)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 7899999999999999999999876 5699999999999999999777777999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+|||++.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 459 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998764432211 1222345688999999999999999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... .... . ..+..++..+.+||.+||+.||++|||+.+|++.|+.
T Consensus 539 Pf~~~~~~~---~~~~i~----~~~~------~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 539 PYKKMKGPE---VMAFIE----QGKR------M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTTTCCSHH---HHHHHH----TTCC------C----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHHH---HHHHHH----cCCC------C----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 998654322 111111 1100 0 1122345789999999999999999999999998863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.46 Aligned_cols=214 Identities=23% Similarity=0.313 Sum_probs=170.7
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|++++.++ +||||+++++++.+.+..|+|||||++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ |
T Consensus 62 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~g---i 137 (342)
T 2qr7_A 62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQG---V 137 (342)
T ss_dssp CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 46899999888 79999999999999999999999999999999996654 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCC----CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 81 IYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 81 iH~dlkp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
+||||||+||++..+ +.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 138 vHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215 (342)
T ss_dssp ECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence 999999999998443 3599999999987544322 2234578999999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
|..||................. .. ...........+..+.+||.+||+.||++|||+.++++|..
T Consensus 216 g~~Pf~~~~~~~~~~~~~~i~~---~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 216 GYTPFANGPDDTPEEILARIGS---GK--------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp SSCSSCSSTTSCHHHHHHHHHH---CC--------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CCCCCCCCCcCCHHHHHHHHcc---CC--------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 9999976433222111111110 00 00111111233578999999999999999999999998743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=295.90 Aligned_cols=214 Identities=23% Similarity=0.338 Sum_probs=171.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCee-EEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~-~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++||||+++++++.+.+.. ++||||+.+++|.+++......+++..++.++.|++.||.|||+.+ +
T Consensus 69 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i 145 (298)
T 3pls_A 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---F 145 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 67899999999999999999999876665 9999999999999999887778999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc--ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
+||||||+||+++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 146 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 225 (298)
T 3pls_A 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRG 225 (298)
T ss_dssp CCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred ccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCC
Confidence 9999999999999999999999999986543221 11223356788999999999999999999999999999999965
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.|+....... ........ . .... .+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~--~~~~~~~~----~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 226 APPYRHIDPF--DLTHFLAQ----G------RRLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCTTTTSCGG--GHHHHHHT----T------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHH--HHHHHhhc----C------CCCC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5543322111 11111110 0 0011 1112346899999999999999999999999988654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=294.42 Aligned_cols=212 Identities=27% Similarity=0.430 Sum_probs=174.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 50 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 126 (267)
T 3t9t_A 50 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126 (267)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 679999999999999999999999999999999999999999999877667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 127 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 205 (267)
T 3t9t_A 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205 (267)
T ss_dssp CSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCC
Confidence 99999999999999999999999998654321 111223456788999999998899999999999999999999 8999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|....... .... .... ..... +...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 206 ~~~~~~~~---~~~~----i~~~------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 206 YENRSNSE---VVED----ISTG------FRLYK----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TTTCCHHH---HHHH----HHTT------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHH---HHHH----HhcC------CcCCC----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 87543211 1110 0000 00011 112246889999999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=297.34 Aligned_cols=213 Identities=24% Similarity=0.381 Sum_probs=164.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~-----~~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
|.+|++++++++||||+++++++.+.+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|
T Consensus 83 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 162 (313)
T 3brb_A 83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162 (313)
T ss_dssp HHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999998765 34999999999999999842 33569999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
||+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++
T Consensus 163 LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 239 (313)
T 3brb_A 163 LSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239 (313)
T ss_dssp HHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHH
Confidence 99998 999999999999999999999999999876543332333345678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 152 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 152 ~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|+|++ |..||........ ...... . .... .+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 240 ~el~~~g~~p~~~~~~~~~---~~~~~~----~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 240 WEIATRGMTPYPGVQNHEM---YDYLLH----G------HRLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTTSCCSSTTCCGGGH---HHHHHT----T------CCCC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCccCCHHHH---HHHHHc----C------CCCC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999 8889876533211 111100 0 0011 112234689999999999999999999999999
Q ss_pred hCCC
Q 021891 231 LKPL 234 (306)
Q Consensus 231 l~~~ 234 (306)
|+.+
T Consensus 303 L~~l 306 (313)
T 3brb_A 303 LEKL 306 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=317.22 Aligned_cols=210 Identities=30% Similarity=0.396 Sum_probs=174.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|++++||||+++++++.+.+..|+||||++||+|.+++...+ ..+++..++.++.||+.||.|||+.+ |
T Consensus 231 ~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---I 307 (576)
T 2acx_A 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---I 307 (576)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 5789999999999999999999999999999999999999999997653 35999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|||++|..|
T Consensus 308 vHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~P 384 (576)
T 2acx_A 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384 (576)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654322 2345799999999999998999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
|...........+..... . .... ++...+.++.+||.+||+.||.+|| ++.|+++|.
T Consensus 385 F~~~~~~~~~~~i~~~i~--~--------~~~~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 385 FQQRKKKIKREEVERLVK--E--------VPEE----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp SSCSSSCCCHHHHHHHHH--H--------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred CcccccchhHHHHHHHhh--c--------cccc----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 987543322111111110 0 0111 1222357899999999999999999 789999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=300.10 Aligned_cols=210 Identities=26% Similarity=0.404 Sum_probs=171.0
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
|.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.+.. ..+++..++.++.||
T Consensus 72 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 151 (327)
T 1fvr_A 72 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151 (327)
T ss_dssp HHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHH
Confidence 67899999999 99999999999999999999999999999999997653 469999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... .......++..|+|||++.+..++.++|||
T Consensus 152 ~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 225 (327)
T 1fvr_A 152 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVW 225 (327)
T ss_dssp HHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcch
Confidence 99999999998 999999999999999999999999999753221 112234568889999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|+|++ |..||....... ... ..... .... .+...+..+.+||.+||+.||.+|||+
T Consensus 226 slG~il~ellt~g~~pf~~~~~~~---~~~----~~~~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~ 288 (327)
T 1fvr_A 226 SYGVLLWEIVSLGGTPYCGMTCAE---LYE----KLPQG------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSF 288 (327)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHH---HHH----HGGGT------CCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHcCCCCCCCCCcHHH---HHH----HhhcC------CCCC----CCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 99999999998 999997643211 110 00000 0111 112234689999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.+++++|+.+
T Consensus 289 ~ell~~L~~~ 298 (327)
T 1fvr_A 289 AQILVSLNRM 298 (327)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=300.35 Aligned_cols=210 Identities=22% Similarity=0.308 Sum_probs=171.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++
T Consensus 62 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iv 137 (321)
T 2a2a_A 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IA 137 (321)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 689999999999999999999999999999999999999999999654 47899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC----cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
||||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 138 H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 214 (321)
T 2a2a_A 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214 (321)
T ss_dssp CCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHC
Confidence 999999999999887 799999999987654322 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
..||........ ..... .... ..++.... ..+..+.+||.+||+.||++|||+.|+++|..
T Consensus 215 ~~pf~~~~~~~~---~~~i~---~~~~----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 215 ASPFLGDTKQET---LANIT---SVSY----DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp CCSSCCSSHHHH---HHHHH---TTCC----CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred CCCCCCCCHHHH---HHHHH---hccc----ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 999975432111 10000 0000 00110001 12467899999999999999999999999743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=300.75 Aligned_cols=219 Identities=27% Similarity=0.390 Sum_probs=173.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+++|++++++++||||+++++++.+. +..++||||+++++|.+++......+++..++.++.|++.||.|||+.+
T Consensus 70 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 146 (302)
T 4e5w_A 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--- 146 (302)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---
Confidence 67899999999999999999999876 6689999999999999999776667999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+||+++.++.+||+|||++......... .......||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 147 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (302)
T 4e5w_A 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226 (302)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence 999999999999999999999999999876544322 2233456788899999999999999999999999999999999
Q ss_pred CCCCCCCC--------CCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRP--------NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.|+..... .............. ........+...+..+.+||.+||+.||.+|||+.++++.
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTL----------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp CGGGSHHHHHHHHHCSCCGGGHHHHHHHHH----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCcchhhHHhhccCCcccccCHHHHHHHH----------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 88643210 00000000000000 0001111222345789999999999999999999999998
Q ss_pred hCC
Q 021891 231 LKP 233 (306)
Q Consensus 231 l~~ 233 (306)
|+.
T Consensus 297 L~~ 299 (302)
T 4e5w_A 297 FEA 299 (302)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=295.58 Aligned_cols=211 Identities=23% Similarity=0.346 Sum_probs=175.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ +
T Consensus 56 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 132 (288)
T 3kfa_A 56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 132 (288)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---C
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---c
Confidence 679999999999999999999999999999999999999999999764 446999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 133 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~ 211 (288)
T 3kfa_A 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211 (288)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998765432 223334567889999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ ...... ..... .+...+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 212 p~~~~~~~~~---~~~~~~----------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 212 PYPGIDLSQV---YELLEK----------DYRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp SSTTCCGGGH---HHHHHT----------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCHHHH---HHHHhc----------cCCCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 9976543221 111100 00111 112235789999999999999999999999998864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=291.92 Aligned_cols=211 Identities=26% Similarity=0.379 Sum_probs=171.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++++.++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++
T Consensus 52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 127 (276)
T 2yex_A 52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---IT 127 (276)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 678999999999999999999999999999999999999999988544 46999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.+||+|||++................|+..|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 128 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 207 (276)
T 2yex_A 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (276)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986543332223344678999999999987665 7799999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|........ ....+.. ... ... .....+..+.+||.+||+.||.+|||+.|++++.
T Consensus 208 ~~~~~~~~~-~~~~~~~-----~~~---~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 208 WDQPSDSCQ-EYSDWKE-----KKT---YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp CSCSCTTSH-HHHHHHT-----TCT---TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCCCchHHH-HHHHhhh-----ccc---ccC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 976543221 1111110 000 000 0112346788999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=292.67 Aligned_cols=204 Identities=26% Similarity=0.433 Sum_probs=167.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++.+.+..++||||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+
T Consensus 56 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~ 131 (279)
T 3fdn_A 56 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR---VI 131 (279)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---CE
T ss_pred HHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 6789999999999999999999999999999999999999999986543 6999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 132 H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 207 (279)
T 3fdn_A 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207 (279)
T ss_dssp ECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cccCChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999998664332 123457899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...........+ . . .... ++...+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 208 ~~~~~~~~~~~~---~---~--------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 208 EANTYQETYKRI---S---R--------VEFT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CCSSHHHHHHHH---H---H--------TCCC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCCcHHHHHHHH---H---h--------CCCC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 754321110000 0 0 0011 1112346789999999999999999999999963
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.61 Aligned_cols=206 Identities=29% Similarity=0.355 Sum_probs=165.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~~~~i 80 (306)
+.+|+++|+.++||||+++++++.+.+..++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+ .+ |
T Consensus 195 ~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~g---i 270 (446)
T 4ejn_A 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN---V 270 (446)
T ss_dssp ------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTC---C
T ss_pred HHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC---E
Confidence 5679999999999999999999999999999999999999999986543 79999999999999999999998 88 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 271 iHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 348 (446)
T 4ejn_A 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348 (446)
T ss_dssp CCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCC
Confidence 9999999999999999999999999986433221 23446799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
|........ .. ...... .. ++...+..+.+||.+||+.||.+|| |++|+++|.
T Consensus 349 f~~~~~~~~---~~---~i~~~~--------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 349 FYNQDHEKL---FE---LILMEE--------IR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp SCCSSHHHH---HH---HHHHCC--------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCCCCHHHH---HH---HHHhCC--------CC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 976432111 11 011110 01 1112346889999999999999999 999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=315.82 Aligned_cols=213 Identities=26% Similarity=0.413 Sum_probs=173.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++|++|+||||+++++++. .+..++|||||.+|+|.+++... ...+++..++.++.||+.||.|||+++ |
T Consensus 230 ~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i 305 (454)
T 1qcf_A 230 FLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 305 (454)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 789999999999999999999986 66789999999999999999754 236899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+|||++.++.+||+|||+++...... ........++..|+|||++....++.++|||||||++|||++ |..
T Consensus 306 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~ 384 (454)
T 1qcf_A 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384 (454)
T ss_dssp CCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCC
Confidence 999999999999999999999999998754321 111223346778999999998999999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
||....... ...... ... .. . .+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 385 P~~~~~~~~---~~~~i~----~~~---~~---~----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 385 PYPGMSNPE---VIRALE----RGY---RM---P----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp SSTTCCHHH---HHHHHH----HTC---CC---C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCHHH---HHHHHH----cCC---CC---C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 997643211 111111 000 11 1 112235789999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=295.23 Aligned_cols=211 Identities=25% Similarity=0.331 Sum_probs=169.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+ +..++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ ++
T Consensus 60 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 135 (281)
T 3cc6_A 60 FMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135 (281)
T ss_dssp HHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 6789999999999999999999764 4578999999999999999776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p 214 (281)
T 3cc6_A 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214 (281)
T ss_dssp CCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987644322 12233456888999999999999999999999999999998 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
|........ ...... .. .... +...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 215 ~~~~~~~~~---~~~~~~----~~------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 215 FFWLENKDV---IGVLEK----GD------RLPK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp TTTSCGGGH---HHHHHH----TC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCChHHH---HHHHhc----CC------CCCC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 975433221 111100 00 0011 112346789999999999999999999999998643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=300.41 Aligned_cols=214 Identities=29% Similarity=0.411 Sum_probs=174.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhcCCCC---------------CCHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKIALG 64 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~---------------l~~~~~~~~~~q 64 (306)
|.+|+++++++ +||||+++++++...+ ..++||||+++++|.+++...... +++..++.++.|
T Consensus 77 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 156 (316)
T 2xir_A 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156 (316)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHH
T ss_pred HHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHH
Confidence 67899999999 7999999999988765 489999999999999999765432 889999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHH
Q 021891 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 144 (306)
Q Consensus 65 i~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 144 (306)
++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............||..|+|||++.+..++.++||
T Consensus 157 i~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 233 (316)
T 2xir_A 157 VAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233 (316)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHH
Confidence 999999999998 99999999999999999999999999987655444344445667899999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 145 YSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 145 wslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
|||||++|+|++ |..||........ ...... ... .... +...+..+.+++.+||+.||.+|||
T Consensus 234 ~slG~il~~l~t~g~~p~~~~~~~~~--~~~~~~----~~~------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 234 WSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLK----EGT------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHH--HHHHHH----HTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCCcccchhHH--HHHHhc----cCc------cCCC----CCCCCHHHHHHHHHHcCCChhhCcC
Confidence 999999999998 9999976543211 111000 000 0111 1123468899999999999999999
Q ss_pred HHHHHHHhCCC
Q 021891 224 MSEVVEALKPL 234 (306)
Q Consensus 224 ~~ell~~l~~~ 234 (306)
+.+++++|+.+
T Consensus 298 ~~ell~~L~~~ 308 (316)
T 2xir_A 298 FSELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=302.94 Aligned_cols=205 Identities=27% Similarity=0.373 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++||||+++++++.+++..++||||+. |+|.+++......+++..++.++.|++.||.|||+.+ |+
T Consensus 101 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 176 (348)
T 1u5q_A 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MI 176 (348)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 6789999999999999999999999999999999996 6888888666668999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++.++.+||+|||+++..... ....||+.|+|||++. ...++.++|||||||++|||++|.
T Consensus 177 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~ 250 (348)
T 1u5q_A 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250 (348)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred eCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999875332 2357899999999985 567899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||........ ....... ..+... ....+..+.+||.+||+.||++|||+.+++++..
T Consensus 251 ~p~~~~~~~~~------~~~~~~~-------~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 251 PPLFNMNAMSA------LYHIAQN-------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CTTTTSCHHHH------HHHHHHS-------CCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCCCCChHHH------HHHHHhc-------CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 99975432111 1000000 001110 1122467899999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=300.14 Aligned_cols=200 Identities=24% Similarity=0.298 Sum_probs=168.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|++++||||+++++++.+.+..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+.+ |
T Consensus 76 ~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---i 151 (335)
T 3dls_A 76 VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKD---I 151 (335)
T ss_dssp EEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 457999999999999999999999999999999999776 9999886544 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~ 159 (306)
+||||||+||+++.++.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus 152 vH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 9999999999999999999999999987654332 233568999999999988776 889999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||........ ..... +...+..+.+||.+||+.||++|||+.+++++..
T Consensus 229 pf~~~~~~~~------------------~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 229 PFCELEETVE------------------AAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp SCSSGGGGTT------------------TCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred chhhHHHHHh------------------hccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 9964211000 00000 1112468899999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=312.42 Aligned_cols=224 Identities=22% Similarity=0.291 Sum_probs=160.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++|++|+||||+++++++... +..|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+
T Consensus 99 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ 176 (458)
T 3rp9_A 99 ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG 176 (458)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 57899999999999999999998543 5789999998 56999988654 47999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-------------------------eeeecccccccccCCc
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPE 131 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE 131 (306)
|+||||||+|||++.++.+||+|||+++........ ......+||++|+|||
T Consensus 177 ---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 177 ---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp ---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred ---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 999999999999999999999999999875432110 1223467899999999
Q ss_pred chh-cCCCCchhHHHHHHHHHHHHHh-----------CCCCCCCCCCCCCc-----------------chHHhhhhhhcc
Q 021891 132 YVM-TGHLTSRSDVYSFGVVLLEMLT-----------GRRSMDKNRPNGEH-----------------NLVEWARPHLGE 182 (306)
Q Consensus 132 ~~~-~~~~~~~~DiwslG~il~ellt-----------g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~ 182 (306)
++. +..|+.++|||||||++|||++ |.++|.+....... ..+.......+.
T Consensus 254 ~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~ 333 (458)
T 3rp9_A 254 LILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333 (458)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCC
T ss_pred HhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCC
Confidence 864 6679999999999999999999 56666543311000 000000000000
Q ss_pred -------------ccccccccCC----ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 183 -------------RRRFYRLIDP----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 183 -------------~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...+...+.. .+.. .....+.++.+||.+||+.||++|||++|+++|.
T Consensus 334 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAE-RFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp CCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG-GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH-HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 0000000000 0000 0112357889999999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=298.83 Aligned_cols=208 Identities=22% Similarity=0.357 Sum_probs=163.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----------------------------------------------------
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD----------------------------------------------------- 28 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~----------------------------------------------------- 28 (306)
|.+|+++|++|+||||+++++++.+..
T Consensus 51 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (332)
T 3qd2_B 51 VMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130 (332)
T ss_dssp HHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------------
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCC
Confidence 679999999999999999999987654
Q ss_pred ----eeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEec
Q 021891 29 ----QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 102 (306)
Q Consensus 29 ----~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D 102 (306)
..++|||||++++|.+++.+.. ...++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 131 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 207 (332)
T 3qd2_B 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 207 (332)
T ss_dssp -CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred CCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEee
Confidence 2799999999999999997653 23566778999999999999999998 99999999999999999999999
Q ss_pred cCCcccCCCCCcc----------eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 021891 103 FGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 172 (306)
Q Consensus 103 fg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 172 (306)
||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..|+...
T Consensus 208 fG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------- 279 (332)
T 3qd2_B 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------- 279 (332)
T ss_dssp CTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------
T ss_pred cCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------
Confidence 9999876543211 1223457899999999999999999999999999999999986654210
Q ss_pred HHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
...... .. ... ........+..+.+||.+||+.||++|||+.|++++.
T Consensus 280 ~~~~~~-~~---------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 280 VRIITD-VR---------NLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHH-HH---------TTC-CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHH-hh---------ccC-CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 000000 00 000 0011123346788999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=293.00 Aligned_cols=220 Identities=26% Similarity=0.335 Sum_probs=167.6
Q ss_pred HHHHHHHHhc--CCCCcccceeeEEEeC----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--
Q 021891 2 WQAEVNFLGD--LVHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-- 73 (306)
Q Consensus 2 ~~~E~~il~~--l~H~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH-- 73 (306)
+.+|.+++.. ++||||+++++++... ...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||
T Consensus 47 ~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~ 124 (301)
T 3q4u_A 47 WFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIE 124 (301)
T ss_dssp HHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHh
Confidence 4566777666 7999999999987653 458999999999999999944 36999999999999999999999
Q ss_pred ------cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhcC------CCC
Q 021891 74 ------EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLT 139 (306)
Q Consensus 74 ------~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~ 139 (306)
+.+ |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++
T Consensus 125 ~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 201 (301)
T 3q4u_A 125 IFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201 (301)
T ss_dssp BCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHH
T ss_pred hhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCC
Confidence 777 9999999999999999999999999997654332221 12234789999999999876 445
Q ss_pred chhHHHHHHHHHHHHHhC----------CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccC-CCCCHHHHHHHHH
Q 021891 140 SRSDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE-GHFSIKGAQKAAQ 208 (306)
Q Consensus 140 ~~~DiwslG~il~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 208 (306)
.++|||||||++|||++| ..||................ .... ...+... ..+....+..+.+
T Consensus 202 ~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~l~~ 274 (301)
T 3q4u_A 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV-VCVD------QQRPNIPNRWFSDPTLTSLAK 274 (301)
T ss_dssp HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH-HTTS------CCCCCCCGGGGGSHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHH-Hhcc------CCCCCCChhhccCccHHHHHH
Confidence 799999999999999999 77876554433221111000 0000 0011111 1123356789999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 209 LAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 209 li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|+.+||+.||++|||+.++++.|+.
T Consensus 275 li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 275 LMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhhcChhhCCCHHHHHHHHhc
Confidence 9999999999999999999998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=304.73 Aligned_cols=230 Identities=25% Similarity=0.315 Sum_probs=175.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEE--eCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCI--EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|++|++++++++||||+++++++. +.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+
T Consensus 71 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--- 147 (327)
T 3lxl_A 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147 (327)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 689999999999999999999987 455789999999999999999775557999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+||+++.++.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 148 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~ 227 (327)
T 3lxl_A 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227 (327)
T ss_dssp EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998765433222 223356788899999999989999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
.||........... .. .............+........+...+..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 228 ~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 228 DKSCSPSAEFLRMM-GC-ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CGGGSHHHHHHHHC-C-----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred CCCccccchhhhhc-cc-ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99864321100000 00 000000000000011111111222345789999999999999999999999999976543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=293.96 Aligned_cols=210 Identities=25% Similarity=0.361 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++ ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++
T Consensus 65 ~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~ 139 (291)
T 1xbb_A 65 LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FV 139 (291)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eE
Confidence 67899999999999999999998 567889999999999999999765 36999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 219 (291)
T 1xbb_A 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219 (291)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999998765433222 1222446788999999998889999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... ... .+. .+...+..+.++|.+||+.||.+|||+.++++.|+.
T Consensus 220 p~~~~~~~~---~~~~~~----~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 220 PYRGMKGSE---VTAMLE----KGE------RMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp SSTTCCHHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHHH---HHHHHH----cCC------CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 997643211 111100 000 011 122335789999999999999999999999998864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.83 Aligned_cols=212 Identities=27% Similarity=0.309 Sum_probs=165.7
Q ss_pred HHHHHH-HhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~i-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
.+|..+ ++.++||||+++++++.+.+..|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||+.+ |+
T Consensus 86 ~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---iv 161 (373)
T 2r5t_A 86 MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLN---IV 161 (373)
T ss_dssp -----CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 455555 567899999999999999999999999999999999986543 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 162 HrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf 239 (373)
T 2r5t_A 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239 (373)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998633221 1234568999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 238 (306)
........ . ....... ... +...+..+.+||.+||+.||.+||++.+.++.+...+.+.
T Consensus 240 ~~~~~~~~---~---~~i~~~~--------~~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 240 YSRNTAEM---Y---DNILNKP--------LQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp CCSBHHHH---H---HHHHHSC--------CCC----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred CCCCHHHH---H---HHHHhcc--------cCC----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 75432111 1 1001000 011 1123468899999999999999999865555444444443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.61 Aligned_cols=227 Identities=22% Similarity=0.236 Sum_probs=176.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC--eeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
+.+|+++|++++||||+++++++...+ ..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+
T Consensus 54 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 132 (396)
T 4eut_A 54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132 (396)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 568999999999999999999998765 7799999999999999996543 23999999999999999999999998
Q ss_pred CCeEeccCCCCCeEE----cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc--------CCCCchhHHH
Q 021891 78 RPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVY 145 (306)
Q Consensus 78 ~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diw 145 (306)
|+||||||+||++ +.++.+||+|||+++...... ......||..|+|||++.+ ..++.++|||
T Consensus 133 --ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diw 207 (396)
T 4eut_A 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207 (396)
T ss_dssp --EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHH
T ss_pred --EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHH
Confidence 9999999999999 778889999999998764432 1234568999999999875 5678899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcc-hHHhhhhhhcc----------ccccccccCCccCCCCCHHHHHHHHHHHHHcc
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGE----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 214 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 214 (306)
||||++|||++|..||.......... .+......... ...+.-.-.......+....+..+.+++.+||
T Consensus 208 SlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L 287 (396)
T 4eut_A 208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287 (396)
T ss_dssp HHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhh
Confidence 99999999999999997544322211 11111100000 00000000111223456788899999999999
Q ss_pred cCCCCCCCCHHHHHHHhCCC
Q 021891 215 SRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 215 ~~~p~~Rps~~ell~~l~~~ 234 (306)
+.||++|||+.++++.++.+
T Consensus 288 ~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 288 EADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp CCCTTTSCCHHHHHHHHHHH
T ss_pred ccChhhhccHHHHHHHHHHH
Confidence 99999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.12 Aligned_cols=213 Identities=24% Similarity=0.376 Sum_probs=168.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++|++|+||||+++++++.+ +..++||||+++|+|.+++... +..+++..+..++.||+.||.|||+++ |
T Consensus 226 ~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i 301 (452)
T 1fmk_A 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 301 (452)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 7899999999999999999999876 6789999999999999999653 346899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 302 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~ 380 (452)
T 1fmk_A 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380 (452)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987543221 12233456788999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
||....... ...... .. .... .+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 381 P~~~~~~~~---~~~~i~----~~------~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 381 PYPGMVNRE---VLDQVE----RG------YRMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp SSTTCCHHH---HHHHHH----TT------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCHHH---HHHHHH----cC------CCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 997643211 111110 00 0011 112335789999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=293.83 Aligned_cols=207 Identities=25% Similarity=0.327 Sum_probs=163.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|+++|++++||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 67 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-- 144 (285)
T 3is5_A 67 IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-- 144 (285)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 679999999999999999999999999999999999999999988542 457999999999999999999999998
Q ss_pred CeEeccCCCCCeEE---cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 79 ~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
|+||||||+||++ +.++.+||+|||++....... ......||..|+|||++. ..++.++|||||||++|+|+
T Consensus 145 -ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp -CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH
T ss_pred -EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHH
Confidence 9999999999999 456889999999998654322 223456899999999875 57899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|..||............. ..... . ..... ..+..+.+||.+||+.||++|||+.|++++
T Consensus 220 ~g~~pf~~~~~~~~~~~~~------~~~~~----~-~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 220 TGCLPFTGTSLEEVQQKAT------YKEPN----Y-AVECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HSSCSSCCSSHHHHHHHHH------HCCCC----C-CC--C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred hCCCCCCCCCHHHHHhhhc------cCCcc----c-ccccC----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999997643211100000 00000 0 00000 124678899999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=311.96 Aligned_cols=210 Identities=24% Similarity=0.340 Sum_probs=172.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|+++|++++||||+++++++.+.+.+|+||||++||+|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 232 ~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-- 309 (543)
T 3c4z_A 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309 (543)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--
Confidence 568999999999999999999999999999999999999999998654 346999999999999999999999998
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 310 -IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~ 386 (543)
T 3c4z_A 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386 (543)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCC
Confidence 99999999999999999999999999987654322 123457999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~ 230 (306)
.||...........+ ........ . .++...+..+.+||.+||+.||.+||++ .+|++|
T Consensus 387 ~PF~~~~~~~~~~~~--~~~i~~~~--------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 387 GPFRARGEKVENKEL--KQRVLEQA--------V----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CSSCCTTCCCCHHHH--HHHHHHCC--------C----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCCCCCccchhHHHH--HHHHhhcc--------c----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 999875432221111 11111110 0 1122335788999999999999999965 667764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=291.19 Aligned_cols=209 Identities=22% Similarity=0.308 Sum_probs=169.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++.+.+..++||||+++++|.+.+..+. .+++..++.++.|++.||.|||+.+ ++
T Consensus 52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 127 (284)
T 3kk8_A 52 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG---IV 127 (284)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cC
Confidence 5789999999999999999999999999999999999999999886553 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCc---EEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++.++. +||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 128 H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence 9999999999976655 99999999987644322 23457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||........ ..... .... ....+ . ....+..+.+||.+||+.||++|||+.|++++.
T Consensus 205 ~pf~~~~~~~~---~~~~~---~~~~---~~~~~-~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 205 PPFWDEDQHRL---YAQIK---AGAY---DYPSP-E----WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp CSSCCSSHHHH---HHHHH---HTCC---CCCTT-T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred CCCCCCchhHH---HHHHH---hccc---cCCch-h----hcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 99975432111 11000 0000 00000 0 112346789999999999999999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=301.36 Aligned_cols=213 Identities=23% Similarity=0.258 Sum_probs=164.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC--------------------------------
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------------------------------- 49 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------------------------- 49 (306)
|.+|++++++++||||+++++++.+.+..++|||||++|+|.+++...
T Consensus 75 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (345)
T 3hko_A 75 IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154 (345)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC
T ss_pred HHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccc
Confidence 678999999999999999999999999999999999999999988421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCC--cEEEeccCCcccCCCCC--cceee
Q 021891 50 -------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGD--KTHVS 118 (306)
Q Consensus 50 -------~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~--~~~~~ 118 (306)
...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+++...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 231 (345)
T 3hko_A 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231 (345)
T ss_dssp --CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccc
Confidence 112467788999999999999999998 99999999999998776 89999999998643221 11123
Q ss_pred ecccccccccCCcchhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCC
Q 021891 119 TRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 196 (306)
Q Consensus 119 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (306)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ . ......... ...+.
T Consensus 232 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~---~~~~~~~~~---~~~~~--- 299 (345)
T 3hko_A 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT---I---SQVLNKKLC---FENPN--- 299 (345)
T ss_dssp ---CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHHCCCC---TTSGG---
T ss_pred cccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH---H---HHHHhcccc---cCCcc---
Confidence 44678999999999975 6789999999999999999999999976432211 1 101100000 00010
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 197 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 197 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
....+..+.+||.+||+.||.+|||+.+++++.
T Consensus 300 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 300 --YNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp --GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred --cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 111346889999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=295.85 Aligned_cols=223 Identities=25% Similarity=0.286 Sum_probs=168.5
Q ss_pred HHHHHHHHhcCC---CCcccceeeEEEeCC-----eeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLV---HLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~---H~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|+++++.++ ||||+++++++.... ..++||||+. ++|.+++.... ..+++..++.++.||+.||.||
T Consensus 58 ~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l 136 (308)
T 3g33_A 58 TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136 (308)
T ss_dssp HHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 467888888775 999999999998765 5799999996 59999987654 3499999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ |+||||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 137 H~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 210 (308)
T 3g33_A 137 HANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 210 (308)
T ss_dssp HHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHH
T ss_pred HHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHH
Confidence 9998 9999999999999999999999999998754322 234467899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhh-----hccccccc-cccCCccC---CCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPH-----LGERRRFY-RLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
+|++|..||...........+...... +.....+. ..+.+... .......+..+.+||.+||+.||++|||
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 290 (308)
T 3g33_A 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290 (308)
T ss_dssp HTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC
Confidence 999999999765432211111000000 00000000 00000000 0001123468899999999999999999
Q ss_pred HHHHHHHh
Q 021891 224 MSEVVEAL 231 (306)
Q Consensus 224 ~~ell~~l 231 (306)
+.|+++|.
T Consensus 291 ~~e~l~h~ 298 (308)
T 3g33_A 291 AFRALQHS 298 (308)
T ss_dssp HHHHHTST
T ss_pred HHHHhcCc
Confidence 99999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=301.08 Aligned_cols=213 Identities=24% Similarity=0.381 Sum_probs=170.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
|.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.
T Consensus 80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 159 (327)
T 2yfx_A 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159 (327)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 6789999999999999999999999999999999999999999997653 3589999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+ |+||||||+||+++. +..+||+|||+++...............|+..|+|||++.+..++.++|||||||++|
T Consensus 160 ~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 236 (327)
T 2yfx_A 160 H---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236 (327)
T ss_dssp T---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred C---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence 8 999999999999984 4569999999987543332222333456788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++ |..||....... ...... ... ... .+...+..+.+||.+||+.||.+|||+.+++++|
T Consensus 237 ellt~g~~p~~~~~~~~---~~~~~~----~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 237 EIFSLGYMPYPSKSNQE---VLEFVT----SGG------RMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp HHHTTSCCSSTTCCHHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCcCHHH---HHHHHh----cCC------CCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 9998 899987543211 111110 000 011 1112346889999999999999999999999998
Q ss_pred CCC
Q 021891 232 KPL 234 (306)
Q Consensus 232 ~~~ 234 (306)
+.+
T Consensus 300 ~~~ 302 (327)
T 2yfx_A 300 EYC 302 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=295.93 Aligned_cols=202 Identities=24% Similarity=0.278 Sum_probs=160.5
Q ss_pred HHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 3 QAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..|+..+.++ +||||+++++++.+.+..++||||+ +++|.+++...+..+++..++.++.||+.||.|||+.+ |+
T Consensus 104 ~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 179 (311)
T 3p1a_A 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LV 179 (311)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 3455555444 9999999999999999999999999 67999998777778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..++
T Consensus 180 H~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp CCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred cCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998754332 2334568999999999876 7999999999999999999997766
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
..... +.. ... ....+.. ....+..+.+||.+||+.||++|||+.|++++.
T Consensus 256 ~~~~~--------~~~--~~~-----~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 256 HGGEG--------WQQ--LRQ-----GYLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp SSHHH--------HHH--HTT-----TCCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCccH--------HHH--Hhc-----cCCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 43210 000 000 0001111 112347899999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=295.95 Aligned_cols=211 Identities=25% Similarity=0.388 Sum_probs=159.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCe----eEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|++|++++++++||||+++++++..... .|+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 59 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~- 136 (311)
T 3ork_A 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG- 136 (311)
T ss_dssp HHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 6789999999999999999999887553 499999999999999996544 6999999999999999999999998
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 137 --ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 214 (311)
T 3ork_A 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214 (311)
T ss_dssp --CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred --CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999999999999999999875443221 22234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|..||........ .......... .+. ......+.++.+||.+||+.||++||++.+++.+
T Consensus 215 g~~pf~~~~~~~~------~~~~~~~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 215 GEPPFTGDSPVSV------AYQHVREDPI-----PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp SSCSCCCSSHHHH------HHHHHHCCCC-----CHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCCCCCChHHH------HHHHhcCCCC-----Ccc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 9999976432111 0000000000 000 0001134688999999999999999987776654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=291.38 Aligned_cols=207 Identities=23% Similarity=0.299 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|++++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++
T Consensus 53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~ 128 (277)
T 3f3z_A 53 FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLN---VA 128 (277)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 6789999999999999999999999999999999999999999886543 6899999999999999999999998 99
Q ss_pred eccCCCCCeEE---cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||++ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|.
T Consensus 129 H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~ 204 (277)
T 3f3z_A 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGY 204 (277)
T ss_dssp CCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSS
T ss_pred CCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCC
Confidence 99999999999 788999999999998765432 2234568999999998865 4899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||........ ..... ..... ...... ...+..+.+||.+||+.||++|||+.+++++
T Consensus 205 ~p~~~~~~~~~---~~~~~---~~~~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 205 PPFSAPTDSEV---MLKIR---EGTFT----FPEKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CSSCCSSHHHH---HHHHH---HCCCC----CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCCCHHHH---HHHHH---hCCCC----CCchhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99976432111 10000 00000 000000 0124688999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=310.17 Aligned_cols=221 Identities=23% Similarity=0.262 Sum_probs=162.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|+.++||||+++++++... ...|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.
T Consensus 108 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~ 183 (464)
T 3ttj_A 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 183 (464)
T ss_dssp HHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC
Confidence 57899999999999999999999765 357999999965 67776643 489999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 184 ~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 257 (464)
T 3ttj_A 184 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257 (464)
T ss_dssp T---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred C---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999998754322 234467899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhh----------------hhhccc-----cccccccCCccC---CCCCHHHHHHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEWAR----------------PHLGER-----RRFYRLIDPRLE---GHFSIKGAQKAAQLAA 211 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~----------------~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~li~ 211 (306)
+|+.||.+....+....+.... ...... ..+...+..... .......+.++.+||.
T Consensus 258 ~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 337 (464)
T 3ttj_A 258 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337 (464)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHH
Confidence 9999998654322111110000 000000 000000000000 0011223678999999
Q ss_pred HcccCCCCCCCCHHHHHHHhC
Q 021891 212 HCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l~ 232 (306)
+||+.||++|||++|+++|..
T Consensus 338 ~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 338 KMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp HHSCSSTTTSCCHHHHHTSTT
T ss_pred HHcCCChhhCCCHHHHhcChh
Confidence 999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=291.77 Aligned_cols=203 Identities=25% Similarity=0.387 Sum_probs=170.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++
T Consensus 61 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 136 (284)
T 2vgo_A 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK---VI 136 (284)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred HHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 6789999999999999999999999999999999999999999986554 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++....... .....|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 137 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 212 (284)
T 2vgo_A 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212 (284)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987654321 23456899999999999989999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
........ ...... .+.. ++...+..+.+||.+||+.||.+|||+.++++|
T Consensus 213 ~~~~~~~~------~~~~~~--------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 213 DSPSHTET------HRRIVN--------VDLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCSSHHHH------HHHHHT--------TCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCCHhHH------HHHHhc--------cccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 75432111 000000 0111 112234688999999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=295.16 Aligned_cols=224 Identities=23% Similarity=0.283 Sum_probs=166.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+
T Consensus 49 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---iv 124 (311)
T 4agu_A 49 ALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN---CI 124 (311)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 578999999999999999999999999999999999998998877544 46999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 125 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 202 (311)
T 4agu_A 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202 (311)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987643322 2234578999999999986 6789999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhh--------hcccccc--ccccCCccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPH--------LGERRRF--YRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|...........+...... ......+ ....++...... ....+..+.+||.+||+.||.+|||++|+
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 282 (311)
T 4agu_A 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282 (311)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence 9765433221111110000 0000000 000011000000 01235678999999999999999999999
Q ss_pred HHHh
Q 021891 228 VEAL 231 (306)
Q Consensus 228 l~~l 231 (306)
++|.
T Consensus 283 l~hp 286 (311)
T 4agu_A 283 LHHP 286 (311)
T ss_dssp HTSG
T ss_pred hcCh
Confidence 9864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.44 Aligned_cols=209 Identities=25% Similarity=0.348 Sum_probs=160.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++||||+++++++. .+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+
T Consensus 187 ~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---iv 261 (419)
T 3i6u_A 187 VETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---II 261 (419)
T ss_dssp HHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 689999999999999999999975 55689999999999999988654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC---cEEEeccCCcccCCCCCcceeeecccccccccCCcchhc---CCCCchhHHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 82 H~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell 155 (306)
||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 262 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp CSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred ccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999997544 59999999998764322 2334679999999999853 57889999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|..||........ ........ ... ..+.... ..+..+.+||.+||+.||++|||+.|+++|.
T Consensus 339 tg~~pf~~~~~~~~--~~~~i~~~---~~~----~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 339 SGYPPFSEHRTQVS--LKDQITSG---KYN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HSSCSSCCCSSSCC--HHHHHHTT---CCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HCCCCCCCCcchHH--HHHHHhcC---CCC----CCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 99999976433221 11111100 000 0000001 1246889999999999999999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=323.58 Aligned_cols=210 Identities=24% Similarity=0.344 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++|+|||||++++++. .+..++|||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 417 ~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---ii 491 (635)
T 4fl3_A 417 LLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FV 491 (635)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 789999999999999999999986 45689999999999999999654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 492 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 571 (635)
T 4fl3_A 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571 (635)
T ss_dssp CSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543221 22233456788999999999999999999999999999998 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||........ ..... .. ... ..+..++.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 572 Pf~~~~~~~~---~~~i~----~~------~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 572 PYRGMKGSEV---TAMLE----KG------ERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp SSTTCCHHHH---HHHHH----TT------CCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHHHH---HHHHH----cC------CCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 9976533211 11100 00 001 1122345789999999999999999999999998863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=298.96 Aligned_cols=226 Identities=30% Similarity=0.436 Sum_probs=173.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++|++++||||+++++++.+. ...++||||+++++|.+++.+. .+++..++.++.||+.||.|||+.+
T Consensus 80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--- 154 (318)
T 3lxp_A 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--- 154 (318)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 68999999999999999999999884 5789999999999999999665 4899999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+||+++.++.+||+|||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 155 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~ 234 (318)
T 3lxp_A 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234 (318)
T ss_dssp EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999886554322 2233456788899999999989999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||........ ....+..... ....+...+........+...+..+.+||.+||+.||++|||+.++++.|+.+
T Consensus 235 ~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 235 DSSQSPPTKFL-ELIGIAQGQM-TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp CGGGSHHHHHH-HHHCSCCHHH-HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccccccchhhh-hhhcccccch-hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 99864311000 0000000000 00000011111111112223457899999999999999999999999988643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.69 Aligned_cols=208 Identities=24% Similarity=0.371 Sum_probs=165.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|.+|++++++++||||+++++++.. ....++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+
T Consensus 72 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~- 149 (290)
T 1t4h_A 72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT- 149 (290)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-
T ss_pred HHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 6789999999999999999999876 34689999999999999999654 46899999999999999999999975
Q ss_pred CCeEeccCCCCCeEEc-CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 78 RPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
.+++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 150 ~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~ 224 (290)
T 1t4h_A 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT 224 (290)
T ss_dssp SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH
T ss_pred CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHh
Confidence 4599999999999997 78999999999997644322 23456899999999886 459999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||........ ...... ... .... ++...+..+.+||.+||+.||.+|||+.++++|.
T Consensus 225 g~~pf~~~~~~~~--~~~~~~----~~~-----~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 225 SEYPYSECQNAAQ--IYRRVT----SGV-----KPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp SSCTTTTCSSHHH--HHHHHT----TTC-----CCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCCcCcHHH--HHHHHh----ccC-----Cccc----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 9999975432111 110000 000 0001 1111235789999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=299.60 Aligned_cols=224 Identities=21% Similarity=0.293 Sum_probs=166.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+.+..++||||++ ++|.+++...+..+++..++.++.||+.||.|||+.+ |+
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---iv 122 (324)
T 3mtl_A 47 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VL 122 (324)
T ss_dssp CCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 3479999999999999999999999999999999996 5999999887778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 123 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp ESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986543221 2234568999999999876 5789999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhh-----hc---cccccccccCCccCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPH-----LG---ERRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|...........+...... +. ....+.....+..... .....+.++.+||.+||+.||.+|||+.|++
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 201 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 9765432211111100000 00 0000000000000000 0112346789999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
+|.
T Consensus 281 ~hp 283 (324)
T 3mtl_A 281 KHP 283 (324)
T ss_dssp TSG
T ss_pred cCh
Confidence 864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=290.18 Aligned_cols=209 Identities=23% Similarity=0.329 Sum_probs=168.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|.+|++++++++||||+++++++.+. +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ .
T Consensus 54 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~ 132 (271)
T 3kmu_A 54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-P 132 (271)
T ss_dssp HHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-S
T ss_pred HHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-C
Confidence 67899999999999999999999887 788999999999999999976543 5899999999999999999999865 4
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCc---hhHHHHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEML 155 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell 155 (306)
+++||||||+||+++.++.++|+|||+...... ....||+.|+|||++.+..++. ++|||||||++|+|+
T Consensus 133 ~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 205 (271)
T 3kmu_A 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205 (271)
T ss_dssp CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH
T ss_pred ceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 599999999999999999999998888754322 2346799999999998765444 899999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
+|..||........ ...... ....+.. +...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 206 ~g~~p~~~~~~~~~------~~~~~~------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 206 TREVPFADLSNMEI------GMKVAL------EGLRPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HCSCTTTTSCHHHH------HHHHHH------SCCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCccccChHHH------HHHHHh------cCCCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 99999975432111 000000 0111111 223356899999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=286.26 Aligned_cols=220 Identities=20% Similarity=0.207 Sum_probs=175.0
Q ss_pred CHHHHHHHHhcCCCCcccceeeEE-EeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
.+.+|+++++.++|++++..+..+ ...+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+
T Consensus 50 ~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--- 125 (296)
T 4hgt_A 50 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--- 125 (296)
T ss_dssp CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 368999999999988877666655 6677889999999 88999999866668999999999999999999999998
Q ss_pred eEeccCCCCCeEE---cCCCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 80 VIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 80 iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
|+||||||+||++ +.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++
T Consensus 126 ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 4hgt_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHH
Confidence 9999999999999 78899999999999876543221 122346789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|+|++|..||...................... . .. .... ..+..+.+|+.+||+.||++|||+.++++.|
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~~----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMST-P-IE----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-C-HH----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred HHHhcCCCCCcccchhhhhhhhhhhhcccccc-h-hh----hhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 99999999998765544433332221110000 0 00 0001 1246899999999999999999999999988
Q ss_pred CCC
Q 021891 232 KPL 234 (306)
Q Consensus 232 ~~~ 234 (306)
+.+
T Consensus 276 ~~~ 278 (296)
T 4hgt_A 276 RNL 278 (296)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=296.75 Aligned_cols=210 Identities=18% Similarity=0.246 Sum_probs=167.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+.+|+.+++.+ .||||+++++++.+.+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 75 ~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--- 151 (327)
T 3lm5_A 75 ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--- 151 (327)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 67899999999 5699999999999999999999999999999998654 457999999999999999999999998
Q ss_pred eEeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+||+++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 152 ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 228 (327)
T 3lm5_A 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228 (327)
T ss_dssp EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999987 78999999999987643321 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||...........+ . .. ............+..+.+||.+||+.||.+|||+++++++.
T Consensus 229 g~~pf~~~~~~~~~~~i---~---~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 229 HTSPFVGEDNQETYLNI---S---QV--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp SSCSSCCSSHHHHHHHH---H---HT--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred CCCCCCCCCchHHHHHH---H---hc--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 99999764321110000 0 00 00001111122356889999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.63 Aligned_cols=222 Identities=24% Similarity=0.272 Sum_probs=172.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++......+++..++.++.|++.||.|||+.+ |+
T Consensus 59 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 134 (346)
T 1ua2_A 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---IL 134 (346)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 56899999999999999999999999999999999975 899998777778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus 135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~ 212 (346)
T 1ua2_A 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 212 (346)
T ss_dssp CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999999987643322 22345789999999999754 589999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcc-----cccccc---ccCCccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGE-----RRRFYR---LIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|.......... ........ ...... .+........ ....+..+.+||.+||+.||.+|||+.|+
T Consensus 213 ~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 289 (346)
T 1ua2_A 213 LPGDSDLDQLT---RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289 (346)
T ss_dssp SCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHH---HHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 97653221111 11000000 000000 0000000000 12234789999999999999999999999
Q ss_pred HHHhC
Q 021891 228 VEALK 232 (306)
Q Consensus 228 l~~l~ 232 (306)
++|..
T Consensus 290 l~h~~ 294 (346)
T 1ua2_A 290 LKMKY 294 (346)
T ss_dssp HTSGG
T ss_pred hcChh
Confidence 99753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.79 Aligned_cols=208 Identities=25% Similarity=0.326 Sum_probs=167.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+.+..++|||||.+++|.+.+.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 68 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---iv 143 (486)
T 3mwu_A 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IV 143 (486)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 6789999999999999999999999999999999999999999886654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEc---CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|.
T Consensus 144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~ 219 (486)
T 3mwu_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT 219 (486)
T ss_dssp CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSS
T ss_pred eccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCC
Confidence 999999999995 45679999999998654332 2234579999999999876 5999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||...........+ . .... ..+... ....+..+.+||.+||+.||.+|||+.++++|.
T Consensus 220 ~pf~~~~~~~~~~~i---~---~~~~----~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 220 PPFYGKNEYDILKRV---E---TGKY----AFDLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp CSSCCSSHHHHHHHH---H---HTCC----CSCSGG----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred CCCCCCCHHHHHHHH---H---hCCC----CCCCcc----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 999764322111111 0 0000 000000 112356889999999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.18 Aligned_cols=208 Identities=23% Similarity=0.361 Sum_probs=170.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|++++++++||||+++++++.+.+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++
T Consensus 53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 128 (304)
T 2jam_A 53 LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENG---IV 128 (304)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 6799999999999999999999999999999999999999999986544 6899999999999999999999998 99
Q ss_pred eccCCCCCeEE---cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||++ +.++.+||+|||++...... ......||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 204 (304)
T 2jam_A 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY 204 (304)
T ss_dssp CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999 78899999999999764322 123356899999999999989999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||....... ...... ..... .... .....+..+.+||.+||+.||++|||+.+++++.
T Consensus 205 ~pf~~~~~~~---~~~~i~---~~~~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 205 PPFYEETESK---LFEKIK---EGYYE----FESP----FWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp CTTTTSCHHH---HHHHHH---HCCCC----CCTT----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCCCCCCHHH---HHHHHH---cCCCC----CCcc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 9997543211 111000 00000 0111 1122357899999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=298.53 Aligned_cols=223 Identities=19% Similarity=0.237 Sum_probs=162.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+++..++||||++ ++|.+++.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~---iv 154 (329)
T 3gbz_A 80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR---CL 154 (329)
T ss_dssp CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 5789999999999999999999999999999999997 59999986654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEE-----cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILL-----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 82 H~dlkp~Nill-----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell 155 (306)
||||||+|||+ +.++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|+|+
T Consensus 155 H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999 4555699999999976543211 22345679999999999864 5899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhh--------hcccccccccc----CCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPH--------LGERRRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
+|..||...........+...... ......+.... .......+....+.++.+||.+||+.||++|||
T Consensus 233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 999999765332111111000000 00000000000 000000001113468899999999999999999
Q ss_pred HHHHHHHh
Q 021891 224 MSEVVEAL 231 (306)
Q Consensus 224 ~~ell~~l 231 (306)
+.|+++|.
T Consensus 313 ~~e~l~hp 320 (329)
T 3gbz_A 313 AKNALEHP 320 (329)
T ss_dssp HHHHHTSG
T ss_pred HHHHhCCc
Confidence 99999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.14 Aligned_cols=223 Identities=22% Similarity=0.315 Sum_probs=165.1
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCC--eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|+.+|+++. ||||+++++++...+ ..|+|||||+ ++|.+++... .+++..+..++.||+.||.|||+.+
T Consensus 55 ~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~-- 129 (388)
T 3oz6_A 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG-- 129 (388)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 468999999997 999999999998654 6899999996 5999988653 6899999999999999999999998
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCC-------------------cceeeecccccccccCCcchhc-CCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT-GHL 138 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~ 138 (306)
|+||||||+|||++.++.+||+|||+++...... ........+||++|+|||++.+ ..+
T Consensus 130 -ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (388)
T 3oz6_A 130 -LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208 (388)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCC
T ss_pred -EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCC
Confidence 9999999999999999999999999998653211 1111234579999999999986 678
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccc---------------c---CCccCCCC--
Q 021891 139 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL---------------I---DPRLEGHF-- 198 (306)
Q Consensus 139 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~---~~~~~~~~-- 198 (306)
+.++|||||||++|||++|.+||.+.........+..... ......+... . .......+
T Consensus 209 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (388)
T 3oz6_A 209 TKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287 (388)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence 9999999999999999999999987543222111110000 0000000000 0 00000000
Q ss_pred ----------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 199 ----------SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 199 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
....+.++.+||.+||+.||++|||+.|+++|.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp HHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred hhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence 001246789999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=293.79 Aligned_cols=212 Identities=31% Similarity=0.464 Sum_probs=163.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++|++++||||+++++++. +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+.++
T Consensus 48 ~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ 125 (307)
T 2eva_A 48 FIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125 (307)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC
T ss_pred HHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 689999999999999999999876 458999999999999999976542 4789999999999999999999932223
Q ss_pred eEeccCCCCCeEEcCCCc-EEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||||+||+++.++. +||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 126 ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 200 (307)
T 2eva_A 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200 (307)
T ss_dssp CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred eecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999988886 799999999764322 22346899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
.||........ ...+... . ...+.... ..+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 201 ~p~~~~~~~~~--~~~~~~~---~------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 201 KPFDEIGGPAF--RIMWAVH---N------GTRPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CTTTTTCSSHH--HHHHHHH---T------TCCCCCBT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred CCchhhCccHH--HHHHHHh---c------CCCCCccc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 99975432211 1111100 0 00111111 23467899999999999999999999999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.31 Aligned_cols=207 Identities=25% Similarity=0.313 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|+.++||||+++++++.+.+..++|||||.+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 83 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---iv 158 (494)
T 3lij_A 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHN---IV 158 (494)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ce
Confidence 6789999999999999999999999999999999999999999886553 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCC---CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++.. +.+||+|||+++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|.
T Consensus 159 H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~ 234 (494)
T 3lij_A 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234 (494)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSS
T ss_pred eccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCC
Confidence 99999999999764 559999999998764432 233457999999999876 56999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||...........+ . .... ........ ..+..+.+||.+||+.||.+|||+.++++|
T Consensus 235 ~pf~~~~~~~~~~~i---~---~~~~----~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 235 PPFGGQTDQEILRKV---E---KGKY----TFDSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSSCCSSHHHHHHHH---H---HTCC----CCCSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCCCHHHHHHHH---H---hCCC----CCCchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 999765332111111 0 0000 01111111 234688999999999999999999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=298.95 Aligned_cols=223 Identities=25% Similarity=0.376 Sum_probs=166.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 71 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---iv 146 (331)
T 4aaa_A 71 AMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN---II 146 (331)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 568999999999999999999999999999999999998888876444 46999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (331)
T 4aaa_A 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224 (331)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999976543221 22345689999999999865 789999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhh--------hhhccccccccccCCccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 161 MDKNRPNGEHNLVEWAR--------PHLGERRRFYRLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|...........+.... ........+.....+...... ....+..+.+||.+||+.||++|||+.|+
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 304 (331)
T 4aaa_A 225 FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304 (331)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred CCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence 97654322111110000 000000000000011111110 11235789999999999999999999999
Q ss_pred HHH
Q 021891 228 VEA 230 (306)
Q Consensus 228 l~~ 230 (306)
++|
T Consensus 305 l~h 307 (331)
T 4aaa_A 305 LHH 307 (331)
T ss_dssp GGS
T ss_pred hcC
Confidence 985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=290.84 Aligned_cols=208 Identities=24% Similarity=0.329 Sum_probs=167.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|++++++++||||+++++++.+.+..++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++
T Consensus 55 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 130 (283)
T 3bhy_A 55 IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IA 130 (283)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 689999999999999999999999999999999999999999998654 36899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC----cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
||||||+||+++.++ .+||+|||++........ .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 207 (283)
T 3bhy_A 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207 (283)
T ss_dssp CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHC
Confidence 999999999998877 899999999987543321 2335689999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
..||........ .... ..... ....... ...+..+.+|+.+||+.||++|||+.+++++
T Consensus 208 ~~p~~~~~~~~~---~~~~---~~~~~----~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 208 ASPFLGETKQET---LTNI---SAVNY----DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp SCTTCCSSHHHH---HHHH---HTTCC----CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCcchHHH---HHHh---Hhccc----CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 999976432111 0000 00000 0000000 1124678999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.65 Aligned_cols=226 Identities=23% Similarity=0.282 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--------CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+++|++++||||+++++++.. .+..++||||+.+ +|.+.+......+++..++.++.||+.||.|||
T Consensus 63 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH 141 (351)
T 3mi9_A 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141 (351)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5689999999999999999999987 3468999999975 888888777678999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc--ceeeecccccccccCCcchhc-CCCCchhHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 150 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~i 150 (306)
+.+ |+||||||+||+++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||+
T Consensus 142 ~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 218 (351)
T 3mi9_A 142 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218 (351)
T ss_dssp HTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred HCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence 998 99999999999999999999999999987543221 112234578999999999876 468999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhc-----ccc--ccccccCCccCCCCC--HH-----HHHHHHHHHHHcccC
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-----ERR--RFYRLIDPRLEGHFS--IK-----GAQKAAQLAAHCLSR 216 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~~--~~-----~~~~~~~li~~~l~~ 216 (306)
+|+|++|..||...........+........ ... ............... .. .+..+.+||.+||+.
T Consensus 219 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 298 (351)
T 3mi9_A 219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298 (351)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence 9999999999986543221111111100000 000 000000000000000 00 135688999999999
Q ss_pred CCCCCCCHHHHHHHh
Q 021891 217 DPKARPLMSEVVEAL 231 (306)
Q Consensus 217 ~p~~Rps~~ell~~l 231 (306)
||++|||+.|+++|.
T Consensus 299 dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 299 DPAQRIDSDDALNHD 313 (351)
T ss_dssp SGGGSCCHHHHHTSG
T ss_pred ChhhCCCHHHHhCCC
Confidence 999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=312.86 Aligned_cols=208 Identities=24% Similarity=0.334 Sum_probs=170.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++||||+++++++.+.+..++|||||.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 73 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---iv 148 (484)
T 3nyv_A 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNK---IV 148 (484)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 6799999999999999999999999999999999999999999986654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEE---cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||++ +.++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 149 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~ 224 (484)
T 3nyv_A 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 224 (484)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred eCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCC
Confidence 99999999999 5678999999999987644322 234579999999999876 6999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||........ ..... ..... .... .....+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 225 ~pf~~~~~~~~---~~~i~---~~~~~----~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 225 PPFNGANEYDI---LKKVE---KGKYT----FELP----QWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp CSSCCSSHHHH---HHHHH---HCCCC----CCSG----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCCCCCCHHHH---HHHHH---cCCCC----CCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 99976533211 11110 00000 0000 0112356889999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=295.89 Aligned_cols=205 Identities=26% Similarity=0.355 Sum_probs=170.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++||||+++++++.+.+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 88 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 163 (335)
T 2owb_A 88 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VI 163 (335)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CE
Confidence 678999999999999999999999999999999999999999988654 46999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 164 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 241 (335)
T 2owb_A 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241 (335)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCC
Confidence 999999999999999999999999987543222 223457899999999999989999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
........ ....... .... +...+..+.+||.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~------~~~~~~~--------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 242 ETSCLKET------YLRIKKN--------EYSI----PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCSSHHHH------HHHHHHT--------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCHHHH------HHHHhcC--------CCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 75432110 0000000 0011 11224678899999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=291.69 Aligned_cols=222 Identities=23% Similarity=0.321 Sum_probs=166.9
Q ss_pred HHHHHHHhcC--CCCcccceeeEEEeC----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-
Q 021891 3 QAEVNFLGDL--VHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE- 75 (306)
Q Consensus 3 ~~E~~il~~l--~H~niv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~- 75 (306)
.+|.+++..+ +||||+++++++... ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.
T Consensus 77 ~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ 154 (337)
T 3mdy_A 77 FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEI 154 (337)
T ss_dssp HHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCB
T ss_pred hhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 4566666655 999999999999987 7899999999999999999654 589999999999999999999998
Q ss_pred -------CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhcCCCCch-----
Q 021891 76 -------AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSR----- 141 (306)
Q Consensus 76 -------~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~----- 141 (306)
+ |+||||||+||+++.++.+||+|||+++......... ......||..|+|||++.+..+..+
T Consensus 155 ~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 231 (337)
T 3mdy_A 155 FSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI 231 (337)
T ss_dssp CSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHH
T ss_pred hhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcc
Confidence 6 9999999999999999999999999997654332211 1124578999999999987766554
Q ss_pred -hHHHHHHHHHHHHHhC----------CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCC-CCHHHHHHHHHH
Q 021891 142 -SDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQL 209 (306)
Q Consensus 142 -~DiwslG~il~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 209 (306)
+|||||||++|||++| ..||............ ... .. .. ....+..... ....++..+.+|
T Consensus 232 ~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~-~~-~~----~~~~~~~~~~~~~~~~~~~l~~l 304 (337)
T 3mdy_A 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED-MRE-IV-CI----KKLRPSFPNRWSSDECLRQMGKL 304 (337)
T ss_dssp HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH-HHH-HH-TT----SCCCCCCCGGGGGSHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh-hHH-HH-hh----hccCccccccchhhHHHHHHHHH
Confidence 9999999999999999 5555543332221110 000 00 00 0111111111 122667889999
Q ss_pred HHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 210 AAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 210 i~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
|.+||+.||.+|||+.+++++|+.+..
T Consensus 305 i~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 305 MTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp HHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999999976543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=290.31 Aligned_cols=220 Identities=25% Similarity=0.279 Sum_probs=165.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|.++ +||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |
T Consensus 57 ~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i 132 (316)
T 2ac3_A 57 VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---I 132 (316)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 67899999985 7999999999999999999999999999999999665 36899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCc---EEEeccCCcccCCCCCc-----ceeeecccccccccCCcchhc-----CCCCchhHHHHH
Q 021891 81 IYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSF 147 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Diwsl 147 (306)
+||||||+||+++.++. +||+|||++........ ........||..|+|||++.+ ..++.++|||||
T Consensus 133 vH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 212 (316)
T 2ac3_A 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212 (316)
T ss_dssp CCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHH
T ss_pred eeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhH
Confidence 99999999999988776 99999999876532211 111223468999999999875 468899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchH--------HhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCC
Q 021891 148 GVVLLEMLTGRRSMDKNRPNGEHNLV--------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 219 (306)
Q Consensus 148 G~il~elltg~~pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 219 (306)
||++|+|++|..||............ .......... . ..+...... ..+..+.+||.+||+.||.
T Consensus 213 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~--~~~~~~~~~----~~~~~~~~li~~~L~~dP~ 285 (316)
T 2ac3_A 213 GVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG-K--YEFPDKDWA----HISCAAKDLISKLLVRDAK 285 (316)
T ss_dssp HHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC-C--CCCCHHHHT----TSCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhcc-C--cccCchhcc----cCCHHHHHHHHHHhhCChh
Confidence 99999999999999876443211000 0000000000 0 000000000 1246889999999999999
Q ss_pred CCCCHHHHHHHhC
Q 021891 220 ARPLMSEVVEALK 232 (306)
Q Consensus 220 ~Rps~~ell~~l~ 232 (306)
+|||+.|+++|..
T Consensus 286 ~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 286 QRLSAAQVLQHPW 298 (316)
T ss_dssp TSCCHHHHHHSTT
T ss_pred hCCCHHHHhcChh
Confidence 9999999999643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.30 Aligned_cols=222 Identities=23% Similarity=0.335 Sum_probs=168.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~~~~i 80 (306)
+.+|++++++++||||+++++++.+++..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+. + |
T Consensus 78 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~---i 153 (360)
T 3eqc_A 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---I 153 (360)
T ss_dssp HHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---C
T ss_pred HHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 6799999999999999999999999999999999999999999996554 689999999999999999999985 7 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 154 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 229 (360)
T 3eqc_A 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229 (360)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCC
T ss_pred EcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998653211 22345789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhh----------------------hhhccccc----cccccCCccCCCCCHHHHHHHHHHHHHcc
Q 021891 161 MDKNRPNGEHNLVEWAR----------------------PHLGERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCL 214 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~----------------------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l 214 (306)
|................ ........ .................+..+.+||.+||
T Consensus 230 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 309 (360)
T 3eqc_A 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 309 (360)
T ss_dssp SSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHh
Confidence 97643211100000000 00000000 00000000000011123568999999999
Q ss_pred cCCCCCCCCHHHHHHHh
Q 021891 215 SRDPKARPLMSEVVEAL 231 (306)
Q Consensus 215 ~~~p~~Rps~~ell~~l 231 (306)
+.||++|||+.|+++|.
T Consensus 310 ~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 310 IKNPAERADLKQLMVHA 326 (360)
T ss_dssp CSSTTTSCCHHHHHTSH
T ss_pred hcChhhCCCHHHHhhCh
Confidence 99999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=301.97 Aligned_cols=155 Identities=28% Similarity=0.376 Sum_probs=130.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++|++++||||+++++++... +..|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+
T Consensus 72 ~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g 149 (432)
T 3n9x_A 72 ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG 149 (432)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 57899999999999999999999876 57899999996 5999998654 47999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--------------------eeeecccccccccCCcch-hc
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYV-MT 135 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~ 135 (306)
|+||||||+|||++.++.+||+|||+++........ ......+||++|+|||++ .+
T Consensus 150 ---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 226 (432)
T 3n9x_A 150 ---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226 (432)
T ss_dssp ---EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC
T ss_pred ---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC
Confidence 999999999999999999999999999876443211 112456789999999986 46
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 136 GHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 136 ~~~~~~~DiwslG~il~elltg~~pf 161 (306)
..|+.++|||||||++|||++|..||
T Consensus 227 ~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 227 ENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp SCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCCcccccchHHHHHHHHHhccccc
Confidence 67999999999999999999855444
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=296.11 Aligned_cols=221 Identities=24% Similarity=0.300 Sum_probs=168.8
Q ss_pred HHHHHHHHhcCC-----CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLV-----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~-----H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+..|+++++.+. ||||+++++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.
T Consensus 78 ~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 156 (360)
T 3llt_A 78 AKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156 (360)
T ss_dssp HHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 567999999996 999999999999999999999999 889999997653 4599999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcC-------------------------CCcEEEeccCCcccCCCCCcceeeecccccccccCC
Q 021891 76 AERPVIYRDFKTSNILLDA-------------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 130 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 130 (306)
+ |+||||||+|||++. ++.+||+|||+++..... .....||+.|+||
T Consensus 157 ~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aP 228 (360)
T 3llt_A 157 S---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAP 228 (360)
T ss_dssp T---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCH
T ss_pred C---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCc
Confidence 8 999999999999975 788999999999864432 2345789999999
Q ss_pred cchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhc----------cccccc-----cccCCccC
Q 021891 131 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----------ERRRFY-----RLIDPRLE 195 (306)
Q Consensus 131 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~-----~~~~~~~~ 195 (306)
|++.+..++.++|||||||++|+|++|..||...........+........ ...... ...-+...
T Consensus 229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 999999999999999999999999999999976543221111111000000 000000 00000000
Q ss_pred CC-------------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 196 GH-------------FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 196 ~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.. +....+..+.+||.+||+.||++|||+.|+++|.
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 00 0000125788999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=299.26 Aligned_cols=218 Identities=23% Similarity=0.318 Sum_probs=168.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|++++||||+++++++...+ ..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.
T Consensus 71 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~ 147 (367)
T 1cm8_A 71 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA 147 (367)
T ss_dssp HHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 578999999999999999999998763 459999999 7899999865 3689999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ |+||||||+||+++.++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||
T Consensus 148 ~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 148 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp T---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred C---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 8 999999999999999999999999999875432 234578999999999987 6899999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhh--------hc--ccccc----ccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPH--------LG--ERRRF----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~--------~~--~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
++|+.||.+.........+...... +. ....+ .......+ .......+..+.+||.+||+.||.+
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~ 298 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQ 298 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhH
Confidence 9999999865432211111000000 00 00000 00000000 0111223578999999999999999
Q ss_pred CCCHHHHHHHh
Q 021891 221 RPLMSEVVEAL 231 (306)
Q Consensus 221 Rps~~ell~~l 231 (306)
|||+.|+++|.
T Consensus 299 R~t~~e~l~hp 309 (367)
T 1cm8_A 299 RVTAGEALAHP 309 (367)
T ss_dssp SCCHHHHHHSG
T ss_pred CCCHHHHhcCh
Confidence 99999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.27 Aligned_cols=214 Identities=25% Similarity=0.370 Sum_probs=171.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.. .++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++
T Consensus 68 ~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 143 (291)
T 1u46_A 68 FIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FI 143 (291)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 678999999999999999999988755 88999999999999999776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
|+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 144 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 223 (291)
T 1u46_A 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223 (291)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998765443222 2233457888999999998889999999999999999999 999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
||....... ... ....... ... .+...+..+.++|.+||+.||.+|||+.++++.|+...
T Consensus 224 p~~~~~~~~---~~~---~~~~~~~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 224 PWIGLNGSQ---ILH---KIDKEGE------RLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TTTTCCHHH---HHH---HHHTSCC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcccCCHHH---HHH---HHHccCC------CCC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 997653211 111 0000000 001 11123578999999999999999999999999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=286.84 Aligned_cols=219 Identities=20% Similarity=0.201 Sum_probs=173.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEE-EeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++.++|++++..+.++ ...+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |
T Consensus 51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 126 (296)
T 3uzp_A 51 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 126 (296)
T ss_dssp HHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 67999999999998877666555 5677889999999 88999999766668999999999999999999999998 9
Q ss_pred EeccCCCCCeEE---cCCCcEEEeccCCcccCCCCCcce-----eeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 81 IYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 81 iH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+||||||+||++ +.++.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|
T Consensus 127 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 206 (296)
T 3uzp_A 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 206 (296)
T ss_dssp ECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred eeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHH
Confidence 999999999999 478899999999998765432211 123457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
+|++|..||...................... ..+.... ..+..+.+|+.+||+.||++|||+.++++.|+
T Consensus 207 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 207 YFNLGSLPWQGLKAATKRQKYERISEKKMST------PIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS------CHHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred HHHhCCCCCCCcCchhhhhhhhhhcccccCC------chHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 9999999998765444333322221110000 0000001 12468899999999999999999999999887
Q ss_pred CC
Q 021891 233 PL 234 (306)
Q Consensus 233 ~~ 234 (306)
.+
T Consensus 277 ~~ 278 (296)
T 3uzp_A 277 NL 278 (296)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=289.44 Aligned_cols=210 Identities=27% Similarity=0.412 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|++++++++||||+++++++. .+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ +
T Consensus 55 ~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 130 (279)
T 1qpc_A 55 FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130 (279)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 689999999999999999999876 456899999999999999986542 36899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+||+++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 131 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 209 (279)
T 1qpc_A 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (279)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred eccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654321 22233456788999999998899999999999999999999 899
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... ...... .. .... .+...+..+.+|+.+||+.||++|||+.++++.|+.
T Consensus 210 p~~~~~~~~---~~~~~~----~~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 210 PYPGMTNPE---VIQNLE----RG------YRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp SSTTCCHHH---HHHHHH----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccCHHH---HHHHHh----cc------cCCC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 997543211 111100 00 0111 111234789999999999999999999999998864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=290.14 Aligned_cols=215 Identities=24% Similarity=0.342 Sum_probs=164.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|.+|++++++++||||+++++++...+..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+
T Consensus 79 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-- 156 (310)
T 2wqm_A 79 CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156 (310)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 67899999999999999999999999999999999999999998864 3456999999999999999999999998
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 157 -i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~ 233 (310)
T 2wqm_A 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233 (310)
T ss_dssp -CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986543221 223456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
.||....... ....... .. .. ..+.. ....+..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 234 ~p~~~~~~~~----~~~~~~~-~~-~~----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 234 SPFYGDKMNL----YSLCKKI-EQ-CD----YPPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp CTTC---CCH----HHHHHHH-HT-TC----SCCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccchhH----HHHHHHh-hc-cc----CCCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 9997543211 1111100 00 00 00100 1123468999999999999999999999999987543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=291.23 Aligned_cols=210 Identities=23% Similarity=0.329 Sum_probs=172.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ ++
T Consensus 71 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~ 147 (314)
T 3com_A 71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KI 147 (314)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---Cc
Confidence 678999999999999999999999999999999999999999999766667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||||+||+++.++.+||+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 148 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 225 (314)
T 3com_A 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225 (314)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999977543221 223456899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
........ . ...... ..+.. ..+...+..+.+||.+||+.||.+|||+.+++++.
T Consensus 226 ~~~~~~~~---~---~~~~~~-------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 226 ADIHPMRA---I---FMIPTN-------PPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp TTSCHHHH---H---HHHHHS-------CCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCCChHHH---H---HHHhcC-------CCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 75432110 0 000000 00000 01112346889999999999999999999999853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=316.94 Aligned_cols=213 Identities=24% Similarity=0.376 Sum_probs=173.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++|++|+||||+++++++.+ +..++|||||.+|+|.+++... ...+++..++.++.||+.||.|||+++ |
T Consensus 309 ~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---i 384 (535)
T 2h8h_A 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 384 (535)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 7899999999999999999999876 6789999999999999999653 346899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 385 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~ 463 (535)
T 2h8h_A 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463 (535)
T ss_dssp CCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCC
T ss_pred eCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998754321 111223446788999999999999999999999999999999 899
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 236 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 236 (306)
||....... ...... .. .... .+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 464 P~~~~~~~~---~~~~i~----~~------~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 464 PYPGMVNRE---VLDQVE----RG------YRMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp SSTTCCHHH---HHHHHH----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCHHH---HHHHHH----cC------CCCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 997643211 111110 00 0011 112335789999999999999999999999999987654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=296.05 Aligned_cols=207 Identities=17% Similarity=0.144 Sum_probs=170.0
Q ss_pred HHHHHHHHhcCC---CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
|.+|+++++.++ |+||+++++++...+..++|||||++|+|.+++.. ....+++..++.++.||+.||.|||+
T Consensus 111 ~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~ 190 (365)
T 3e7e_A 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190 (365)
T ss_dssp HHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 678888888887 89999999999999999999999999999999964 34579999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcC-----------CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhH
Q 021891 75 EAERPVIYRDFKTSNILLDA-----------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 143 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~-----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 143 (306)
.+ |+||||||+|||++. ++.+||+|||+++..............+||..|+|||++.+..++.++|
T Consensus 191 ~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 267 (365)
T 3e7e_A 191 CE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQID 267 (365)
T ss_dssp TT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHH
T ss_pred CC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcccc
Confidence 88 999999999999988 8999999999997643323333445578999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-
Q 021891 144 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP- 222 (306)
Q Consensus 144 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp- 222 (306)
||||||++|||++|+.||........ .....+.. . ..++.+.+++..||+.+|.+|+
T Consensus 268 iwslG~il~elltg~~pf~~~~~~~~---------------~~~~~~~~-----~--~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 268 YFGVAATVYCMLFGTYMKVKNEGGEC---------------KPEGLFRR-----L--PHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHHHHHHHHHHSSCCCEEEETTEE---------------EECSCCTT-----C--SSHHHHHHHHHHHHCCCCTTCCC
T ss_pred HHHHHHHHHHHHhCCCccccCCCCce---------------eechhccc-----c--CcHHHHHHHHHHHcCCCCCCcch
Confidence 99999999999999999864322110 00001100 0 1146788999999999999995
Q ss_pred CHHHHHHHhCC
Q 021891 223 LMSEVVEALKP 233 (306)
Q Consensus 223 s~~ell~~l~~ 233 (306)
+++++.+.|+.
T Consensus 326 ~~~~l~~~l~~ 336 (365)
T 3e7e_A 326 SLDLLRQKLKK 336 (365)
T ss_dssp CHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 77777776653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.88 Aligned_cols=212 Identities=27% Similarity=0.343 Sum_probs=170.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|+++ +||||+++++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |
T Consensus 105 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---i 180 (355)
T 1vzo_A 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---I 180 (355)
T ss_dssp CCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 45799999999 79999999999999999999999999999999996554 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc--CCCCchhHHHHHHHHHHHHHhCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~ 158 (306)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 181 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259 (355)
T ss_dssp CCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999986543222 22334679999999999985 35789999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l~ 232 (306)
.||...........+ ....... .+.. +...+..+.+||.+||+.||.+|| |++|++++..
T Consensus 260 ~pf~~~~~~~~~~~~--~~~~~~~--------~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 260 SPFTVDGEKNSQAEI--SRRILKS--------EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CTTSCTTSCCCHHHH--HHHHHHC--------CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCCccCCccchHHHH--HHHHhcc--------CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 999765433221111 1111100 1111 122346788999999999999999 9999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.90 Aligned_cols=206 Identities=26% Similarity=0.349 Sum_probs=170.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++
T Consensus 62 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 137 (294)
T 2rku_A 62 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VI 137 (294)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 678999999999999999999999999999999999999999988654 36999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 215 (294)
T 2rku_A 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215 (294)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987543222 123456899999999999888999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
........ ....... .... +...+..+.+|+.+||+.||++|||+.+++++.
T Consensus 216 ~~~~~~~~------~~~~~~~--------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 216 ETSCLKET------YLRIKKN--------EYSI----PKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp CCSSHHHH------HHHHHTT--------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CCCCHHHH------HHHHhhc--------cCCC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 75432110 0000000 0011 112346789999999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.20 Aligned_cols=218 Identities=25% Similarity=0.362 Sum_probs=162.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-------~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+.+|++++++++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+
T Consensus 60 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 139 (303)
T 2vwi_A 60 LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139 (303)
T ss_dssp ------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 67899999999999999999999999999999999999999999863 24468999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc---ceeeecccccccccCCcchhc-CCCCchhHHHHHHHH
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVV 150 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~i 150 (306)
.+ ++||||||+||+++.++.+||+|||++........ ........||..|+|||++.+ ..++.++|||||||+
T Consensus 140 ~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 216 (303)
T 2vwi_A 140 NG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216 (303)
T ss_dssp TT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHH
T ss_pred CC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHH
Confidence 98 99999999999999999999999999876543221 112234578999999999875 578999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccc-cccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY-RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
+|+|++|..||......... .... ........ ...++.... ..+..+.+||.+||+.||.+|||+.++++
T Consensus 217 l~~l~~g~~pf~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 217 AIELATGAAPYHKYPPMKVL---MLTL--QNDPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHSSCTTTTSCGGGHH---HHHH--TSSCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCCccCchhhHH---HHHh--ccCCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 99999999999765432111 0000 00000000 001111111 22467899999999999999999999998
Q ss_pred Hh
Q 021891 230 AL 231 (306)
Q Consensus 230 ~l 231 (306)
+.
T Consensus 288 h~ 289 (303)
T 2vwi_A 288 HK 289 (303)
T ss_dssp ST
T ss_pred Ch
Confidence 63
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=298.73 Aligned_cols=227 Identities=22% Similarity=0.295 Sum_probs=158.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~--------~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
+.+|+++|++|+||||+++++++.. ....++||||+. ++|.+++... ...+++..++.++.||+.||.|
T Consensus 65 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 143 (405)
T 3rgf_A 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143 (405)
T ss_dssp HHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999999965 668999999996 5888877521 2249999999999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEE----cCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhc-CCCCchhHHH
Q 021891 72 LHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVY 145 (306)
Q Consensus 72 LH~~~~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 145 (306)
||+.+ |+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||
T Consensus 144 LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 220 (405)
T 3rgf_A 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220 (405)
T ss_dssp HHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred HHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence 99998 9999999999999 67789999999999876432211 22334678999999999987 4589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCc------chHHhhhhhhcc-----cccc---------ccccCCccCCCCC------
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEH------NLVEWARPHLGE-----RRRF---------YRLIDPRLEGHFS------ 199 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~------~~~~~~~~~~~~-----~~~~---------~~~~~~~~~~~~~------ 199 (306)
||||++|+|++|..||......... ..+.......+. ...+ ...+.........
T Consensus 221 SlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (405)
T 3rgf_A 221 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300 (405)
T ss_dssp HHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHh
Confidence 9999999999999999765432100 000000000000 0000 0000000000000
Q ss_pred ---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 200 ---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 200 ---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
...+..+.+||.+||+.||.+|||+.|+++|..
T Consensus 301 ~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 011457889999999999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=295.44 Aligned_cols=216 Identities=20% Similarity=0.371 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|++++++++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ ++
T Consensus 76 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~ 152 (319)
T 2y4i_B 76 FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152 (319)
T ss_dssp CCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 568999999999999999999999999999999999999999999777668999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCC---cceeeecccccccccCCcchhc---------CCCCchhHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMT---------GHLTSRSDVYSFGV 149 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~ 149 (306)
||||||+||+++ ++.+||+|||+++...... .........|+..|+|||++.+ ..++.++|||||||
T Consensus 153 H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp CCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred ccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 999999999998 6799999999987643211 1112223458999999999864 35789999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
++|+|++|..||........ . +. .... ..+... ....+..+.+|+.+||..||++|||+.++++
T Consensus 232 il~el~~g~~p~~~~~~~~~---~-~~---~~~~------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 232 IWYELHAREWPFKTQPAEAI---I-WQ---MGTG------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHHSSCSSSSCCHHHH---H-HH---HHTT------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHhCCCCCCCCCHHHH---H-HH---hccC------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999975432111 0 00 0000 011110 0012357889999999999999999999999
Q ss_pred HhCCCCCC
Q 021891 230 ALKPLPNL 237 (306)
Q Consensus 230 ~l~~~~~~ 237 (306)
.|+.+...
T Consensus 296 ~l~~l~~~ 303 (319)
T 2y4i_B 296 MLEKLPKR 303 (319)
T ss_dssp HHTTC---
T ss_pred HHHHHHHh
Confidence 99987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.16 Aligned_cols=209 Identities=25% Similarity=0.313 Sum_probs=169.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++|+||||+++++++.+.+..++|||||++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 93 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---iv 168 (504)
T 3q5i_A 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHN---IV 168 (504)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 5789999999999999999999999999999999999999999886653 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC---cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~ 244 (504)
T 3q5i_A 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244 (504)
T ss_dssp CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSS
T ss_pred eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCC
Confidence 999999999998776 69999999998765432 223457999999999986 46999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||...........+. .... ..+..... ..+..+.+||.+||+.||.+|||+.|+++|..
T Consensus 245 ~pf~~~~~~~~~~~i~------~~~~----~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 245 PPFGGQNDQDIIKKVE------KGKY----YFDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp CSSCCSSHHHHHHHHH------HCCC----CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCCCHHHHHHHHH------cCCC----CCCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 9997653321111110 0000 00000001 12468899999999999999999999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.24 Aligned_cols=208 Identities=26% Similarity=0.412 Sum_probs=163.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-CeeEEEEEcCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|++++++++||||+++++++.+. +..++||||+++++|.+++.+... .+++..++.++.|++.||.|||+.+
T Consensus 61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 137 (278)
T 1byg_A 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 137 (278)
T ss_dssp HHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 67899999999999999999987654 478999999999999999965432 3889999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
++||||||+||+++.++.+||+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 138 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 212 (278)
T 1byg_A 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212 (278)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998764332 122356889999999999999999999999999999998 99
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||....... ...... . ..... .+...+..+.++|.+||+.||.+|||+.++++.|+.+
T Consensus 213 ~p~~~~~~~~---~~~~~~----~------~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 213 VPYPRIPLKD---VVPRVE----K------GYKMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CSCTTSCGGG---HHHHHT----T------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHH---HHHHHh----c------CCCCC----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 9997643221 111000 0 00111 1223357899999999999999999999999988643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=289.03 Aligned_cols=215 Identities=24% Similarity=0.257 Sum_probs=164.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+
T Consensus 81 ~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 156 (309)
T 2h34_A 81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---AT 156 (309)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CC
Confidence 678999999999999999999999999999999999999999998654 36999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.++.+||+|||++........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 157 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (309)
T 2h34_A 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY 235 (309)
T ss_dssp CSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999977544321 1223456899999999999889999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPN 236 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~ell~~l~~~~~ 236 (306)
...... ............. .......+..+.+||.+||+.||++|| |++++++.|+....
T Consensus 236 ~~~~~~-------~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 236 QGDQLS-------VMGAHINQAIPRP--------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CSCHHH-------HHHHHHHSCCCCG--------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CCchHH-------HHHHHhccCCCCc--------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 754221 0111111100000 011122346788999999999999999 99999999875443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=296.96 Aligned_cols=223 Identities=19% Similarity=0.248 Sum_probs=173.1
Q ss_pred CHHHHHHHHhcCCCCcccc---------------eeeEEEe-CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHH
Q 021891 1 MWQAEVNFLGDLVHLNLVK---------------LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIAL 63 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~ 63 (306)
.+.+|++++++++||||++ +++++.. ++..++||||+ +++|.+++... ...+++..++.++.
T Consensus 88 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~ 166 (352)
T 2jii_A 88 RLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166 (352)
T ss_dssp THHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHH
Confidence 3789999999999999987 6778776 67889999999 89999999765 35799999999999
Q ss_pred HHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCC--cEEEeccCCcccCCCCCcce-----eeecccccccccCCcchhcC
Q 021891 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTG 136 (306)
Q Consensus 64 qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~ 136 (306)
||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+++......... ......||+.|+|||++.+.
T Consensus 167 qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 243 (352)
T 2jii_A 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC 243 (352)
T ss_dssp HHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC
T ss_pred HHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC
Confidence 9999999999998 99999999999999998 89999999998754322111 11335789999999999998
Q ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccC
Q 021891 137 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 137 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 216 (306)
.++.++|||||||++|+|++|..||........ .............. ........ ....+..+.+||.+||+.
T Consensus 244 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~ 316 (352)
T 2jii_A 244 GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE-DIMKQKQKFVDKPG---PFVGPCGH---WIRPSETLQKYLKVVMAL 316 (352)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-HHHHHHHHHHHSCC---CEECTTSC---EECCCHHHHHHHHHHHTC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH-HHHHHHHhccCChh---hhhhhccc---cCCCcHHHHHHHHHHHhC
Confidence 999999999999999999999999976542211 11111111011100 11111000 001246899999999999
Q ss_pred CCCCCCCHHHHHHHhCCC
Q 021891 217 DPKARPLMSEVVEALKPL 234 (306)
Q Consensus 217 ~p~~Rps~~ell~~l~~~ 234 (306)
||++|||+.+|++.|+.+
T Consensus 317 dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 317 TYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp CTTCCCCHHHHHHHHHHH
T ss_pred ChhhCCCHHHHHHHHHHH
Confidence 999999999999988654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=317.70 Aligned_cols=205 Identities=23% Similarity=0.338 Sum_probs=170.6
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|.++|..+ +||||+++++++.+.+.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||+.+ |
T Consensus 388 ~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---I 463 (674)
T 3pfq_A 388 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---I 463 (674)
T ss_dssp HHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS---E
T ss_pred HHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 46789999988 79999999999999999999999999999999997654 6999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..|
T Consensus 464 iHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~P 541 (674)
T 3pfq_A 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541 (674)
T ss_dssp ECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCC
Confidence 9999999999999999999999999986433222 23456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~ell~~ 230 (306)
|........ .. ...... . .++...+.++.+||.+||+.||++||++ +||++|
T Consensus 542 f~~~~~~~~---~~---~i~~~~--------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 542 FEGEDEDEL---FQ---SIMEHN--------V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SCCSSHHHH---HH---HHHSSC--------C----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCCCCHHHH---HH---HHHhCC--------C----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 976432211 11 111110 0 1122345789999999999999999997 777765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=289.31 Aligned_cols=207 Identities=26% Similarity=0.390 Sum_probs=171.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 67 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 141 (303)
T 3a7i_A 67 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KI 141 (303)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 68899999999999999999999999999999999999999999854 36899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
|+||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 142 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 219 (303)
T 3a7i_A 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219 (303)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999998754322 1223457899999999999989999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
....... ..... .. ...+..... .+..+.+||.+||+.||.+|||+.+++++..
T Consensus 220 ~~~~~~~---~~~~~----~~------~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 220 SELHPMK---VLFLI----PK------NNPPTLEGN----YSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp TTSCHHH---HHHHH----HH------SCCCCCCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCcCHHH---HHHHh----hc------CCCCCCccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 7543211 11000 00 011111222 2467899999999999999999999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=301.06 Aligned_cols=222 Identities=22% Similarity=0.288 Sum_probs=164.3
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCe------eEEEEEcCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
.+|+++|+.++||||+++++++...+. .++||||++++ +.+.+. .....+++..++.++.||+.||.|||
T Consensus 80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH 158 (394)
T 4e7w_A 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158 (394)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 479999999999999999999976443 78999999764 444332 23457999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEc-CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVL 151 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il 151 (306)
+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 159 SIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232 (394)
T ss_dssp HTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 998 99999999999998 799999999999987644322 2345689999999998765 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhh--------hhc-c--ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARP--------HLG-E--RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~--------~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
|||++|+.||.+.........+..... ... . ...+.......+...+....+.++.+||.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 233 AELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 999999999987543221111100000 000 0 00000000000001112224578999999999999999
Q ss_pred CCCHHHHHHHh
Q 021891 221 RPLMSEVVEAL 231 (306)
Q Consensus 221 Rps~~ell~~l 231 (306)
|||+.|+++|.
T Consensus 313 R~t~~e~l~hp 323 (394)
T 4e7w_A 313 RLTAIEALCHP 323 (394)
T ss_dssp SCCHHHHHTSG
T ss_pred CCCHHHHhcCh
Confidence 99999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=283.91 Aligned_cols=205 Identities=25% Similarity=0.365 Sum_probs=161.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++
T Consensus 58 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 133 (276)
T 2h6d_A 58 IKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHM---VV 133 (276)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHC---SS
T ss_pred HHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 5789999999999999999999999999999999999999999996553 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p 160 (306)
|+||||+||+++.++.+||+|||++....... ......|+..|+|||++.+..+ +.++||||||+++|+|++|..|
T Consensus 134 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 210 (276)
T 2h6d_A 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210 (276)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998764432 1233568999999999987765 6899999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|....... ...... ... ... +...+..+.++|.+||+.||.+|||+.+++++.
T Consensus 211 ~~~~~~~~---~~~~~~---~~~--------~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 211 FDDEHVPT---LFKKIR---GGV--------FYI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp SCCSSHHH---HHHHHH---HCC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred CCCCcHHH---HHHHhh---cCc--------ccC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 96532111 111000 000 001 112246789999999999999999999999963
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=290.17 Aligned_cols=213 Identities=24% Similarity=0.336 Sum_probs=167.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|.+|++++++++||||+++++++.+ .+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+
T Consensus 52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 131 (279)
T 2w5a_A 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131 (279)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhccc
Confidence 6789999999999999999998854 56889999999999999998653 345999999999999999999999865
Q ss_pred --CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHH
Q 021891 77 --ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 --~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 154 (306)
..+++||||||+||+++.++.+||+|||+++....... ......|+..|+|||++.+..++.++||||||+++|+|
T Consensus 132 ~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 209 (279)
T 2w5a_A 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209 (279)
T ss_dssp ------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHH
T ss_pred CCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHH
Confidence 23399999999999999999999999999987543221 12335689999999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
++|..||...... ....... .. . .+. ++...+..+.++|.+||+.||.+|||+.||+++++.
T Consensus 210 ~~g~~p~~~~~~~---~~~~~i~----~~-~-----~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 210 CALMPPFTAFSQK---ELAGKIR----EG-K-----FRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHSSCSSCCSSHH---HHHHHHH----HT-C-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHCCCCCcccCHH---HHHHHHh----hc-c-----ccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 9999999764321 1111000 00 0 011 112235789999999999999999999999997754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=286.02 Aligned_cols=207 Identities=28% Similarity=0.409 Sum_probs=170.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----------------CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALG 64 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~q 64 (306)
+.+|++++++++||||+++++++.. ....++||||+++++|.+++... ...+++..++.++.|
T Consensus 51 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 130 (284)
T 2a19_B 51 AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130 (284)
T ss_dssp GHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHH
Confidence 6799999999999999999998865 44579999999999999999654 357999999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHH
Q 021891 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 144 (306)
Q Consensus 65 i~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 144 (306)
|+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .....|+..|+|||++.+..++.++||
T Consensus 131 i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (284)
T 2a19_B 131 ITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDL 204 (284)
T ss_dssp HHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred HHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhh
Confidence 999999999998 99999999999999999999999999987654322 233468999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 145 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 145 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
|||||++|+|++|..|+.... .... .. ........ .+..+.+||.+||+.||.+|||+
T Consensus 205 ~slG~il~~l~~~~~~~~~~~--------~~~~-~~---------~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~ 262 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFETS--------KFFT-DL---------RDGIISDI----FDKKEKTLLQKLLSKKPEDRPNT 262 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHHH--------HHHH-HH---------HTTCCCTT----SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHhcCCcchhHH--------HHHH-Hh---------hccccccc----CCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999988764210 0000 00 01111111 24678899999999999999999
Q ss_pred HHHHHHhCCCCC
Q 021891 225 SEVVEALKPLPN 236 (306)
Q Consensus 225 ~ell~~l~~~~~ 236 (306)
.|++++|+.+..
T Consensus 263 ~e~l~~l~~~~~ 274 (284)
T 2a19_B 263 SEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHHTC
T ss_pred HHHHHHHHHHhh
Confidence 999999875543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=290.56 Aligned_cols=209 Identities=26% Similarity=0.364 Sum_probs=166.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++||||+++++++..++ .++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 62 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 136 (322)
T 2ycf_A 62 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---II 136 (322)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 679999999999999999999987654 89999999999999988654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCc---EEEeccCCcccCCCCCcceeeecccccccccCCcchh---cCCCCchhHHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 82 H~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell 155 (306)
||||||+||+++.++. +||+|||+++...... ......||..|+|||++. ...++.++|||||||++|+|+
T Consensus 137 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred ccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999987654 9999999998754321 123456899999999974 467899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|..||........ ....... .... ..+.... ..+..+.+||.+||+.||++|||+.+++++.
T Consensus 214 ~g~~pf~~~~~~~~--~~~~~~~---~~~~----~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 214 SGYPPFSEHRTQVS--LKDQITS---GKYN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp HSSCSSCSTTCSSC--HHHHHHH---TCCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hCCCCCcccchHHH--HHHHHHh---Cccc----cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 99999976543322 1111110 0000 0000001 1246889999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.35 Aligned_cols=220 Identities=20% Similarity=0.208 Sum_probs=175.1
Q ss_pred CHHHHHHHHhcCCC-CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
++.+|+++++.|+| ++|..+..++...+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+
T Consensus 48 ~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--- 123 (483)
T 3sv0_A 48 QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--- 123 (483)
T ss_dssp CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 47899999999987 56667777777888999999999 88999999876678999999999999999999999998
Q ss_pred eEeccCCCCCeEE---cCCCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 80 VIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 80 iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
|+||||||+|||| +.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++
T Consensus 124 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil 203 (483)
T 3sv0_A 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL 203 (483)
T ss_dssp EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999 58899999999999876543321 112356799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|||++|..||..................... ..... +.. .++.++.+||.+||+.||++||++.+|++.|
T Consensus 204 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~~-----l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 204 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIEA-----LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp HHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHHH-----HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHhCCCCCccccchhHHHHHHHHhhcccc-ccHHH-----Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 9999999999876554333222221111000 00000 001 1246899999999999999999999999988
Q ss_pred CCC
Q 021891 232 KPL 234 (306)
Q Consensus 232 ~~~ 234 (306)
+.+
T Consensus 274 ~~l 276 (483)
T 3sv0_A 274 RDL 276 (483)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=287.26 Aligned_cols=210 Identities=23% Similarity=0.342 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|.+|+++++.++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+
T Consensus 66 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 142 (295)
T 2clq_A 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142 (295)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6789999999999999999999999999999999999999999997653 34678999999999999999999998
Q ss_pred eEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC--CCCchhHHHHHHHHHHHHHh
Q 021891 80 VIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 80 iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt 156 (306)
++|+||||+||+++. ++.+||+|||++........ ......|+..|+|||++.+. .++.++||||||+++|+|++
T Consensus 143 i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 220 (295)
T 2clq_A 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220 (295)
T ss_dssp EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH
T ss_pred EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999987 89999999999987543221 22345689999999999764 38999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||....... ........ ....+.. +...+..+.+||.+||+.||++|||+.+++++-
T Consensus 221 g~~pf~~~~~~~---~~~~~~~~--------~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 221 GKPPFYELGEPQ---AAMFKVGM--------FKVHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp TSCTTGGGSSHH---HHHHHHHH--------HCCCCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred CCCCccCCCchh---HHHHhhcc--------ccccccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 999996432211 00000000 0011111 222356889999999999999999999999853
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=297.48 Aligned_cols=209 Identities=24% Similarity=0.375 Sum_probs=169.0
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ +
T Consensus 146 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i 221 (365)
T 2y7j_A 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---I 221 (365)
T ss_dssp HHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 57899999999 8999999999999999999999999999999998654 36999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc------CCCCchhHHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el 154 (306)
+|+||||+||+++.+|.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 222 ~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 298 (365)
T 2y7j_A 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298 (365)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHH
Confidence 9999999999999999999999999987654322 234678999999999864 3588999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
++|..||....... ....... .... ....... ..+..+.+||.+||+.||++|||+.++++|.
T Consensus 299 l~g~~pf~~~~~~~---~~~~i~~---~~~~----~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 299 LAGSPPFWHRRQIL---MLRMIME---GQYQ----FSSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHSSCSSCCSSHHH---HHHHHHH---TCCC----CCHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHCCCCCCCCCHHH---HHHHHHh---CCCC----CCCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 99999997542211 1111000 0000 0000001 1245789999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=291.81 Aligned_cols=220 Identities=24% Similarity=0.360 Sum_probs=172.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC--eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|++|++++++++||||+++++++...+ ..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+
T Consensus 89 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--- 165 (326)
T 2w1i_A 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165 (326)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 689999999999999999999987654 789999999999999999877667999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-eeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
++||||||+||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 166 ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~ 245 (326)
T 2w1i_A 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245 (326)
T ss_dssp EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTT
T ss_pred EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999998765433221 122345677899999999888999999999999999999999
Q ss_pred CCCCCCCC--------CCCcchH-HhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 159 RSMDKNRP--------NGEHNLV-EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 159 ~pf~~~~~--------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
.||..... ....... ........... .. ..+...+..+.+||.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG------RL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC------CC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC------CC----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88753210 0000000 00000000000 01 112233578999999999999999999999999
Q ss_pred HhCCC
Q 021891 230 ALKPL 234 (306)
Q Consensus 230 ~l~~~ 234 (306)
.|+.+
T Consensus 316 ~L~~l 320 (326)
T 2w1i_A 316 RVDQI 320 (326)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=290.40 Aligned_cols=217 Identities=25% Similarity=0.363 Sum_probs=169.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+.+|+++++.++||||+++++++.. ....++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+
T Consensus 73 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 152 (317)
T 2buj_A 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152 (317)
T ss_dssp HHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 6799999999999999999999873 3478999999999999998865 35679999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-------eeecccccccccCCcchhcCC---CCchhHH
Q 021891 75 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSRSDV 144 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Di 144 (306)
.+ |+||||||+||+++.++.+||+|||++.......... ......||..|+|||++.+.. ++.++||
T Consensus 153 ~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 229 (317)
T 2buj_A 153 KG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229 (317)
T ss_dssp TT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHH
T ss_pred CC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhH
Confidence 98 9999999999999999999999999987643211000 011245799999999987554 6899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 145 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 145 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
|||||++|+|++|..||......... ..... ... ..... ....+..+.+||.+||+.||.+|||+
T Consensus 230 ~slG~il~el~~g~~p~~~~~~~~~~-~~~~~----~~~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~ 294 (317)
T 2buj_A 230 WSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV----QNQ------LSIPQ----SPRHSSALWQLLNSMMTVDPHQRPHI 294 (317)
T ss_dssp HHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH----HCC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHhCCCChhhhhcccch-hhHHh----hcc------CCCCc----cccCCHHHHHHHHHHhhcChhhCCCH
Confidence 99999999999999998532111110 00000 000 00000 11234689999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 021891 225 SEVVEALKPLPN 236 (306)
Q Consensus 225 ~ell~~l~~~~~ 236 (306)
.+++++|+.+..
T Consensus 295 ~~ll~~L~~~~~ 306 (317)
T 2buj_A 295 PLLLSQLEALQP 306 (317)
T ss_dssp HHHHHHHHHTCC
T ss_pred HHHHHHhhhcCC
Confidence 999999986654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=294.90 Aligned_cols=221 Identities=19% Similarity=0.288 Sum_probs=170.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHH------hhcC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+
T Consensus 90 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp HHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 68999999999999999999999999999999999999999998 5442 4579999999999999999999998
Q ss_pred -CCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCc-hhHHHHHHHHH
Q 021891 75 -EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTS-RSDVYSFGVVL 151 (306)
Q Consensus 75 -~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il 151 (306)
.+ ++||||||+||+++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++
T Consensus 170 ~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 242 (348)
T 2pml_X 170 EKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242 (348)
T ss_dssp TSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHH
T ss_pred cCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHH
Confidence 88 999999999999999999999999999875432 23446789999999999876 6666 99999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhhhhccc----cccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGER----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 227 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 227 (306)
|+|++|..||....... ............. ..+................+..+.+||.+||+.||.+|||+.|+
T Consensus 243 ~~l~~g~~pf~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~ 320 (348)
T 2pml_X 243 YVMFYNVVPFSLKISLV--ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320 (348)
T ss_dssp HHHHHSSCSSCCSSCSH--HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHhCCCCCCCCCcHH--HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99999999998654311 1111110000000 00000000000000112345789999999999999999999999
Q ss_pred HHHh
Q 021891 228 VEAL 231 (306)
Q Consensus 228 l~~l 231 (306)
++|.
T Consensus 321 l~hp 324 (348)
T 2pml_X 321 LKHE 324 (348)
T ss_dssp HTSG
T ss_pred hcCc
Confidence 9863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.84 Aligned_cols=197 Identities=18% Similarity=0.219 Sum_probs=155.4
Q ss_pred HHHHH---HHHhcCCCCccccee-------eEEEeCCe-----------------eEEEEEcCCCCCHHHHhhcCCC---
Q 021891 2 WQAEV---NFLGDLVHLNLVKLI-------GYCIEDDQ-----------------RLLVYEFMPRGSLENHLFRRSL--- 51 (306)
Q Consensus 2 ~~~E~---~il~~l~H~niv~~~-------~~~~~~~~-----------------~~lv~e~~~~~sL~~~l~~~~~--- 51 (306)
|++|+ ++|++++|||||+++ +++.+.+. .|+||||+ +|+|.+++.+...
T Consensus 120 ~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~ 198 (377)
T 3byv_A 120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS 198 (377)
T ss_dssp HHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT
T ss_pred HHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc
Confidence 67899 555666899999998 77766542 78999999 6799999975421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeeccccccccc
Q 021891 52 ---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128 (306)
Q Consensus 52 ---~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 128 (306)
.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ......| ..|+
T Consensus 199 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~ 269 (377)
T 3byv_A 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFE 269 (377)
T ss_dssp TTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCC
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCcc
Confidence 2335888899999999999999998 99999999999999999999999999986322 2334567 9999
Q ss_pred CCcchhcC-----------CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCC
Q 021891 129 APEYVMTG-----------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH 197 (306)
Q Consensus 129 aPE~~~~~-----------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (306)
|||++.+. .++.++|||||||++|||++|..||...........+ ... ..
T Consensus 270 aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~~--~~- 330 (377)
T 3byv_A 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FRS--CK- 330 (377)
T ss_dssp CHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GSS--CC-
T ss_pred ChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hhh--cc-
Confidence 99999877 8999999999999999999999999765433221111 000 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 198 FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 198 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
..+..+.+||.+||+.||++|||+.+++++
T Consensus 331 ---~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 331 ---NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp ---CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred ---CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 124688999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=285.42 Aligned_cols=208 Identities=20% Similarity=0.293 Sum_probs=164.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEE--eCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCI--EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
|++|++++++++||||+++++++. +.+..++||||+.++ |.+++... ...+++..++.++.||+.||.|||+.+
T Consensus 53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-- 129 (305)
T 2wtk_C 53 VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG-- 129 (305)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 679999999999999999999984 455789999999875 77776543 457999999999999999999999998
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC--CCchhHHHHHHHHHHHHHh
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ellt 156 (306)
++||||||+||+++.++.+||+|||++................||..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 130 -i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (305)
T 2wtk_C 130 -IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208 (305)
T ss_dssp -EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred -eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999998765433333344567899999999987644 3789999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||....... . ... .... ...... ..+..+.+||.+||+.||.+|||+.|++++.
T Consensus 209 g~~p~~~~~~~~---~---~~~-i~~~-------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 209 GLYPFEGDNIYK---L---FEN-IGKG-------SYAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp SSCSCCCSSHHH---H---HHH-HHHC-------CCCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CCCCCCCchHHH---H---HHH-HhcC-------CCCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 999997542211 1 100 0000 001111 2346788999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=297.70 Aligned_cols=221 Identities=19% Similarity=0.236 Sum_probs=169.4
Q ss_pred HHHHHHHHhcCC--------CCcccceeeEEE----eCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLV--------HLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKG 68 (306)
Q Consensus 2 ~~~E~~il~~l~--------H~niv~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~ 68 (306)
+.+|+++|++++ |+||+++++++. .....++||||+ +++|.+.+.+. ...+++..++.++.||+.|
T Consensus 80 ~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a 158 (397)
T 1wak_A 80 ALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158 (397)
T ss_dssp HHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence 578999999985 788999999988 456889999999 55666666544 4679999999999999999
Q ss_pred HHHhhcC-CCCCeEeccCCCCCeEEcCCC-------------------------------------------------cE
Q 021891 69 LAFLHEE-AERPVIYRDFKTSNILLDADY-------------------------------------------------NA 98 (306)
Q Consensus 69 l~~LH~~-~~~~iiH~dlkp~Nill~~~~-------------------------------------------------~~ 98 (306)
|.|||++ + |+||||||+|||++.++ .+
T Consensus 159 L~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (397)
T 1wak_A 159 LDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235 (397)
T ss_dssp HHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCE
T ss_pred HHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccce
Confidence 9999998 8 99999999999998775 79
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhh
Q 021891 99 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178 (306)
Q Consensus 99 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 178 (306)
||+|||+++..... .....||..|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 236 kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 310 (397)
T 1wak_A 236 KIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310 (397)
T ss_dssp EECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHH
T ss_pred Eecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHH
Confidence 99999999875432 2335689999999999999999999999999999999999999987654432211111100
Q ss_pred ---hhcc------------------ccccccccCCc---------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 179 ---HLGE------------------RRRFYRLIDPR---------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 179 ---~~~~------------------~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
.... ...+....... ....++...+..+.+||.+||+.||++|||+.|++
T Consensus 311 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 390 (397)
T 1wak_A 311 IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390 (397)
T ss_dssp HHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHH
T ss_pred HHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 0000 00000000000 00124567788999999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
+|.
T Consensus 391 ~hp 393 (397)
T 1wak_A 391 RHP 393 (397)
T ss_dssp TSG
T ss_pred hCc
Confidence 864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.11 Aligned_cols=215 Identities=20% Similarity=0.277 Sum_probs=166.9
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|+++|++++ ||||+++++++.+ ....++||||+.+++|.+++. .+++..+..++.||+.||.|||+.+
T Consensus 77 ~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-- 150 (330)
T 3nsz_A 77 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG-- 150 (330)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 679999999997 9999999999988 667899999999999999884 3889999999999999999999998
Q ss_pred CeEeccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHh
Q 021891 79 PVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+|||++.++ .+||+|||+++....... .....|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 151 -ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 226 (330)
T 3nsz_A 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226 (330)
T ss_dssp -EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred -eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh
Confidence 99999999999999776 899999999987654322 233568999999999986 678999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhh----h----h-----------------ccccccccccCCccCCCCCHHHHHHHHHHHH
Q 021891 157 GRRSMDKNRPNGEHNLVEWARP----H----L-----------------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~----~----~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 211 (306)
|..||......... ....... . . .....+...... ......+..+.+||.
T Consensus 227 g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~ 301 (330)
T 3nsz_A 227 RKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS----ENQHLVSPEALDFLD 301 (330)
T ss_dssp TCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT----TTGGGCCHHHHHHHH
T ss_pred CCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccc----cccccCCHHHHHHHH
Confidence 99999654322110 0000000 0 0 000000011111 111123578999999
Q ss_pred HcccCCCCCCCCHHHHHHHh
Q 021891 212 HCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l 231 (306)
+||+.||++|||+.|+++|.
T Consensus 302 ~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 302 KLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp TTSCSSGGGSCCHHHHHTSG
T ss_pred HHhcCCcccCCCHHHHhcCc
Confidence 99999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.59 Aligned_cols=220 Identities=24% Similarity=0.289 Sum_probs=159.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++++.++||||+++++++...+ ..++||||+. ++|.+.+.. .+++..+..++.||+.||.|||+.
T Consensus 71 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~ 146 (371)
T 2xrw_A 71 AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 146 (371)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC
Confidence 578999999999999999999998765 7899999996 488888852 489999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ |+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|+
T Consensus 147 ~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 220 (371)
T 2xrw_A 147 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220 (371)
T ss_dssp T---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred C---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence 8 9999999999999999999999999998654321 223457899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHh----------------hhhhhcccc-----ccccccCCcc---CCCCCHHHHHHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEW----------------ARPHLGERR-----RFYRLIDPRL---EGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~----------------~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~li~ 211 (306)
+|..||.+.........+.. ......... .+...+.... ........+..+.+||.
T Consensus 221 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 300 (371)
T 2xrw_A 221 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 300 (371)
T ss_dssp HSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHH
Confidence 99999976532211000000 000000000 0000000000 00112234678999999
Q ss_pred HcccCCCCCCCCHHHHHHHh
Q 021891 212 HCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l 231 (306)
+||+.||++|||++|+++|.
T Consensus 301 ~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 301 KMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHSCSSGGGSCCHHHHHHSH
T ss_pred HHCcCChhhCCCHHHHhCCc
Confidence 99999999999999999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=297.39 Aligned_cols=222 Identities=22% Similarity=0.306 Sum_probs=165.6
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeC--------------------------------------CeeEEEEEcCCCCCHHH
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIED--------------------------------------DQRLLVYEFMPRGSLEN 44 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~--------------------------------------~~~~lv~e~~~~~sL~~ 44 (306)
.+|+++|+.++||||+++++++... ...++||||++ ++|.+
T Consensus 48 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 126 (383)
T 3eb0_A 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHK 126 (383)
T ss_dssp CHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHH
T ss_pred HHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHH
Confidence 5799999999999999999998543 34889999997 58777
Q ss_pred Hhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEc-CCCcEEEeccCCcccCCCCCcceeeec
Q 021891 45 HLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTR 120 (306)
Q Consensus 45 ~l~---~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 120 (306)
.+. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|||+++....... ...
T Consensus 127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 200 (383)
T 3eb0_A 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVA 200 (383)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcC
Confidence 764 34567999999999999999999999998 99999999999997 689999999999987644322 234
Q ss_pred ccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhh-----h----c--ccccccc
Q 021891 121 VMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-----L----G--ERRRFYR 188 (306)
Q Consensus 121 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~----~--~~~~~~~ 188 (306)
..||..|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+...... + . ....+..
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 280 (383)
T 3eb0_A 201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280 (383)
T ss_dssp CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCC
T ss_pred cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCc
Confidence 5689999999998865 5899999999999999999999999865432211111000000 0 0 0000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 189 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.....+...++...+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 0000111112223457899999999999999999999999853
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=297.55 Aligned_cols=210 Identities=13% Similarity=0.030 Sum_probs=149.8
Q ss_pred HHHHH---HHHhcCCCCccccee-------eEEEeCC-----------------eeEEEEEcCCCCCHHHHhhcCCCCCC
Q 021891 2 WQAEV---NFLGDLVHLNLVKLI-------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSLPLP 54 (306)
Q Consensus 2 ~~~E~---~il~~l~H~niv~~~-------~~~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~~l~ 54 (306)
+++|+ ++|+. +||||++++ +++...+ ..|+|||||+ ++|.+++...+..++
T Consensus 109 ~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~ 186 (371)
T 3q60_A 109 LHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYV 186 (371)
T ss_dssp HHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccc
Confidence 46774 45555 799987755 5555433 3799999998 799999976544566
Q ss_pred HHHH------HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeeccccccccc
Q 021891 55 WSIR------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 128 (306)
Q Consensus 55 ~~~~------~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 128 (306)
+..+ ..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....+|+.|+
T Consensus 187 ~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~ 258 (371)
T 3q60_A 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYA 258 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGC
T ss_pred hhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCc
Confidence 6666 778899999999999998 999999999999999999999999999875321 22445679999
Q ss_pred CCcchhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHH
Q 021891 129 APEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA 206 (306)
Q Consensus 129 aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (306)
|||++.+ ..++.++|||||||++|||++|..||............... . ................+..+
T Consensus 259 aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~ 329 (371)
T 3q60_A 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS---L------RVPGTDSLAFGSCTPLPDFV 329 (371)
T ss_dssp CHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCC---T------TSCCCCSCCCTTSSCCCHHH
T ss_pred ChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhh---h------hhccccccchhhccCCCHHH
Confidence 9999987 68999999999999999999999999876433211110000 0 00000000000111235789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 021891 207 AQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 207 ~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.+||.+||+.||++|||+.++++|
T Consensus 330 ~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 330 KTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=301.20 Aligned_cols=223 Identities=25% Similarity=0.315 Sum_probs=164.2
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
.+|+++|++|+|||||++++++... ..+++||||+++ +|.+.+. .....+++..++.++.||+.||.|||
T Consensus 95 ~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 173 (420)
T 1j1b_A 95 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173 (420)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999999998642 136799999975 6766554 34567999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCC-CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVL 151 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il 151 (306)
+.+ |+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 174 ~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 247 (420)
T 1j1b_A 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247 (420)
T ss_dssp TTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence 988 9999999999999965 6789999999987644322 2345789999999999764 799999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhh-----hhhcc-ccccccccCCccCC-----CCCHHHHHHHHHHHHHcccCCCCC
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWAR-----PHLGE-RRRFYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
|||++|+.||.+.........+.... ..+.. ...+.....+.... .+....+.++.+||.+||+.||.+
T Consensus 248 ~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 99999999998754322111110000 00000 00000000011100 012223578999999999999999
Q ss_pred CCCHHHHHHHhC
Q 021891 221 RPLMSEVVEALK 232 (306)
Q Consensus 221 Rps~~ell~~l~ 232 (306)
|||+.|+++|..
T Consensus 328 R~t~~e~l~hp~ 339 (420)
T 1j1b_A 328 RLTPLEACAHSF 339 (420)
T ss_dssp SCCHHHHHTSGG
T ss_pred CCCHHHHhCCHh
Confidence 999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=286.34 Aligned_cols=202 Identities=19% Similarity=0.230 Sum_probs=163.4
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
+.+|+.++..+ +||||+++++++.+.+..++||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+
T Consensus 57 ~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~- 135 (289)
T 1x8b_A 57 ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135 (289)
T ss_dssp HHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 56899999999 9999999999999999999999999999999999654 256899999999999999999999998
Q ss_pred CCeEeccCCCCCeEEcCC-------------------CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-C
Q 021891 78 RPVIYRDFKTSNILLDAD-------------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-H 137 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 137 (306)
|+||||||+||+++.+ ..+||+|||++....... ...||..|+|||++.+. .
T Consensus 136 --ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~ 207 (289)
T 1x8b_A 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYT 207 (289)
T ss_dssp --EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCT
T ss_pred --EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCC
Confidence 9999999999999844 479999999998754322 23589999999999865 5
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 138 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 138 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
++.++|||||||++|+|++|.+++.... ...... ....+.... ..+..+.+||.+||+.|
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~-----------~~~~~~~~~----~~~~~~~~li~~~l~~d 267 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLPRNGD-----QWHEIR-----------QGRLPRIPQ----VLSQEFTELLKVMIHPD 267 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCCSSSH-----HHHHHH-----------TTCCCCCSS----CCCHHHHHHHHHHTCSS
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcchh-----HHHHHH-----------cCCCCCCCc----ccCHHHHHHHHHHhCCC
Confidence 6789999999999999999987764321 000000 000111111 23468899999999999
Q ss_pred CCCCCCHHHHHHHhC
Q 021891 218 PKARPLMSEVVEALK 232 (306)
Q Consensus 218 p~~Rps~~ell~~l~ 232 (306)
|++|||+.++++|..
T Consensus 268 p~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 268 PERRPSAMALVKHSV 282 (289)
T ss_dssp GGGSCCHHHHHTCTT
T ss_pred cccCCCHHHHhhChH
Confidence 999999999998643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=315.15 Aligned_cols=210 Identities=24% Similarity=0.370 Sum_probs=169.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++..+...+++..++.++.|++.||.|||+.+ |+
T Consensus 438 ~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iv 513 (656)
T 2j0j_A 438 FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 513 (656)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 678999999999999999999984 56789999999999999999877667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 514 HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~P 592 (656)
T 2j0j_A 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592 (656)
T ss_dssp CSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccccchHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987644322 22233456789999999999999999999999999999997 9999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|....... ...... ... ... .+...+..+.+||.+||+.||++|||+.++++.|+.
T Consensus 593 f~~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 593 FQGVKNND---VIGRIE----NGE------RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp TTTCCHHH---HHHHHH----HTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHH---HHHHHH----cCC------CCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 97643221 111110 000 011 112235788999999999999999999999998864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=293.72 Aligned_cols=212 Identities=23% Similarity=0.288 Sum_probs=150.8
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEe--------CCeeEEEEEcCCCCCHHHHhhc--CCCCCCHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLA 70 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~--~~~~l~~~~~~~~~~qi~~~l~ 70 (306)
+.+|+.+++++. ||||+++++++.. ....++||||+. |+|.+++.. ....+++..++.++.||+.||.
T Consensus 72 ~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~ 150 (337)
T 3ll6_A 72 IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150 (337)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 678999999995 9999999999953 345799999995 699998864 3456999999999999999999
Q ss_pred HhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce----------eeecccccccccCCcch---hcCC
Q 021891 71 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYV---MTGH 137 (306)
Q Consensus 71 ~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~ 137 (306)
|||+.+ .+|+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++ .+..
T Consensus 151 ~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 229 (337)
T 3ll6_A 151 HMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229 (337)
T ss_dssp HHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSC
T ss_pred HHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCC
Confidence 999865 459999999999999999999999999998765432211 11134689999999998 4667
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 138 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 138 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
++.++|||||||++|+|++|..||.......... . ........ ..+..+.+||.+||+.|
T Consensus 230 ~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----------~------~~~~~~~~----~~~~~~~~li~~~l~~~ 289 (337)
T 3ll6_A 230 IGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN----------G------KYSIPPHD----TQYTVFHSLIRAMLQVN 289 (337)
T ss_dssp SSHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCCTTC----CSSGGGHHHHHHHSCSS
T ss_pred CChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc----------C------cccCCccc----ccchHHHHHHHHHccCC
Confidence 8999999999999999999999997543221100 0 00000001 11245789999999999
Q ss_pred CCCCCCHHHHHHHhCCCC
Q 021891 218 PKARPLMSEVVEALKPLP 235 (306)
Q Consensus 218 p~~Rps~~ell~~l~~~~ 235 (306)
|.+|||+.|++++|+.+.
T Consensus 290 p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 290 PEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999987554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=288.15 Aligned_cols=221 Identities=27% Similarity=0.366 Sum_probs=171.0
Q ss_pred HHHHHHHHhc--CCCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--
Q 021891 2 WQAEVNFLGD--LVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-- 73 (306)
Q Consensus 2 ~~~E~~il~~--l~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH-- 73 (306)
+.+|++++.. ++||||+++++++...+ ..++||||+++|+|.+++.+. .+++..++.++.|++.||.|||
T Consensus 81 ~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~ 158 (342)
T 1b6c_B 81 WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHME 158 (342)
T ss_dssp HHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHH
Confidence 5688888887 79999999999998876 789999999999999999654 5899999999999999999999
Q ss_pred ------cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhcCC------CC
Q 021891 74 ------EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LT 139 (306)
Q Consensus 74 ------~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~ 139 (306)
+.+ |+||||||+||+++.++.+||+|||+++......... ......||..|+|||++.+.. ++
T Consensus 159 ~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 235 (342)
T 1b6c_B 159 IVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235 (342)
T ss_dssp BCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHH
T ss_pred HhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccC
Confidence 777 9999999999999999999999999997654433221 123457899999999997652 33
Q ss_pred chhHHHHHHHHHHHHHhC----------CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCC-CCHHHHHHHHH
Q 021891 140 SRSDVYSFGVVLLEMLTG----------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQ 208 (306)
Q Consensus 140 ~~~DiwslG~il~elltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 208 (306)
.++|||||||++|||++| ..||.......... ..+..... . ....+..... .....+..+.+
T Consensus 236 ~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~l~~ 308 (342)
T 1b6c_B 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-EEMRKVVC-E-----QKLRPNIPNRWQSCEALRVMAK 308 (342)
T ss_dssp HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HHHHHHHT-T-----SCCCCCCCGGGGTSHHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH-HHHHHHHH-H-----HHhCCCCcccccchhHHHHHHH
Confidence 789999999999999999 66776543322211 11111000 0 1111111111 12356778999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 209 LAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 209 li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||.+||+.||++|||+.+++++|+.+
T Consensus 309 li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 309 IMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.03 Aligned_cols=228 Identities=22% Similarity=0.314 Sum_probs=163.3
Q ss_pred HHHHHH--HhcCCCCcccceeeEEEe-----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 3 QAEVNF--LGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 3 ~~E~~i--l~~l~H~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
..|.++ +..++||||+++++++.. ...+++|||||++|+|.+++.... .++..++.++.||+.||.|||+.
T Consensus 53 ~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp HHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhh
Confidence 344444 455899999999986653 225789999999999999996654 58999999999999999999998
Q ss_pred ---------CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc------ceeeecccccccccCCcchhc-----
Q 021891 76 ---------AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT----- 135 (306)
Q Consensus 76 ---------~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----- 135 (306)
+ |+||||||+|||++.++.+||+|||+++....... ........||..|+|||++.+
T Consensus 131 ~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 131 LPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp BCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred hccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc
Confidence 7 99999999999999999999999999987543211 112224569999999999976
Q ss_pred --CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchH-Hhhhhhhcccccc-----ccccCCccCC--CCCHHHHHH
Q 021891 136 --GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHLGERRRF-----YRLIDPRLEG--HFSIKGAQK 205 (306)
Q Consensus 136 --~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~ 205 (306)
..++.++|||||||++|||++|..||............ ............. .....+.+.. ......+..
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHH
Confidence 35667999999999999999997776544332221110 0000000000000 0001111111 112346778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 206 AAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 206 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
+.+||.+||+.||++|||+.|+++.|+.+.
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 999999999999999999999999887543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=296.27 Aligned_cols=223 Identities=22% Similarity=0.257 Sum_probs=161.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|.+|++++++++||||+++++++... ...++||||+. |+|.+.+......+++..++.++.||+.||.|||+.+
T Consensus 76 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 154 (362)
T 3pg1_A 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG 154 (362)
T ss_dssp HHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 67899999999999999999998653 36899999997 6899988877778999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell 155 (306)
|+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 155 ---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 155 ---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp ---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred ---CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 9999999999999999999999999997543322 2234568999999999886 67899999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhh----------hcccccc-ccc---cCCccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPH----------LGERRRF-YRL---IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
+|..||...........+...... ....... ... .............+..+.+||.+||+.||.+|
T Consensus 229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 999999765322111111000000 0000000 000 00000000111224678999999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
||+.|+++|.
T Consensus 309 pt~~ell~hp 318 (362)
T 3pg1_A 309 ISTEQALRHP 318 (362)
T ss_dssp CCHHHHHTSG
T ss_pred CCHHHHHcCc
Confidence 9999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=289.38 Aligned_cols=210 Identities=23% Similarity=0.367 Sum_probs=166.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++++.++||||+++++++.+.+..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ ++
T Consensus 63 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 139 (302)
T 2j7t_A 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---II 139 (302)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cc
Confidence 678999999999999999999999999999999999999999998776667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+||+++.++.+||+|||++...... ........||..|+|||++. +..++.++|||||||++|+|++
T Consensus 140 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 217 (302)
T 2j7t_A 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ 217 (302)
T ss_dssp CCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc
Confidence 9999999999999999999999987532110 11122356899999999984 5678999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||........ ........ .+.. ..+...+..+.+||.+||+.||.+|||+.++++|.
T Consensus 218 g~~p~~~~~~~~~------~~~~~~~~-------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 218 IEPPHHELNPMRV------LLKIAKSD-------PPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp SSCTTTTSCHHHH------HHHHHHSC-------CCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred CCCCCccCCHHHH------HHHHhccC-------Cccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 9999976432110 00000000 0000 01122346789999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.96 Aligned_cols=206 Identities=24% Similarity=0.326 Sum_probs=153.6
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcC-CCC
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AER 78 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~-~~~ 78 (306)
.++..+++.++||||+++++++.+.+..++||||++ ++|.+++.. ....+++..++.++.|++.||.|||++ +
T Consensus 54 ~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-- 130 (290)
T 3fme_A 54 MDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 130 (290)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--
T ss_pred HHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--
Confidence 345556888999999999999999999999999997 588777653 456799999999999999999999997 8
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcch----hcCCCCchhHHHHHHHHHHHH
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el 154 (306)
++||||||+||+++.++.+||+|||+++...... ......||+.|+|||++ .+..++.++|||||||++|+|
T Consensus 131 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l 206 (290)
T 3fme_A 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206 (290)
T ss_dssp -CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHH
T ss_pred -eecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998754332 12334689999999996 456789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
++|..||....... ..... .... ..+... ....+..+.+||.+||+.||++|||+.|+++|
T Consensus 207 ~~g~~p~~~~~~~~----~~~~~-~~~~-------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 207 AILRFPYDSWGTPF----QQLKQ-VVEE-------PSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHTSCSSCCCSCHH----HHHHH-HHHS-------CCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHCCCCccccCchH----HHHHH-Hhcc-------CCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 99999997532211 00000 0000 000000 11234688999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.68 Aligned_cols=209 Identities=25% Similarity=0.341 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++++++. ||||+++++++...+..++||||+++++|.+++..+ ..+++..++.++.||+.||.|||+.+ +
T Consensus 70 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i 145 (298)
T 1phk_A 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---I 145 (298)
T ss_dssp HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 568999999995 999999999999999999999999999999999654 46999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh------cCCCCchhHHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el 154 (306)
+|+||||+||+++.++.+||+|||++........ .....|+..|+|||++. ...++.++||||||+++|+|
T Consensus 146 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l 222 (298)
T 1phk_A 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222 (298)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHH
Confidence 9999999999999999999999999987654322 23456899999999985 45688999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
++|..||....... ... ....... ....+ .....+..+.+||.+||+.||.+|||+.+++++.
T Consensus 223 ~~g~~p~~~~~~~~---~~~---~~~~~~~---~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 223 LAGSPPFWHRKQML---MLR---MIMSGNY---QFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHSSCSSCCSSHHH---HHH---HHHHTCC---CCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHCCCCCcCccHHH---HHH---HHhcCCc---ccCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 99999997543211 111 0000000 00000 1112356899999999999999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=286.88 Aligned_cols=209 Identities=24% Similarity=0.376 Sum_probs=160.6
Q ss_pred HHHHHHHHhcCC--CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|++|++++++++ |+||+++++++.+.+..++|||+ .+++|.+++.... .+++..++.++.|++.||.|||+.+
T Consensus 73 ~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--- 147 (313)
T 3cek_A 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--- 147 (313)
T ss_dssp HHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 678999999997 59999999999999999999995 5789999997654 7899999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-----------CCCCchhHHHHHH
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFG 148 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG 148 (306)
|+||||||+||++++ +.+||+|||+++...............|+..|+|||++.+ ..++.++||||||
T Consensus 148 ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG 226 (313)
T 3cek_A 148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226 (313)
T ss_dssp CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence 999999999999964 8999999999987654433333344578999999999875 4788999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|++|+|++|..||...... ...... ..++.....++...+..+.+||.+||+.||.+|||+.|++
T Consensus 227 ~il~el~~g~~pf~~~~~~-----~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 227 CILYYMTYGKTPFQQIINQ-----ISKLHA----------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp HHHHHHHHSSCTTTTCCSH-----HHHHHH----------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHhCCCchhhHHHH-----HHHHHH----------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 9999999999999654221 111110 1111111111112246889999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
++.
T Consensus 292 ~h~ 294 (313)
T 3cek_A 292 AHP 294 (313)
T ss_dssp TSH
T ss_pred cCc
Confidence 864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=296.19 Aligned_cols=211 Identities=23% Similarity=0.335 Sum_probs=160.7
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|+++ +|||||++++++.+.+..|+|||||. |+|.+++......+.+..++.++.||+.||.|||+.+ |
T Consensus 64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 139 (432)
T 3p23_A 64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---I 139 (432)
T ss_dssp CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---C
Confidence 47899999999 89999999999999999999999996 5999999877666777778899999999999999998 9
Q ss_pred EeccCCCCCeEEcC-----CCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchh---cCCCCchhHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDA-----DYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 81 iH~dlkp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il 151 (306)
+||||||+||+++. ...+||+|||+++........ .......||+.|+|||++. ...++.++|||||||++
T Consensus 140 vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il 219 (432)
T 3p23_A 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219 (432)
T ss_dssp CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence 99999999999953 235789999999876543211 2234467999999999997 45678899999999999
Q ss_pred HHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 152 LEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 152 ~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|||++ |..||....... .... . ..... ... ......+..+.+||.+||+.||.+|||+.++++|
T Consensus 220 ~ellt~g~~pf~~~~~~~----~~~~---~-~~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 220 YYVISEGSHPFGKSLQRQ----ANIL---L-GACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHTTSCBTTBSTTTHH----HHHH---T-TCCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCCCcchhhHHH----HHHH---h-ccCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 99999 889985432210 0000 0 00000 000 0112345678999999999999999999999986
Q ss_pred h
Q 021891 231 L 231 (306)
Q Consensus 231 l 231 (306)
.
T Consensus 285 p 285 (432)
T 3p23_A 285 P 285 (432)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=282.74 Aligned_cols=212 Identities=22% Similarity=0.351 Sum_probs=160.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-------------CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 68 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~ 68 (306)
+.+|++++++++||||+++++++.+ .+..++||||+++++|.+++......+++..++.++.|++.|
T Consensus 49 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~ 128 (303)
T 1zy4_A 49 ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128 (303)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHH
Confidence 6789999999999999999998865 356799999999999999998776678899999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCc------------ceeeecccccccccCCcchhcC
Q 021891 69 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG 136 (306)
Q Consensus 69 l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~ 136 (306)
|.|||+.+ ++||||||+||+++.++.+||+|||+++....... ........||..|+|||++.+.
T Consensus 129 l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp HHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred HHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 99999998 99999999999999999999999999987543210 1122345689999999999864
Q ss_pred -CCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHccc
Q 021891 137 -HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 215 (306)
Q Consensus 137 -~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 215 (306)
.++.++|||||||++|+|++ ||.... ........... ........+....+..+.+||.+||+
T Consensus 206 ~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~ 269 (303)
T 1zy4_A 206 GHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLID 269 (303)
T ss_dssp SCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTC
T ss_pred CCCcchhhHHHHHHHHHHHHh---ccCCch-----hHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHh
Confidence 78999999999999999998 443210 00000000000 01111222333345678999999999
Q ss_pred CCCCCCCCHHHHHHHhC
Q 021891 216 RDPKARPLMSEVVEALK 232 (306)
Q Consensus 216 ~~p~~Rps~~ell~~l~ 232 (306)
.||.+|||+.+++++..
T Consensus 270 ~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 270 HDPNKRPGARTLLNSGW 286 (303)
T ss_dssp SSGGGSCCHHHHHHSSC
T ss_pred cCcccCcCHHHHhCCCC
Confidence 99999999999999643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=296.85 Aligned_cols=219 Identities=23% Similarity=0.319 Sum_probs=153.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|+.++||||+++++++... ...++|||++ +++|.+++.. ..+++..+..++.||+.||.|||+.
T Consensus 75 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~ 151 (367)
T 2fst_X 75 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA 151 (367)
T ss_dssp HHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 56899999999999999999998754 5679999999 6799998854 4699999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ |+||||||+||+++.++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||
T Consensus 152 g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 223 (367)
T 2fst_X 152 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223 (367)
T ss_dssp T---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHH
T ss_pred C---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHH
Confidence 8 999999999999999999999999999864332 234578999999999886 6889999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhh-----hcc-----ccccccccCCccCCC---CCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPH-----LGE-----RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|+.||.+.........+...... +.. ...+...+....... .....+..+.+||.+||+.||.+|
T Consensus 224 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R 303 (367)
T 2fst_X 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303 (367)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence 9999999865432211111100000 000 000000000000000 001124678999999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
||+.|+++|.
T Consensus 304 ~t~~e~L~hp 313 (367)
T 2fst_X 304 ITAAQALAHA 313 (367)
T ss_dssp CCHHHHHTSG
T ss_pred cCHHHHhcCh
Confidence 9999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=288.70 Aligned_cols=225 Identities=22% Similarity=0.268 Sum_probs=168.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++|++++||||+++++++... ...++||||+. ++|.+++... .+++..++.++.||+.||.|||+.+
T Consensus 72 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ 148 (364)
T 3qyz_A 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN 148 (364)
T ss_dssp HHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 67899999999999999999999765 36899999996 5999988654 5999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
|+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 149 ---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 225 (364)
T 3qyz_A 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225 (364)
T ss_dssp ---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHH
T ss_pred ---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHH
Confidence 999999999999999999999999999875432211 11234578999999998764 5589999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhh-----cc-----cccc-ccccCCccC--CCCCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHL-----GE-----RRRF-YRLIDPRLE--GHFSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~-----~~-----~~~~-~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+....... .. ...+ ......... .......+..+.+||.+||+.||++|
T Consensus 226 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 305 (364)
T 3qyz_A 226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305 (364)
T ss_dssp HHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence 99999998765433222111000000 00 0000 000000000 00011224678999999999999999
Q ss_pred CCHHHHHHHhC
Q 021891 222 PLMSEVVEALK 232 (306)
Q Consensus 222 ps~~ell~~l~ 232 (306)
||+.|+++|..
T Consensus 306 ~t~~e~l~hp~ 316 (364)
T 3qyz_A 306 IEVEQALAHPY 316 (364)
T ss_dssp CCHHHHHTSGG
T ss_pred CCHHHHhcCcc
Confidence 99999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=298.11 Aligned_cols=156 Identities=22% Similarity=0.308 Sum_probs=138.0
Q ss_pred HHHHHHHHhcC------CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDL------VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l------~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+.+|+++++.+ +|+||+++++++...+..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 140 ~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 218 (429)
T 3kvw_A 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218 (429)
T ss_dssp HHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 56788888877 57799999999999999999999995 69999887654 459999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCCCc--EEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 75 EAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
.+ |+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 219 ~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 290 (429)
T 3kvw_A 219 NR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILA 290 (429)
T ss_dssp HT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHH
T ss_pred CC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHH
Confidence 98 999999999999999887 999999999764332 22357899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC
Q 021891 153 EMLTGRRSMDKNRP 166 (306)
Q Consensus 153 elltg~~pf~~~~~ 166 (306)
||++|.+||.....
T Consensus 291 elltG~~pf~~~~~ 304 (429)
T 3kvw_A 291 ELLTGYPLLPGEDE 304 (429)
T ss_dssp HHHHSSCSSCCSSH
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999976543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=284.96 Aligned_cols=222 Identities=24% Similarity=0.313 Sum_probs=168.4
Q ss_pred HHHHHHHHhcC---CCCcccceeeEEE-----eCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDL---VHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l---~H~niv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~L 72 (306)
+.+|+++++.+ +||||+++++++. .....++||||+. ++|.+++.... ..+++..++.++.||+.||.||
T Consensus 58 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l 136 (326)
T 1blx_A 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136 (326)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 56888888777 8999999999987 4567899999997 69999987653 4599999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+.+ ++||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|
T Consensus 137 H~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (326)
T 1blx_A 137 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210 (326)
T ss_dssp HHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence 9998 9999999999999999999999999998654321 223457899999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhh-----hhcc-----ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARP-----HLGE-----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
+|++|..||...........+..... .+.. ...+.. ........+....+..+.+||.+||+.||.+||
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 289 (326)
T 1blx_A 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 289 (326)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcc-cCcchhhhccccCCHHHHHHHHHHcCCCcccCC
Confidence 99999999976543211111100000 0000 000000 000000111223457889999999999999999
Q ss_pred CHHHHHHHh
Q 021891 223 LMSEVVEAL 231 (306)
Q Consensus 223 s~~ell~~l 231 (306)
|+.++++|.
T Consensus 290 t~~e~l~hp 298 (326)
T 1blx_A 290 SAYSALSHP 298 (326)
T ss_dssp CHHHHHTSG
T ss_pred CHHHHhcCc
Confidence 999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=287.53 Aligned_cols=209 Identities=28% Similarity=0.395 Sum_probs=161.3
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEe------CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+++++++ +||||+++++++.. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||
T Consensus 67 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 146 (326)
T 2x7f_A 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146 (326)
T ss_dssp HHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 67899999999 89999999999987 46889999999999999999764 356899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFG 148 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG 148 (306)
+.+ ++|+||||+||+++.++.+||+|||++........ ......|+..|+|||++. +..++.++||||||
T Consensus 147 ~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG 221 (326)
T 2x7f_A 147 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221 (326)
T ss_dssp HTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHH
T ss_pred HCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHH
Confidence 998 99999999999999999999999999986543211 223456899999999986 56789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 021891 149 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228 (306)
Q Consensus 149 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 228 (306)
|++|+|++|..||........ . ... .. . ..+... ....+..+.+||.+||..||.+|||+.+++
T Consensus 222 ~il~~l~~g~~p~~~~~~~~~---~-~~~--~~--~-----~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 285 (326)
T 2x7f_A 222 ITAIEMAEGAPPLCDMHPMRA---L-FLI--PR--N-----PAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLM 285 (326)
T ss_dssp HHHHHHHHSSCTTTTSCHHHH---H-HHH--HH--S-----CCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCCcHHHH---H-HHh--hc--C-----ccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 999999999999965432110 0 000 00 0 001100 112246889999999999999999999999
Q ss_pred HHh
Q 021891 229 EAL 231 (306)
Q Consensus 229 ~~l 231 (306)
++.
T Consensus 286 ~hp 288 (326)
T 2x7f_A 286 KHP 288 (326)
T ss_dssp TSH
T ss_pred hCh
Confidence 863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=285.40 Aligned_cols=220 Identities=22% Similarity=0.331 Sum_probs=169.1
Q ss_pred HHHHHHHHhcCCCCc------ccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~n------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+.+|+++++.++|+| |+++++++.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 58 ~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 136 (339)
T 1z57_A 58 ARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136 (339)
T ss_dssp HHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 578999999887654 999999999999999999999 789999987654 468999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcC-------------------CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc
Q 021891 75 EAERPVIYRDFKTSNILLDA-------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 135 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 135 (306)
.+ |+||||||+||+++. ++.+||+|||+++..... .....||..|+|||++.+
T Consensus 137 ~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 137 NK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp TT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTT
T ss_pred CC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhC
Confidence 98 999999999999987 668999999999874332 233578999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhcc-------ccccc------------------ccc
Q 021891 136 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-------RRRFY------------------RLI 190 (306)
Q Consensus 136 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~------------------~~~ 190 (306)
..++.++|||||||++|||++|..||...........+......... ..... ...
T Consensus 209 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (339)
T 1z57_A 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288 (339)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC
Confidence 99999999999999999999999999765432211111110000000 00000 000
Q ss_pred CC-ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 191 DP-RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 191 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.+ ..........+..+.+||.+||+.||.+|||+.|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 00 00011123457889999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=294.45 Aligned_cols=214 Identities=22% Similarity=0.298 Sum_probs=159.1
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCC------CCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+.+|+++|+++ +||||+++++++.+.+..++|||||. |+|.+++...... ..+..++.++.||+.||.|||+
T Consensus 55 ~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 133 (434)
T 2rio_A 55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133 (434)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH
Confidence 56899999886 89999999999999999999999995 6999999765321 1233457899999999999999
Q ss_pred CCCCCeEeccCCCCCeEEcCC-------------CcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhc----
Q 021891 75 EAERPVIYRDFKTSNILLDAD-------------YNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT---- 135 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~~~-------------~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~---- 135 (306)
.+ |+||||||+|||++.+ +.+||+|||+++......... ......||+.|+|||++.+
T Consensus 134 ~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 210 (434)
T 2rio_A 134 LK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210 (434)
T ss_dssp TT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT
T ss_pred CC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc
Confidence 98 9999999999999754 489999999998765432211 1234579999999999975
Q ss_pred ---CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHH
Q 021891 136 ---GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 136 ---~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 211 (306)
..++.++|||||||++|||++ |..||....... ..... .... .+..........+.++.+||.
T Consensus 211 ~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~i~~----~~~~-----~~~~~~~~~~~~~~~~~~li~ 277 (434)
T 2rio_A 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----SNIIR----GIFS-----LDEMKCLHDRSLIAEATDLIS 277 (434)
T ss_dssp SCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----HHHHH----TCCC-----CCCCTTCCCHHHHHHHHHHHH
T ss_pred ccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----HHHhc----CCCC-----cccccccccccchHHHHHHHH
Confidence 578999999999999999999 999996542211 00000 0000 011111223466789999999
Q ss_pred HcccCCCCCCCCHHHHHHHhC
Q 021891 212 HCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l~ 232 (306)
+||+.||.+|||+.++++|..
T Consensus 278 ~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 278 QMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp HHTCSSGGGSCCHHHHHTSGG
T ss_pred HHhhCChhhCCCHHHHHhCCc
Confidence 999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=279.36 Aligned_cols=207 Identities=24% Similarity=0.346 Sum_probs=166.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+.+..++||||+++++|.+.+.... .+++..++.++.||+.||.|||+.+ ++
T Consensus 68 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---i~ 143 (287)
T 2wei_A 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IV 143 (287)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 6789999999999999999999999999999999999999999886543 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCC---CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDAD---YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
|+||||+||+++.+ +.+||+|||++........ .....|+..|+|||++.+ .++.++||||||+++|+|++|.
T Consensus 144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~ 219 (287)
T 2wei_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT 219 (287)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCC
Confidence 99999999999764 4699999999986543321 223458899999998865 4899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.||....... ...... .... ..+..... ..+..+.+||.+||+.||.+|||+.+++++
T Consensus 220 ~p~~~~~~~~---~~~~~~---~~~~----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 220 PPFYGKNEYD---ILKRVE---TGKY----AFDLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CSSCCSSHHH---HHHHHH---HCCC----CCCSGGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCHHH---HHHHHH---cCCC----CCCchhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 9997643211 111000 0000 00000001 224688999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=287.28 Aligned_cols=224 Identities=22% Similarity=0.270 Sum_probs=164.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|++++++++||||+++++++... ...++||||+. ++|.+++... .+++..+..++.|++.||.|||+.+
T Consensus 56 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ 132 (353)
T 2b9h_A 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN 132 (353)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 56899999999999999999988764 67899999996 5999988653 5899999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--------eeecccccccccCCcchhc-CCCCchhHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSF 147 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 147 (306)
|+||||||+||+++.++.+||+|||+++......... ......||..|+|||++.+ ..++.++|||||
T Consensus 133 ---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 133 ---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp ---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred ---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 9999999999999999999999999998754322111 1123568999999998764 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhc--------cc---cccccccC---CccCCCCCHHHHHHHHHHHHHc
Q 021891 148 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--------ER---RRFYRLID---PRLEGHFSIKGAQKAAQLAAHC 213 (306)
Q Consensus 148 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------~~---~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~ 213 (306)
||++|+|++|..||...........+........ .. ......+. ...........+..+.+||.+|
T Consensus 210 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (353)
T 2b9h_A 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM 289 (353)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHh
Confidence 9999999999999976532111100000000000 00 00000000 0000000112356889999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 021891 214 LSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 214 l~~~p~~Rps~~ell~~l 231 (306)
|+.||++|||+.|+++|.
T Consensus 290 L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 290 LVFDPAKRITAKEALEHP 307 (353)
T ss_dssp SCSSGGGSCCHHHHHTSG
T ss_pred cCcCcccCCCHHHHhcCc
Confidence 999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=283.80 Aligned_cols=218 Identities=22% Similarity=0.320 Sum_probs=162.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCee------EEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++++.++||||+++++++...+.. ++||||+. ++|.+.+. ..+++..+..++.||+.||.|||+.
T Consensus 88 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~ 163 (371)
T 4exu_A 88 AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA 163 (371)
T ss_dssp HHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 57899999999999999999999887655 99999996 68888773 3489999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ |+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 164 ~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (371)
T 4exu_A 164 G---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 235 (371)
T ss_dssp T---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHH
T ss_pred C---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHH
Confidence 8 999999999999999999999999999864332 234578999999999987 6889999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhh--------hhcc--ccccccccCCccCCC---CCHHHHHHHHHHHHHcccCCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARP--------HLGE--RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKAR 221 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R 221 (306)
++|..||...........+..... .... ...+...+....... .....+..+.+||.+||+.||++|
T Consensus 236 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (371)
T 4exu_A 236 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 315 (371)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence 999999976532211111000000 0000 000000000000000 011235789999999999999999
Q ss_pred CCHHHHHHHh
Q 021891 222 PLMSEVVEAL 231 (306)
Q Consensus 222 ps~~ell~~l 231 (306)
||+.|+++|.
T Consensus 316 pt~~ell~hp 325 (371)
T 4exu_A 316 LTAAQALTHP 325 (371)
T ss_dssp CCHHHHHTSG
T ss_pred CCHHHHhcCc
Confidence 9999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.01 Aligned_cols=210 Identities=27% Similarity=0.357 Sum_probs=145.8
Q ss_pred HHHHH-HHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcC-C
Q 021891 3 QAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-A 76 (306)
Q Consensus 3 ~~E~~-il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ 76 (306)
.+|+. +++.++||||+++++++.+.+..++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +
T Consensus 68 ~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 146 (327)
T 3aln_A 68 LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146 (327)
T ss_dssp HHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence 44555 77788999999999999999999999999975 88887752 245799999999999999999999998 8
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcch----hcCCCCchhHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ 152 (306)
++||||||+||+++.++.+||+|||+++...... ......||..|+|||++ .+..++.++|||||||++|
T Consensus 147 ---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 220 (327)
T 3aln_A 147 ---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220 (327)
T ss_dssp ---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHH
T ss_pred ---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999998754322 12234689999999998 4567899999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++|..||......... . . .......+.+........+..+.+||.+||+.||++|||+.+++++.
T Consensus 221 ~l~~g~~pf~~~~~~~~~--~---~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 221 ELATGRFPYPKWNSVFDQ--L---T-------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp HHHHSCCCSSCC------------C-------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred HHHHCCCCCCCcchHHHH--H---H-------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 999999999764321100 0 0 00000011111111112356899999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.15 Aligned_cols=208 Identities=21% Similarity=0.248 Sum_probs=142.0
Q ss_pred HHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 7 NFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 7 ~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
..++.+.||||+++++++.. ....++|||||++|+|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+
T Consensus 74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---iv 150 (336)
T 3fhr_A 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IA 150 (336)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 34567799999999999986 445899999999999999997664 46999999999999999999999998 99
Q ss_pred eccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||+++. ++.+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (336)
T 3fhr_A 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226 (336)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 9999999999976 455999999999865432 123456899999999998888999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||................ .. .. .. .... .....+..+.+||.+||+.||++|||+.|++++.
T Consensus 227 ~pf~~~~~~~~~~~~~~~~---~~-~~-~~-~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 227 PPFYSNTGQAISPGMKRRI---RL-GQ-YG-FPNP----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CCC--------------------------C-CCTT----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCCCCccchhhhhhHHHhh---hc-cc-cc-cCch----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 9997654332111000000 00 00 00 0000 1112357889999999999999999999999965
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.93 Aligned_cols=221 Identities=21% Similarity=0.291 Sum_probs=166.0
Q ss_pred HHHHHHHHhcCC-----------CCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLV-----------HLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l~-----------H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi 65 (306)
+.+|++++++++ |+||+++++++...+ ..++||||+ +++|.+++... ...+++..++.++.||
T Consensus 62 ~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi 140 (373)
T 1q8y_A 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140 (373)
T ss_dssp HHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHH
Confidence 578999999886 899999999998754 789999999 88999999764 3469999999999999
Q ss_pred HHHHHHhhcC-CCCCeEeccCCCCCeEEc------CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC
Q 021891 66 AKGLAFLHEE-AERPVIYRDFKTSNILLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 138 (306)
Q Consensus 66 ~~~l~~LH~~-~~~~iiH~dlkp~Nill~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 138 (306)
+.||.|||++ + |+||||||+|||++ ..+.+||+|||+++..... .....||..|+|||++.+..+
T Consensus 141 ~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~ 212 (373)
T 1q8y_A 141 LLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPW 212 (373)
T ss_dssp HHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCC
Confidence 9999999997 8 99999999999994 4458999999999875432 223468999999999999999
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHh---hhhhhcc-----------------ccccccccCC------
Q 021891 139 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW---ARPHLGE-----------------RRRFYRLIDP------ 192 (306)
Q Consensus 139 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~~-----------------~~~~~~~~~~------ 192 (306)
+.++|||||||++|||++|..||.............. ....... .......+..
T Consensus 213 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (373)
T 1q8y_A 213 GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292 (373)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCH
T ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccch
Confidence 9999999999999999999999986543221111000 0000000 0000000000
Q ss_pred ----ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 193 ----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 193 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.....++...+..+.+||.+||+.||++|||+.|+++|.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 001124567788999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=283.90 Aligned_cols=220 Identities=20% Similarity=0.262 Sum_probs=166.7
Q ss_pred HHHHHHHHhcCCCCc------ccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLVHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~H~n------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+.+|++++++++|++ ++.+++++...+..++||||+ +++|.+.+... ...+++..++.++.||+.||.|||+
T Consensus 63 ~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~ 141 (355)
T 2eu9_A 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141 (355)
T ss_dssp HHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 578999999997765 899999999999999999999 56777776554 3579999999999999999999999
Q ss_pred CCCCCeEeccCCCCCeEE-------------------cCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc
Q 021891 75 EAERPVIYRDFKTSNILL-------------------DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 135 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill-------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 135 (306)
.+ |+||||||+|||+ +.++.+||+|||+++..... .....||..|+|||++.+
T Consensus 142 ~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 142 NQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILE 213 (355)
T ss_dssp TT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTT
T ss_pred CC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeec
Confidence 98 9999999999999 56789999999999864332 233578999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhcc-------cccc------------------cccc
Q 021891 136 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-------RRRF------------------YRLI 190 (306)
Q Consensus 136 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~------------------~~~~ 190 (306)
..++.++|||||||++|||++|..||...........+......... .... ....
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 2eu9_A 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293 (355)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC
Confidence 99999999999999999999999999765432211111110000000 0000 0000
Q ss_pred CC-ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 191 DP-RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 191 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.+ ..........+..+.+||.+||+.||++|||+.|+++|
T Consensus 294 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00001122446789999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=279.68 Aligned_cols=224 Identities=22% Similarity=0.303 Sum_probs=163.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEE--------------eCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCI--------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 67 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~ 67 (306)
+.+|++++++++||||+++++++. +.+..++||||+. |+|.+++.+ ..+++..++.++.|++.
T Consensus 55 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~ 131 (320)
T 2i6l_A 55 ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLR 131 (320)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHH
Confidence 678999999999999999999874 3467899999997 599999854 36899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEEc-CCCcEEEeccCCcccCCCCCc-ceeeecccccccccCCcchhc-CCCCchhHH
Q 021891 68 GLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDV 144 (306)
Q Consensus 68 ~l~~LH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 144 (306)
||.|||+.+ |+||||||+||+++ .++.+||+|||+++....... ........++..|+|||++.+ ..++.++||
T Consensus 132 ~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 208 (320)
T 2i6l_A 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208 (320)
T ss_dssp HHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred HHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence 999999998 99999999999997 567999999999987543211 112233567899999998875 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhhhhc--cccccccc--------c-CCcc-CCCCCHHHHHHHHHHHHH
Q 021891 145 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--ERRRFYRL--------I-DPRL-EGHFSIKGAQKAAQLAAH 212 (306)
Q Consensus 145 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--------~-~~~~-~~~~~~~~~~~~~~li~~ 212 (306)
|||||++|+|++|..||...........+........ ....+... . .+.. ........+..+.+||.+
T Consensus 209 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (320)
T 2i6l_A 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ 288 (320)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH
Confidence 9999999999999999986543211111100000000 00000000 0 0000 000011235789999999
Q ss_pred cccCCCCCCCCHHHHHHHh
Q 021891 213 CLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 213 ~l~~~p~~Rps~~ell~~l 231 (306)
||+.||++|||+.|+++|.
T Consensus 289 ~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 289 ILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp TSCSSGGGSCCHHHHHTSH
T ss_pred HcCCCccccCCHHHHhCCc
Confidence 9999999999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=282.95 Aligned_cols=223 Identities=24% Similarity=0.302 Sum_probs=163.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCe-------eEEEEEcCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAF 71 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~-------~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~~~~qi~~~l~~ 71 (306)
+.+|++.++.++||||+++++++...+. .++||||+++ +|.+.+. .....+++..++.++.|++.||.|
T Consensus 66 ~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 144 (360)
T 3e3p_A 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144 (360)
T ss_dssp HHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4567788888999999999999976443 7899999976 5555443 345578999999999999999999
Q ss_pred hh--cCCCCCeEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHH
Q 021891 72 LH--EEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSF 147 (306)
Q Consensus 72 LH--~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl 147 (306)
|| +.+ |+||||||+|||++. ++.+||+|||+++....... .....||..|+|||++.+. .++.++|||||
T Consensus 145 lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 218 (360)
T 3e3p_A 145 LHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218 (360)
T ss_dssp HTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence 99 877 999999999999997 89999999999987654322 2345689999999998765 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchHHhhh--------hhhccccccccccCC------ccCCCCCHHHHHHHHHHHHHc
Q 021891 148 GVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------PHLGERRRFYRLIDP------RLEGHFSIKGAQKAAQLAAHC 213 (306)
Q Consensus 148 G~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~ 213 (306)
||++|+|++|..||...........+.... .............+. ..........+..+.+||.+|
T Consensus 219 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 298 (360)
T 3e3p_A 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298 (360)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence 999999999999998654322111110000 000000000000000 000011122467899999999
Q ss_pred ccCCCCCCCCHHHHHHHh
Q 021891 214 LSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 214 l~~~p~~Rps~~ell~~l 231 (306)
|+.||.+|||+.|+++|.
T Consensus 299 L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 299 LQYLPEERMKPYEALCHP 316 (360)
T ss_dssp TCSSGGGSCCHHHHTTSG
T ss_pred hccCccccCCHHHHhcCc
Confidence 999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.15 Aligned_cols=223 Identities=24% Similarity=0.252 Sum_probs=166.7
Q ss_pred HHHHHHHHhcCC-CC-----cccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhc
Q 021891 2 WQAEVNFLGDLV-HL-----NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHE 74 (306)
Q Consensus 2 ~~~E~~il~~l~-H~-----niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~ 74 (306)
+++|+++++.++ |+ +|+++++++...+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+
T Consensus 97 ~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 175 (382)
T 2vx3_A 97 AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175 (382)
T ss_dssp HHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc
Confidence 567889988885 55 49999999999999999999996 59999987653 569999999999999999999995
Q ss_pred CCCCCeEeccCCCCCeEEc--CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 75 EAERPVIYRDFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 75 ~~~~~iiH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+. .+|+||||||+|||++ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 249 (382)
T 2vx3_A 176 PE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILV 249 (382)
T ss_dssp TT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHH
Confidence 31 2399999999999994 4788999999999876432 23457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhh-----h---ccccc-cccccC----------------Cc--------------
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPH-----L---GERRR-FYRLID----------------PR-------------- 193 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~-----~---~~~~~-~~~~~~----------------~~-------------- 193 (306)
||++|..||...........+...... . ..... +..+.+ +.
T Consensus 250 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 329 (382)
T 2vx3_A 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329 (382)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhcccc
Confidence 999999999865432211111100000 0 00000 000000 00
Q ss_pred -------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 194 -------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 194 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
-...........+.+||.+||+.||++|||+.|+++|.
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp 374 (382)
T 2vx3_A 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 374 (382)
T ss_dssp SGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred CCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCc
Confidence 00112234456899999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=283.62 Aligned_cols=217 Identities=22% Similarity=0.325 Sum_probs=162.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCe------eEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+.++++++||||+++++++...+. .++||||+. ++|.+++.. .+++..++.++.||+.||.|||+.
T Consensus 70 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~ 145 (353)
T 3coi_A 70 AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSA 145 (353)
T ss_dssp HHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 5789999999999999999999987654 499999996 588887632 489999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 154 (306)
+ |+||||||+||+++.++.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 146 ~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el 217 (353)
T 3coi_A 146 G---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217 (353)
T ss_dssp T---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHH
T ss_pred C---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHH
Confidence 8 999999999999999999999999999864322 233568999999999886 6789999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhh--------hhccc--ccccccc----CCccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARP--------HLGER--RRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
++|..||...........+..... ..... ..+...+ .... .......+..+.+||.+||+.||++
T Consensus 218 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~ 296 (353)
T 3coi_A 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDK 296 (353)
T ss_dssp HHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTT
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCccc
Confidence 999999976542211110000000 00000 0000000 0000 1111234578999999999999999
Q ss_pred CCCHHHHHHHh
Q 021891 221 RPLMSEVVEAL 231 (306)
Q Consensus 221 Rps~~ell~~l 231 (306)
|||+.++++|.
T Consensus 297 Rpt~~e~l~hp 307 (353)
T 3coi_A 297 RLTAAQALTHP 307 (353)
T ss_dssp SCCHHHHHTSG
T ss_pred CCCHHHHhcCc
Confidence 99999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=281.44 Aligned_cols=198 Identities=22% Similarity=0.328 Sum_probs=164.8
Q ss_pred HHHHHHHHhcCC--CCcccceeeEEEeCCeeEEEEEcCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|++++++++ |+||+++++++...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||+.+
T Consensus 93 ~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~-- 169 (320)
T 3a99_A 93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG-- 169 (320)
T ss_dssp EEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 457999999996 59999999999999999999999976 8999998654 36899999999999999999999998
Q ss_pred CeEeccCCCCCeEEc-CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHh
Q 021891 79 PVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 79 ~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt 156 (306)
|+||||||+||+++ .++.+||+|||+++...... .....||..|+|||++.+..+ +.++|||||||++|||++
T Consensus 170 -ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~ 244 (320)
T 3a99_A 170 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244 (320)
T ss_dssp -EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred -cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH
Confidence 99999999999999 78999999999998764322 233568999999999987665 688999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||..... ... .. .. ... ..+..+.+||.+||+.||++|||+.+++++.
T Consensus 245 g~~pf~~~~~--------~~~----~~----~~----~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 245 GDIPFEHDEE--------IIR----GQ----VF----FRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp SSCSCCSHHH--------HHH----CC----CC----CSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCChhh--------hhc----cc----cc----ccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 9999964210 000 00 00 111 1246889999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=279.13 Aligned_cols=199 Identities=24% Similarity=0.356 Sum_probs=161.5
Q ss_pred HHHHHHHHhcC----CCCcccceeeEEEeCCeeEEEEEc-CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDL----VHLNLVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l----~H~niv~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++++++ +|+||+++++++...+..++|||+ +.+++|.+++.++. .+++..++.++.||+.||.|||+.+
T Consensus 81 ~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ 159 (312)
T 2iwi_A 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRG 159 (312)
T ss_dssp CCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45799999998 899999999999999999999999 78899999996644 6999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEc-CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCC-chhHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el 154 (306)
|+||||||+||+++ .++.+||+|||+++...... .....|+..|+|||++.+..+. .++|||||||++|+|
T Consensus 160 ---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 232 (312)
T 2iwi_A 160 ---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM 232 (312)
T ss_dssp ---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred ---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHH
Confidence 99999999999999 88999999999998765432 2345689999999999876664 599999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
++|..||..... .. ... .. ++...+..+.+||.+||+.||++|||+.|++++..
T Consensus 233 ~~g~~pf~~~~~--------~~----~~~--------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 233 VCGDIPFERDQE--------IL----EAE--------LH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp HHSSCSCCSHHH--------HH----HTC--------CC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred HHCCCCCCChHH--------Hh----hhc--------cC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 999999964210 00 000 00 11123467899999999999999999999999643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=277.08 Aligned_cols=208 Identities=28% Similarity=0.392 Sum_probs=154.4
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeE
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVI 81 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~~~~ii 81 (306)
..+..+++.++||||+++++++.+.+..++||||+ ++.+..+.......+++..++.++.|++.||.|||+. + ++
T Consensus 72 ~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~ 147 (318)
T 2dyl_A 72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VI 147 (318)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CC
T ss_pred HHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EE
Confidence 34556788889999999999999999999999999 5677666655456799999999999999999999995 8 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+||+++.++.+||+|||++....... ......||..|+|||++. ...++.++|||||||++|+|++
T Consensus 148 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~ 224 (318)
T 2dyl_A 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224 (318)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh
Confidence 99999999999999999999999997654322 123356899999999984 4578999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||....... ... ....... .+.... ....+..+.+||.+||+.||.+|||+.+++++.
T Consensus 225 g~~pf~~~~~~~--~~~---~~~~~~~-------~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 225 GQFPYKNCKTDF--EVL---TKVLQEE-------PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp SSCTTTTCCSHH--HHH---HHHHHSC-------CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCCCCCCCCccH--HHH---HHHhccC-------CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 999997532210 111 1111110 000100 011246889999999999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.89 Aligned_cols=215 Identities=27% Similarity=0.336 Sum_probs=166.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe------CCeeEEEEEcCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
|.+|++++++++||||+++++++.. .+..++|||||++++|.+++.... ..+++..++.++.|++.||.|||
T Consensus 59 ~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH 138 (676)
T 3qa8_A 59 WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138 (676)
T ss_dssp HHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999998765 667899999999999999997643 36899999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCc---EEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 150 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 150 (306)
+.+ |+||||||+||+++.++. +||+|||++........ .....||..|+|||++.+..++.++|||||||+
T Consensus 139 s~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGvi 212 (676)
T 3qa8_A 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212 (676)
T ss_dssp HTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHH
T ss_pred HCC---CccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHH
Confidence 998 999999999999987665 89999999987654322 234578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhh-------------hhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARP-------------HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
+|+|++|..||...... ..|... .......+.. .......+....+..+.+||.+||+.|
T Consensus 213 LyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~D 285 (676)
T 3qa8_A 213 AFECITGFRPFLPNWQP-----VQWHGKVREKSNEHIVVYDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWH 285 (676)
T ss_dssp HHHHHSSCSSCCSSCHH-----HHSSTTCC------CCSCCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSS
T ss_pred HHHHHHCCCCCCcccch-----hhhhhhhhcccchhhhhhhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCC
Confidence 99999999999653110 000000 0000000000 011122344556789999999999999
Q ss_pred CCCCCCHHHHHH
Q 021891 218 PKARPLMSEVVE 229 (306)
Q Consensus 218 p~~Rps~~ell~ 229 (306)
|++|||+.++++
T Consensus 286 P~kRPTa~elL~ 297 (676)
T 3qa8_A 286 QRQRGTDPQNPN 297 (676)
T ss_dssp CC---CCTTCCC
T ss_pred HhhCcCHHHHhc
Confidence 999999987553
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.06 Aligned_cols=192 Identities=27% Similarity=0.393 Sum_probs=155.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCe-----eEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|.+|+++|++++||||+++++++...+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||+.+
T Consensus 126 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g 202 (681)
T 2pzi_A 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG 202 (681)
T ss_dssp HHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 6789999999999999999999988765 7999999999999987643 6899999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+||+++.+ .+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++
T Consensus 203 ---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~ 271 (681)
T 2pzi_A 203 ---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTL 271 (681)
T ss_dssp ---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHS
T ss_pred ---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHh
Confidence 9999999999999875 8999999999875432 335689999999998765 4899999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~ell~~l 231 (306)
|.+||......... ........+..+.+||.+||+.||.+||+ ++++.+.|
T Consensus 272 g~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 272 DLPTRNGRYVDGLP------------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp CCCEETTEECSSCC------------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCCCCccccccccc------------------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 99888643211100 00011123467889999999999999995 55555444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.70 Aligned_cols=193 Identities=20% Similarity=0.269 Sum_probs=149.0
Q ss_pred HHHHHHHH-hcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFL-GDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il-~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|++++ +.++||||+++++++.. ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.
T Consensus 57 ~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (299)
T 3m2w_A 57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136 (299)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 57899988 56699999999999987 677899999999999999997653 4699999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+ |+||||||+||+++. ++.+||+|||++.... +..++.++|||||||++|
T Consensus 137 ~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~ 189 (299)
T 3m2w_A 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMY 189 (299)
T ss_dssp T---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHH
T ss_pred C---cccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHH
Confidence 8 999999999999988 7889999999986532 235688999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+|++|..||............. . .. ...............+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 190 el~tg~~pf~~~~~~~~~~~~~-------~--~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 190 ILLCGYPPFYSNHGLAISPGMK-------T--RI-RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHHHSSCSCCC-------CCSC-------C--SS-CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHCCCCCCCCcchhhhHHHH-------H--HH-hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 9999999997643321100000 0 00 00000000000012357899999999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=255.93 Aligned_cols=186 Identities=13% Similarity=0.079 Sum_probs=147.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+. .....+..++.||+.||.|||+.+ |+
T Consensus 78 ~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g---iv 151 (286)
T 3uqc_A 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG---VA 151 (286)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 689999999999999999999999999999999999999999998432 356678899999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+||+++.+|.+||+++| |++ .++.++|||||||++|||++|+.||
T Consensus 152 H~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf 202 (286)
T 3uqc_A 152 LSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPL 202 (286)
T ss_dssp CCCCSGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECS
T ss_pred cCCCCcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999997543 333 3689999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
............. ...... .. .........+..+.+||.+||+.||++| |+.|+++.|+..
T Consensus 203 ~~~~~~~~~~~~~---~~~~~~------~~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 203 PEAGVRSGLAPAE---RDTAGQ------PI--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp CCCSBCCCSEECC---BCTTSC------BC--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred CcCCcchhhHHHH---HHhccC------CC--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 8765432110000 000000 00 0000111234678999999999999999 999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=272.55 Aligned_cols=170 Identities=18% Similarity=0.234 Sum_probs=135.7
Q ss_pred eeEEEEEcCCCCCHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEec
Q 021891 29 QRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 102 (306)
Q Consensus 29 ~~~lv~e~~~~~sL~~~l~------~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~D 102 (306)
..+++|+++ +++|.+++. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEe
Confidence 457888877 679999884 23445788899999999999999999998 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCCcch----------hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 021891 103 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 172 (306)
Q Consensus 103 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 172 (306)
||+++..... ....+| +.|+|||++ .+..++.++|||||||++|||++|+.||...........
T Consensus 255 FG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~ 328 (413)
T 3dzo_A 255 FEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328 (413)
T ss_dssp GGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG
T ss_pred ccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH
Confidence 9998864322 344567 999999999 445688899999999999999999999976533221111
Q ss_pred HHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.+... . ..+..+.+||.+||+.||++|||+.+++++
T Consensus 329 ----------------~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 329 ----------------IFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp ----------------GGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----------------HHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01100 1 124689999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=263.88 Aligned_cols=202 Identities=13% Similarity=0.071 Sum_probs=150.7
Q ss_pred HHHHHHHHhcCC---------CCcccceeeEE-----------------Ee-------------CCeeEEEEEcCCCCCH
Q 021891 2 WQAEVNFLGDLV---------HLNLVKLIGYC-----------------IE-------------DDQRLLVYEFMPRGSL 42 (306)
Q Consensus 2 ~~~E~~il~~l~---------H~niv~~~~~~-----------------~~-------------~~~~~lv~e~~~~~sL 42 (306)
+.+|+++|++|+ ||||+++.+++ .+ .+..|+|||||++|++
T Consensus 70 ~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~l 149 (336)
T 2vuw_A 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID 149 (336)
T ss_dssp HHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEE
T ss_pred HHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCcc
Confidence 578999999886 66666666553 32 6789999999999977
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCCeEEcCCC--------------------cEEEe
Q 021891 43 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY--------------------NAKLS 101 (306)
Q Consensus 43 ~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~~~~iiH~dlkp~Nill~~~~--------------------~~kl~ 101 (306)
.+.+.+ ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++ .+||+
T Consensus 150 l~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~ 224 (336)
T 2vuw_A 150 LEQMRT--KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224 (336)
T ss_dssp TGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEEC
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEe
Confidence 666644 46899999999999999999999 888 99999999999999887 89999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCCCCCcchHHhhhhhh
Q 021891 102 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180 (306)
Q Consensus 102 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 180 (306)
|||+++..... ...||+.|+|||++.+.. +.++||||||++ .+++++|..||... ..........
T Consensus 225 DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~ 290 (336)
T 2vuw_A 225 DYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKM 290 (336)
T ss_dssp CCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHH
T ss_pred eccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhh
Confidence 99999865321 347899999999998766 899999998777 77788898887421 0000000000
Q ss_pred ccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHh
Q 021891 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV-EAL 231 (306)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell-~~l 231 (306)
.... ..............+.++.+||.+||+.| |+.|++ +|.
T Consensus 291 ~~~~----~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 291 LKQM----TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHTC----CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred hhhh----ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence 0000 00111111223457889999999999976 999999 763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=272.06 Aligned_cols=150 Identities=19% Similarity=0.181 Sum_probs=114.5
Q ss_pred CHHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+|.+|+++|+++ .|+||+++++++++++..|||||||+|++|.++|.+.+ .+++. .++.||+.||.|||++|
T Consensus 287 ~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~G--- 359 (569)
T 4azs_A 287 ELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQG--- 359 (569)
T ss_dssp HHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCC---
Confidence 488999999999 79999999999999999999999999999999997654 67665 47899999999999999
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||||+|||++.+|.+||+|||+|+....... .....+||+.|+|||++.+ .+..++|+||+|+++++|.++..
T Consensus 360 IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 360 FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 99999999999999999999999999987644322 2345689999999999875 46778999999999887766543
Q ss_pred C
Q 021891 160 S 160 (306)
Q Consensus 160 p 160 (306)
+
T Consensus 437 ~ 437 (569)
T 4azs_A 437 N 437 (569)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-27 Score=219.36 Aligned_cols=146 Identities=18% Similarity=0.210 Sum_probs=125.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++||||+++..++...+..|+|||||++++|.+++.+ +..++.|++.||.|||+++ |+
T Consensus 386 ~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---Ii 453 (540)
T 3en9_A 386 TAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VI 453 (540)
T ss_dssp HHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---Cc
Confidence 68999999999999999766666678888999999999999999855 5689999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce-----eeecccccccccCCcchhc--CCCCchhHHHHHHHHHHHH
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el 154 (306)
||||||+|||++. .+||+|||+++......... ......||+.|+|||++.. ..|+..+|+|+..+-..+.
T Consensus 454 HrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~ 531 (540)
T 3en9_A 454 HNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKD 531 (540)
T ss_dssp CTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred cCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence 9999999999998 99999999999865432111 1235689999999999986 6788899999999988888
Q ss_pred HhCCCCC
Q 021891 155 LTGRRSM 161 (306)
Q Consensus 155 ltg~~pf 161 (306)
+.++.+|
T Consensus 532 v~~r~rY 538 (540)
T 3en9_A 532 VERRARY 538 (540)
T ss_dssp HHTCSCC
T ss_pred HHhcccc
Confidence 8766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=7.5e-21 Score=161.32 Aligned_cols=102 Identities=12% Similarity=0.056 Sum_probs=85.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++ | +++++++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+.+ |+
T Consensus 151 ~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---ii 215 (282)
T 1zar_A 151 ARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IV 215 (282)
T ss_dssp HHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CE
Confidence 679999999999 5 777776544 55699999999999988 421 224579999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 134 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 134 (306)
||||||+|||++ ++.+||+|||+++. +..++|||++.
T Consensus 216 HrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 216 HGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred eCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999999999999 99999999999864 33478888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=132.35 Aligned_cols=95 Identities=18% Similarity=0.102 Sum_probs=76.7
Q ss_pred HHHHHHHHhcCCCCcc--cceeeEEEeCCeeEEEEEcCCC-C----CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-
Q 021891 2 WQAEVNFLGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH- 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~ni--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH- 73 (306)
+.+|+++|+.|.|++| ..++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.|||
T Consensus 117 ~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 117 TEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH
Confidence 5789999999988864 444442 356899999942 3 77776532 235567889999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccC
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 109 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 109 (306)
+.+ |+||||||+|||++. .++|+|||++...
T Consensus 189 ~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 988 999999999999988 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=114.56 Aligned_cols=94 Identities=13% Similarity=0.087 Sum_probs=68.3
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
+|...|.+|.+.++.-..-+.. . ..+|||||++|++|.++.. . .....++.||+.+|.+||+.+ ||||
T Consensus 162 kE~~nL~rL~~~gv~vp~p~~~-~-~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g---IVHr 229 (397)
T 4gyi_A 162 KEFAFMKALYEEGFPVPEPIAQ-S-RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG---LIHG 229 (397)
T ss_dssp HHHHHHHHHHHTTCSCCCEEEE-E-TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHHHHhcCCCCCeeeec-c-CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC---CcCC
Confidence 5667777775544322211111 2 2379999999988876432 1 234567899999999999998 9999
Q ss_pred cCCCCCeEEcCCC----------cEEEeccCCcccC
Q 021891 84 DFKTSNILLDADY----------NAKLSDFGLAKDG 109 (306)
Q Consensus 84 dlkp~Nill~~~~----------~~kl~Dfg~a~~~ 109 (306)
||||.|||++.+| .+.|+||+-+...
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999998776 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-11 Score=100.93 Aligned_cols=101 Identities=17% Similarity=0.054 Sum_probs=81.0
Q ss_pred CHHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC---
Q 021891 1 MWQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--- 76 (306)
Q Consensus 1 ~~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--- 76 (306)
.+++|+++|+.|. +..+.++++++.+.+..|+||||++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 55 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~ 128 (263)
T 3tm0_A 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISD 128 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCccc
Confidence 3789999999994 6778899999999889999999999999987642 11223467889999999999811
Q ss_pred -----------------------------------------------------CCCeEeccCCCCCeEEcCCCcEEEecc
Q 021891 77 -----------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDF 103 (306)
Q Consensus 77 -----------------------------------------------------~~~iiH~dlkp~Nill~~~~~~kl~Df 103 (306)
...++|+|+++.||+++.++.+.|+||
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDw 208 (263)
T 3tm0_A 129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL 208 (263)
T ss_dssp CSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCC
T ss_pred CCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEc
Confidence 123899999999999987656679999
Q ss_pred CCcc
Q 021891 104 GLAK 107 (306)
Q Consensus 104 g~a~ 107 (306)
+.+.
T Consensus 209 e~a~ 212 (263)
T 3tm0_A 209 GRSG 212 (263)
T ss_dssp TTCE
T ss_pred hhcc
Confidence 8764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=5.5e-10 Score=97.66 Aligned_cols=105 Identities=14% Similarity=0.238 Sum_probs=83.7
Q ss_pred CHHHHHHHHhcCC--CCcccceeeEEEeC---CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 1 MWQAEVNFLGDLV--HLNLVKLIGYCIED---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 1 ~~~~E~~il~~l~--H~niv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
.+.+|+++++.|. +..+.+++.++.+. +..|+||||++|..+.+.. ...++......++.+++..|..||+.
T Consensus 82 ~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~ 158 (359)
T 3dxp_A 82 AIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTV 158 (359)
T ss_dssp CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCC
Confidence 3678999999996 45678999988776 4579999999988775422 22467888889999999999999973
Q ss_pred C-------------------------------------------------------CCCeEeccCCCCCeEEcCCCc--E
Q 021891 76 A-------------------------------------------------------ERPVIYRDFKTSNILLDADYN--A 98 (306)
Q Consensus 76 ~-------------------------------------------------------~~~iiH~dlkp~Nill~~~~~--~ 98 (306)
. ...++|+|+++.||+++.++. +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~ 238 (359)
T 3dxp_A 159 DYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVL 238 (359)
T ss_dssp CTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEE
T ss_pred CchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEE
Confidence 1 134999999999999987653 6
Q ss_pred EEeccCCccc
Q 021891 99 KLSDFGLAKD 108 (306)
Q Consensus 99 kl~Dfg~a~~ 108 (306)
.|+||+.+..
T Consensus 239 ~viDwe~a~~ 248 (359)
T 3dxp_A 239 AVLDWELSTL 248 (359)
T ss_dssp EECCCTTCEE
T ss_pred EEECcccccc
Confidence 8999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=5.7e-10 Score=92.79 Aligned_cols=99 Identities=18% Similarity=0.093 Sum_probs=74.9
Q ss_pred CHHHHHHHHhcCCCCc--ccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--
Q 021891 1 MWQAEVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-- 76 (306)
Q Consensus 1 ~~~~E~~il~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-- 76 (306)
.+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 59 ~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~ 129 (264)
T 1nd4_A 59 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPA 129 (264)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGG
T ss_pred hhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCC
Confidence 3679999999995544 557899888888899999999998884 211 12 2256677778888888643
Q ss_pred -----------------------------------------------------CCCeEeccCCCCCeEEcCCCcEEEecc
Q 021891 77 -----------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDF 103 (306)
Q Consensus 77 -----------------------------------------------------~~~iiH~dlkp~Nill~~~~~~kl~Df 103 (306)
...++|+|++|.||+++.++.+.|+||
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~ 209 (264)
T 1nd4_A 130 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC 209 (264)
T ss_dssp GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred CCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence 112999999999999987766779999
Q ss_pred CCccc
Q 021891 104 GLAKD 108 (306)
Q Consensus 104 g~a~~ 108 (306)
|.+..
T Consensus 210 ~~a~~ 214 (264)
T 1nd4_A 210 GRLGV 214 (264)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 98753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=7.2e-10 Score=94.62 Aligned_cols=151 Identities=20% Similarity=0.208 Sum_probs=97.5
Q ss_pred HHHHHHHHhcC-CCCc--ccceeeEEEeCC---eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDL-VHLN--LVKLIGYCIEDD---QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l-~H~n--iv~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|+.| .+.. +.+++......+ ..|+||++++|.+|.+... ..++.+....++.+++..|..||+.
T Consensus 57 ~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~ 133 (304)
T 3sg8_A 57 LFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSI 133 (304)
T ss_dssp HHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcC
Confidence 67899999888 3433 345555443333 3478999999988875432 2467777788888888888888862
Q ss_pred C-------------------------------------------------------CCCeEeccCCCCCeEEcC--CCcE
Q 021891 76 A-------------------------------------------------------ERPVIYRDFKTSNILLDA--DYNA 98 (306)
Q Consensus 76 ~-------------------------------------------------------~~~iiH~dlkp~Nill~~--~~~~ 98 (306)
. ...++|+|+++.||+++. ++.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~ 213 (304)
T 3sg8_A 134 NISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTIC 213 (304)
T ss_dssp CCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEE
T ss_pred CCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEE
Confidence 1 123799999999999988 4567
Q ss_pred EEeccCCcccCCCCCcceeeecccccccc---cCCcchhc-----CC---------CCchhHHHHHHHHHHHHHhCCCCC
Q 021891 99 KLSDFGLAKDGPEGDKTHVSTRVMGTYGY---AAPEYVMT-----GH---------LTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 99 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-----~~---------~~~~~DiwslG~il~elltg~~pf 161 (306)
.|+||+.+....... .......+ ..|+.... .. ...-.+.|++|.++|.+.+|..+|
T Consensus 214 ~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 214 GIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp EECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred EEEeCCCCccCChHH------HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 899999886532110 00000011 12221110 01 122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=4.5e-07 Score=75.67 Aligned_cols=102 Identities=20% Similarity=0.093 Sum_probs=73.8
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC----
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---- 76 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---- 76 (306)
+.+|..+|+.|. +--|.++++++.+.+..++|||+++|.++.+..... ......+..+++..|.-||...
T Consensus 66 ~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~ 140 (272)
T 4gkh_A 66 VTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNC 140 (272)
T ss_dssp HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGC
T ss_pred HHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccC
Confidence 678999998884 333678999999999999999999998887755321 1222344555555555555421
Q ss_pred ---------------------------------------------------CCCeEeccCCCCCeEEcCCCcEEEeccCC
Q 021891 77 ---------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGL 105 (306)
Q Consensus 77 ---------------------------------------------------~~~iiH~dlkp~Nill~~~~~~kl~Dfg~ 105 (306)
...++|+|+++.||+++.++.+-|+||+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~ 220 (272)
T 4gkh_A 141 PFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGR 220 (272)
T ss_dssp CBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTT
T ss_pred CcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcc
Confidence 01279999999999999877777999998
Q ss_pred ccc
Q 021891 106 AKD 108 (306)
Q Consensus 106 a~~ 108 (306)
+..
T Consensus 221 a~~ 223 (272)
T 4gkh_A 221 VGI 223 (272)
T ss_dssp CEE
T ss_pred ccc
Confidence 753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.8e-06 Score=73.56 Aligned_cols=104 Identities=20% Similarity=0.186 Sum_probs=71.5
Q ss_pred HHHHHHHHhcCCCC---cccceeeEEE-eCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-
Q 021891 2 WQAEVNFLGDLVHL---NLVKLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA- 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~---niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~- 76 (306)
+.+|+++|+.|.+. .|.+++.++. ..+..++|||+++|..|.+.... .++......++.++...|..||+..
T Consensus 56 ~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~ 132 (306)
T 3tdw_A 56 LNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPV 132 (306)
T ss_dssp HHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCH
T ss_pred HHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 67899999999653 3567777764 34567899999999888763211 2344444555555555555555422
Q ss_pred --------------------------------------------------------CCCeEeccCCCCCeEEcC---CCc
Q 021891 77 --------------------------------------------------------ERPVIYRDFKTSNILLDA---DYN 97 (306)
Q Consensus 77 --------------------------------------------------------~~~iiH~dlkp~Nill~~---~~~ 97 (306)
...++|+|+++.||+++. ++.
T Consensus 133 ~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~ 212 (306)
T 3tdw_A 133 ETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP 212 (306)
T ss_dssp HHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC
T ss_pred ccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc
Confidence 123699999999999987 455
Q ss_pred -EEEeccCCccc
Q 021891 98 -AKLSDFGLAKD 108 (306)
Q Consensus 98 -~kl~Dfg~a~~ 108 (306)
+.|+||+.+..
T Consensus 213 ~~~~iD~~~a~~ 224 (306)
T 3tdw_A 213 LTGIIDFGDAAI 224 (306)
T ss_dssp EEEECCCTTCEE
T ss_pred eEEEEehhhcCC
Confidence 48999998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=3.1e-06 Score=73.60 Aligned_cols=42 Identities=0% Similarity=-0.022 Sum_probs=31.8
Q ss_pred HHHHHHHHhcCC-C--CcccceeeEEEeC---CeeEEEEEcCCCCCHH
Q 021891 2 WQAEVNFLGDLV-H--LNLVKLIGYCIED---DQRLLVYEFMPRGSLE 43 (306)
Q Consensus 2 ~~~E~~il~~l~-H--~niv~~~~~~~~~---~~~~lv~e~~~~~sL~ 43 (306)
+.+|+.+|+.|. + -.+.+++.++.+. +..++|||+++|..+.
T Consensus 74 ~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 74 LDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp HHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred HHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 678999999884 3 3567888887655 3568999999887654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.08 E-value=2e-05 Score=62.59 Aligned_cols=98 Identities=15% Similarity=0.088 Sum_probs=66.0
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeec
Q 021891 41 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120 (306)
Q Consensus 41 sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 120 (306)
||.+.|...+.+++++++|.++.|.+.+|.-+-.... -..+=+-|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------------
Confidence 8999998889999999999999999999877621110 11233446889999999888764 1110
Q ss_pred ccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 121 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122366888753 345688899999999998885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00012 Score=62.76 Aligned_cols=31 Identities=19% Similarity=0.198 Sum_probs=27.2
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4499999999999998888899999997753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00086 Score=57.43 Aligned_cols=31 Identities=29% Similarity=0.320 Sum_probs=26.9
Q ss_pred CCeEeccCCCCCeEEcCC----CcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~~ 108 (306)
..++|+|+++.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999874 6789999998865
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00084 Score=57.03 Aligned_cols=41 Identities=20% Similarity=0.289 Sum_probs=34.5
Q ss_pred HHHHHHHHhcCC---CCcccceeeEEEeCCeeEEEEEcCCCCCH
Q 021891 2 WQAEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSL 42 (306)
Q Consensus 2 ~~~E~~il~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~~sL 42 (306)
|..|++.|+.|. ...+.++++++...+..++||||++|..+
T Consensus 75 ~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 75 FRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 678999999883 35688999998888889999999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00079 Score=59.18 Aligned_cols=29 Identities=24% Similarity=0.261 Sum_probs=24.9
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++|+|+++.||+++.+ .++|+||..+..
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 39999999999999876 488999987764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.001 Score=58.15 Aligned_cols=103 Identities=15% Similarity=0.123 Sum_probs=62.9
Q ss_pred HHHHHHHHhcCCCCc-ccceeeEEEeCCeeEEEEEcCCCCCHHHH----------h----h---cC----CCCCC--HHH
Q 021891 2 WQAEVNFLGDLVHLN-LVKLIGYCIEDDQRLLVYEFMPRGSLENH----------L----F---RR----SLPLP--WSI 57 (306)
Q Consensus 2 ~~~E~~il~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~~sL~~~----------l----~---~~----~~~l~--~~~ 57 (306)
+.+|+++++.|.-.+ ..++++++. + .+||||++|..|... + . .- .+... +.+
T Consensus 100 ~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~ 175 (379)
T 3feg_A 100 LVLESVMFAILAERSLGPQLYGVFP--E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGT 175 (379)
T ss_dssp HHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHH
Confidence 458999998884333 356776654 2 289999988654311 1 0 11 11122 355
Q ss_pred HHHHHHHHHH-------------------HHHHh----hcCC-CCCeEeccCCCCCeEEcCC----CcEEEeccCCccc
Q 021891 58 RMKIALGAAK-------------------GLAFL----HEEA-ERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 108 (306)
Q Consensus 58 ~~~~~~qi~~-------------------~l~~L----H~~~-~~~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~~ 108 (306)
+..+..++.. .+..| ...+ ...++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 176 i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 176 MERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 5556554422 12232 2211 2348999999999999876 7899999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0029 Score=53.31 Aligned_cols=30 Identities=17% Similarity=0.059 Sum_probs=25.2
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 34899999999999 5667789999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.58 E-value=0.011 Score=52.27 Aligned_cols=29 Identities=17% Similarity=0.272 Sum_probs=26.1
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++|+|+++.||+++.++ ++|+||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 399999999999998876 99999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.24 Score=39.13 Aligned_cols=116 Identities=9% Similarity=0.080 Sum_probs=79.7
Q ss_pred CCCCcccceeeEEEeCCeeEEEEEcCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 021891 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 90 (306)
Q Consensus 12 l~H~niv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Ni 90 (306)
..||+++.. .+-.+.+.+.+.++.-+.+ ++.. + +.++....+.++.+|+....++++ -+|--|+|+|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 367888876 5566667666666554322 3333 2 246788999999999988866665 67889999999
Q ss_pred EEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 91 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 91 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
+++.++.+++.-.|+-.. ++|. .++...=.-.+=|++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999987665322 2222 22333334577788899999887764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.71 E-value=0.07 Score=45.14 Aligned_cols=29 Identities=24% Similarity=0.286 Sum_probs=24.8
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3489999999999998 4 889999988754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.61 E-value=0.023 Score=48.06 Aligned_cols=31 Identities=29% Similarity=0.285 Sum_probs=25.8
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3499999999999998876668999987753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.05 E-value=0.39 Score=39.74 Aligned_cols=36 Identities=22% Similarity=0.245 Sum_probs=25.1
Q ss_pred HHHHHHHHhcCCCC---cccceeeEEEeCCeeEEEEEcCCCCC
Q 021891 2 WQAEVNFLGDLVHL---NLVKLIGYCIEDDQRLLVYEFMPRGS 41 (306)
Q Consensus 2 ~~~E~~il~~l~H~---niv~~~~~~~~~~~~~lv~e~~~~~s 41 (306)
|+.|+..|+.|.-. -+.+++++. .-++||||+.++.
T Consensus 58 ~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 58 FRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp HHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred HHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 78899999988432 345666542 3478999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.75 E-value=0.081 Score=45.24 Aligned_cols=31 Identities=13% Similarity=0.153 Sum_probs=27.2
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.55 E-value=0.12 Score=46.27 Aligned_cols=36 Identities=22% Similarity=0.191 Sum_probs=26.0
Q ss_pred HHHHHHHhcCCCCcc-cceeeEEEeCCeeEEEEEcCCCCCH
Q 021891 3 QAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVYEFMPRGSL 42 (306)
Q Consensus 3 ~~E~~il~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~~sL 42 (306)
.+|+.+++.|...++ .++++++ .+ .+||||++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 689999999966555 4777766 23 359999987543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.41 E-value=0.54 Score=37.24 Aligned_cols=114 Identities=10% Similarity=0.118 Sum_probs=76.8
Q ss_pred CCCcccceeeEEEeCCeeEEEEEcCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCeEeccCCCCCe
Q 021891 13 VHLNLVKLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLA-FLHEEAERPVIYRDFKTSNI 90 (306)
Q Consensus 13 ~H~niv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~-~LH~~~~~~iiH~dlkp~Ni 90 (306)
.||++ --.+-.+++.+.+.++.-+++ ++.. + +.++...++.++.+|+.... +++. -+|--|+|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 57777 333446677777777665333 4443 3 24678899999999988776 5655 67889999999
Q ss_pred EEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 91 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 91 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
+++.++.++|.-.|+-.. ++|.- .+...=.-.+=|++..++.++..|.
T Consensus 116 ~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999987665322 33321 2222234467788888888776654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.10 E-value=0.064 Score=46.35 Aligned_cols=29 Identities=21% Similarity=0.251 Sum_probs=24.2
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++|+|+++.||+++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 489999999999997655 89999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=91.34 E-value=0.064 Score=47.53 Aligned_cols=37 Identities=27% Similarity=0.249 Sum_probs=24.6
Q ss_pred HHHHHHHHhcCCCCcc-cceeeEEEeCCeeEEEEEcCCCCCH
Q 021891 2 WQAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVYEFMPRGSL 42 (306)
Q Consensus 2 ~~~E~~il~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~~sL 42 (306)
+.+|+.+++.|...++ .++++.+. + .+|+||++|.+|
T Consensus 122 li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~l 159 (429)
T 1nw1_A 122 LVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCccc
Confidence 3468888888854444 57777553 2 389999986443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.06 E-value=0.18 Score=44.20 Aligned_cols=29 Identities=28% Similarity=0.319 Sum_probs=24.8
Q ss_pred eEeccCCCCCeEE------cCCCcEEEeccCCccc
Q 021891 80 VIYRDFKTSNILL------DADYNAKLSDFGLAKD 108 (306)
Q Consensus 80 iiH~dlkp~Nill------~~~~~~kl~Dfg~a~~ 108 (306)
++|+|+.+.||++ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=85.89 E-value=0.3 Score=43.09 Aligned_cols=29 Identities=17% Similarity=0.332 Sum_probs=25.7
Q ss_pred CeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 79 PVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7788999999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 306 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-66
Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 19/237 (8%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
++ EV L H+N++ +GY Q +V ++ SL +HL +
Sbjct: 50 AFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
IA A+G+ +LH + +I+RD K++NI L D K+ DFGLA +H +
Sbjct: 109 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 121 VMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ G+ + APE + + +SDVY+FG+VL E++TG+ P N +
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQII 219
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
+G L ++ + + +L A CL + RPL +++ +++ L
Sbjct: 220 FMVGRGYLSPDL--SKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 7e-56
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 20/233 (8%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ E + L H LV+L G C+E LV+EFM G L ++L + + +
Sbjct: 47 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGM 106
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
L +G+A+L E VI+RD N L+ + K+SDFG+ + + D+ ST
Sbjct: 107 CLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGT 162
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
+A+PE +S+SDV+SFGV++ E+ + + +NR N E +VE
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI----- 215
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
+RL PRL + Q+ HC P+ RP S ++ L +
Sbjct: 216 --STGFRLYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-55
Identities = 45/231 (19%), Positives = 91/231 (39%), Gaps = 20/231 (8%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ E + +L H LV+L G C + ++ E+M G L N+L +++
Sbjct: 46 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 105
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + +L + ++RD N L++ K+SDFGL++ + D+ S
Sbjct: 106 CKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGS 161
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
++ PE +M +S+SD+++FGV++ E+ + + + N E
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------------ 209
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
I L + ++K + C RP ++ +
Sbjct: 210 ----TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-55
Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 23/259 (8%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIR 58
+AE+ L H N++ I +D+ Q LV ++ GSL ++L R +
Sbjct: 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGM 102
Query: 59 MKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
+K+AL A GLA LH E + + +RD K+ NIL+ + ++D GLA
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162
Query: 114 KT--HVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRR----SM 161
T +GT Y APE + R+D+Y+ G+V E+
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 221
D P + + + + + +L S + + A++ C + AR
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 222 PLMSEVVEALKPLPNLKDM 240
+ + L L + +
Sbjct: 283 LTALRIKKTLSQLSQQEGI 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-54
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 24/247 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
+ E + D H N++ L+G C+ + L+V +M G L N + + +
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVS 118
L AKG+ FL + ++RD N +LD + K++DFGLA+D E D H
Sbjct: 135 FGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
T + A E + T T++SDV+SFGV+L E++T P + N +
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVY 246
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 238
L + RL+ P ++ C + RP SE+V + +
Sbjct: 247 LL----QGRRLLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FS 293
Query: 239 DMASSSY 245
Y
Sbjct: 294 TFIGEHY 300
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-53
Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 22/234 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMK 60
+ AE N + L H LV+L + ++ E+M GSL + L S + L + +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
+A A+G+AF+ E R I+RD + +NIL+ + K++DFGLA+ + ++
Sbjct: 114 MAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREG 169
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ APE + G T +SDV+SFG++L E++T R N E +
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VI 220
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
R YR++ P + ++ QL C P+ RP + L+
Sbjct: 221 QNLERGYRMVRPD---NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 53/253 (20%), Positives = 101/253 (39%), Gaps = 33/253 (13%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E+ L + +V G D + + E M GSL+ L + +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+ KGL +L E+ +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR----------------------- 159
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 160 ---SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 216
+ + +RP + +++ S + + CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 217 DPKARPLMSEVVE 229
+P R + +++
Sbjct: 285 NPAERADLKQLMV 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-52
Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 24/246 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTR 120
G A G+ +L ++RD NIL++++ K+SDFGL++ + + T+ ++
Sbjct: 116 LRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ APE + TS SDV+SFG+V+ E++T N E
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------- 221
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL----PN 236
+ I+ + QL C ++ RP +++V L L +
Sbjct: 222 -----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
Query: 237 LKDMAS 242
LK +A
Sbjct: 277 LKTLAD 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-52
Identities = 55/253 (21%), Positives = 94/253 (37%), Gaps = 41/253 (16%)
Query: 3 QAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------- 51
+E+ + L H N+V L+G C L++E+ G L N+L +
Sbjct: 88 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147
Query: 52 ------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 99
L + + A AKG+ FL + ++RD N+L+ K
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVK 204
Query: 100 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159
+ DFGLA+D V + APE + G T +SDV+S+G++L E+ +
Sbjct: 205 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
Query: 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 219
+ P + FY+LI + ++ + C + D +
Sbjct: 265 NPYPGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 309
Query: 220 ARPLMSEVVEALK 232
RP + L
Sbjct: 310 KRPSFPNLTSFLG 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-52
Identities = 54/249 (21%), Positives = 98/249 (39%), Gaps = 22/249 (8%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
E + L + +V+LIG C + + +LV E G L L + +P S ++
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTR 120
+ G+ +L E + ++RD N+LL + AK+SDFGL+K G + +
Sbjct: 115 LHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ APE + +SRSDV+S+GV + E L+ + +P + E
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE------ 220
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-PLPNLKD 239
I+ + + L + C + RP V + ++ +L
Sbjct: 221 -----VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
Query: 240 MASSSYYFQ 248
++
Sbjct: 276 KVEGHHHHH 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-52
Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 26/233 (11%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRM 59
+ AE + + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +
Sbjct: 47 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 106
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 119
K +L + + +L ++RD N+L+ D AK+SDFGL K+ T
Sbjct: 107 KFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---- 159
Query: 120 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
+ APE + +++SDV+SFG++L E+ + R P L +
Sbjct: 160 -GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV--- 210
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
R + ++ +C D RP ++ E L+
Sbjct: 211 ----PRVEKGYKMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 1e-51
Identities = 52/236 (22%), Positives = 97/236 (41%), Gaps = 22/236 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ +E + +G H N++ L G + +++ EFM GSL++ L + + +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
G A G+ +L + ++RD NIL++++ K+SDFGL++ + T
Sbjct: 134 LRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190
Query: 122 ---MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ APE + TS SDV+S+G+V+ E+++ RP + +
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMTNQDV--- 242
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
I+ + QL C +D RP ++V L +
Sbjct: 243 --------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 2e-51
Identities = 51/234 (21%), Positives = 100/234 (42%), Gaps = 21/234 (8%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMK 60
+ E + ++ H NLV+L+G C + ++ EFM G+L ++L + + + +
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
+A + + +L + + I+RD N L+ ++ K++DFGL++ GD
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAG 175
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ APE + + +SDV++FGV+L E+ T S +
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------- 224
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
Y L++ +K +L C +P RP +E+ +A + +
Sbjct: 225 -----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-51
Identities = 63/260 (24%), Positives = 98/260 (37%), Gaps = 41/260 (15%)
Query: 3 QAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR------------ 49
+E+ L L H+N+V L+G C L++ E+ G L N L R+
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 50 -----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 104
L L + + AKG+AFL + I+RD NILL K+ DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFG 190
Query: 105 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 164
LA+D V + APE + T SDV+S+G+ L E+ + S
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 165 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224
P FY++I + + C DP RP
Sbjct: 251 MPVDSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 225 SEVVEALKPLPNLKDMASSS 244
++V+ ++ K ++ S+
Sbjct: 296 KQIVQLIE-----KQISEST 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 3e-51
Identities = 58/256 (22%), Positives = 97/256 (37%), Gaps = 42/256 (16%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------- 51
+Q E + + + N+VKL+G C L++E+M G L L S
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 52 -------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 98
PL + ++ IA A G+A+L E R ++RD T N L+ +
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 99 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158
K++DFGL+++ D + PE + T+ SDV+++GVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP 218
+ E ++ + R G L L C S+ P
Sbjct: 240 LQPYYGMAHEE--VIYYVRD--GNILACPENCPLEL------------YNLMRLCWSKLP 283
Query: 219 KARPLMSEVVEALKPL 234
RP + L+ +
Sbjct: 284 ADRPSFCSIHRILQRM 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-50
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 26/229 (11%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
+ EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 52 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTAT 110
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
A L++ H + VI+RD K N+LL + K++DFG + P +T +
Sbjct: 111 YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL--- 164
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
GT Y PE + + D++S GV+ E L G+ P + E +
Sbjct: 165 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRIS 217
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
F + A L + L +P RP++ EV+E
Sbjct: 218 RVEFTFPDFVTE------------GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-50
Identities = 54/246 (21%), Positives = 100/246 (40%), Gaps = 24/246 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
AE N + L + +V++IG C E + +LV E G L +L + + +++
Sbjct: 55 LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIEL 112
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTR 120
+ G+ +L E ++RD N+LL + AK+SDFGL+K + T
Sbjct: 113 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ APE + +S+SDV+SFGV++ E + + +P E
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE------ 218
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 240
+++ ++ L C + D + RP + V L+ D+
Sbjct: 219 -----VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDV 271
Query: 241 ASSSYY 246
+ ++
Sbjct: 272 VNEGHH 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 32/247 (12%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
L +LH + +I+RD K NIL D + KL+DFG++ + +
Sbjct: 117 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFI 171
Query: 123 GTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
GT + APE VM ++DV+S G+ L+EM P+ E N +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLL 225
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV-------VEA 230
+ L P +S CL ++ AR S++ V++
Sbjct: 226 KIA--KSEPPTLAQPS---RWS----SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
Query: 231 LKPLPNL 237
KP+ L
Sbjct: 277 NKPIREL 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-49
Identities = 44/232 (18%), Positives = 92/232 (39%), Gaps = 20/232 (8%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E + + + ++ +L+G C+ +L + + MP G L +++ + +
Sbjct: 59 LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+ AKG+ +L + R +++RD N+L+ + K++DFGLAK +K + +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
+ A E ++ T +SDV+S+GV + E++T P E
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------- 221
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
+++ + C D +RP E++ +
Sbjct: 222 ---ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-49
Identities = 60/232 (25%), Positives = 93/232 (40%), Gaps = 20/232 (8%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ EVN + L H NL++L G + ++ V E P GSL + L + +
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STR 120
A+ A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ + APE + T + SD + FGV L EM T + P N +
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKID 228
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
E R PR E Q + C + P+ RP + + L
Sbjct: 229 KEGERL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-49
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 20/228 (8%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ E+ L H N+VK G+ E + + L E+ G L + + +P +
Sbjct: 51 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFF 109
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++
Sbjct: 110 HQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 123 GTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT Y APE + + DV+S G+VL ML G D+ + +
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----------- 215
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ + + + K L L +P AR + ++ +
Sbjct: 216 ----YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-48
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 26/236 (11%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPW 55
M +EVN L +L H N+V+ I+ L V E+ G L + + + + L
Sbjct: 49 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 108
Query: 56 SIRMKIALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 113
+++ L H + V++RD K +N+ LD N KL DFGLA+
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNH 166
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 173
T + +GT Y +PE + +SD++S G +L E+ P +
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQK 220
Query: 174 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
E A + R+ +S + ++ L+ RP + E++E
Sbjct: 221 ELAGKIREGKF-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-48
Identities = 52/234 (22%), Positives = 94/234 (40%), Gaps = 22/234 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMK 60
+ E + L H LV+L ++ +V E+M +GSL + L L +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
+A A G+A++ ++RD + +NIL+ + K++DFGLA+ + ++
Sbjct: 118 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 173
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ APE + G T +SDV+SFG++L E+ T R N E
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------- 222
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
++ + + L C ++P+ RP + L+
Sbjct: 223 -----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 54/249 (21%), Positives = 96/249 (38%), Gaps = 38/249 (15%)
Query: 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL--------- 51
+ E+ L L H N++ L+G C L E+ P G+L + L + +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 52 ------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 105
L + A A+G+ +L + + I+RD NIL+ +Y AK++DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 106 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 165
++ K T + A E + T+ SDV+S+GV+L E+++ +
Sbjct: 174 SRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----- 225
Query: 166 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
P E Y + + + L C P RP +
Sbjct: 226 PYCGMTCAEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 226 EVVEALKPL 234
+++ +L +
Sbjct: 275 QILVSLNRM 283
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-47
Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 27/233 (11%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 57
++ E L L H N+V+ +LV E M G+L+ +L R + +
Sbjct: 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKV 113
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTH 116
KGL FLH P+I+RD K NI + + K+ D GLA +
Sbjct: 114 LRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRAS 168
Query: 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 176
+ V+GT + APE + DVY+FG+ +LEM T + + +
Sbjct: 169 FAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------ 221
Query: 177 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ R+ F + ++ C+ ++ R + +++
Sbjct: 222 ---------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 3e-47
Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 31/231 (13%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
EV FL L H N ++ G + + LV E+ + + + PL +
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVT 121
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
GA +GLA+LH +I+RD K NILL KL DFG A + +
Sbjct: 122 HGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFV 172
Query: 123 GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARP 178
GT + APE ++ G + DV+S G+ +E+ + + + N + +++ + P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
GH+S + CL + P+ RP +++
Sbjct: 233 -------------ALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-46
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 23/234 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ E + H ++VKLIG ++ ++ E G L + L R L + +
Sbjct: 55 FLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
A + LA+L + ++RD N+L+ ++ KL DFGL++ + + +++
Sbjct: 114 AYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKG 169
Query: 122 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL- 180
+ APE + TS SDV+ FGV + E+L +P +
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIEN 224
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
GER P L L C + DP RP +E+ L +
Sbjct: 225 GERLPMPPNCPPTL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 32/256 (12%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLP 52
+ E + + + ++V+L+G + L++ E M RG L+++L P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 53 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 112
S +++A A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 113 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 172
D + + + +PE + G T+ SDV+SFGVVL E+ T + N +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 243
Query: 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
R + +L C +PK RP E++ ++K
Sbjct: 244 -------------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 233 PL--PNLKDMASSSYY 246
P +++ S YY
Sbjct: 291 EEMEPGFREV--SFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-44
Identities = 54/245 (22%), Positives = 96/245 (39%), Gaps = 27/245 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ + + + N+V + + D+ +V E++ GSL + + + +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRE 124
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+ L FLH VI+RD K+ NILL D + KL+DFG + ++GT
Sbjct: 125 CLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGT 179
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 184
+ APE V + D++S G++ +EM+ G P N +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA--TN 231
Query: 185 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-----ALKPLPNLKD 239
L +P S CL D + R E+++ KPL +L
Sbjct: 232 GTPELQNPE---KLS----AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
Query: 240 MASSS 244
+ +++
Sbjct: 285 LIAAA 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-43
Identities = 65/237 (27%), Positives = 93/237 (39%), Gaps = 34/237 (14%)
Query: 14 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SLPLPWSI 57
HLN+V L+G C + L ++ EF G+L +L + L
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
+ + AKG+ FL R I+RD NILL K+ DFGLA+D +
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ APE + T +SDV+SFGV+L E+ + S P + E
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFC 247
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234
L E R R + + + Q C +P RP SE+VE L L
Sbjct: 248 RRLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-42
Identities = 47/226 (20%), Positives = 81/226 (35%), Gaps = 22/226 (9%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E + + L H VKL +D++ + G L ++ + +
Sbjct: 58 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAE 116
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
L +LH + +I+RD K NILL+ D + +++DFG AK K + +GT
Sbjct: 117 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 184
Y +PE + SD+++ G ++ +++ G P N + +
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEY 227
Query: 185 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230
F P KA L L D R E+
Sbjct: 228 DFPEKFFP------------KARDLVEKLLVLDATKRLGCEEMEGY 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-42
Identities = 58/249 (23%), Positives = 98/249 (39%), Gaps = 35/249 (14%)
Query: 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------- 52
+E+ + + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 53 -------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 105
L + A A+G+ +L + I+RD N+L+ D K++DFGL
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 106 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 165
A+D D +T + APE + T +SDV+SFGV+L E+ T S
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 166 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
P E ++L+ + + C P RP
Sbjct: 242 PVEE----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 226 EVVEALKPL 234
++VE L +
Sbjct: 286 QLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (367), Expect = 1e-41
Identities = 59/291 (20%), Positives = 112/291 (38%), Gaps = 29/291 (9%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ E++ + L H L+ L + + +L+ EF+ G L + + + + +
Sbjct: 74 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTR 120
A +GL +H E +++ D K NI+ + + K+ DFGLA +
Sbjct: 134 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---V 187
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
T +AAPE V + +D+++ GV+ +L+G P + +E +
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVK 241
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKP-LPNL 237
F + +A + L ++P+ R + + +E LK NL
Sbjct: 242 RCDWEFDEDAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
Query: 238 KDMASSSYYFQTMQ--AERIGSSPNTRNGIR--AQGGSLSRNGQRSLSIPN 284
SS Y + Q E+ P + I A SL ++ + I +
Sbjct: 294 TSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 1e-41
Identities = 51/229 (22%), Positives = 83/229 (36%), Gaps = 22/229 (9%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ E+ + L H LV L +D++ +++YEFM G L + + ++
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTR 120
KGL +H E ++ D K NI+ + KL DFGL V
Sbjct: 131 RQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--- 184
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
GT +AAPE + +D++S GV+ +L+G P G N E R
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVK 238
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+ ++ L DP R + + +E
Sbjct: 239 SCDWNMDDSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-40
Identities = 47/297 (15%), Positives = 110/297 (37%), Gaps = 35/297 (11%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ E++ L H N++ L ++ ++++EF+ + + + L +
Sbjct: 49 KKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV 108
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTR 120
+ L FLH + + D + NI+ ++ K+ +FG A+ GD +
Sbjct: 109 HQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--- 162
Query: 121 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 180
+ Y APE +++ +D++S G ++ +L+G P + +
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIM 216
Query: 181 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EALKPL 234
F + + +A L ++ K+R SE + + ++ +
Sbjct: 217 NAEYTFDEEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
Query: 235 PN--LKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYAS 289
++ + YY ++ + R + GG++ Q+ +S+ AS
Sbjct: 269 STKVIRTLKHRRYYHTLIKKDLNMVVSAAR---ISCGGAIRS--QKGVSVAKVKVAS 320
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (346), Expect = 2e-39
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 24/235 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIR 58
+ E L H +V + + +V E++ +L + + P+
Sbjct: 55 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRA 113
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHV 117
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+
Sbjct: 114 IEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
+ V+GT Y +PE + +RSDVYS G VL E+LTG P + V A
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAY 224
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 231
H+ E L + + L+++P+ R +E+ L
Sbjct: 225 QHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 136 bits (344), Expect = 5e-39
Identities = 55/235 (23%), Positives = 89/235 (37%), Gaps = 28/235 (11%)
Query: 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
EV+ L + H N+++L + LV++ M +G L ++L + L K
Sbjct: 56 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRK 114
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
I + + LH+ +++RD K NILLD D N KL+DFG + G+K
Sbjct: 115 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---RE 168
Query: 121 VMGTYGYAAPEYVMTGHL------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
V GT Y APE + D++S GV++ +L G P +
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQML 222
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
R + +F + L + L P+ R E +
Sbjct: 223 MLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 2e-38
Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 24/221 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ ++ + +V + D+ + + M G L HL + + +R A
Sbjct: 55 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYA 113
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
GL +H R V+YRD K +NILLD + ++SD GLA D + +
Sbjct: 114 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166
Query: 123 GTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 181
GT+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 224
Query: 182 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
L FS + L L RD R
Sbjct: 225 ---------AVELPDSFS----PELRSLLEGLLQRDVNRRL 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 1e-37
Identities = 44/227 (19%), Positives = 78/227 (34%), Gaps = 18/227 (7%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ E+ L + H N+V L L+ + + G L + + + ++
Sbjct: 55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLI 113
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+ +LH+ + LD D +SDFGL+K D V +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 170
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
GT GY APE + + D +S GV+ +L G P + N + L
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKA 224
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
F + + A H + +DP+ R + ++
Sbjct: 225 EYEFDSPYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-37
Identities = 55/211 (26%), Positives = 80/211 (37%), Gaps = 24/211 (11%)
Query: 12 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 71
H L + + V E++ G L H+ S A GL F
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQF 118
Query: 72 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 131
LH + ++YRD K NILLD D + K++DFG+ K+ GD GT Y APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 132 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 191
++ D +SFGV+L EML G+ P + E + + R ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 192 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
A L R+P+ R
Sbjct: 228 KE------------AKDLLVKLFVREPEKRL 246
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 8e-37
Identities = 39/238 (16%), Positives = 72/238 (30%), Gaps = 21/238 (8%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E + + I +C + ++ + SLE+ S + +A
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGD-----K 114
+ ++H + I+RD K N L + DFGLAK +
Sbjct: 110 DQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 115 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 174
+ + GT YA+ + + R D+ S G VL+ G + + E
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 175 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
+ L + + A C S +P S + + +
Sbjct: 227 R------ISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 9e-36
Identities = 54/253 (21%), Positives = 91/253 (35%), Gaps = 24/253 (9%)
Query: 4 AEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR 58
A + L H N+V+L C LV+E + + +P
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 119 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMAL 172
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV----- 173
T V+ T Y APE ++ + D++S G + EM + + + +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 174 -----EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 228
+W R R+ F+ +E + + L CL+ +P R +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYSAL 291
Query: 229 EA--LKPLPNLKD 239
+ L K+
Sbjct: 292 SHPYFQDLERCKE 304
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-36
Identities = 54/240 (22%), Positives = 93/240 (38%), Gaps = 17/240 (7%)
Query: 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
E+ L +L H N++ L+ LV++FM LE + SL L S
Sbjct: 46 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKA 104
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 120
L +GL +LH+ +++RD K +N+LLD + KL+DFGLAK ++ + T
Sbjct: 105 YMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--TH 159
Query: 121 VMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRP----------NGE 169
+ T Y APE + + D+++ G +L E+L + + G
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219
Query: 170 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+W ++ H L +P AR ++ ++
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-35
Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 25/231 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ EV+ L ++ H N++ L +L+ E + G L + L + L +
Sbjct: 61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFL 119
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVS 118
G+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 173
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
+ GT + APE V L +D++S GV+ +L+G P E
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLAN 227
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
F + A L +DPK R + + ++
Sbjct: 228 VSAVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (318), Expect = 5e-35
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 27/220 (12%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E L + H ++++ G + Q ++ +++ G L R+S P + A
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYA 110
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
L +LH + +IYRD K NILLD + + K++DFG AK P+ T
Sbjct: 111 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----- 162
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
GT Y APE V T D +SFG+++ EML G P + N ++ L
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNA 216
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
RF + L + ++RD R
Sbjct: 217 ELRFPPFFNE------------DVKDLLSRLITRDLSQRL 244
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-34
Identities = 54/251 (21%), Positives = 100/251 (39%), Gaps = 21/251 (8%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E++ L +L H N+VKL+ +++ LV+EF+ + + +P +
Sbjct: 51 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
+GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ + V+
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTL 166
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 184
+ A + + ++ D++S G + EM+T R + + + E
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 185 RFYRLIDPRLEGHFSIKGAQK-----------AAQLAAHCLSRDPKARPLMSEVV----- 228
P + F Q L + L DP R +
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 229 -EALKPLPNLK 238
+ KP+P+L+
Sbjct: 287 QDVTKPVPHLR 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (312), Expect = 3e-34
Identities = 34/242 (14%), Positives = 69/242 (28%), Gaps = 23/242 (9%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
+ E L + + Y ++ ++ + SLE+ L A
Sbjct: 48 RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 107
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGD---- 113
+ +HE + ++YRD K N L+ + + DFG+ K +
Sbjct: 108 KQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 114 -KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 172
+ GT Y + + + R D+ + G V + L G +
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 173 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232
E + L F ++ + + + A P +
Sbjct: 225 YERI------GEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 233 PL 234
+
Sbjct: 275 KV 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-33
Identities = 49/245 (20%), Positives = 91/245 (37%), Gaps = 20/245 (8%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRM 59
E+ L H N++ + + ++ + L++ ++ L
Sbjct: 53 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC 112
Query: 60 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVS 118
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T
Sbjct: 113 YFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
T + T Y APE ++ ++S D++S G +L EML+ R + N +
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229
Query: 178 PHLGERRRFYRLIDPRLEGHFSIKGAQK-------------AAQLAAHCLSRDPKARPLM 224
+ + S+ K A L L+ +P R +
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
Query: 225 SEVVE 229
+ +
Sbjct: 290 EQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 119 bits (300), Expect = 1e-32
Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 16/238 (6%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E++ L +L H N+VKL + +LV+E + L+ L L
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFL 106
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
L G+A+ H+ R V++RD K N+L++ + K++DFGLA+ + + ++
Sbjct: 107 LQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIV 162
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNL 172
+ A + + ++ D++S G + EM+ G G N
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 173 VEWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
W L + + + +P F + L + L DP R + +E
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-32
Identities = 63/220 (28%), Positives = 82/220 (37%), Gaps = 24/220 (10%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E L + H L L D+ V E+ G L HL R
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYG 111
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC 166
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
GT Y APE + D + GVV+ EM+ GR P + L E
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME 220
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
RF R + P +A L A L +DPK R
Sbjct: 221 EIRFPRTLSP------------EAKSLLAGLLKKDPKQRL 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-32
Identities = 46/231 (19%), Positives = 76/231 (32%), Gaps = 35/231 (15%)
Query: 3 QAEVNFLGDL--VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 60
EV L + +++L+ + D +L+ E L +
Sbjct: 55 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 61 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVST 119
+ + H V++RD K NIL+D + KL DFG K V T
Sbjct: 115 FFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167
Query: 120 RVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 178
GT Y+ PE++ RS V+S G++L +M+ G + + ++
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRG--- 219
Query: 179 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
S + L CL+ P RP E+
Sbjct: 220 ------------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-32
Identities = 44/224 (19%), Positives = 78/224 (34%), Gaps = 24/224 (10%)
Query: 14 HLNLVKLIGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 68
++V+++ L+V E + G L + + R +I +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 69 LAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTY 125
+ +LH + +RD K N+L + KL+DFG AK+ + T
Sbjct: 124 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177
Query: 126 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 185
Y APE + D++S GV++ +L G H L R
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMG 232
Query: 186 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
Y +P S ++ L + L +P R ++E +
Sbjct: 233 QYEFPNPEWS-EVS----EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-31
Identities = 58/269 (21%), Positives = 93/269 (34%), Gaps = 34/269 (12%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLP 54
E+ + L H N+V+L + ++ LV +++P H R LP
Sbjct: 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 55 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGD 113
+ LA++H + +RD K N+LLD D KL DFG AK G+
Sbjct: 121 VIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 173
+ + Y A TS DV+S G VL E+L G+ + + +
Sbjct: 178 PNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 174 EWARPHLGE-----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR- 221
+F ++ F + +A L + L P AR
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 222 --------PLMSEVVEALKPLPNLKDMAS 242
E+ + LPN +D +
Sbjct: 296 TPLEACAHSFFDELRDPNVKLPNGRDTPA 324
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-29
Identities = 50/250 (20%), Positives = 84/250 (33%), Gaps = 29/250 (11%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWS 56
E+ L L H N+V LI C LV++F S
Sbjct: 59 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLS 117
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
++ GL ++H +++RD K +N+L+ D KL+DFGLA+ +
Sbjct: 118 EIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 117 VS--TRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 173
+ T + T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 174 -------------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ-LAAHCLSRDPK 219
L E+ + +++ A L L DP
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 220 ARPLMSEVVE 229
R + +
Sbjct: 295 QRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-28
Identities = 47/237 (19%), Positives = 84/237 (35%), Gaps = 17/237 (7%)
Query: 5 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 64
E+ L +L H N+V+L D + LV+EF + + I
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQ 109
Query: 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 124
KGL F H R V++RD K N+L++ + KL++FGLA+ + + S V+
Sbjct: 110 LLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTL 165
Query: 125 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLV 173
+ ++ D++S G + E+ R + G
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 174 EWAR-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229
+W L + + + + K L + L +P R E ++
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (264), Expect = 6e-27
Identities = 47/220 (21%), Positives = 75/220 (34%), Gaps = 27/220 (12%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 62
E L + LVKL ++ +V E++ G + +HL R A
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYA 147
Query: 63 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 122
+LH +IYRD K N+L+D +++DFG AK T +
Sbjct: 148 AQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 199
Query: 123 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 182
GT APE +++ D ++ GV++ EM G P ++ +
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSG 253
Query: 183 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222
+ RF L + L D R
Sbjct: 254 KVRFPSHFSS------------DLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 9e-27
Identities = 50/267 (18%), Positives = 94/267 (35%), Gaps = 25/267 (9%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF---MPRGSLENHLFRRSLPLPWSIR 58
E+ L + H N++ L+ D+ +F MP + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 118
+ KGL ++H +I+RD K N+ ++ D K+ DFGLA+ ++
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMT 176
Query: 119 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV----- 173
V+ + A + T D++S G ++ EM+TG+ + + +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 174 ----EWARPHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMS 225
E+ + + + Y P LE + A L L D + R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 226 EVVEA--LKPLPNLKDMASSSYYFQTM 250
E + + L + +D Y +
Sbjct: 297 EALAHPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-24
Identities = 55/254 (21%), Positives = 99/254 (38%), Gaps = 23/254 (9%)
Query: 3 QAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 61
+ E L + LV L + + L+ +++ G L HL +R +++ +
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135
Query: 62 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 121
+ + L + +IYRD K NILLD++ + L+DFGL+K+ + +
Sbjct: 136 G----EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDF 190
Query: 122 MGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 179
GT Y AP+ V G D +S GV++ E+LTG +++ E +R
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDGEKNSQAEISRRI 248
Query: 180 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLK 238
L + + + A L L +DPK R + +K +
Sbjct: 249 LKSEPPYPQEMSA------------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
Query: 239 DMASSSYYFQTMQA 252
+ + + A
Sbjct: 297 KINWDDLAAKKVPA 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 96.4 bits (239), Expect = 1e-23
Identities = 43/254 (16%), Positives = 83/254 (32%), Gaps = 35/254 (13%)
Query: 1 MWQAEVNFLGDL-VHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSI 57
+ E+ L +L N++ L + R LV+E + + L
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYD 130
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTH 116
K L + H +++RD K N+++D + +L D+GLA+ G +
Sbjct: 131 IRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 117 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-------- 167
+ + + PE ++ D++S G +L M+ + N
Sbjct: 187 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 168 ---GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQK---------AAQLAAHCLS 215
G +L ++ + E + I R + A L
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 216 RDPKARPLMSEVVE 229
D ++R E +E
Sbjct: 305 YDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 6e-22
Identities = 51/257 (19%), Positives = 90/257 (35%), Gaps = 40/257 (15%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 56
E+ + + H N++ L+ E LV E M +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHE 119
Query: 57 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 116
+ G+ LH +I+RD K SNI++ +D K+ DFGLA+
Sbjct: 120 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 175
Query: 117 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RS 160
T + T Y APE ++ D++S G ++ EM+ +
Sbjct: 176 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL--------EGHFSIKGAQKAAQLAAH 212
+ P L R ++ R ++ L P+L + + A +A L +
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293
Query: 213 CLSRDPKARPLMSEVVE 229
L DP R + + ++
Sbjct: 294 MLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 1e-19
Identities = 48/243 (19%), Positives = 90/243 (37%), Gaps = 27/243 (11%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 57
E+ L + H N++ L+ +E+ + + + L N + + L
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDH 122
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 117
+ +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V
Sbjct: 123 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN----------RPN 167
+TR + A + H D++S G ++ E+LTGR R
Sbjct: 180 ATR----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 168 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLM 224
G + R + + + + +F+ I A L L D R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 225 SEV 227
++
Sbjct: 296 AQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.7 bits (195), Expect = 2e-17
Identities = 43/262 (16%), Positives = 86/262 (32%), Gaps = 37/262 (14%)
Query: 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIR 58
A+ + +++KL+ + +V+E + L +P
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHV 117
+I+ GL ++H +I+ D K N+L++ D L +A G
Sbjct: 128 KQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 118 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 177
T + T Y +PE ++ +D++S ++ E++TG + + + +
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 178 ------------------------PHLGERRRFYRLIDPRLEG------HFSIKGAQKAA 207
G R +L LE FS A++ +
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 208 QLAAHCLSRDPKARPLMSEVVE 229
+ L DP+ R +V
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.6 bits (115), Expect = 1e-07
Identities = 13/111 (11%), Positives = 33/111 (29%), Gaps = 16/111 (14%)
Query: 2 WQAEVNFLGDLVHLNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSI 57
+ L KL G + + ++ E + L
Sbjct: 53 FSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVEN 104
Query: 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108
++ + +A + R +++ D N+L+ + + DF + +
Sbjct: 105 PDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 91.5 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-54 Score=359.89 Aligned_cols=212 Identities=26% Similarity=0.357 Sum_probs=174.9
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
.|++|+++|++++|||||++++++.+++..|+|||||++|+|.+++.++ ..+++..++.++.||+.||+|||+++ |
T Consensus 49 ~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---I 124 (271)
T d1nvra_ 49 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---I 124 (271)
T ss_dssp CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---C
Confidence 4789999999999999999999999999999999999999999998544 47999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHhCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~ 159 (306)
+||||||+|||++.++.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.
T Consensus 125 iHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~ 204 (271)
T d1nvra_ 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 204 (271)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCC
Confidence 9999999999999999999999999987654443334455789999999999988776 578999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||........... ... .... ........+.++.+||.+||+.||++|||++|+++|-
T Consensus 205 pf~~~~~~~~~~~-~~~-----~~~~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 261 (271)
T d1nvra_ 205 PWDQPSDSCQEYS-DWK-----EKKT---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 261 (271)
T ss_dssp SCSSSSTTSHHHH-HHH-----TTCT---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCCCCChHHHHHH-HHh-----cCCC---------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 9976543221111 000 0000 0000112346888999999999999999999998864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=358.64 Aligned_cols=217 Identities=27% Similarity=0.460 Sum_probs=170.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+++|++++|||||++++++. ++.+++|||||++|+|.+++......+++..+..++.||+.||+|||+++ |+
T Consensus 51 ~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iv 126 (276)
T d1uwha_ 51 FKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126 (276)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---Ee
Confidence 789999999999999999999875 45689999999999999999777778999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc---CCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+|||++.++.+||+|||+++...............||+.|+|||++.+ ..|+.++|||||||++|||+||+
T Consensus 127 HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence 999999999999999999999999987655444444456789999999999864 35899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||.+....... ..... .. ...+. ....+..+++.+.+||.+||+.||++|||+.||+++|+.+
T Consensus 207 ~Pf~~~~~~~~~--~~~~~----~~-----~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 207 LPYSNINNRDQI--IFMVG----RG-----YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CTTTTCCCHHHH--HHHHH----HT-----SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCChHHHH--HHHHh----cC-----CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999765432111 10000 00 01111 0112223457899999999999999999999999998743
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=355.03 Aligned_cols=203 Identities=27% Similarity=0.426 Sum_probs=172.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++++|||||++++++.+++..|+|||||++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+
T Consensus 53 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~---iv 128 (263)
T d2j4za1 53 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR---VI 128 (263)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 6789999999999999999999999999999999999999999996544 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.++.+||+|||+++...... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||
T Consensus 129 HrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf 204 (263)
T d2j4za1 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204 (263)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred eeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCC
Confidence 99999999999999999999999998754332 23467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
....... ..... ... ... ++...++++.+||.+||+.||++|||++|+++|
T Consensus 205 ~~~~~~~---~~~~i---~~~--------~~~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 205 EANTYQE---TYKRI---SRV--------EFT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCSSHHH---HHHHH---HTT--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCHHH---HHHHH---HcC--------CCC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 7643211 11100 000 011 112235789999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=354.75 Aligned_cols=207 Identities=23% Similarity=0.323 Sum_probs=173.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++.++ .+++..+..++.||+.||.|||+++ |+
T Consensus 64 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---ii 138 (293)
T d1yhwa1 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VI 138 (293)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 689999999999999999999999999999999999999999988654 5999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||
T Consensus 139 HrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf 216 (293)
T d1yhwa1 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (293)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCC
Confidence 999999999999999999999999987654322 234567999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.+...... .... .... .... ..+...+..+.+||.+||+.||++|||+.|+++|
T Consensus 217 ~~~~~~~~---~~~~---~~~~-----~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 217 LNENPLRA---LYLI---ATNG-----TPEL----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TTSCHHHH---HHHH---HHHC-----SCCC----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHH---HHHH---HhCC-----CCCC----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 75432211 1100 0000 0000 1122335789999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-52 Score=356.86 Aligned_cols=212 Identities=24% Similarity=0.393 Sum_probs=167.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++|+|||||+++|++.+++..++|||||++|+|.+++......+++..+..++.||+.||.|||+.+ |+
T Consensus 74 ~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---ii 150 (299)
T d1jpaa_ 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YV 150 (299)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---Cc
Confidence 789999999999999999999999999999999999999999999877778999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee---eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-C
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-G 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g 157 (306)
||||||+|||++.++.+||+|||+++.......... .....||+.|+|||++.+..|+.++|||||||++|||+| |
T Consensus 151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g 230 (299)
T d1jpaa_ 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230 (299)
T ss_dssp CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCC
Confidence 999999999999999999999999987654322211 122457899999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
..||....... ...... ... .+. .+...+..+.+||.+||+.||++|||+.||++.|+.
T Consensus 231 ~~Pf~~~~~~~---~~~~i~----~~~------~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 231 ERPYWDMTNQD---VINAIE----QDY------RLP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CCTTTTCCHHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCHHH---HHHHHH----cCC------CCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99997653321 111111 100 011 122345789999999999999999999999998864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=357.47 Aligned_cols=207 Identities=22% Similarity=0.279 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++...+ .+++..++.++.|++.||.|||+.+ |+
T Consensus 55 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---ii 130 (288)
T d1uu3a_ 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG---II 130 (288)
T ss_dssp HHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcccc---EE
Confidence 6799999999999999999999999999999999999999999886554 7999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|..||
T Consensus 131 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (288)
T d1uu3a_ 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210 (288)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCC
Confidence 99999999999999999999999998875544444445568999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
...+.......+ ... ... ++...+.++.+||.+||+.||++|||++|++++
T Consensus 211 ~~~~~~~~~~~i------~~~--------~~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 211 RAGNEYLIFQKI------IKL--------EYD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCSSHHHHHHHH------HTT--------CCC----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCcCHHHHHHHH------HcC--------CCC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 764321111000 000 011 122235688999999999999999999997654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=348.27 Aligned_cols=208 Identities=24% Similarity=0.376 Sum_probs=166.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|++|+++|++|+|||||++++++.+ +..+|+|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++
T Consensus 55 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~- 132 (270)
T d1t4ha_ 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT- 132 (270)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 7899999999999999999999875 34679999999999999999654 37999999999999999999999976
Q ss_pred CCeEeccCCCCCeEEc-CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 78 RPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
.+|+||||||+|||++ .++.+||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++
T Consensus 133 ~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~ 207 (270)
T d1t4ha_ 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT 207 (270)
T ss_dssp SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH
T ss_pred CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHH
Confidence 5599999999999996 5789999999999864332 2334679999999998865 69999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|+.||....... ...... .... ..+. ++...+.++.+||.+||+.||++|||+.|+++|-
T Consensus 208 g~~Pf~~~~~~~--~~~~~i----~~~~-----~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 208 SEYPYSECQNAA--QIYRRV----TSGV-----KPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp SSCTTTTCSSHH--HHHHHH----TTTC-----CCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCCcccHH--HHHHHH----HcCC-----CCcc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 999997543211 111110 0000 0011 1112245789999999999999999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=354.53 Aligned_cols=210 Identities=25% Similarity=0.381 Sum_probs=173.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++|+|||||++++++.+++..++|||||++|+|.+++.+....+++..+..++.||+.||.|||+++ |+
T Consensus 56 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---iv 132 (288)
T d2jfla1 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---II 132 (288)
T ss_dssp THHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 689999999999999999999999999999999999999999998776668999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-----cCCCCchhHHHHHHHHHHHHHh
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt 156 (306)
||||||+|||++.+|.+||+|||+++..... ........||+.|+|||++. +..|+.++|||||||++|||++
T Consensus 133 HrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt 210 (288)
T d2jfla1 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210 (288)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH
T ss_pred EeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh
Confidence 9999999999999999999999999764321 11223467999999999984 4568999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||...........+ .. ... +.. ..+...+.++.+||.+||+.||++|||+.|+++|-
T Consensus 211 g~~Pf~~~~~~~~~~~i---~~--~~~--------~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 211 IEPPHHELNPMRVLLKI---AK--SEP--------PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp SSCTTTTSCGGGHHHHH---HH--SCC--------CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred CCCCCCCCCHHHHHHHH---Hc--CCC--------CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 99999765432211110 00 000 000 11223457899999999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=359.51 Aligned_cols=212 Identities=24% Similarity=0.385 Sum_probs=176.7
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC----------------------CCCCHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIR 58 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~l~~~~~ 58 (306)
|.+|+++|+++ +|||||++++++.+.+..++|||||++|+|.+++..+. ..+++..+
T Consensus 87 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 166 (325)
T d1rjba_ 87 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 166 (325)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred HHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHH
Confidence 67899999998 89999999999999999999999999999999996543 24889999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC
Q 021891 59 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 138 (306)
Q Consensus 59 ~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 138 (306)
+.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+...............||+.|+|||++.+..|
T Consensus 167 ~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 167 LCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp HHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence 999999999999999988 99999999999999999999999999987655444444455678999999999999999
Q ss_pred CchhHHHHHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCC
Q 021891 139 TSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 217 (306)
Q Consensus 139 ~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 217 (306)
+.++|||||||++|||+| |..||.+...... ...... .. ..+. .+...++++.+||.+||+.|
T Consensus 244 ~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~--~~~~~~----~~------~~~~----~p~~~~~~l~~li~~cl~~d 307 (325)
T d1rjba_ 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--FYKLIQ----NG------FKMD----QPFYATEEIYIIMQSCWAFD 307 (325)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHH----TT------CCCC----CCTTCCHHHHHHHHHHTCSS
T ss_pred CcceeccchhHHHHHHHhCCCCCCCCCCHHHH--HHHHHh----cC------CCCC----CCCcCCHHHHHHHHHHcCCC
Confidence 999999999999999998 8999976543321 111111 10 1111 12233578999999999999
Q ss_pred CCCCCCHHHHHHHhC
Q 021891 218 PKARPLMSEVVEALK 232 (306)
Q Consensus 218 p~~Rps~~ell~~l~ 232 (306)
|++|||++||+++|.
T Consensus 308 P~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 308 SRKRPSFPNLTSFLG 322 (325)
T ss_dssp GGGSCCHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHh
Confidence 999999999999984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=349.27 Aligned_cols=213 Identities=29% Similarity=0.463 Sum_probs=165.7
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|++++++++|||||+++|+|.+++..++|||||++|+|.+++......+++..+..++.||+.||.|||+.+ |
T Consensus 46 ~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---i 122 (263)
T d1sm2a_ 46 DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122 (263)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---e
Confidence 3789999999999999999999999999999999999999999999877778999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC-CC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~ 159 (306)
+||||||+|||++.++.+||+|||+++........ ......||..|+|||++.+..|+.++|||||||++|||+|+ .+
T Consensus 123 iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp CCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCC
Confidence 99999999999999999999999999876543222 23345789999999999999999999999999999999995 45
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
||..... ........ .. .....+ ..++.++.+||.+||+.||++|||++||+++|+.+
T Consensus 202 ~~~~~~~---~~~~~~i~----~~---~~~~~p-------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 202 PYENRSN---SEVVEDIS----TG---FRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TTCSCCH---HHHHHHHH----HT---CCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCH---HHHHHHHH----hc---CCCCCc-------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 4443221 11111111 10 011111 12346889999999999999999999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=350.53 Aligned_cols=211 Identities=25% Similarity=0.374 Sum_probs=175.3
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|+++|++++|||||++++++.+ +..|+|||||++|+|.+++......+++..+..++.||+.||.|||+++ |
T Consensus 55 ~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---i 130 (285)
T d1u59a_ 55 EMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---F 130 (285)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 37899999999999999999999865 5689999999999999998777678999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 131 iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~ 210 (285)
T d1u59a_ 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210 (285)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCC
Confidence 99999999999999999999999999876544322 22234568999999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
.||....... ...... ... .+. .+..++.++.+||.+||+.||++|||+.+|++.|+
T Consensus 211 ~Pf~~~~~~~---~~~~i~----~~~------~~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 211 KPYKKMKGPE---VMAFIE----QGK------RME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp CTTTTCCTHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHH---HHHHHH----cCC------CCC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9998654321 111111 110 111 12234578999999999999999999999998875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=360.10 Aligned_cols=218 Identities=25% Similarity=0.377 Sum_probs=170.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~~~~i 80 (306)
+.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.+++.+++ .+++..++.++.|++.||.|||++ + |
T Consensus 51 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~---I 126 (322)
T d1s9ja_ 51 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---I 126 (322)
T ss_dssp HHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---C
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 6799999999999999999999999999999999999999999996654 699999999999999999999974 7 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.+|.+||+|||+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus 127 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~P 202 (322)
T d1s9ja_ 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202 (322)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCC
T ss_pred EccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999999864321 22346899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHH-hhhhhhcc------------------c----------cccccccCCccCCCCCHHHHHHHHHHHH
Q 021891 161 MDKNRPNGEHNLVE-WARPHLGE------------------R----------RRFYRLIDPRLEGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 161 f~~~~~~~~~~~~~-~~~~~~~~------------------~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~ 211 (306)
|............. ........ . ........+... ....+.++.+||.
T Consensus 203 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~ 279 (322)
T d1s9ja_ 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVN 279 (322)
T ss_dssp SSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHH
Confidence 97654321100000 00000000 0 000000001111 1112468899999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 021891 212 HCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~ 230 (306)
+||+.||++|||++|+++|
T Consensus 280 ~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 280 KCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp HHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCChhHCcCHHHHhhC
Confidence 9999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-51 Score=352.92 Aligned_cols=209 Identities=22% Similarity=0.336 Sum_probs=160.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+++|++|+|||||++++++.+++.+|+|||||+||+|.+++.++ ..+++..+..++.||+.||.|||+.+ |+
T Consensus 54 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---ii 129 (307)
T d1a06a_ 54 MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IV 129 (307)
T ss_dssp -CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---ee
Confidence 568999999999999999999999999999999999999999999654 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEc---CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+||++. .++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~ 206 (307)
T d1a06a_ 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206 (307)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCC
Confidence 999999999994 57899999999998754332 233467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||....... .... ...... ..........+.++.+||.+||+.||++|||+.|+++|.
T Consensus 207 ~Pf~~~~~~~---~~~~---i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 207 PPFYDENDAK---LFEQ---ILKAEY--------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp CSCCCSSHHH---HHHH---HHTTCC--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCCCCCCHHH---HHHH---HhccCC--------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 9997643211 1110 000000 011111123357899999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=350.65 Aligned_cols=211 Identities=24% Similarity=0.351 Sum_probs=160.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--CCeeEEEEEcCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
|.+|+++|++++|||||++++++.+ ++.+|+|||||++|+|.+++.+ ....+++..++.++.||+.||.|||+.+
T Consensus 50 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~ 129 (269)
T d2java1 50 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129 (269)
T ss_dssp HHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 6799999999999999999999865 4568999999999999999864 2457999999999999999999999864
Q ss_pred C--CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHH
Q 021891 77 E--RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 77 ~--~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 154 (306)
. .+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|||
T Consensus 130 ~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel 207 (269)
T d2java1 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 207 (269)
T ss_dssp C---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHH
Confidence 1 2499999999999999999999999999987654322 23456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
+||..||....... ...... . .. .+. .+...++++.+||.+||+.||++|||+.|+++|.
T Consensus 208 ~tg~~Pf~~~~~~~---~~~~i~----~-~~-----~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 208 CALMPPFTAFSQKE---LAGKIR----E-GK-----FRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp HHSSCSCCCSSHHH---HHHHHH----H-TC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hhCCCCCCCCCHHH---HHHHHH----c-CC-----CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 99999997543211 111110 0 00 011 1223357899999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=347.63 Aligned_cols=209 Identities=24% Similarity=0.362 Sum_probs=170.8
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++|+|||||+++++|.+ +..++|||||++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+
T Consensus 55 ~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~---ii 129 (277)
T d1xbba_ 55 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN---FV 129 (277)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCC---cc
Confidence 7899999999999999999999865 56789999999999999986554 6999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..
T Consensus 130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~ 209 (277)
T d1xbba_ 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209 (277)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCC
Confidence 9999999999999999999999999876544332 22334578999999999999999999999999999999998 899
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
||.+..... ...... ... .+. .+..++.++.+||.+||+.||++|||+.+|++.|+
T Consensus 210 Pf~~~~~~~---~~~~i~----~~~------~~~----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 210 PYRGMKGSE---VTAMLE----KGE------RMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp SSTTCCHHH---HHHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCCHHH---HHHHHH----cCC------CCC----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 997653221 111111 110 111 12234578999999999999999999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-50 Score=352.44 Aligned_cols=210 Identities=20% Similarity=0.305 Sum_probs=175.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++|+|||||++++++.+++.+|+|||||+||+|.+++.+.+..+++..++.++.||+.||.|||+++ |+
T Consensus 73 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---ii 149 (352)
T d1koba_ 73 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149 (352)
T ss_dssp HHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 578999999999999999999999999999999999999999988777778999999999999999999999998 99
Q ss_pred eccCCCCCeEEc--CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||..
T Consensus 150 HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 226 (352)
T d1koba_ 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 226 (352)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred ecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCC
Confidence 999999999997 57899999999998875433 2334578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||.+.........+ . .. +...........+.++.+||.+||+.||.+|||+.|+++|-
T Consensus 227 Pf~~~~~~~~~~~i---~---~~--------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 227 PFAGEDDLETLQNV---K---RC--------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp SSCCSSHHHHHHHH---H---HC--------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCCCCCHHHHHHHH---H---hC--------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 99764332111110 0 00 00111111223357889999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-51 Score=348.34 Aligned_cols=215 Identities=22% Similarity=0.324 Sum_probs=176.5
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+|++|+++|++|+|||||+++++|.+++..++|||||++|+|.+++.+. ...+++..+..++.||+.||.|||+++
T Consensus 59 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--- 135 (287)
T d1opja_ 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 135 (287)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3789999999999999999999999999999999999999999998654 457999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
|+||||||+|||++.++.+||+|||+++...... ........|+..|+|||++.+..|+.++|||||||++|||++|..
T Consensus 136 iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCccccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 9999999999999999999999999998765432 223344568899999999999999999999999999999999777
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
||....... ....... . ...+. .+...+.++.+||.+||+.||++|||+.||++.|+.+.
T Consensus 215 p~~~~~~~~--~~~~~i~----~------~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 215 SPYPGIDLS--QVYELLE----K------DYRME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CSSTTCCHH--HHHHHHH----T------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCcchHH--HHHHHHh----c------CCCCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 664432211 1111110 0 01111 12233578999999999999999999999999887553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-51 Score=355.48 Aligned_cols=210 Identities=22% Similarity=0.301 Sum_probs=174.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++|+|||||++++++.+++.+|+|||||+||+|.+++.+....+++..+..++.||+.||.|||+++ |+
T Consensus 70 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---ii 146 (350)
T d1koaa2 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146 (350)
T ss_dssp HHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---Ce
Confidence 679999999999999999999999999999999999999999999776668999999999999999999999999 99
Q ss_pred eccCCCCCeEEc--CCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLD--ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus 147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~ 223 (350)
T d1koaa2 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 223 (350)
T ss_dssp CCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCC
Confidence 999999999995 46889999999998765433 2344679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||.+.........+ . ..... ... ......++++.+||.+||+.||++|||+.|+++|-
T Consensus 224 Pf~~~~~~~~~~~i---~---~~~~~----~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 224 PFGGENDDETLRNV---K---SCDWN----MDD----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp SSCCSSHHHHHHHH---H---HTCCC----SCC----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred CCCCCCHHHHHHHH---H---hCCCC----CCc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 99765322111111 0 00000 011 11112356889999999999999999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=340.04 Aligned_cols=212 Identities=21% Similarity=0.377 Sum_probs=178.1
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|++|++++++++|||||+++++|.+++.+++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |
T Consensus 45 ~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---i 121 (258)
T d1k2pa_ 45 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121 (258)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---B
T ss_pred HHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---c
Confidence 4789999999999999999999999999999999999999999998777778999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 159 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~ 159 (306)
+||||||+||+++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 122 iH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~ 200 (258)
T d1k2pa_ 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200 (258)
T ss_dssp CCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCC
Confidence 99999999999999999999999999876543322 2334678999999999999999999999999999999998 799
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
||....... .... +.... .... +...+..+.+||.+||+.||++|||+++|+++|..
T Consensus 201 Pf~~~~~~~---~~~~----i~~~~---~~~~-------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 201 PYERFTNSE---TAEH----IAQGL---RLYR-------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTTTSCHHH---HHHH----HHTTC---CCCC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCHHH---HHHH----HHhCC---CCCC-------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 997654321 1111 11110 1111 12234689999999999999999999999999854
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-51 Score=348.02 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=168.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++|+|||||++++++.+++..|+|||||.+|+|..++..+ ..+++..++.++.||+.||.|||+++ |+
T Consensus 62 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---ii 137 (309)
T d1u5ra_ 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MI 137 (309)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 678999999999999999999999999999999999999887666444 47999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc---CCCCchhHHHHHHHHHHHHHhCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~ 158 (306)
||||||+|||++.++.+||+|||+++.... .....||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 138 HrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~ 211 (309)
T d1u5ra_ 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (309)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCC
Confidence 999999999999999999999999987533 234579999999999864 46899999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
.||........ . ...... ..+... +...+..+.+||.+||+.||.+|||+.|+++|.
T Consensus 212 ~Pf~~~~~~~~---~---~~i~~~-------~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 212 PPLFNMNAMSA---L---YHIAQN-------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp CTTTTSCHHHH---H---HHHHHS-------CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCCHHHH---H---HHHHhC-------CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 99975432111 1 000000 001111 112357899999999999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=341.87 Aligned_cols=214 Identities=24% Similarity=0.389 Sum_probs=168.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++|+|||||+++|++.+.+..++|||||.+++|.+++......+++..+..++.||+.||.|||+.+ |+
T Consensus 56 ~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---ii 132 (283)
T d1mqba_ 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YV 132 (283)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cc
Confidence 789999999999999999999999999999999999999999998877778999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCc-ceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+||||+.++.+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|||++|..|
T Consensus 133 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~ 212 (283)
T d1mqba_ 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212 (283)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence 999999999999999999999999987644322 2223345689999999999999999999999999999999997666
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
+...... ........ .. ..+. .+...+..+.+||.+||+.||++|||+.||++.|+.+
T Consensus 213 ~~~~~~~--~~~~~~i~----~~------~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 213 PYWELSN--HEVMKAIN----DG------FRLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp TTTTCCH--HHHHHHHH----TT------CCCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccccCCH--HHHHHHHh----cc------CCCC----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 5433221 11111111 11 1111 1223457899999999999999999999999988643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=343.98 Aligned_cols=209 Identities=23% Similarity=0.327 Sum_probs=172.1
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|++|+++|++|+|||||++++++.+++.+|+|||||++|+|.+++.+++ .+++..++.++.||+.||.|||+.+ |+
T Consensus 60 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~---iv 135 (293)
T d1jksa_ 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ---IA 135 (293)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc---ee
Confidence 6899999999999999999999999999999999999999999996654 7999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCC----cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhC
Q 021891 82 YRDFKTSNILLDADY----NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 157 (306)
Q Consensus 82 H~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 157 (306)
||||||+||+++.++ .+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g 212 (293)
T d1jksa_ 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212 (293)
T ss_dssp CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcC
Confidence 999999999998776 499999999987654322 2345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 158 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 158 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
..||.+.........+ ......+ ... .....+..+.+||.+||+.||++|||++|+++|-
T Consensus 213 ~~Pf~~~~~~~~~~~i------~~~~~~~----~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 213 ASPFLGDTKQETLANV------SAVNYEF----EDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp SCSSCCSSHHHHHHHH------HTTCCCC----CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CCCCCCCCHHHHHHHH------HhcCCCC----Cch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 9999764322111100 0000000 000 0112346889999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=345.04 Aligned_cols=206 Identities=30% Similarity=0.362 Sum_probs=173.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+
T Consensus 52 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~---ii 127 (337)
T d1o6la_ 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD---VV 127 (337)
T ss_dssp HHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CB
T ss_pred HHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC---cc
Confidence 5789999999999999999999999999999999999999999986654 7899999999999999999999999 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||
T Consensus 128 HRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf 205 (337)
T d1o6la_ 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205 (337)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCC
Confidence 999999999999999999999999987543222 234578999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
.+.+.... .. ..... ... ++...+.++.+||.+||++||.+|++ ++|+++|.
T Consensus 206 ~~~~~~~~---~~---~i~~~--------~~~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 206 YNQDHERL---FE---LILME--------EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp CCSSHHHH---HH---HHHHC--------CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCcCHHHH---HH---HHhcC--------CCC----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 87543211 11 11101 111 12223568899999999999999994 88888863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=339.31 Aligned_cols=210 Identities=27% Similarity=0.397 Sum_probs=169.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++|++++|||||++++++. ++..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+.+ |
T Consensus 55 ~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---i 130 (272)
T d1qpca_ 55 FLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130 (272)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 789999999999999999999875 45679999999999999987544 335999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.++.+||+|||+|+...... ........||..|+|||++.+..++.++|||||||++|||+||..|
T Consensus 131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999998865432 2233446789999999999999999999999999999999997655
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 232 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 232 (306)
+...... ........ . ...+... ...+.++.+||.+||+.||++|||+++|++.|+
T Consensus 210 ~~~~~~~--~~~~~~i~----~------~~~~~~p----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 210 PYPGMTN--PEVIQNLE----R------GYRMVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp SSTTCCH--HHHHHHHH----T------TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCH--HHHHHHHH----h------cCCCCCc----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 4432211 11111111 1 0111111 223568999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=337.47 Aligned_cols=210 Identities=24% Similarity=0.361 Sum_probs=164.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++|||||++++++. ++..++|||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+
T Consensus 55 ~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ii 130 (273)
T d1mp8a_ 55 FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 130 (273)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---ee
Confidence 789999999999999999999985 56789999999999999998777778999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+|
T Consensus 131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P 209 (273)
T d1mp8a_ 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209 (273)
T ss_dssp CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCC
Confidence 999999999999999999999999987544322 22334568999999999999999999999999999999998 8899
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|........ ..... ... .+. .+...+..+.+||.+||+.||++|||+.||+++|+.
T Consensus 210 ~~~~~~~~~---~~~i~----~~~------~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 210 FQGVKNNDV---IGRIE----NGE------RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp TTTCCGGGH---HHHHH----TTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHH---HHHHH----cCC------CCC----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 976543321 11111 100 011 122335789999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=343.40 Aligned_cols=211 Identities=20% Similarity=0.312 Sum_probs=172.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++|||||+++++|.++ ..++++||+.+|+|.+.+......+++..+..++.||+.||.|||+++ |+
T Consensus 58 ~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ii 133 (317)
T d1xkka_ 58 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LV 133 (317)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cc
Confidence 78999999999999999999999865 567889999999999999888788999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p 160 (306)
||||||+|||++.++.+||+|||+++...............||..|+|||++.++.|+.++|||||||++|||+| |.+|
T Consensus 134 HrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p 213 (317)
T d1xkka_ 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213 (317)
T ss_dssp CSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCC
Confidence 999999999999999999999999998765544444455678999999999999999999999999999999998 7888
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
|........ ..... .+. .+. .+..++..+.+||.+||+.||.+|||+.||+++|+.
T Consensus 214 ~~~~~~~~~---~~~i~----~~~------~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 214 YDGIPASEI---SSILE----KGE------RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp TTTSCGGGH---HHHHH----HTC------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHH---HHHHH----cCC------CCC----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 876543221 11111 100 011 112235688999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-49 Score=337.19 Aligned_cols=203 Identities=27% Similarity=0.394 Sum_probs=171.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+.+|++++|||||++++++.+++..|+|||||.||+|..++.... .+++..+..++.||+.||.|||+++ |+
T Consensus 51 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ii 126 (316)
T d1fota_ 51 TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD---II 126 (316)
T ss_dssp HHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred HHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCc---EE
Confidence 6789999999999999999999999999999999999999999886554 6899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||
T Consensus 127 HrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf 201 (316)
T d1fota_ 127 YRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201 (316)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence 9999999999999999999999999876432 23467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
........ .. ..... ... ++...+.++.+++.+||+.||.+|+ |++++++|.
T Consensus 202 ~~~~~~~~---~~---~i~~~--------~~~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp 258 (316)
T d1fota_ 202 YDSNTMKT---YE---KILNA--------ELR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258 (316)
T ss_dssp CCSSHHHH---HH---HHHHC--------CCC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCcCHHHH---HH---HHHcC--------CCC----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence 76432111 11 00000 011 1112346789999999999999996 899999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=339.14 Aligned_cols=210 Identities=18% Similarity=0.236 Sum_probs=173.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+++|++++|||||++++++.+++.+|+|||||+||+|.+++.+++..+++..++.++.||+.||.|||+.+ |+
T Consensus 48 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---ii 124 (321)
T d1tkia_ 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124 (321)
T ss_dssp HHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CC
Confidence 679999999999999999999999999999999999999999999777768999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCC--CcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 82 YRDFKTSNILLDAD--YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 82 H~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+..|+.++|||||||++|+|++|..
T Consensus 125 HrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~ 201 (321)
T d1tkia_ 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCC
Confidence 99999999999854 589999999998764432 2334578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||...........+ . ..... ++..... ..+.++.+||.+||+.||++|||+.|+++|-
T Consensus 202 Pf~~~~~~~~~~~i---~---~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 202 PFLAETNQQIIENI---M---NAEYT----FDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp TTCCSSHHHHHHHH---H---HTCCC----CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCCCCHHHHHHHH---H---hCCCC----CChhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 99765332111110 0 00000 0000001 1246789999999999999999999999963
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=340.06 Aligned_cols=213 Identities=20% Similarity=0.251 Sum_probs=169.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEe----CCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+++|++++.++ +|||||+++++|.+ +..+|+|||||+||+|.+++.++ ...+++..++.++.||+.||+|||+.
T Consensus 51 ~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~ 130 (335)
T d2ozaa1 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130 (335)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc
Confidence 57899987654 89999999999876 45789999999999999999765 35799999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
+ |+||||||+|||++. ++.+||+|||+++....... .....||+.|+|||++.+..|+.++|||||||++|
T Consensus 131 ~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily 204 (335)
T d2ozaa1 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 204 (335)
T ss_dssp T---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHH
T ss_pred C---CccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHH
Confidence 8 999999999999975 56799999999987654332 33467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 153 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 153 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
+|+||+.||.+.........+.. .. ...............++++.+||.+||+.||++|||+.|+++|
T Consensus 205 ~lltg~~Pf~~~~~~~~~~~~~~---~i-------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 205 ILLCGYPPFYSNHGLAISPGMKT---RI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHTTSSCSCEETTCC-----------CC-------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhCCCCCCCCCHHHHHHHHHH---HH-------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 99999999976544322111100 00 0000011111122446789999999999999999999999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-49 Score=330.23 Aligned_cols=208 Identities=25% Similarity=0.336 Sum_probs=171.7
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|++|+ |||||++++++.+++..|+|||||++|+|.+++..++ .+++..+..++.||+.||+|||+++ |
T Consensus 56 ~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~---i 131 (277)
T d1phka_ 56 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN---I 131 (277)
T ss_dssp HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC---C
Confidence 678999999996 9999999999999999999999999999999997654 7999999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc------CCCCchhHHHHHHHHHHHH
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el 154 (306)
+||||||+||+++.++.+||+|||+++....... .....||..|+|||++.+ ..++.++||||+||++|||
T Consensus 132 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem 208 (277)
T d1phka_ 132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 208 (277)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred cccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence 9999999999999999999999999988654332 234679999999999863 3568899999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
++|..||...........+ ..... . .........++++.+|+.+||+.||.+|||++|+++|
T Consensus 209 l~g~~Pf~~~~~~~~~~~i------~~~~~---~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 209 LAGSPPFWHRKQMLMLRMI------MSGNY---Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHSSCSSCCSSHHHHHHHH------HHTCC---C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccCCCCCCCCCHHHHHHHH------HhCCC---C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 9999999865322111110 00000 0 0111112345789999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-48 Score=340.05 Aligned_cols=205 Identities=25% Similarity=0.325 Sum_probs=168.6
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 021891 4 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 83 (306)
Q Consensus 4 ~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH~ 83 (306)
+|+++++.++|||||++++++.+.+.+|+|||||+||+|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~---iiHr 131 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF---VVYR 131 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCC---ccce
Confidence 45778888899999999999999999999999999999999996654 6899999999999999999999999 9999
Q ss_pred cCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 021891 84 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMD 162 (306)
Q Consensus 84 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~ 162 (306)
||||+|||++.+|.+||+|||+|+...... .....||+.|+|||++. +..|+.++|||||||++|||+||..||.
T Consensus 132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 132 DLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp CCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998765432 23457999999999997 4578999999999999999999999998
Q ss_pred CCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh
Q 021891 163 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 231 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~ell~~l 231 (306)
............ .... ....... ..+.++.+||.+||+.||++||| ++|+++|-
T Consensus 208 ~~~~~~~~~~~~---~~~~--------~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 208 QHKTKDKHEIDR---MTLT--------MAVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp SSCSSCHHHHHH---HSSS--------CCCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred CCCHHHHHHHHH---hccc--------CCCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence 654432211111 0000 0111111 23568999999999999999999 68888863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-48 Score=338.10 Aligned_cols=203 Identities=23% Similarity=0.272 Sum_probs=171.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++|||||++++++.+.+..++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+
T Consensus 88 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~---ii 163 (350)
T d1rdqe_ 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LI 163 (350)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 5789999999999999999999999999999999999999999986654 6999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 161 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 161 (306)
||||||+|||++.+|.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|||+||..||
T Consensus 164 HRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf 238 (350)
T d1rdqe_ 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC
Confidence 9999999999999999999999999876432 23467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 021891 162 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 231 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~l 231 (306)
.+..... ..... ... .... +...+.++.+||.+||+.||.+|+ |+++|++|-
T Consensus 239 ~~~~~~~---~~~~i---~~~--------~~~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 239 FADQPIQ---IYEKI---VSG--------KVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CCSSHHH---HHHHH---HHC--------CCCC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCcCHHH---HHHHH---hcC--------CCCC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 7643211 11110 000 0111 112356889999999999999994 899998853
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=330.40 Aligned_cols=213 Identities=26% Similarity=0.359 Sum_probs=172.4
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+|.+|+++|++++|||||++++++.+ +..++|||||++|+|.+++..+...+++..+..++.||+.||.|||+++ |
T Consensus 57 ~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---i 132 (273)
T d1u46a_ 57 DFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---F 132 (273)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---E
Confidence 37899999999999999999999965 5678999999999999988777667999999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCccee-eecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
+||||||+||+++.++.+||+|||+++.......... .....|+..|+|||++.+..++.++|||||||++|||+| |.
T Consensus 133 iHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~ 212 (273)
T d1u46a_ 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212 (273)
T ss_dssp ECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred eeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCC
Confidence 9999999999999999999999999998755433322 233457889999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 233 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 233 (306)
.||........ .... .... ..+.. +...+..+.+||.+||+.||++|||+.||++.|+.
T Consensus 213 ~Pf~~~~~~~~---~~~i---~~~~------~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 213 EPWIGLNGSQI---LHKI---DKEG------ERLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CTTTTCCHHHH---HHHH---HTSC------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcCHHHH---HHHH---HhCC------CCCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 99975433211 1111 0111 11111 12234689999999999999999999999988753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=333.28 Aligned_cols=223 Identities=22% Similarity=0.225 Sum_probs=169.7
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++|||||++++++.+++..|+|||||.++++..+. .....+++..+..++.||+.||+|||+++ |+
T Consensus 47 ~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---ii 122 (299)
T d1ua2a_ 47 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---IL 122 (299)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---ee
Confidence 678999999999999999999999999999999999887666554 55567999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+|
T Consensus 123 HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 200 (299)
T d1ua2a_ 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200 (299)
T ss_dssp CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence 999999999999999999999999987654322 2234578999999999874 4689999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhh-----hhccccccccccCCccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARP-----HLGERRRFYRLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|......+....+..... .+.................. ....++++.+||.+||+.||++|||++|+++|
T Consensus 201 f~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 201 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 976543221111110000 00000000000000000000 11235689999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-49 Score=335.55 Aligned_cols=214 Identities=25% Similarity=0.400 Sum_probs=174.3
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-----------------------CCCCHHH
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSI 57 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~l~~~~ 57 (306)
+|.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++..
T Consensus 62 ~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 141 (301)
T d1lufa_ 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141 (301)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred HHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHH
Confidence 37899999999999999999999999999999999999999999986432 2488999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC
Q 021891 58 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 137 (306)
Q Consensus 58 ~~~~~~qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 137 (306)
+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++...............|++.|+|||++.+..
T Consensus 142 ~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 142 QLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 9999999999999999988 9999999999999999999999999998654443333444567889999999999999
Q ss_pred CCchhHHHHHHHHHHHHHhCC-CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccC
Q 021891 138 LTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 138 ~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 216 (306)
|+.++|||||||++|||++|. +||......+ ...... ... .+.. +...+.++.+||.+||+.
T Consensus 219 ~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e---~~~~v~----~~~------~~~~----p~~~~~~~~~li~~cl~~ 281 (301)
T d1lufa_ 219 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---VIYYVR----DGN------ILAC----PENCPLELYNLMRLCWSK 281 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH----TTC------CCCC----CTTCCHHHHHHHHHHTCS
T ss_pred CChhhhhccchhhHHHHHccCCCCCCCCCHHH---HHHHHH----cCC------CCCC----CccchHHHHHHHHHHcCC
Confidence 999999999999999999986 5676543221 111111 110 0111 223346889999999999
Q ss_pred CCCCCCCHHHHHHHhCCC
Q 021891 217 DPKARPLMSEVVEALKPL 234 (306)
Q Consensus 217 ~p~~Rps~~ell~~l~~~ 234 (306)
||++|||+.||++.|+.+
T Consensus 282 ~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 282 LPADRPSFCSIHRILQRM 299 (301)
T ss_dssp SGGGSCCHHHHHHHHHHT
T ss_pred ChhHCcCHHHHHHHHHHh
Confidence 999999999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=329.34 Aligned_cols=214 Identities=24% Similarity=0.358 Sum_probs=166.5
Q ss_pred CHHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
+|.+|+.+|++++|||||++++++. ++..++|||||++|+|..++... ...+++..+..++.||+.||.|||+.+
T Consensus 58 ~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--- 133 (285)
T d1fmka3 58 AFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133 (285)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---
Confidence 3789999999999999999999985 45689999999999999988653 346999999999999999999999998
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 159 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 159 (306)
|+||||||+||||+.++.+||+|||+++....... .......||+.|+|||++....++.++|||||||++|||++|..
T Consensus 134 ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~ 212 (285)
T d1fmka3 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212 (285)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCC
Confidence 99999999999999999999999999987643322 22344578999999999999999999999999999999999766
Q ss_pred CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 021891 160 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 235 (306)
Q Consensus 160 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 235 (306)
|+...... ........ . ...... +...++++.+||.+||+.||++|||+++|++.|+...
T Consensus 213 p~~~~~~~--~~~~~~i~----~------~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 213 VPYPGMVN--REVLDQVE----R------GYRMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CSSTTCCH--HHHHHHHH----T------TCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCH--HHHHHHHH----h------cCCCCC----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 65443221 11111111 0 011111 2233578999999999999999999999999887543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-47 Score=324.72 Aligned_cols=214 Identities=24% Similarity=0.358 Sum_probs=165.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
|++|+++|++++|||||++++++...+ ..|+|||||+|++|.+++...+ .+++..+..++.||+.||.|||+.+
T Consensus 54 ~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~- 131 (277)
T d1o6ya_ 54 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG- 131 (277)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 789999999999999999999998754 3789999999999999886554 7999999999999999999999998
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCC-cceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+|||++.++.++|+|||.+....... ........+||+.|+|||++.+..|+.++|||||||++|||+|
T Consensus 132 --iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt 209 (277)
T d1o6ya_ 132 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 209 (277)
T ss_dssp --EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred --ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh
Confidence 9999999999999999999999999987654322 2223345679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCC
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKP 233 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~ell~~l~~ 233 (306)
|..||....... .............. ......+.++.+||.+||+.||++|| |++++++.|.+
T Consensus 210 G~~Pf~~~~~~~------~~~~~~~~~~~~~~--------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 210 GEPPFTGDSPVS------VAYQHVREDPIPPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSCSCCCSSHHH------HHHHHHHCCCCCGG--------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCCCcCHHH------HHHHHHhcCCCCCc--------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999997643211 11111111111000 11112347899999999999999999 89999988754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=326.12 Aligned_cols=208 Identities=26% Similarity=0.408 Sum_probs=164.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
|++|+++|++++|||||+++|++.+ .+.+++||||+++|+|.+++.++. ..+++..++.++.||+.||.|||+.+
T Consensus 47 ~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--- 123 (262)
T d1byga_ 47 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 123 (262)
T ss_dssp HHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---
Confidence 7899999999999999999999865 456899999999999999996543 35899999999999999999999988
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHh-CC
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 158 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 158 (306)
|+||||||+||+++.++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||+| |.
T Consensus 124 ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~ 198 (262)
T d1byga_ 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 198 (262)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCC
Confidence 999999999999999999999999999864332 233467889999999999999999999999999999998 67
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
+||....... ...... . ...+. ++...+..+.+||.+||+.||++|||+.+|+++|+.+
T Consensus 199 ~p~~~~~~~~---~~~~i~----~------~~~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 199 VPYPRIPLKD---VVPRVE----K------GYKMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CSCTTSCGGG---HHHHHT----T------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHH---HHHHHH----c------CCCCC----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 7776543221 221111 1 01111 2223346889999999999999999999999998643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=332.75 Aligned_cols=213 Identities=27% Similarity=0.405 Sum_probs=176.5
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~qi 65 (306)
|.+|+.++.++ +|||||+++++|.+++..++|||||.+|+|.+++..+. ..+++..++.++.||
T Consensus 65 ~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 144 (299)
T d1fgka_ 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 144 (299)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHH
Confidence 67899999888 89999999999999999999999999999999996543 358999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............|++.|+|||++.++.|+.++|||
T Consensus 145 ~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Diw 221 (299)
T d1fgka_ 145 ARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 221 (299)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhH
Confidence 99999999998 999999999999999999999999999876554444444556789999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++ |.+||....... ... .+.... .+.... ..+..+.+||.+||+.||.+|||+
T Consensus 222 S~Gvvl~ell~~g~~p~~~~~~~~---~~~----~i~~~~------~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~ 284 (299)
T d1fgka_ 222 SFGVLLWEIFTLGGSPYPGVPVEE---LFK----LLKEGH------RMDKPS----NCTNELYMMMRDCWHAVPSQRPTF 284 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHH---HHH----HHHTTC------CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhHHHHHHhccCCCCCCCCCCHHH---HHH----HHHcCC------CCCCCc----cchHHHHHHHHHHccCCHhHCcCH
Confidence 99999999998 688886543221 111 111111 111112 234689999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
.||++.|+.+
T Consensus 285 ~eil~~L~~i 294 (299)
T d1fgka_ 285 KQLVEDLDRI 294 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=331.94 Aligned_cols=213 Identities=28% Similarity=0.376 Sum_probs=164.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCC-eeEEEEEcCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALG 64 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~~~~q 64 (306)
|.+|.+++.++ +|+||+++++++...+ .+++|||||++|+|.+++..+. ..+++..+..++.|
T Consensus 63 ~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (299)
T d1ywna1 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 142 (299)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHH
Confidence 56778888777 6899999999887654 6899999999999999996432 34889999999999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHH
Q 021891 65 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 144 (306)
Q Consensus 65 i~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 144 (306)
|+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++||
T Consensus 143 i~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDi 219 (299)
T d1ywna1 143 VAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 219 (299)
T ss_dssp HHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccce
Confidence 999999999998 99999999999999999999999999987655444434445679999999999999999999999
Q ss_pred HHHHHHHHHHHhCC-CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 145 YSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 145 wslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
|||||++|||++|. +||........ ..... ... ..+.. +...+.++.+||.+||+.||++|||
T Consensus 220 wS~Gvil~ellt~~~~p~~~~~~~~~--~~~~~----~~~------~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt 283 (299)
T d1ywna1 220 WSFGVLLWEIFSLGASPYPGVKIDEE--FCRRL----KEG------TRMRA----PDYTTPEMYQTMLDCWHGEPSQRPT 283 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHH--HHHHH----HHT------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHH--HHHHH----hcC------CCCCC----CccCCHHHHHHHHHHcCCChhHCcC
Confidence 99999999999875 57765433211 11111 111 11111 1223468999999999999999999
Q ss_pred HHHHHHHhCC
Q 021891 224 MSEVVEALKP 233 (306)
Q Consensus 224 ~~ell~~l~~ 233 (306)
+.||+++|+.
T Consensus 284 ~~eil~~L~~ 293 (299)
T d1ywna1 284 FSELVEHLGN 293 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=330.63 Aligned_cols=210 Identities=25% Similarity=0.371 Sum_probs=171.4
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGA 65 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~~~~qi 65 (306)
|.+|+++|+++ +|||||++++++.+++..++|||||++|+|.+++.++ ...+++..++.++.||
T Consensus 57 ~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 136 (309)
T d1fvra_ 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136 (309)
T ss_dssp HHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHH
Confidence 78999999999 7999999999999999999999999999999998653 3579999999999999
Q ss_pred HHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHH
Q 021891 66 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 145 (306)
Q Consensus 66 ~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 145 (306)
+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..|+.++|||
T Consensus 137 a~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvw 210 (309)
T d1fvra_ 137 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVW 210 (309)
T ss_dssp HHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHH
T ss_pred HHHHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceee
Confidence 99999999988 9999999999999999999999999998653322 22345689999999999999999999999
Q ss_pred HHHHHHHHHHhCCC-CCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 021891 146 SFGVVLLEMLTGRR-SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 224 (306)
Q Consensus 146 slG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 224 (306)
||||++|||++|.. ||....... ..... ... ..+. .+...++++.+||.+||+.||++|||+
T Consensus 211 SfGvil~ell~~~~~p~~~~~~~~---~~~~i----~~~------~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~ 273 (309)
T d1fvra_ 211 SYGVLLWEIVSLGGTPYCGMTCAE---LYEKL----PQG------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSF 273 (309)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHH---HHHHG----GGT------CCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhHHHHHHHHhcCCCCCCCCCHHH---HHHHH----Hhc------CCCC----CCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999764 565432211 11111 111 1111 122345789999999999999999999
Q ss_pred HHHHHHhCCC
Q 021891 225 SEVVEALKPL 234 (306)
Q Consensus 225 ~ell~~l~~~ 234 (306)
+||+++|+.+
T Consensus 274 ~eil~~L~~i 283 (309)
T d1fvra_ 274 AQILVSLNRM 283 (309)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=327.91 Aligned_cols=214 Identities=27% Similarity=0.438 Sum_probs=174.2
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe-CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
|.+|+++|++|+|||||+++|++.+ ++..++|||||++|+|.+++......+++..+..++.|++.||.|||+.+ |
T Consensus 75 ~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---i 151 (311)
T d1r0pa_ 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---F 151 (311)
T ss_dssp HHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---c
Confidence 7899999999999999999999876 45889999999999999999887778899999999999999999999988 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 158 (306)
+||||||+|||++.++.+||+|||+++........ .......||..|+|||.+....++.++|||||||++|||+||.
T Consensus 152 iHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~ 231 (311)
T d1r0pa_ 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231 (311)
T ss_dssp CCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCC
Confidence 99999999999999999999999999876543222 1223356899999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 234 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 234 (306)
.||....... ....... ... +...+ ...+..+.+||.+||+.||++|||+.||+++|+.+
T Consensus 232 ~p~~~~~~~~--~~~~~i~----~g~---~~~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 232 APPYPDVNTF--DITVYLL----QGR---RLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CCSCC--------CHHHHH----TTC---CCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHH--HHHHHHH----cCC---CCCCc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 8776543221 1111111 011 11111 12346899999999999999999999999998755
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=330.39 Aligned_cols=213 Identities=27% Similarity=0.403 Sum_probs=175.9
Q ss_pred HHHHHHHHhcC-CCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCC-----------------CCCCHHHHHHHHH
Q 021891 2 WQAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIAL 63 (306)
Q Consensus 2 ~~~E~~il~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~l~~~~~~~~~~ 63 (306)
|.+|+.+++++ +|||||++++++.+.+..++|||||++|+|.+++.+.. ..+++..+..++.
T Consensus 73 ~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 152 (311)
T d1t46a_ 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152 (311)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHH
Confidence 78999999999 79999999999999999999999999999999986532 2589999999999
Q ss_pred HHHHHHHHhhcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhH
Q 021891 64 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSD 143 (306)
Q Consensus 64 qi~~~l~~LH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 143 (306)
||+.||+|||+++ ++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|
T Consensus 153 qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 229 (311)
T d1t46a_ 153 QVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229 (311)
T ss_dssp HHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCccc
Confidence 9999999999998 9999999999999999999999999999876655555556678999999999999999999999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 144 VYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 144 iwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
||||||++|||+|+ .+||........ ...... . ...+.. +...+..+.+||.+||+.||++||
T Consensus 230 IwS~G~~l~ellt~g~p~~~~~~~~~~--~~~~i~----~------~~~~~~----~~~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 230 VWSYGIFLWELFSLGSSPYPGMPVDSK--FYKMIK----E------GFRMLS----PEHAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHH--HHHHHH----H------TCCCCC----CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccchHHHHHHHHhCCCCCCCCCCHHHH--HHHHHh----c------CCCCCC----cccccHHHHHHHHHHcCCChhHCc
Confidence 99999999999995 555544332211 111111 0 011111 112347899999999999999999
Q ss_pred CHHHHHHHhCC
Q 021891 223 LMSEVVEALKP 233 (306)
Q Consensus 223 s~~ell~~l~~ 233 (306)
|+.+|++.|+.
T Consensus 294 s~~~il~~L~~ 304 (311)
T d1t46a_ 294 TFKQIVQLIEK 304 (311)
T ss_dssp CHHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 99999998863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=329.70 Aligned_cols=205 Identities=28% Similarity=0.408 Sum_probs=169.1
Q ss_pred HHHHHHHHh-cCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~-~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|..++. .++|||||++++++.+++..|+|||||++|+|.+++.... .+++..+..++.||+.||.|||+++ |
T Consensus 49 ~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~---i 124 (320)
T d1xjda_ 49 TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG---I 124 (320)
T ss_dssp HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 456666665 6899999999999999999999999999999999996544 6899999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHHhCCCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 160 (306)
+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|||++|..|
T Consensus 125 iHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC
Confidence 9999999999999999999999999987543322 23446799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 230 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-ell~~ 230 (306)
|.+..... ...... .. .+.. +...+.++.+||.+||+.||++|||+. ++++|
T Consensus 203 F~~~~~~~---~~~~i~---~~--------~~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 203 FHGQDEEE---LFHSIR---MD--------NPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp SCCSSHHH---HHHHHH---HC--------CCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCCCHHH---HHHHHH---cC--------CCCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 97643221 111110 00 1111 122356899999999999999999996 78765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=326.12 Aligned_cols=224 Identities=22% Similarity=0.269 Sum_probs=167.6
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+.+|+++|++++|||||++++++.+++..|+|||||.++.+..........+++..++.++.||+.||.|||+.+ |+
T Consensus 48 ~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---Ii 124 (298)
T d1gz8a_ 48 AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VL 124 (298)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EE
Confidence 678999999999999999999999999999999999764444444455667999999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC-CCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.|
T Consensus 125 HrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~P 202 (298)
T d1gz8a_ 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202 (298)
T ss_dssp CSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCC
Confidence 999999999999999999999999987543322 233457899999999987655 57899999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhh-----hhccccc---cccccCCccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARP-----HLGERRR---FYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
|...+.......+..... .+..... ............ .....+.++.+||.+||+.||++|||++|+++
T Consensus 203 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 976432211110000000 0000000 000000000000 01123468899999999999999999999998
Q ss_pred H
Q 021891 230 A 230 (306)
Q Consensus 230 ~ 230 (306)
|
T Consensus 283 H 283 (298)
T d1gz8a_ 283 H 283 (298)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=324.03 Aligned_cols=222 Identities=23% Similarity=0.290 Sum_probs=169.4
Q ss_pred HHHHHHHHhcC---CCCcccceeeEEEe-----CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDL---VHLNLVKLIGYCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l---~H~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+++|+.| +||||++++++|.. ....+++||||.++++..........+++..++.++.|++.||+|||
T Consensus 54 ~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH 133 (305)
T d1blxa_ 54 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133 (305)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 56888888776 79999999999864 24679999999887776666666678999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 153 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 153 (306)
+++ |+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++||
T Consensus 134 ~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~e 207 (305)
T d1blxa_ 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 207 (305)
T ss_dssp HTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred hCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHH
Confidence 998 999999999999999999999999998864332 23345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCcchHHhhhh-----hhcc-----ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 021891 154 MLTGRRSMDKNRPNGEHNLVEWARP-----HLGE-----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 223 (306)
Q Consensus 154 lltg~~pf~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 223 (306)
|++|+.||...........+..... .+.. ...+.. ........+....++.+.+||.+||+.||++|||
T Consensus 208 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s 286 (305)
T d1blxa_ 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286 (305)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcc-ccccchhhccccCCHHHHHHHHHHCcCChhHCcC
Confidence 9999999976543221111111000 0000 000000 0000111122233568899999999999999999
Q ss_pred HHHHHHH
Q 021891 224 MSEVVEA 230 (306)
Q Consensus 224 ~~ell~~ 230 (306)
+.|+++|
T Consensus 287 a~e~L~H 293 (305)
T d1blxa_ 287 AYSALSH 293 (305)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=325.16 Aligned_cols=213 Identities=25% Similarity=0.389 Sum_probs=175.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFL 72 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------~~~l~~~~~~~~~~qi~~~l~~L 72 (306)
|.+|++++++++|||||++++++..++..++|||||.+|+|.+++... ...+++..+..++.|++.||.||
T Consensus 70 ~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L 149 (308)
T d1p4oa_ 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149 (308)
T ss_dssp HHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 789999999999999999999999999999999999999999988532 23578999999999999999999
Q ss_pred hcCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHH
Q 021891 73 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 152 (306)
Q Consensus 73 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 152 (306)
|+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|
T Consensus 150 H~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 150 NANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp HHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 9988 9999999999999999999999999998765444444445567899999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 153 EMLTGR-RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 153 elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
||+||. +||....... ...... .... +. .+...+..+.+||.+||+.||++|||+++|+++|
T Consensus 227 El~t~~~~p~~~~~~~~---~~~~i~----~~~~------~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQ---VLRFVM----EGGL------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp HHHHTSCCTTTTSCHHH---HHHHHH----TTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHH---HHHHHH----hCCC------CC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999985 6665432211 111110 1100 11 1122346899999999999999999999999999
Q ss_pred CCC
Q 021891 232 KPL 234 (306)
Q Consensus 232 ~~~ 234 (306)
+..
T Consensus 290 ~~~ 292 (308)
T d1p4oa_ 290 KEE 292 (308)
T ss_dssp GGG
T ss_pred HHh
Confidence 764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=323.51 Aligned_cols=198 Identities=23% Similarity=0.337 Sum_probs=164.1
Q ss_pred HHHHHHHHhcCC--CCcccceeeEEEeCCeeEEEEEcCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+.+|+++|++++ |||||++++++.+++..++||||+.+ +++.+++.++ ..+++..++.++.||+.||.|||+.+
T Consensus 54 ~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~-- 130 (273)
T d1xwsa_ 54 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG-- 130 (273)
T ss_dssp EEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 468999999996 89999999999999999999999976 5788877554 47999999999999999999999998
Q ss_pred CeEeccCCCCCeEEcC-CCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCC-CchhHHHHHHHHHHHHHh
Q 021891 79 PVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt 156 (306)
|+||||||+|||++. ++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++
T Consensus 131 -iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~ 205 (273)
T d1xwsa_ 131 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205 (273)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred -CccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence 999999999999985 479999999999875432 2334679999999999987765 577999999999999999
Q ss_pred CCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 021891 157 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 231 (306)
|..||..... + .. .. ..... ..+.++.+||.+||+.||++|||++|+++|.
T Consensus 206 g~~Pf~~~~~------i--~~----~~--------~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 206 GDIPFEHDEE------I--IR----GQ--------VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp SSCSCCSHHH------H--HH----CC--------CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCCchH------H--hh----cc--------cCCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 9999964210 0 00 00 01111 2246889999999999999999999999863
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=318.96 Aligned_cols=225 Identities=26% Similarity=0.322 Sum_probs=166.8
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-- 76 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-- 76 (306)
+.|+..+++++|||||++++++.+.+ .+|+|||||++|+|.+++.+. .+++..++.++.|++.||.|||+..
T Consensus 45 e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~ 122 (303)
T d1vjya_ 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 34555666889999999999998754 579999999999999999764 5899999999999999999999741
Q ss_pred ---CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcce--eeecccccccccCCcchhcCC------CCchhHHH
Q 021891 77 ---ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LTSRSDVY 145 (306)
Q Consensus 77 ---~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Diw 145 (306)
.++|+||||||+||||+.++.+||+|||+++......... ......||+.|+|||++.+.. ++.++|||
T Consensus 123 ~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~ 202 (303)
T d1vjya_ 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202 (303)
T ss_dssp TTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred hccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhh
Confidence 1239999999999999999999999999998764432221 223467999999999987542 57799999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCcch--------HHhhhhhhccccccccccCCccCCCC-CHHHHHHHHHHHHHcccC
Q 021891 146 SFGVVLLEMLTGRRSMDKNRPNGEHNL--------VEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 146 slG~il~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~ 216 (306)
||||++|||+||..||........... ........ .....++.+.... .......+.+|+.+||+.
T Consensus 203 S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T d1vjya_ 203 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCS
T ss_pred hhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHccc
Confidence 999999999999988754332211100 00000000 0111222222211 234566799999999999
Q ss_pred CCCCCCCHHHHHHHhCCC
Q 021891 217 DPKARPLMSEVVEALKPL 234 (306)
Q Consensus 217 ~p~~Rps~~ell~~l~~~ 234 (306)
||++|||+.||+++|+.+
T Consensus 278 dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 278 NGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHH
Confidence 999999999999998644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-45 Score=313.42 Aligned_cols=223 Identities=22% Similarity=0.256 Sum_probs=165.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
|.+|+++|++++|||||++++++.+++..+++|||+.++.+..+ ......+++..++.++.||+.||+|||+.+ |+
T Consensus 47 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---Iv 122 (286)
T d1ob3a_ 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122 (286)
T ss_dssp HHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCc---EE
Confidence 67999999999999999999999999999999999977555554 455568999999999999999999999988 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+|||++.++.+||+|||++........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.|
T Consensus 123 HrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p 200 (286)
T d1ob3a_ 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (286)
T ss_dssp CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence 999999999999999999999999987543222 22334689999999998754 568999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhh-----hhccccccc------cccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 161 MDKNRPNGEHNLVEWARP-----HLGERRRFY------RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~-----~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
|...........+..... .+....... ....+.....+....++.+.+||.+||+.||++|||++|+++
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 976532211111100000 000000000 000010011112223568899999999999999999999998
Q ss_pred H
Q 021891 230 A 230 (306)
Q Consensus 230 ~ 230 (306)
|
T Consensus 281 H 281 (286)
T d1ob3a_ 281 H 281 (286)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=315.94 Aligned_cols=223 Identities=25% Similarity=0.287 Sum_probs=163.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l--~~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+++|++|+||||++++++|... .++++|||||+++.+..+. ......+++..++.++.||+.||+|||
T Consensus 60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 35899999999999999999998653 3578999999765433332 234557999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcceeeecccccccccCCcchhc-CCCCchhHHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVL 151 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il 151 (306)
+++ |+||||||+|||++.++ .+||+|||+++....... .....||..|+|||.+.+ ..|+.++|||||||++
T Consensus 140 ~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213 (350)
T ss_dssp TTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred hcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEE
Confidence 988 99999999999999775 899999999987644322 234578999999998875 5789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhh---------hhhhcc--ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWA---------RPHLGE--RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~---------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
|||++|..||...........+... ...... ...+................+.++.+||.+||+.||++
T Consensus 214 ~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 293 (350)
T d1q5ka_ 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293 (350)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred EehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhH
Confidence 9999999999765432211111000 000000 00000000000111112233568999999999999999
Q ss_pred CCCHHHHHHH
Q 021891 221 RPLMSEVVEA 230 (306)
Q Consensus 221 Rps~~ell~~ 230 (306)
|||+.|+++|
T Consensus 294 R~ta~e~L~H 303 (350)
T d1q5ka_ 294 RLTPLEACAH 303 (350)
T ss_dssp SCCHHHHHTS
T ss_pred CcCHHHHhcC
Confidence 9999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=312.05 Aligned_cols=217 Identities=24% Similarity=0.321 Sum_probs=165.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC------eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|++++|||||+++++|...+ .+|+||||| +.+|..++... .+++..++.++.||+.||.|||++
T Consensus 64 ~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~ 140 (346)
T d1cm8a_ 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA 140 (346)
T ss_dssp HHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhC
Confidence 578999999999999999999998765 569999999 66888876443 699999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEM 154 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el 154 (306)
+ |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 141 ~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (346)
T d1cm8a_ 141 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212 (346)
T ss_dssp T---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred C---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHH
Confidence 9 999999999999999999999999999875432 2345789999999998864 568999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchHHhhhhh--------h--cc----ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 021891 155 LTGRRSMDKNRPNGEHNLVEWARPH--------L--GE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 220 (306)
Q Consensus 155 ltg~~pf~~~~~~~~~~~~~~~~~~--------~--~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 220 (306)
++|..||.................. . .. ...+........ .......+..+.+||.+||+.||.+
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~ 291 (346)
T d1cm8a_ 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQ 291 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhH
Confidence 9999999765332211111000000 0 00 000000000000 0111123467899999999999999
Q ss_pred CCCHHHHHHH
Q 021891 221 RPLMSEVVEA 230 (306)
Q Consensus 221 Rps~~ell~~ 230 (306)
|||+.|+++|
T Consensus 292 R~ta~eiL~H 301 (346)
T d1cm8a_ 292 RVTAGEALAH 301 (346)
T ss_dssp SCCHHHHHHS
T ss_pred CcCHHHHhcC
Confidence 9999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=305.29 Aligned_cols=226 Identities=22% Similarity=0.268 Sum_probs=164.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEe--------CCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 73 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH 73 (306)
+.+|+++|++++||||+++++++.. ++..++|||||.++.+. .+......+++..++.++.||+.||.|||
T Consensus 56 ~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH 134 (318)
T d3blha1 56 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134 (318)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc
Confidence 5799999999999999999999865 34689999999765554 45456668999999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc--eeeecccccccccCCcchhcC-CCCchhHHHHHHHH
Q 021891 74 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVV 150 (306)
Q Consensus 74 ~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~i 150 (306)
+.+ |+||||||+|||++.++.+||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||+
T Consensus 135 ~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvi 211 (318)
T d3blha1 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211 (318)
T ss_dssp HTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred cCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCce
Confidence 998 999999999999999999999999999875543221 122335799999999998765 68999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchHHhhhhhhccc-------cccccccCCccCCCCC-------HHHHHHHHHHHHHcccC
Q 021891 151 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-------RRFYRLIDPRLEGHFS-------IKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 151 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~ 216 (306)
+|||++|+.||.+.........+.......... ................ ...+..+.+||.+||+.
T Consensus 212 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~ 291 (318)
T d3blha1 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291 (318)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred eeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC
Confidence 999999999997643322211111111000000 0000000000000000 11145778999999999
Q ss_pred CCCCCCCHHHHHHHh
Q 021891 217 DPKARPLMSEVVEAL 231 (306)
Q Consensus 217 ~p~~Rps~~ell~~l 231 (306)
||++|||++|+++|-
T Consensus 292 dP~~R~sa~elL~Hp 306 (318)
T d3blha1 292 DPAQRIDSDDALNHD 306 (318)
T ss_dssp STTTSCCHHHHHHSG
T ss_pred ChhHCcCHHHHHcCh
Confidence 999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=309.12 Aligned_cols=210 Identities=27% Similarity=0.352 Sum_probs=170.6
Q ss_pred HHHHHHHHhcCCC-CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 021891 2 WQAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 80 (306)
Q Consensus 2 ~~~E~~il~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~i 80 (306)
+.+|+++|++++| |||+++++++.+....++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+.+ |
T Consensus 75 ~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---i 150 (322)
T d1vzoa_ 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---I 150 (322)
T ss_dssp CCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---E
Confidence 5689999999976 899999999999999999999999999999986554 6789999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC--CCCchhHHHHHHHHHHHHHhCC
Q 021891 81 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 158 (306)
Q Consensus 81 iH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~ 158 (306)
+||||||+||+++.+|.+||+|||+++........ ......|++.|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus 151 vHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~ 229 (322)
T d1vzoa_ 151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229 (322)
T ss_dssp CCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred EeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876443222 23446789999999999754 4688999999999999999999
Q ss_pred CCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 021891 159 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 230 (306)
Q Consensus 159 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~ 230 (306)
.||...........+.... ... .+. ++...+.++.+||.+||+.||++|| |++|+++|
T Consensus 230 ~PF~~~~~~~~~~~i~~~~--~~~--------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 230 SPFTVDGEKNSQAEISRRI--LKS--------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CTTSCTTSCCCHHHHHHHH--HHC--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhc--ccC--------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 9998765544332221111 000 111 1223457899999999999999999 47899875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-43 Score=302.43 Aligned_cols=218 Identities=19% Similarity=0.170 Sum_probs=166.9
Q ss_pred CHHHHHHHHhcCCCCccc-ceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H~niv-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
++.+|+++++.++|+|++ .+.+++.+.+..++||||+ +++|.+.+......+++..+..++.|++.||+|||+++
T Consensus 48 ~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 123 (299)
T d1ckia_ 48 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--- 123 (299)
T ss_dssp CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---
Confidence 478999999999877654 5566667788899999999 56888877777778999999999999999999999999
Q ss_pred eEeccCCCCCeEEcC---CCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 80 VIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 80 iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
|+||||||+|||++. +..+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 999999999999864 457999999999876543321 122346799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchHHhhhh-hhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 152 LEMLTGRRSMDKNRPNGEHNLVEWARP-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 152 ~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
|||++|..||................. .... ..+.... ..+.++.+||.+||+.||++||++.++.+.
T Consensus 204 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~ 272 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKAATKRQKYERISEKKMST-------PIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272 (299)
T ss_dssp HHHHHSSCTTCCCC-------HHHHHHHHHHS-------CHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHH
T ss_pred HHHHhCCCcccccchHHHHHHHHHhhcccCCC-------ChhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999987655443322211111 0000 0000111 224678999999999999999999988776
Q ss_pred hCC
Q 021891 231 LKP 233 (306)
Q Consensus 231 l~~ 233 (306)
|+.
T Consensus 273 l~~ 275 (299)
T d1ckia_ 273 FRN 275 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=304.97 Aligned_cols=224 Identities=21% Similarity=0.267 Sum_probs=164.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC----eeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 77 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~ 77 (306)
+.+|+++|++|+||||+++++++.... ..+++++|+.+|+|.+++..+ .+++..++.++.||+.||+|||+++
T Consensus 53 ~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~- 129 (345)
T d1pmea_ 53 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN- 129 (345)
T ss_dssp HHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 578999999999999999999997653 234445566689999999654 5999999999999999999999998
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcc-eeeecccccccccCCcchh-cCCCCchhHHHHHHHHHHHHH
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell 155 (306)
|+||||||+|||++.++.+||+|||+++........ ......+||+.|+|||++. +..++.++||||+||++|+|+
T Consensus 130 --iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp --EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH
T ss_pred --CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHh
Confidence 999999999999999999999999999875433221 1234467899999999985 557799999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhcc----------ccccccccCCccCC---CCCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
+|..||..................... .............. ......+.++.+|+.+||+.||.+||
T Consensus 208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence 999999765432111111000000000 00000000000000 00011235789999999999999999
Q ss_pred CHHHHHHH
Q 021891 223 LMSEVVEA 230 (306)
Q Consensus 223 s~~ell~~ 230 (306)
|++|+++|
T Consensus 288 ta~e~L~h 295 (345)
T d1pmea_ 288 EVEQALAH 295 (345)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-43 Score=298.27 Aligned_cols=219 Identities=16% Similarity=0.137 Sum_probs=174.9
Q ss_pred CHHHHHHHHhcCCC-CcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021891 1 MWQAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 79 (306)
Q Consensus 1 ~~~~E~~il~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ 79 (306)
++++|+++++.|+| +||+.+++++..+...++||||+ +++|.+++...+..+++..+..++.|++.||+|||+.+
T Consensus 46 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--- 121 (293)
T d1csna_ 46 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 121 (293)
T ss_dssp CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---
Confidence 36899999999976 89999999999999999999999 68999999877778999999999999999999999999
Q ss_pred eEeccCCCCCeEEcC-----CCcEEEeccCCcccCCCCCcc-----eeeecccccccccCCcchhcCCCCchhHHHHHHH
Q 021891 80 VIYRDFKTSNILLDA-----DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 149 (306)
Q Consensus 80 iiH~dlkp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 149 (306)
|+||||||+||+++. ++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||
T Consensus 122 iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (293)
T d1csna_ 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201 (293)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhH
Confidence 999999999999964 578999999999876543221 1223467999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCcchHHhhhhhhccccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 021891 150 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 229 (306)
Q Consensus 150 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 229 (306)
++|||++|..||................... ...... .+.. ..++++.+++..|+..+|++||+++.+.+
T Consensus 202 ~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~-----~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 202 VFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLR-----ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHH-----HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCChH-----HhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 9999999999998665443322221111100 000000 0111 12467899999999999999999988887
Q ss_pred HhCC
Q 021891 230 ALKP 233 (306)
Q Consensus 230 ~l~~ 233 (306)
.|+.
T Consensus 272 ~l~~ 275 (293)
T d1csna_ 272 LFSK 275 (293)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-43 Score=304.91 Aligned_cols=220 Identities=18% Similarity=0.228 Sum_probs=164.9
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeC--CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 78 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~ 78 (306)
+++|+++|++++ ||||+++++++... ...++|||||.+++|..+. +.+++..+..++.||+.||.|||+++
T Consensus 76 ~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g-- 149 (328)
T d3bqca1 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG-- 149 (328)
T ss_dssp HHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--
Confidence 678999999995 99999999999854 5689999999999987754 36899999999999999999999999
Q ss_pred CeEeccCCCCCeEEcCCC-cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHHh
Q 021891 79 PVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 156 (306)
Q Consensus 79 ~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt 156 (306)
|+||||||+|||++.++ .+||+|||+++....... .....||..|+|||.+.+. .++.++||||+||++|+|++
T Consensus 150 -IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~ 225 (328)
T d3bqca1 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225 (328)
T ss_dssp -EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred -cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc
Confidence 99999999999998654 699999999987654322 3345789999999998865 57999999999999999999
Q ss_pred CCCCCCCCCCCCCcchH-H----------hhh-hhhccccccccccCC--------ccCCCCCHHHHHHHHHHHHHcccC
Q 021891 157 GRRSMDKNRPNGEHNLV-E----------WAR-PHLGERRRFYRLIDP--------RLEGHFSIKGAQKAAQLAAHCLSR 216 (306)
Q Consensus 157 g~~pf~~~~~~~~~~~~-~----------~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~ 216 (306)
|..||............ . +.. ........+...... ..........+.++.+||.+||+.
T Consensus 226 g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~ 305 (328)
T d3bqca1 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305 (328)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCS
T ss_pred CCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccC
Confidence 99999765432111000 0 000 000000000000000 000111122356889999999999
Q ss_pred CCCCCCCHHHHHHHh
Q 021891 217 DPKARPLMSEVVEAL 231 (306)
Q Consensus 217 ~p~~Rps~~ell~~l 231 (306)
||++|||++|+++|-
T Consensus 306 dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 306 DHQSRLTAREAMEHP 320 (328)
T ss_dssp SGGGSCCHHHHHTSG
T ss_pred ChhHCcCHHHHhcCc
Confidence 999999999999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=297.43 Aligned_cols=222 Identities=21% Similarity=0.238 Sum_probs=170.0
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 81 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~ii 81 (306)
+++|+.+|++++||||+++++++.+.+..++|++++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+
T Consensus 48 ~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~---Iv 123 (292)
T d1unla_ 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123 (292)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC---Ee
Confidence 6799999999999999999999999999999999999888877764 4457899999999999999999999998 99
Q ss_pred eccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCC-CCchhHHHHHHHHHHHHHhCCCC
Q 021891 82 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRS 160 (306)
Q Consensus 82 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p 160 (306)
||||||+|||++.++.+||+|||.++........ .....++..|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 124 HrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p 201 (292)
T d1unla_ 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred eecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCC
Confidence 9999999999999999999999999876543322 22345678899999987654 68999999999999999999999
Q ss_pred CCCCCCCCCcchHHhhhhhhcc--------------ccccccccCCccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 021891 161 MDKNRPNGEHNLVEWARPHLGE--------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 226 (306)
Q Consensus 161 f~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 226 (306)
|........ ........... ....................+..+.+||.+||+.||++|||++|
T Consensus 202 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 202 LFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp SCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 764332211 11110000000 00000000001111122334568899999999999999999999
Q ss_pred HHHHh
Q 021891 227 VVEAL 231 (306)
Q Consensus 227 ll~~l 231 (306)
+++|-
T Consensus 280 ~L~Hp 284 (292)
T d1unla_ 280 ALQHP 284 (292)
T ss_dssp HTTSG
T ss_pred HhcCh
Confidence 99863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=302.85 Aligned_cols=220 Identities=23% Similarity=0.289 Sum_probs=158.9
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC------CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 75 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 75 (306)
+.+|+++|++++|||||+++++|... ..+|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||+.
T Consensus 63 ~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~ 138 (355)
T d2b1pa1 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA 138 (355)
T ss_dssp HHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 57899999999999999999999643 6889999999764 444442 3589999999999999999999999
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHHHHHH
Q 021891 76 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 76 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 155 (306)
+ |+||||||+|||++.++.+|++|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 139 g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell 212 (355)
T d2b1pa1 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212 (355)
T ss_dssp T---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred c---cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHh
Confidence 9 9999999999999999999999999988754332 234457899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHh---------hh-------hhhccc-----cccccccCCcc---CCCCCHHHHHHHHHHHH
Q 021891 156 TGRRSMDKNRPNGEHNLVEW---------AR-------PHLGER-----RRFYRLIDPRL---EGHFSIKGAQKAAQLAA 211 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~---------~~-------~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~li~ 211 (306)
+|+.||.+.........+.. .. ...... ......+.... ........+.++.+||.
T Consensus 213 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~ 292 (355)
T d2b1pa1 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292 (355)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHH
Confidence 99999976532211110000 00 000000 00000110000 11122345778999999
Q ss_pred HcccCCCCCCCCHHHHHHHh
Q 021891 212 HCLSRDPKARPLMSEVVEAL 231 (306)
Q Consensus 212 ~~l~~~p~~Rps~~ell~~l 231 (306)
+||+.||++|||++|+++|-
T Consensus 293 ~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 293 KMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HHSCSSTTTSCCHHHHHTST
T ss_pred HHCcCChhHCcCHHHHhcCc
Confidence 99999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=297.64 Aligned_cols=220 Identities=22% Similarity=0.291 Sum_probs=160.4
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeC-----CeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021891 2 WQAEVNFLGDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 76 (306)
Q Consensus 2 ~~~E~~il~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 76 (306)
+.+|+++|++|+|||||++++++... ...++|++|+.+|+|.+++.. +.+++..++.++.||+.||+|||+++
T Consensus 64 ~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g 141 (348)
T d2gfsa1 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD 141 (348)
T ss_dssp HHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 56899999999999999999998643 344667777889999998854 36999999999999999999999998
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcC-CCCchhHHHHHHHHHHHHH
Q 021891 77 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEML 155 (306)
Q Consensus 77 ~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell 155 (306)
|+||||||+|||++.+|.+|++|||++..... ......|+..|+|||++.+. .++.++|||||||++|+|+
T Consensus 142 ---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp ---CCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH
T ss_pred ---CcccccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHH
Confidence 99999999999999999999999999976432 22345789999999987765 4689999999999999999
Q ss_pred hCCCCCCCCCCCCCcchHHhhhhhhcc----------ccccccccCCccCCC---CCHHHHHHHHHHHHHcccCCCCCCC
Q 021891 156 TGRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARP 222 (306)
Q Consensus 156 tg~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 222 (306)
+|..||.+.........+......... ............... .....+.++.+||.+||+.||.+||
T Consensus 214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (348)
T d2gfsa1 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293 (348)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence 999999765432211111100000000 000000000000000 0012246789999999999999999
Q ss_pred CHHHHHHHh
Q 021891 223 LMSEVVEAL 231 (306)
Q Consensus 223 s~~ell~~l 231 (306)
|+.|+++|-
T Consensus 294 ta~elL~Hp 302 (348)
T d2gfsa1 294 TAAQALAHA 302 (348)
T ss_dssp CHHHHHTSG
T ss_pred CHHHHhcCH
Confidence 999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.3e-37 Score=267.95 Aligned_cols=221 Identities=21% Similarity=0.251 Sum_probs=156.6
Q ss_pred HHHHHHHHhcCC-----------CCcccceeeEEEe--CCeeEEEEEcCCCCCH-HH-HhhcCCCCCCHHHHHHHHHHHH
Q 021891 2 WQAEVNFLGDLV-----------HLNLVKLIGYCIE--DDQRLLVYEFMPRGSL-EN-HLFRRSLPLPWSIRMKIALGAA 66 (306)
Q Consensus 2 ~~~E~~il~~l~-----------H~niv~~~~~~~~--~~~~~lv~e~~~~~sL-~~-~l~~~~~~l~~~~~~~~~~qi~ 66 (306)
+.+|+++|+.++ |+||+++++++.. ....+++++++..+.. .. ........+++..++.++.||+
T Consensus 56 ~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil 135 (362)
T d1q8ya_ 56 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135 (362)
T ss_dssp HHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHH
Confidence 468999998875 4789999998865 3456666666655432 22 2234456789999999999999
Q ss_pred HHHHHhhc-CCCCCeEeccCCCCCeEEcCCC------cEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCC
Q 021891 67 KGLAFLHE-EAERPVIYRDFKTSNILLDADY------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 139 (306)
Q Consensus 67 ~~l~~LH~-~~~~~iiH~dlkp~Nill~~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 139 (306)
.||.|||+ .+ |+||||||+|||++.++ .++++|||.+...... ....+||+.|+|||++.+..|+
T Consensus 136 ~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 136 LGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp HHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCC
Confidence 99999997 77 99999999999997665 3899999999864332 2345799999999999999999
Q ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCCCCcchHHhhhh---hhcc--------c---------cccccccCC-------
Q 021891 140 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP---HLGE--------R---------RRFYRLIDP------- 192 (306)
Q Consensus 140 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~--------~---------~~~~~~~~~------- 192 (306)
.++||||+||++++|++|+.||................. ..+. . ......+..
T Consensus 208 ~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T d1q8ya_ 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 287 (362)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh
Confidence 999999999999999999999976543322111111000 0000 0 000000000
Q ss_pred ---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 021891 193 ---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 230 (306)
Q Consensus 193 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 230 (306)
.....+....+.++.+||.+||+.||.+|||++|+++|
T Consensus 288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01122456678899999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=4e-20 Score=145.95 Aligned_cols=128 Identities=13% Similarity=0.113 Sum_probs=91.9
Q ss_pred HHHHHHHhcCCCCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 021891 3 QAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 82 (306)
Q Consensus 3 ~~E~~il~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~~~~iiH 82 (306)
.+|...+.++.|.+++..+++. ..++||||+++..+.+ ++...+..++.|++.+|.|||+.+ |+|
T Consensus 62 ~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiH 126 (191)
T d1zara2 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVH 126 (191)
T ss_dssp HHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEE
Confidence 5688999999999999988753 2379999998765543 344456788999999999999998 999
Q ss_pred ccCCCCCeEEcCCCcEEEeccCCcccCCCCCcceeeecccccccccCCcchhcCCCCchhHHHHHHHHH
Q 021891 83 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 151 (306)
Q Consensus 83 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 151 (306)
|||||+|||++++ .++|+|||+|+..............+.. -.+ +....|+.++|+||+.--+
T Consensus 127 rDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 127 GDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp SCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred ccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 9999999999865 4899999999775433211100000000 001 1235688899999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=1.8e-06 Score=69.61 Aligned_cols=101 Identities=17% Similarity=0.080 Sum_probs=69.7
Q ss_pred HHHHHHHHhcCC-CCcccceeeEEEeCCeeEEEEEcCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC----
Q 021891 2 WQAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---- 76 (306)
Q Consensus 2 ~~~E~~il~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---- 76 (306)
+.+|..+|..|. +--+.++++++.+++..++||++++|.++.+...... ....++.+++..+..||+..
T Consensus 56 ~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~ 129 (263)
T d1j7la_ 56 VEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDC 129 (263)
T ss_dssp HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTC
T ss_pred HHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCcccc
Confidence 578999988874 3336788888888899999999999988866542211 11223344444444444321
Q ss_pred ----------------------------------------------------CCCeEeccCCCCCeEEcCCCcEEEeccC
Q 021891 77 ----------------------------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFG 104 (306)
Q Consensus 77 ----------------------------------------------------~~~iiH~dlkp~Nill~~~~~~kl~Dfg 104 (306)
...++|+|+.|.||++++++..-|+||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe 209 (263)
T d1j7la_ 130 PYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG 209 (263)
T ss_dssp SCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred ccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeech
Confidence 0127899999999999877666799998
Q ss_pred Cccc
Q 021891 105 LAKD 108 (306)
Q Consensus 105 ~a~~ 108 (306)
.+..
T Consensus 210 ~a~~ 213 (263)
T d1j7la_ 210 RSGR 213 (263)
T ss_dssp TCEE
T ss_pred hccc
Confidence 7753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.84 E-value=1.3e-05 Score=64.04 Aligned_cols=43 Identities=19% Similarity=0.149 Sum_probs=33.6
Q ss_pred CHHHHHHHHhcCCC--CcccceeeEEEeCCeeEEEEEcCCCCCHH
Q 021891 1 MWQAEVNFLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLE 43 (306)
Q Consensus 1 ~~~~E~~il~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 43 (306)
++..|+..|+.|.. -.+.+++++..+++..++||++++|.++.
T Consensus 50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 36789999988843 33567888888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.89 E-value=0.0011 Score=56.27 Aligned_cols=28 Identities=25% Similarity=0.227 Sum_probs=24.8
Q ss_pred eEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 80 VIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 80 iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
++|+|+++.|||+++++ ++|+||..+..
T Consensus 225 LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 225 LIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred eeccCCcCCceeEcCCc-eEEechhhccc
Confidence 89999999999998765 89999988765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.00053 Score=58.24 Aligned_cols=36 Identities=28% Similarity=0.263 Sum_probs=25.7
Q ss_pred HHHHHHHhcCCCCcc-cceeeEEEeCCeeEEEEEcCCCCCH
Q 021891 3 QAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVYEFMPRGSL 42 (306)
Q Consensus 3 ~~E~~il~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~~sL 42 (306)
.+|..+++.+.-.++ .++++++. + .+|+||++|..|
T Consensus 92 ~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~efi~g~~l 128 (395)
T d1nw1a_ 92 VAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred HHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEEeccccC
Confidence 578899988853444 47888764 2 678999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.12 E-value=0.0068 Score=49.27 Aligned_cols=31 Identities=29% Similarity=0.285 Sum_probs=27.0
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
.++||+|+.++||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4599999999999999887778999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=91.50 E-value=0.1 Score=42.23 Aligned_cols=29 Identities=21% Similarity=0.178 Sum_probs=23.3
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEeccCCccc
Q 021891 78 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 108 (306)
Q Consensus 78 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~ 108 (306)
..+||+|+++.|||+++ + ..++||+-++.
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 45899999999999974 3 45789998764
|